@article{ehrmann2026_116822,
  title = {Improvements in Glycemic Control With a Digital Diabetes Logbook : Secondary Analysis of a Randomized Controlled Trial Enriched by Observational, Real-World Data},
  author = {Ehrmann, Dominic and Ruch, Bernhard and Mitter, Michael and Kober, Johanna and Hermanns, Norbert and Schäfer, Vanessa and Kulzer, Bernhard and Silbermann, Stephan},
  year = {2026},
  pages = {1-14},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-irb-116822x},
  url = {https://fis.uni-bamberg.de/handle/uniba/116822},
  language = {eng},
  abstract = {Background: The treatment of diabetes requires substantial self-management. Digital tools can help reduce the burden of self-management and may improve glycemic control.

Objective: This study aims to determine whether the use of a digital diabetes logbook increased the likelihood of achieving optimal glycemic control (glycated hemoglobin [HbA1c] ≤6.5\%) after 3 months, based on a secondary analysis of randomized controlled trial (RCT) data. A secondary objective was to evaluate the long-term impact of the logbook on mean blood glucose levels over 3 and 12 months using observational, real-world data (RWD).

Methods: Data from 342 participants with type 1 or type 2 diabetes enrolled in the mySugr PRO-RCT were analyzed. A robust logistic regression was performed to examine the likelihood of achieving optimal glycemic control, defined as an HbA1c value ≤6.5\% at the 3-month follow-up. The dependent variable was the dichotomous outcome indicating whether this threshold was met. The primary independent variable was group allocation, with baseline HbA1c included as a covariate. For the analysis of RWD, a total of 2861 participants with type 1 or type 2 diabetes were identified using propensity score matching to align their characteristics with those of the RCT participants closely. One-sample t tests were conducted to analyze changes in mean blood glucose separately for each diabetes type, from baseline to 3 months of app use, and from baseline to 12 months of app use (in a subcohort of 1176 participants).

Results: The RCT data showed that the likelihood of achieving optimal glycemic control was nearly doubled in the intervention group compared with the control group (odds ratio 2.24, 95\% CI 1.12-4.47; P=.02). RWD indicated that mean blood glucose levels significantly improved over 3 months of app use in both groups (type 1: –16.3 mg/dL; 95\% CI –20.6 to –12.4; P<.001 and type 2: –27.3 mg/dL, 95\% CI –28.7 to –25.9; P<.001). Participants with an estimated HbA1c>8.5\% at baseline (before app use) showed the greatest reductions in mean blood glucose (type 1: –82.2 mg/dL; 95\% CI –102.0 to –61.8; P<.001; type 2: –104.6 mg/dL, 95\% CI –109.1 to –100.3; P<.001). Long-term analyses revealed a sustained reduction in mean blood glucose over a 12-month period, with a mean decrease of –19.8 mg/dL (95\% CI –21.8 to –17.9; P<.001) after 12 months of app use in the total RWD sample.

Conclusions: The secondary analysis of the RCT demonstrated a significant increase in the likelihood of achieving optimal glycemic control after 3 months of using the mySugr logbook. This finding was supported by observational, real-world data, which showed significant reductions in mean blood glucose after 3 and 12 months of app use—particularly among individuals with elevated baseline HbA1c levels.

Trial Registration: German Clinical Trials Register DRKS00022923; https://drks.de/search/en/trial/DRKS00022923/details},
  keywords = {randomized controlled trial, real-world data, glycemic control, digital health app, type 1 diabetes, type 2 diabetes}
}

@article{lehmann2026_114947,
  title = {Uncovering distinct predictors of diabetes distress and depressive symptoms in a longitudinal survival analysis of incidence and remission : indication for diverging aetiological paths},
  author = {Lehmann, Gina and Ehrmann, Dominic and Olesen, Birgit and Priesterroth, Lilli-Sophie and Kulzer, Bernhard and Haak, Thomas and Hermanns, Norbert},
  year = {2026},
  pages = {1205-1215},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-irb-114947x},
  url = {https://fis.uni-bamberg.de/handle/uniba/114947},
  language = {eng},
  abstract = {Aims/hypothesis:
The aim of the study was to examine the course of diabetes distress and depressive symptoms and their predictors of incidence and remission in individuals with type 1 and type 2 diabetes.

Methods:
Data were collected every 6 months over a 24 month period. Participants (n=654) completed measures of diabetes distress (Problem Areas in Diabetes Scale) and depressive symptoms (Patient Health Questionnaire 8). Cox proportional hazards models were applied to examine predictors of incidence and remission, considering demographic, clinical and psychosocial factors. All predictors were assessed at baseline, except for HbA1c, which was modelled as a time-varying covariate.

Results:
Diabetes distress showed cumulative incident cases in 21\% of the sample and a remission rate of 70\% across 24 months. For depressive symptoms, cumulative 24 month incidence was 33\% and remission was 67\%. The median onset time was 18 months for diabetes distress and 24 months for depressive symptoms; the median remission time for both was 6 months. Higher HbA1c (HR=1.02, p=0.022), female gender (male gender HR=0.55, p=0.043), long-term complications (HR=2.11, p=0.009) and a history of anxiety disorders (HR=2.57, p=0.029) significantly predicted the incidence of diabetes distress, while no predictors were associated with remission. For depressive symptoms, higher HbA1c (HR=1.03, p<0.001), prior depression (HR=2.63, p=0.001) and eating disorders (HR=2.20, p=0.044) predicted incidence. Remission was significantly associated only with older age (HR=1.02, p=0.045).

Conclusions/interpretation:
Suboptimal glycaemic outcomes predicted both diabetes distress and depression; however, diabetes distress was associated with anxiety disorders, whereas depressive symptoms were linked to prior depression and eating disorders, hinting at distinct aetiologies.},
  keywords = {Anxiety disorder, Depression, Diabetes distress, Incidence, Longitudinal, Remission, Survival analysis}
}

@article{lehmann2026_114896,
  title = {Uncovering distinct predictors of diabetes distress and depressive symptoms in a longitudinal survival analysis of incidence and remission : indication for diverging aetiological paths},
  author = {Lehmann, Gina and Ehrmann, Dominic and Olesen, Birgit and Priesterroth, Lilli-Sophie and Kulzer, Bernhard and Haak, Thomas and Hermanns, Norbert},
  year = {2026},
  journal = {Diabetologia : journal of the European Association for the Study of Diabetes (EASD)},
  volume = {69},
  number = {5},
  pages = {1205-1215},
  publisher = {Springer},
  address = {Berlin ; Heidelberg},
  issn = {1432-0428},
  doi = {10.1007/s00125-026-06666-w},
  url = {https://fis.uni-bamberg.de/handle/uniba/114896},
  language = {eng},
  abstract = {Aims/hypothesis:
The aim of the study was to examine the course of diabetes distress and depressive symptoms and their predictors of incidence and remission in individuals with type 1 and type 2 diabetes.

Methods:
Data were collected every 6 months over a 24 month period. Participants (n=654) completed measures of diabetes distress (Problem Areas in Diabetes Scale) and depressive symptoms (Patient Health Questionnaire 8). Cox proportional hazards models were applied to examine predictors of incidence and remission, considering demographic, clinical and psychosocial factors. All predictors were assessed at baseline, except for HbA1c, which was modelled as a time-varying covariate.

Results:
Diabetes distress showed cumulative incident cases in 21\% of the sample and a remission rate of 70\% across 24 months. For depressive symptoms, cumulative 24 month incidence was 33\% and remission was 67\%. The median onset time was 18 months for diabetes distress and 24 months for depressive symptoms; the median remission time for both was 6 months. Higher HbA1c (HR=1.02, p=0.022), female gender (male gender HR=0.55, p=0.043), long-term complications (HR=2.11, p=0.009) and a history of anxiety disorders (HR=2.57, p=0.029) significantly predicted the incidence of diabetes distress, while no predictors were associated with remission. For depressive symptoms, higher HbA1c (HR=1.03, p<0.001), prior depression (HR=2.63, p=0.001) and eating disorders (HR=2.20, p=0.044) predicted incidence. Remission was significantly associated only with older age (HR=1.02, p=0.045).

Conclusions/interpretation:
Suboptimal glycaemic outcomes predicted both diabetes distress and depression; however, diabetes distress was associated with anxiety disorders, whereas depressive symptoms were linked to prior depression and eating disorders, hinting at distinct aetiologies.},
  keywords = {Anxiety disorder, Depression, Diabetes distress, Incidence, Longitudinal, Remission, Survival analysis}
}

@article{ehrmann2026_114285,
  title = {Ecological Momentary Assessment of Person-Reported Outcomes in Diabetes : Unlocking Insights with Continuous Glucose Monitoring and the Potential for Precision Medicine},
  author = {Ehrmann, Dominic and Hermanns, Norbert and Schmitt, Andreas and Klinker, Laura Y. and Kulzer, Bernhard},
  year = {2026},
  pages = {1-16},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-irb-114285x},
  url = {https://fis.uni-bamberg.de/handle/uniba/114285},
  language = {eng},
  abstract = {Purpose of Review:
Diabetes self-management is accompanied by time-varying emotional and motivational challenges that impact mental health. These day-to-day fluctuations can be assessed via ecological momentary assessment (EMA), that allows the repeated sampling of psychosocial variables in everyday life. The benefits of EMA over questionnaires mirror the benefits of continuous glucose monitoring (CGM) over HbA1c. We describe the insights generated by combining EMA and CGM and highlight its potential.

Recent Findings:
Research shows that glucose levels can influence subsequent mood, stress, cognitive functioning, and symptom reporting, with nocturnal hypoglycemia and overnight glucose being particularly relevant. Studies demonstrated the importance of differentiating between subjective person-interpreted and objectively sensor-assessed glucose levels. N-of-1 analyses revealed relevant intraindividual differences in the association between glycemic and psychosocial parameters.

Summary:
Combining EMA and CGM can enhance our understanding of the dynamic relationship between glycemic and psychosocial variables, supporting precision medicine approaches for mental health in diabetes.},
  keywords = {Ecological momentary assessment, Continuous glucose monitoring, Precision medicine, Mental health, Person-reported outcomes}
}

@article{ehrmann2026_114259,
  title = {Ecological Momentary Assessment of Person-Reported Outcomes in Diabetes : Unlocking Insights with Continuous Glucose Monitoring and the Potential for Precision Medicine},
  author = {Ehrmann, Dominic and Hermanns, Norbert and Schmitt, Andreas and Klinker, Laura Y. and Kulzer, Bernhard},
  year = {2026},
  journal = {Current diabetes reports},
  volume = {26},
  number = {1, 4},
  pages = {1-16},
  publisher = {Springer},
  address = {Heidelberg [u.a.]},
  issn = {1539-0829},
  doi = {10.1007/s11892-026-01618-5},
  url = {https://fis.uni-bamberg.de/handle/uniba/114259},
  language = {eng},
  abstract = {Purpose of Review:
Diabetes self-management is accompanied by time-varying emotional and motivational challenges that impact mental health. These day-to-day fluctuations can be assessed via ecological momentary assessment (EMA), that allows the repeated sampling of psychosocial variables in everyday life. The benefits of EMA over questionnaires mirror the benefits of continuous glucose monitoring (CGM) over HbA1c. We describe the insights generated by combining EMA and CGM and highlight its potential.

Recent Findings:
Research shows that glucose levels can influence subsequent mood, stress, cognitive functioning, and symptom reporting, with nocturnal hypoglycemia and overnight glucose being particularly relevant. Studies demonstrated the importance of differentiating between subjective person-interpreted and objectively sensor-assessed glucose levels. N-of-1 analyses revealed relevant intraindividual differences in the association between glycemic and psychosocial parameters.

Summary:
Combining EMA and CGM can enhance our understanding of the dynamic relationship between glycemic and psychosocial variables, supporting precision medicine approaches for mental health in diabetes.},
  keywords = {Ecological momentary assessment, Continuous glucose monitoring, Precision medicine, Mental health, Person-reported outcomes}
}

@article{seufert2026_113086,
  title = {Kontinuierliche Glukosemessung bei Menschen mit Typ-2-Diabetes ohne intensivierte Insulintherapie : eine Standortbestimmung},
  author = {Seufert, Jochen and Dänschel, Ingrid and Gölz, Stefan and Haller, Nicola and Kulzer, Bernhard and Reger-Tan, Susanne and Schnell, Oliver and Wiesner, Tobias and Kroeger, Jens},
  year = {2026},
  pages = {356-368},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-irb-113086x},
  url = {https://fis.uni-bamberg.de/handle/uniba/113086},
  language = {deu},
  abstract = {Zahlreiche Studien haben den klinischen Nutzen der kontinuierlichen Glukosemessung (CGM) bei Menschen mit Typ-1Diabetes belegt, was auch zu einer positiven Empfehlung des Gemeinsamen Bundesausschusses (GBA) für CGM-Systeme bei Menschen mit Diabetes und intensivierter Insulintherapie (ICT/Insulinpumpentherapie) geführt hat. Inzwischen liegen die Ergebnisse zahlreicher randomisierter, beobachtender und retrospektiver Studien zum Einsatz von CGM bei Menschen mit Typ-2-Diabetes und einer nicht intensivierten Insulintherapie (BOT/SIT/CT) oder einer Therapie ohne Insulin vor. In diesem Artikel wird die aktuelle Evidenz zum Einsatz von CGM bei diesen Patientengruppen zusammengefasst und diskutiert. Die Ergebnisse dieser Studien deuten darauf hin, dass CGM auch bei Menschen ohne intensivierte Insulintherapie wirksam ist, um die glykämische Kontrolle zu verbessern und mögliche Nebenwirkungen der Insulintherapie (Hypoglykämien) zu vermeiden.},
  keywords = {CGM, Typ 2 Diabetes, kontinuierliche Glukosemessung, intensivierte Insulintherapie, Basalinsulin unterstützte orale antidiabetische Therapie CGM, Type 2 diabetes, Continuous glucose monitoring, multiple daily injections, Basal insulin supplemented oral antidiabetic therapy}
}

@article{schliess2026_113073,
  title = {The German Fast Track Toward Reimbursement of Digital Health Applications (DiGA) : Opportunities and Challenges for Manufacturers, Healthcare Providers, and People With Diabetes},
  author = {Schliess, Freimut and Affini Dicenzo, Tatiana and Gaus, Nandor and Bourez, Jean-Marc and Stegbauer, Constance and Szecsenyi, Joachim and Jacobsen, Malte and Müller-Wieland, Dirk and Kulzer, Bernhard and Heinemann, Lutz},
  year = {2026},
  pages = {470-476},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-irb-113073x},
  url = {https://fis.uni-bamberg.de/handle/uniba/113073},
  language = {eng},
  abstract = {Background: Digital health applications (DiGA) supporting the management of diabetes are among the most commonly available digital health technologies. However, transparent quality assurance of DiGA and clinical proof of a positive healthcare effect is often missing, which creates skepticism of some stakeholders regarding the usage and reimbursement of these applications. 
Methods: This article reviews the recently established fast-track integration of DiGA in the German reimbursement market, with emphasis on the current impact for manufacturers, healthcare providers, and people with diabetes. The German DiGA fast track is contextualised with corresponding initiatives in Europe. 
Results: The option of a provisional prescription and reimbursement of DiGA while proving a positive healthcare effect in parallel may expedite the adoption of DiGA in Germany and beyond. However, hurdles for a permanent prescription and reimbursement of DiGA are high and only one of 12 that have achieved this status specifically addresses people with diabetes. 
Conclusion: The DiGA fast track needs to be further enhanced to cope with remaining skepticism and contribute even more to a value-based diabetes care.},
  keywords = {clinical trials, digital health, evidence, Germany, reimbursement, value-based healthcare}
}

@article{mader2026_113072,
  title = {Relationship Between Lipohypertrophy, Glycemic Control, and Insulin Dosing : A Systematic Meta-Analysis},
  author = {Mader, Julia K. and Fornengo, Ricardo and Hassoun, Ahmed and Heinemann, Lutz and Kulzer, Bernhard and Monica, Magdalena and Nguyen, Trung and Jochen Sieber and Renard, Eric and Reznik, Yves and Ryś, Przemysław and Stożek-Tutro, Anita and Wilmot, Emma G.},
  year = {2026},
  pages = {351-362},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-irb-113072x},
  url = {https://fis.uni-bamberg.de/handle/uniba/113072},
  language = {eng},
  abstract = {Background: Lipohypertrophy is a common complication in patients with diabetes receiving insulin therapy. There is a lack of consensus regarding how much lipohypertrophy affects diabetes management. Our study aimed to assess the potential correlation between lipohypertrophy and glycemic control, as well as insulin dosing in patients with diabetes. Methods: We performed a systematic review followed by a meta-analysis to collect data about glycemic control and insulin dosing in diabetic patients with and without lipohypertrophy. To identify relevant studies published in English, we searched medical databases (MEDLINE/PubMed, Embase, and CENTRAL) from 1990 to January 20, 2023. An additional hand-search of references was performed to retrieve publications not indexed in medical databases. Results of meta-analyses were presented either as prevalence odds ratios (pORs) or mean differences (MDs) with 95\% confidence intervals (95\% CIs). This study was registered on PROSPERO (CRD42023393103). Results: Of the 5540 records and 240 full-text articles screened, 37 studies fulfilled the prespecified inclusion criteria. Performed meta-analyses showed that patients with lipohypertrophy compared with those without lipohypertrophy were more likely to experience unexplained hypoglycemia (pOR [95\% CI] =6.98 [3.30– 14.77]), overall hypoglycemia (pOR [95\% CI] =6.65 [1.37–32.36]), and glycemic variability (pOR [95\%CI] =5.24 [2.68–10.23]). Patients with lipohypertrophy also had higher HbA1c (MD [95\% CI] =0.55 [0.23–
0.87] \%), and increased daily insulin consumption (MD [95\% CI] =7.68 IU [5.31–10.06]). Conclusions: These results suggest that overall glycemic control is worse in patients with lipohypertrophy than in those without this condition.},
  keywords = {Diabetes, Glycemic Control, Insulin-injection technique, Lipohypertrophy, Meta-analysis, Systematic review}
}

@article{kulzer2026_113063,
  title = {Nocturnal Hypoglycemia in the Era of Continuous Glucose Monitoring},
  author = {Kulzer, Bernhard and Freckmann, Guido and Ziegler, Ralph and Schnell, Oliver and Glatzer, Timor and Heinemann, Lutz},
  year = {2026},
  pages = {1052-1060},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-irb-113063x},
  url = {https://fis.uni-bamberg.de/handle/uniba/113063},
  language = {eng},
  abstract = {Nocturnal hypoglycemia is a common acute complication of people with diabetes on insulin therapy. In particular, the inability to control glucose levels during sleep, the impact of external factors such as exercise, or alcohol and the influence of hormones are the main causes. Nocturnal hypoglycemia has several negative somatic, psychological, and social effects for people with diabetes, which are summarized in this article. With the advent of continuous glucose monitoring (CGM), it has been shown that the number of nocturnal hypoglycemic events was significantly underestimated when traditional blood glucose monitoring was used. The CGM can reduce the number of nocturnal hypoglycemia episodes with the help of alarms, trend arrows, and evaluation routines. In combination with CGM with an insulin pump and an algorithm, automatic glucose adjustment (AID) systems have their particular strength in nocturnal glucose regulation and the prevention of nocturnal hypoglycemia. Nevertheless, the problem of nocturnal hypoglycemia has not yet been solved completely with the technologies currently available. The CGM systems that use predictive models to warn of hypoglycemia, improved AID systems that recognize hypoglycemia patterns even better, and the increasing integration of artificial intelligence methods are promising approaches in the future to significantly minimize the risk of a side effect of insulin therapy that is burdensome for people with diabetes.},
  keywords = {diabetes, nocturnal hypoglycemia, continuous glucose monitoring, predictive models}
}

@article{hermanns2026_113062,
  title = {Einstellung zur Insulinpumpentherapie bei Menschen mit Typ-1-Diabetes sechs Monate nach Umstellung im Vergleich zu mehrfach täglichen Insulininjektionen : Eine Beobachtungstudie},
  author = {Hermanns, Norbert and Ehrmann, Dominic and Kulzer, Bernhard and Kalt, Lucas and Seufert, Jochen},
  year = {2026},
  pages = {426-432},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-irb-113062x},
  url = {https://fis.uni-bamberg.de/handle/uniba/113062},
  language = {deu},
  abstract = {Hintergrund Obwohl die Insulinpumpentherapie (CSII) derzeit im Vergleich zur Insulininjektionstherapie eine deutlich physiologischere Methode der Insulinsubstitution darstellt, wenden in Deutschland im Vergleich zu anderen Ländern weniger Menschen mit einem Typ-1-Diabetes diese Therapieform an. Eine Bedeutung könnten hierbei psychologische Faktoren wie Erwartungen und Einstellungen gegenüber einer Insulinpumpentherapie zukommen. In dieser nicht-interventionellen Beobachtungsstudie wurden die Einstellungen zur Insulinpumpentherapie erwachsener Insulinpumpenträger 6 Monate nach Neueinstellung mit Erwachsenen mit einer mehrfachen täglichen Insulininjektionstherapie (MDI) verglichen. 
Methoden Einstellungen zur CSII-Therapie wurden mit dem Insulin Pump Attitudes Questionnaire (IPA-Q) erfasst, sowohl bei Teilnehmern der YES-Studie, einer nicht-interventionellen Post Market Surveillance Study zur Effektivität und Sicherheit der mylife YpsoPump (ohne Hybrid-Closed-Loop Algorithmus ( = CSII-Nutzer), als auch bei MDI-Anwendern der IPA-Q-Evaluierungsstudie. 
Ergebnisse Es wurden die Fragebogendaten von n = 191 Teilnehmern (CSII-Nutzer: n = 81 Teilnehmer der YES-Studie; MDI-Nutzer: n = 110 Teilnehmer der IPA-Q Evaluierungsstudie) ausgewertet. CSII-Nutzer, die eine mylife YpsoPump verwenden, standen 6 Monate nach der Neueinstellung oder Umstellung auf eine CSII-Therapie einer solchen signifikant positiver gegenüber als Nutzer einer MDI-Therapie, während gleichzeitig weniger Nachteile der Insulinpumpentherapie berichtet wurden. 
Schlussfolgerungen Diese Studie zeigt eine hohe Relevanz psychologischer Faktoren für die Akzeptanz und Implementierung einer Insulinpumpentherapie. Strukturierte Diabetesschulungen für Menschen mit Typ-1-Diabetes und eine gute technische Einweisung bei Personen, die sich für eine Insulinpumpentherapie entschieden haben, können dazu beitragen, unrealistische Erwartungen und inadäquate negative Einstellungen zur Insulinpumpentherapie abzubauen.},
  keywords = {-}
}

@article{eichenlaub2026_113061,
  title = {Characteristics of Nocturnal Hypoglycaemic Events and Their Impact on Glycaemia},
  author = {Eichenlaub, Manuel and Öter, Sükrü and Waldenmaier, Delia and Kulzer, Bernd and Heinemann, Lutz and Ziegler, Ralph and Schnell, Oliver and Glatzer, Timor and Freckmann, Guido},
  year = {2026},
  pages = {1035-1043},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-irb-113061x},
  url = {https://fis.uni-bamberg.de/handle/uniba/113061},
  language = {eng},
  abstract = {Background: Nocturnal hypoglycaemia is a burden for people with diabetes, particularly when treated with multiple daily injections (MDI) therapy. However, the characteristics of nocturnal hypoglycaemic events in this patient group are only poorly described in the literature.
Method: Continuous glucose monitoring (CGM) data from 185 study participants with type 1 diabetes using MDI therapy were collected under everyday conditions for up to 13 weeks. Hypoglycaemic events were identified as episodes of consecutive CGM readings <70 mg/dl or <54 mg/dl for at least 15 minutes. Subsequently, the time <54 mg/dl (TB54), time below range (TBR), time in range (TIR), time above range (TAR), glucose coefficient of variation (CV), and incidence of hypoglycaemic events were calculated for diurnal and nocturnal periods. Furthermore, the effect of nocturnal hypoglycaemic events on glucose levels the following day was assessed.
Results: The incidence of hypoglycaemic events <70 mg/dl was significantly lower during the night compared to the day, with 0.8 and 3.8 events per week, respectively, while the TBR, TB54, and incidence of events with CGM readings <54 mg/ dl was not significantly different. Nocturnal hypoglycaemic events <70 mg/dl were significantly longer (60 vs 35 minutes) and enveloped by less rapidly changing glucose levels. On days following nights containing hypoglycaemic events, there was a decrease in TAR, mean CGM glucose level and morning glucose levels and an increase in TB54, TBR, and CV.
Conclusions: The results showed that nocturnal hypoglycaemic events are a common occurrence in persons with type 1 diabetes using MDI with significant differences between the characteristics of nocturnal and diurnal events.},
  keywords = {nocturnal hypoglycaemia, time below range, hypoglycaemic event incidence, glycemic variability, somogyi effect}
}

@article{hermanns2026_113139,
  title = {Independent associations of mental health and diabetes complications with health‐related quality of life : Evidence from a cross‐sectional study},
  author = {Hermanns, Norbert and Kittel, Philip and Cerletti, Paco and Kulzer, Bernhard and Ehrmann, Dominic},
  year = {2026},
  pages = {2383-2392},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-irb-113139x},
  url = {https://fis.uni-bamberg.de/handle/uniba/113139},
  language = {eng},
  abstract = {Aims:
Health-related quality of life (HRQoL) is a key patient-reported outcome in diabetes care, yet the extent to which somatic and psychological factors are associated with HRQoL remains unclear. This study examined how demographic, diabetes-related, medical, and psychological factors were independently associated with HRQoL in adults with diabetes.

Materials and Methods:
A cross-sectional online survey was conducted among adults with diabetes in Germany (September 2024–February 2025). HRQoL was assessed using the EuroQol 5-Dimension 5-Level questionnaire (EQ-5D-5L). Participants also completed the PHQ-8 for depressive symptoms, the problem areas in diabetes (PAID) scale, and the hypoglycaemia fear survey (HFS-II). Clinical variables were self-reported and included diabetes type, duration, HbA1c, body mass index (BMI), and complications. Tobit regression accounted for the censored EQ-5D distribution. Blockwise multivariable models evaluated incremental explained variance across demographic, diabetes-related, comorbidity, and mental-health domains.

Results:
Of 1581 invitees, 734 completed the EQ-5D (mean age 56 ± 14 years; 73\% type I). In multivariable analyses, female sex (β = −0.045), higher BMI (β = −0.029), diabetic foot syndrome (β = −0.078), neuropathy (β = −0.123), and elevated depressive symptoms (β = −0.212), diabetes distress (β = −0.069), and fear of hypoglycaemia (β = −0.085) were all independently associated with lower EQ-5D utilities (p < 0.01). Mental-health variables explained a similar proportion of variance (≈22\%) as diabetes-related complications (≈20\%). Mental health factors like depression, diabetes distress, and fear of hypoglycaemia showed highly significant associations with reduced HRQoL by up to 27\%.

Conclusions:
Both diabetes complications and mental health determine HRQoL in people with diabetes. Depression emerged as the strongest independent predictor reducing HRQoL by up to 21\%. This underscores the importance of mental health for HRQoL. This findings highlight the relevance of integrating mental health assessment into diabetes management.},
  keywords = {health economics, observational study, patient reported outcomes, real-world evidence}
}

@article{hermanns2026_113106,
  title = {Independent associations of mental health and diabetes complications with health‐related quality of life : Evidence from a cross‐sectional study},
  author = {Hermanns, Norbert and Kittel, Philip and Cerletti, Paco and Kulzer, Bernhard and Ehrmann, Dominic},
  year = {2026},
  journal = {Diabetes, obesity and metabolism},
  volume = {28},
  number = {3},
  pages = {2383-2392},
  publisher = {Wiley-Blackwell},
  address = {Oxford [u.a.]},
  issn = {1463-1326},
  doi = {10.1111/dom.70434},
  url = {https://fis.uni-bamberg.de/handle/uniba/113106},
  language = {eng},
  abstract = {Aims:
Health-related quality of life (HRQoL) is a key patient-reported outcome in diabetes care, yet the extent to which somatic and psychological factors are associated with HRQoL remains unclear. This study examined how demographic, diabetes-related, medical, and psychological factors were independently associated with HRQoL in adults with diabetes.

Materials and Methods:
A cross-sectional online survey was conducted among adults with diabetes in Germany (September 2024–February 2025). HRQoL was assessed using the EuroQol 5-Dimension 5-Level questionnaire (EQ-5D-5L). Participants also completed the PHQ-8 for depressive symptoms, the problem areas in diabetes (PAID) scale, and the hypoglycaemia fear survey (HFS-II). Clinical variables were self-reported and included diabetes type, duration, HbA1c, body mass index (BMI), and complications. Tobit regression accounted for the censored EQ-5D distribution. Blockwise multivariable models evaluated incremental explained variance across demographic, diabetes-related, comorbidity, and mental-health domains.

Results:
Of 1581 invitees, 734 completed the EQ-5D (mean age 56 ± 14 years; 73\% type I). In multivariable analyses, female sex (β = −0.045), higher BMI (β = −0.029), diabetic foot syndrome (β = −0.078), neuropathy (β = −0.123), and elevated depressive symptoms (β = −0.212), diabetes distress (β = −0.069), and fear of hypoglycaemia (β = −0.085) were all independently associated with lower EQ-5D utilities (p < 0.01). Mental-health variables explained a similar proportion of variance (≈22\%) as diabetes-related complications (≈20\%). Mental health factors like depression, diabetes distress, and fear of hypoglycaemia showed highly significant associations with reduced HRQoL by up to 27\%.

Conclusions:
Both diabetes complications and mental health determine HRQoL in people with diabetes. Depression emerged as the strongest independent predictor reducing HRQoL by up to 21\%. This underscores the importance of mental health for HRQoL. This findings highlight the relevance of integrating mental health assessment into diabetes management.},
  keywords = {health economics, observational study, patient reported outcomes, real-world evidence}
}

@article{herder2026_112913,
  title = {Biomarkers of inflammation and improvement in depressive symptoms in type 1 and type 2 diabetes : differential associations with depressive symptom clusters},
  author = {Herder, Christian and Zhu, Anna and Schmitt, Andreas and Spagnuolo, Maria C. and Kulzer, Bernhard and Roden, Michael and Ehrmann, Dominic and Hermanns, Norbert},
  year = {2026},
  pages = {2057-2068},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-irb-112913x},
  url = {https://fis.uni-bamberg.de/handle/uniba/112913},
  language = {eng},
  abstract = {Aims/hypothesis:
People with diabetes and depression show large heterogeneity in their response to depression treatment. This study aimed to identify biomarkers of subclinical inflammation that were associated with improvement of depressive symptoms in people with type 1 diabetes and type 2 diabetes.

Methods:
The prospective analysis combined data from three studies (DIAMOS, ECCE HOMO and DDCT). A total of 332 people with type 1 diabetes and 189 people with type 2 diabetes completed both the baseline and 1 year follow-up examinations. Depressive symptoms were assessed using the Center for Epidemiological Studies depression scale (CES-D). Associations between baseline serum levels of 76 biomarkers of inflammation and 1 year changes in depressive symptoms were estimated using multiple linear regression.

Results:
In people with type 2 diabetes, higher levels of 26 biomarkers were associated with greater reductions in depressive symptoms (β=0.128 to 0.255; p<0.05), whereas in people with type 1 diabetes, higher levels of 13 biomarkers were linked with lower reductions in depressive symptoms (β=−0.189 to −0.094; p<0.05). A significant effect modification was observed for 33 biomarkers (pinteraction<0.05). The positive associations in type 2 diabetes were strongest for improvements in cognitive-affective and anhedonia symptoms, while the inverse associations in type 1 diabetes were strongest for improvements in somatic symptoms.

Conclusions/interpretation:
Higher baseline levels of multiple biomarkers of inflammation were associated with greater depression reduction in type 2 diabetes but lower depression reduction in type 1 diabetes. There were also diabetes type-specific differences in the associations with symptom clusters of depression. This suggests that different inflammation-related pathways may be relevant for the response to depression treatment in people with type 1 diabetes or type 2 diabetes.},
  keywords = {Biomarker, CES-D, Depression, Depressive symptoms, Diabetes, Inflammation, Treatment response, Type 1 diabetes, Type 2 diabetes}
}

@article{regertan2025_116847,
  title = {Digitalization in Diabetology},
  author = {Reger-Tan, Susanne and Deml, Angelika and Ickrath, Manuel and Kröger, Jens and Kulzer, Bernhard and Petry, Friedhelm and Scheper, Nikolaus and Schubert-Olesen, Oliver and Schwarz, Peter and Tews, Dietrich and Verket, Marlo and Vite, Sabrina and Wiesner, Tobias and Müller-Wieland, Dirk},
  year = {2025},
  journal = {Experimental and clinical endocrinology \& diabetes},
  volume = {133},
  number = {04},
  pages = {197-204},
  publisher = {Thieme},
  address = {Stuttgart [u.a.]},
  issn = {1439-3646},
  doi = {10.1055/a-2490-5192},
  url = {https://fis.uni-bamberg.de/handle/uniba/116847},
  language = {eng}
}

@article{ehrmann2025_116737,
  title = {Improvements in Glycemic Control With a Digital Diabetes Logbook : Secondary Analysis of a Randomized Controlled Trial Enriched by Observational, Real-World Data},
  author = {Ehrmann, Dominic and Ruch, Bernhard and Mitter, Michael and Kober, Johanna and Hermanns, Norbert and Schäfer, Vanessa and Kulzer, Bernhard and Silbermann, Stephan},
  year = {2025},
  journal = {Journal of Medical Internet Research},
  volume = {27},
  number = {e68933},
  pages = {1-14},
  publisher = {JMIR Publications},
  address = {Richmond, Va.},
  issn = {1438-8871},
  doi = {10.2196/68933},
  url = {https://fis.uni-bamberg.de/handle/uniba/116737},
  language = {eng},
  abstract = {Background: The treatment of diabetes requires substantial self-management. Digital tools can help reduce the burden of self-management and may improve glycemic control.

Objective: This study aims to determine whether the use of a digital diabetes logbook increased the likelihood of achieving optimal glycemic control (glycated hemoglobin [HbA1c] ≤6.5\%) after 3 months, based on a secondary analysis of randomized controlled trial (RCT) data. A secondary objective was to evaluate the long-term impact of the logbook on mean blood glucose levels over 3 and 12 months using observational, real-world data (RWD).

Methods: Data from 342 participants with type 1 or type 2 diabetes enrolled in the mySugr PRO-RCT were analyzed. A robust logistic regression was performed to examine the likelihood of achieving optimal glycemic control, defined as an HbA1c value ≤6.5\% at the 3-month follow-up. The dependent variable was the dichotomous outcome indicating whether this threshold was met. The primary independent variable was group allocation, with baseline HbA1c included as a covariate. For the analysis of RWD, a total of 2861 participants with type 1 or type 2 diabetes were identified using propensity score matching to align their characteristics with those of the RCT participants closely. One-sample t tests were conducted to analyze changes in mean blood glucose separately for each diabetes type, from baseline to 3 months of app use, and from baseline to 12 months of app use (in a subcohort of 1176 participants).

Results: The RCT data showed that the likelihood of achieving optimal glycemic control was nearly doubled in the intervention group compared with the control group (odds ratio 2.24, 95\% CI 1.12-4.47; P=.02). RWD indicated that mean blood glucose levels significantly improved over 3 months of app use in both groups (type 1: –16.3 mg/dL; 95\% CI –20.6 to –12.4; P<.001 and type 2: –27.3 mg/dL, 95\% CI –28.7 to –25.9; P<.001). Participants with an estimated HbA1c>8.5\% at baseline (before app use) showed the greatest reductions in mean blood glucose (type 1: –82.2 mg/dL; 95\% CI –102.0 to –61.8; P<.001; type 2: –104.6 mg/dL, 95\% CI –109.1 to –100.3; P<.001). Long-term analyses revealed a sustained reduction in mean blood glucose over a 12-month period, with a mean decrease of –19.8 mg/dL (95\% CI –21.8 to –17.9; P<.001) after 12 months of app use in the total RWD sample.

Conclusions: The secondary analysis of the RCT demonstrated a significant increase in the likelihood of achieving optimal glycemic control after 3 months of using the mySugr logbook. This finding was supported by observational, real-world data, which showed significant reductions in mean blood glucose after 3 and 12 months of app use—particularly among individuals with elevated baseline HbA1c levels.

Trial Registration: German Clinical Trials Register DRKS00022923; https://drks.de/search/en/trial/DRKS00022923/details},
  keywords = {randomized controlled trial, real-world data, glycemic control, digital health app, type 1 diabetes, type 2 diabetes}
}

@article{penfornis2025_110667,
  title = {European Survey on Adults with Type 1 Diabetes and their Caregivers : Insights into Personal Experience and Needs for Improving Diabetes Care},
  author = {Penfornis, Alfred and Down, Su and Seignez, Antoine and Vives, Alizé and Bonnemaire, Mireille and Kulzer, Bernhard},
  year = {2025},
  pages = {471-484},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-irb-110667x},
  url = {https://fis.uni-bamberg.de/handle/uniba/110667},
  language = {eng},
  abstract = {Introduction: Type 1 diabetes (T1D) requires constant self-management and substantially impacts daily life. We surveyed the experiences/ burdens of people with T1D (PWD) and their caregivers. 
Methods: An online survey of PWD/caregivers (aged ≥ 18 years) living in fve European countries was conducted from July to August 2021. The survey included questions on the impact of T1D on physical and mental abilities, the frequency of hypoglycemic and hyperglycemic episodes and the impact of T1D on the daily lives of PWD.
Results: Respondents included 458 PWD and 54 caregivers. The main impacts of T1D included fatigue (50\% of PWD rated a high/very high impact), a hindrance to daily activities (43\%), feeling different than others (42\%), and anxiety (40\%). The perceived impact of complication risk was signifcantly lower for PWD paying more attention to controlling their disease (p<0.001). Most caregivers (80\%) reported feeling more anxious than the PWD about their T1D complications. Hypoglycemia/hyperglycemia was a signifcant predictor of perceived distress owing to T1D. Most PWD (68\%) would have liked more psychological support. Over half of respondents (PWD: 53\%, caregivers: 56\%) felt they had insufficient knowledge about T1D. Acceptance, positivity, and self-organization are the main strategies recommended by PWD/ caregivers for living with T1D.
Conclusions: T1D remains a signifcant burden for PWD/caregivers, and more educational and psychological support for T1D management is required.},
  keywords = {Burden, Complications, Diabetes distress, Hyperglycemia, Hypoglycemia, Type 1 diabetes}
}

@article{herder2025_110513,
  title = {Association between pro- and anti-inflammatory cytokines and depressive symptoms in patients with diabetes : potential differences by diabetes type and depression scores},
  author = {Herder, Christian and Schmitt, Andreas and Budden, Florian and Reimer, André and Kulzer, Bernhard and Roden, Michael and Haak, Thomas and Hermanns, Norbert},
  year = {2025},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-irb-110513x},
  url = {https://fis.uni-bamberg.de/handle/uniba/110513},
  language = {eng},
  abstract = {Subclinical inflammation has been implicated in the development of depression, a common comorbidity of type 1 diabetes (T1D) and type 2 diabetes (T2D). This study aimed to characterise the relationships between biomarkers of inflammation and depressive symptoms in T1D and T2D. Biomarkers of inflammation were measured in serum of participants with elevated depressive symptoms and T1D (n = 389, mean age 38 years, diabetes duration 15 ± 11 years) or T2D (n = 204, mean age 56 years, diabetes duration 13 ± 8 years). Subclinical depression was examined using three questionnaires (Center for Epidemiologic Studies Depression [CES-D], Patient Health Questionnaire-9 [PHQ-9], 5-item World Health Organization Well-Being Index [WHO-5]). In T1D, levels of interleukin-1 receptor antagonist (IL-1RA) were positively associated with two depression scores (CES-D, PHQ-9), and high-sensitivity C-reactive protein (hsCRP) was positively associated with depression for one score (WHO-5) after adjustment for age, sex, body mass index, diabetes duration, metabolic variables, medication and comorbidities (P = 0.008-0.042). In T2D, IL-18 and IL-1RA were positively associated with depression for two scores (IL-18: PHQ-9, WHO-5; IL-1RA: CES-D, WHO-5), hsCRP was associated with one depression score (PHQ-9), and adiponectin showed an inverse association with one depression score (PHQ-9) after adjustment (P = 0.006–0.048). No associations were found for IL-6 and CC-chemokine ligand 2 (CCL2). In conclusion, we observed associations between hsCRP, IL-1RA and depressive symptoms in patients with diabetes. In T2D, there was additional evidence for associations of IL-18 and (inversely) adiponectin with depressive symptoms. The strength of the associations appeared to depend on diabetes type and the method used to asssess depressive symptoms.},
  keywords = {-}
}

@article{roos2025_111972,
  title = {Effect of automated insulin delivery systems on person-reported outcomes in people with diabetes : a systematic review and meta-analysis},
  author = {Roos, Timm and Hermanns, Norbert and Groß, Christopher and Kulzer, Bernhard and Haak, Thomas and Ehrmann, Dominic},
  year = {2025},
  pages = {1-18},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-irb-111972x},
  url = {https://fis.uni-bamberg.de/handle/uniba/111972},
  language = {eng},
  abstract = {Background:
Conclusive evidence on the benefits of automated insulin delivery (AID) systems on person-reported outcomes (PROs) is missing.

Methods:
In this systematic review and meta-analysis, four databases (PubMed, PsycINFO, Cochrane, and GoogleScholar) were searched from inception up to August 7th, 2024. All types of studies were included if studies reported on PROs in people with diabetes using an AID system. All types of control groups in randomised controlled trials (RCT) were included. Summary data were extracted by three reviewers. Main outcomes focused on diabetes distress, fear of hypoglycaemia and quality of life. Meta-analyses were conducted for RCTs and observational studies separately. When five or more studies could be pooled, random-effects meta-analysis was used, otherwise common-effects meta-analysis was used. Risk of bias was evaluated with Cochrane tools. This study was registered with PROSPERO, CRD42022352502.

Findings:
A total of 62 studies (n = 9253) were included reporting on 45 different questionnaires. Twenty-seven studies were RCTs and 25 were observational studies. RCT meta-analyses showed reduced diabetes distress (standardised mean difference [95\% CI]: −0.159 [−0.309, −0.010], I2 = 23.0\%), reduced fear of hypoglycaemia (−0.339 [−0.566, −0.111], I2 = 42.6\%), and improved hypoglycaemia unawareness (−0.231 [−0.424, −0.037], I2 = 0.0\%), quality of life in adults (0.347 [0.134, 0.560], I2 = 0.0\%) and children/adolescents (0.249 [0.050, 0.448], I2 = 0.0\%). Observational meta-analyses corroborated improvements in diabetes distress (−0.217 [−0.403, −0.031], I2 = 68.5\%), fear of hypoglycaemia (−0.445 [−0.540, −0.349], I2 = 0.0\%), hypoglycaemia unawareness (−0.212 [−0.419, −0.004], I2 = 0.0\%), and showed improved sleep quality (−0.158 [−0.255, −0.061], I2 = 0.0\%).

Interpretation:
We found low to moderate effect sizes indicating that AID therapy is associated with reduced burden and improved well-being in people with diabetes. Evidence comes from both RCTs and observational studies. However, for some PROs only a limited number of studies could be pooled with a large heterogeneity in questionnaires used. More research is needed with a more uniformed assessment of PROs to demonstrate the added value of AID therapy on psychosocial outcomes.},
  keywords = {Diabetes mellitus, Automated insulin delivery, Person-reported outcomes, Meta-analysis, Systematic review}
}

@article{herder2025_111635,
  title = {Biomarkers of inflammation and improvement in depressive symptoms in type 1 and type 2 diabetes : differential associations with depressive symptom clusters},
  author = {Herder, Christian and Zhu, Anna and Schmitt, Andreas and Spagnuolo, Maria C. and Kulzer, Bernhard and Roden, Michael and Ehrmann, Dominic and Hermanns, Norbert},
  year = {2025},
  journal = {Diabetologia},
  volume = {68},
  number = {9},
  pages = {2057-2068},
  publisher = {Springer},
  address = {Berlin ; Heidelberg},
  issn = {1432-0428},
  doi = {10.1007/s00125-025-06472-w},
  url = {https://fis.uni-bamberg.de/handle/uniba/111635},
  language = {eng},
  abstract = {Aims/hypothesis:
People with diabetes and depression show large heterogeneity in their response to depression treatment. This study aimed to identify biomarkers of subclinical inflammation that were associated with improvement of depressive symptoms in people with type 1 diabetes and type 2 diabetes.

Methods:
The prospective analysis combined data from three studies (DIAMOS, ECCE HOMO and DDCT). A total of 332 people with type 1 diabetes and 189 people with type 2 diabetes completed both the baseline and 1 year follow-up examinations. Depressive symptoms were assessed using the Center for Epidemiological Studies depression scale (CES-D). Associations between baseline serum levels of 76 biomarkers of inflammation and 1 year changes in depressive symptoms were estimated using multiple linear regression.

Results:
In people with type 2 diabetes, higher levels of 26 biomarkers were associated with greater reductions in depressive symptoms (β=0.128 to 0.255; p<0.05), whereas in people with type 1 diabetes, higher levels of 13 biomarkers were linked with lower reductions in depressive symptoms (β=−0.189 to −0.094; p<0.05). A significant effect modification was observed for 33 biomarkers (pinteraction<0.05). The positive associations in type 2 diabetes were strongest for improvements in cognitive-affective and anhedonia symptoms, while the inverse associations in type 1 diabetes were strongest for improvements in somatic symptoms.

Conclusions/interpretation:
Higher baseline levels of multiple biomarkers of inflammation were associated with greater depression reduction in type 2 diabetes but lower depression reduction in type 1 diabetes. There were also diabetes type-specific differences in the associations with symptom clusters of depression. This suggests that different inflammation-related pathways may be relevant for the response to depression treatment in people with type 1 diabetes or type 2 diabetes.},
  keywords = {Biomarker, CES-D, Depression, Depressive symptoms, Diabetes, Inflammation, Treatment response, Type 1 diabetes, Type 2 diabetes}
}

@article{linnenkamp2025_110970,
  title = {PHQ-9, CES-D, health insurance data : who is identified with depression? ; A Population-based study in persons with diabetes},
  author = {Linnenkamp, Ute and Gontscharuk, Veronika and Ogurtsova, Katherine and Brüne, Manuela and Chernyak, Nadezda and Kvitkina, Tatjana and Arend, Werner and Schmitz-Losem, Imke and Kruse, Johannes and Hermanns, Norbert and Kulzer, Bernd and Evers, Silvia M. A. A. and Hiligsmann, Mickaël and Hoffmann, Barbara and Icks, Andrea and Andrich, Silke},
  year = {2025},
  pages = {1-13},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-irb-110970x},
  url = {https://fis.uni-bamberg.de/handle/uniba/110970},
  language = {eng},
  abstract = {Aims:
Several instruments are used to identify depression among patients with diabetes and have been compared for their test criteria, but, not for the overlaps and differences, for example, in the sociodemographic and clinical characteristics of the individuals identified with different instruments.

Methods:
We conducted a cross-sectional survey among a random sample of a statutory health insurance (SHI) (n = 1,579) with diabetes and linked it with longitudinal SHI data. Depression symptoms were identified using either the Centre for Epidemiological Studies Depression (CES-D) scale or the Patient Health Questionnaire-9 (PHQ-9), and a depressive disorder was identified with a diagnosis in SHI data, resulting in 8 possible groups. Groups were compared using a multinomial logistic model.

Results:
In total 33·0\% of our analysis sample were identified with depression by at least one method. 5·0\% were identified with depression by all methods. Multinomial logistic analysis showed that identification through SHI data only compared to the group with no depression was associated with gender (women). Identification through at least SHI data was associated with taking antidepressants and previous depression. Health related quality of life, especially the mental summary score was associated with depression but not when identified through SHI data only.

Conclusion:
The methods overlapped less than expected. We did not find a clear pattern between methods used and characteristics of individuals identified. However, we found first indications that the choice of method is related to specific underlying characteristics in the identified population. These findings need to be confirmed by further studies with larger study samples.},
  keywords = {Depressive disorder diagnosis, Depressive disorder epidemiology, Diabetes Mellitus Type 2 psychology, Diabetes complications}
}

@article{heinemann2025_110969,
  title = {Needle Technology for Insulin Administration : A Century of Innovation},
  author = {Heinemann, Lutz and Nguyen, Trung and Bailey, Timothy S. and Hassoun, Ahmed and Kulzer, Bernd and Oliveria, Teresa and Reznik, Yves and de Valk, Harold W. and Mader, Julia K.},
  year = {2025},
  pages = {449-457},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-irb-110969x},
  url = {https://fis.uni-bamberg.de/handle/uniba/110969},
  language = {eng},
  abstract = {Innovations in syringe and pen needle (PN) technology over the last 100 years have led to important advances in insulin delivery for people with diabetes, paralleling the strides made in developing recombinant DNA human insulin and insulin analogs with varying onset and duration of action. In this review, the history of advances in insulin delivery is described, focusing on progress in syringe, needle, and PN technologies. The early glass and metal syringes that required sterilization by boiling have been replaced by disposable, single-use syringes or pens with clear labeling for precise insulin dosing. The early needles ranging in length from 19 to 26 mm that required manual sharpening against a whetstone have been replaced by syringe needles of 6 mm and PNs of 4 mm in length as slender as 34 gauge. Imaging studies using ultrasound and computed tomography measured the thickness of skin and subcutaneous tissue layers to show feasibility of targeted insulin administration with shorter needles. These developments, coupled with innovations in needle/PN wall and tip structure, have led to improved injection experience for people with diabetes. It is also important to acknowledge the role of injection technique education, together with these advances in injection technology, for improving clinical outcomes and patient satisfaction. With continued projected growth of diabetes prevalence, particularly in developing countries where expensive and complex insulin delivery systems may not be practical, insulin syringes and pens will continue to serve as reliable and cost-effective means of insulin delivery for people with diabetes.},
  keywords = {insulin administration, insulin therapy, needle length, insulin pen, subcutaneous, syringe}
}

@article{lunkenheimer2025_110967,
  title = {Posttraumatic stress disorder and diabetes-related outcomes in patients with type 1 diabetes},
  author = {Lunkenheimer, Frederike and Eckert, Alexander J. and Hilgard, Dörte and Köth, Daniel and Kulzer, Bernhard and Lück, Ursula and Lüdecke, Blanca and Müller, Antonia and Baumeister, Harald and Holl, Reinhard W.},
  year = {2025},
  pages = {1-11},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-irb-110967x},
  url = {https://fis.uni-bamberg.de/handle/uniba/110967},
  language = {eng},
  abstract = {Mental comorbidities in patients with type 1 diabetes mellitus (T1D) are common, and can have a negative impact on acute blood glucose levels and long-term metabolic control. Information on the association of T1D and comorbid posttraumatic stress disorder (PTSD) with diabetes-related outcomes is limited. The aim was to examine the associations between a clinical diagnosis of PTSD and diabetes-related outcomes in patients with T1D. Patients with T1D and comorbid documented PTSD from the DPV database (n = 179) were compared to a group with T1D without PTSD (n = 895), and compared to a group with T1D without comorbid mental disorder (n = 895) by matching demographics (age, gender, duration of diabetes, therapy and migration background) 1:5. Clinical diabetes-related outcomes \{body mass index (BMI), hemoglobin A1c (hbA1c), daily insulin dose, diabetic ketoacidosis (DKA), hypoglycemia, number of hospital admissions, number of hospital days\} were analyzed, stratified by age groups (≤ 25 years vs. > 25 years). Patients with comorbid PTSD aged ≤ 25 years compared with patients without PTSD or patients without mental disorders had significantly higher HbA1c (8.71 vs. 8.30 or 8.24\%), higher number of hospital admissions (0.94 vs. 0.44 or 0.32 per year) and higher rates of DKA (0.10 vs. 0.02 or 0.01 events/year). Patients with comorbid PTSD aged ≤ 25 years compared with patients without PTSD had significantly higher BMI (0.85 vs. 0.59) and longer hospital stays (15.89 vs.11.58 days) than patients without PTSD. Patients with PTSD > 25 years compared with patients without PTSD or without any mental comorbidities had significantly fewer hospital admissions (0.49 vs. 0.77 or 0.69), but a longer hospital length of stay (20.35 vs. 11.58 or 1.09 days). We found that PTSD in younger patients with T1D is significantly related to diabetes outcome. In adult patients with T1D, comorbid PTSD is associated with fewer, but longer hospitalizations. Awareness of PTSD in the care of patients with T1D should be raised and psychological intervention should be provided when necessary.},
  keywords = {diabetes}
}

@article{klinker2025_109915,
  title = {Detecting clinical cases of binge eating in diabetes care : Introducing the Diabetes Eating Problem Survey-10 (DEPS-10) for type 1 and type 2 diabetes},
  author = {Klinker, Laura Yvonne and Schmitt, Andreas and Ehrmann, Dominic and Kulzer, Bernhard and Hermanns, Norbert},
  year = {2025},
  pages = {1-10},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-irb-109915x},
  url = {https://fis.uni-bamberg.de/handle/uniba/109915},
  language = {eng},
  abstract = {Aims:
Binge eating disorders (BED) are underdiagnosed in diabetes care, despite being the most common eating problem for diabetes patients. While diabetes-specific screening for disordered eating behaviour is recommended, the only diabetes-specific instrument available, Diabetes Eating Problem Survey-Revised (DEPS-R), focuses on type 1 diabetes and rapid-acting insulin, limiting its use across diabetes types and treatment regimens. This study aimed to develop a non-insulin version of the DEPS-R and evaluate its screening performance for BED in people with type 1 and type 2 diabetes.

Methods:
The DEPS-R was reduced to 10 non-insulin-specific items (DEPS-10). As part of the ongoing pro-mental study, 679 people with type 1 or type 2 diabetes completed the baseline survey and took part in diagnostic interviews to assess BED. The screening performance of the DEPS-10 was tested via receiver operating characteristic (ROC) curve analysis and compared with DEPS-R and food-related items of the Problem Areas In Diabetes (PAID).

Results:
N = 24 participants (total = 3.5\%; type 1 = 2.9\%, type 2 = 4.3\%) were diagnosed with a current BED. The DEPS-10 performed well in screening for BED (area under the curve [AUC] = 0.92, p < 0.001) comparable with the DEPS-R (AUC = 0.92, p < 0.001) and exceeded the performance of food-related PAID items (AUC = 0.82, p < 0.001). A cut-off score of ≥15 showed optimal sensitivity and specificity in BED screening. People who met the cut-off had significantly higher BMI and HbA1c and more diabetes distress, depressive and anxiety symptoms.

Conclusions:
DEPS-10 is a reliable screening instrument for BED. Its associations with glycaemic and mental health outcomes reflect its good construct validity comparable to DEPS-R.},
  keywords = {assessment tool, binge eating disorder, diabetes mellitus, disordered eating behaviour, questionnaire, screening}
}

@article{klinker2025_109873,
  title = {Detecting clinical cases of binge eating in diabetes care : Introducing the Diabetes Eating Problem Survey-10 (DEPS-10) for type 1 and type 2 diabetes},
  author = {Klinker, Laura Yvonne and Schmitt, Andreas and Ehrmann, Dominic and Kulzer, Bernhard and Hermanns, Norbert},
  year = {2025},
  journal = {Diabetic medicine},
  volume = {42},
  number = {8, e70060},
  pages = {1-10},
  publisher = {Wiley},
  address = {Chichester [u.a.]},
  issn = {1464-5491},
  doi = {10.1111/dme.70060},
  url = {https://fis.uni-bamberg.de/handle/uniba/109873},
  language = {eng},
  abstract = {Aims:
Binge eating disorders (BED) are underdiagnosed in diabetes care, despite being the most common eating problem for diabetes patients. While diabetes-specific screening for disordered eating behaviour is recommended, the only diabetes-specific instrument available, Diabetes Eating Problem Survey-Revised (DEPS-R), focuses on type 1 diabetes and rapid-acting insulin, limiting its use across diabetes types and treatment regimens. This study aimed to develop a non-insulin version of the DEPS-R and evaluate its screening performance for BED in people with type 1 and type 2 diabetes.

Methods:
The DEPS-R was reduced to 10 non-insulin-specific items (DEPS-10). As part of the ongoing pro-mental study, 679 people with type 1 or type 2 diabetes completed the baseline survey and took part in diagnostic interviews to assess BED. The screening performance of the DEPS-10 was tested via receiver operating characteristic (ROC) curve analysis and compared with DEPS-R and food-related items of the Problem Areas In Diabetes (PAID).

Results:
N = 24 participants (total = 3.5\%; type 1 = 2.9\%, type 2 = 4.3\%) were diagnosed with a current BED. The DEPS-10 performed well in screening for BED (area under the curve [AUC] = 0.92, p < 0.001) comparable with the DEPS-R (AUC = 0.92, p < 0.001) and exceeded the performance of food-related PAID items (AUC = 0.82, p < 0.001). A cut-off score of ≥15 showed optimal sensitivity and specificity in BED screening. People who met the cut-off had significantly higher BMI and HbA1c and more diabetes distress, depressive and anxiety symptoms.

Conclusions:
DEPS-10 is a reliable screening instrument for BED. Its associations with glycaemic and mental health outcomes reflect its good construct validity comparable to DEPS-R.},
  keywords = {assessment tool, binge eating disorder, diabetes mellitus, disordered eating behaviour, questionnaire, screening}
}

@article{schmitt2025_109679,
  title = {Assessing diabetes self-management with the Diabetes Self-Management Questionnaire (DSMQ) can help analyse behavioural problems related to reduced glycaemic control},
  author = {Schmitt, Andreas and Reimer, André and Hermanns, Norbert and Huber, Jörg and Ehrmann, Dominic and Schall, Sabine and Kulzer, Bernhard},
  year = {2025},
  pages = {1-12},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-irb-109679x},
  url = {https://fis.uni-bamberg.de/handle/uniba/109679},
  language = {eng},
  abstract = {Aim: To appraise the Diabetes Self-Management Questionnaire (DSMQ)’s measurement of diabetes self-management as a statistical predictor of glycaemic control relative to the widely used SDSCA.

Methods: 248 patients with type 1 diabetes and 182 patients with type 2 diabetes were cross-sectionally assessed using the two self-report measures of diabetes self-management DSMQ and SDSCA; the scales were used as competing predictors of HbA1c. We developed a structural equation model of self-management as measured by the DSMQ and analysed the amount of variation explained in HbA1c; an analogue model was developed for the SDSCA.

Results: The structural equation models of self-management and glycaemic control showed very good fit to the data. The DSMQ’s measurement of self-management showed associations with HbA1c of –0.53 for type 1 and –0.46 for type 2 diabetes (both P < 0.001), explaining 21\% and 28\% of variation in glycaemic control, respectively. The SDSCA’s measurement showed associations with HbA1c of –0.14 (P = 0.030) for type 1 and –0.31 (P = 0.003) for type 2 diabetes, explaining 2\% and 10\% of glycaemic variation. Predictive power for glycaemic control was significantly higher for the DSMQ (P < 0.001).

Conclusions: This study supports the DSMQ as the preferred tool when analysing self-reported behavioural problems related to reduced glycaemic control. The scale may be useful for clinical assessments of patients with suboptimal diabetes outcomes or research on factors affecting associations between self-management behaviours and glycaemic control.},
  keywords = {Diabetes melitus, HbA1c, Type 2 diabetes, Blood sugar, Behavior, Patients, Diet, Pychometrics}
}

@article{hermanns2025_109419,
  title = {The impact of a structured education and treatment programme (FLASH) for people with diabetes using a flash sensor-based glucose monitoring system : Results of a randomized controlled trial},
  author = {Hermanns, Norbert and Ehrmann, Dominic and Schipfer, Melanie and Kröger, Jens and Haak, Thomas and Kulzer, Bernhard},
  year = {2025},
  pages = {111-121},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-irb-109419x},
  url = {https://fis.uni-bamberg.de/handle/uniba/109419},
  language = {eng},
  abstract = {Aims: Flash sensor-based glucose monitoring (FSGM) provides people with diabetes considerably more information on their glycaemic control. We have developed and evaluated a structured education and treatment programme, termed FLASH, to assist FSGM users to understand and use the available glycaemic information for optimization of their diabetes treatment.

Methods: We report on a multi-centre, randomized, parallel trial with a six-month follow-up involving 216 eligible participants (16–75 years old) on intensive insulin therapy. The primary outcome was HbA1c change from baseline to six months. Secondary outcomes were measures of glucose control as assessed by FSGM, as well as changes in behavioural and psychosocial measures.

Results: At six months, the between-group difference in HbA1c reduction was significant, favouring FLASH education compared to the control group receiving no FLASH education (−0.28\%, 95\% CI −0.16\% to −0.40\% vs.−0.11\%, 95\% CI 0.00\% to −0.22\%; with a between-group difference of −0.17\%, 95\% CI −0.01\% to −0.33\%; p = 0.033). Participation in FLASH education also resulted in significant improvements in time spent in the target glucose range, in diabetes-related distress scores and in satisfaction with the glucose monitoring method. FLASH education also resulted in significant improvements in the use of glycaemic information provided by FSGM and in reduced self-monitoring of blood glucose (SMBG) fingerstick testing.},
  keywords = {Diabetes, Flash glucose monitoring, Education, Self-management}
}

@article{hermanns2025_108387,
  title = {Continuous glucose monitoring as equinox of nocturnal and daytime hypoglycaemia in type 1 diabetes : insights from the randomized controlled HypoDE trial},
  author = {Hermanns, Norbert and Heinemann, Lutz and Kulzer, Bernhard and Schäfer, Arne and Jacobsen, Malte and Ehrmann, Dominic},
  year = {2025},
  pages = {1-8},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-irb-1083871},
  url = {https://fis.uni-bamberg.de/handle/uniba/108387},
  language = {eng},
  abstract = {Aims:
This study re-analysed data from the HypoDE trial to assess the prevalence of nocturnal hypoglycaemia, evaluate the impact of continuous glucose monitoring (CGM) on nocturnal and daytime hypoglycaemia, and explore their influence on severe hypoglycaemia (SH).

Methods:
The HypoDE trial was a randomized controlled trial involving 141 adults with type 1 diabetes, impaired hypoglycaemia awareness, or prior SH. Participants were randomized to CGM (Dexcom G5) or self-monitoring of blood glucose (control). Outcomes included the percentage of time spent in hypoglycaemia (<3.9 mmol/L, <3.0 mmol/L), episode duration, and SH incidence.

Results:
At baseline, nocturnal hypoglycaemia (<3.0 mmol/L) exposure exceeded daytime by 1.4 percentage points (95 \% CI 0.6–2.2; p < 0.002), with episodes lasting 30.7 min longer (CI 21.5–39.9). Using CGM, these differences disappeared (<3.0 mmol/L: 0.3 percentage points, CI 0.7–1.3), while they persisted in the control group. Daytime hypoglycaemia significantly increased SH risk (IRR 1.10 per percentage point, CI 1.01–1.21; IRR 1.04 per minute, CI 1.01–1.07).

Conclusions:
CGM effectively reduced nocturnal and daytime hypoglycaemia. Without CGM, nocturnal hypoglycaemia contributes to daytime risks, while daytime hypoglycaemia elevates SH risk. Expanding CGM access and addressing nocturnal hypoglycaemia in resource-limited settings are critical.

Trial registrationClinicaltrials.gov: NCT02671968.},
  keywords = {Diabetestechnology, Continuous glucose monitoring, Nocturnal hypoglycaemia, Severe hypoglycemia}
}

@article{hermanns2025_108385,
  title = {Continuous glucose monitoring as equinox of nocturnal and daytime hypoglycaemia in type 1 diabetes : insights from the randomized controlled HypoDE trial},
  author = {Hermanns, Norbert and Heinemann, Lutz and Kulzer, Bernhard and Schäfer, Arne and Jacobsen, Malte and Ehrmann, Dominic},
  year = {2025},
  journal = {Diabetes research and clinical practice},
  volume = {224},
  number = {112228},
  pages = {1-8},
  publisher = {Elsevier},
  address = {Amsterdam},
  issn = {1872-8227},
  doi = {10.1016/j.diabres.2025.112228},
  url = {https://fis.uni-bamberg.de/handle/uniba/108385},
  language = {eng},
  abstract = {Aims:
This study re-analysed data from the HypoDE trial to assess the prevalence of nocturnal hypoglycaemia, evaluate the impact of continuous glucose monitoring (CGM) on nocturnal and daytime hypoglycaemia, and explore their influence on severe hypoglycaemia (SH).

Methods:
The HypoDE trial was a randomized controlled trial involving 141 adults with type 1 diabetes, impaired hypoglycaemia awareness, or prior SH. Participants were randomized to CGM (Dexcom G5) or self-monitoring of blood glucose (control). Outcomes included the percentage of time spent in hypoglycaemia (<3.9 mmol/L, <3.0 mmol/L), episode duration, and SH incidence.

Results:
At baseline, nocturnal hypoglycaemia (<3.0 mmol/L) exposure exceeded daytime by 1.4 percentage points (95 \% CI 0.6–2.2; p < 0.002), with episodes lasting 30.7 min longer (CI 21.5–39.9). Using CGM, these differences disappeared (<3.0 mmol/L: 0.3 percentage points, CI 0.7–1.3), while they persisted in the control group. Daytime hypoglycaemia significantly increased SH risk (IRR 1.10 per percentage point, CI 1.01–1.21; IRR 1.04 per minute, CI 1.01–1.07).

Conclusions:
CGM effectively reduced nocturnal and daytime hypoglycaemia. Without CGM, nocturnal hypoglycaemia contributes to daytime risks, while daytime hypoglycaemia elevates SH risk. Expanding CGM access and addressing nocturnal hypoglycaemia in resource-limited settings are critical.

Trial registrationClinicaltrials.gov: NCT02671968.},
  keywords = {Diabetestechnology, Continuous glucose monitoring, Nocturnal hypoglycaemia, Severe hypoglycemia}
}

@article{schmid2025_107014,
  title = {Psychosocial Impact of the COVID-19 Pandemic on People With Type 1 Diabetes : Results of an Ecological Momentary Assessment Study},
  author = {Schmid, Fabienne and Schmitt, Andreas Jürgen and Hermanns, Norbert and Kulzer, Bernhard and Ehrmann, Dominic},
  year = {2025},
  pages = {1-10},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-irb-1070145},
  url = {https://fis.uni-bamberg.de/handle/uniba/107014},
  language = {eng},
  abstract = {-},
  keywords = {diabetes distress, depression, COVID-19-related burden, ecological momentary assessment, COVID-19 incidence rate}
}

@article{regertan2025_107529,
  title = {Digitalisierung in der Diabetologie},
  author = {Reger-Tan, Susanne and Deml, Angelika and Ickrath, Manuel and Kröger, Jens and Kulzer, Bernhard and Petry, Friedhelm and Scheper, Nikolaus and Schubert-Olesen, Oliver and Schwarz, Peter and Tews, Dietrich and Verket, Marlo and Vite, Sabrina and Wiesner, Tobias and Müller-Wieland, Dirk},
  year = {2025},
  journal = {Die Diabetologie : Organ der Deutschen Gesellschaft für Innere Medizin, des Berufsverbandes Deutscher Internistinnen und Internisten, des Berufsverbandes Deutscher Endokrinologen und der Arbeitsgemeinschaft niedergelassener diabetologisch Tätiger Ärzte e.V.},
  volume = {21},
  number = {2},
  pages = {166-174},
  publisher = {Springer Medizin Verlag GmbH},
  address = {Berlin},
  issn = {2731-7455},
  doi = {10.1007/s11428-024-01278-7},
  url = {https://fis.uni-bamberg.de/handle/uniba/107529},
  language = {deu}
}

@article{penfornis2025_107522,
  title = {European Survey on Adults with Type 1 Diabetes and their Caregivers : Insights into Personal Experience and Needs for Improving Diabetes Care},
  author = {Penfornis, Alfred and Down, Su and Seignez, Antoine and Vives, Alizé and Bonnemaire, Mireille and Kulzer, Bernhard},
  year = {2025},
  journal = {Diabetes therapy : research, treatment and education of diabetes and related disorders},
  volume = {16},
  number = {4},
  pages = {471-484},
  publisher = {Springer Healthcare Communications},
  address = {New York, NY [u.a.]},
  issn = {1869-6961},
  doi = {10.1007/s13300-024-01685-5},
  url = {https://fis.uni-bamberg.de/handle/uniba/107522},
  language = {eng},
  abstract = {Introduction: Type 1 diabetes (T1D) requires constant self-management and substantially impacts daily life. We surveyed the experiences/ burdens of people with T1D (PWD) and their caregivers. 
Methods: An online survey of PWD/caregivers (aged ≥ 18 years) living in fve European countries was conducted from July to August 2021. The survey included questions on the impact of T1D on physical and mental abilities, the frequency of hypoglycemic and hyperglycemic episodes and the impact of T1D on the daily lives of PWD.
Results: Respondents included 458 PWD and 54 caregivers. The main impacts of T1D included fatigue (50\% of PWD rated a high/very high impact), a hindrance to daily activities (43\%), feeling different than others (42\%), and anxiety (40\%). The perceived impact of complication risk was signifcantly lower for PWD paying more attention to controlling their disease (p<0.001). Most caregivers (80\%) reported feeling more anxious than the PWD about their T1D complications. Hypoglycemia/hyperglycemia was a signifcant predictor of perceived distress owing to T1D. Most PWD (68\%) would have liked more psychological support. Over half of respondents (PWD: 53\%, caregivers: 56\%) felt they had insufficient knowledge about T1D. Acceptance, positivity, and self-organization are the main strategies recommended by PWD/ caregivers for living with T1D.
Conclusions: T1D remains a signifcant burden for PWD/caregivers, and more educational and psychological support for T1D management is required.},
  keywords = {Burden, Complications, Diabetes distress, Hyperglycemia, Hypoglycemia, Type 1 diabetes}
}

@article{herder2025_105977,
  title = {Associations between biomarkers of inflammation and depressive symptoms : potential differences between diabetes types and symptom clusters of depression},
  author = {Herder, Christian and Zhu, Anna and Schmitt, Andreas and Spagnuolo, Maria C. and Kulzer, Bernhard and Roden, Michael and Hermanns, Norbert and Ehrmann, Dominic},
  year = {2025},
  pages = {1-9},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-irb-1059775},
  url = {https://fis.uni-bamberg.de/handle/uniba/105977},
  language = {eng},
  abstract = {Inflammation is a probable biological pathway underlying the relationship between diabetes and depression, but data on differences between diabetes types and symptom clusters of depression are scarce. Therefore, this cross-sectional study aimed to compare associations of a multimarker panel of biomarkers of inflammation with depressive symptoms and its symptom clusters between people with type 1 diabetes (T1D) and type 2 diabetes (T2D). This cross-sectional study combined data from five studies including 1260 participants (n = 706 T1D, n = 454 T2D). Depressive symptoms were assessed using the Center for Epidemiological Studies-Depression Scale (CES-D). Serum levels of 92 biomarkers of inflammation were quantified with proximity extension assay technology. After quality control, 76 biomarkers of inflammation remained for statistical analysis. Associations between biomarkers and depressive symptom scores and clusters (cognitive-affective, somatic, anhedonia) were estimated with multivariable linear regression models. Nine biomarkers were positively associated with depressive symptoms in the total sample (CCL11/eotaxin, CCL25, CDCP1, FGF-21, IL-8, IL-10RB, IL-18, MMP-10, TNFRSF9; all p < 0.05) without interaction by diabetes type. Associations differed for eight biomarkers (pinteraction < 0.05). TNFβ was inversely associated with depressive symptoms in T1D, whereas three biomarkers (GDNF, IL-18R1, LIF-R) were positively associated with depressive symptoms in T2D. For the remaining four biomarkers (CD6, CD244, FGF-5, IFNγ) associations were not significant in either subgroup. Biomarker associations were more pronounced with somatic and anhedonia than with cognitive-affective symptoms. These results indicate that different proinflammatory pathways may contribute to depression in T1D and T2D and that there may be a symptom specificity in the link between subclinical inflammation and depression.},
  keywords = {Diabetes mellitus, Depression, Inflammation}
}

@article{ehrmann2025_107021,
  title = {Perceived glucose levels matter more than CGM-based data in predicting diabetes distress in type 1 or type 2 diabetes : a precision mental health approach using n-of-1 analyses},
  author = {Ehrmann, Dominic and Hermanns, Norbert and Schmitt, Andreas and Klinker, Laura and Haak, Thomas and Kulzer, Bernhard},
  year = {2025},
  pages = {2433-2445},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-irb-1070210},
  url = {https://fis.uni-bamberg.de/handle/uniba/107021},
  language = {eng},
  abstract = {Aims/hypothesis:
Diabetes distress is one of the most frequent mental health issues identified in people with type 1 and type 2 diabetes. Little is known about the role of glucose control as a potential contributor to diabetes distress and whether the subjective perception of glucose control or the objective glycaemic parameters are more important for the experience. With the emergence of continuous glucose monitoring (CGM), this is a relevant question as glucose values are now visible in real-time. We employed a precision monitoring approach to analyse the independent associations of perceived and measured glucose control with diabetes distress on a daily basis. By using n-of-1 analyses, we aimed to identify individual contributors to diabetes distress per person and analyse the associations of these individual contributors with mental health at a 3 month follow-up.

Methods:
In this prospective, observational study, perceived (hypoglycaemia/hyperglycaemia/glucose variability burden) and measured glucose control (time in hypoglycaemia and hyperglycaemia, CV) were assessed daily for 17 days using an ecological momentary assessment (EMA) approach with a special EMA app and CGM, respectively. Mixed-effect regression analysis was performed, with daily diabetes distress as the dependent variable and daily perceived and CGM-measured metrics of glucose control as random factors. Individual regression coefficients of daily distress with perceived and CGM-measured metrics were correlated with levels of psychosocial well-being at a 3 month follow-up.

Results:
Data from 379 participants were analysed (50.9\% type 1 diabetes; 49.6\% female). Perceived glucose variability (t=14.360; p<0.0001) and perceived hyperglycaemia (t=13.637; p<0.0001) were the strongest predictors of daily diabetes distress, while CGM-based glucose variability was not significantly associated (t=1.070; p=0.285). There was great heterogeneity between individuals in the associations of perceived and measured glucose parameters with diabetes distress. Individuals with a stronger association between perceived glucose control and daily distress had more depressive symptoms (β=0.32), diabetes distress (β=0.39) and hypoglycaemia fear (β=0.34) at follow-up (all p<0.001). Individuals with a stronger association between CGM-measured glucose control and daily distress had higher levels of psychosocial well-being at follow-up (depressive symptoms: β=−0.31; diabetes distress: β=−0.33; hypoglycaemia fear: β=−0.27; all p<0.001) but also higher HbA1c (β=0.12; p<0.05).

Conclusions/interpretation:
Overall, subjective perceptions of glucose seem to be more influential on diabetes distress than objective CGM parameters of glycaemic control. N-of-1 analyses showed that CGM-measured and perceived glucose control had differential associations with diabetes distress and psychosocial well-being 3 months later. The results highlight the need to understand the individual drivers of diabetes distress to develop personalised interventions within a precision mental health approach.},
  keywords = {Continuous glucose monitoring, Diabetes distress, Ecological momentary assessment, Precision mental health, Precision monitoring}
}

@article{hermanns2025_107073,
  title = {Somatic and mental symptoms associated with dysglycaemia, diabetes‐related complications and mental conditions in people with diabetes : Assessments in daily life using continuous glucose monitoring and ecological momentary assessment},
  author = {Hermanns, Norbert and Ehrmann, Dominic and Kulzer, Bernhard and Klinker, Laura and Haak, Thomas and Schmitt, Andreas},
  year = {2025},
  pages = {61-70},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-irb-1070734},
  url = {https://fis.uni-bamberg.de/handle/uniba/107073},
  language = {eng},
  abstract = {Aim:
To analyse the potential drivers (glucose level, complications, diabetes type, gender, age and mental health) of diabetes symptoms using continuous glucose monitoring (CGM) and ecological momentary assessment.

Materials and Methods:
Participants used a smartphone application to rate 25 diabetes symptoms in their daily lives over 8 days. These symptoms were grouped into four blocks so that each symptom was rated six times on 2 days (noon, afternoon and evening). The symptom ratings were associated with the glucose levels for the previous 2 hours, measured with CGM. Linear mixed-effects models were used, allowing for nested random effects and the conduct of N = 1 analysis of individual associations.

Results:
In total, 192 individuals with type 1 diabetes and 179 with type 2 diabetes completed 6380 app check-ins. Four symptoms showed a significant negative association with glucose values, indicating higher ratings at lower glucose (speech difficulties, P = .003; coordination problems, P = .00005; confusion, P = .049; and food cravings, P = .0003). Four symptoms showed a significant positive association with glucose values, indicating higher scores at higher glucose (thirst, P = .0001; urination, P = .0003; taste disturbances, P = .021; and itching, P = .0120). There were also significant positive associations between microangiopathy and eight symptoms. Elevated depression and diabetes distress were associated with higher symptom scores. N = 1 analysis showed highly idiosyncratic associations between symptom reports and glucose levels.

Conclusions:
The N = 1 analysis facilitated the creation of personalized symptom profiles related to glucose levels with consideration of factors such as complications, gender, body mass index, depression and diabetes distress. This approach can enhance precision monitoring for diabetes symptoms in precision medicine.},
  keywords = {continuous glucose monitoring, hypoglycaemia, patient-reported outcomes, type 1 diabetes, type 2 diabetes}
}

@article{herder2025_106806,
  title = {Associations between biomarkers of inflammation and depressive symptoms : potential differences between diabetes types and symptom clusters of depression},
  author = {Herder, Christian and Zhu, Anna and Schmitt, Andreas and Spagnuolo, Maria C. and Kulzer, Bernhard and Roden, Michael and Hermanns, Norbert and Ehrmann, Dominic},
  year = {2025},
  journal = {Translational Psychiatry},
  volume = {15},
  number = {1, 9},
  pages = {1-9},
  publisher = {Nature Publishing Group},
  address = {London},
  issn = {2158-3188},
  doi = {10.1038/s41398-024-03209-y},
  url = {https://fis.uni-bamberg.de/handle/uniba/106806},
  language = {eng},
  abstract = {Inflammation is a probable biological pathway underlying the relationship between diabetes and depression, but data on differences between diabetes types and symptom clusters of depression are scarce. Therefore, this cross-sectional study aimed to compare associations of a multimarker panel of biomarkers of inflammation with depressive symptoms and its symptom clusters between people with type 1 diabetes (T1D) and type 2 diabetes (T2D). This cross-sectional study combined data from five studies including 1260 participants (n = 706 T1D, n = 454 T2D). Depressive symptoms were assessed using the Center for Epidemiological Studies-Depression Scale (CES-D). Serum levels of 92 biomarkers of inflammation were quantified with proximity extension assay technology. After quality control, 76 biomarkers of inflammation remained for statistical analysis. Associations between biomarkers and depressive symptom scores and clusters (cognitive-affective, somatic, anhedonia) were estimated with multivariable linear regression models. Nine biomarkers were positively associated with depressive symptoms in the total sample (CCL11/eotaxin, CCL25, CDCP1, FGF-21, IL-8, IL-10RB, IL-18, MMP-10, TNFRSF9; all p < 0.05) without interaction by diabetes type. Associations differed for eight biomarkers (pinteraction < 0.05). TNFβ was inversely associated with depressive symptoms in T1D, whereas three biomarkers (GDNF, IL-18R1, LIF-R) were positively associated with depressive symptoms in T2D. For the remaining four biomarkers (CD6, CD244, FGF-5, IFNγ) associations were not significant in either subgroup. Biomarker associations were more pronounced with somatic and anhedonia than with cognitive-affective symptoms. These results indicate that different proinflammatory pathways may contribute to depression in T1D and T2D and that there may be a symptom specificity in the link between subclinical inflammation and depression.},
  keywords = {Diabetes mellitus, Depression, Inflammation}
}

@article{ehrmann2025_105979,
  title = {Real-Life Wear Time and Reasons for Reduced Wear Time of Glucose Sensors of CGM Systems : Findings from the DiaLink Panel},
  author = {Ehrmann, Dominic and Olesen, Birgit and Roos, Timm and Kulzer, Bernhard and Hermanns, Norbert and Heinemann, Lutz},
  year = {2025},
  journal = {Journal of Diabetes Science and Technology},
  publisher = {Sage Publishing},
  address = {London},
  issn = {1932-2968},
  doi = {10.1177/19322968241310889},
  url = {https://fis.uni-bamberg.de/handle/uniba/105979},
  language = {eng}
}

@article{ehrmann2025_104721,
  title = {Efficacy of a Digital Diabetes Logbook for People With Type 1, Type 2, and Gestational Diabetes : Results From a Multicenter, Open-Label, Parallel-Group, Randomized Controlled Trial},
  author = {Ehrmann, Dominic and Hermanns, Norbert and Finke-Gröne, Katharina and Roos, Timm and Kober, Johanna and Schäfer, Vanessa and Haak, Thomas Jürgen and Krichbaum, Michael and Ziegler, Ralph and Heinemann, Lutz and Rieger, Cosima and Bingol, Ezgi and Kulzer, Bernhard and Silbermann, Stephan},
  year = {2025},
  journal = {Journal of Diabetes Science and Technology : JDST},
  volume = {19},
  number = {5},
  pages = {1362-1373},
  publisher = {Sage Publishing},
  address = {London},
  issn = {1932-2968},
  doi = {10.1177/19322968241239870},
  url = {https://fis.uni-bamberg.de/handle/uniba/104721},
  language = {eng}
}

@article{thomas2025_104722,
  title = {How to Use Continuous Glucose Monitoring Efficiently in Diabetes Management : Opinions and Recommendations by German Experts on the Status and Open Questions},
  author = {Thomas, Andreas and Haak, Thomas Jürgen and Tombek, Astrid and Kulzer, Bernhard and Ehrmann, Dominic and Kordonouri, Olga and Kröger, Jens and Schubert-Olesen, Oliver and Kolassa, Ralf and Siegmund, Thorsten and Haller, Nicola and Heinemann, Lutz},
  year = {2025},
  journal = {Journal of Diabetes Science and Technology : JDST},
  volume = {19},
  number = {6},
  pages = {1671-1680},
  publisher = {Sage Publishing},
  address = {London},
  issn = {1932-2968},
  doi = {10.1177/19322968241267768},
  url = {https://fis.uni-bamberg.de/handle/uniba/104722},
  language = {eng}
}

@article{hermanns2025_104723,
  title = {Somatic and mental symptoms associated with dysglycaemia, diabetes‐related complications and mental conditions in people with diabetes : Assessments in daily life using continuous glucose monitoring and ecological momentary assessment},
  author = {Hermanns, Norbert and Ehrmann, Dominic and Kulzer, Bernhard and Klinker, Laura and Haak, Thomas and Schmitt, Andreas},
  year = {2025},
  journal = {Diabetes, Obesity and Metabolism},
  volume = {27},
  number = {1},
  pages = {61-70},
  publisher = {Wiley-Blackwell},
  address = {Oxford},
  issn = {1463-1326},
  doi = {10.1111/dom.15983},
  url = {https://fis.uni-bamberg.de/handle/uniba/104723},
  language = {eng},
  abstract = {Aim:
To analyse the potential drivers (glucose level, complications, diabetes type, gender, age and mental health) of diabetes symptoms using continuous glucose monitoring (CGM) and ecological momentary assessment.

Materials and Methods:
Participants used a smartphone application to rate 25 diabetes symptoms in their daily lives over 8 days. These symptoms were grouped into four blocks so that each symptom was rated six times on 2 days (noon, afternoon and evening). The symptom ratings were associated with the glucose levels for the previous 2 hours, measured with CGM. Linear mixed-effects models were used, allowing for nested random effects and the conduct of N = 1 analysis of individual associations.

Results:
In total, 192 individuals with type 1 diabetes and 179 with type 2 diabetes completed 6380 app check-ins. Four symptoms showed a significant negative association with glucose values, indicating higher ratings at lower glucose (speech difficulties, P = .003; coordination problems, P = .00005; confusion, P = .049; and food cravings, P = .0003). Four symptoms showed a significant positive association with glucose values, indicating higher scores at higher glucose (thirst, P = .0001; urination, P = .0003; taste disturbances, P = .021; and itching, P = .0120). There were also significant positive associations between microangiopathy and eight symptoms. Elevated depression and diabetes distress were associated with higher symptom scores. N = 1 analysis showed highly idiosyncratic associations between symptom reports and glucose levels.

Conclusions:
The N = 1 analysis facilitated the creation of personalized symptom profiles related to glucose levels with consideration of factors such as complications, gender, body mass index, depression and diabetes distress. This approach can enhance precision monitoring for diabetes symptoms in precision medicine.},
  keywords = {continuous glucose monitoring, hypoglycaemia, patient-reported outcomes, type 1 diabetes, type 2 diabetes}
}

@inproceedings{hermanns2024_110194,
  title = {960-P: Perceived Consequences of AID Systems for the Care of People with Diabetes in Switzerland, Austria, and Germany},
  author = {Hermanns, Norbert and Ehrmann, Dominic and Roos, Timm and Heinemann, Lutz and Kulzer, Bernhard},
  year = {2024},
  volume = {73},
  number = {Supplement\_1},
  pages = {960-P},
  address = {Alexandria, Va},
  issn = {1939-327X},
  doi = {10.2337/db24-960-p},
  url = {https://fis.uni-bamberg.de/handle/uniba/110194},
  language = {eng}
}

@inproceedings{ehrmann2024_110195,
  title = {968-P: Factors Associated with the Decision to Use an Implantable AID System},
  author = {Ehrmann, Dominic and Finke-Groene, Katharina and Kulzer, Bernhard and Hermanns, Norbert},
  year = {2024},
  volume = {73},
  number = {Supplement\_1},
  pages = {968-P},
  address = {Alexandria, Va},
  issn = {1939-327X},
  doi = {10.2337/db24-968-p},
  url = {https://fis.uni-bamberg.de/handle/uniba/110195},
  language = {eng}
}

@inproceedings{eichenlaub2024_110198,
  title = {Characteristics of nocturnal hypoglycaemic events and their impact on glycaemia in people with type 1 diabetes},
  author = {Eichenlaub, Manuel and Öter, Sükrü and Waldenmaier, Delia and Kulzer, Bernhard and Heinemann, Lutz and Ziegler, Ralph and Schnell, O. and Glatzer, T. and Freckmann, G.},
  year = {2024},
  volume = {67},
  number = {S1},
  pages = {S409},
  publisher = {Springer},
  address = {Berlin ; Heidelberg},
  issn = {1432-0428},
  doi = {10.1007/s00125-024-06226-0},
  url = {https://fis.uni-bamberg.de/handle/uniba/110198},
  language = {eng}
}

@inproceedings{ehrmann2024_110199,
  title = {Prevalence and incidence of elevated diabetes distress and depressive symptoms at 6, 12 and 18-months in people with diabetes : a cox-regression analysis},
  author = {Ehrmann, Dominic and Lehmann, G. and Olesen, B. and Priesterroth, Lilli-Sophie and Roos, Timm and Haak, Thomas and Hermanns, Norbert and Kulzer, Bernhard},
  year = {2024},
  volume = {67},
  number = {S1},
  pages = {S417-S418},
  publisher = {Springer},
  address = {Berlin ; Heidelberg},
  issn = {1432-0428},
  doi = {10.1007/s00125-024-06226-0},
  url = {https://fis.uni-bamberg.de/handle/uniba/110199},
  language = {eng}
}

@inproceedings{kulzer2024_110200,
  title = {Can AID systems reduce diabetes-related stress?},
  author = {Kulzer, Bernhard and Ehrmann, Dominic and Heinemann, Lutz and Faber-Heinemann, Gabriele and Roos, Timm and Resl, M. and Mader, J. and Diem, Peter and Truempy, C. and Brandt, D. and Hermanns, Norbert},
  year = {2024},
  volume = {67},
  number = {S1},
  pages = {S419},
  publisher = {Springer},
  address = {Berlin ; Heidelberg},
  issn = {1432-0428},
  doi = {10.1007/s00125-024-06226-0},
  url = {https://fis.uni-bamberg.de/handle/uniba/110200},
  language = {eng}
}

@inproceedings{herder2024_110201,
  title = {Diabetes type-specific associations between baseline levels of biomarkers of inflammation and changes in depressive symptoms in three intervention studies},
  author = {Herder, Christian and Zhu, A. and Spagnuolo, M. and Kulzer, Bernhard and Roden, Michael and Ehrmann, Dominic and Hermanns, Norbert and Schmitt, A.},
  year = {2024},
  volume = {67},
  number = {S1},
  pages = {S466},
  publisher = {Springer},
  address = {Berlin ; Heidelberg},
  issn = {1432-0428},
  doi = {10.1007/s00125-024-06226-0},
  url = {https://fis.uni-bamberg.de/handle/uniba/110201},
  language = {eng}
}

@inproceedings{roos2024_110202,
  title = {Verbesserung des psychosozialen Wohlbefindens durch AID-Systeme: eine Meta-Analyse randomisierter kontrollierter Studien},
  author = {Roos, Timm and Groß, Christopher and Hermanns, Norbert and Kulzer, Bernhard and Haak, Thomas and Ehrmann, Dominic},
  year = {2024},
  volume = {19},
  number = {S 01},
  pages = {S14},
  publisher = {Thieme},
  address = {Stuttgart},
  issn = {1861-9002},
  doi = {10.1055/s-0044-1785258},
  url = {https://fis.uni-bamberg.de/handle/uniba/110202},
  language = {deu}
}

@inproceedings{mader2024_110203,
  title = {Relationship between lipohypertrophy, glycemic control, and insulin dosing: a systematic meta-analysis},
  author = {Mader, Julia K. and Fornengo, Ricardo and Hassoun, Ahmed and Heinemann, Lutz and Kulzer, Bernhard and Monica, Magdalena and Nguyen, Trung and Sieber, Jochen and Renard, Eric and Reznik, Yves and Ryś, Przemysław and Stożek-Tutro, Anita and Wilmot, Emma G.},
  year = {2024},
  volume = {19},
  number = {S 01},
  pages = {S31},
  publisher = {Thieme},
  address = {Stuttgart},
  issn = {1861-9002},
  doi = {10.1055/s-0044-1785292},
  url = {https://fis.uni-bamberg.de/handle/uniba/110203},
  language = {deu}
}

@inproceedings{kulzer2024_110208,
  title = {Bedeutung und Nutzung der Videoschulung},
  author = {Kulzer, Bernhard and Hermanns, Norbert and Ehrmann, Dominic and Roos, Timm and Heinemann, Lutz},
  year = {2024},
  volume = {19},
  number = {S 01},
  pages = {S60},
  publisher = {Thieme},
  address = {Stuttgart [u.a.]},
  issn = {1861-9002},
  doi = {10.1055/s-0044-1785353},
  url = {https://fis.uni-bamberg.de/handle/uniba/110208},
  language = {deu}
}

@inproceedings{hermanns2024_110209,
  title = {Welche Faktoren sind mit einer erhöhten Diabetesbelastung bei Nutzern von AID-Systemen assoziiert? : Ergebnisse einer multinationalen Analyse der Daten des Digitalisierungs- und Technologie-Reports 2024.},
  author = {Hermanns, Norbert and Ehrmann, Dominic and Roos, Timm and Heinemann, Lutz and Diem, Peter and Tinner, Myriam and Trümpy, Cordelia and Brandt, Derek and Mader, Julia and Resl, Michael and Kulzer, Bernhard},
  year = {2024},
  volume = {19},
  number = {S 01},
  pages = {S62},
  publisher = {Thieme},
  address = {Stuttgart [u.a.]},
  issn = {1861-9002},
  doi = {10.1055/s-0044-1785357},
  url = {https://fis.uni-bamberg.de/handle/uniba/110209},
  language = {deu}
}

@inproceedings{ehrmann2024_110210,
  title = {AID-Systeme in der Praxis : Nutzungshäufigkeit, Therapieverbesserung und Gründe für die Ablehnung und den Abbruch der AID-Therapie},
  author = {Ehrmann, Dominic and Roos, Timm and Hermanns, Norbert and Kulzer, Bernhard and Heinemann, Lutz},
  year = {2024},
  volume = {19},
  number = {S 01},
  pages = {S62-S63},
  publisher = {Thieme},
  address = {Stuttgart [u.a.]},
  issn = {1861-9002},
  doi = {10.1055/s-0044-1785358},
  url = {https://fis.uni-bamberg.de/handle/uniba/110210},
  language = {deu}
}

@inproceedings{herder2024_110211,
  title = {Differential associations between biomarkers of inflammation and depressive symptoms in people with type 1 and type 2 diabetes},
  author = {Herder, Christian and Zhu, Anna and Spagnuolo, Maria and Schmitt, Andreas and Kulzer, Bernhard and Roden, Michael and Ehrmann, Dominic and Hermanns, Norbert},
  year = {2024},
  volume = {19},
  number = {S 01},
  pages = {S63},
  publisher = {Thieme},
  address = {Stuttgart [u.a.]},
  issn = {1861-9002},
  doi = {10.1055/s-0044-1785360},
  url = {https://fis.uni-bamberg.de/handle/uniba/110211},
  language = {deu}
}

@inproceedings{ehrmann2024_110212,
  title = {Objektive vs. subjektive Quellen für Diabetes Distress: ein Präzisionsmedizinischer Ansatz mittels Ecological Momentary Assessment und CGM},
  author = {Ehrmann, Dominic and Kulzer, Bernhard and Schmitt, Andreas and Klinker, Laura and Haak, Thomas and Hermanns, Norbert},
  year = {2024},
  volume = {19},
  number = {S 01},
  pages = {S64},
  publisher = {Thieme},
  address = {Stuttgart [u.a.]},
  issn = {1861-9002},
  doi = {10.1055/s-0044-1785361},
  url = {https://fis.uni-bamberg.de/handle/uniba/110212},
  language = {deu}
}

@inproceedings{klinker2024_110215,
  title = {Belastungen im Zusammenhang mit dem Essverhalten als relevanter Faktor von Diabetes Distress : Ergebnisse aus fünf Studien zu Diabetes Distress aus der tertiären Versorgung},
  author = {Klinker, Laura and Schmitt, Andreas and Ehrmann, Dominic and Kulzer, Bernhard and Hermanns, Norbert},
  year = {2024},
  volume = {19},
  number = {S 01},
  pages = {S64-S65},
  publisher = {Thieme},
  address = {Stuttgart [u.a.]},
  issn = {1861-9002},
  doi = {10.1055/s-0044-1785362},
  url = {https://fis.uni-bamberg.de/handle/uniba/110215},
  language = {deu}
}

@inproceedings{schmitt2024_110219,
  title = {Hypoglykämieangst : Häufigkeit, Relevanz und Erfassung mithilfe der deutschen Version des Hypoglycemia Fear Survey II–Short Form},
  author = {Schmitt, Andreas and Klinker, Laura and Ehrmann, Dominic and Hermanns, Norbert and Kulzer, Bernhard},
  year = {2024},
  volume = {19},
  number = {S 01},
  pages = {S65},
  publisher = {Thieme},
  address = {Stuttgart [u.a.]},
  issn = {1861-9002},
  doi = {10.1055/s-0044-1785363},
  url = {https://fis.uni-bamberg.de/handle/uniba/110219},
  language = {deu}
}

@inproceedings{klinker2024_110220,
  title = {Assoziationen zwischen Belastungen bzgl. des Essverhaltens und glykämischen Parametern : Ergebnisse der dia-link Studien 1 \& 2},
  author = {Klinker, Laura and Schmitt, Andreas and Ehrmann, Dominic and Kulzer, Bernhard and Hermanns, Norbert},
  year = {2024},
  volume = {19},
  number = {S 01},
  pages = {S65-S66},
  publisher = {Thieme},
  address = {Stuttgart [u.a.]},
  issn = {1861-9002},
  doi = {10.1055/s-0044-1785364},
  url = {https://fis.uni-bamberg.de/handle/uniba/110220},
  language = {deu}
}

@inproceedings{schmitt2024_110221,
  title = {Epidemiologie psychischer Störungen bei Diabetes im strukturierten klinischen Interview : Affektive Störungen, Angststörungen, Essstörungen – Erste Ergebnisse der PRO-MENTAL-Studie},
  author = {Schmitt, Andreas and Klinker, Laura and Ehrmann, Dominic and Haak, Thomas and Kulzer, Bernhard and Hermanns, Norbert},
  year = {2024},
  volume = {19},
  number = {S 01},
  pages = {S66},
  publisher = {Thieme},
  address = {Stuttgart [u.a.]},
  issn = {1861-9002},
  doi = {10.1055/s-0044-1785365},
  url = {https://fis.uni-bamberg.de/handle/uniba/110221},
  language = {deu}
}

@inproceedings{hermanns2024_110193,
  title = {650-P: Attitudes and Barriers to Implantable AID Solutions : Development of a New Assessment Tool},
  author = {Hermanns, Norbert and Finke-Groene, Katharina and Kulzer, Bernhard and Ehrmann, Dominic},
  year = {2024},
  volume = {73},
  number = {Supplement\_1},
  pages = {960-P},
  address = {Alexandria, Va},
  issn = {1939-327X},
  doi = {10.2337/db24-650-p},
  url = {https://fis.uni-bamberg.de/handle/uniba/110193},
  language = {eng}
}

@inproceedings{hermanns2024_110192,
  title = {239-OR: CGM Has a Specific Effect on the Reduction of Nocturnal Hypoglycemia in People with Type 1 Diabetes on an MDI Treatment Regimen},
  author = {Hermanns, Norbert and Ehrmann, Dominic and Kulzer, Bernhard and Freckmann, Guido and Heinemann, Lutz},
  year = {2024},
  volume = {73},
  number = {Supplement\_1},
  pages = {239-OR},
  address = {Alexandria, Va},
  issn = {1939-327X},
  doi = {10.2337/db24-239-or},
  url = {https://fis.uni-bamberg.de/handle/uniba/110192},
  language = {eng}
}

@inproceedings{ehrmann2024_110191,
  title = {53-OR: Individual Sources of Diabetes Distress : A Precision Mental Health Approach Combining Ecological Momentary Assessment and Continuous Glucose Monitoring},
  author = {Ehrmann, Dominic and Kulzer, Bernhard and Schmitt, Andreas Jürgen and Hermanns, Norbert},
  year = {2024},
  volume = {73},
  number = {Supplement\_1},
  pages = {53-OR},
  address = {Alexandria, Va},
  issn = {1939-327X},
  doi = {10.2337/db24-53-or},
  url = {https://fis.uni-bamberg.de/handle/uniba/110191},
  language = {eng}
}

@inproceedings{kulzer2024_110207,
  title = {Wie sehen Diabetologen aus Deutschland, Österreich und Schweiz die Indikation von CGM-Systemen bei Menschen mit Diabetes? : Ergebnisse einer multinationalen Analyse der Daten des DT-Report 2024},
  author = {Kulzer, Bernhard and Hermanns, Norbert and Ehrmann, Dominic and Roos, Timm and Diem, Peter and Trümpy, Cordelia and Brandt, Derek and Mader, Julia and Resl, Michael and Heinemann, Lutz and Tinner, Myriam},
  year = {2024},
  volume = {19},
  number = {S 01},
  pages = {S59-S60},
  publisher = {Thieme},
  address = {Stuttgart [u.a.]},
  issn = {1861-9002},
  doi = {10.1055/s-0044-1785352},
  url = {https://fis.uni-bamberg.de/handle/uniba/110207},
  language = {deu}
}

@inproceedings{mader2024_110189,
  title = {Relationship between lipohypertrophy, glycemic control, and insulin dosing : a systematic meta-analysis},
  author = {Mader, Julia K. and Nguyen, T. and Fornengo, Ricardo and Wilmot, Emma G. and Kulzer, Bernhard and Monica, M. and Stożek-Tutro, Anita and Renard, Eric and Reznik, Yves and Heinemann, Lutz and Sieber, J. and Rys, P. and Hassoun, Ahmed},
  year = {2024},
  volume = {26},
  number = {S2},
  pages = {A366},
  publisher = {Liebert},
  address = {Larchmont, NY},
  issn = {1520-9156},
  doi = {10.1089/dia.2024.2525.abstracts},
  url = {https://fis.uni-bamberg.de/handle/uniba/110189},
  language = {eng}
}

@inproceedings{heinemann2024_110186,
  title = {Relevance, use, and barriers to the use of smart insulin pens},
  author = {Heinemann, Lutz and Roos, Timm and Ehrmann, Dominic and Hermanns, Norbert and Kulzer, Bernhard},
  year = {2024},
  volume = {26},
  number = {S2},
  pages = {A359},
  publisher = {Liebert},
  address = {Larchmont, NY},
  issn = {1520-9156},
  doi = {10.1089/dia.2024.2525.abstracts},
  url = {https://fis.uni-bamberg.de/handle/uniba/110186},
  language = {eng}
}

@inproceedings{schmitt2024_110222,
  title = {Welche komorbiden psychischen Störungen sind bei Diabetes mit einer weniger guten Glukoseeinstellung assoziiert? : Erste Ergebnisse der PRO-MENTAL-Studie},
  author = {Schmitt, Andreas and Klinker, Laura and Ehrmann, Dominic and Haak, Thomas and Kulzer, Bernhard and Hermanns, Norbert},
  year = {2024},
  volume = {19},
  number = {S 01},
  pages = {S66-S67},
  publisher = {Thieme},
  address = {Stuttgart [u.a.]},
  issn = {1861-9002},
  doi = {10.1055/s-0044-1785366},
  url = {https://fis.uni-bamberg.de/handle/uniba/110222},
  language = {deu}
}

@inproceedings{ehrmann2024_110184,
  title = {Barriers for the use of different diabetes technology in healthcare professionals : a network analysis},
  author = {Ehrmann, Dominic and Hermanns, Norbert and Roos, Timm and Heinemann, Lutz and Kulzer, Bernhard},
  year = {2024},
  volume = {26},
  number = {S2},
  pages = {A317-A318},
  publisher = {Liebert},
  address = {Larchmont, NY},
  issn = {1520-9156},
  doi = {10.1089/dia.2024.2525.abstracts},
  url = {https://fis.uni-bamberg.de/handle/uniba/110184},
  language = {eng}
}

@inproceedings{hermanns2024_110182,
  title = {Less severe hypo- and hyperglycaemic events after using a digital diabetes logbook : safety analysis of the MySugr PRO randomised controlled trial},
  author = {Hermanns, Norbert and Silbermann, Stephan and Ehrmann, Dominic and Kober, J. and Finke-Gröne, Katharina and Roos, Timm and Kulzer, Bernhard},
  year = {2024},
  volume = {26},
  number = {S2},
  pages = {A260},
  publisher = {Liebert},
  address = {Larchmont, NY},
  issn = {1520-9156},
  doi = {10.1089/dia.2024.2525.abstracts},
  url = {https://fis.uni-bamberg.de/handle/uniba/110182},
  language = {eng}
}

@inproceedings{ehrmann2024_110179,
  title = {Higher chance to achieve optimal glycaemic control via a digital diabetes logbook : subanalysis of the MySugr PRO randomised controlled trial},
  author = {Ehrmann, Dominic and Kulzer, Bernhard and Silbermann, Stephan and Kober, J. and Finke-Gröne, Katharina and Roos, Timm and Hermanns, Norbert},
  year = {2024},
  volume = {26},
  number = {S2},
  pages = {A257-A258},
  publisher = {Liebert},
  address = {Larchmont, NY},
  issn = {1520-9156},
  doi = {10.1089/dia.2024.2525.abstracts},
  url = {https://fis.uni-bamberg.de/handle/uniba/110179},
  language = {eng}
}

@inproceedings{kulzer2024_110176,
  title = {Use of AID systems in clinical practice},
  author = {Kulzer, Bernhard and Roos, Timm and Ehrmann, Dominic and Hermanns, Norbert and Heinemann, Lutz},
  year = {2024},
  volume = {26},
  number = {S2},
  pages = {A183},
  publisher = {Liebert},
  address = {Larchmont, NY},
  issn = {1520-9156},
  doi = {10.1089/dia.2024.2525.abstracts},
  url = {https://fis.uni-bamberg.de/handle/uniba/110176},
  language = {eng}
}

@inproceedings{hermanns2024_110173,
  title = {Self-reported Hba1c values in AID users increased slightly from 2019 to 2021 : longitudinal data of the Digitalization and Technology report (DT Report)},
  author = {Hermanns, Norbert and Ehrmann, Dominic and Roos, Timm and Heinemann, Lutz and Kulzer, Bernhard},
  year = {2024},
  volume = {26},
  number = {S2},
  pages = {A179-A180},
  publisher = {Liebert},
  address = {Larchmont, NY},
  issn = {1520-9156},
  doi = {10.1089/dia.2024.2525.abstracts},
  url = {https://fis.uni-bamberg.de/handle/uniba/110173},
  language = {eng}
}

@inproceedings{heinemann2024_110170,
  title = {Importance of AID-systems for physicians, people with diabetes, and parents : longitudinal findings from the Digitalisation and Technology report Germany},
  author = {Heinemann, Lutz and Roos, Timm and Kulzer, Bernhard and Hermanns, Norbert and Ehrmann, Dominic},
  year = {2024},
  volume = {26},
  number = {S2},
  pages = {A45},
  publisher = {Liebert},
  address = {Larchmont, NY},
  issn = {1520-9156},
  doi = {10.1089/dia.2024.2525.abstracts},
  url = {https://fis.uni-bamberg.de/handle/uniba/110170},
  language = {eng}
}

@article{seufert2024_109986,
  title = {Kontinuierliche Glukosemessung bei Menschen mit Typ-2-Diabetes ohne intensivierte Insulintherapie : eine Standortbestimmung},
  author = {Seufert, Jochen and Dänschel, Ingrid and Gölz, Stefan and Haller, Nicola and Kulzer, Bernhard and Reger-Tan, Susanne and Schnell, Oliver and Wiesner, Tobias and Kroeger, Jens},
  year = {2024},
  journal = {Diabetologie und Stoffwechsel},
  volume = {19},
  number = {5},
  pages = {356-368},
  publisher = {Thieme},
  address = {Stuttgart [u.a.]},
  issn = {1861-9010},
  doi = {10.1055/a-2305-9093},
  url = {https://fis.uni-bamberg.de/handle/uniba/109986},
  language = {deu},
  abstract = {Zahlreiche Studien haben den klinischen Nutzen der kontinuierlichen Glukosemessung (CGM) bei Menschen mit Typ-1Diabetes belegt, was auch zu einer positiven Empfehlung des Gemeinsamen Bundesausschusses (GBA) für CGM-Systeme bei Menschen mit Diabetes und intensivierter Insulintherapie (ICT/Insulinpumpentherapie) geführt hat. Inzwischen liegen die Ergebnisse zahlreicher randomisierter, beobachtender und retrospektiver Studien zum Einsatz von CGM bei Menschen mit Typ-2-Diabetes und einer nicht intensivierten Insulintherapie (BOT/SIT/CT) oder einer Therapie ohne Insulin vor. In diesem Artikel wird die aktuelle Evidenz zum Einsatz von CGM bei diesen Patientengruppen zusammengefasst und diskutiert. Die Ergebnisse dieser Studien deuten darauf hin, dass CGM auch bei Menschen ohne intensivierte Insulintherapie wirksam ist, um die glykämische Kontrolle zu verbessern und mögliche Nebenwirkungen der Insulintherapie (Hypoglykämien) zu vermeiden.},
  keywords = {CGM, Typ 2 Diabetes, kontinuierliche Glukosemessung, intensivierte Insulintherapie, Basalinsulin unterstützte orale antidiabetische Therapie CGM, Type 2 diabetes, Continuous glucose monitoring, multiple daily injections, Basal insulin supplemented oral antidiabetic therapy}
}

@article{mader2024_109982,
  title = {Relationship Between Lipohypertrophy, Glycemic Control, and Insulin Dosing : A Systematic Meta-Analysis},
  author = {Mader, Julia K. and Fornengo, Ricardo and Hassoun, Ahmed and Heinemann, Lutz and Kulzer, Bernhard and Monica, Magdalena and Nguyen, Trung and Sieber, Jochen and Renard, Eric and Reznik, Yves and Ryś, Przemysław and Stożek-Tutro, Anita and Wilmot, Emma G.},
  year = {2024},
  journal = {Diabetes Technology \& Therapeutics},
  volume = {26},
  number = {5},
  pages = {351-362},
  publisher = {Liebert},
  address = {Larchmont, NY},
  issn = {1520-9156},
  doi = {10.1089/dia.2023.0491},
  url = {https://fis.uni-bamberg.de/handle/uniba/109982},
  language = {eng},
  abstract = {Background: Lipohypertrophy is a common complication in patients with diabetes receiving insulin therapy. There is a lack of consensus regarding how much lipohypertrophy affects diabetes management. Our study aimed to assess the potential correlation between lipohypertrophy and glycemic control, as well as insulin dosing in patients with diabetes. Methods: We performed a systematic review followed by a meta-analysis to collect data about glycemic control and insulin dosing in diabetic patients with and without lipohypertrophy. To identify relevant studies published in English, we searched medical databases (MEDLINE/PubMed, Embase, and CENTRAL) from 1990 to January 20, 2023. An additional hand-search of references was performed to retrieve publications not indexed in medical databases. Results of meta-analyses were presented either as prevalence odds ratios (pORs) or mean differences (MDs) with 95\% confidence intervals (95\% CIs). This study was registered on PROSPERO (CRD42023393103). Results: Of the 5540 records and 240 full-text articles screened, 37 studies fulfilled the prespecified inclusion criteria. Performed meta-analyses showed that patients with lipohypertrophy compared with those without lipohypertrophy were more likely to experience unexplained hypoglycemia (pOR [95\% CI] =6.98 [3.30– 14.77]), overall hypoglycemia (pOR [95\% CI] =6.65 [1.37–32.36]), and glycemic variability (pOR [95\%CI] =5.24 [2.68–10.23]). Patients with lipohypertrophy also had higher HbA1c (MD [95\% CI] =0.55 [0.23–
0.87] \%), and increased daily insulin consumption (MD [95\% CI] =7.68 IU [5.31–10.06]). Conclusions: These results suggest that overall glycemic control is worse in patients with lipohypertrophy than in those without this condition.},
  keywords = {Keywords: Diabetes, Glycemic Control, Insulin-injection technique, Lipohypertrophy, Meta-analysis, Systematic review.}
}

@article{kulzer2024_109980,
  title = {Prädiabetes : Motivation zu mehr Bewegung lohnt sich},
  author = {Kulzer, Bernhard and Schäfer, Arne},
  year = {2024},
  journal = {MMW - Fortschritte der Medizin},
  volume = {166},
  number = {10},
  pages = {63-67},
  publisher = {Springer Medizin Verlag},
  address = {Berlin},
  issn = {1613-3560},
  doi = {10.1007/s15006-024-3893-4},
  url = {https://fis.uni-bamberg.de/handle/uniba/109980},
  language = {deu}
}

@article{kulzer2024_109979,
  title = {Predicting Glucose Values : A New Era for Continuous Glucose Monitoring},
  author = {Kulzer, Bernhard and Heinemann, Lutz},
  year = {2024},
  journal = {Journal of Diabetes Science and Technology},
  volume = {18},
  number = {5},
  pages = {1000-1003},
  publisher = {Sage Publishing},
  address = {London},
  issn = {1932-2968},
  doi = {10.1177/19322968241271925},
  url = {https://fis.uni-bamberg.de/handle/uniba/109979},
  language = {eng}
}

@article{kulzer2024_109978,
  title = {Nocturnal Hypoglycemia in the Era of Continuous Glucose Monitoring},
  author = {Kulzer, Bernhard and Freckmann, Guido and Ziegler, Ralph and Schnell, Oliver and Glatzer, Timor and Heinemann, Lutz},
  year = {2024},
  journal = {Journal of Diabetes Science and Technology},
  volume = {18},
  number = {5},
  pages = {1052-1060},
  publisher = {Sage},
  address = {London},
  issn = {1932-2968},
  doi = {10.1177/19322968241267823},
  url = {https://fis.uni-bamberg.de/handle/uniba/109978},
  language = {eng},
  abstract = {Nocturnal hypoglycemia is a common acute complication of people with diabetes on insulin therapy. In particular, the inability to control glucose levels during sleep, the impact of external factors such as exercise, or alcohol and the influence of hormones are the main causes. Nocturnal hypoglycemia has several negative somatic, psychological, and social effects for people with diabetes, which are summarized in this article. With the advent of continuous glucose monitoring (CGM), it has been shown that the number of nocturnal hypoglycemic events was significantly underestimated when traditional blood glucose monitoring was used. The CGM can reduce the number of nocturnal hypoglycemia episodes with the help of alarms, trend arrows, and evaluation routines. In combination with CGM with an insulin pump and an algorithm, automatic glucose adjustment (AID) systems have their particular strength in nocturnal glucose regulation and the prevention of nocturnal hypoglycemia. Nevertheless, the problem of nocturnal hypoglycemia has not yet been solved completely with the technologies currently available. The CGM systems that use predictive models to warn of hypoglycemia, improved AID systems that recognize hypoglycemia patterns even better, and the increasing integration of artificial intelligence methods are promising approaches in the future to significantly minimize the risk of a side effect of insulin therapy that is burdensome for people with diabetes.},
  keywords = {diabetes, nocturnal hypoglycemia, continuous glucose monitoring, predictive models}
}

@article{hermanns2024_109975,
  title = {Einstellung zur Insulinpumpentherapie bei Menschen mit Typ-1-Diabetes sechs Monate nach Umstellung im Vergleich zu mehrfach täglichen Insulininjektionen : Eine Beobachtungstudie},
  author = {Hermanns, Norbert and Ehrmann, Dominic and Kulzer, Bernhard and Kalt, Lucas and Seufert, Jochen},
  year = {2024},
  journal = {Diabetologie und Stoffwechsel},
  volume = {19},
  number = {6},
  pages = {426-432},
  publisher = {Thieme},
  address = {Stuttgart [u.a.]},
  issn = {1861-9010},
  doi = {10.1055/a-2280-8966},
  url = {https://fis.uni-bamberg.de/handle/uniba/109975},
  language = {deu},
  abstract = {Hintergrund Obwohl die Insulinpumpentherapie (CSII) derzeit im Vergleich zur Insulininjektionstherapie eine deutlich physiologischere Methode der Insulinsubstitution darstellt, wenden in Deutschland im Vergleich zu anderen Ländern weniger Menschen mit einem Typ-1-Diabetes diese Therapieform an. Eine Bedeutung könnten hierbei psychologische Faktoren wie Erwartungen und Einstellungen gegenüber einer Insulinpumpentherapie zukommen. In dieser nicht-interventionellen Beobachtungsstudie wurden die Einstellungen zur Insulinpumpentherapie erwachsener Insulinpumpenträger 6 Monate nach Neueinstellung mit Erwachsenen mit einer mehrfachen täglichen Insulininjektionstherapie (MDI) verglichen. 
Methoden Einstellungen zur CSII-Therapie wurden mit dem Insulin Pump Attitudes Questionnaire (IPA-Q) erfasst, sowohl bei Teilnehmern der YES-Studie, einer nicht-interventionellen Post Market Surveillance Study zur Effektivität und Sicherheit der mylife YpsoPump (ohne Hybrid-Closed-Loop Algorithmus ( = CSII-Nutzer), als auch bei MDI-Anwendern der IPA-Q-Evaluierungsstudie. 
Ergebnisse Es wurden die Fragebogendaten von n = 191 Teilnehmern (CSII-Nutzer: n = 81 Teilnehmer der YES-Studie; MDI-Nutzer: n = 110 Teilnehmer der IPA-Q Evaluierungsstudie) ausgewertet. CSII-Nutzer, die eine mylife YpsoPump verwenden, standen 6 Monate nach der Neueinstellung oder Umstellung auf eine CSII-Therapie einer solchen signifikant positiver gegenüber als Nutzer einer MDI-Therapie, während gleichzeitig weniger Nachteile der Insulinpumpentherapie berichtet wurden. 
Schlussfolgerungen Diese Studie zeigt eine hohe Relevanz psychologischer Faktoren für die Akzeptanz und Implementierung einer Insulinpumpentherapie. Strukturierte Diabetesschulungen für Menschen mit Typ-1-Diabetes und eine gute technische Einweisung bei Personen, die sich für eine Insulinpumpentherapie entschieden haben, können dazu beitragen, unrealistische Erwartungen und inadäquate negative Einstellungen zur Insulinpumpentherapie abzubauen.},
  keywords = {-}
}

@article{eichenlaub2024_109973,
  title = {Characteristics of Nocturnal Hypoglycaemic Events and Their Impact on Glycaemia},
  author = {Eichenlaub, Manuel and Öter, Sükrü and Waldenmaier, Delia and Kulzer, Bernd and Heinemann, Lutz and Ziegler, Ralph and Schnell, Oliver and Glatzer, Timor and Freckmann, Guido},
  year = {2024},
  journal = {Journal of Diabetes Science and Technology},
  volume = {18},
  number = {5},
  pages = {1035-1043},
  publisher = {Sage Publishing},
  address = {London},
  issn = {1932-2968},
  doi = {10.1177/19322968241267765},
  url = {https://fis.uni-bamberg.de/handle/uniba/109973},
  language = {eng},
  abstract = {Background: Nocturnal hypoglycaemia is a burden for people with diabetes, particularly when treated with multiple daily injections (MDI) therapy. However, the characteristics of nocturnal hypoglycaemic events in this patient group are only poorly described in the literature.
Method: Continuous glucose monitoring (CGM) data from 185 study participants with type 1 diabetes using MDI therapy were collected under everyday conditions for up to 13 weeks. Hypoglycaemic events were identified as episodes of consecutive CGM readings <70 mg/dl or <54 mg/dl for at least 15 minutes. Subsequently, the time <54 mg/dl (TB54), time below range (TBR), time in range (TIR), time above range (TAR), glucose coefficient of variation (CV), and incidence of hypoglycaemic events were calculated for diurnal and nocturnal periods. Furthermore, the effect of nocturnal hypoglycaemic events on glucose levels the following day was assessed.
Results: The incidence of hypoglycaemic events <70 mg/dl was significantly lower during the night compared to the day, with 0.8 and 3.8 events per week, respectively, while the TBR, TB54, and incidence of events with CGM readings <54 mg/ dl was not significantly different. Nocturnal hypoglycaemic events <70 mg/dl were significantly longer (60 vs 35 minutes) and enveloped by less rapidly changing glucose levels. On days following nights containing hypoglycaemic events, there was a decrease in TAR, mean CGM glucose level and morning glucose levels and an increase in TB54, TBR, and CV.
Conclusions: The results showed that nocturnal hypoglycaemic events are a common occurrence in persons with type 1 diabetes using MDI with significant differences between the characteristics of nocturnal and diurnal events.},
  keywords = {nocturnal hypoglycaemia, time below range, hypoglycaemic event incidence, glycemic variability, somogyi effect}
}

@article{ebert2024_109971,
  title = {Diabetes and Road Traffic},
  author = {Ebert, Oliver and Bohn, Barbara and Bertram, Bernd and Buchberger, Barbara and Finck, Hermann and Hoß, Jürgen and Hübner, Peter and Krabbe, Laura and Kulzer, Bernhard and Küstner, Eva and Lachenmayr, Bernhard and Lemmen, Klaus-Dieter and Petry, Friedhelm and Rinnert, Kurt and Salomon, Markus and Schütt, Wolfgang and Holl, Reinhard W. and Maxeiner, Stephan and Wagener, Wolfgang},
  year = {2024},
  journal = {Experimental and Clinical Endocrinology \& Diabetes},
  volume = {132},
  number = {9},
  pages = {481-496},
  publisher = {Thieme},
  address = {Stuttgart},
  issn = {2196-7407},
  doi = {10.1055/a-2166-6928},
  url = {https://fis.uni-bamberg.de/handle/uniba/109971},
  language = {eng}
}

@article{schmitt2024_107892,
  title = {PRO-MENTAL : Präzisionsmedizinansatz zur mentalen Gesundheit für Menschen mit Diabetes ; Subtypen und Verläufe psychischer Gesundheit und Glukose bei Typ-1- und Typ-2-Diabetes},
  author = {Schmitt, Andreas and Klinker, Laura and Ehrmann, Dominic and Kulzer, Bernhard and Pryss, Rüdiger and Kruse, Johannes and Hermanns, Norbert},
  year = {2024},
  journal = {Die Diabetologie : Organ der Deutschen Gesellschaft für Innere Medizin, des Berufsverbandes Deutscher Internistinnen und Internisten, des Berufsverbandes Deutscher Endokrinologen und der Arbeitsgemeinschaft niedergelassener diabetologisch Tätiger Ärzte e.V.},
  volume = {20},
  number = {8},
  pages = {861-872},
  publisher = {Springer Medizin Verlag GmbH},
  address = {Berlin},
  issn = {2731-7455},
  doi = {10.1007/s11428-024-01213-w},
  url = {https://fis.uni-bamberg.de/handle/uniba/107892},
  language = {deu}
}

@article{kulzer2024_108198,
  title = {Kognition und Depression bei älteren Menschen mit Diabetes},
  author = {Kulzer, Bernhard},
  year = {2024},
  journal = {Der Nervenarzt},
  volume = {95},
  number = {1},
  pages = {46-52},
  publisher = {Springer},
  address = {Berlin ; Heidelberg},
  issn = {1433-0407},
  doi = {10.1007/s00115-023-01599-w},
  url = {https://fis.uni-bamberg.de/handle/uniba/108198},
  language = {deu}
}

@article{kulzer2024_108197,
  title = {Grundlagen des Diabetesmanagements},
  author = {Kulzer, Bernhard and Aberle, Jens and Haak, Thomas and Kaltheuner, Matthias and Kröger, Jens and Landgraf, Rüdiger and Kellerer, Monika},
  year = {2024},
  journal = {Die Diabetologie : Organ der Deutschen Gesellschaft für Innere Medizin, des Berufsverbandes Deutscher Internistinnen und Internisten, des Berufsverbandes Deutscher Endokrinologen und der Arbeitsgemeinschaft niedergelassener diabetologisch Tätiger Ärzte e.V.},
  volume = {20},
  number = {5},
  pages = {637-648},
  publisher = {Springer Medizin Verlag GmbH},
  address = {Berlin},
  issn = {2731-7455},
  doi = {10.1007/s11428-023-01143-z},
  url = {https://fis.uni-bamberg.de/handle/uniba/108197},
  language = {deu}
}

@article{kulzer2024_108196,
  title = {Fundamentals of Diabetes Management},
  author = {Kulzer, Bernhard and Aberle, Jens and Haak, Thomas and Kaltheuner, Matthias and Kröger, Jens and Landgraf, Rüdiger and Kellerer, Monika},
  year = {2024},
  journal = {Experimental and clinical endocrinology \& diabetes},
  volume = {132},
  number = {4},
  pages = {171-180},
  publisher = {Thieme},
  address = {Stuttgart [u.a.]},
  issn = {1439-3646},
  doi = {10.1055/a-2166-6566},
  url = {https://fis.uni-bamberg.de/handle/uniba/108196},
  language = {eng}
}

@article{hermanns2024_107921,
  title = {Patientenberichtete Ergebnisse (PRO) und Erfahrungen (PRE) in der Diabetesversorgung},
  author = {Hermanns, Norbert and Kulzer, Bernhard and Schäfer, Arne and Icks, Andrea and Ehrmann, Dominic},
  year = {2024},
  journal = {Die Diabetologie : Organ der Deutschen Gesellschaft für Innere Medizin, des Berufsverbandes Deutscher Internistinnen und Internisten, des Berufsverbandes Deutscher Endokrinologen und der Arbeitsgemeinschaft niedergelassener diabetologisch Tätiger Ärzte e.V.},
  volume = {20},
  number = {8},
  pages = {842-850},
  publisher = {Springer Medizin Verlag GmbH},
  address = {Berlin},
  issn = {2731-7455},
  doi = {10.1007/s11428-024-01197-7},
  url = {https://fis.uni-bamberg.de/handle/uniba/107921},
  language = {deu}
}

@article{vomhof2024_107897,
  title = {Preferences of people with diabetes for diabetes care in Germany : a discrete choice experiment},
  author = {Vomhof, Markus and Boersma, Anna C. and Hertroijs, Dorijn F. L. and Kaltheuner, Matthias and Krichbaum, Michael and Kulzer, Bernhard and Icks, Andrea and Hiligsmann, Mickael},
  year = {2024},
  journal = {Expert review of pharmacoeconomics and outcomes research},
  volume = {24},
  number = {8},
  pages = {997-1007},
  publisher = {Taylor \& Francis Group},
  address = {Abingdon},
  issn = {1744-8379},
  doi = {10.1080/14737167.2024.2369293},
  url = {https://fis.uni-bamberg.de/handle/uniba/107897},
  language = {eng}
}

@article{regertan2024_107629,
  title = {Digitalisierung in der Diabetologie},
  author = {Reger-Tan, Susanne and Deml, Angelika and Ickrath, Manuel and Kröger, Jens and Kulzer, Bernhard and Petry, Friedhelm and Scheper, Nikolaus and Schubert-Olesen, Oliver and Schwarz, Peter and Tews, Dietrich and Verket, Marlo and Vite, Sabrina and Wiesner, Tobias and Müller-Wieland, Dirk},
  year = {2024},
  journal = {Diabetologie und Stoffwechsel : offizielles Organ der Deutschen Diabetes Gesellschaft},
  volume = {19},
  number = {S 02},
  pages = {427-436},
  publisher = {Thieme},
  address = {Stuttgart [u.a.]},
  issn = {1861-9010},
  doi = {10.1055/a-2076-0353},
  url = {https://fis.uni-bamberg.de/handle/uniba/107629},
  language = {deu}
}

@article{kulzer2024_107594,
  title = {Integration von personenbezogenen Ergebnissen („person reported outcomes“ [PROs]) in die klinische Praxis},
  author = {Kulzer, Bernhard and Schäfer, A. and Maier, B. and Klinker, L. and Schmitt, A. and Ehrmann, D. and Hermanns, N. and Reger-Tan, S. and Müller-Wieland, D.},
  year = {2024},
  journal = {Die Diabetologie : Organ der Deutschen Gesellschaft für Innere Medizin, des Berufsverbandes Deutscher Internistinnen und Internisten, des Berufsverbandes Deutscher Endokrinologen und der Arbeitsgemeinschaft niedergelassener diabetologisch Tätiger Ärzte e.V.},
  volume = {20},
  number = {8},
  pages = {851-860},
  publisher = {Springer Medizin Verlag GmbH},
  address = {Berlin},
  issn = {2731-7455},
  doi = {10.1007/s11428-024-01258-x},
  url = {https://fis.uni-bamberg.de/handle/uniba/107594},
  language = {deu}
}

@article{kulzer2024_107582,
  title = {Stärkung der Patientenperspektive in der Diabetologie},
  author = {Kulzer, B. and Schmitt, A. and Ehrmann, N. and Hermanns, N. and Schäfer, A.},
  year = {2024},
  journal = {Die Diabetologie : Organ der Deutschen Gesellschaft für Innere Medizin, des Berufsverbandes Deutscher Internistinnen und Internisten, des Berufsverbandes Deutscher Endokrinologen und der Arbeitsgemeinschaft niedergelassener diabetologisch Tätiger Ärzte e.V.},
  volume = {20},
  number = {8},
  pages = {839-841},
  publisher = {Springer Medizin Verlag GmbH},
  address = {Berlin},
  issn = {2731-7455},
  doi = {10.1007/s11428-024-01254-1},
  url = {https://fis.uni-bamberg.de/handle/uniba/107582},
  language = {deu}
}

@article{ehrmann2024_104718,
  title = {More Frequent Use of Glucose Alarms Is Associated with Continuous Glucose Monitoring-Specific Diabetes Education : Findings from the Dia·Link Diabetes Panel},
  author = {Ehrmann, Dominic and Priesterroth, Lilli-Sophie and Olesen, Birgit and Haak, Thomas Jürgen and Kulzer, Bernhard and Hermanns, Norbert},
  year = {2024},
  journal = {Diabetes Technology \& Therapeutics},
  volume = {26},
  number = {1},
  publisher = {Liebert},
  address = {Larchmont, NY},
  issn = {1557-8593},
  doi = {10.1089/dia.2023.0333},
  url = {https://fis.uni-bamberg.de/handle/uniba/104718},
  language = {eng}
}

@article{roos2024_104715,
  title = {Effect of automated insulin delivery systems on person-reported outcomes in people with diabetes : a systematic review and meta-analysis},
  author = {Roos, Timm and Hermanns, Norbert and Groß, Christopher and Kulzer, Bernhard and Haak, Thomas and Ehrmann, Dominic},
  year = {2024},
  journal = {eClinicalMedicine},
  volume = {76},
  number = {102852},
  pages = {1-18},
  publisher = {Elsevier BV},
  address = {Amsterdam},
  issn = {2589-5370},
  doi = {10.1016/j.eclinm.2024.102852},
  url = {https://fis.uni-bamberg.de/handle/uniba/104715},
  language = {eng},
  abstract = {Background:
Conclusive evidence on the benefits of automated insulin delivery (AID) systems on person-reported outcomes (PROs) is missing.

Methods:
In this systematic review and meta-analysis, four databases (PubMed, PsycINFO, Cochrane, and GoogleScholar) were searched from inception up to August 7th, 2024. All types of studies were included if studies reported on PROs in people with diabetes using an AID system. All types of control groups in randomised controlled trials (RCT) were included. Summary data were extracted by three reviewers. Main outcomes focused on diabetes distress, fear of hypoglycaemia and quality of life. Meta-analyses were conducted for RCTs and observational studies separately. When five or more studies could be pooled, random-effects meta-analysis was used, otherwise common-effects meta-analysis was used. Risk of bias was evaluated with Cochrane tools. This study was registered with PROSPERO, CRD42022352502.

Findings:
A total of 62 studies (n = 9253) were included reporting on 45 different questionnaires. Twenty-seven studies were RCTs and 25 were observational studies. RCT meta-analyses showed reduced diabetes distress (standardised mean difference [95\% CI]: −0.159 [−0.309, −0.010], I2 = 23.0\%), reduced fear of hypoglycaemia (−0.339 [−0.566, −0.111], I2 = 42.6\%), and improved hypoglycaemia unawareness (−0.231 [−0.424, −0.037], I2 = 0.0\%), quality of life in adults (0.347 [0.134, 0.560], I2 = 0.0\%) and children/adolescents (0.249 [0.050, 0.448], I2 = 0.0\%). Observational meta-analyses corroborated improvements in diabetes distress (−0.217 [−0.403, −0.031], I2 = 68.5\%), fear of hypoglycaemia (−0.445 [−0.540, −0.349], I2 = 0.0\%), hypoglycaemia unawareness (−0.212 [−0.419, −0.004], I2 = 0.0\%), and showed improved sleep quality (−0.158 [−0.255, −0.061], I2 = 0.0\%).

Interpretation:
We found low to moderate effect sizes indicating that AID therapy is associated with reduced burden and improved well-being in people with diabetes. Evidence comes from both RCTs and observational studies. However, for some PROs only a limited number of studies could be pooled with a large heterogeneity in questionnaires used. More research is needed with a more uniformed assessment of PROs to demonstrate the added value of AID therapy on psychosocial outcomes.},
  keywords = {Diabetes mellitus, Automated insulin delivery, Person-reported outcomes, Meta-analysis, Systematic review}
}

@article{ehrmann2024_104713,
  title = {Assessing Barriers and Adherence to Insulin Injection Technique in People With Diabetes : Development and Validation of New Assessment Tools},
  author = {Ehrmann, Dominic and Kulzer, Bernhard and Inka Wienbarg and Jochen Sieber and Weber, Siegfried and Haak, Thomas Jürgen and Hermanns, Norbert},
  year = {2024},
  journal = {Journal of diabetes science and technology : JDST},
  volume = {18},
  number = {6},
  pages = {1362-1369},
  publisher = {Sage Publishing},
  address = {London},
  issn = {1932-2968},
  doi = {10.1177/19322968231175920},
  url = {https://fis.uni-bamberg.de/handle/uniba/104713},
  language = {eng}
}

@article{ehrmann2024_104714,
  title = {Perceived glucose levels matter more than CGM-based data in predicting diabetes distress in type 1 or type 2 diabetes : a precision mental health approach using n-of-1 analyses},
  author = {Ehrmann, Dominic and Hermanns, Norbert and Schmitt, Andreas Jürgen and Klinker, Laura and Haak, Thomas Jürgen and Kulzer, Bernhard},
  year = {2024},
  journal = {Diabetologia : journal of the European Association for the Study of Diabetes (EASD)},
  volume = {67},
  number = {11},
  pages = {2433-2445},
  publisher = {Springer},
  address = {Berlin},
  issn = {1432-0428},
  doi = {10.1007/s00125-024-06239-9},
  url = {https://fis.uni-bamberg.de/handle/uniba/104714},
  language = {eng},
  abstract = {Aims/hypothesis:
Diabetes distress is one of the most frequent mental health issues identified in people with type 1 and type 2 diabetes. Little is known about the role of glucose control as a potential contributor to diabetes distress and whether the subjective perception of glucose control or the objective glycaemic parameters are more important for the experience. With the emergence of continuous glucose monitoring (CGM), this is a relevant question as glucose values are now visible in real-time. We employed a precision monitoring approach to analyse the independent associations of perceived and measured glucose control with diabetes distress on a daily basis. By using n-of-1 analyses, we aimed to identify individual contributors to diabetes distress per person and analyse the associations of these individual contributors with mental health at a 3 month follow-up.

Methods:
In this prospective, observational study, perceived (hypoglycaemia/hyperglycaemia/glucose variability burden) and measured glucose control (time in hypoglycaemia and hyperglycaemia, CV) were assessed daily for 17 days using an ecological momentary assessment (EMA) approach with a special EMA app and CGM, respectively. Mixed-effect regression analysis was performed, with daily diabetes distress as the dependent variable and daily perceived and CGM-measured metrics of glucose control as random factors. Individual regression coefficients of daily distress with perceived and CGM-measured metrics were correlated with levels of psychosocial well-being at a 3 month follow-up.

Results:
Data from 379 participants were analysed (50.9\% type 1 diabetes; 49.6\% female). Perceived glucose variability (t=14.360; p<0.0001) and perceived hyperglycaemia (t=13.637; p<0.0001) were the strongest predictors of daily diabetes distress, while CGM-based glucose variability was not significantly associated (t=1.070; p=0.285). There was great heterogeneity between individuals in the associations of perceived and measured glucose parameters with diabetes distress. Individuals with a stronger association between perceived glucose control and daily distress had more depressive symptoms (β=0.32), diabetes distress (β=0.39) and hypoglycaemia fear (β=0.34) at follow-up (all p<0.001). Individuals with a stronger association between CGM-measured glucose control and daily distress had higher levels of psychosocial well-being at follow-up (depressive symptoms: β=−0.31; diabetes distress: β=−0.33; hypoglycaemia fear: β=−0.27; all p<0.001) but also higher HbA1c (β=0.12; p<0.05).

Conclusions/interpretation:
Overall, subjective perceptions of glucose seem to be more influential on diabetes distress than objective CGM parameters of glycaemic control. N-of-1 analyses showed that CGM-measured and perceived glucose control had differential associations with diabetes distress and psychosocial well-being 3 months later. The results highlight the need to understand the individual drivers of diabetes distress to develop personalised interventions within a precision mental health approach.},
  keywords = {Continuous glucose monitoring, Diabetes distress, Ecological momentary assessment, Precision mental health, Precision monitoring}
}

@article{lehmann2024_95710,
  title = {Explaining improvement in diabetes distress : a longitudinal analysis of the predictive relevance of resilience and acceptance in people with type 1 diabetes},
  author = {Lehmann, Gina and Ziebell, Philipp and Schmitt, Andreas and Kulzer, Bernhard and Hermanns, Norbert and Ehrmann, Dominic},
  year = {2024},
  pages = {151-159},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-irb-957108},
  url = {https://fis.uni-bamberg.de/handle/uniba/95710},
  language = {eng},
  abstract = {Aims:
To analyze if midterm improvement in diabetes distress can be explained by resilience, diabetes acceptance, and patient characteristics.

Methods:
N = 179 adults with type 1 diabetes were enrolled during their stay at a tertiary diabetes center (monocentric enrolment) and followed up over three months in a prospective, observational study (‘DIA-LINK1’). Improvement in diabetes distress was assessed as reduction in the Problem Areas in Diabetes Scale score from baseline to follow-up. Resilience (Resilience Scale-13), acceptance (Diabetes Acceptance Scale), and patient characteristics were analyzed as predictors of improvement in diabetes distress using hierarchical multiple regression.

Results:
Greater reductions in diabetes distress were significantly explained by lower diabetes acceptance at baseline (β = −0.34, p < 0.01), while resilience, diabetes complications, and other person-related variables were not significantly related to changes in diabetes distress (all p > 0.05). When change in diabetes acceptance from baseline to follow-up was added to the model, improved diabetes distress was explained by increasing diabetes acceptance (β = 0.41, p < 0.01) and a shorter duration of diabetes (β = -0.18, p = 0.03), while baseline diabetes acceptance was no longer significantly associated (β = −0.14, p > 0.05).

Conclusions:
Diabetes acceptance is inversely related to diabetes distress, and increasing acceptance explained greater improvement in diabetes distress. These findings suggest that increasing diabetes acceptance may facilitate the reduction of diabetes distress. Treatment approaches targeting acceptance might be useful for the mental healthcare of people with type 1 diabetes and clinically elevated diabetes distress.},
  keywords = {Mental health, Diabetes distress, Psychological resilience, Diabetes acceptance, Prospective study, Diabetes acceptance Prospective study}
}

@article{lehmann2024_95707,
  title = {Explaining improvement in diabetes distress : a longitudinal analysis of the predictive relevance of resilience and acceptance in people with type 1 diabetes},
  author = {Lehmann, Gina and Ziebell, Philipp and Schmitt, Andreas and Kulzer, Bernhard and Hermanns, Norbert and Ehrmann, Dominic},
  year = {2024},
  journal = {Acta diabetologica},
  volume = {61},
  number = {2},
  pages = {151-159},
  publisher = {Springer},
  address = {Mailand},
  issn = {0940-5429},
  doi = {10.1007/s00592-023-02180-2},
  url = {https://fis.uni-bamberg.de/handle/uniba/95707},
  language = {eng},
  abstract = {Aims:
To analyze if midterm improvement in diabetes distress can be explained by resilience, diabetes acceptance, and patient characteristics.

Methods:
N = 179 adults with type 1 diabetes were enrolled during their stay at a tertiary diabetes center (monocentric enrolment) and followed up over three months in a prospective, observational study (‘DIA-LINK1’). Improvement in diabetes distress was assessed as reduction in the Problem Areas in Diabetes Scale score from baseline to follow-up. Resilience (Resilience Scale-13), acceptance (Diabetes Acceptance Scale), and patient characteristics were analyzed as predictors of improvement in diabetes distress using hierarchical multiple regression.

Results:
Greater reductions in diabetes distress were significantly explained by lower diabetes acceptance at baseline (β = −0.34, p < 0.01), while resilience, diabetes complications, and other person-related variables were not significantly related to changes in diabetes distress (all p > 0.05). When change in diabetes acceptance from baseline to follow-up was added to the model, improved diabetes distress was explained by increasing diabetes acceptance (β = 0.41, p < 0.01) and a shorter duration of diabetes (β = -0.18, p = 0.03), while baseline diabetes acceptance was no longer significantly associated (β = −0.14, p > 0.05).

Conclusions:
Diabetes acceptance is inversely related to diabetes distress, and increasing acceptance explained greater improvement in diabetes distress. These findings suggest that increasing diabetes acceptance may facilitate the reduction of diabetes distress. Treatment approaches targeting acceptance might be useful for the mental healthcare of people with type 1 diabetes and clinically elevated diabetes distress.},
  keywords = {Mental health, Diabetes distress, Psychological resilience, Diabetes acceptance, Prospective study, Diabetes acceptance Prospective study}
}

@article{hermanns2024_94649,
  title = {Person-reported outcomes in diabetes care : What are they and why are they so important?},
  author = {Hermanns, Norbert and Kulzer, Bernhard and Ehrmann, Dominic},
  year = {2024},
  pages = {30-45},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-irb-946496},
  url = {https://fis.uni-bamberg.de/handle/uniba/94649},
  language = {eng},
  abstract = {In this review, we aim to show how person-reported outcomes (PROs) and person-reported experiences (PREs) can significantly contribute to the way diabetes care is delivered, the involvement of people with diabetes in diabetes care, and the collaboration between health care professionals and people with diabetes. This review focuses on the definition and measurement of PROs and PREs, the importance of PROs and PREs for person-centred diabetes care, and integrating the perspectives of people with diabetes in the evaluation of medical, psychological and technological interventions. PROs have been increasingly accepted by Health Technology Assessment bodies and are therefore valued in the context of reimbursement decisions and consequently by regulators and other health care stakeholders for the allocation of health care resources. Furthermore, the review identified current challenges to the assessment and use of PROs and PREs in clinical care and research. These challenges relate to the combination of questionnaires and ecological momentary assessment for measuring PROs and PREs, lack of consensus on a core outcome set, limited sensitivity to change within many measures and insufficient standardization of what can be considered a minimal clinically important difference. Another issue that has not been sufficiently addressed is the involvement of people with diabetes in the design and development of measures to assess PROs and PREs.},
  keywords = {health economics, patient reported outcomes, type 1 diabetes, type 2 diabetes}
}

@article{hermanns2024_94648,
  title = {Person-reported outcomes in diabetes care : What are they and why are they so important?},
  author = {Hermanns, Norbert and Kulzer, Bernhard and Ehrmann, Dominic},
  year = {2024},
  journal = {Diabetes, obesity and metabolism},
  volume = {26},
  number = {S1},
  pages = {30-45},
  publisher = {Wiley-Blackwell},
  address = {Oxford [u.a.]},
  issn = {1462-8902},
  doi = {10.1111/dom.15471},
  url = {https://fis.uni-bamberg.de/handle/uniba/94648},
  language = {eng},
  abstract = {In this review, we aim to show how person-reported outcomes (PROs) and person-reported experiences (PREs) can significantly contribute to the way diabetes care is delivered, the involvement of people with diabetes in diabetes care, and the collaboration between health care professionals and people with diabetes. This review focuses on the definition and measurement of PROs and PREs, the importance of PROs and PREs for person-centred diabetes care, and integrating the perspectives of people with diabetes in the evaluation of medical, psychological and technological interventions. PROs have been increasingly accepted by Health Technology Assessment bodies and are therefore valued in the context of reimbursement decisions and consequently by regulators and other health care stakeholders for the allocation of health care resources. Furthermore, the review identified current challenges to the assessment and use of PROs and PREs in clinical care and research. These challenges relate to the combination of questionnaires and ecological momentary assessment for measuring PROs and PREs, lack of consensus on a core outcome set, limited sensitivity to change within many measures and insufficient standardization of what can be considered a minimal clinically important difference. Another issue that has not been sufficiently addressed is the involvement of people with diabetes in the design and development of measures to assess PROs and PREs.},
  keywords = {health economics, patient reported outcomes, type 1 diabetes, type 2 diabetes}
}

@article{schmitt2024_93100,
  title = {Evaluation of a Stepped Care Approach to Manage Depression and Diabetes Distress in Patients with Type 1 Diabetes and Type 2 Diabetes : Results of a Randomized Controlled Trial (ECCE HOMO Study)},
  author = {Schmitt, Andreas and Kulzer, Bernhard and Reimer, Andre and Herder, Christian and Roden, Michael and Haak, Thomas and Hermanns, Norbert},
  year = {2024},
  pages = {107-122},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-irb-931006},
  url = {https://fis.uni-bamberg.de/handle/uniba/93100},
  language = {eng},
  abstract = {Introduction: Depression is a common and serious complication of diabetes. Treatment approaches addressing the specific demands of affected patients are scarce. 

Objective: The aim of this work was to test whether a stepped care approach for patients with diabetes and depression and/or diabetes distress yields greater depression reduction than treatment-as-usual. 

Methods: Two-hundred and sixty patients with diabetes and elevated depressive symptoms (CES-D ≥16) and/or elevated diabetes distress (PAID ≥40) were randomized to stepped care for depression or diabetes treatment-as-usual. The primary outcome was the rate of meaningful depression reduction at the 12-month follow-up according to the HAMD (score <9 or reduction by ≥50\%). Secondary outcomes were changes in depression scores (HAMD/CES-D), diabetes distress (PAID), diabetes acceptance (AADQ), well-being (WHO-5), quality of life (EQ-5D/SF-36), self-care behavior (SDSCA/DSMQ), HbA1c, and biomarkers of inflammation. 

Results: One-hundred and thirty-one individuals were assigned to stepped care and 129 to treatment-as-usual. Overall, 15.4\% were lost to follow-up. Meaningful depression reduction was observed in 80.2 versus 51.2\% in stepped care versus treatment-as-usual (p < 0.001, intention-to-treat analysis). Of the secondary measures, the HAMD (∆ –3.2, p < 0.001), WHO-5 (∆ 1.5, p = 0.007), and AADQ (∆ –1.0, p = 0.008) displayed significant treatment effects, while effects on CES-D (∆ –2.3, p = 0.065), PAID (∆ –3.5, p = 0.109), and SDSCA (∆ 0.20, p = 0.081) were not significantly different. Both groups showed comparable changes in EQ-5D/SF-36, DSMQ, HbA1c, and biomarkers of inflammation (all p ≥ 0.19). 

Conclusions: The stepped care approach improved depression, well-being, and acceptance. The results support that increasing treatment intensity on demand is effective and can help provide more optimal treatment. The inclusion of diabetes-specific interventions may be beneficial for patients with diabetes and elevated depression.},
  keywords = {Cognitive-behavioral therapy, Mood disorder, Depressive symptoms, Emotional distress, Stepped care approach}
}

@article{bendig2024_93098,
  title = {ACTonDiabetes : study protocol of a pragmatic randomised controlled trial for the evaluation of an acceptance and commitment-based internet-based and mobile-based intervention for adults living with type 1 or type 2 diabetes},
  author = {Bendig, Eileen and Schmitt, Andreas and Wittenberg, Amelie and Kulzer, Bernhard and Hermanns, Norbert and Moshagen, Morten and Baumeister, Harald},
  year = {2024},
  pages = {1-13},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-irb-930984},
  url = {https://fis.uni-bamberg.de/handle/uniba/93098},
  language = {eng},
  abstract = {Introduction 
Living with diabetes can be burdensome and lead to serious emotional distress and impaired mental health. Acceptance and commitment therapy (ACT) can support people facing the challenges of living with diabetes. This trial aims to evaluate the effectiveness and cost-effectiveness of the internet-based and mobile-based intervention (IMI) ‘ACTonDiabetes’ in reducing diabetes distress against enhanced treatment as usual (TAU+) following specialised diabetes care.

Methods and analysis 
A two-armed pragmatic randomised controlled trial will be conducted to evaluate the guided IMI ACTonDiabetes against TAU+. A total of 210 adults with type 1 or type 2 diabetes and elevated diabetes distress (Problem Areas in Diabetes ≥40) will be recruited at a specialised diabetes centre. The intervention begins 2–4 weeks after hospital discharge and takes about 7–10 weeks to complete. Assessments are performed at baseline and 5 and 10 weeks as well as 6 and 12 months after randomisation. The primary outcome is diabetes distress at a 10-week follow-up (T2). Secondary outcomes are depression (Patient Health Questionnaire-8), psychological well-being (WHO-5), quality of life (Assessment of Quality of Life-8 Dimension), Diabetes-related Self-Management Questionnaire, diabetes acceptance (Acceptance and Action Diabetes Questionnaire) and negative treatment effects (Inventory for the Assessment of Negative Effects of Psychotherapy). All statistical analyses will be performed based on the intention-to-treat principle with additional per-protocol analyses. Changes in outcomes will be evaluated using the general linear model. A health-economic evaluation will be conducted from a societal perspective. Reasons for drop-out will be systematically investigated.

Ethics and dissemination 
This clinical trial has been approved by the State Medical Chamber of Baden-Württemberg (file no. B-F-2019-010). Trial results will be submitted for publication in a peer-reviewed journal and presented at conferences.

Trial registration number DRKS00016738.},
  keywords = {Diabetes}
}

@article{hermanns2023_109974,
  title = {Evaluation of a Digital Health Tool for Titration of Basal Insulin in People With Type 2 Diabetes : Rationale and Design of a Randomized Controlled Trial},
  author = {Hermanns, Norbert and Ehrmann, Dominic and Finke-Gröne, Katharina and Roos, Timm and Freckmann, Guido and Kulzer, Bernhard},
  year = {2023},
  journal = {Journal of Diabetes Science and Technology},
  volume = {18},
  number = {4},
  pages = {946-955},
  publisher = {Sage Publishing},
  address = {London},
  issn = {1932-2968},
  doi = {10.1177/19322968221148756},
  url = {https://fis.uni-bamberg.de/handle/uniba/109974},
  language = {eng}
}

@article{kulzer2023_108638,
  title = {Grundlagen des Diabetesmanagements},
  author = {Kulzer, Bernhard and Aberle, Jens and Haak, Thomas and Kaltheuner, Matthias and Kröger, Jens and Landgraf, Rüdiger and Kellerer, Monika},
  year = {2023},
  journal = {Die Diabetologie : Organ der Deutschen Gesellschaft für Innere Medizin, des Berufsverbandes Deutscher Internistinnen und Internisten, des Berufsverbandes Deutscher Endokrinologen und der Arbeitsgemeinschaft niedergelassener diabetologisch Tätiger Ärzte e.V.},
  volume = {19},
  number = {2},
  pages = {144-154},
  publisher = {Springer Medizin Verlag GmbH},
  address = {Berlin},
  issn = {2731-7455},
  doi = {10.1007/s11428-023-01007-6},
  url = {https://fis.uni-bamberg.de/handle/uniba/108638},
  language = {deu}
}

@article{penfornis2023_108618,
  title = {Use of devices and digital tools for T1D management : insights from a survey of people with T1D and their caregivers},
  author = {Penfornis, A. and Kulzer, B. and Down, S. and Seignez, A. and Vives, A. and Bonnemaire, M.},
  year = {2023},
  journal = {Diabetes Research and Clinical Practice},
  volume = {197},
  number = {Supplement 1, 110332},
  pages = {22-23},
  publisher = {Elsevier Science},
  address = {Amsterdam [u.a.]},
  issn = {1872-8227},
  doi = {10.1016/j.diabres.2023.110332},
  url = {https://fis.uni-bamberg.de/handle/uniba/108618},
  language = {eng}
}

@article{kulzer2023_108547,
  title = {Grundlagen des Diabetesmanagements},
  author = {Kulzer, Bernhard and Aberle, Jens and Haak, Thomas and Kaltheuner, Matthias and Kröger, Jens and Landgraf, Rüdiger and Kellerer, Monika},
  year = {2023},
  journal = {Diabetologie und Stoffwechsel : offizielles Organ der Deutschen Diabetes-Gesellschaft},
  volume = {18},
  number = {S2},
  pages = {S89-S99},
  publisher = {Thieme},
  address = {Stuttgart},
  issn = {1861-9002},
  doi = {10.1055/a-2075-9798},
  url = {https://fis.uni-bamberg.de/handle/uniba/108547},
  language = {deu}
}

@inproceedings{olesen2023_97754,
  title = {Psychosoziale Versorgung in Deutschland: Erkenntnisse aus dem dia·link Diabetes-Panel},
  author = {Olesen, Birgit and Priesterroth, Lilli and Ehrmann, Dominic and Roos, Timm and Haak, Thomas and Kulzer, Bernhard and Hermanns, Norbert},
  year = {2023},
  volume = {18},
  number = {Suppl.1},
  pages = {71},
  publisher = {Georg Thieme Verlag},
  address = {Stuttgart},
  issn = {1861-9010},
  doi = {10.1055/s-0043-1768006},
  url = {https://fis.uni-bamberg.de/handle/uniba/97754},
  language = {deu}
}

@inproceedings{priesterroth2023_97753,
  title = {Das dia·link online-Panel für Menschen mit Diabetes, Angehörige und Behandler*innen},
  author = {Priesterroth, Lilli and Ehrmann, Dominic and Roos, Timm and Haak, Thomas and Hermanns, Norbert and Kulzer, Bernhard and Olesen, Birgit},
  year = {2023},
  volume = {18},
  number = {Suppl.1},
  pages = {47-48},
  publisher = {Georg Thieme Verlag},
  address = {Stuttgart},
  issn = {1861-9010},
  doi = {10.1055/s-0043-1767946},
  url = {https://fis.uni-bamberg.de/handle/uniba/97753},
  language = {deu}
}

@inproceedings{kulzer2023_97755,
  title = {Optimierungsmöglichkeiten von AID-Systemen, Insulinpumpen und CGM : Einschätzungen von Diabetologen/innen und Diabetesberatern/assistenten/innen},
  author = {Kulzer, Bernhard and Roos, Timm and Ehrmann, Dominic and Hermanns, Norbert and Heinemann, Lutz},
  year = {2023},
  volume = {18},
  number = {Suppl.1},
  pages = {36-37},
  publisher = {Georg Thieme Verlag},
  address = {Stuttgart},
  issn = {1861-9010},
  doi = {10.1055/s-0043-1767919},
  url = {https://fis.uni-bamberg.de/handle/uniba/97755},
  language = {deu}
}

@inproceedings{kulzer2023_97756,
  title = {Wie zufrieden sind Menschen mit Typ-2-Diabetes mit einer App zur Basalinsulin-Titration?},
  author = {Kulzer, Bernhard and Ehrmann, Dominic and Finke-Gröne, Katharina and Roos, Timm and Hermanns, Norbert},
  year = {2023},
  volume = {18},
  number = {Suppl.1},
  pages = {66},
  publisher = {Georg Thieme Verlag},
  address = {Stuttgart},
  issn = {1861-9010},
  doi = {10.1055/s-0043-1767993},
  url = {https://fis.uni-bamberg.de/handle/uniba/97756},
  language = {deu}
}

@inproceedings{heinemann2023_97757,
  title = {Bedeutung und Nutzung von smarten Insulin-Pens},
  author = {Heinemann, Lutz and Hermanns, Norbert and Roos, Timm and Ehrmann, Dominic and Kulzer, Bernhard},
  year = {2023},
  volume = {18},
  number = {Suppl.1},
  pages = {34},
  publisher = {Georg Thieme Verlag},
  address = {Stuttgart},
  issn = {1861-9010},
  doi = {10.1055/s-0043-1767912},
  url = {https://fis.uni-bamberg.de/handle/uniba/97757},
  language = {deu}
}

@inproceedings{kulzer2023_97759,
  title = {Efficacy of a digital diabetes logbook : findings from a randomised controlled trial},
  author = {Kulzer, Bernhard and Ehrmann, Dominic and Silbermann, Stephan and Finke-Gröne, Katharina and Roos, Timm and Schäfer, V. and Vesper, Iris and Hermanns, Norbert and Kober, Johanna},
  year = {2023},
  volume = {66},
  number = {S1},
  pages = {83-84},
  publisher = {Springer Science and Business Media LLC},
  address = {Berlin},
  issn = {1432-0428},
  doi = {10.1007/s00125-023-05969-6},
  url = {https://fis.uni-bamberg.de/handle/uniba/97759},
  language = {eng}
}

@inproceedings{hermanns2023_97760,
  title = {Efficacy of a basal insulin titration app on glycaemic outcomes in people with type 2 diabetes on an oral-basal insulin regimen : results of an RCT},
  author = {Hermanns, Norbert and Ehrmann, Dominic and Finke-Gröne, Katharina and Roos, Timm and Kulzer, Bernhard},
  year = {2023},
  volume = {66},
  number = {S1},
  pages = {S417},
  publisher = {Springer Science and Business Media LLC},
  address = {Berlin},
  issn = {1432-0428},
  doi = {10.1007/s00125-023-05969-6},
  url = {https://fis.uni-bamberg.de/handle/uniba/97760},
  language = {eng}
}

@inproceedings{heinemann2023_97758,
  title = {Wie viele Menschen mit Diabetes haben eine Indikation für moderne Diabetestechnologien?},
  author = {Heinemann, Lutz and Roos, Timm and Ehrmann, Dominic and Hermanns, Norbert and Kulzer, Bernhard},
  year = {2023},
  volume = {18},
  number = {Suppl.1},
  pages = {36},
  publisher = {Georg Thieme Verlag},
  address = {Stuttgart},
  issn = {1861-9010},
  doi = {10.1055/s-0043-1767918},
  url = {https://fis.uni-bamberg.de/handle/uniba/97758},
  language = {deu}
}

@inproceedings{ehrmann2023_97762,
  title = {Anticipated reduction in hypoglycaemia fear and diabetes distress from increasing the glucose prediction of current CGM algorithms},
  author = {Ehrmann, Dominic and Glatzer, T. and Babio, N. and Priesterroth, Lilli and Olesen, B. and Kulzer, Bernhard and Hermanns, Norbert},
  year = {2023},
  volume = {66},
  number = {S1},
  pages = {428-429},
  publisher = {Springer Science and Business Media LLC},
  address = {Berlin},
  issn = {1432-0428},
  doi = {10.1007/s00125-023-05969-6},
  url = {https://fis.uni-bamberg.de/handle/uniba/97762},
  language = {eng}
}

@inproceedings{finkegrone2023_97761,
  title = {Reductions in hyperglycaemic events following use of a digital diabetes logbook : results of a randomised controlled trial},
  author = {Finke-Gröne, Katharina and Hermanns, Norbert and Silbermann, Stephan and Ehrmann, Dominic and Kober, Johanna and Roos, Timm and Vesper, Iris and Schäfer, V. and Kulzer, Bernhard},
  year = {2023},
  volume = {66},
  number = {S1},
  pages = {434},
  publisher = {Springer Science and Business Media LLC},
  address = {Berlin},
  issn = {1432-0428},
  doi = {10.1007/s00125-023-05969-6},
  url = {https://fis.uni-bamberg.de/handle/uniba/97761},
  language = {eng}
}

@inproceedings{heinemann2023_97770,
  title = {Importance and Use of Smart Insulin Pens with Connectivity for Diabetes Management},
  author = {Heinemann, Lutz and Ehrmann, Dominic and Hermanns, Norbert and Roos, Timm and Kulzer, Bernhard},
  year = {2023},
  volume = {72},
  number = {Supplement\_1},
  pages = {984-P},
  publisher = {American Diabetes Association},
  address = {Alexandria, Va},
  issn = {1939-327X},
  doi = {10.2337/db23-984-p},
  url = {https://fis.uni-bamberg.de/handle/uniba/97770},
  language = {eng}
}

@inproceedings{kulzer2023_97764,
  title = {Interoperability as an Important Factor for Achieving the Full Potential of a Digital Diabetes Logbook},
  author = {Kulzer, Bernhard and Hermanns, Norbert and Vesper, Iris and Schaefer, Vanessa L. and Silbermann, Stephan and Kober, Johanna and Finke-Gröne, Katharina and Roos, Timm and Bingol, Ezgi and Ehrmann, Dominic},
  year = {2023},
  volume = {72},
  number = {Supplement\_1},
  pages = {P-698},
  publisher = {American Diabetes Association},
  address = {Alexandria, Va},
  issn = {1939-327X},
  doi = {10.2337/db23-698-p},
  url = {https://fis.uni-bamberg.de/handle/uniba/97764},
  language = {eng}
}

@article{kulzer2023_97794,
  title = {Kognition und Depression bei älteren Menschen mit Diabetes},
  author = {Kulzer, Bernhard},
  year = {2023},
  journal = {Die Diabetologie : Organ der Deutschen Gesellschaft für Innere Medizin, des Berufsverbandes Deutscher Internistinnen und Internisten, des Berufsverbandes Deutscher Endokrinologen und der Arbeitsgemeinschaft niedergelassener diabetologisch Tätiger Ärzte e.V.},
  volume = {19},
  number = {7},
  pages = {835-841},
  publisher = {Springer Science and Business Media LLC},
  address = {Berlin},
  issn = {2731-7455},
  doi = {10.1007/s11428-023-01102-8},
  url = {https://fis.uni-bamberg.de/handle/uniba/97794},
  language = {deu}
}

@inproceedings{ehrmann2023_97766,
  title = {How Satisfied Are People with Type 2 Diabetes with a Basal Insulin Titration App? : Findings from the Intervention Group of a Randomized Controlled Trial},
  author = {Ehrmann, Dominic and Hermanns, Norbert and Roos, Timm and Finke-Gröne, Katharina and Kulzer, Bernhard},
  year = {2023},
  volume = {72},
  number = {Supplement\_1},
  pages = {666-P},
  publisher = {American Diabetes Association},
  address = {Alexandria, Va},
  issn = {1939-327X},
  doi = {10.2337/db23-666-p},
  url = {https://fis.uni-bamberg.de/handle/uniba/97766},
  language = {eng}
}

@inproceedings{hermanns2023_97768,
  title = {Impact of a Titration App for Basal Insulin on Glycaemic Outcomes in People with Type 2 Diabetes on an Oral-Basal Insulin Regimen : Results of an RCT},
  author = {Hermanns, Norbert and Ehrmann, Dominic and Roos, Timm and Finke-Gröne, Katharina and Kulzer, Bernhard},
  year = {2023},
  volume = {72},
  number = {Supplement\_1},
  pages = {932-P},
  publisher = {American Diabetes Association},
  address = {Alexandria, Va},
  issn = {1939-327X},
  doi = {10.2337/db23-932-p},
  url = {https://fis.uni-bamberg.de/handle/uniba/97768},
  language = {eng}
}

@inproceedings{kulzer2023_97765,
  title = {Is Insulin Titration Supported by a Titration App Safe? : Safety Results of an RCT},
  author = {Kulzer, Bernhard and Ehrmann, Dominic and Roos, Timm and Finke-Gröne, Katharina and Hermanns, Norbert},
  year = {2023},
  volume = {72},
  number = {Supplement\_1},
  pages = {985-P},
  publisher = {American Diabetes Association},
  address = {Alexandria, Va},
  issn = {1939-327X},
  doi = {10.2337/db23-985-p},
  url = {https://fis.uni-bamberg.de/handle/uniba/97765},
  language = {eng}
}

@inproceedings{ehrmann2023_97767,
  title = {Efficacy of a Digital Diabetes Logbook for Reducing Treatment Burden : Results of a Randomized Controlled Trial},
  author = {Ehrmann, Dominic and Hermanns, Norbert and Silbermann, Stephan and Kober, Johanna and Finke-Gröne, Katharina and Roos, Timm and Vesper, Iris and Schaefer, Vanessa L and Kulzer, Bernhard},
  year = {2023},
  volume = {72},
  number = {Supplement\_1},
  pages = {664-P},
  publisher = {American Diabetes Association},
  address = {Alexandria, Va},
  issn = {1939-327X},
  doi = {10.2337/db23-664-p},
  url = {https://fis.uni-bamberg.de/handle/uniba/97767},
  language = {eng}
}

@inproceedings{hermanns2023_97774,
  title = {A randomized controlled trial to test the efficacy of a titration app for people with type 2 diabetes : Baseline characteristics},
  author = {Hermanns, Norbert and Ehrmann, Dominic and Finke-Gröne, Katharina and Roos, Timm and Kulzer, Bernhard},
  year = {2023},
  volume = {25},
  number = {S2},
  pages = {A98-A99},
  publisher = {Mary Ann Liebert Inc},
  address = {Larchmont, NY},
  issn = {1557-8593},
  doi = {10.1089/dia.2023.2525.abstracts},
  url = {https://fis.uni-bamberg.de/handle/uniba/97774},
  language = {eng}
}

@inproceedings{hermanns2023_97773,
  title = {Satisfaction with mySugr in the intervention group of a randomized controlled trial},
  author = {Hermanns, Norbert and Ehrmann, Dominic and Silbermann, Stephan and Kober, J. and Finke-Gröne, Katharina and Roos, Timm and Bingol E and Schäfer V and Kulzer, Bernhard},
  year = {2023},
  volume = {25},
  number = {S2},
  pages = {A78},
  publisher = {Mary Ann Liebert Inc},
  address = {Larchmont, NY},
  issn = {1557-8593},
  doi = {10.1089/dia.2023.2525.abstracts},
  url = {https://fis.uni-bamberg.de/handle/uniba/97773},
  language = {eng}
}

@inproceedings{heinemann2023_97775,
  title = {Current and future importance and use of smart insulin pens},
  author = {Heinemann, Lutz and Ehrmann, Dominic and Roos, Timm and Hermanns, Norbert and Kulzer, Bernhard},
  year = {2023},
  volume = {25},
  number = {S2},
  pages = {A216},
  publisher = {Mary Ann Liebert Inc},
  address = {Larchmont, NY},
  issn = {1557-8593},
  doi = {10.1089/dia.2023.2525.abstracts},
  url = {https://fis.uni-bamberg.de/handle/uniba/97775},
  language = {eng}
}

@inproceedings{kulzer2023_97772,
  title = {Do modern diabetes technologies burden or unburden people with diabetes?},
  author = {Kulzer, Bernhard and Hermanns, Norbert and Ehrmann, Dominic and Roos, Timm and Heinemann, Lutz},
  year = {2023},
  volume = {25},
  number = {S2},
  pages = {A78},
  publisher = {Mary Ann Liebert Inc},
  address = {Larchmont, NY},
  issn = {1557-8593},
  doi = {10.1089/dia.2023.2525.abstracts},
  url = {https://fis.uni-bamberg.de/handle/uniba/97772},
  language = {eng}
}

@inproceedings{kulzer2023_97771,
  title = {100 years of insulin : What do people with diabetes think about insulin, what are their wishes and hopes for the future?},
  author = {Kulzer, Bernhard and Roos, Timm and Ehrmann, Dominic and Hermanns, Norbert and Kröger J},
  year = {2023},
  volume = {25},
  number = {S2},
  pages = {A217-A218},
  publisher = {Mary Ann Liebert Inc},
  address = {Larchmont, NY},
  issn = {1557-8593},
  doi = {10.1089/dia.2023.2525.abstracts},
  url = {https://fis.uni-bamberg.de/handle/uniba/97771},
  language = {eng}
}

@inproceedings{hermanns2023_97769,
  title = {How Frequently Do People with Diabetes Use a Digital Diabetes Logbook and How Satisfied Are They with It?},
  author = {Hermanns, Norbert and Ehrmann, Dominic and Silbermann, Stephan and Kober, Johanna and Vesper, Iris and Finke-Gröne, Katharina and Roos, Timm and Bingol, Ezgi and Kulzer, Bernhard},
  year = {2023},
  volume = {72},
  number = {Supplement\_1},
  pages = {715-P},
  publisher = {American Diabetes Association},
  address = {Alexandria, Va},
  issn = {1939-327X},
  doi = {10.2337/db23-715-p},
  url = {https://fis.uni-bamberg.de/handle/uniba/97769},
  language = {eng}
}

@article{schmitt2023_97781,
  title = {Depressionen bei Diabetes mellitus (Teil 2) : Praxis der Diagnostik und Behandlung},
  author = {Schmitt, Andreas and Kulzer, Bernhard and Kruse, Johannes and Ehrmann, Dominic and Haak, Thomas and Hermanns, Norbert},
  year = {2023},
  journal = {Die Diabetologie : Organ der Deutschen Gesellschaft für Innere Medizin, des Berufsverbandes Deutscher Internistinnen und Internisten, des Berufsverbandes Deutscher Endokrinologen und der Arbeitsgemeinschaft niedergelassener diabetologisch Tätiger Ärzte e.V.},
  volume = {19},
  number = {6},
  pages = {789-800},
  publisher = {Springer Science and Business Media LLC},
  address = {Berlin},
  issn = {2731-7455},
  doi = {10.1007/s11428-023-01015-6},
  url = {https://fis.uni-bamberg.de/handle/uniba/97781},
  language = {deu}
}

@article{schmitt2023_97780,
  title = {Depressionen bei Diabetes mellitus (Teil 1) : Merkmale, Verbreitung, Entstehung, Auswirkungen},
  author = {Schmitt, Andreas and Kulzer, Bernhard and Kruse, Johannes and Ehrmann, Dominic and Haak, Thomas and Hermanns, Norbert},
  year = {2023},
  journal = {Die Diabetologie : Organ der Deutschen Gesellschaft für Innere Medizin, des Berufsverbandes Deutscher Internistinnen und Internisten, des Berufsverbandes Deutscher Endokrinologen und der Arbeitsgemeinschaft niedergelassener diabetologisch Tätiger Ärzte e.V.},
  volume = {19},
  number = {4},
  pages = {533-542},
  publisher = {Springer Science and Business Media LLC},
  address = {Berlin},
  issn = {2731-7455},
  doi = {10.1007/s11428-022-00990-6},
  url = {https://fis.uni-bamberg.de/handle/uniba/97780},
  language = {deu}
}

@inproceedings{ehrmann2023_97778,
  title = {Evaluating the efficacy of mySugr in a randomized controlled trial : Baseline characteristics},
  author = {Ehrmann, Dominic and Kulzer, Bernhard and Silbermann, Stephan and Kober, J. and Finke-Gröne, Katharina and Roos, Timm and Vesper, Iris and Schäfer, V. and Hermanns, Norbert},
  year = {2023},
  volume = {25},
  number = {S2},
  pages = {A66},
  publisher = {Mary Ann Liebert Inc},
  address = {Larchmont, NY},
  issn = {1557-8593},
  doi = {10.1089/dia.2023.2525.abstracts},
  url = {https://fis.uni-bamberg.de/handle/uniba/97778},
  language = {eng}
}

@inproceedings{ehrmann2023_97777,
  title = {Assessing barriers and adherence to insulin injection technique in people with diabetes : Development and validation of a new assessment tool},
  author = {Ehrmann, Dominic and Kulzer, Bernhard and Wienbarg, I. and Sieber, J. and Weber, S. and Haak, Thomas and Hermanns, Norbert},
  year = {2023},
  volume = {25},
  number = {S2},
  pages = {A213-A214},
  publisher = {Mary Ann Liebert Inc.},
  address = {Larchmont, NY},
  issn = {1557-8593},
  doi = {10.1089/dia.2023.2525.abstracts},
  url = {https://fis.uni-bamberg.de/handle/uniba/97777},
  language = {eng}
}

@article{tittel2023_97779,
  title = {The WHO-5 well-being questionnaire in type 1 diabetes : screening for depression in pediatric and young adult subjects},
  author = {Tittel, Sascha René and Kulzer, Bernhard and Warschburger, Petra and Merz, Ulrich and Galler, Angela and Wagner, Christian and Plaumann, Maike and Siegel, Erhard G. and Holl, Reinhard Walter},
  year = {2023},
  journal = {The journal of pediatric endocrinology and metabolism : JPEM},
  volume = {36},
  number = {4},
  pages = {384-392},
  publisher = {Walter de Gruyter GmbH},
  address = {Berlin},
  issn = {2191-0251},
  doi = {10.1515/jpem-2023-0013},
  url = {https://fis.uni-bamberg.de/handle/uniba/97779},
  language = {eng}
}

@inproceedings{heinemann2023_97776,
  title = {Digital diabetes clinic},
  author = {Heinemann, Lutz and Ehrmann, Dominic and Roos, Timm and Hermanns, Norbert and Kulzer, Bernhard},
  year = {2023},
  volume = {25},
  number = {S2},
  pages = {A201},
  publisher = {Mary Ann Liebert Inc},
  address = {Larchmont, NY},
  issn = {1557-8593},
  doi = {10.1089/dia.2023.2525.abstracts},
  url = {https://fis.uni-bamberg.de/handle/uniba/97776},
  language = {eng}
}

@article{hermanns2023_97789,
  title = {Evidence and Diabetes Technology : A Catch-22?},
  author = {Hermanns, Norbert and Kulzer, Bernd and Klonoff, David C. and Heinemann, Lutz},
  year = {2023},
  journal = {Journal of diabetes science and technology : JDST},
  volume = {17},
  number = {6},
  pages = {1427-1432},
  publisher = {SAGE Publications},
  address = {London},
  issn = {1932-2968},
  doi = {10.1177/19322968231170884},
  url = {https://fis.uni-bamberg.de/handle/uniba/97789},
  language = {eng}
}

@article{schmitt2023_97782,
  title = {Assessing fear of complications in people with type 1 and type 2 diabetes with the Fear of Diabetes Complications Questionnaire},
  author = {Schmitt, Andreas and Ehrmann, Dominic and Kuniss, Nadine and Müller, Nicolle and Kulzer, Bernhard and Hermanns, Norbert},
  year = {2023},
  journal = {Health Psychology},
  volume = {42},
  number = {9},
  pages = {674-685},
  publisher = {American Psychological Association (APA)},
  address = {Washington, DC},
  issn = {1930-7810},
  doi = {10.1037/hea0001304},
  url = {https://fis.uni-bamberg.de/handle/uniba/97782},
  language = {eng}
}

@article{linnenkamp2023_97786,
  title = {PHQ-9, CES-D, health insurance data : who is identified with depression? ; A Population-based study in persons with diabetes},
  author = {Linnenkamp, Ute and Gontscharuk, Veronika and Ogurtsova, Katherine and Brüne, Manuela and Chernyak, Nadezda and Kvitkina, Tatjana and Arend, Werner and Schmitz-Losem, Imke and Kruse, Johannes and Hermanns, Norbert and Kulzer, Bernd and Evers, Silvia M. A. A. and Hiligsmann, Mickaël and Hoffmann, Barbara and Icks, Andrea and Andrich, Silke},
  year = {2023},
  journal = {Diabetology \& metabolic syndrome : official publication of the Brazilian Diabetes Society},
  volume = {15},
  number = {54},
  pages = {1-13},
  publisher = {BMC, United Kingdom},
  address = {London},
  issn = {1758-5996},
  doi = {10.1186/s13098-023-01028-7},
  url = {https://fis.uni-bamberg.de/handle/uniba/97786},
  language = {eng},
  abstract = {Aims:
Several instruments are used to identify depression among patients with diabetes and have been compared for their test criteria, but, not for the overlaps and differences, for example, in the sociodemographic and clinical characteristics of the individuals identified with different instruments.

Methods:
We conducted a cross-sectional survey among a random sample of a statutory health insurance (SHI) (n = 1,579) with diabetes and linked it with longitudinal SHI data. Depression symptoms were identified using either the Centre for Epidemiological Studies Depression (CES-D) scale or the Patient Health Questionnaire-9 (PHQ-9), and a depressive disorder was identified with a diagnosis in SHI data, resulting in 8 possible groups. Groups were compared using a multinomial logistic model.

Results:
In total 33·0\% of our analysis sample were identified with depression by at least one method. 5·0\% were identified with depression by all methods. Multinomial logistic analysis showed that identification through SHI data only compared to the group with no depression was associated with gender (women). Identification through at least SHI data was associated with taking antidepressants and previous depression. Health related quality of life, especially the mental summary score was associated with depression but not when identified through SHI data only.

Conclusion:
The methods overlapped less than expected. We did not find a clear pattern between methods used and characteristics of individuals identified. However, we found first indications that the choice of method is related to specific underlying characteristics in the identified population. These findings need to be confirmed by further studies with larger study samples.},
  keywords = {Depressive disorder diagnosis, Depressive disorder epidemiology, Diabetes Mellitus Type 2 psychology, Diabetes complications}
}

@article{kulzer2023_97793,
  title = {Künstliche Intelligenz (KI) in der Diabetologie : jetzt und in der Zukunft},
  author = {Kulzer, Bernhard},
  year = {2023},
  journal = {Die Diabetologie : Organ der Deutschen Gesellschaft für Innere Medizin, des Berufsverbandes Deutscher Internistinnen und Internisten, des Berufsverbandes Deutscher Endokrinologen und der Arbeitsgemeinschaft niedergelassener diabetologisch Tätiger Ärzte e.V.},
  volume = {19},
  number = {1},
  pages = {35-43},
  publisher = {Springer Science and Business Media LLC},
  address = {Berlin},
  issn = {2731-7455},
  doi = {10.1007/s11428-022-00996-0},
  url = {https://fis.uni-bamberg.de/handle/uniba/97793},
  language = {deu}
}

@article{kulzer2023_97788,
  title = {Psychosocial Factors and Diabetes},
  author = {Kulzer, Bernhard and Albus, Christian and Herpertz, Stephan and Kruse, Johannes and Lange, Karin and Lederbogen, Florian and Petrak, Frank},
  year = {2023},
  journal = {Experimental and clinical endocrinology \& diabetes : official journal},
  volume = {131},
  number = {01/02},
  pages = {94-109},
  publisher = {Georg Thieme Verlag KG},
  address = {Stuttgart},
  issn = {1439-3646},
  doi = {10.1055/a-1946-3863},
  url = {https://fis.uni-bamberg.de/handle/uniba/97788},
  language = {eng}
}

@article{lunkenheimer2023_97785,
  title = {Posttraumatic stress disorder and diabetes-related outcomes in patients with type 1 diabetes},
  author = {Lunkenheimer, Frederike and Eckert, Alexander J. and Hilgard, Dörte and Köth, Daniel and Kulzer, Bernhard and Lück, Ursula and Lüdecke, Blanca and Müller, Antonia and Baumeister, Harald and Holl, Reinhard W.},
  year = {2023},
  journal = {Scientific Reports},
  volume = {13},
  number = {1, 1556},
  pages = {1-11},
  publisher = {Springer Nature},
  address = {London},
  issn = {2045-2322},
  doi = {10.1038/s41598-023-28373-x},
  url = {https://fis.uni-bamberg.de/handle/uniba/97785},
  language = {eng},
  abstract = {Mental comorbidities in patients with type 1 diabetes mellitus (T1D) are common, and can have a negative impact on acute blood glucose levels and long-term metabolic control. Information on the association of T1D and comorbid posttraumatic stress disorder (PTSD) with diabetes-related outcomes is limited. The aim was to examine the associations between a clinical diagnosis of PTSD and diabetes-related outcomes in patients with T1D. Patients with T1D and comorbid documented PTSD from the DPV database (n = 179) were compared to a group with T1D without PTSD (n = 895), and compared to a group with T1D without comorbid mental disorder (n = 895) by matching demographics (age, gender, duration of diabetes, therapy and migration background) 1:5. Clinical diabetes-related outcomes \{body mass index (BMI), hemoglobin A1c (hbA1c), daily insulin dose, diabetic ketoacidosis (DKA), hypoglycemia, number of hospital admissions, number of hospital days\} were analyzed, stratified by age groups (≤ 25 years vs. > 25 years). Patients with comorbid PTSD aged ≤ 25 years compared with patients without PTSD or patients without mental disorders had significantly higher HbA1c (8.71 vs. 8.30 or 8.24\%), higher number of hospital admissions (0.94 vs. 0.44 or 0.32 per year) and higher rates of DKA (0.10 vs. 0.02 or 0.01 events/year). Patients with comorbid PTSD aged ≤ 25 years compared with patients without PTSD had significantly higher BMI (0.85 vs. 0.59) and longer hospital stays (15.89 vs.11.58 days) than patients without PTSD. Patients with PTSD > 25 years compared with patients without PTSD or without any mental comorbidities had significantly fewer hospital admissions (0.49 vs. 0.77 or 0.69), but a longer hospital length of stay (20.35 vs. 11.58 or 1.09 days). We found that PTSD in younger patients with T1D is significantly related to diabetes outcome. In adult patients with T1D, comorbid PTSD is associated with fewer, but longer hospitalizations. Awareness of PTSD in the care of patients with T1D should be raised and psychological intervention should be provided when necessary.},
  keywords = {diabetes}
}

@article{schmitt2023_92508,
  title = {A Self-Report Measure of Diabetes Self-Management for Type 1 and Type 2 Diabetes : The Diabetes Self-Management Questionnaire-Revised (DSMQ-R) – Clinimetric Evidence From Five Studies},
  author = {Schmitt, Andreas and Kulzer, Bernhard and Ehrmann, Dominic and Haak, Thomas and Hermanns, Norbert},
  year = {2023},
  pages = {1-16},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-irb-925083},
  url = {https://fis.uni-bamberg.de/handle/uniba/92508},
  language = {eng},
  abstract = {Aims: Measurement tools to evaluate self-management behavior are useful for diabetes research and clinical practice. The Diabetes Self-Management Questionnaire (DSMQ) was introduced in 2013 and has become a widely used tool. This article presents a revised and updated version, DSMQ-R, and evaluates its properties in assessing self-management practices in type 1 diabetes (T1D) and type 2 diabetes (T2D).

Methods: The DSMQ-R is a multidimensional questionnaire with 27 items regarding essential self-management practices for T1D and T2D (including diabetes-adjusted eating, glucose testing/monitoring, medication taking, physical activity and cooperation with the diabetes team). For the revised form, the original items were partially amended and the wording was updated; eleven items were newly added. The tool was applied as part of health-related surveys in five clinical studies (two cross-sectional, three prospective) including a total of 1,447 people with T1D and T2D. Using this data base, clinimetric properties were rigorously tested.

Results: The analyses showed high internal and retest reliability coefficients for the total scale and moderate to high coefficients for the subscales. Reliability coefficients for scales including the new items were consistently higher. Correlations with convergent criteria and related variables supported validity. Responsiveness was supported by significant short to medium term changes in prospective studies. Significant associations with glycemic outcomes were observed for DSMQ-R-assessed medication taking, glucose monitoring and eating behaviors.

Conclusions: The results support good clinimetric properties of the DSMQ-R. The tool can be useful for research and clinical practice and may facilitate the identification of improvable self-management practices in individuals.},
  keywords = {diabetes, treatment behavior, self-managament, health behavior, clinimetric, measurement instrument, questionnaire, evaluation}
}

@article{kulzer2023_92296,
  title = {Patch Pumps : What are the advantages for people with diabetes?},
  author = {Kulzer, Bernhard and Freckmann, Guido and Heinemann, Lutz and Schnell, Oliver and Hinzmann, Rolf and Ziegler, Ralph},
  year = {2023},
  pages = {109858},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-irb-922964},
  url = {https://fis.uni-bamberg.de/handle/uniba/92296},
  language = {eng},
  abstract = {Aim

Patch pumps, i.e. insulin pumps without tubing, are an attractive alternative to conventional insulin pumps for people with type 1 diabetes and type 2 diabetes on insulin therapy. In this review, potential patient-relevant advantages and disadvantages of patch pumps are summarized and respective studies on patient-reported outcomes (PROs) are assessed.

Methods

Relevant studies were identified through a systematic PubMed search. Reference lists in respective articles and Google Scholar were also checked for additional references. Articles in English published before June 30, 2021, were included; no other criteria on publication dates were set.

Results

A total of 12 studies were included. The results of this analysis provide evidence that patch pumps improve quality of life, reduce diabetes-related distress, increase patient satisfaction, and are preferred by patients compared to conventional insulin pumps and multiple daily injection therapy (MDI). However, several methodological limitations of the studies identified constrain the significance of this analysis.

Conclusions

Despite the limited number of studies evaluating the benefits of patch pumps on PROs, there is increasing evidence that people with diabetes prefer patch pumps. Although there are numerous PROs for patch pumps, it is surprising that this aspect has been relatively understudied. More systematic evaluation studies of the benefits of patch pumps on PROs are needed.},
  keywords = {Patch pump, Tubeless insulin pump, Patient-reported outcomes, Quality of life, Diabetes-related distress, Treatment satisfaction, Patient preference}
}

@article{ehrmann2023_91226,
  title = {Health care effects and medical benefits of a smartphone-based diabetes self-management application : study protocol for a randomized controlled trial},
  author = {Ehrmann, Dominic and Eichinger, V. and Vesper, Iris and Kober, J. and Kraus, M. and Schäfer, V. and Hermanns, Norbert and Kulzer, Bernhard and Silbermann, Stephan},
  year = {2023},
  pages = {1-8},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-irb-912263},
  url = {https://fis.uni-bamberg.de/handle/uniba/91226},
  language = {eng},
  abstract = {Background:
Diabetes self-management is a mainstay of diabetes care, but the implementation of self-management regimens into daily life is complex and often results in discouragement and distress. Modern approaches such as smartphone-based self-management applications are therefore needed to support people with diabetes. Since reimbursability would increase the availability of such digital applications to people with diabetes, we designed a study that meets all scientific and methodological requirements set by the German Digital Healthcare Act to allow reimbursement for a specific application (mySugr PRO). Here, we report the protocol of this study that aims at evaluating the efficacy of the digital self-management application with regard to patient-reported outcomes and medical benefits.

Methods/design:
This multicenter, open-label, randomized, parallel-group, controlled trial will evaluate the health care effects and medical benefits of mySugr PRO. A total of 466 people with diabetes will be randomly allocated (2:1 randomization) to the interventional group (n = 311) that will use the digital self-management application during the 12-week study period or the control group (n = 155; no usage of the application). Baseline and follow-up examinations will assess diabetes distress as the primary endpoint as well as empowerment, HbA1c, blood glucose data, self-management, general well-being, and treatment satisfaction as secondary endpoints. Statistical analyses will use an intention-to-treat procedure (using multiple imputation for missing values) as well as a per-protocol approach for sensitivity analysis.

Discussion:
To the best of our knowledge, this study will be one of the largest diabetes-specific evaluations of a digital health application supporting people with diabetes in their diabetes self-management that follow the requirements of the German Digital Healthcare Act.

Trial registration:
German Clinical Trial Register DRKS00022923. Registered on 22 October 2020.},
  keywords = {Diabetes, Self-management, Diabetes distress, Digital health application}
}

@article{icks2023_91237,
  title = {High Depressive Symptoms in Previously Undetected Diabetes : 10-Year Follow-Up Results of the Heinz Nixdorf Recall Study},
  author = {Icks, Andrea and Wittgens, Charlotte and Haastert, Burkhard and Jöckel, Karl-Heinz and Engel, Miriam and Erbel, Raimund and Andrich, Silke and Kruse, Johannes and Kulzer, Bernd and Hermanns, Norbert and Herder, Christian and Moebus, Susanne and Stang, Andreas and Kowall, Bernd},
  year = {2023},
  journal = {Clinical Epidemiolog},
  pages = {429-438},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-irb-912376},
  url = {https://fis.uni-bamberg.de/handle/uniba/91237},
  language = {eng},
  abstract = {Aim: To determine the 10-year cumulative incidence of high depressive symptoms in people with diagnosed and, in particular, previously undetected diabetes compared to those without diabetes in a population-based cohort study in Germany.

Materials and Methods: We included 2813 participants (52.9\% men, mean age (SD) 58.9 (7.7) years, 7.1\% diagnosed diabetes, 5.6\% previously undetected diabetes) from the Heinz Nixdorf Recall study. We calculated the odds ratios (OR) with 95\% confidence intervals (CI) using multiple logistic regression analyses for diagnosed and undetected diabetes.

Results: Cumulative 10-year incidences (95\%-CI) of high depressive symptoms in participants with diagnosed diabetes, previously undetected diabetes, and without diabetes were 15.4\% (10.7– 21.2), 10.1\% (5.9– 15.9), and 12.4\% (11.1– 13.8), respectively. Age-sex-adjusted ORs were 1.51 (1.01– 2.28) in participants with diagnosed diabetes compared to those without, 1.40 (0.92– 2.12) after adjustment for BMI, physical activity, education, and smoking, and 1.33 (0.87– 2.02) after further adjustment for stroke and myocardial infarction. ORs in participants with previously undetected diabetes were 0.96 (0.56– 1.65), 0.85 (0.49– 1.47), and 0.85 (0.49– 1.48), respectively, and lower in men than in women.

Conclusion: As expected, we found an increased odds of developing high depressive symptoms in participants with diagnosed diabetes. However, the odds ratios decreased when we considered comorbidities and other covariates. Interestingly, in participants with previously undetected diabetes, the odds was not increased, even 10 years after detection of diabetes. These results support the hypothesis that high depressive symptoms develop due to diabetes-related burdens and comorbidities and not due to hyperglycemia or hyperinsulinemia.},
  keywords = {diabetes, undetected diabetes, depressive symptoms, prospective population-based cohort study}
}

@article{hermanns2023_89983,
  title = {Use of smartphone application versus written titration charts for basal insulin titration in adults with type 2 diabetes and suboptimal glycaemic control (My Dose Coach) : multicentre, open-label, parallel, randomised controlled trial},
  author = {Hermanns, Norbert and Ehrmann, Dominic and Krichbaum, Michael and Roos, Timm and Haak, Thomas Jürgen and Freckmann, Guido and Kulzer, Bernhard and Finke-Gröne, Katharina},
  year = {2023},
  pages = {1-12},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-irb-899837},
  url = {https://fis.uni-bamberg.de/handle/uniba/89983},
  language = {eng},
  abstract = {Background
The majority of people with type 2 diabetes who require insulin therapy use only basal insulin in combination with other anti-diabetic agents. We tested whether using a smartphone application to titrate insulin could improve glycaemic control in people with type 2 diabetes who use basal insulin.

Methods
This was a 12-week, multicentre, open-label, parallel, randomised controlled trial conducted in 36 diabetes practices in Germany. Eligible participants had type 2 diabetes, a BMI ≥25.0 kg/m2, were on basal insulin therapy or were initiating basal insulin therapy, and had suboptimal glycaemic control (HbA1c >7.5\%; 58.5 mmol/mol). Block randomisation with 1:1 allocation was performed centrally. Participants in the intervention group titrated their basal insulin dose using a smartphone application (My Dose Coach) for 12 weeks. Control group participants titrated their basal insulin dose according to a written titration chart. The primary outcome was the baseline-adjusted change in HbA1c at 12 weeks. The intention-to-treat analysis included all randomised participants.

Results
Between 13 July 2021 and 21 March 2022, 251 study participants were randomly assigned (control group: n = 123; intervention group: n = 128), and 236 completed the follow-up phase (control group: n = 119; intervention group: n = 117). Regarding the HbA1c a model-based adjusted between-group difference of −0.31\% (95\% CI: 0.01\%–0.69\%; p = 0.0388) in favour of the intervention group was observed. There were 30 adverse events reported: 16 in the control group, 14 in the intervention group. Of these, 15 adverse events were serious. No event was considered to be related to the investigational device.

Interpretation
Study results suggest that utilizing this digital health smartphone application for basal insulin titration may have resulted in a comparatively greater reduction in HbA1c levels among individuals with type 2 diabetes, as compared to basal insulin titration guided by a written titration schedule. No negative effect on safety outcomes was observed.

Funding
Sanofi-Aventis Deutschland GmbH.},
  keywords = {Type 2 diabetes, Basal insulin, Insulin titration, Digital health tool, Titration app}
}

@article{hermanns2023_90005,
  title = {Use of smartphone application versus written titration charts for basal insulin titration in adults with type 2 diabetes and suboptimal glycaemic control (My Dose Coach) : multicentre, open-label, parallel, randomised controlled trial},
  author = {Hermanns, Norbert and Ehrmann, Dominic and Krichbaum, Michael and Haak, Thomas Jürgen and Freckmann, Guido and Kulzer, Bernhard and Finke-Groene, Katharina and Roos, Timm},
  year = {2023},
  journal = {The Lancet Regional Health - Europe},
  number = {Online},
  pages = {1-12},
  publisher = {Elsevier},
  address = {Amsterdam},
  issn = {2666-7762},
  doi = {10.1016/j.lanepe.2023.100702},
  url = {https://fis.uni-bamberg.de/handle/uniba/90005},
  language = {eng},
  abstract = {Background
The majority of people with type 2 diabetes who require insulin therapy use only basal insulin in combination with other anti-diabetic agents. We tested whether using a smartphone application to titrate insulin could improve glycaemic control in people with type 2 diabetes who use basal insulin.

Methods
This was a 12-week, multicentre, open-label, parallel, randomised controlled trial conducted in 36 diabetes practices in Germany. Eligible participants had type 2 diabetes, a BMI ≥25.0 kg/m2, were on basal insulin therapy or were initiating basal insulin therapy, and had suboptimal glycaemic control (HbA1c >7.5\%; 58.5 mmol/mol). Block randomisation with 1:1 allocation was performed centrally. Participants in the intervention group titrated their basal insulin dose using a smartphone application (My Dose Coach) for 12 weeks. Control group participants titrated their basal insulin dose according to a written titration chart. The primary outcome was the baseline-adjusted change in HbA1c at 12 weeks. The intention-to-treat analysis included all randomised participants.

Results
Between 13 July 2021 and 21 March 2022, 251 study participants were randomly assigned (control group: n = 123; intervention group: n = 128), and 236 completed the follow-up phase (control group: n = 119; intervention group: n = 117). Regarding the HbA1c a model-based adjusted between-group difference of −0.31\% (95\% CI: 0.01\%–0.69\%; p = 0.0388) in favour of the intervention group was observed. There were 30 adverse events reported: 16 in the control group, 14 in the intervention group. Of these, 15 adverse events were serious. No event was considered to be related to the investigational device.

Interpretation
Study results suggest that utilizing this digital health smartphone application for basal insulin titration may have resulted in a comparatively greater reduction in HbA1c levels among individuals with type 2 diabetes, as compared to basal insulin titration guided by a written titration schedule. No negative effect on safety outcomes was observed.

Funding
Sanofi-Aventis Deutschland GmbH.},
  keywords = {Type 2 diabetes, Basal insulin, Insulin titration, Digital health tool, Titration app}
}

@article{ehrmann2023_59711,
  title = {Reduced heart rate variability in people with type 1 diabetes and elevated diabetes distress: Results from the longitudinal observational DIA‐LINK1 study},
  author = {Ehrmann, Dominic and Hermanns, Norbert and Kulzer, Bernhard and Chatwin, Hannah and Schmitt, Andreas and Soeholm, Uffe and Axelsen, Johanne Lundager and Broadley, Melanie and Haak, Thomas and Pouwer, Frans},
  year = {2023},
  pages = {1-11},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-irb-597115},
  url = {https://fis.uni-bamberg.de/handle/uniba/59711},
  language = {eng},
  abstract = {Aims

People with type 1 diabetes have a higher risk for cardiovascular disease (CVD). Reduced heart rate variability (HRV) is a clinical marker for CVD. In this observational study using continuous HRV measurement across 26 days, we investigated whether psychological stressors (diabetes distress, depressive symptoms) and glycaemic parameters (hypo- and hyperglycaemic exposure, glycaemic variability and HbA1c) are associated with lower HRV in people with type 1 diabetes.

Methods

Data from the non-interventional prospective DIA-LINK1 study were analysed. At baseline, depressive symptoms and diabetes distress were assessed. Glucose values and HRV were recorded daily for 26 days using continuous glucose monitoring (CGM) and a wrist-worn health tracker respectively. Multilevel modelling with participant as nesting factor was used to analyse associations between day-to-day HRV and diabetes distress, depressive symptoms and CGM-derived parameters.

Results

Data from 149 participants were analysed (age: 38.3 ± 13.1 years, HbA1c: 8.6 ± 1.9\%). Participants with elevated diabetes distress had a significantly lower HRV across the 26 days compared to participants without elevated distress (β = −0.28; p = 0.004). Elevated depressive symptoms were not significantly associated with HRV (β = −0.18; p = 0.074). Higher daily exposure to hyperglycaemia (β = −0.44; p = 0.044), higher average exposure to hypoglycaemia (β = −0.18; p = 0.042) and higher HbA1c (β = −0.20; p = 0.018) were associated with reduced HRV across the 26 days. Sensitivity analysis with HRV averaged across all days corroborated these results.

Conclusions

Diabetes distress is a clinically meaningful psychosocial stressor that could play a role in the cardiovascular health of people with type 1 diabetes. These findings highlight the need for integrated psychosocial care in diabetes management.},
  keywords = {cardiovascular health, depression, diabetes distress, heart rate variability, type 1 diabetes}
}

@article{ehrmann2023_59675,
  title = {Reduced heart rate variability in people with type 1 diabetes and elevated diabetes distress : Results from the longitudinal observational DIA‐LINK1 study},
  author = {Ehrmann, Dominic and Chatwin, Hannah and Schmitt, Andreas and Soeholm, Uffe and Kulzer, Bernhard and Axelsen, Johanne Lundager and Broadley, Melanie and Haak, Thomas and Pouwer, Frans and Hermanns, Norbert},
  year = {2023},
  journal = {Diabetic Medicine},
  volume = {40},
  number = {4, e15040},
  pages = {1-11},
  publisher = {John Wiley \& Sons},
  address = {Hoboken, New Jersey, Vereinigte Staaten},
  issn = {1464-5491},
  doi = {10.1111/dme.15040},
  url = {https://fis.uni-bamberg.de/handle/uniba/59675},
  language = {eng},
  abstract = {Aims

People with type 1 diabetes have a higher risk for cardiovascular disease (CVD). Reduced heart rate variability (HRV) is a clinical marker for CVD. In this observational study using continuous HRV measurement across 26 days, we investigated whether psychological stressors (diabetes distress, depressive symptoms) and glycaemic parameters (hypo- and hyperglycaemic exposure, glycaemic variability and HbA1c) are associated with lower HRV in people with type 1 diabetes.

Methods

Data from the non-interventional prospective DIA-LINK1 study were analysed. At baseline, depressive symptoms and diabetes distress were assessed. Glucose values and HRV were recorded daily for 26 days using continuous glucose monitoring (CGM) and a wrist-worn health tracker respectively. Multilevel modelling with participant as nesting factor was used to analyse associations between day-to-day HRV and diabetes distress, depressive symptoms and CGM-derived parameters.

Results

Data from 149 participants were analysed (age: 38.3 ± 13.1 years, HbA1c: 8.6 ± 1.9\%). Participants with elevated diabetes distress had a significantly lower HRV across the 26 days compared to participants without elevated distress (β = −0.28; p = 0.004). Elevated depressive symptoms were not significantly associated with HRV (β = −0.18; p = 0.074). Higher daily exposure to hyperglycaemia (β = −0.44; p = 0.044), higher average exposure to hypoglycaemia (β = −0.18; p = 0.042) and higher HbA1c (β = −0.20; p = 0.018) were associated with reduced HRV across the 26 days. Sensitivity analysis with HRV averaged across all days corroborated these results.

Conclusions

Diabetes distress is a clinically meaningful psychosocial stressor that could play a role in the cardiovascular health of people with type 1 diabetes. These findings highlight the need for integrated psychosocial care in diabetes management.},
  keywords = {cardiovascular health, depression, diabetes distress, heart rate variability, type 1 diabetes}
}

@article{schliess2022_109985,
  title = {The German Fast Track Toward Reimbursement of Digital Health Applications (DiGA) : Opportunities and Challenges for Manufacturers, Healthcare Providers, and People With Diabetes},
  author = {Schliess, Freimut and Affini Dicenzo, Tatiana and Gaus, Nandor and Bourez, Jean-Marc and Stegbauer, Constance and Szecsenyi, Joachim and Jacobsen, Malte and Müller-Wieland, Dirk and Kulzer, Bernhard and Heinemann, Lutz},
  year = {2022},
  journal = {Journal of Diabetes Science and Technology},
  volume = {18},
  number = {2},
  pages = {470-476},
  publisher = {Sage Publishing},
  address = {London},
  issn = {1932-2968},
  doi = {10.1177/19322968221121660},
  url = {https://fis.uni-bamberg.de/handle/uniba/109985},
  language = {eng},
  abstract = {Background: Digital health applications (DiGA) supporting the management of diabetes are among the most commonly available digital health technologies. However, transparent quality assurance of DiGA and clinical proof of a positive healthcare effect is often missing, which creates skepticism of some stakeholders regarding the usage and reimbursement of these applications. 
Methods: This article reviews the recently established fast-track integration of DiGA in the German reimbursement market, with emphasis on the current impact for manufacturers, healthcare providers, and people with diabetes. The German DiGA fast track is contextualised with corresponding initiatives in Europe. 
Results: The option of a provisional prescription and reimbursement of DiGA while proving a positive healthcare effect in parallel may expedite the adoption of DiGA in Germany and beyond. However, hurdles for a permanent prescription and reimbursement of DiGA are high and only one of 12 that have achieved this status specifically addresses people with diabetes. 
Conclusion: The DiGA fast track needs to be further enhanced to cope with remaining skepticism and contribute even more to a value-based diabetes care.},
  keywords = {clinical trials, digital health, evidence, Germany, reimbursement, value-based healthcare}
}

@article{schmitt2022_92507,
  title = {A Self-Report Measure of Diabetes Self-Management for Type 1 and Type 2 Diabetes : The Diabetes Self-Management Questionnaire-Revised (DSMQ-R) – Clinimetric Evidence From Five Studies},
  author = {Schmitt, Andreas and Kulzer, Bernhard and Ehrmann, Dominic and Haak, Thomas and Hermanns, Norbert},
  year = {2022},
  journal = {Frontiers in Clinical Diabetes and Healthcare},
  volume = {2},
  number = {823046},
  pages = {1-16},
  publisher = {Frontiers Media},
  address = {Lausanne},
  issn = {2673-6616},
  doi = {10.3389/fcdhc.2021.823046},
  url = {https://fis.uni-bamberg.de/handle/uniba/92507},
  language = {eng},
  abstract = {Aims: Measurement tools to evaluate self-management behavior are useful for diabetes research and clinical practice. The Diabetes Self-Management Questionnaire (DSMQ) was introduced in 2013 and has become a widely used tool. This article presents a revised and updated version, DSMQ-R, and evaluates its properties in assessing self-management practices in type 1 diabetes (T1D) and type 2 diabetes (T2D).

Methods: The DSMQ-R is a multidimensional questionnaire with 27 items regarding essential self-management practices for T1D and T2D (including diabetes-adjusted eating, glucose testing/monitoring, medication taking, physical activity and cooperation with the diabetes team). For the revised form, the original items were partially amended and the wording was updated; eleven items were newly added. The tool was applied as part of health-related surveys in five clinical studies (two cross-sectional, three prospective) including a total of 1,447 people with T1D and T2D. Using this data base, clinimetric properties were rigorously tested.

Results: The analyses showed high internal and retest reliability coefficients for the total scale and moderate to high coefficients for the subscales. Reliability coefficients for scales including the new items were consistently higher. Correlations with convergent criteria and related variables supported validity. Responsiveness was supported by significant short to medium term changes in prospective studies. Significant associations with glycemic outcomes were observed for DSMQ-R-assessed medication taking, glucose monitoring and eating behaviors.

Conclusions: The results support good clinimetric properties of the DSMQ-R. The tool can be useful for research and clinical practice and may facilitate the identification of improvable self-management practices in individuals.},
  keywords = {diabetes, treatment behavior, self-managament, health behavior, clinimetric, measurement instrument, questionnaire, evaluation}
}

@misc{heinemann2022_90819,
  title = {Digitalisierungs- und Technologiereport Diabetes 2022},
  author = {Heinemann, Lutz and Braune, Katarina and Keuthage, Winfried and Heinemann, Stefan and Hochstadt, Sabine and Kröger, Jens and Kraatz, Katrin and Kulzer, Bernhard and Leyck Dieken, Markus and Lueg, Andreas and Mühlen, Hansjörg and Richter, Nico and Scheper, Nikolaus and Schütte, Lisa},
  editor = {Kulzer, Bernhard and Heinemann, Lutz},
  year = {2022},
  volume = {2022},
  publisher = {Kirchheim},
  address = {Mainz},
  issn = {2627-4140},
  url = {https://fis.uni-bamberg.de/handle/uniba/90819},
  language = {deu}
}

@article{lange2022_90818,
  title = {Psychosoziale Versorgung von Menschen mit Diabetes : aktuelle Aspekte},
  author = {Lange, Karin and Neu, Andreas and Kulzer, Bernhard},
  year = {2022},
  journal = {Deutscher Gesundheitsbericht Diabetes : die Bestandsaufnahme},
  pages = {210-216},
  publisher = {Kirchheim},
  address = {Mainz},
  issn = {1614-824X},
  url = {https://fis.uni-bamberg.de/handle/uniba/90818},
  language = {deu}
}

@article{kulzer2022_90820,
  title = {Künstliche Intelligenz in der Diabetestherapie},
  author = {Kulzer, Bernhard},
  year = {2022},
  journal = {Digitalisierungs- und Technologiereport Diabetes : D. U. T.},
  pages = {206-222},
  publisher = {Kirchheim},
  address = {Mainz},
  issn = {2627-4140},
  url = {https://fis.uni-bamberg.de/handle/uniba/90820},
  language = {deu}
}

@article{kroger2022_90817,
  title = {Auswirkungen des modernen Glukosemonitorings auf Therapie und Schulung},
  author = {Kröger, Jens and Kulzer, Bernhard},
  year = {2022},
  journal = {Deutscher Gesundheitsbericht Diabetes : die Bestandsaufnahme},
  pages = {175-184},
  publisher = {Kirchheim},
  address = {Mainz},
  issn = {1614-824X},
  url = {https://fis.uni-bamberg.de/handle/uniba/90817},
  language = {deu}
}

@article{kulzer2022_90821,
  title = {ePA und eDA : aktueller Stand und zukünftige Entwicklung},
  author = {Kulzer, Bernhard and Richter, Nico and Hochstadt, Sabine},
  year = {2022},
  journal = {Digitalisierungs- und Technologiereport Diabetes : D. U. T.},
  pages = {232-245},
  publisher = {Kirchheim},
  address = {Mainz},
  issn = {2627-4140},
  url = {https://fis.uni-bamberg.de/handle/uniba/90821},
  language = {deu}
}

@article{kulzer2022_90822,
  title = {Prävention des Typ-2-Diabetes : digitale Präventionsstrategien},
  author = {Kulzer, Bernhard and Kröger, Jens},
  year = {2022},
  journal = {Digitalisierungs- und Technologiereport Diabetes : D. U. T.},
  pages = {190-201},
  publisher = {Kirchheim},
  address = {Mainz},
  issn = {2627-4132},
  url = {https://fis.uni-bamberg.de/handle/uniba/90822},
  language = {deu}
}

@inproceedings{ehrmann2022_90771,
  title = {Attitudes towards a fully implantable bionic invisible pancreas : results of a qualitative study in people with type 1 diabetes},
  author = {Ehrmann, Dominic and Finke-Gröne, Katharina and Kulzer, Bernhard and Hermanns, Norbert},
  year = {2022},
  volume = {24},
  number = {S1},
  pages = {A70},
  publisher = {Liebert},
  address = {Larchmont, NY},
  issn = {1520-9156},
  doi = {10.1089/dia.2022.2525.abstracts},
  url = {https://fis.uni-bamberg.de/handle/uniba/90771},
  language = {eng}
}

@inproceedings{hermanns2022_90772,
  title = {How do physicians rate the indication for modern technologies in people with diabetes?},
  author = {Hermanns, Norbert and Ehrmann, Dominic and Roos, Timm and Heinemann, Lutz and Kulzer, Bernhard},
  year = {2022},
  volume = {24},
  number = {S1},
  pages = {A97},
  publisher = {Liebert},
  address = {Larchmont, NY},
  issn = {1520-9156},
  doi = {10.1089/dia.2022.2525.abstracts},
  url = {https://fis.uni-bamberg.de/handle/uniba/90772},
  language = {eng}
}

@inproceedings{ehrmann2022_90773,
  title = {Current and future importance of AID systems for people with diabetes},
  author = {Ehrmann, Dominic and Heinemann, Lutz and Hermanns, Norbert and Roos, Timm and Kulzer, Bernhard},
  year = {2022},
  volume = {24},
  number = {S1},
  pages = {A97-A98},
  publisher = {Liebert},
  address = {Larchmont, NY},
  issn = {1520-9156},
  doi = {10.1089/dia.2022.2525.abstracts},
  url = {https://fis.uni-bamberg.de/handle/uniba/90773},
  language = {eng}
}

@inproceedings{hermanns2022_90774,
  title = {Human factors of a fully implantable bionic invisible pancreas : perceived potential benefit and barriers of people with type 1 diabetes},
  author = {Hermanns, Norbert and Finke-Gröne, Katharina and Kulzer, Bernhard and Ehrmann, Dominic},
  year = {2022},
  volume = {24},
  number = {S1},
  pages = {A205-A206},
  publisher = {Liebert},
  address = {Larchmont, NY},
  issn = {1520-9156},
  doi = {10.1089/dia.2022.2525.abstracts},
  url = {https://fis.uni-bamberg.de/handle/uniba/90774},
  language = {eng}
}

@inproceedings{kulzer2022_90775,
  title = {European survey on adult people with type 1 diabetes (T1D) and their caregivers : Insights into the use of technological devices and digital tools},
  author = {Kulzer, Bernhard and Penfornis, A. and Down, S. and Seignez, A. and Vives, A. and Bonnemaire, M.},
  year = {2022},
  volume = {24},
  number = {S1},
  pages = {A206-A207},
  publisher = {Liebert},
  address = {Larchmont, NY},
  issn = {1520-9156},
  doi = {10.1089/dia.2022.2525.abstracts},
  url = {https://fis.uni-bamberg.de/handle/uniba/90775},
  language = {eng}
}

@inproceedings{kulzer2022_90776,
  title = {Comparison of attitudes of physicians, parents, and people with diabetes towards digitalization and new technologies in diabetes},
  author = {Kulzer, Bernhard and Hermanns, Norbert and Ehrmann, Dominic and Roos, Timm and Heinemann, Lutz},
  year = {2022},
  volume = {24},
  number = {S1},
  pages = {A215},
  publisher = {Liebert},
  address = {Larchmont, NY},
  issn = {1520-9156},
  doi = {10.1089/dia.2022.2525.abstracts},
  url = {https://fis.uni-bamberg.de/handle/uniba/90776},
  language = {eng}
}

@inproceedings{heinemann2022_90777,
  title = {Green diabetes : Packaging waste and sustainability},
  author = {Heinemann, Lutz and Roos, Timm and Hermanns, Norbert and Ehrmann, Dominic and Kulzer, Bernhard},
  year = {2022},
  volume = {24},
  number = {S1},
  pages = {A215},
  publisher = {Liebert},
  address = {Larchmont, NY},
  issn = {1520-9156},
  doi = {10.1089/dia.2022.2525.abstracts},
  url = {https://fis.uni-bamberg.de/handle/uniba/90777},
  language = {eng}
}

@inproceedings{heinemann2022_90778,
  title = {Green Diabetes : What Do People with Diabetes Think about Packaging Waste and Sustainability?},
  author = {Heinemann, Lutz and Ehrmann, Dominic and Roos, Timm and Hermanns, Norbert and Kulzer, Bernhard},
  year = {2022},
  volume = {71},
  number = {Supplement\_1},
  pages = {591-P},
  publisher = {American Diabetes Association},
  address = {Alexandria, VA.},
  issn = {0012-1797},
  doi = {10.2337/db22-591-p},
  url = {https://fis.uni-bamberg.de/handle/uniba/90778},
  language = {eng}
}

@inproceedings{ehrmann2022_90780,
  title = {What Do People with Type 1 Diabetes Think of a Fully Implantable Bionic Invisible Pancreas? : A Qualitative Study},
  author = {Ehrmann, Dominic and Kulzer, Bernhard and Hermanns, Norbert and Finke-Groene, Katharina},
  year = {2022},
  volume = {71},
  number = {Supplement\_1},
  pages = {606-P},
  publisher = {American Diabetes Association},
  address = {Alexandria, VA.},
  issn = {0012-1797},
  doi = {10.2337/db22-606-p},
  url = {https://fis.uni-bamberg.de/handle/uniba/90780},
  language = {eng}
}

@inproceedings{kulzer2022_90781,
  title = {TheraKey Diabetes 3.0 App : Better Self-Management, Well-Being, Adherence, and Less Diabetes Distress of People with Diabetes},
  author = {Kulzer, Bernhard and Ehrmann, Dominic and Roos, Timm and Hermanns, Norbert},
  year = {2022},
  volume = {71},
  number = {Supplement\_1},
  pages = {626-P},
  publisher = {American Diabetes Association},
  address = {Alexandria, VA.},
  issn = {0012-1797},
  doi = {10.2337/db22-626-p},
  url = {https://fis.uni-bamberg.de/handle/uniba/90781},
  language = {eng}
}

@inproceedings{kulzer2022_90782,
  title = {Comparison of Attitudes of Physcians, Parents, and People with Diabetes towards Digitalization and New Technologies in Diabetes},
  author = {Kulzer, Bernhard and Hermanns, Norbert and Ehrmann, Dominic and Roos, Timm and Heinemann, Lutz},
  year = {2022},
  volume = {71},
  number = {Supplement\_1},
  pages = {627-P},
  publisher = {American Diabetes Association},
  address = {Alexandria, VA.},
  issn = {0012-1797},
  doi = {10.2337/db22-627-p},
  url = {https://fis.uni-bamberg.de/handle/uniba/90782},
  language = {eng}
}

@inproceedings{heinemann2022_90783,
  title = {Significance and Future Trends of AID Systems from the Perspective of Physicians},
  author = {Heinemann, Lutz and Hermanns, Norbert and Ehrmann, Dominic and Roos, Timm and Kulzer, Bernhard},
  year = {2022},
  volume = {71},
  number = {Supplement\_1},
  pages = {795-P},
  publisher = {American Diabetes Association},
  address = {Alexandria, VA.},
  issn = {0012-1797},
  doi = {10.2337/db22-795-p},
  url = {https://fis.uni-bamberg.de/handle/uniba/90783},
  language = {eng}
}

@inproceedings{hermanns2022_90784,
  title = {Perceived Potential Benefits and Barriers for Using a Bionic Invisible Pancreas},
  author = {Hermanns, Norbert and Kulzer, Bernhard and Ehrmann, Dominic and Finke-Groene, Katharina},
  year = {2022},
  volume = {71},
  number = {Supplement\_1},
  pages = {796-P},
  publisher = {American Diabetes Association},
  address = {Alexandria, VA.},
  issn = {0012-1797},
  doi = {10.2337/db22-796-p},
  url = {https://fis.uni-bamberg.de/handle/uniba/90784},
  language = {eng}
}

@inproceedings{kroger2022_90785,
  title = {Zufriedenheit mit der Insulintherapie, Wünsche für die Zukunft},
  author = {Kröger, Jens and Roos, Timm and Hermanns, Norbert and Ehrmann, Dominic and Kulzer, Bernhard},
  year = {2022},
  volume = {17},
  number = {S 01},
  pages = {S19-S20},
  publisher = {Thieme},
  address = {Stuttgart},
  issn = {1861-9010},
  doi = {10.1055/s-0042-1746265},
  url = {https://fis.uni-bamberg.de/handle/uniba/90785},
  language = {deu}
}

@inproceedings{schmitt2022_90786,
  title = {Zentrale Belastungen im Alltag mit Typ-2-Diabetes und ihre Assoziationen mit Glukoseoutcome und depressiver Stimmung : Ergebnisse der DIA-LINK2-Studie mit CGM und ambulantem Assessment},
  author = {Schmitt, Andreas and Ehrmann, Dominic and Kulzer, Bernhard and Haak, Thomas and Hermanns, Norbert},
  year = {2022},
  volume = {17},
  number = {S 01},
  pages = {S42-S43},
  publisher = {Thieme},
  address = {Stuttgart},
  issn = {1861-9010},
  doi = {10.1055/s-0042-1746325},
  url = {https://fis.uni-bamberg.de/handle/uniba/90786},
  language = {deu}
}

@inproceedings{heinemann2022_90787,
  title = {Wie schätzen Diabetologen die aktuelle und zukünftig Bedeutung von AID-Systemen ein?},
  author = {Heinemann, Lutz and Hermanns, Norbert and Ehrmann, Dominic and Roos, Timm and Kulzer, Bernhard},
  year = {2022},
  volume = {17},
  number = {S 01},
  pages = {S57-S58},
  publisher = {Thieme},
  address = {Stuttgart},
  issn = {1861-9010},
  doi = {10.1055/s-0042-1746368},
  url = {https://fis.uni-bamberg.de/handle/uniba/90787},
  language = {deu}
}

@inproceedings{hermanns2022_90788,
  title = {Wie nehmen Menschen mit einem Typ 1 Diabetes Vorteile aber auch Hindernisse für den Einsatz einer vollautomatisierten intraperitonealen Insulinpumpe wahr?},
  author = {Hermanns, Norbert and Finke-Gröne, Katharina and Kulzer, Bernhard and Ehrmann, Dominic},
  year = {2022},
  volume = {17},
  number = {S 01},
  pages = {S58},
  publisher = {Thieme},
  address = {Stuttgart},
  issn = {1861-9010},
  doi = {10.1055/s-0042-1746370},
  url = {https://fis.uni-bamberg.de/handle/uniba/90788},
  language = {deu}
}

@inproceedings{kulzer2022_90789,
  title = {Vergleich der Einstellungen von Menschen mit Typ-1-Diabetes, Eltern von Kindern mit Typ-1-Diabetes und Diabetologen zur Digitalisierung und neuen Methoden bei Diabetes},
  author = {Kulzer, Bernhard and Hermanns, Norbert and Ehrmann, Dominic and Roos, Timm and Heinemann, Lutz},
  year = {2022},
  volume = {17},
  number = {S 01},
  pages = {S59},
  publisher = {Thieme},
  address = {Stuttgart},
  issn = {1861-9010},
  doi = {10.1055/s-0042-1746371},
  url = {https://fis.uni-bamberg.de/handle/uniba/90789},
  language = {deu}
}

@inproceedings{kulzer2022_90790,
  title = {Patch Pumpen : Was sind die Vorteile für Menschen mit Diabetes?},
  author = {Kulzer, Bernhard and Freckmann, Guido and Heinemann, Lutz and Schnell, Oliver and Hinzmann, Rolf and Ziegler, Ralph},
  year = {2022},
  volume = {17},
  number = {S 01},
  pages = {S59-S60},
  publisher = {Thieme},
  address = {Stuttgart},
  issn = {1861-9010},
  doi = {10.1055/s-0042-1746373},
  url = {https://fis.uni-bamberg.de/handle/uniba/90790},
  language = {deu}
}

@inproceedings{heinemann2022_90791,
  title = {Grüner Diabetes : Was denken Menschen mit Diabetes über Verpackungsmüll und Nachhaltigkeit?},
  author = {Heinemann, Lutz and Ehrmann, Dominic and Hermanns, Norbert and Roos, Timm and Kulzer, Bernhard},
  year = {2022},
  volume = {17},
  number = {S 01},
  pages = {S60},
  publisher = {Thieme},
  address = {Stuttgart},
  issn = {1861-9010},
  doi = {10.1055/s-0042-1746374},
  url = {https://fis.uni-bamberg.de/handle/uniba/90791},
  language = {deu}
}

@inproceedings{ehrmann2022_90792,
  title = {Einstellungen zu einer voll implantierbaren bionischen Bauchspeicheldrüse : eine qualitative Studie bei Menschen mit Typ-1-Diabetes},
  author = {Ehrmann, Dominic and Finke-Gröne, Katharina and Kulzer, Bernhard and Hermanns, Norbert},
  year = {2022},
  volume = {17},
  number = {S 01},
  pages = {S60-S61},
  publisher = {Thieme},
  address = {Stuttgart},
  issn = {1861-9010},
  doi = {10.1055/s-0042-1746376},
  url = {https://fis.uni-bamberg.de/handle/uniba/90792},
  language = {deu}
}

@inproceedings{heinemann2022_90704,
  title = {Significance and future trends of AID systems from the perspective of physicians},
  author = {Heinemann, Lutz and Ehrmann, Dominic and Hermanns, Norbert and Roos, Timm and Kulzer, Bernhard},
  year = {2022},
  volume = {24},
  number = {S1},
  pages = {A58-A59},
  publisher = {Liebert},
  address = {Larchmont, NY},
  issn = {1520-9156},
  doi = {10.1089/dia.2022.2525.abstracts},
  url = {https://fis.uni-bamberg.de/handle/uniba/90704},
  language = {eng}
}

@inproceedings{kulzer2022_90703,
  title = {Patch pumps : What are the advantages for people with diabetes?},
  author = {Kulzer, Bernhard and Freckmann, Guido and Heinemann, Lutz and Schnell, O. and Hinzmann, Rolf and Ziegler, Ralph},
  year = {2022},
  volume = {24},
  number = {S1},
  pages = {A20},
  publisher = {Liebert},
  address = {Larchmont, NY},
  issn = {1520-9156},
  doi = {10.1089/dia.2022.2525.abstracts},
  url = {https://fis.uni-bamberg.de/handle/uniba/90703},
  language = {eng}
}

@article{schmitt2022_90687,
  title = {Evaluation of a Stepped Care Approach to Manage Depression and Diabetes Distress in Patients with Type 1 Diabetes and Type 2 Diabetes : Results of a Randomized Controlled Trial (ECCE HOMO Study)},
  author = {Schmitt, Andreas and Kulzer, Bernhard and Reimer, Andre and Herder, Christian and Roden, Michael and Haak, Thomas and Hermanns, Norbert},
  year = {2022},
  journal = {Psychotherapy and psychosomatics},
  volume = {91},
  number = {2},
  publisher = {Karger},
  address = {Basel},
  issn = {0033-3190},
  doi = {10.1159/000520319},
  url = {https://fis.uni-bamberg.de/handle/uniba/90687},
  language = {eng},
  abstract = {Introduction: Depression is a common and serious complication of diabetes. Treatment approaches addressing the specific demands of affected patients are scarce. 

Objective: The aim of this work was to test whether a stepped care approach for patients with diabetes and depression and/or diabetes distress yields greater depression reduction than treatment-as-usual. 

Methods: Two-hundred and sixty patients with diabetes and elevated depressive symptoms (CES-D ≥16) and/or elevated diabetes distress (PAID ≥40) were randomized to stepped care for depression or diabetes treatment-as-usual. The primary outcome was the rate of meaningful depression reduction at the 12-month follow-up according to the HAMD (score <9 or reduction by ≥50\%). Secondary outcomes were changes in depression scores (HAMD/CES-D), diabetes distress (PAID), diabetes acceptance (AADQ), well-being (WHO-5), quality of life (EQ-5D/SF-36), self-care behavior (SDSCA/DSMQ), HbA1c, and biomarkers of inflammation. 

Results: One-hundred and thirty-one individuals were assigned to stepped care and 129 to treatment-as-usual. Overall, 15.4\% were lost to follow-up. Meaningful depression reduction was observed in 80.2 versus 51.2\% in stepped care versus treatment-as-usual (p < 0.001, intention-to-treat analysis). Of the secondary measures, the HAMD (∆ –3.2, p < 0.001), WHO-5 (∆ 1.5, p = 0.007), and AADQ (∆ –1.0, p = 0.008) displayed significant treatment effects, while effects on CES-D (∆ –2.3, p = 0.065), PAID (∆ –3.5, p = 0.109), and SDSCA (∆ 0.20, p = 0.081) were not significantly different. Both groups showed comparable changes in EQ-5D/SF-36, DSMQ, HbA1c, and biomarkers of inflammation (all p ≥ 0.19). 

Conclusions: The stepped care approach improved depression, well-being, and acceptance. The results support that increasing treatment intensity on demand is effective and can help provide more optimal treatment. The inclusion of diabetes-specific interventions may be beneficial for patients with diabetes and elevated depression.},
  keywords = {Cognitive-behavioral therapy, Mood disorder, Depressive symptoms, Emotional distress, Stepped care approach}
}

@article{schmitt2022_90686,
  title = {Diabetes Distress and Depression during COVID-19 : Response to Breznoscakova et al. Uncovering the Untold Emotional Toll of Living with Diabetes in the COVID-19 Era},
  author = {Schmitt, Andreas and Kulzer, Bernhard and Ehrmann, Dominic and Haak, Thomas and Hermanns, Norbert},
  year = {2022},
  journal = {Psychotherapy and psychosomatics},
  volume = {91},
  number = {4},
  pages = {288-289},
  publisher = {Karger},
  address = {Basel},
  issn = {0033-3190},
  doi = {10.1159/000524602},
  url = {https://fis.uni-bamberg.de/handle/uniba/90686},
  language = {eng}
}

@article{roos2022_90683,
  title = {Level of Digitalization in Germany : Results of the Diabetes Digitalization and Technology (D.U.T) Report 2020},
  author = {Roos, Timm and Hochstadt, Sabine and Keuthage, Winfried and Kröger, Jens and Lueg, Andreas and Mühlen, Hansjörg and Schütte, Lisa and Scheper, Nikolaus and Ehrmann, Dominic and Hermanns, Norbert and Heinemann, Lutz and Kulzer, Bernhard},
  year = {2022},
  journal = {Journal of diabetes science and technology : JDST},
  volume = {16},
  number = {1},
  pages = {144-151},
  publisher = {Sage Publishing},
  address = {London},
  issn = {1932-2968},
  doi = {10.1177/1932296820965553},
  url = {https://fis.uni-bamberg.de/handle/uniba/90683},
  language = {eng}
}

@article{kulzer2022_90682,
  title = {Patients’ Experience of New Technologies and Digitalization in Diabetes Care in Germany},
  author = {Kulzer, Bernhard and Heinemann, Lutz and Roos, Timm},
  year = {2022},
  journal = {Journal of diabetes science and technology : JDST},
  volume = {16},
  number = {6},
  pages = {1521-1531},
  publisher = {Sage Publishing},
  address = {London},
  issn = {1932-2968},
  doi = {10.1177/19322968211041377},
  url = {https://fis.uni-bamberg.de/handle/uniba/90682},
  language = {eng}
}

@article{kulzer2022_90679,
  title = {Psychosoziales und Diabetes},
  author = {Kulzer, Bernhard and Albus, Christian and Herpertz, Stephan and Kruse, Johannes and Lange, Karin and Lederbogen, Florian and Petrak, Frank},
  year = {2022},
  journal = {Der Diabetologe},
  volume = {18},
  number = {2},
  pages = {153-168},
  publisher = {Springer},
  address = {Berlin ; Heidelberg [u.a.]},
  issn = {1860-9716},
  doi = {10.1007/s11428-022-00864-x},
  url = {https://fis.uni-bamberg.de/handle/uniba/90679},
  language = {deu}
}

@article{kulzer2022_90678,
  title = {Grundlagen des Diabetesmanagements},
  author = {Kulzer, Bernhard and Aberle, Jens and Haak, Thomas and Kaltheuner, Matthias and Kröger, Jens and Landgraf, Rüdiger and Kellerer, Monika},
  year = {2022},
  journal = {Der Diabetologe},
  volume = {18},
  number = {2},
  pages = {142-152},
  publisher = {Springer},
  address = {Berlin ; Heidelberg [u.a.]},
  issn = {1860-9716},
  doi = {10.1007/s11428-022-00863-y},
  url = {https://fis.uni-bamberg.de/handle/uniba/90678},
  language = {deu}
}

@article{kulzer2022_90677,
  title = {Fundamentals of Diabetes Management},
  author = {Kulzer, Bernhard and Aberle, Jens and Haak, Thomas and Kaltheuner, Matthias and Kröger, Jens and Landgraf, Rüdiger and Kellerer, Monika},
  year = {2022},
  journal = {Experimental and clinical endocrinology \& diabetes},
  volume = {130},
  number = {S 01},
  pages = {S9-S18},
  publisher = {Thieme},
  address = {Stuttgart},
  issn = {0947-7349},
  doi = {10.1055/a-1624-5080},
  url = {https://fis.uni-bamberg.de/handle/uniba/90677},
  language = {eng}
}

@article{kulzer2022_90676,
  title = {Demenzrisiko bei Diabetes mellitus erhöht},
  author = {Kulzer, Bernhard},
  year = {2022},
  journal = {MMW - Fortschritte der Medizin},
  volume = {164},
  number = {S3},
  pages = {70-72},
  publisher = {Springer},
  address = {Berlin},
  issn = {1438-3276},
  doi = {10.1007/s15006-022-2032-3},
  url = {https://fis.uni-bamberg.de/handle/uniba/90676},
  language = {deu}
}

@article{kulzer2022_90667,
  title = {Gesundheitspass Diabetes},
  author = {Kulzer, Bernhard},
  year = {2022},
  journal = {Der Diabetologe},
  volume = {18},
  number = {3},
  pages = {324-326},
  publisher = {Springer},
  address = {Berlin ; Heidelberg [u.a.]},
  issn = {1860-9716},
  doi = {10.1007/s11428-022-00885-6},
  url = {https://fis.uni-bamberg.de/handle/uniba/90667},
  language = {deu}
}

@article{kampling2022_90666,
  title = {An integrated psychosomatic treatment program for people with diabetes (psy-PAD)},
  author = {Kampling, Hanna and Köhler, Birgit and Germerott, Isabell and Haastert, Burkhard and Icks, Andrea and Kulzer, Bernd and Nowotny, Bettina and Hermanns, Norbert and Kruse, Johannes},
  year = {2022},
  journal = {Deutsches Ärzteblatt international : a weekly online journal of clinical medicine and public health},
  volume = {119},
  number = {14},
  pages = {245-252},
  publisher = {Deutscher Ärzte-Verlag},
  address = {Köln},
  issn = {1866-0452},
  doi = {10.3238/arztebl.m2022.0094},
  url = {https://fis.uni-bamberg.de/handle/uniba/90666},
  language = {eng}
}

@article{ehrmann2022_90660,
  title = {Health care effects and medical benefits of a smartphone-based diabetes self-management application : study protocol for a randomized controlled trial},
  author = {Ehrmann, Dominic and Eichinger, V. and Vesper, Iris and Kober, J. and Kraus, M. and Schäfer, V. and Hermanns, Norbert and Kulzer, Bernhard and Silbermann, Stephan},
  year = {2022},
  journal = {Trials},
  volume = {23},
  number = {1},
  pages = {282},
  publisher = {BioMed Central},
  address = {London},
  issn = {1745-6215},
  doi = {10.1186/s13063-022-06248-2},
  url = {https://fis.uni-bamberg.de/handle/uniba/90660},
  language = {eng},
  abstract = {Background:
Diabetes self-management is a mainstay of diabetes care, but the implementation of self-management regimens into daily life is complex and often results in discouragement and distress. Modern approaches such as smartphone-based self-management applications are therefore needed to support people with diabetes. Since reimbursability would increase the availability of such digital applications to people with diabetes, we designed a study that meets all scientific and methodological requirements set by the German Digital Healthcare Act to allow reimbursement for a specific application (mySugr PRO). Here, we report the protocol of this study that aims at evaluating the efficacy of the digital self-management application with regard to patient-reported outcomes and medical benefits.

Methods/design:
This multicenter, open-label, randomized, parallel-group, controlled trial will evaluate the health care effects and medical benefits of mySugr PRO. A total of 466 people with diabetes will be randomly allocated (2:1 randomization) to the interventional group (n = 311) that will use the digital self-management application during the 12-week study period or the control group (n = 155; no usage of the application). Baseline and follow-up examinations will assess diabetes distress as the primary endpoint as well as empowerment, HbA1c, blood glucose data, self-management, general well-being, and treatment satisfaction as secondary endpoints. Statistical analyses will use an intention-to-treat procedure (using multiple imputation for missing values) as well as a per-protocol approach for sensitivity analysis.

Discussion:
To the best of our knowledge, this study will be one of the largest diabetes-specific evaluations of a digital health application supporting people with diabetes in their diabetes self-management that follow the requirements of the German Digital Healthcare Act.

Trial registration:
German Clinical Trial Register DRKS00022923. Registered on 22 October 2020.},
  keywords = {Diabetes, Self-management, Diabetes distress, Digital health application}
}

@article{ebert2022_90659,
  title = {Diabetes und Straßenverkehr},
  author = {Ebert, Oliver and Bohn, Barbara and Bertram, Bernd and Buchberger, Barbara and Finck, Hermann and Hoß, Jürgen and Hübner, Peter and Krabbe, Laura and Kulzer, Bernhard and Küstner, Eva and Lachenmayr, Bernhard and Lemmen, Klaus-Dieter and Petry, Friedhelm and Rinnert, Kurt and Salomon, Markus and Schütt, Wolfgang and Holl, Reinhard W.},
  year = {2022},
  journal = {Der Diabetologe},
  volume = {18},
  number = {2},
  pages = {184-197},
  publisher = {Springer},
  address = {Berlin ; Heidelberg [u.a.]},
  issn = {1860-9716},
  doi = {10.1007/s11428-022-00867-8},
  url = {https://fis.uni-bamberg.de/handle/uniba/90659},
  language = {deu}
}

@article{ebert2022_90658,
  title = {Diabetes und Straßenverkehr},
  author = {Ebert, Oliver and Bohn, Barbara and Bertram, Bernd and Buchberger, Barbara and Finck, Hermann and Hoß, Jürgen and Hübner, Peter and Krabbe, Laura and Kulzer, Bernhard and Küstner, Eva and Lachenmayr, Bernhard and Lemmen, Klaus-Dieter and Petry, Friedhelm and Rinnert, Kurt and Salomon, Markus and Schütt, Wolfgang and Holl, Reinhard W. and Maxeiner, Stephan and Wagener, Wolfgang},
  year = {2022},
  journal = {Diabetologie und Stoffwechsel : offizielles Organ der Deutschen Diabetes Gesellschaft},
  volume = {17},
  number = {S 02},
  pages = {S376-S393},
  publisher = {Thieme},
  address = {Stuttgart},
  issn = {1861-9002},
  doi = {10.1055/a-1916-6909},
  url = {https://fis.uni-bamberg.de/handle/uniba/90658},
  language = {deu}
}

@article{ebert2022_90657,
  title = {Diabetes and Road Traffic},
  author = {Ebert, Oliver and Bohn, Barbara and Bertram, Bernd and Buchberger, Barbara and Finck, Hermann and Hoß, Jürgen and Hübner, Peter and Krabbe, Laura and Kulzer, Bernhard and Küstner, Eva and Lachenmayr, Bernhard and Lemmen, Klaus-Dieter and Petry, Friedhelm and Rinnert, Kurt and Salomon, Markus and Schütt, Wolfgang and Holl, Reinhard W.},
  year = {2022},
  journal = {Experimental and clinical endocrinology \& diabetes},
  volume = {130},
  number = {S 01},
  pages = {S137-S150},
  publisher = {Thieme},
  address = {Stuttgart},
  issn = {0947-7349},
  doi = {10.1055/a-1624-3655},
  url = {https://fis.uni-bamberg.de/handle/uniba/90657},
  language = {eng}
}

@article{bendig2022_90638,
  title = {ACTonDiabetes : study protocol of a pragmatic randomised controlled trial for the evaluation of an acceptance and commitment-based internet-based and mobile-based intervention for adults living with type 1 or type 2 diabetes},
  author = {Bendig, Eileen and Schmitt, Andreas and Wittenberg, Amelie and Kulzer, Bernhard and Hermanns, Norbert and Moshagen, Morten and Baumeister, Harald},
  year = {2022},
  journal = {BMJ open},
  volume = {12},
  number = {9, e059336},
  pages = {1-13},
  publisher = {BMJ Publishing Group},
  address = {London},
  issn = {2044-6055},
  doi = {10.1136/bmjopen-2021-059336},
  url = {https://fis.uni-bamberg.de/handle/uniba/90638},
  language = {eng},
  abstract = {Introduction 
Living with diabetes can be burdensome and lead to serious emotional distress and impaired mental health. Acceptance and commitment therapy (ACT) can support people facing the challenges of living with diabetes. This trial aims to evaluate the effectiveness and cost-effectiveness of the internet-based and mobile-based intervention (IMI) ‘ACTonDiabetes’ in reducing diabetes distress against enhanced treatment as usual (TAU+) following specialised diabetes care.

Methods and analysis 
A two-armed pragmatic randomised controlled trial will be conducted to evaluate the guided IMI ACTonDiabetes against TAU+. A total of 210 adults with type 1 or type 2 diabetes and elevated diabetes distress (Problem Areas in Diabetes ≥40) will be recruited at a specialised diabetes centre. The intervention begins 2–4 weeks after hospital discharge and takes about 7–10 weeks to complete. Assessments are performed at baseline and 5 and 10 weeks as well as 6 and 12 months after randomisation. The primary outcome is diabetes distress at a 10-week follow-up (T2). Secondary outcomes are depression (Patient Health Questionnaire-8), psychological well-being (WHO-5), quality of life (Assessment of Quality of Life-8 Dimension), Diabetes-related Self-Management Questionnaire, diabetes acceptance (Acceptance and Action Diabetes Questionnaire) and negative treatment effects (Inventory for the Assessment of Negative Effects of Psychotherapy). All statistical analyses will be performed based on the intention-to-treat principle with additional per-protocol analyses. Changes in outcomes will be evaluated using the general linear model. A health-economic evaluation will be conducted from a societal perspective. Reasons for drop-out will be systematically investigated.

Ethics and dissemination 
This clinical trial has been approved by the State Medical Chamber of Baden-Württemberg (file no. B-F-2019-010). Trial results will be submitted for publication in a peer-reviewed journal and presented at conferences.

Trial registration number DRKS00016738.},
  keywords = {Diabetes}
}

@article{kulzer2022_89995,
  title = {Patch Pumps : What are the advantages for people with diabetes?},
  author = {Kulzer, Bernhard and Freckmann, Guido and Heinemann, Lutz and Schnell, Oliver and Hinzmann, Rolf and Ziegler, Ralph},
  year = {2022},
  journal = {Diabetes research and clinical practice},
  volume = {187},
  number = {May 2022},
  pages = {109858},
  publisher = {Elsevier},
  address = {Amsterdam [u.a.]},
  issn = {0168-8227},
  doi = {10.1016/j.diabres.2022.109858},
  url = {https://fis.uni-bamberg.de/handle/uniba/89995},
  language = {eng},
  abstract = {Aim

Patch pumps, i.e. insulin pumps without tubing, are an attractive alternative to conventional insulin pumps for people with type 1 diabetes and type 2 diabetes on insulin therapy. In this review, potential patient-relevant advantages and disadvantages of patch pumps are summarized and respective studies on patient-reported outcomes (PROs) are assessed.

Methods

Relevant studies were identified through a systematic PubMed search. Reference lists in respective articles and Google Scholar were also checked for additional references. Articles in English published before June 30, 2021, were included; no other criteria on publication dates were set.

Results

A total of 12 studies were included. The results of this analysis provide evidence that patch pumps improve quality of life, reduce diabetes-related distress, increase patient satisfaction, and are preferred by patients compared to conventional insulin pumps and multiple daily injection therapy (MDI). However, several methodological limitations of the studies identified constrain the significance of this analysis.

Conclusions

Despite the limited number of studies evaluating the benefits of patch pumps on PROs, there is increasing evidence that people with diabetes prefer patch pumps. Although there are numerous PROs for patch pumps, it is surprising that this aspect has been relatively understudied. More systematic evaluation studies of the benefits of patch pumps on PROs are needed.},
  keywords = {Patch pump, Tubeless insulin pump, Patient-reported outcomes, Quality of life, Diabetes-related distress, Treatment satisfaction, Patient preference}
}

@article{kulzer2022_89947,
  title = {Grundlagen des Diabetesmanagements},
  author = {Kulzer, Bernhard and Aberle, Jens and Haak, Thomas and Kaltheuner, Matthias and Kröger, Jens and Landgraf, Rüdiger and Kellerer, Monika},
  year = {2022},
  journal = {Diabetologie und Stoffwechsel : offizielles Organ der Deutschen Diabetes Gesellschaft},
  volume = {17},
  number = {S 02},
  pages = {S87-S97},
  publisher = {Thieme},
  address = {Stuttgart},
  issn = {1861-9002},
  doi = {10.1055/a-1916-2262},
  url = {https://fis.uni-bamberg.de/handle/uniba/89947},
  language = {deu}
}

@article{kulzer2022_55978,
  title = {Körperliche und psychische Folgeerkrankungen bei Diabetes mellitus},
  author = {Kulzer, Bernhard},
  year = {2022},
  pages = {503-510},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-irb-559784},
  url = {https://fis.uni-bamberg.de/handle/uniba/55978},
  language = {deu},
  abstract = {Trotz Verbesserungen in der Therapie des Diabetes und besseren Versorgungbedingungen weisen die Betroffenen aktuell im Vergleich zur Allgemeinbevölkerung noch immer ein deutlich erhöhtes Risiko für physische wie psychische Folgeerkrankungen sowie eine reduzierte Lebensqualität auf. Etwa 21 \% aller Todesfälle sind in Deutschland auf Diabetes und seine Folgeerkrankungen zurückzuführen, das Mortalitätsrisiko ist für Menschen mit Diabetes um mehr als das 1,5-Fache gegenüber Menschen ohne Diabetes erhöht. In dieser Übersicht werden die Verbreitung und die Risikofaktoren für die häufigsten körperlichen und psychischen Folgen des Diabetes beschrieben sowie deren Einflüsse auf die Lebensqualität der Patienten. Zusammenhänge zwischen den Folgeerkrankungen und einer erhöhten Mortalität werden aufgezeigt.

In großen Interventionsstudien konnte die Bedeutung einer guten Glukoseeinstellung – vor allem zu Beginn der Erkrankung – in Hinblick auf eine Senkung der Mortalitätsrate gezeigt werden, weitere wichtige Einflussfaktoren sind z. B. Blutdruck, Blutfette und Rauchen. Weltweite Studienergebnisse deuten auf einen stabilen Trend hinsichtlich einer verbesserten Lebenserwartung von Menschen mit Diabetes in den letzten Jahren hin. Zukünftig könnte der positive Trend durch bessere Versorgungsstrukturen und neue Technologien sowie digitale Anwendungen in der Forschung und Therapie fortgesetzt werden. Mithilfe der Präzisionsmedizin könnten individuelle Risikofaktoren und protektive Faktoren erkannt werden, um der Entstehung von Folgekomplikationen noch besser vorzubeugen.},
  keywords = {Mikroangiopathie, Makrangiopathie, Depressionen, Lebensqualität, Mortalität, Microangiopathy, Macroangiopathy, Depression, Quality of life, Mortality}
}

@article{hermanns2022_55979,
  title = {Coordination of glucose monitoring, self-care behaviour and mental health : achieving precision monitoring in diabetes},
  author = {Hermanns, Norbert and Ehrmann, Dominic and Shapira, Amit and Kulzer, Bernhard and Schmitt, Andreas and Laffel, Lori},
  year = {2022},
  pages = {1883–1894},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-irb-559795},
  url = {https://fis.uni-bamberg.de/handle/uniba/55979},
  language = {eng},
  abstract = {Monitoring of glucose plays an essential role in the management of diabetes. However, to fully understand and meaningfully interpret glucose levels, additional information on context is necessary. Important contextual factors include data on behaviours such as eating, exercise, medication-taking and sleep, as well as data on mental health aspects such as stress, affect, diabetes distress and depressive symptoms. This narrative review provides an overview of the current state and future directions of precision monitoring in diabetes. Precision monitoring of glucose has made great progress over the last 5 years with the emergence of continuous glucose monitoring (CGM), automated analysis of new glucose variables and visualisation of CGM data via the ambulatory glucose profile. Interestingly, there has been little progress in the identification of subgroups of people with diabetes based on their glycaemic profile. The integration of behavioural and mental health data could enrich such identification of subgroups to stimulate precision medicine. There are a handful of studies that have used innovative methodology such as ecological momentary assessment to monitor behaviour and mental health in people’s everyday life. These studies indicate the importance of the interplay between behaviour, mental health and glucose. However, automated integration and intelligent interpretation of these data sources are currently not available. Automated integration of behaviour, mental health and glucose could lead to the identification of certain subgroups that, for example, show a strong association between mental health and glucose in contrast to subgroups that show independence of mental health and glucose. This could inform precision diagnostics and precision therapeutics. We identified just-in-time adaptive interventions as a potential means by which precision monitoring could lead to precision therapeutics. Just-in-time adaptive interventions consist of micro-interventions that are triggered in people’s everyday lives when a certain problem is identified using monitored behaviour, mental health and glucose variables. Thus, these micro-interventions are responsive to real-life circumstances and are adaptive to the specific needs of an individual with diabetes. We conclude that, with current developments in big data analysis, there is a huge potential for precision monitoring in diabetes.},
  keywords = {Behavioural parameters, Diabetes, Ecological momentary assessment, Glucose monitoring, Mental health, Personalised medicine, Precision medicine, Review}
}

@article{kulzer2022_55977,
  title = {Körperliche und psychische Folgeerkrankungen bei Diabetes mellitus},
  author = {Kulzer, Bernhard},
  year = {2022},
  journal = {Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz},
  volume = {65},
  number = {4},
  pages = {503-510},
  publisher = {Springer},
  address = {Berlin ; Heidelberg},
  issn = {1437-1588},
  doi = {10.1007/s00103-022-03517-y},
  url = {https://fis.uni-bamberg.de/handle/uniba/55977},
  language = {deu},
  abstract = {Trotz Verbesserungen in der Therapie des Diabetes und besseren Versorgungbedingungen weisen die Betroffenen aktuell im Vergleich zur Allgemeinbevölkerung noch immer ein deutlich erhöhtes Risiko für physische wie psychische Folgeerkrankungen sowie eine reduzierte Lebensqualität auf. Etwa 21 \% aller Todesfälle sind in Deutschland auf Diabetes und seine Folgeerkrankungen zurückzuführen, das Mortalitätsrisiko ist für Menschen mit Diabetes um mehr als das 1,5-Fache gegenüber Menschen ohne Diabetes erhöht. In dieser Übersicht werden die Verbreitung und die Risikofaktoren für die häufigsten körperlichen und psychischen Folgen des Diabetes beschrieben sowie deren Einflüsse auf die Lebensqualität der Patienten. Zusammenhänge zwischen den Folgeerkrankungen und einer erhöhten Mortalität werden aufgezeigt.

In großen Interventionsstudien konnte die Bedeutung einer guten Glukoseeinstellung – vor allem zu Beginn der Erkrankung – in Hinblick auf eine Senkung der Mortalitätsrate gezeigt werden, weitere wichtige Einflussfaktoren sind z. B. Blutdruck, Blutfette und Rauchen. Weltweite Studienergebnisse deuten auf einen stabilen Trend hinsichtlich einer verbesserten Lebenserwartung von Menschen mit Diabetes in den letzten Jahren hin. Zukünftig könnte der positive Trend durch bessere Versorgungsstrukturen und neue Technologien sowie digitale Anwendungen in der Forschung und Therapie fortgesetzt werden. Mithilfe der Präzisionsmedizin könnten individuelle Risikofaktoren und protektive Faktoren erkannt werden, um der Entstehung von Folgekomplikationen noch besser vorzubeugen.},
  keywords = {Mikroangiopathie, Makrangiopathie, Depressionen, Lebensqualität, Mortalität, Microangiopathy, Macroangiopathy, Depression, Quality of life, Mortality}
}

@article{schmid2022_54750,
  title = {Psychosocial Impact of the COVID-19 Pandemic on People With Type 1 Diabetes : Results of an Ecological Momentary Assessment Study},
  author = {Schmid, Fabienne and Schmitt, Andreas and Hermanns, Norbert and Kulzer, Bernhard and Ehrmann, Dominic},
  year = {2022},
  journal = {Frontiers in Clinical Diabetes and Healthcare},
  volume = {3},
  number = {834643},
  pages = {1-10},
  publisher = {Frontiers Media},
  address = {Lausanne},
  issn = {2673-6616},
  doi = {10.3389/fcdhc.2022.834643},
  url = {https://fis.uni-bamberg.de/handle/uniba/54750},
  language = {eng},
  abstract = {-},
  keywords = {diabetes distress, depression, COVID-19-related burden, ecological momentary assessment, COVID-19 incidence rate}
}

@article{hermanns2022_54749,
  title = {Coordination of glucose monitoring, self-care behaviour and mental health : achieving precision monitoring in diabetes},
  author = {Hermanns, Norbert and Ehrmann, Dominic and Shapira, Amit and Kulzer, Bernhard and Schmitt, Andreas and Laffel, Lori},
  year = {2022},
  journal = {Diabetologia},
  volume = {65},
  number = {11},
  pages = {1883–1894},
  publisher = {Springer},
  address = {Berlin ; Heidelberg},
  issn = {1432-0428},
  doi = {10.1007/s00125-022-05685-7},
  url = {https://fis.uni-bamberg.de/handle/uniba/54749},
  language = {eng},
  abstract = {Monitoring of glucose plays an essential role in the management of diabetes. However, to fully understand and meaningfully interpret glucose levels, additional information on context is necessary. Important contextual factors include data on behaviours such as eating, exercise, medication-taking and sleep, as well as data on mental health aspects such as stress, affect, diabetes distress and depressive symptoms. This narrative review provides an overview of the current state and future directions of precision monitoring in diabetes. Precision monitoring of glucose has made great progress over the last 5 years with the emergence of continuous glucose monitoring (CGM), automated analysis of new glucose variables and visualisation of CGM data via the ambulatory glucose profile. Interestingly, there has been little progress in the identification of subgroups of people with diabetes based on their glycaemic profile. The integration of behavioural and mental health data could enrich such identification of subgroups to stimulate precision medicine. There are a handful of studies that have used innovative methodology such as ecological momentary assessment to monitor behaviour and mental health in people’s everyday life. These studies indicate the importance of the interplay between behaviour, mental health and glucose. However, automated integration and intelligent interpretation of these data sources are currently not available. Automated integration of behaviour, mental health and glucose could lead to the identification of certain subgroups that, for example, show a strong association between mental health and glucose in contrast to subgroups that show independence of mental health and glucose. This could inform precision diagnostics and precision therapeutics. We identified just-in-time adaptive interventions as a potential means by which precision monitoring could lead to precision therapeutics. Just-in-time adaptive interventions consist of micro-interventions that are triggered in people’s everyday lives when a certain problem is identified using monitored behaviour, mental health and glucose variables. Thus, these micro-interventions are responsive to real-life circumstances and are adaptive to the specific needs of an individual with diabetes. We conclude that, with current developments in big data analysis, there is a huge potential for precision monitoring in diabetes.},
  keywords = {Behavioural parameters, Diabetes, Ecological momentary assessment, Glucose monitoring, Mental health, Personalised medicine, Precision medicine, Review}
}

@article{ehrmann2022_54748,
  title = {Time With Diabetes Distress and Glycemia-Specific Distress : New Patient-Reported Outcome Measures for the Psychosocial Burden of Diabetes Using Ecological Momentary Assessment in an Observational Study},
  author = {Ehrmann, Dominic and Schmitt, Andreas and Priesterroth, Lilli and Kulzer, Bernhard and Haak, Thomas and Hermanns, Norbert},
  year = {2022},
  journal = {Diabetes care},
  volume = {45},
  number = {7},
  pages = {1522-1531},
  address = {Alexandria, Va.},
  issn = {1935-5548},
  doi = {10.2337/dc21-2339},
  url = {https://fis.uni-bamberg.de/handle/uniba/54748},
  language = {eng}
}

@article{kulzer2021_115812,
  title = {Grundlagen des Diabetesmanagements},
  author = {Kulzer, Bernd and Aberle, Jens and Haak, Thomas and Kaltheuner, Matthias and Kröger, Jens and Landgraf, Rüdiger and Kellerer, Monika},
  year = {2021},
  journal = {Diabetologie und Stoffwechsel},
  volume = {16},
  number = {S 02},
  pages = {99-109},
  publisher = {Thieme},
  address = {Stuttgart [u.a.]},
  issn = {1861-9010},
  doi = {10.1055/a-1590-7867},
  url = {https://fis.uni-bamberg.de/handle/uniba/115812},
  language = {deu}
}

@article{kulzer2021_111150,
  title = {Informationstechnologie in der Diabetesbehandlung : Erleben der Patienten},
  author = {Kulzer, B. and Heinemann, L. and Roos, Timm},
  year = {2021},
  journal = {Der Diabetologe},
  volume = {17},
  pages = {265-274},
  publisher = {Springer},
  address = {Berlin ; Heidelberg [u.a.]},
  issn = {1860-9724},
  doi = {10.1007/s11428-021-00753-9},
  url = {https://fis.uni-bamberg.de/handle/uniba/111150},
  language = {deu}
}

@article{heinemann2021_97792,
  title = {Needle Technology for Insulin Administration : A Century of Innovation},
  author = {Heinemann, Lutz and Nguyen, Trung and Bailey, Timothy S. and Hassoun, Ahmed and Kulzer, Bernd and Oliveria, Teresa and Reznik, Yves and de Valk, Harold W. and Mader, Julia K.},
  year = {2021},
  journal = {Journal of diabetes science and technology : JDST},
  volume = {17},
  number = {2},
  pages = {449-457},
  publisher = {SAGE Publications},
  address = {London},
  issn = {1932-2968},
  doi = {10.1177/19322968211059564},
  url = {https://fis.uni-bamberg.de/handle/uniba/97792},
  language = {eng},
  abstract = {Innovations in syringe and pen needle (PN) technology over the last 100 years have led to important advances in insulin delivery for people with diabetes, paralleling the strides made in developing recombinant DNA human insulin and insulin analogs with varying onset and duration of action. In this review, the history of advances in insulin delivery is described, focusing on progress in syringe, needle, and PN technologies. The early glass and metal syringes that required sterilization by boiling have been replaced by disposable, single-use syringes or pens with clear labeling for precise insulin dosing. The early needles ranging in length from 19 to 26 mm that required manual sharpening against a whetstone have been replaced by syringe needles of 6 mm and PNs of 4 mm in length as slender as 34 gauge. Imaging studies using ultrasound and computed tomography measured the thickness of skin and subcutaneous tissue layers to show feasibility of targeted insulin administration with shorter needles. These developments, coupled with innovations in needle/PN wall and tip structure, have led to improved injection experience for people with diabetes. It is also important to acknowledge the role of injection technique education, together with these advances in injection technology, for improving clinical outcomes and patient satisfaction. With continued projected growth of diabetes prevalence, particularly in developing countries where expensive and complex insulin delivery systems may not be practical, insulin syringes and pens will continue to serve as reliable and cost-effective means of insulin delivery for people with diabetes.},
  keywords = {insulin administration, insulin therapy, needle length, insulin pen, subcutaneous, syringe}
}

@article{freckmann2021_90633,
  title = {Insulin Pump Therapy for Patients With Type 2 Diabetes Mellitus : Evidence, Current Barriers, and New Technologies},
  author = {Freckmann, Guido and Buck, Sina and Waldenmaier, Delia and Kulzer, Bernhard and Schnell, Oliver and Gelchsheimer, Ulrich and Ziegler, Ralph and Heinemann, Lutz},
  year = {2021},
  journal = {Journal of diabetes science and technology : JDST},
  volume = {15},
  number = {4},
  pages = {901-915},
  publisher = {Sage Publishing},
  address = {London},
  issn = {1932-2968},
  doi = {10.1177/1932296820928100},
  url = {https://fis.uni-bamberg.de/handle/uniba/90633},
  language = {eng}
}

@article{landgraf2021_90636,
  title = {Neu: Nationale VersorgungsLeitlinie Typ-2-Diabetes : Wichtige Teile der Langfassung publiziert!},
  author = {Landgraf, Rüdiger and Aberle, Jens and Kulzer, Bernhard},
  year = {2021},
  journal = {MMW - Fortschritte der Medizin},
  volume = {163},
  number = {8},
  pages = {42-47},
  publisher = {Springer Medizin Verlag GmbH},
  address = {Berlin},
  issn = {1438-3276},
  doi = {10.1007/s15006-021-9814-x},
  url = {https://fis.uni-bamberg.de/handle/uniba/90636},
  language = {deu}
}

@article{lange2021_90541,
  title = {Psychosoziale Versorgung von Menschen mit Diabetes : aktuelle Aspekte},
  author = {Lange, Karin and Neu, Andreas and Kulzer, Bernhard},
  year = {2021},
  journal = {Deutscher Gesundheitsbericht Diabetes : die Bestandsaufnahme},
  pages = {211-218},
  publisher = {Kirchheim},
  address = {Mainz},
  issn = {1614-824X},
  url = {https://fis.uni-bamberg.de/handle/uniba/90541},
  language = {deu}
}

@article{kulzer2021_90540,
  title = {Start der elektronischen Patientenakte},
  author = {Kulzer, Bernhard and Richter, Nico and Hochstadt, Sabine},
  year = {2021},
  journal = {Digitalisierungs- und Technologiereport Diabetes : D. U. T.},
  pages = {220-232},
  publisher = {Kirchheim},
  address = {Mainz},
  issn = {2627-4132},
  url = {https://fis.uni-bamberg.de/handle/uniba/90540},
  language = {deu}
}

@article{kulzer2021_90539,
  title = {Digitale Prävention des Typ-2-Diabetes},
  author = {Kulzer, Bernhard and Kröger, Jens},
  year = {2021},
  journal = {Digitalisierungs- und Technologiereport Diabetes : D. U. T.},
  pages = {190-201},
  publisher = {Kirchheim},
  address = {Mainz},
  issn = {2627-4132},
  url = {https://fis.uni-bamberg.de/handle/uniba/90539},
  language = {deu}
}

@article{kulzer2021_90538,
  title = {Künstliche Intelligenz, Big Data},
  author = {Kulzer, Bernhard},
  year = {2021},
  journal = {Digitalisierungs- und Technologiereport Diabetes : D. U. T.},
  pages = {162-171},
  publisher = {Kirchheim},
  address = {Mainz},
  issn = {2627-4132},
  url = {https://fis.uni-bamberg.de/handle/uniba/90538},
  language = {deu}
}

@incollection{kulzer2021_90536,
  title = {16 Diabetes als Verhaltensmedizinische Erkrankung},
  author = {Kulzer, Bernhard and Hermanns, Norbert},
  year = {2021},
  booktitle = {Diabetologie in Klinik und Praxis},
  pages = {291-308},
  publisher = {Thieme},
  address = {Stuttgart},
  edition = {7., vollständig überarbeitete und erweiterte Auflage},
  isbn = {978-3-13-242891-1},
  url = {https://fis.uni-bamberg.de/handle/uniba/90536},
  language = {deu}
}

@incollection{kulzer2021_90535,
  title = {7 Grundlagen des Diabetesmanagements},
  author = {Kulzer, Bernhard and Haak, Thomas},
  year = {2021},
  booktitle = {Diabetologie in Klinik und Praxis},
  pages = {164-177},
  publisher = {Thieme},
  address = {Stuttgart},
  edition = {7., vollständig überarbeitete und erweiterte Auflage},
  isbn = {978-3-13-242891-1},
  url = {https://fis.uni-bamberg.de/handle/uniba/90535},
  language = {deu}
}

@incollection{hanschke2021_90534,
  title = {12 Diabetes und Psyche},
  author = {Hanschke, Nina and Thomas, Christine and Kulzer, Bernhard},
  year = {2021},
  booktitle = {Komplikationen des Diabetes Mellitus : Praxisorientiertes Wissen zu Begleit- und Folgeerkrankungen},
  pages = {279-300},
  publisher = {De Gruyter},
  address = {Berlin/Boston},
  edition = {1. Auflage},
  isbn = {978-3-11-059095-1},
  doi = {10.1515/9783110590951-012},
  url = {https://fis.uni-bamberg.de/handle/uniba/90534},
  language = {deu}
}

@inproceedings{schmid2021_90533,
  title = {Emotionale Belastungen und wahrgenommene Risiken von Menschen mit Typ-1-Diabetes innerhalb der COVID-19-Pandemie},
  author = {Schmid, Fabienne and Schmitt, Andreas and Ehrmann, Dominic and Kulzer, Bernhard and Haak, Thomas and Hermanns, Norbert},
  year = {2021},
  volume = {16},
  number = {S 01},
  pages = {S60},
  publisher = {Thieme},
  address = {Stuttgart},
  issn = {1861-9010},
  doi = {10.1055/s-0041-1727487},
  url = {https://fis.uni-bamberg.de/handle/uniba/90533},
  language = {deu}
}

@inproceedings{schmitt2021_90532,
  title = {Welches sind die gravierendsten Diabetesbelastungen im Alltag von Menschen mit T1DM? : Eine Längsschnittstudie mit ambulantem Assessment und kontinuierlicher Glukosemessung (CGM)},
  author = {Schmitt, Andreas and Kulzer, Bernhard and Ehrmann, Dominic and Haak, Thomas and Hermanns, Norbert},
  year = {2021},
  volume = {16},
  number = {S 01},
  pages = {S59},
  publisher = {Thieme},
  address = {Stuttgart},
  issn = {1861-9010},
  doi = {10.1055/s-0041-1727483},
  url = {https://fis.uni-bamberg.de/handle/uniba/90532},
  language = {deu}
}

@inproceedings{schmitt2021_90531,
  title = {Glukoseparameter bei Typ-1-Diabetes in Abhängigkeit von Depressivität und Diabetes Distress : Eine Längsschnittstudie mit kontinuierlicher Glukosemessung (CGM)},
  author = {Schmitt, Andreas and Ehrmann, Dominic and Kulzer, Bernhard and Haak, Thomas and Hermanns, Norbert},
  year = {2021},
  volume = {16},
  number = {S 01},
  pages = {S61},
  publisher = {Thieme},
  address = {Stuttgart},
  issn = {1861-9010},
  doi = {10.1055/s-0041-1727488},
  url = {https://fis.uni-bamberg.de/handle/uniba/90531},
  language = {deu}
}

@inproceedings{roos2021_90530,
  title = {Neue Diabetes-Technologien und ihre Verbreitung in Deutschland : Eine Frage des Alters?},
  author = {Roos, Timm and Hermanns, Norbert and Ehrmann, Dominic and Heinemann, Lutz and Kulzer, Bernhard},
  year = {2021},
  volume = {16},
  number = {S 01},
  pages = {S63-S64},
  publisher = {Thieme},
  address = {Stuttgart},
  issn = {1861-9010},
  doi = {10.1055/s-0041-1727495},
  url = {https://fis.uni-bamberg.de/handle/uniba/90530},
  language = {deu}
}

@inproceedings{priesterroth2021_90529,
  title = {Glukoseschwankungen und Distress im Alltag : Vergleich zwischen subjektivem Erleben und objektiven CGM-Parametern},
  author = {Priesterroth, Lilli and Ehrmann, Dominic and Schmitt, Andreas and Hermanns, Norbert and Kulzer, Bernhard},
  year = {2021},
  volume = {16},
  number = {S 01},
  pages = {S60},
  publisher = {Thieme},
  address = {Stuttgart},
  issn = {1861-9010},
  doi = {10.1055/s-0041-1727486},
  url = {https://fis.uni-bamberg.de/handle/uniba/90529},
  language = {deu}
}

@inproceedings{kulzer2021_90527,
  title = {Vergleich der Einstellungen von Ärzten, Eltern und Menschen mit Diabetes zur Digitalisierung und neuen Technologien bei Diabetes},
  author = {Kulzer, Bernhard and Roos, Timm and Ehrmann, Dominic and Hermanns, Norbert and Heinemann, Lutz},
  year = {2021},
  volume = {16},
  number = {S 01},
  pages = {S65},
  publisher = {Thieme},
  address = {Stuttgart},
  issn = {1861-9010},
  doi = {10.1055/s-0041-1727499},
  url = {https://fis.uni-bamberg.de/handle/uniba/90527},
  language = {deu}
}

@inproceedings{kulzer2021_90526,
  title = {Starker Anstieg moderner Technologien in der Diabetologie},
  author = {Kulzer, Bernhard and Roos, Timm and Ehrmann, Dominic and Hermanns, Norbert and Heinemann, Lutz},
  year = {2021},
  volume = {16},
  number = {S 01},
  pages = {S65},
  publisher = {Thieme},
  address = {Stuttgart},
  issn = {1861-9010},
  doi = {10.1055/s-0041-1727500},
  url = {https://fis.uni-bamberg.de/handle/uniba/90526},
  language = {deu}
}

@inproceedings{hermanns2021_90525,
  title = {Haben „Looper“ eine bessere glykämische Kontrolle?},
  author = {Hermanns, Norbert and Ehrmann, Dominic and Roos, Timm and Heinemann, Lutz and Kulzer, Bernhard},
  year = {2021},
  volume = {16},
  number = {S 01},
  pages = {S64-S65},
  publisher = {Thieme},
  address = {Stuttgart},
  issn = {1861-9010},
  doi = {10.1055/s-0041-1727498},
  url = {https://fis.uni-bamberg.de/handle/uniba/90525},
  language = {deu}
}

@inproceedings{heinemann2021_90524,
  title = {Neue Technologien und Digitalisierung : Welche Einstellungen haben Diabetologen, welche Vor- und Nachteile sind bedeutsam?},
  author = {Heinemann, Lutz and Roos, Timm and Ehrmann, Dominic and Hermanns, Norbert and Kulzer, Bernhard},
  year = {2021},
  volume = {16},
  number = {S 01},
  pages = {S64},
  publisher = {Thieme},
  address = {Stuttgart},
  issn = {1861-9010},
  doi = {10.1055/s-0041-1727497},
  url = {https://fis.uni-bamberg.de/handle/uniba/90524},
  language = {deu}
}

@inproceedings{ehrmann2021_90523,
  title = {Prädiktoren von täglichem Diabetes Distress bei Typ-1-Diabetes : Kombination aus Ecological Momentary Assessment und CGM},
  author = {Ehrmann, Dominic and Schmitt, Andreas and Priesterroth, Lilli and Kulzer, Bernhard and Hermanns, Norbert},
  year = {2021},
  volume = {16},
  number = {S 01},
  pages = {S60},
  publisher = {Thieme},
  address = {Stuttgart},
  issn = {1861-9010},
  doi = {10.1055/s-0041-1727485},
  url = {https://fis.uni-bamberg.de/handle/uniba/90523},
  language = {deu}
}

@inproceedings{ehrmann2021_90522,
  title = {Assoziationen zwischen Stimmung und Stimmungsschwankungen mit Parametern der glykämischen Kontrolle bei Menschen mit Typ-1-Diabetes : Längsschnittliche Analyse des Tagesverlaufs},
  author = {Ehrmann, Dominic and Schmitt, Andreas and Kulzer, Bernhard and Haak, Thomas and Hermanns, Norbert},
  year = {2021},
  volume = {16},
  number = {S 01},
  pages = {S58},
  publisher = {Thieme},
  address = {Stuttgart},
  issn = {1861-9010},
  doi = {10.1055/s-0041-1727481},
  url = {https://fis.uni-bamberg.de/handle/uniba/90522},
  language = {deu}
}

@inproceedings{ehrmann2021_90521,
  title = {Lassen sich Stimmung und Energieniveau durch vorausgegangene Glukosewerte vorhersagen? : Die Kombination von Ecological Momentary Assessment (EMA) und Continuous Glucose Monitoring (CGM)},
  author = {Ehrmann, Dominic and Hermanns, Norbert and Schmitt, Andreas and Haak, Thomas and Kulzer, Bernhard},
  year = {2021},
  volume = {16},
  number = {S 01},
  pages = {S58-S59},
  publisher = {Thieme},
  address = {Stuttgart},
  issn = {1861-9010},
  doi = {10.1055/s-0041-1727482},
  url = {https://fis.uni-bamberg.de/handle/uniba/90521},
  language = {deu}
}

@inproceedings{hermanns2021_90520,
  title = {Association between Glucose Levels and Diabetes Symptoms},
  author = {Hermanns, Norbert and Schmitt, Andreas Jürgen and Kulzer, Bernhard and Priesterroth, Lilli and Ehrmann, Dominic},
  year = {2021},
  volume = {70},
  number = {Supplement\_1},
  pages = {558-P},
  publisher = {American Diabetes Association},
  address = {Alexandria, VA.},
  issn = {0012-1797},
  doi = {10.2337/db21-558-p},
  url = {https://fis.uni-bamberg.de/handle/uniba/90520},
  language = {eng}
}

@inproceedings{ehrmann2021_90519,
  title = {Predictors of Daily Diabetes Distress in Type 1 Diabetes},
  author = {Ehrmann, Dominic and Schmitt, Andreas and Priesterroth, Lilli and Kulzer, Bernhard and Hermanns, Norbert},
  year = {2021},
  volume = {70},
  number = {Supplement\_1},
  pages = {540-P},
  publisher = {American Diabetes Association},
  address = {Alexandria, VA.},
  issn = {0012-1797},
  doi = {10.2337/db21-540-p},
  url = {https://fis.uni-bamberg.de/handle/uniba/90519},
  language = {eng}
}

@inproceedings{priesterroth2021_90518,
  title = {Is It All In Your Head? : Associations between Subjective and Objective Measures of Glycemic Variability},
  author = {Priesterroth, Lilli and Ehrmann, Dominic and Hermanns, Norbert and Schmitt, Andreas and Kulzer, Bernhard},
  year = {2021},
  volume = {70},
  number = {Supplement\_1},
  pages = {525-P},
  publisher = {American Diabetes Association},
  address = {Alexandria, VA.},
  issn = {0012-1797},
  doi = {10.2337/db21-525-p},
  url = {https://fis.uni-bamberg.de/handle/uniba/90518},
  language = {eng}
}

@article{ziegler2021_90512,
  title = {Intermittent Use of Continuous Glucose Monitoring : Expanding the Clinical Value of CGM},
  author = {Ziegler, Ralph and Heinemann, Lutz and Freckmann, Guido and Schnell, Oliver and Hinzmann, Rolf and Kulzer, Bernhard},
  year = {2021},
  journal = {Journal of diabetes science and technology : JDST},
  volume = {15},
  number = {3},
  pages = {684-694},
  publisher = {Sage Publishing},
  address = {London},
  issn = {1932-2968},
  doi = {10.1177/1932296820905577},
  url = {https://fis.uni-bamberg.de/handle/uniba/90512},
  language = {eng}
}

@article{schmitt2021_90509,
  title = {Associations of depression and diabetes distress with self-management behavior and glycemic control},
  author = {Schmitt, Andreas and Bendig, Eileen and Baumeister, Harald and Hermanns, Norbert and Kulzer, Bernhard},
  year = {2021},
  journal = {Health Psychology},
  volume = {40},
  number = {2},
  pages = {113-124},
  publisher = {American Psychological Association (APA)},
  address = {Washington, DC},
  issn = {1930-7810},
  doi = {10.1037/hea0001037},
  url = {https://fis.uni-bamberg.de/handle/uniba/90509},
  language = {eng}
}

@article{kulzer2021_90508,
  title = {Psychosocial Factors and Diabetes},
  author = {Kulzer, Bernhard and Albus, Christian and Herpertz, Stephan and Kruse, Johannes and Lange, Karin and Lederbogen, Florian and Petrak, Frank},
  year = {2021},
  journal = {Experimental and Clinical Endocrinology \& Diabetes},
  volume = {129},
  number = {S 01},
  pages = {91-105},
  publisher = {Thieme},
  address = {Stuttgart},
  issn = {0947-7349},
  doi = {10.1055/a-1284-6524},
  url = {https://fis.uni-bamberg.de/handle/uniba/90508},
  language = {eng}
}

@article{kulzer2021_90507,
  title = {Wie profitieren Menschen mit Diabetes von Big Data und künstlicher Intelligenz?},
  author = {Kulzer, Bernhard},
  year = {2021},
  journal = {Der Diabetologe},
  volume = {17},
  number = {8},
  pages = {799-806},
  publisher = {Springer},
  address = {Berlin ; Heidelberg},
  issn = {1860-9716},
  doi = {10.1007/s11428-021-00818-9},
  url = {https://fis.uni-bamberg.de/handle/uniba/90507},
  language = {deu}
}

@article{kulzer2021_90506,
  title = {Digitale Prävention des Typ-2-Diabetes},
  author = {Kulzer, Bernhard},
  year = {2021},
  journal = {Public-Health-Forum : Forschung, Lehre, Praxis},
  volume = {29},
  number = {4},
  pages = {297-300},
  publisher = {de Gruyter},
  address = {Berlin ; Boston},
  issn = {1876-4851},
  doi = {10.1515/pubhef-2021-0114},
  url = {https://fis.uni-bamberg.de/handle/uniba/90506},
  language = {deu}
}

@article{icks2021_90504,
  title = {High Depressive Symptoms in Previously Undetected Diabetes : 10-Year Follow-Up Results of the Heinz Nixdorf Recall Study},
  author = {Icks, Andrea and Wittgens, Charlotte and Haastert, Burkhard and Jöckel, Karl-Heinz and Engel, Miriam and Erbel, Raimund and Andrich, Silke and Kruse, Johannes and Kulzer, Bernd and Hermanns, Norbert and Herder, Christian and Moebus, Susanne and Stang, Andreas and Kowall, Bernd},
  year = {2021},
  journal = {Clinical Epidemiology},
  volume = {Volume 13},
  pages = {429-438},
  publisher = {Dove Medical Press},
  address = {Albany, Auckland},
  issn = {1179-1349},
  doi = {10.2147/clep.s294342},
  url = {https://fis.uni-bamberg.de/handle/uniba/90504},
  language = {eng},
  abstract = {Aim: To determine the 10-year cumulative incidence of high depressive symptoms in people with diagnosed and, in particular, previously undetected diabetes compared to those without diabetes in a population-based cohort study in Germany.

Materials and Methods: We included 2813 participants (52.9\% men, mean age (SD) 58.9 (7.7) years, 7.1\% diagnosed diabetes, 5.6\% previously undetected diabetes) from the Heinz Nixdorf Recall study. We calculated the odds ratios (OR) with 95\% confidence intervals (CI) using multiple logistic regression analyses for diagnosed and undetected diabetes.

Results: Cumulative 10-year incidences (95\%-CI) of high depressive symptoms in participants with diagnosed diabetes, previously undetected diabetes, and without diabetes were 15.4\% (10.7– 21.2), 10.1\% (5.9– 15.9), and 12.4\% (11.1– 13.8), respectively. Age-sex-adjusted ORs were 1.51 (1.01– 2.28) in participants with diagnosed diabetes compared to those without, 1.40 (0.92– 2.12) after adjustment for BMI, physical activity, education, and smoking, and 1.33 (0.87– 2.02) after further adjustment for stroke and myocardial infarction. ORs in participants with previously undetected diabetes were 0.96 (0.56– 1.65), 0.85 (0.49– 1.47), and 0.85 (0.49– 1.48), respectively, and lower in men than in women.

Conclusion: As expected, we found an increased odds of developing high depressive symptoms in participants with diagnosed diabetes. However, the odds ratios decreased when we considered comorbidities and other covariates. Interestingly, in participants with previously undetected diabetes, the odds was not increased, even 10 years after detection of diabetes. These results support the hypothesis that high depressive symptoms develop due to diabetes-related burdens and comorbidities and not due to hyperglycemia or hyperinsulinemia.},
  keywords = {diabetes, undetected diabetes, depressive symptoms, prospective population-based cohort study}
}

@article{hermanns2021_90503,
  title = {Psychosoziale Aspekte und Diabetes},
  author = {Hermanns, Norbert and Kulzer, Bernhard},
  year = {2021},
  journal = {Public Health Forum : Forschung, Lehre, Praxis},
  volume = {29},
  number = {4},
  pages = {346-348},
  publisher = {de Gruyter},
  address = {Berlin ; Boston},
  issn = {1876-4851},
  doi = {10.1515/pubhef-2021-0093},
  url = {https://fis.uni-bamberg.de/handle/uniba/90503},
  language = {deu}
}

@misc{boehm2021_90537,
  title = {D.U.T Digitalisierungs- und Technologiereport Diabetes 2021},
  author = {Boehm, Kathrin and Braune, Katarina and Deml, Angelika and Gantner, Tobias D. and Heinemann, Lutz and Hochstadt, Sabine and Keuthage, Winfried and Kraatz, Katrin and Kröger, Jens and Kulzer, Bernhard and Lueg, Andreas and Mühlen, Hansjörg and Neu, Andreas and Richter, Nico and Scheper, Nikolaus and Schütte, Lisa and von Sengbusch, Simone and Ziegler, Ralph},
  editor = {Kulzer, Bernhard and Heinemann, Lutz},
  year = {2021},
  volume = {1},
  publisher = {Kirchheim},
  address = {Mainz},
  issn = {2627-4132},
  url = {https://fis.uni-bamberg.de/handle/uniba/90537},
  language = {deu}
}

@inproceedings{kulzer2021_90513,
  title = {Physicians‘ attitudes toward AID-systems and their implications for diabetes care},
  author = {Kulzer, Bernhard and Heinemann, Lutz and Hermanns, Norbert and Ehrmann, Dominic and Roos, Timm},
  year = {2021},
  volume = {23},
  number = {S2},
  pages = {A22},
  publisher = {Liebert},
  address = {Larchmont, NY},
  issn = {1520-9156},
  doi = {10.1089/dia.2021.2525.abstract},
  url = {https://fis.uni-bamberg.de/handle/uniba/90513},
  language = {eng}
}

@inproceedings{heinemann2021_90514,
  title = {Time trend of diabetologists’ attitudes towards digitalization and new technologies and their advantages and disadvantages},
  author = {Heinemann, Lutz and Hermanns, Norbert and Ehrmann, Dominic and Roos, Timm and Kulzer, Bernhard},
  year = {2021},
  volume = {23},
  number = {S2},
  pages = {A67},
  publisher = {Liebert},
  address = {Larchmont, NY},
  issn = {1520-9156},
  doi = {10.1089/dia.2021.2525.abstract},
  url = {https://fis.uni-bamberg.de/handle/uniba/90514},
  language = {eng}
}

@inproceedings{kulzer2021_90515,
  title = {Rapid increase in the proportion of CGM and insulin pumps among people with type 1 and type 2 diabetes},
  author = {Kulzer, Bernhard and Roos, Timm and Ehrmann, Dominic and Hermanns, Norbert and Heinemann, Lutz},
  year = {2021},
  volume = {23},
  number = {S2},
  pages = {A67-A68},
  publisher = {Liebert},
  address = {Larchmont, NY},
  issn = {1520-9156},
  doi = {10.1089/dia.2021.2525.abstract},
  url = {https://fis.uni-bamberg.de/handle/uniba/90515},
  language = {eng}
}

@article{ehrmann2021_54746,
  title = {Associations of Time in Range and Other Continuous Glucose Monitoring–Derived Metrics With Well-Being and Patient-Reported Outcomes : Overview and Trends},
  author = {Ehrmann, Dominic and Priesterroth, Lilli and Schmitt, Andreas and Kulzer, Bernhard and Hermanns, Norbert},
  year = {2021},
  journal = {Diabetes Spectrum},
  volume = {34},
  number = {2},
  pages = {149–155},
  address = {Alexandria, Va.},
  issn = {1040-9165},
  doi = {10.2337/ds20-0096},
  url = {https://fis.uni-bamberg.de/handle/uniba/54746},
  language = {eng}
}

@article{kress2020_90505,
  title = {Preulcerous Risk Situation in Diabetic Foot Syndrome : Proposal for a Simple Ulcer Prevention Score},
  author = {Kress, Stephan and Anderten, Helmut and Borck, Anja and Freckmann, Guido and Heinemann, Lutz and Holzmüller, Ulrike and Kulzer, Bernhard and Portele, Alexandra and Schnell, Oliver and Varlemann, Helga and Zemmrich, Claudia and Lobmann, Ralf},
  year = {2020},
  journal = {Journal of diabetes science and technology : JDST},
  volume = {15},
  number = {4},
  pages = {816-826},
  publisher = {Sage Publishing},
  address = {London},
  issn = {1932-2968},
  doi = {10.1177/1932296820922592},
  url = {https://fis.uni-bamberg.de/handle/uniba/90505},
  language = {eng}
}

@inproceedings{ehrmann2020_90358,
  title = {Better skills in carbohydrate estimation is associated with higher time in range},
  author = {Ehrmann, Dominic and Kulzer, Bernhard and Hermanns, Norbert},
  year = {2020},
  volume = {22},
  number = {S1},
  pages = {A-224},
  publisher = {Liebert},
  address = {Larchmont, NY},
  issn = {1520-9156},
  doi = {10.1089/dia.2020.2525.abstracts},
  url = {https://fis.uni-bamberg.de/handle/uniba/90358},
  language = {eng}
}

@inproceedings{hermanns2020_90359,
  title = {How differ attitudes towards the role of digitalization in diabetes care between people with diabetes and health care professionals?},
  author = {Hermanns, Norbert and Roos, Timm and Heinemann, Lutz and Ehrmann, Dominic and Kulzer, Bernhard},
  year = {2020},
  volume = {22},
  number = {S1},
  pages = {A-227-A-228},
  publisher = {Liebert},
  address = {Larchmont, NY},
  issn = {1520-9156},
  doi = {10.1089/dia.2020.2525.abstracts},
  url = {https://fis.uni-bamberg.de/handle/uniba/90359},
  language = {eng}
}

@inproceedings{kulzer2020_90360,
  title = {Physicians’ perceptions and attitudes towards digitalization and new technologies in diabetes care},
  author = {Kulzer, Bernhard and Hermanns, Norbert and Roos, Timm},
  year = {2020},
  volume = {22},
  number = {S1},
  pages = {A-228},
  publisher = {Liebert},
  address = {Larchmont, NY},
  issn = {1520-9156},
  doi = {10.1089/dia.2020.2525.abstracts},
  url = {https://fis.uni-bamberg.de/handle/uniba/90360},
  language = {eng}
}

@inproceedings{hermanns2020_90361,
  title = {Impact of Carbohydrate Counting on Glycaemic Control in People with Type 1 and Type 2 Diabetes on Intensified Insulin Therapy},
  author = {Hermanns, Norbert and Ehrmann, Dominic and Kulzer, Bernhard},
  year = {2020},
  volume = {69},
  number = {S1},
  pages = {797-P},
  publisher = {American Diabetes Association},
  address = {Alexandria, Va},
  issn = {0012-1797},
  doi = {10.2337/db20-797-P},
  url = {https://fis.uni-bamberg.de/handle/uniba/90361},
  language = {eng}
}

@inproceedings{kulzer2020_90362,
  title = {Attitudes of Physicians to Chances, Risks, and Future Options Regarding Digitalization and New Technologies in Diabetes},
  author = {Kulzer, Bernhard and Hermanns, Norbert and Ehrmann, Dominic and Heinemann, Lutz},
  year = {2020},
  volume = {69},
  number = {Supplement\_1},
  pages = {857-P},
  publisher = {American Diabetes Association},
  address = {Alexandria, Va},
  issn = {0012-1797},
  doi = {10.2337/db20-857-p},
  url = {https://fis.uni-bamberg.de/handle/uniba/90362},
  language = {eng}
}

@inproceedings{kulzer2020_90364,
  title = {Trends in the Use of Diabetes Technologies in Germany},
  author = {Kulzer, Bernhard and Hermanns, Norbert and Ehrmann, Dominic and Heinemann, Lutz},
  year = {2020},
  volume = {69},
  number = {Supplement\_1},
  pages = {2179-PUB},
  publisher = {American Diabetes Association},
  issn = {0012-1797},
  doi = {10.2337/db20-2179-pub},
  url = {https://fis.uni-bamberg.de/handle/uniba/90364},
  language = {eng}
}

@inproceedings{ehrmann2020_90365,
  title = {Can Mood and Energy Levels Be Predicted by Preceding Glucose Values? : Combining Ecological Momentary Assessment (EMA) and Continuous Glucose Monitoring (CGM)},
  author = {Ehrmann, Dominic and Schmitt, A. and Rubertus, Paula and Kulzer, Bernhard and Hermanns, Norbert},
  year = {2020},
  volume = {69},
  number = {Supplement\_1},
  pages = {783-P},
  publisher = {American Diabetes Association},
  address = {Alexandria, Va},
  issn = {0012-1797},
  doi = {10.2337/db20-783-p},
  url = {https://fis.uni-bamberg.de/handle/uniba/90365},
  language = {eng}
}

@inproceedings{hermanns2020_90366,
  title = {How frequent experience people with type 1 diabetes worries about hypoglycaemia and hyperglycaemia and how are these worries associated with the course of glucose?},
  author = {Hermanns, Norbert and Schmitt, A. and Ehrmann, Dominic and Haak, T. and Kulzer, Bernhard},
  year = {2020},
  volume = {63},
  number = {S1},
  pages = {360},
  publisher = {Springer},
  address = {Berlin ; Heidelberg},
  issn = {0012-186X},
  doi = {10.1007/s00125-020-05221-5},
  url = {https://fis.uni-bamberg.de/handle/uniba/90366},
  language = {eng}
}

@inproceedings{priesterroth2020_90367,
  title = {Can mood and energy levels be predicted by glucose levels? : The combination of continuous glucose monitoring and ecological momentary assessment},
  author = {Priesterroth, Lilli and Ehrmann, Dominic and Schmitt, A. and Rubertus, P. and Hermanns, Norbert and Kulzer, Bernhard},
  year = {2020},
  volume = {63},
  number = {S1},
  pages = {S367},
  publisher = {Springer},
  address = {Berlin ; Heidelberg},
  issn = {0012-186X},
  doi = {10.1007/s00125-020-05221-5},
  url = {https://fis.uni-bamberg.de/handle/uniba/90367},
  language = {eng}
}

@inproceedings{kulzer2020_90363,
  title = {Different Attitudes of Physicians, Parents of Children with Diabetes, and People with Diabetes towards Digitization in Diabetes},
  author = {Kulzer, Bernhard and Hermanns, Norbert and Ehrmann, Dominic and Heinemann, Lutz},
  year = {2020},
  volume = {69},
  number = {Supplement\_1},
  pages = {858-P},
  publisher = {American Diabetes Association},
  address = {Alexandria, Va},
  issn = {0012-1797},
  doi = {10.2337/db20-858-p},
  url = {https://fis.uni-bamberg.de/handle/uniba/90363},
  language = {eng}
}

@inproceedings{ehrmann2020_90368,
  title = {Associations between mood and mood swings with parameters of glycaemic control in people with type 1 diabetes : longitudinal analysis of daily data},
  author = {Ehrmann, Dominic and Schmitt, A. and Rubertus, P. and Kulzer, Bernhard and Hermanns, Norbert},
  year = {2020},
  volume = {63},
  number = {S1},
  pages = {S371},
  publisher = {Springer},
  address = {Berlin ; Heidelberg},
  issn = {0012-186X},
  doi = {10.1007/s00125-020-05221-5},
  url = {https://fis.uni-bamberg.de/handle/uniba/90368},
  language = {eng}
}

@inproceedings{heinemann2020_90369,
  title = {Trends in the use of diabetes technologies in Germany},
  author = {Heinemann, Lutz and Roos, Timm and Hermanns, Norbert and Ehrmann, Dominic and Kulzer, Bernhard},
  year = {2020},
  volume = {63},
  number = {S1},
  pages = {381-382},
  publisher = {Springer},
  address = {Berlin ; Heidelberg},
  issn = {0012-186X},
  doi = {10.1007/s00125-020-05221-5},
  url = {https://fis.uni-bamberg.de/handle/uniba/90369},
  language = {eng}
}

@inproceedings{roos2020_90370,
  title = {Do "looper" have better glycaemic control?},
  author = {Roos, Timm and Hermanns, Norbert and Ehrmann, Dominic and Heinemann, Lutz and Kulzer, Bernhard},
  year = {2020},
  volume = {63},
  number = {S1},
  pages = {381},
  publisher = {Springer},
  address = {Berlin ; Heidelberg},
  issn = {0012-186X},
  doi = {10.1007/s00125-020-05221-5},
  url = {https://fis.uni-bamberg.de/handle/uniba/90370},
  language = {eng}
}

@article{hermanns2020_50960,
  title = {Trends in diabetes self-management education : where are we coming from and where are we going? A narrative review},
  author = {Hermanns, Norbert and Ehrmann, Dominic and Finke-Groene, Katharina and Kulzer, Bernhard},
  year = {2020},
  journal = {Diabetic medicine : journal of Diabetes UK},
  volume = {37},
  number = {3},
  pages = {436-447},
  publisher = {Wiley-Blackwell},
  address = {Oxford [u.a.]},
  issn = {0742-3071},
  doi = {10.1111/dme.14256},
  url = {https://fis.uni-bamberg.de/handle/uniba/50960},
  language = {eng}
}

@article{hermanns2020_50961,
  title = {Professional mode flash glucose monitoring in type 2 diabetes},
  author = {Hermanns, Norbert and Ehrmann, Dominic and Kulzer, Bernhard},
  year = {2020},
  journal = {The lancet : Diabetes \& Endocrinology},
  volume = {8},
  number = {1},
  pages = {2-3},
  publisher = {Elsevier},
  address = {Oxford},
  issn = {2213-8587},
  doi = {10.1016/S2213-8587(19)30386-9},
  url = {https://fis.uni-bamberg.de/handle/uniba/50961},
  language = {eng}
}

@article{kulzer2020_50962,
  title = {Ist die elektronische Patientenakte bei Diabetes Fluch oder Segen?},
  author = {Kulzer, Bernhard},
  year = {2020},
  journal = {Info Diabetologie},
  volume = {14},
  number = {2},
  pages = {29-34},
  publisher = {Springer Medizin Urban \& Vogel},
  address = {München},
  issn = {1865-5459},
  doi = {10.1007/s15034-020-0635-2},
  url = {https://fis.uni-bamberg.de/handle/uniba/50962},
  language = {deu}
}

@article{kulzer2020_50963,
  title = {DDG Praxisempfehlungen : Psychosoziales und Diabetes},
  author = {Kulzer, Bernhard and Albus, Christian and Herpertz, Stephan and Kruse, Johannes and Lange, Karin and Lederbogen, Florian and Petrak, Frank},
  year = {2020},
  journal = {Der Diabetologe},
  volume = {16},
  number = {2},
  pages = {144-160},
  publisher = {Springer},
  address = {Berlin ; Heidelberg [u.a.]},
  issn = {1860-9724},
  doi = {10.1007/s11428-020-00595-x},
  url = {https://fis.uni-bamberg.de/handle/uniba/50963},
  language = {deu}
}

@article{kulzer2020_50964,
  title = {DDG Praxisempfehlungen : Psychosoziales und Diabetes},
  author = {Kulzer, Bernhard and Albus, Christian and Herpertz, Stephan and Kruse, Johannes and Lange, Karin and Lederbogen, Florian and Petrak, Frank},
  year = {2020},
  journal = {Diabetologie und Stoffwechsel},
  volume = {15},
  number = {Supplement 1},
  pages = {232-248},
  publisher = {Thieme},
  address = {Stuttgart},
  issn = {1861-9002},
  doi = {10.1055/a-1194-2962},
  url = {https://fis.uni-bamberg.de/handle/uniba/50964},
  language = {deu}
}

@article{kulzer2020_50965,
  title = {Essstörungen bei Menschen mit Diabetes.},
  author = {Kulzer, Bernhard and Hermanns, Norbert and Ehrmann, Dominic and Al-Khatib, Mohammed and Haak, Thomas and Krichbaum M,},
  year = {2020},
  journal = {CME : Premium-Fortbildung für die medizinische Praxis},
  volume = {17},
  number = {12},
  pages = {59–66},
  publisher = {Springer},
  address = {Berlin ; Heidelberg [u.a.]},
  issn = {1614-371X},
  doi = {10.1007\%2Fs11298-020-8057-y},
  url = {https://fis.uni-bamberg.de/handle/uniba/50965},
  language = {deu}
}

@article{kulzer2020_50966,
  title = {Essstörungen bei Menschen mit Diabetes},
  author = {Kulzer, Bernhard},
  year = {2020},
  journal = {Info Diabetologie},
  volume = {14},
  number = {3},
  pages = {36-42},
  publisher = {Springer Medizin Urban \& Vogel},
  address = {München},
  issn = {1865-5459},
  doi = {10.1007/s15034-019-0002-3},
  url = {https://fis.uni-bamberg.de/handle/uniba/50966},
  language = {deu}
}

@article{kulzer2020_50968,
  title = {Depressive Störungen : Eine oft unterschätzte Komorbidität bei Diabetes},
  author = {Kulzer, Bernhard and Priesterroth, Lilli},
  year = {2020},
  journal = {Deutsche medizinische Wochenschrift : DMW},
  volume = {145},
  number = {22},
  pages = {1614-1623},
  publisher = {Thieme},
  address = {Stuttgart},
  issn = {0012-0472},
  doi = {10.1055/a-1038-0408},
  url = {https://fis.uni-bamberg.de/handle/uniba/50968},
  language = {deu}
}

@incollection{kulzer2020_50971,
  title = {Psychodiabetologie in der Rehabilitation},
  author = {Kulzer, Bernhard and Petrak, Frank},
  year = {2020},
  booktitle = {Psychologie in der medizinischen Rehabilitation : Somatopsychologie und Verhaltensmedizin},
  pages = {327-342},
  publisher = {Springer},
  address = {Berlin, Heidelberg},
  edition = {2., aktualisierte und erweiterte Auflage},
  isbn = {978-3-662-61169-2},
  doi = {10.1007/978-3-662-61170-8\_26},
  url = {https://fis.uni-bamberg.de/handle/uniba/50971},
  language = {deu}
}

@misc{kulzer2020_50973,
  title = {Digitalisierungs- und Technologiereport Diabetes 2020},
  editor = {Kulzer, Bernhard and Heinemann, Lutz},
  year = {2020},
  volume = {2},
  publisher = {Kirchheim},
  address = {Mainz},
  issn = {2627-4140},
  url = {https://fis.uni-bamberg.de/handle/uniba/50973},
  language = {deu}
}

@article{kroger2020_50975,
  title = {Neue Formen des Glukosemonitorings und die Auswirkungen auf Therapie und Schulung in Deutschland},
  author = {Kröger, Jens and Kulzer, Bernhard},
  year = {2020},
  journal = {Deutscher Gesundheitsbericht Diabetes 2021 : die Bestandsaufnahme},
  pages = {173-182},
  publisher = {Kirchheim},
  address = {Mainz},
  issn = {1614-824X},
  url = {https://fis.uni-bamberg.de/handle/uniba/50975},
  language = {deu}
}

@article{lange2020_50976,
  title = {Psychosoziale Versorgung von Menschen mit Diabetes : aktuelle Aspekte},
  author = {Lange, Karin and Neu, Andreas and Kulzer, Bernhard},
  year = {2020},
  journal = {Deutscher Gesundheitsbericht Diabetes 2021 : die Bestandsaufnahme},
  pages = {238-244},
  publisher = {Kirchheim},
  address = {Mainz},
  issn = {1614-824X},
  url = {https://fis.uni-bamberg.de/handle/uniba/50976},
  language = {deu}
}

@article{kulzer2020_50958,
  title = {Verbesserung der Blutzuckereinstellung und des Empowerments bei Patienten mit Diabetes durch Selbstkontrolle des HbA1c-Werts – eine nicht interventionelle Studie},
  author = {Kulzer, Bernhard and Anderten, Helmut and Borck, Anja and Freckmann, Guido},
  year = {2020},
  journal = {Diabetes, Stoffwechsel und Herz = Diabetes, metabolism, and the heart},
  volume = {29},
  number = {1},
  pages = {9-15},
  publisher = {Kirchheim-Verlag},
  address = {Mainz},
  issn = {1861-7603},
  url = {https://fis.uni-bamberg.de/handle/uniba/50958},
  language = {deu}
}

@article{ebert2020_50662,
  title = {DDG Praxisempfehlungen . Diabetes und Straßenverkehr},
  author = {Ebert, Oliver and Bohn, Barbara and Bertram, Bernd and Buchberger, Barbara and Finck, Hermann and Hoß, Jürgen and Hübner, Peter and Krabbe, Laura and Kulzer, Bernhard and Küstner, Eva and Lachenmayr, Bernhard and Lemmen, Klaus-Dieter and Petry, Friedhelm and Rinnert, Kurt and Salomon, Markus and Schütt, Wolfgang and Holl, Reinhard W.},
  year = {2020},
  journal = {Der Diabetologe},
  volume = {16},
  number = {2},
  pages = {172-185},
  publisher = {Springer},
  address = {Berlin ; Heidelberg [u.a.]},
  issn = {1860-9716},
  doi = {10.1007/s11428-020-00591-1},
  url = {https://fis.uni-bamberg.de/handle/uniba/50662},
  language = {deu}
}

@article{ehrmann2020_50235,
  title = {Risk factors and prevention strategies for diabetic ketoacidosis in people with established type 1 diabetes},
  author = {Ehrmann, Dominic and Kulzer, Bernhard and Haak, Thomas and Al-Khatib, Mohammed and Hermanns, Norbert and Roos, Timm},
  year = {2020},
  journal = {The lancet : Diabetes \& Endocrinology},
  volume = {8},
  number = {5},
  pages = {436-446},
  publisher = {Elsevier},
  address = {Oxford},
  issn = {2213-8587},
  doi = {10.1016/S2213-8587(20)30042-5},
  url = {https://fis.uni-bamberg.de/handle/uniba/50235},
  language = {eng}
}

@inproceedings{schmitt2020_47067,
  title = {Effekt eines Behandlungsprogramms für Menschen mit Diabetes und gestörter Krankheitsakzeptanz : Eine nicht-randomisierte Matched-Pair-Pilotstudie},
  author = {Schmitt, Andreas and Reimer, Andre and Kulzer, Bernhard and Schäfer, Arne and Maier, Berthold and Haak, Thomas and Hermanns, Norbert},
  year = {2020},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  doi = {10.20378/irb-47067},
  urn = {urn:nbn:de:bvb:473-irb-470673},
  url = {https://fis.uni-bamberg.de/handle/uniba/47067},
  language = {deu}
}

@inproceedings{hermanns2020_47001,
  title = {Reduktion schwerer Hypoglykämien nach Teilnahme an einem neuen strukturierten Schulungs- und Behandlungsprogramm für die Insulinpumpentherapie (INPUT)},
  author = {Hermanns, Norbert and Ehrmann, Dominic and Schipfer, Melanie and Lippmann-Grob, Bernhard and Haak, Thomas and Kulzer, Bernhard},
  year = {2020},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  doi = {10.20378/irb-47001},
  urn = {urn:nbn:de:bvb:473-irb-470019},
  url = {https://fis.uni-bamberg.de/handle/uniba/47001},
  language = {deu}
}

@inproceedings{hermanns2020_46999,
  title = {Gibt es einen Unterschied in der glykämischen Kontrolle zwischen erfahrenen und neuen Nutzern von Flash Glucose Monitoring?},
  author = {Hermanns, Norbert and Ehrmann, Dominic and Schipfer, Melanie and Haak, Thomas and Kulzer, Bernhard},
  year = {2020},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  doi = {10.20378/irb-46999},
  urn = {urn:nbn:de:bvb:473-irb-469998},
  url = {https://fis.uni-bamberg.de/handle/uniba/46999},
  language = {deu}
}

@inproceedings{ehrmann2020_46965,
  title = {Comparison of glycemic control between experienced users of flash glucose monitoring vs. flash-naïve patients},
  author = {Ehrmann, Dominic and Kulzer, Bernhard and Schipfer, Melanie and Haak, Thomas and Hermanns, Norbert},
  year = {2020},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  doi = {10.20378/irb-46965},
  urn = {urn:nbn:de:bvb:473-irb-469654},
  url = {https://fis.uni-bamberg.de/handle/uniba/46965},
  language = {eng},
  abstract = {We conducted a randomized controlled trial to evaluate the efficacy of a newly developed education program for Flash Glucose Monitoring (Flash). Eligible participants were all patients with intensified insulin therapy who either had experience with Flash or no experience. In this observational analysis, we used baseline-date of our study to analyze whether patients who were experienced with Flash (Flash-experienced) achieved better glycemic control than patients who newly received Flash (Flash-naïve).
A total of 216 patients were recruited. All patients received Flash at baseline and used it for 2 weeks before being randomized to either receive the education program or using Flash without education. 133 patients who indicated at the beginning of the 2-week period that they have used Flash in the last 6 months were compared to 83 patients who had no prior experience with Flash.
HbA1c at the beginning of the 2 weeks was comparable between groups (8.4 ± 1.0 vs. 8.4 ± 0.9; p = .89). At the end of the 2 weeks, Flash-naïve patients achieved lower mean glucose values than Flash-experienced patients (179.6 ± 25.9 vs. 192.3 ± 39.2 mg/dl, p = 0.005). While time spent in hypoglycemia (≤ 70 mg/dl) was not different between the groups (69.3 ± 52.0 vs. 67.9 ± 52.9 min/day, p = .85), Flash-naïve patients had a higher time in range (71-180 mg/dl) (716.5 ± 174.1 vs. 660.2 ± 209.2 min/day, p = .036) and spent less time in hyperglycemia (> 180 mg/dl) (656.0 ± 194.0 vs. 715.0 ± 232.8 min/day, p = .048).
Interestingly, Flash-experienced patients had no better glycemic control than patients previously using SMBG. Thus, experienced as well as naïve patients could benefit from the education program. During the 2 weeks, Flash-naïve patients achieved a better glycemic profile than Flash-experienced patients. Bearing in mind the limitations of the observational analysis, this could be due to the introduction of a new technology and a higher motivation in patients newly switched to Flash.}
}

@inproceedings{hermanns2020_47106,
  title = {Comparison of Satisfaction with their Glucose Monitoring Device in Patients Using Flash Glucose Monitoring vs. Patients Using SMBG},
  author = {Hermanns, Norbert and Ehrmann, Dominic and Schipfer, Melanie and Haak, Thomas and Kulzer, Bernhard},
  year = {2020},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  doi = {10.20378/irb-47106},
  urn = {urn:nbn:de:bvb:473-irb-471069},
  url = {https://fis.uni-bamberg.de/handle/uniba/47106},
  language = {eng},
  abstract = {Flash Glucose Monitoring offers several benefits to patients such as ease of use and no additional finger pricks. However, there are also some limitations that are being discussed such as perceived lack of accuracy and skin irritations. We analyzed different aspects of patients’ satisfaction with Flash Glucose Monitoring (Flash) by comparing Flash users to patients who use SMBG.
We used the Glucose Monitoring Satisfaction Survey that consists of 15 items with a scale range of 1 to 5. 133 patients who were using Flash for 7.9 ± 9.5 months were compared with 83 patients who used SMBG. As a measure of between-group effect size, Cohens d was used.
In general, Flash users were significantly more satisfied with how things were going with their diabetes (d = 0.31; p = 0.024). SMBG users indicated that measurement takes more time to use (d = 0.67; p < 0.001), makes them worry more (d = 0.32; p = 0.024), is more of a hassle to use (d = 0.45; p = 0.002), and is more painful to use (d = 0.55; p < 0.001) when compared to Flash users. Feeling frustrated with diabetes (d = 0.31; p = 0.027) as well as being depressed (d = 0.40; p = 0.002) were scored lower by Flash users.
In addition, Flash users felt less restricted by diabetes (d = 0.52; p < 0.001) and more spontaneous (d = 0.67; p < 0.001). Interestingly, there were no significant differences regarding the rating of accuracy (d = 0.19; p = 0.157), trusting the numbers (d = 0.01; p = 0.934), and skin irritations (d = 0.26; p = 0.053).
The comparison demonstrated that there are several perceived benefits associated with using Flash. Ease of use and gaining more flexibility or feeling less restricted were important topics for Flash users. Possible limitations of Flash were not perceived as such by the users.}
}

@inproceedings{schmitt2020_47069,
  title = {Evaluation eines Stepped-Care-Ansatzes zur Behandlung von Depression und Diabetes Distress bei Menschen mit Diabetes : Ergebnisse der randomisiert-kontrollierten ECCE HOMO-Studie},
  author = {Schmitt, Andreas and Reimer, Andre and Kulzer, Bernhard and Haak, Thomas and Hermanns, Norbert},
  year = {2020},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  doi = {10.20378/irb-47069},
  urn = {urn:nbn:de:bvb:473-irb-470696},
  url = {https://fis.uni-bamberg.de/handle/uniba/47069},
  language = {deu}
}

@inproceedings{kulzer2020_47105,
  title = {More Patients with Optimal Glycemic Control after Participation in a CSII-specific Education Program (INPUT) : Results from a Randomized Controlled Trial},
  author = {Kulzer, Bernhard and Ehrmann, Dominic and Schipfer, Melanie and Lippmann-Grob, Bernhard and Haak, Thomas and Hermanns, Norbert},
  year = {2020},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  doi = {10.20378/irb-47105},
  urn = {urn:nbn:de:bvb:473-irb-471059},
  url = {https://fis.uni-bamberg.de/handle/uniba/47105},
  language = {eng},
  abstract = {Despite the technological advances of CSII-therapy, many patients with CSII-therapy do not achieve optimal glycemic control. We developed an education program for CSII-therapy (INPUT) and evaluated its efficacy in a randomized controlled trial with a six-month follow-up. INPUT addresses the specific knowledge and skills to effectively handle CSII-therapy as well as possible psychological barriers.
We analyzed whether participation in the INPUT program increased the number of patients with optimal glycemic control (HbA1c < 7.5\%).
254 patients with CSII-therapy were randomized to either receive the INPUT education program or treatment-as-usual and assessed at follow-up. All patients were already performing CSII-therapy for 8.7 ± 6.8 years, with a mean diabetes duration of 23.1 ± 12.6 years. HbA1c at baseline was 8.3 ± 0.9\%. Optimal glycemic control at baseline was achieved by 13\% in the INPUT group and 20\% in the control group.
Logistic regression with group as independent factor controlling for optimal glycemic control at baseline was performed. Dependent variable was optimal glycemic control at the six-month followup.
Group was a significant predictor with INPUT patients having a 2-fold higher chance to achieve optimal glycemic control (OR = 1.98; 95\% CI 1.04 – 3.78; p = 0.037) compared to patients in the control group. At follow-up, 27\% of the INPUT group had achieved optimal glycemic control while only 18 \% in the control group.
In this study, patients performed CSII-therapy for almost 10 years without achieving optimal glycemic control. After participation in INPUT, patient more often achieved optimal glycemic control compared to a treatment-as-usual control group. Thus, the INPUT education program was effective in improving glycemic control in patients with long-standing diabetes. Considering the higher costs of CSII-therapy, this beneficial effect of the education program has health-economic implications.}
}

@inproceedings{schmitt2020_47068,
  title = {Stellen Patienten mit Depressivität sowie gleichzeitig Diabetes Distress eine Hochrisikogruppe dar? : Baseline-Ergebnisse des „Depression and Diabetes Control Trial (DDCT)“},
  author = {Schmitt, Andreas and Reimer, Andre and Hermanns, Norbert and Haak, Thomas and Kulzer, Bernhard},
  year = {2020},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  doi = {10.20378/irb-47068},
  urn = {urn:nbn:de:bvb:473-irb-470681},
  url = {https://fis.uni-bamberg.de/handle/uniba/47068},
  language = {deu}
}

@inproceedings{maier2020_47066,
  title = {Junge Erwachsene mit Typ-1-Diabetes (18-25 Jahre) : Ein neues, stationäres Therapiekonzept},
  author = {Maier, Berthold and Kulzer, Bernhard and Schäfer, Arne and Tombek, Astrid and Greiner, Joana and Brämswig, Susanne and Haak, Thomas},
  year = {2020},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  doi = {10.20378/irb-47066},
  urn = {urn:nbn:de:bvb:473-irb-470663},
  url = {https://fis.uni-bamberg.de/handle/uniba/47066},
  language = {deu}
}

@inproceedings{kulzer2020_47065,
  title = {Verbessertes psychosoziales Wohlbefinden nach Teilnahme an einem strukturierten Schulungs- und Behandlungsprogramm für die Insulinpumpentherapie (INPUT)},
  author = {Kulzer, Bernhard and Ehrmann, Dominic and Schipfer, Melanie and Lippmann-Grob, Bernhard and Haak, Thomas and Hermanns, Norbert},
  year = {2020},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  doi = {10.20378/irb-47065},
  urn = {urn:nbn:de:bvb:473-irb-470658},
  url = {https://fis.uni-bamberg.de/handle/uniba/47065},
  language = {deu}
}

@inproceedings{ehrmann2020_46996,
  title = {Wie zufrieden sind Menschen mit Diabetes mit Flash Glucose Monitoring im Vergleich zur Blutzuckermessung?},
  author = {Ehrmann, Dominic and Hermanns, Norbert and Schipfer, Melanie and Haak, Thomas and Kulzer, Bernhard},
  year = {2020},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  doi = {10.20378/irb-46996},
  urn = {urn:nbn:de:bvb:473-irb-469962},
  url = {https://fis.uni-bamberg.de/handle/uniba/46996},
  language = {deu}
}

@inproceedings{kulzer2019_115836,
  title = {Incidence and risk as well as protective factors regarding diabetic ketosis in people with type 1 diabetes: a secondary analysis of the PRIMAS and INPUT studies},
  author = {Kulzer, Bernhard and Ehrmann, Dominic and Albrecht, C. and Mahr M, Haak T, and Hermanns, Norbert},
  year = {2019},
  volume = {62},
  number = {Suppl 1},
  pages = {293},
  publisher = {Springer},
  address = {Berlin ; Heidelberg},
  issn = {1432-0428},
  url = {https://fis.uni-bamberg.de/handle/uniba/115836},
  language = {eng}
}

@inproceedings{hermanns2019_115835,
  title = {Comparable efficacy of a newly developed education programme for CSII-users (INPUT) under routine care conditions compared to the RCTsetting},
  author = {Hermanns, Norbert and Ehrmann, Dominic and Albrecht, C. and Bergis, Nikola and Haak, Thomas and Kulzer, Bernhard},
  year = {2019},
  volume = {62},
  number = {Suppl 1},
  pages = {402},
  publisher = {Springer},
  address = {Berlin ; Heidelberg},
  issn = {1432-0428},
  url = {https://fis.uni-bamberg.de/handle/uniba/115835},
  language = {eng}
}

@article{heinemann2019_48312,
  title = {Diabetes-Technologie in der Patientenversorgung/Diabetes-Therapie: Nutzen für Betroffene - Nutzen für Praxen und Kliniken},
  author = {Heinemann, Lutz and Keuthage, Winfried and Kulzer, Bernhard},
  year = {2019},
  journal = {Deutscher Gesundheitsbericht Diabetes 2020},
  pages = {239-246},
  publisher = {Kirchheim},
  address = {Mainz},
  issn = {1614-824X},
  url = {https://fis.uni-bamberg.de/handle/uniba/48312},
  language = {deu}
}

@article{kroger2019_48313,
  title = {Digitalisierung und Glukosemonitoring verändern die Diabetestherapie und -schulung},
  author = {Kröger, Jens and Kulzer, Bernhard},
  year = {2019},
  journal = {Deutscher Gesundheitsbericht Diabetes 2020},
  pages = {247-254},
  publisher = {Kirchheim},
  address = {Mainz},
  issn = {1614-824X},
  url = {https://fis.uni-bamberg.de/handle/uniba/48313},
  language = {deu}
}

@incollection{zeyfang2019_48307,
  title = {Der geriatrische Mensch mit Diabetes mellitus},
  author = {Zeyfang, Andrej and Volkert, Dorothee and Kettner, Sarah and Rißmann, Ulrich and Jamour, Michael and Grammes, Jennifer and Kubiak, Thomas and Kulzer, Bernhard and Krichbaum, Michael and Ehrmann, Dominic and Schmitt, Andreas and Hermanns, Norbert and Haak, Thomas and Bergis, Dominik and Wernecke, Jürgen},
  year = {2019},
  booktitle = {Diabetes im Alter},
  pages = {13-68},
  publisher = {De Gruyter},
  address = {Berlin, Boston},
  isbn = {978-3-11-044118-5},
  doi = {10.1515/9783110436457},
  url = {https://fis.uni-bamberg.de/handle/uniba/48307},
  language = {deu}
}

@incollection{kulzer2019_48306,
  title = {Big Data und künstliche Intelligenz},
  author = {Kulzer, Bernhard},
  year = {2019},
  booktitle = {Digitalisierungs- und Technologiereport Diabetes 2019},
  publisher = {Kirchheim},
  address = {Mainz},
  url = {https://fis.uni-bamberg.de/handle/uniba/48306},
  language = {deu}
}

@incollection{kulzer2019_48305,
  title = {Digitale Prävention des Typ-2-Diabetes},
  author = {Kulzer, Bernhard and Kröger, Jens},
  year = {2019},
  booktitle = {Digitalisierungs- und Technologiereport Diabetes 2019},
  publisher = {Kirchheim},
  address = {Mainz},
  url = {https://fis.uni-bamberg.de/handle/uniba/48305},
  language = {deu}
}

@misc{heinemann2019_48304,
  title = {Digitalisierungs- und Technologiereport Diabetes 2019},
  editor = {Heinemann, Lutz and Kulzer, Bernhard},
  year = {2019},
  volume = {1},
  publisher = {Kirchheim},
  address = {Mainz},
  issn = {2627-4132},
  url = {https://fis.uni-bamberg.de/handle/uniba/48304},
  language = {deu}
}

@article{heinemann2019_48186,
  title = {Patch pumps : Are they all the same?},
  author = {Heinemann, Lutz and Waldenmaier, Delia and Kulzer, Bernhard and Ziegler, Ralph and Ginsberg, Barry and Freckmann, Guido},
  year = {2019},
  journal = {Journal of diabetes science and technology : JDST},
  volume = {13},
  number = {1},
  pages = {34-40},
  publisher = {Sage Publishing},
  address = {London},
  issn = {1932-2968},
  doi = {10.1177/1932296818795150},
  url = {https://fis.uni-bamberg.de/handle/uniba/48186},
  language = {eng}
}

@article{heinemann2019_48187,
  title = {Patch-Pumpen : Sind die alle gleich?},
  author = {Heinemann, Lutz and Waldenmaier, Delia and Kulzer, Bernhard and Ziegler, Ralph and Ginsberg, Barry and Freckmann, Guido},
  year = {2019},
  journal = {Diabetes, Stoffwechsel und Herz = Diabetes, metabolism, and the heart},
  volume = {28},
  number = {3},
  pages = {131-137},
  publisher = {Kirchheim-Verlag},
  address = {Mainz},
  issn = {1861-7603},
  url = {https://fis.uni-bamberg.de/handle/uniba/48187},
  language = {deu}
}

@article{kulzer2019_48188,
  title = {Wie digital ist die Diabetologie in Deutschland? : Ergebnisse des Digitalisierungs- und Technologiereports Diabetes 2019},
  author = {Kulzer, Bernhard and Heinemann, Lutz and Hochstadt, Sabine and Keuthage, Winfried and Kröger, Jens and Lueg, Andreas and Mühlen, Hansjörg and Schütte, Lisa and Ehrmann, Dominic and Hermanns, Norbert and Roos, Timm},
  year = {2019},
  journal = {Diabetes, Stoffwechsel und Herz = Diabetes, metabolism, and the heart},
  volume = {28},
  number = {4},
  pages = {189-196},
  publisher = {Kirchheim-Verlag},
  address = {Mainz},
  issn = {1861-7603},
  url = {https://fis.uni-bamberg.de/handle/uniba/48188},
  language = {deu}
}

@article{hermanns2019_48157,
  title = {Continuous glucose monitoring-based technologies in hypoglycaemia-prone patients with type 1 diabetes},
  author = {Hermanns, Norbert and Ehrmann, Dominic and Kulzer, Bernhard},
  year = {2019},
  journal = {The lancet. Diabetes \& Endocrinology},
  volume = {7},
  number = {6},
  pages = {419-421},
  publisher = {Elsevier},
  address = {Oxford},
  issn = {2213-8587},
  doi = {10.1016/S2213-8587(19)30146-9},
  url = {https://fis.uni-bamberg.de/handle/uniba/48157},
  language = {eng}
}

@article{ebert2019_48154,
  title = {Diabetes and Road Traffic : German Diabetes Association ; Clinical Practice Guidelines},
  author = {Ebert, Oliver and Bohn, Barbara and Bertram, Bernd and Buchberger, Barbara and Finck, Hermann and Hoß, Jürgen and Hübner, Peter and Krabbe, Laura and Kulzer, Bernhard and Küstner, Eva and Lachenmayr, Bernhard and Lemmen, Klaus-Dieter and Petry, Friedhelm and Rinnert, Kurt and Salomon, Markus and Schütt, Wolfgang and Holl, Reinhard W.},
  year = {2019},
  journal = {Experimental and clinical endocrinology \& diabetes},
  volume = {127},
  number = {S 01},
  pages = {114-123},
  publisher = {Thieme},
  address = {Stuttgart [u.a.]},
  issn = {0947-7349},
  doi = {10.1055/a-1018-9262},
  url = {https://fis.uni-bamberg.de/handle/uniba/48154},
  language = {eng}
}

@article{bergis2019_48152,
  title = {Perceived benefits and barriers regarding CSII treatment : Development and psychometric evaluation of the Insulin Pump Attitudes Questionnaire (IPA-Questionnaire)},
  author = {Bergis, Dominik and Ehrmann, Dominic and Schmitt, Andreas and Schipfer, Melanie and Haak, Thomas and Kulzer, Bernhard and Hermanns, Norbert and Roos, Timm},
  year = {2019},
  journal = {Experimental and clinical endocrinology \& diabetes},
  publisher = {Thieme},
  address = {Stuttgart [u.a.]},
  issn = {1439-3646},
  doi = {10.1055/a-0899-4980},
  url = {https://fis.uni-bamberg.de/handle/uniba/48152},
  language = {eng}
}

@article{heinemann2019_48151,
  title = {Benefit of digital tools used for integrated personalized diabetes management : Results from the PDM-ProValue study program},
  author = {Heinemann, Lutz and Schramm, Wendelin and Koenig, Helena and Moritz, Annette and Vesper, Iris and Weissmann, Joerg and Kulzer, Bernhard},
  year = {2019},
  journal = {Journal of diabetes science and technology : JDST},
  volume = {14},
  number = {2},
  pages = {240-249},
  publisher = {Sage Publishing},
  address = {London},
  issn = {1932-2968},
  doi = {10.1177/1932296819867686},
  url = {https://fis.uni-bamberg.de/handle/uniba/48151},
  language = {eng}
}

@article{bergis2019_47490,
  title = {Comparison of the efficacy of an education program for people with diabetes and insulin pump treatment (INPUT) in a randomized controlled trial setting and the effectiveness in a routine care setting: Results of a comparative effectiveness study},
  author = {Bergis, Dominik and Ehrmann, Dominic and Albrecht, Carmen and Haak, Thomas and Kulzer, Bernhard and Hermanns, Norbert},
  year = {2019},
  journal = {Patient Education and Counseling},
  volume = {102},
  number = {10},
  pages = {1868-1874},
  publisher = {Elsevier},
  address = {Amsterdam [u.a.]},
  issn = {0738-3991},
  doi = {10.1016/j.pec.2019.04.021},
  url = {https://fis.uni-bamberg.de/handle/uniba/47490},
  language = {eng}
}

@article{hermanns2019_47486,
  title = {The impact of a structured education and treatment programme (FLASH) for people with diabetes using a flash sensor-based glucose monitoring system : Results of a randomized controlled trial},
  author = {Hermanns, Norbert and Ehrmann, Dominic and Schipfer, Melanie and Kröger, Jens and Haak, Thomas and Kulzer, Bernhard},
  year = {2019},
  journal = {Diabetes research and clinical practice},
  volume = {150},
  pages = {111-121},
  publisher = {Elsevier},
  address = {Amsterdam [u.a.]},
  issn = {0168-8227},
  doi = {10.1016/j.diabres.2019.03.003},
  url = {https://fis.uni-bamberg.de/handle/uniba/47486},
  language = {eng},
  abstract = {Aims: Flash sensor-based glucose monitoring (FSGM) provides people with diabetes considerably more information on their glycaemic control. We have developed and evaluated a structured education and treatment programme, termed FLASH, to assist FSGM users to understand and use the available glycaemic information for optimization of their diabetes treatment.

Methods: We report on a multi-centre, randomized, parallel trial with a six-month follow-up involving 216 eligible participants (16–75 years old) on intensive insulin therapy. The primary outcome was HbA1c change from baseline to six months. Secondary outcomes were measures of glucose control as assessed by FSGM, as well as changes in behavioural and psychosocial measures.

Results: At six months, the between-group difference in HbA1c reduction was significant, favouring FLASH education compared to the control group receiving no FLASH education (−0.28\%, 95\% CI −0.16\% to −0.40\% vs.−0.11\%, 95\% CI 0.00\% to −0.22\%; with a between-group difference of −0.17\%, 95\% CI −0.01\% to −0.33\%; p = 0.033). Participation in FLASH education also resulted in significant improvements in time spent in the target glucose range, in diabetes-related distress scores and in satisfaction with the glucose monitoring method. FLASH education also resulted in significant improvements in the use of glycaemic information provided by FSGM and in reduced self-monitoring of blood glucose (SMBG) fingerstick testing.},
  keywords = {Diabetes, Flash glucose monitoring, Education, Self-management}
}

@article{heinemann2018_48314,
  title = {Improvements in Patient Care by an Integrated Personalized Diabetes Management (iPDM) Approach May Be Driven by the Structured Process and How Physicians Use Data Sources},
  author = {Heinemann, Lutz and Messinger, Diethelm and Schramm, Wendelin and Vesper, Iris and Weissmann, Joerg and Kulzer, Bernhard},
  year = {2018},
  journal = {Diabetes},
  volume = {67},
  number = {Suppl. 1},
  pages = {LB39 (139-LB)},
  address = {Alexandria, Va},
  issn = {0012-1797},
  doi = {10.2337/db18-139-LB},
  url = {https://fis.uni-bamberg.de/handle/uniba/48314},
  language = {eng}
}

@article{ehrmann2018_47107,
  title = {Structured self-management education for insulin pump therapy (INPUT): results from a randomised controlled trial},
  author = {Ehrmann, Dominic and Kulzer, Bernhard and Schipfer, Melanie and Lippmann-Grob, Bernhard and Haak, Thomas and Hermanns, Norbert},
  year = {2018},
  journal = {Diabetologia : journal of the European Association for the Study of Diabetes (EASD)},
  volume = {61},
  number = {Suppl. 1},
  pages = {S30 (OP 56)},
  publisher = {Springer},
  address = {Berlin ; Heidelberg [u.a.]},
  issn = {0012-186X},
  doi = {10.1007/s00125-018-4693-0},
  url = {https://fis.uni-bamberg.de/handle/uniba/47107},
  language = {eng}
}

@article{kulzer2018_47057,
  title = {Integrated Personalized Diabetes Management (iPDM) improves satisfaction of patients with insulin-treated type 2 diabetes and their physicians: Results from the PDM-ProValue Study Program},
  author = {Kulzer, Bernhard and Daenschel, Wilfried and Daenschel, Ingrid and Messinger, Diethelm and Schramm, Wendelin and Vesper, Iris and Weissmann, Joerg and Heinemann, Lutz},
  year = {2018},
  journal = {Diabetes Technology \& Therapeutics},
  volume = {20},
  number = {Suppl. 1},
  pages = {A115 (ATTD8-0085)},
  publisher = {Liebert},
  address = {Larchmont, NY},
  issn = {1520-9156},
  doi = {10.1089/dia.2018.2525.abstracts},
  url = {https://fis.uni-bamberg.de/handle/uniba/47057},
  language = {eng}
}

@article{heinemann2018_47056,
  title = {Integrated Personalized Diabetes Management (iPDM) in patients with insulintreated T2DM: Results of the PDM-ProValue Study Program},
  author = {Heinemann, Lutz and Daenschel, Ingrid and Daenschel, Wilfried and Messinger, Diethelm and Schramm, Wendelin and Vesper, Iris and Weissmann, Joerg and Kulzer, Bernhard},
  year = {2018},
  journal = {Diabetes Technology \& Therapeutics},
  volume = {20},
  number = {Suppl. 1},
  pages = {A114 (ATTD8-0086)},
  publisher = {Liebert},
  address = {Larchmont, NY},
  issn = {1520-9156},
  doi = {10.1089/dia.2018.2525.abstracts},
  url = {https://fis.uni-bamberg.de/handle/uniba/47056},
  language = {eng}
}

@inproceedings{kulzer2018_47026,
  title = {More Patients with Optimal Glycemic Control after Participation in a CSII-Specific Education Program (INPUT)—Results from a Randomized Controlled Study},
  author = {Kulzer, Bernhard and Ehrmann, Dominic and Schipfer, Melanie and Lippmann-Grob, Bernhard and Haak, Thomas and Hermanns, Norbert},
  year = {2018},
  volume = {67},
  number = {Suppl. 1},
  pages = {A176 (671-P)},
  address = {Alexandria, VA.},
  issn = {0012-1797},
  doi = {10.2337/db18-671-P},
  url = {https://fis.uni-bamberg.de/handle/uniba/47026},
  language = {eng},
  abstract = {Despite the technological advances of CSII-therapy, many patients with CSII-therapy do not achieve optimal glycemic control. We developed an education program for CSII-therapy (INPUT) and evaluated its efficacy in a randomized controlled trial with a six-month follow-up. INPUT addresses the specific knowledge and skills to effectively handle CSII-therapy as well as possible psychological barriers.
We analyzed whether participation in the INPUT program increased the number of patients with optimal glycemic control (HbA1c < 7.5\%).
254 patients with CSII-therapy were randomized to either receive the INPUT education program or treatment-as-usual and assessed at follow-up. All patients were already performing CSII-therapy for 8.7 ± 6.8 years, with a mean diabetes duration of 23.1 ± 12.6 years. HbA1c at baseline was 8.3 ± 0.9\%. Optimal glycemic control at baseline was achieved by 13\% in the INPUT group and 20\% in the control group.
Logistic regression with group as independent factor controlling for optimal glycemic control at baseline was performed. Dependent variable was optimal glycemic control at the six-month followup.
Group was a significant predictor with INPUT patients having a 2-fold higher chance to achieve optimal glycemic control (OR = 1.98; 95\% CI 1.04 – 3.78; p = 0.037) compared to patients in the control group. At follow-up, 27\% of the INPUT group had achieved optimal glycemic control while only 18 \% in the control group.
In this study, patients performed CSII-therapy for almost 10 years without achieving optimal glycemic control. After participation in INPUT, patient more often achieved optimal glycemic control compared to a treatment-as-usual control group. Thus, the INPUT education program was effective in improving glycemic control in patients with long-standing diabetes. Considering the higher costs of CSII-therapy, this beneficial effect of the education program has health-economic implications.}
}

@inproceedings{hermanns2018_47023,
  title = {Comparison of Satisfaction with Their Glucose Monitoring Device in Patients Using Flash Glucose Monitoring vs. Patients Using SMBG},
  author = {Hermanns, Norbert and Ehrmann, Dominic and Schipfer, Melanie and Haak, Thomas and Kulzer, Bernhard},
  year = {2018},
  volume = {67},
  number = {Suppl. 1},
  pages = {A237-A238 (914-P)},
  address = {Alexandria, VA.},
  issn = {0012-1797},
  doi = {10.2337/db18-914-P},
  url = {https://fis.uni-bamberg.de/handle/uniba/47023},
  language = {eng},
  abstract = {Flash Glucose Monitoring offers several benefits to patients such as ease of use and no additional finger pricks. However, there are also some limitations that are being discussed such as perceived lack of accuracy and skin irritations. We analyzed different aspects of patients’ satisfaction with Flash Glucose Monitoring (Flash) by comparing Flash users to patients who use SMBG.
We used the Glucose Monitoring Satisfaction Survey that consists of 15 items with a scale range of 1 to 5. 133 patients who were using Flash for 7.9 ± 9.5 months were compared with 83 patients who used SMBG. As a measure of between-group effect size, Cohens d was used.
In general, Flash users were significantly more satisfied with how things were going with their diabetes (d = 0.31; p = 0.024). SMBG users indicated that measurement takes more time to use (d = 0.67; p < 0.001), makes them worry more (d = 0.32; p = 0.024), is more of a hassle to use (d = 0.45; p = 0.002), and is more painful to use (d = 0.55; p < 0.001) when compared to Flash users. Feeling frustrated with diabetes (d = 0.31; p = 0.027) as well as being depressed (d = 0.40; p = 0.002) were scored lower by Flash users.
In addition, Flash users felt less restricted by diabetes (d = 0.52; p < 0.001) and more spontaneous (d = 0.67; p < 0.001). Interestingly, there were no significant differences regarding the rating of accuracy (d = 0.19; p = 0.157), trusting the numbers (d = 0.01; p = 0.934), and skin irritations (d = 0.26; p = 0.053).
The comparison demonstrated that there are several perceived benefits associated with using Flash. Ease of use and gaining more flexibility or feeling less restricted were important topics for Flash users. Possible limitations of Flash were not perceived as such by the users.}
}

@article{ehrmann2018_47022,
  title = {Comparison of Glycemic Control between Experienced Users of Flash Glucose Monitoring vs. Flash-Naïve Patients},
  author = {Ehrmann, Dominic and Schipfer, Melanie and Haak, Thomas and Kulzer, Bernhard and Hermanns, Norbert},
  year = {2018},
  journal = {Diabetes : the journal of the American Diabetes Association},
  volume = {67},
  number = {Suppl. 1},
  pages = {A237 (912-P)},
  address = {Alexandria, VA},
  issn = {0012-1797},
  doi = {10.2337/db18-912-P},
  url = {https://fis.uni-bamberg.de/handle/uniba/47022},
  language = {eng},
  abstract = {We conducted a randomized controlled trial to evaluate the efficacy of a newly developed education program for Flash Glucose Monitoring (Flash). Eligible participants were all patients with intensified insulin therapy who either had experience with Flash or no experience. In this observational analysis, we used baseline-date of our study to analyze whether patients who were experienced with Flash (Flash-experienced) achieved better glycemic control than patients who newly received Flash (Flash-naïve).
A total of 216 patients were recruited. All patients received Flash at baseline and used it for 2 weeks before being randomized to either receive the education program or using Flash without education. 133 patients who indicated at the beginning of the 2-week period that they have used Flash in the last 6 months were compared to 83 patients who had no prior experience with Flash.
HbA1c at the beginning of the 2 weeks was comparable between groups (8.4 ± 1.0 vs. 8.4 ± 0.9; p = .89). At the end of the 2 weeks, Flash-naïve patients achieved lower mean glucose values than Flash-experienced patients (179.6 ± 25.9 vs. 192.3 ± 39.2 mg/dl, p = 0.005). While time spent in hypoglycemia (≤ 70 mg/dl) was not different between the groups (69.3 ± 52.0 vs. 67.9 ± 52.9 min/day, p = .85), Flash-naïve patients had a higher time in range (71-180 mg/dl) (716.5 ± 174.1 vs. 660.2 ± 209.2 min/day, p = .036) and spent less time in hyperglycemia (> 180 mg/dl) (656.0 ± 194.0 vs. 715.0 ± 232.8 min/day, p = .048).
Interestingly, Flash-experienced patients had no better glycemic control than patients previously using SMBG. Thus, experienced as well as naïve patients could benefit from the education program. During the 2 weeks, Flash-naïve patients achieved a better glycemic profile than Flash-experienced patients. Bearing in mind the limitations of the observational analysis, this could be due to the introduction of a new technology and a higher motivation in patients newly switched to Flash.}
}

@article{kulzer2018_46311,
  title = {Integriertes Personalisiertes Diabetes-Management (iPDM) verbessert die Therapiezufriedenheit von Ärzten und insulinbehandelten Patienten mit Typ-2 Diabetes: Ergebnisse des PDM-ProValue Studienprogramms},
  author = {Kulzer, Bernhard and Dänschel, Wilfried and Dänschel, Ingrid and Messinger, Diethelm and Schramm, Wendelin and Vesper, Iris and Weißmann, Jörg and Heinemann, Lutz},
  year = {2018},
  journal = {Diabetologie und Stoffwechsel},
  volume = {13},
  number = {Suppl. 1},
  pages = {S65 (P192)},
  publisher = {Thieme},
  address = {Stuttgart [u.a.]},
  issn = {1861-9002},
  doi = {10.1055/s-0038-1641950},
  url = {https://fis.uni-bamberg.de/handle/uniba/46311},
  language = {deu},
  abstract = {Fragestellung:

Die Wirksamkeit von iPDM, einem digital unterstützten, strukturierten Behandlungskonzept, wurde im PDM-ProValue Studienprogramm bei insulinbehandelten Patienten mit Typ-2 Diabetes (T2D) untersucht. Neben klinischen Parametern wurden die Therapiezufriedenheit von Patienten, die Behandlungszufriedenheit der Ärzte sowie die Adhärenz der Patienten erfasst.

Methode:

In dem prospektiven, kontrollierten, cluster-randomisierten ProValue Studienprogramm wurden 907 Patienten aus 101 Hausarzt- und diabetologischen Schwerpunktpraxen über 12 Monate beobachtet (iPDM, n = 53; Usual Care-Gruppe CNL, n = 48). Die Intervention erfolgte als 6-stufiger, digital unterstützter Prozess, mit strukturierter Messung, digitaler Auswertung und Visualisierung der Blutzuckerdaten und gemeinsamer Entscheidungsfindung von Arzt und Patient bezüglich Therapieanpassungen. Therapiezufriedenheit der Patienten wurde anhand des Diabetes Treatment Satisfaction Questionnaire (DTSQs/DTSQc) erfasst, Zufriedenheit der Ärzte mit dem Diabetes Treatment Physician Satisfaction Questionnaire (DT-PSQ) und die Adhärenz anhand eine Likert-Skala.

Ergebnisse:

Die Patienten beider Studienarme (iPDM/Usual Care-Kontrolle, CNL) waren hinsichtlich demographischer Daten, Therapiedaten und Therapiezufriedenheit vergleichbar. Nach 12 Monaten Studienteilnahme war die iPDM-Gruppe mit der Therapie signifikant zufriedener als die CNL-Gruppe (DTSQc: 12,2 vs. 10,4, Delta = 1,8, p = 0,004; DTSQs: 31,0 vs. 30,1; Delta = 0,9, p = 0,02). Auch bezüglich der Behandlungszufriedenheit der Ärzte waren diese signifikant mit dem iPDM-Prozess zufriedener (9,7 vs. 4,9 Punkte (Delta = 4,9, p < 0,0001). Dies zeigte sich auch in jeweils signifikant (jeweils p < 0,0001) verbesserten Skalen „Therapieergebnisse“, „Analyse der Ergebnisse/Diskussion mit dem Patienten“, „Vorteil SMBG“ und „Kommunikation mit Patienten“. Der Anteil an Patienten mit einer laut Arzteinschätzung verbesserten Therapieadhärenz war in der iPDM-Gruppe ebenfalls höher als in der CNL-Gruppe (Odds Ratio = 2,34; p = 0,0015).

Schlussfolgerung:

iPDM führt zu einer verbesserten Therapiezufriedenheit bei Patienten, einer gesteigerten Adhärenz und einer ebenfalls verbesserten Behandlerzufrienheit.}
}

@article{danschel2018_46303,
  title = {Therapieoptimierung durch integriertes Personalisiertes Diabetesmanagement: Ergebnisse des PDM-ProValue-Studienprogramms},
  author = {Dänschel, Ingrid and Dänschel, Wilfried and Messinger, Diethelm and Schramm, Wendelin and Vesper, Iris and Weißmann, Jörg and Heinemann, Lutz and Kulzer, Bernhard},
  year = {2018},
  journal = {Diabetologie und Stoffwechsel},
  volume = {13},
  number = {Suppl. 1},
  pages = {S34 (P98)},
  publisher = {Thieme},
  address = {Stuttgart [u.a.]},
  issn = {1861-9002},
  doi = {10.1055/s-0038-1641856},
  url = {https://fis.uni-bamberg.de/handle/uniba/46303},
  language = {deu},
  abstract = {Fragestellung:

Viele Menschen mit insulinbehandeltem Typ-2 Diabetes (T2D) erreichen nicht ihre Behandlungsziele. Das PDM-ProValue Studienprogramm untersuchte, inwieweit ein digital unterstütztes, strukturiertes Behandlungskonzept (integriertes, personalisiertes Diabetes-Management, iPDM) durch Förderung gemeinsamer Therapieentscheidungen von Arzt und Patient die glykämische Einstellung bei diesem Kollektiv verbessern kann.

Methode:

In dem prospektiven, kontrollierten, cluster-randomisierten Studienprogramm wurden 907 Patienten aus 101 Hausarzt- und diabetologischen Schwerpunktpraxen über 12 Monate beobachtet (iPDM, n = 53; Usual Care-Gruppe (CNL, n = 48). Die Intervention erfolgte als 6-stufiger, digital unterstützter Prozess, mit strukturierter Messung, digitaler Auswertung und Visualisierung der Blutzuckerdaten und gemeinsamer Entscheidungsfindung von Arzt und Patient bezüglich Therapieanpassungen. Diese wurden in Hinblick auf Häufigkeit, Zeitpunkt, Art und Therapieform (BOT, SIT, CT und ICT) ausgewertet.

Ergebnisse:

Die Patienten der iPDM und der CNL-Gruppe waren zu Studienbeginn vergleichbar (Alter: iPDM 65 ± 11 (MW ± SD) vs. CNL 65 ± 10 Jahre; Geschlecht (männlich): 60,5\% vs. 55,9\%; Diabetesdauer: 14 ± 9 vs. 14 ± 8 Jahre; BMI: 33,8 ± 6,1 vs. 34,0 ± 6,1 kg/m2; HbA1c: 8,5 ± 1,1\% vs. 8,4 ± 1,0\%, Therapieform ICT/BOT/Andere: 61\%/29\%/10\% vs. 62\%/29\%/10). Deutlich mehr iPDM-Patienten erhielten die Empfehlung zur Anpassung ihrer Insulintherapie (Monat 3: 49,5\% vs. 34,0\%; p = 0,001), zur Diabetesschulung (22,3\% vs. 14,1\%; p = 0,045), körperlichen Bewegung (40,4\% vs. 20,3\%; p = 0,0063) und Ernährungsberatung (37,0\% vs. 23,3\%; p = 0,013). Ingesamt profitierte die BOT-Patientengruppe am stärksten von iPDM. Im iPDM-Arm wurden früher und häufiger Therapieanpassungen empfohlen, insbesondere Anpassungen der Basalinsulindosis.

Schlussfolgerung:

Die Ergebnisse verdeutlichen das Potential des iPDM-Konzepts für eine verbesserte Entscheidungsfindung von Ärzten und Patienten. Die Effekte scheinen besonders bei BOT-Patienten ausgeprägt, bei denen eine Titrierung als Therapieanpassung häufig unterbleibt. iPDM scheint ein geeignetes Konzept gegen „Clinical Inertia“ zu sein.}
}

@article{schmitt2018_46284,
  title = {Differentielle Assoziationen von Depressivität versus Diabetes Distress mit Selbstbehandlungsverhalten und HbA1c – Eine Strukturgleichungsanalyse},
  author = {Schmitt, Andreas and Reimer, André and Hermanns, Norbert and Baumeister, Harald and Bendig, Eileen and Haak, Thomas and Kulzer, Bernhard},
  year = {2018},
  journal = {Diabetologie und Stoffwechsel},
  volume = {13},
  number = {Suppl. 1},
  pages = {S9 (FV 25)},
  publisher = {Thieme},
  address = {Stuttgart [u.a.]},
  issn = {1861-9002},
  doi = {10.1055/s-0038-1641783},
  url = {https://fis.uni-bamberg.de/handle/uniba/46284},
  language = {deu},
  abstract = {Fragestellung:

Snoek et al. (Lancet Diabetes Endocrinol 2015;3:450 – 460) entwickelten ein Modell möglicher direkter und indirekter Effekte von Depression und Diabetes Distress auf Diabetes-Selbstbehandlung und glykämische Kontrolle. Dieses wurde jedoch bisher nicht empirisch überprüft. Die vorliegende Studie modellierte die hypothetischen Assoziationen anhand des Modells mittels linearer Strukturgleichung.

Methodik:

340 Personen mit T1DM und 266 mit T2DM (weiblich: 60\% bzw. 46\%; Alter: 43 ± 14J. bzw. 58 ± 11J.; Diabetesdauer: 18 ± 13J. bzw. 12 ± 7J.; HbA1c[\%]: 8,3 ± 1,6 bzw. 8,0 ± 1,7) nahmen an einer Querschnittsstudie teil. Sie wurden mittels Fragebögen zu Depressivität (PHQ-9), Diabetes Distress (PAID-5) und Selbstbehandlungsverhalten (DSMQ) befragt und der HbA1c-Wert wurde bestimmt. Standardisierte Assoziationen (β) zwischen diesen Variablen wurden in Strukturgleichungsmodellen getrennt nach DM-Typ und adjustiert für Alter, Geschlecht und Bildungsjahre untersucht.

Ergebnisse:

Bei T1DM waren sowohl höhere Depressions- als auch Diabetes Distress-Werte direkt mit einer geringeren Selbstbehandlungsadhärenz (β=-0,35 bzw. -0,18, p≤0,003) und darüber vermittelt (indirekt) mit einem höheren HbA1c-Wert (β= 0,22 bzw. 0,11, p≤0,005) assoziiert. Direkte Assoziationen mit dem HbA1c-Wert zeigten sich nicht (p≥0,25). Bei T2DM waren höhere Depressionswerte direkt mit einer geringeren Selbstbehandlungsadhärenz (β=-0,42, p< 0,001) und darüber (indirekt) mit einem höheren HbA1c-Wert (β= 0,19, p< 0,001) assoziiert, jedoch zeigten sich keine solchen Assoziationen für Diabetes Distress (p≥0,23). Allerdings war Diabetes Distress hier direkt mit einem höheren HbA1c-Wert assoziiert (β= 0,23, p< 0,001).

Schlussfolgerungen:

Diese querschnittlichen Befunde sprechen dafür, dass Depressivität eine suboptimale Diabetes-Selbstbehandlung und infolgedessen schlechtere Blutzuckereinstellung erklären kann. Die Ergebnisse bezüglich Diabetes Distress waren weniger einheitlich; Evidenz für einen verhaltensvermittelten Zusammenhang mit dem HbA1c-Wert zeigte sich nur bei T1DM.}
}

@article{schmitt2018_46289,
  title = {Effekt eines Behandlungsprogramms für Menschen mit Diabetes und gestörter Krankheitsakzeptanz - Eine nicht-randomisierte Matched-Pair-Studie},
  author = {Schmitt, Andreas and Reimer, André and Kulzer, Bernhard and Schäfer, Arne and Maier, Berthold and Haak, Thomas and Hermanns, Norbert},
  year = {2018},
  journal = {Diabetologie und Stoffwechsel},
  volume = {13},
  number = {Suppl. 1},
  pages = {S73 (P215)},
  publisher = {Thieme},
  address = {Stuttgart [u.a.]},
  issn = {1861-9002},
  doi = {10.1055/s-0038-1641973},
  url = {https://fis.uni-bamberg.de/handle/uniba/46289},
  language = {deu},
  abstract = {Fragestellung:

Diabetes-Nonakzeptanz ist assoziiert mit non-adhärenter Selbstbehandlung und hyperglykämischer Stoffwechsellage. In dieser prospektiven Matched-Pair-Pilotstudie wurden die Effekte eines Gruppen-Interventionsprogramms für Personen mit Diabetesakzeptanzstörungen erstmals untersucht.

Methodik:

Zwischen 11/2015 und 4/2017 nahmen 48 Personen an einem Gruppenprogramm für Diabetesakzeptanzstörungen teil (10 Einheiten zu je 2 Std.; CBT- und ACT-basierte Interventionen). Die Behandlung zu 7 – 8 Personen erfolgte während eines zweiwöchigen DZM-Aufenthalts. 48 reguläre Klinikbesucher wurden hinsichtlich Diabetesakzeptanzwert, Geschlecht und Alter auf die Gruppenteilnehmer gematcht (= Kontrollgruppe). Primäres Zielkriterium war die Veränderung des Diabetesakzeptanzwertes (DAS-Fragebogen). Sekundäre Zielkriterien waren Veränderungen bzgl. Diabetesbelastung (PAID-Fragebogen) und Selbstbehandlungsverhalten (DSMQ-Fragebogen). Messzeitpunkte waren Prätest, Posttest und 9-Monats-FU. Auswertung mittels ANOVA, adjustiert für Geschlecht, Alter und Baseline-Messwerte.

Ergebnisse:

Stichprobe: n= 96; 64\% weiblich; Alter: 36 ± 12J.; 92\% T1DM; Diabetesdauer: 15 ± 9J.; HbA1c: 9,4 ± 1,8\%). Matching: Keine sign. Baseline-Gruppenunterschiede bzgl. DAS-Wert, Alter und Geschlecht. An Posttest und FU nahmen 88 (92\%) bzw. 52 Personen (54\%) teil. Die Treatmentgruppe zeigte eine Steigerung des Diabetesakzeptanzwertes von 23,4 (Prätest) auf 57,5 (Posttest) und 34,3 (FU), die Kontrollgruppe von 25,9 (Prätest) auf 49,0 (Posttest) und 32,3 (FU); adjustierte Differenzen zwischen den Gruppen: +7,4 DAS-Punkte im Posttest (p< 0,001), +5,7 DAS-Punkte im FU (p= 0,08). Bzgl. der Diabetesbelastung zeigten sich ähnliche Ergebnisse, bzgl. des Selbstbehandlungsverhaltens keine signifikanten Gruppenunterschiede.

Schlussfolgerungen:

Die Behandlung ergab eine signifikant größere Verbesserung der Diabetesakzeptanz im Prä-Post-Vergleich. Zum FU-Zeitpunkt war der Treatment-Effekt zwar größer als in der Kontrollgruppe, der Unterschied jedoch nicht signifikant. Die Nachhaltigkeit des akzeptanzförderlichen Effekts muss anhand größerer Fallzahl nachgeprüft werden. Spezifische Effekte auf die Diabetes-Selbstbehandlung zeigten sich nicht.}
}

@inproceedings{hermanns2018_46281,
  title = {Reduktion schwerer Hypoglykämien nach Teilnahme an einem neuen strukturierten Schulungs- und Behandlungsprogramm für die Insulinpumpentherapie (INPUT)},
  author = {Hermanns, Norbert and Ehrmann, Dominic and Schipfer, Melanie and Lippmann-Grob, Bernhard and Haak, Thomas and Kulzer, Bernhard},
  year = {2018},
  volume = {13},
  number = {Suppl. 1},
  pages = {S72 (P212)},
  publisher = {Thieme},
  address = {Stuttgart [u.a.]},
  issn = {1861-9002},
  doi = {10.1055/s-0038-1641970},
  url = {https://fis.uni-bamberg.de/handle/uniba/46281},
  language = {deu},
  abstract = {Fragestellung:

In einer randomisierten, kontrollierten Studie mit 6-Monats-Follow-up zur Effektivität eines neuen 12-stündigen, strukturierten Schulungs- und Behandlungsprogramms für die Insulinpumpentherapie (INPUT) konnte eine signifikante Verbesserung des HbA1c-Wertes um 0,3 Prozentpunkte erreicht werden. In dieser Auswertung wurde geprüft, inwieweit diese HbA1c-Absenkung mit einer Erhöhung der Hypoglykämierate assoziiert ist.

Methodik:

Studienteilnehmer mussten bereits eine Insulinpumpentherapie durchführen und zwischen 16 und 75 Jahre alt sein. Studienteilnehmer wurden per Zufall zwei Gruppen zugeteilt: INPUT-Schulung oder Warte-Kontrollgruppe. Als eine schwere Hypoglykämie (SH) wurde ein hypoglykämisches Ereignis mit Notwendigkeit zur Fremdhilfe definiert und weiter differenziert, ob es sich bei der Fremdhilfe um eine medizinische Intervention (Glukose- oder Glukagon-Injektion) oder um eine einfache Fremdhilfe bei der unterzuckerungsbehandlung durch Dritte handelte.

Ergebnisse:

Insgesamt wurde n 268 Menschen mit Diabetes randomisiert. Zum 6-Monats-Follow-up konnten Daten von 254 Studienteilnehmern ausgewertet werden (INPUT n = 128; Kontrollgruppe n = 126). Die durchschnittliche Diabetesdauer betrug 22,9 ± 12,5 Jahre, die durchschnittliche Dauer der Insulinpumpentherapie 8,6 ± 6,7 Jahre. In der INPUT Gruppe traten insgesamt 11 SH auf, in der Kontrollgruppe 44 SH (Inzidenz-Rate-Ratio (IRR) 3,55; 95\%-KI 1,50 bis 8,43; p = 0,0041). Bei den SH ohne medizinische Fremdhilfe war der Unterschied ebenfalls signifikant (11 vs. 35 Ereignisse; p = 0,0012). SH mit medizinischer Fremdhilfe traten nur in der KG nicht jedoch in INPUT auf (0 vs. 9 Ereignisse; p = 0,004).

Schlussfolgerungen:

Die Teilnahme an INPUT führte neben einer Verbesserung der glykämischen Kontrolle auch zu einer signifikanten Reduktion von SH. Bemerkenswert ist, dass mit INPUT keine SH auftrat, die eine medizinische Fremdhilfe benötigt. INPUT verbessert nicht nur die glykämische Kontrolle, sondern auch die Sicherheit der Insulinpumpentherapie.}
}

@inproceedings{schmitt2018_46286,
  title = {Stellen Patienten mit Depressivität sowie gleichzeitig Diabetes Distress eine Hochrisikogruppe dar? – Baseline-Ergebnisse des Depression and Diabetes Control Trial (DCCT)},
  author = {Schmitt, Andreas and Reimer, André and Hermanns, Norbert and Haak, Thomas and Kulzer, Bernhard},
  year = {2018},
  volume = {13},
  number = {Suppl. 1},
  pages = {S72-S73 (P214)},
  publisher = {Thieme},
  address = {Stuttgart [u.a.]},
  issn = {1861-9002},
  doi = {10.1055/s-0038-1641972},
  url = {https://fis.uni-bamberg.de/handle/uniba/46286},
  language = {deu},
  abstract = {Fragestellung:

Depressivität und Diabetes Distress sind häufige Begleiterscheinungen bei T1/T2DM und assoziiert mit ungünstigeren Behandlungsoutcomes. Anhand der Baseline-Daten der DDCT-Studie wurden in dieser Analyse Merkmale von Diabetespatienten mit Depressivität und/oder Diabetes Distress verglichen.

Methodik:

DDCT ist eine randomisiert-kontrollierte Studie zur Evaluation einer CBT-Behandlung für Depressivität und/oder Diabetes Distress bei Diabetes mit 213 Teilnehmern. Die vorliegende Analyse verglich Personen mit Depressivität (CES-D-Wert≥16) versus Diabetes Distress (PAID-Wert≥40) versus beidem hinsichtlich gesundheitsbezogener Lebensqualität (EQ-5D), Selbstbehandlungsverhalten (DSMQ), HbA1c und Personen-/Diabetesmerkmalen.

Ergebnisse:

Von den 213 Teilnehmern berichteten 87 (41\%) Depressivität ohne Diabetes Distress (= Gruppe „Dep“), 34 (16\%) Diabetes Distress ohne Depressivität („Dis“) und 92 (43\%) sowohl Depressivität als auch Diabetes Distress („DepDis“). Personen in „DepDis“ wiesen einen signifikant höheren HbA1c-Wert (9,6 ± 1,6\%) auf als Personen in „Dep“ (9,1 ± 1,3\%, p= 0,03), der Unterschied zu „Dis“ (9,0 ± 0,9\%) war nicht signifikant (p= 0,07). „DepDis“-Personen berichteten ferner eine signifikant geringere Selbstbehandlungsadhärenz (5,0 ± 1,8 DSMQ-Punkte) als Personen in „Dep“ (5,9 ± 1,9, p< 0,01), jedoch nicht als die in „Dis“ (5,1 ± 2,1, p= 0,92). Schließlich wiesen „DepDis“-Personen eine signifikant schlechtere Lebensqualität (56,9 ± 18,4 EQ-5D-VAS-Punkte) auf als diejenigen in „Dep“ oder „Dis“ (67,0 ± 19,5 bzw. 71,6 ± 14,3; beide p< 0,01). Es zeigten sich keine signifikanten Gruppenunterschiede hinsichtlich Alter, Geschlecht und Diabetesdauer und Folgekrankheiten (alle p≥0,24), allerdings hatten „Dis“-Personen häufiger T1DM (82\% vs. 66\%/58\% in „Dep“/DepDis“, p= 0,04).

Schlussfolgerungen:

Personen mit komorbider Depressivität und gleichzeitig hohem Diabetes Distress erscheinen als Hochrisikogruppe mit den schlechtesten Ergebnissen hinsichtlich Lebensqualität, Diabetes-Selbstbehandlung und Blutzuckereinstellung. Da Depressivität und Diabetes Distress häufig gemeinsam vorkommen, erscheint bei Risikopersonen eine gezielte Fragebogen-Diagnostik sinnvoll.}
}

@inproceedings{kulzer2018_46283,
  title = {Verbessertes psychosoziales Wohlbefinden nach Teilnahme an einem strukturierten Schulungs- und Behandlungsprogramm für die Insulinpumpentherapie (INPUT)},
  author = {Kulzer, Bernhard and Ehrmann, Dominic and Schipfer, Melanie and Lippmann-Grob, Bernhard and Haak, Thomas and Hermanns, Norbert},
  year = {2018},
  volume = {13},
  number = {Suppl. 1},
  pages = {S75 (P222)},
  publisher = {Thieme},
  address = {Stuttgart [u.a.]},
  issn = {1861-9002},
  doi = {10.1055/s-0038-1641980},
  url = {https://fis.uni-bamberg.de/handle/uniba/46283},
  language = {deu},
  abstract = {Fragestellung:

Das Ziel von strukturierten Schulungs- und Behandlungsprogrammen besteht auch darin, mögliche Barrieren für die Diabetestherapie sowie diabetesbezogene Belastungen zu reduzieren. Mit INPUT wurde ein neues 12-stündiges Schulungs- und Behandlungsprogramm für die Insulinpumpentherapie entwickelt, welches auch auf psychosoziale Outcomes abzielt. In einer randomisierten, kontrollierten Studie wurde evaluiert, ob dieses Ziel erreicht wurde.

Methodik:

Studienteilnehmer im Alter zwischen 16 und 75 Jahre mit Erfahrung in der Insulinpumpentherapie wurden per Zufall auf das INPUT-Schulungsprogramm oder eine Warte-Kontrollgruppe zugeteilt. Vor der Schulung (Baseline) sowie 6 Monate nach Ende der Schulung (Follow-up) füllten die Teilnehmer Fragebögen zur Erfassung von diabetesbezogenen Belastungen (PAID), Depressivität (CESD), Therapiezufriedenheit (TS) und Empowerment (DES) aus. Insgesamt wurden 268 Menschen mit Diabetes randomisiert. Zum 6-Monats-Follow-up konnten Daten von 254 Studienteilnehmern ausgewertet werden (INPUT n = 128; Kontrollgruppe n = 126).

Ergebnisse:

INPUT führte zu einer signifikant stärkeren Senkung der Depressivität (INPUT 15,87 ± 9,21 vs. 14,41 ± 9,39; Kontrollgruppe 13,42 ± 8,28 vs. 14,05 ± 9,26; Δ=-2,09; p = 0,011) und diabetesbezogener Belastungen (INPUT 28,32 ± 16,26 vs. 23,03 ± 15,98; Kontrollgruppe 27,46 ± 16,25 vs. 27,97 ± 18,33; Δ=-5,80; p = 0,0003) als in der Kontrollgruppe. Zudem konnte durch INPUT die Zufriedenheit mit der Therapie (INPUT 28,54 ± 6,95 vs. 26,00 ± 6,53; Kontrollgruppe 28,80 ± 6,93 vs. 29,75 ± 7,03; Δ=-3,49; p < 0,0001) als auch das diabetesspezifische Empowerment (INPUT 25,15 ± 4,80 vs. 26,76 ± 4,44; Kontrollgruppe 24,63 ± 5,21 vs. 25,02 ± 5,33; Δ= 1,22; p = 0,02) signifikant stärker verbessert werden, als in der Kontrollgruppe.

Schlussfolgerungen:

Mit INPUT konnten wesentliche Barrieren der Diabetestherapie (Depressivität, diabetesbezogene Belastungen) bedeutsam reduziert werden. Gleichzeitig waren Patienten nach der Teilnahme an der INPUT-Schulung zufriedener mit ihrer Insulinpumpentherapie und berichteten über ein erhöhtes Diabetes-Empowerment. Das psychosoziale Wohlbefinden konnte folglich durch INPUT signifikant verbessert werden.}
}

@article{heinemann2018_46275,
  title = {Integriertes Personalisiertes Diabetes-Management (iPDM) verbessert die glykämische Einstellung von insulinbehandelten Patienten mit Typ-2 Diabetes: Ergebnisse des PDM-ProValue Studienprogramms},
  author = {Heinemann, Lutz and Dänschel, Wilfried and Dänschel, Ingrid and Messinger, Diethelm and Schramm, Wendelin and Vesper, Iris and Weißmann, Jörg and Kulzer, Bernhard},
  year = {2018},
  journal = {Diabetologie und Stoffwechsel},
  volume = {13},
  number = {Suppl. 1},
  pages = {S12 (FV 32)},
  publisher = {Thieme},
  address = {Stuttgart [u.a.]},
  issn = {1861-9002},
  doi = {10.1055/s-0038-1641790},
  url = {https://fis.uni-bamberg.de/handle/uniba/46275},
  language = {deu},
  abstract = {Fragestellung:

Viele Patienten mit insulinbehandeltem Typ-2 Diabetes (T2D) erreichen nicht ihre Behandlungsziele. Das PDM-ProValue Studienprogramm untersuchte die Wirksamkeit eines digital unterstützen, strukturierten Behandlungsprozesses (integriertes Personalisiertes Diabetes-Management, iPDM) auf glykämische Einstellung und andere Parameter bei diesem Patientenkollektiv. Es werden die Ergebnisse bezüglich des HbA1c-Verlaufes berichtet.

Methode:

In dem prospektiven, kontrollierten, cluster-randomisierten ProValue Studienprogramm wurden 907 Patienten aus 101 Hausarzt- und diabetologischen Schwerpunktpraxen über 12 Monate beobachtet (iPDM, n = 53; Usual Care-Gruppe (CNL), n = 48). Die Intervention erfolgte als 6-stufiger, digital unterstützter Prozess, mit strukturierter Messung, digitaler Auswertung und Visualisierung der Blutzuckerdaten und gemeinsamer Entscheidungsfindung von Arzt und Patient bezüglich Therapieanpassungen.

Ergebnisse:

Die Patienten der iPDM und der CNL-Gruppe waren zu Studienbeginn vergleichbar (Alter: 65 ± 11 (MW ± SD) vs. 65 ± 10 Jahre; Geschlecht (männlich): iPDM 60,5\% vs. CNL 55,9\%; Diabetesdauer: 14 ± 9 vs. 14 ± 8 Jahre; BMI: 33,8 ± 6,1 vs. 34,0 ± 6,1 kg/m2; HbA1c: 8,5 ± 1,1\% vs. 8,4 ± 1,0\%). Nach 12 Monaten wiesen die Personen der iPDM-Gruppe eine signifikant stärkere Reduktion des HbA1c (0,5\%, p < 0,0001) als die CNL-Gruppe auf (within: 0,3\%, p < 0,0001, between: 0,2, p < 0,05). Eine siginiflkante HbA1c-Verbesserung wurde bereits nach drei Monaten beobachtet, welche im weiteren Verlauf nahezu stabil blieb. Zudem war der Anteil von Patienten mit einer HbA1c-Absenkung von > 0,5\% (6mmol/mol) in der iPDM-Gruppe nach 3, 6 und 9 Monaten signifikant größer als in der CNL-Gruppe.

Schlussfolgerung:

Der iPDM-Ansatz erbrachte im 12 Monats-Follow-up signifikant bessere Ergebnisse bezüglich der glykämischen Kontrolle, wobei die Reduktion des HbA1c-Wertes relativ rasch erfolgte. Die strukturierte, digital unterstützte Optimierung der Diabetestherapie scheint für eine Verbesserung der glykämischen Kontrolle hilfreich zu sein.}
}

@inproceedings{ehrmann2018_46278,
  title = {Wie zufrieden sind Menschen mit Diabetes mit Flash Glucose Monitoring im Vergleich zur Blutzuckermessung?},
  author = {Ehrmann, Dominic and Hermanns, Norbert and Schipfer, Melanie and Haak, Thomas and Kulzer, Bernhard},
  year = {2018},
  volume = {13},
  number = {Suppl. 1},
  pages = {S73-S74 (P217)},
  publisher = {Thieme},
  address = {Stuttgart [u.a.]},
  issn = {1861-9002},
  doi = {10.1055/s-0038-1641975},
  url = {https://fis.uni-bamberg.de/handle/uniba/46278},
  language = {deu},
  abstract = {Fragestellung:

Bisher gibt es nur wenige Untersuchungen von patientenbezogenen Outcomes bzgl. des Vergleichs von Flash-Glucose-Monitoring (FlashGM) mit der konventionellen Blutzuckermessung (SMBG). In dieser Studie wurden erfahrene Nutzer von FlashGM mit Teilnehmern verglichen, die bisher SMBG durchführten.

Methodik:

Es wurden 133 FlashGM-Nutzer (Nutzung seit 7,9 ± 9,5 Monaten) mit 83 SMBG-Nutzern verglichen. Die Zufriedenheit mit der jeweiligen Glukosemonitoringmethode wurde mit dem Glucose Monitoring Satisfaction Survey (GMSS) gemessen. Aus den 15 GMSS-Items kann ein Gesamtscore für die Zufriedenheit gebildet werden, sowie 4 Subskalen (Offenheit, Verhaltensbarrieren, emotionale Barrieren und Vertrauen in die Messmethode).

Ergebnisse:

FlashGM-Nutzer waren signifikant jünger als SMBG-Nutzer (44,3 ± 13,5 vs. 48,3 ± 14,1 Jahre; p = 0,044) und insgesamt zufriedener mit ihrer Glukosemonitoringmethode (3,9 vs. 3,5; Δ= 0,4; 95\%-KI 0,2 bis 0,6; p < 0,01) als SMBG-Nutzer. Auch in den Subskalen beschrieben FlashGM-Nutzer eine positivere Einschätzung als SMBG-Nutzer (Offenheit 3,7 vs. 3,2; Δ= 0,5; 95\%-KI 0,3 bis 0,7; p < 0,001; emotionale Barrieren 2,1 vs. 2,4; Δ=-0,3; -0,1 bis -0,5; p = 0,013; und Verhaltensbarrieren 1,9 vs. 2,5 Δ=-0,6; -0,3 bis -0,8, p < 0,01). In Bezug auf das Vertrauen in die Zuverlässigkeit der jeweiligen Methode unterscheiden sich die beiden Gruppen nicht (4,0 vs. 3,9; Δ= 0,1; -0,1 bis 0,3; p = 0,372).

Schlussfolgerungen:

Die Nutzung von FlashGM ist gegenüber der SMBG-Methode mit wahrgenommenen Vorteilen assoziiert, die sich auf eine größere Spontaneität, geringerer Besorgnis und geringerer Belastung durch FlashGM beziehen. Interessanterweise hatten beide Gruppen ein vergleichbares Zutrauen in die Zuverlässigkeit der Messergebnisse. Allerdings sollte man bei der Interpretation berücksichtigen, dass sich auch die SMBG Nutzer für die Nutzung von FlashGM interessierten.}
}

@inproceedings{schmitt2018_46270,
  title = {Evaluation eines Stepped-Care-Ansatzes zur Behandlung von Depression und Diabetes Distress bei Menschen mit Diabetes: Ergebnisse der randomisiert-kontrollierten ECCE HOMO-Studie},
  author = {Schmitt, Andreas and Reimer, André and Kulzer, Bernhard and Haak, Thomas and Hermanns, Norbert},
  year = {2018},
  volume = {13},
  number = {Suppl. 1},
  pages = {S72 (P213)},
  publisher = {Thieme},
  address = {Stuttgart [u.a.]},
  issn = {1861-9002},
  doi = {10.1055/s-0038-1641971},
  url = {https://fis.uni-bamberg.de/handle/uniba/46270},
  language = {deu},
  abstract = {Fragestellung:

Depressionssymptome und Diabetesbelastungen sind bei T1/T2DM verbreitet und mit ungünstigeren Behandlungsoutcomes assoziiert. Diese prospektive, randomisiert-kontrollierte Studie untersuchte Effekte eines Stepped-Care-Ansatzes für Diabetespatienten mit komorbider Depression und/oder Diabetes Distress.

Methodik:

Personen mit T1/T2DM und Depression (CES-D-Wert≥16) und/oder Diabetes Distress (PAID-Wert≥40) erhielten Stepped-Care oder Usual-Care. Stepped-Care: Gruppen-CBT für Diabetesbelastungen/Depressivität (5 Sitzungen); bei Persistenz der Depressivität: Einzel-CBT für Depression (12 Telefon-Sitzungen); bei Persistenz: Überweisung in ambulant-psychotherapeutische/-psychiatrische Behandlung. Usual-Care: Diabetesschulung/-beratung. Primärzielkriterium war eine klinisch bedeutsame Senkung des HAMD-Depressionswertes (< Cut-Off-Wert = 9 oder ≥50\%) im 12-Monats-FU. Sekundärzielkriterien waren Verbesserungen hinsichtlich Depressivität (HAMD, CES-D), Diabetes Distress (PAID), Wohlbefinden (WHO-5), Lebensqualität (EQ-5D), Diabetesakzeptanz (AADQ), Selbstbehandlungsverhalten (SDSCA), HbA1c.

Ergebnisse:

260 Teilnehmer wurden randomisiert (weiblich = 55\%; Alter = 45 ± 14J.; T1DM = 64\%; Baseline-CES-D-/-PAID-Werte = 23,8 ± 9,6/39,9 ± 18,5). 131 Personen erhielten Stepped-Care, 129 Usual-Care. Drop-Out = 15\%. Eine bedeutsame Depressionsreduktion im 12-Monats-FU berichteten 87,0\% versus 48,2\% der Treatment- versus Kontrollgruppenteilnehmer (p< 0,01). Treatmentteilnehmer berichteten auch eine signifikant größere Depressionsreduktionen im HAMD-Interview (-6,3 vs. -3,3 HAMD-Punkte, adj. Diff.=-3,2, p< 0,01). Der CES-D-Fragebogen zeigte jedoch keine signifikant größere Depressionsreduktion der Treatmentgruppe an (-9,3 vs. -6,6, adj. Diff.=-2,1, p= 0,08). Diabetes Distress wurde unter Stepped-Care und Usual-Care reduziert ohne signifikanten Gruppenunterschied (-11,6 vs. -8,2 PAID-Punkte, adj. Diff.=-3,3, p= 0,13). Ferner zeigte die Treatmentgruppe größere Verbesserungen hinsichtlich Wohlbefinden (adj. Diff.=+1,4 WHO-5-Punkte, p= 0,01) und Diabetesakzeptanz (adj. Diff.=+1,2 AADQ-Punkte, p= 0,04). Es zeigten sich keine Gruppenunterschiede hinsichtlich Verbesserungen von Lebensqualität, Selbstbehandlungsverhalten und HbA1c (p≥0,09).

Schlussfolgerungen:

Der Stepped-Care-Ansatz erzielte Verbesserungen hinsichtlich Depression, Wohlbefinden und Diabetesakzeptanz, bei Diabetes Distress nur post-treatment. Die Verbesserungen von Lebensqualität, Selbstbehandlungsverhalten und HbA1c waren nicht größer als unter Usual-Care.}
}

@inproceedings{maier2018_46264,
  title = {Junge Erwachsene mit Typ-1-Diabetes (18 – 25 Jahre): ein neues stationäres Therapiekonzept},
  author = {Maier, Berthold and Kulzer, Bernhard and Schäfer, Arne and Tombek, Astrid and Greiner, Joana and Brämswig, Susanne and Haak, Thomas},
  year = {2018},
  volume = {13},
  number = {Suppl. 1},
  pages = {S75 (P221)},
  publisher = {Thieme},
  address = {Stuttgart [u.a.]},
  issn = {1861-9002},
  doi = {10.1055/s-0038-1641979},
  url = {https://fis.uni-bamberg.de/handle/uniba/46264},
  language = {deu},
  abstract = {Fragestellung:

Junge Erwachsene (JE) mit Typ-1-Diabetes sind eine Risikogruppe in Bezug auf erhöhte HbA1c-Werte, schwere Unterzuckerungen, Ketoazidosen, psychische Probleme, Risikoverhalten mit möglichen negativen Konsequenzen für die gesundheitliche Prognose sowie in Bezug auf eine diskontinuierliche Betreuung.

Methodik:

Wir entwickelten ein spezielles stationäres Gruppenkonzept (8 Teilnehmer) für diese Altersgruppe, angepasst auf die spezifischen Bedürfnisse und Probleme dieser Zielgruppe. Der Fokus des Therapiekonzepts liegt auf Coaching, psychologischer Unterstützung und der Vermittlung von Kenntnissen/Fertigkeiten zu neuen Diabetestechnologien. Wir berichten über die Teilnehmer der ersten 7 Therapiegruppen.

Ergebnisse:

n = 56 JE, Alter 21,0 ± 1,5J., berufstätig 39,3\% (22), in Ausbildung 42,9\% (24), arbeitslos 17,9\% (10), Diabetesdauer 9,0 ± 5,2J., ICT 55,4\% (31), CSII 44,6\% (25), Blutzuckerselbstkontrolle 44,6\% (25), FGM 42,9\% (24), CGM 0\% (0), keine Selbstkontrolle 12,5\% (7), HbA1c 9,5 ± 5,7\%, HbA1c > 8,5\% 67,9\% (38), mind. 1 schwere Hypoglykämie (SH, 12 Mon.) 7,1\% (5 SH), mind. 1 Ketoazidose (KA, 12 Mon.) 14,3\% (18 KA), Folgekomplikationen 16,1\% (9), Alkoholkonsum 62,5\% (35), Nikotinkonsum 44,6\% (25), ärztlich-klinischer Eindruck „Motivations- und Akzeptanzprobleme“ 35,7\% (20).

Schlussfolgerungen:

Zum Zeitpunkt der stationären Aufnahme weisen mehr als zwei Drittel der JE eine ausgeprägt hyperglykäme Stoffwechsellage auf. Weiterhin stellen das vermehrte Auftreten von Akutkomplikationen, ein beträchtlicher Anteil von JE mit fehlender oder defizitärer Glukoseselbstkontrolle sowie die Häufung von Motivations- und Akzeptanzproblemen eine Akkumulation von Risiken für die weitere gesundheitliche und psychische Entwicklung in dieser Altersgruppe dar. Zusammenfassend unterstreichen die Daten die Dringlichkeit eines spezifischen Therapiekonzepts für JE mit Typ-1- Diabetes.}
}

@article{ehrmann2018_46254,
  title = {Evaluierung der Wirksamkeit eines neuen strukturierten Schulungs- und Behandlungsprogramms für die Insulinpumpentherapie (INPUT): Ergebnisse einer randomisierten, kontrollierten Studie},
  author = {Ehrmann, Dominic and Kulzer, Bernhard and Schipfer, Melanie and Lippmann-Grob, Bernhard and Haak, Thomas and Hermanns, Norbert},
  year = {2018},
  journal = {Diabetologie und Stoffwechsel},
  volume = {13},
  number = {Suppl. 1},
  pages = {S10-S11 (FV 28)},
  publisher = {Thieme},
  address = {Stuttgart [u.a.]},
  issn = {1861-9002},
  doi = {10.1055/s-0038-1641786},
  url = {https://fis.uni-bamberg.de/handle/uniba/46254},
  language = {deu},
  abstract = {Fragestellung:

Insulinpumpen bieten viele Möglichkeiten für eine Feinsteuerung des Insulinbedarfs. Jedoch müssen Menschen mit Diabetes Wissen und Fertigkeiten erwerben, um die Insulinpumpe auch effektiv nutzen zu können. Mit INPUT wurde ein neues 12-stündiges, strukturiertes Schulungs- und Behandlungsprogramm für die Insulinpumpentherapie entwickelt. Die Wirksamkeit wurde in einer randomisierten, kontrollierten Studie mit 6-Monats-Follow-up getestet.

Methodik:

Die Evaluationsstudie wurde in 26 Studienzentren durchgeführt. Studienteilnehmer mussten bereits eine Insulinpumpentherapie durchführen und zwischen 16 und 75 Jahre alt sein. Studienteilnehmer wurden per Zufall zwei Gruppen zugeteilt: Schulung mit INPUT oder Warte-Kontrollgruppe. Primärer Endpunkt war die Verbesserung des HbA1c-Wertes sechs Monate nach Ende der Schulung.

Ergebnisse:

Insgesamt wurden 268 Menschen mit Diabetes randomisiert. Zum 6-Monats-Follow-up konnten Daten von 254 Studienteilnehmern ausgewertet werden (INPUT n = 128; Kontrollgruppe n = 126). Die Studienteilnehmer hatten im Durchschnitt seit 22,9 ± 12,5 Jahren Diabetes und waren seit 8,6 ± 6,7 Jahren auf eine Insulinpumpentherapie eingestellt. In der INPUT-Gruppe verbesserte sich der HbA1c signifikant (8,33 ± 0,8\% vs. 8,04 ± 0,9\%; p < 0,0001), in der Kontrollgruppe jedoch nicht (8,33 ± 1,0\% vs. 8,27 ± 1,0\%; p = 0,11). Der Unterschied zwischen beiden Gruppen war hochsignifikant (-0,28\% vs. -0,06\%; Δ=-0,22\%, 95\%-KI -0,38 bis -0,06; p = 0,003). Der Anteil der Studienteilnehmer mit einem HbA1c-Wert von ≤7,5\% war in der INPUT-Gruppe signifikant höher (Odds-Ratio 5,344; 95\%-KI 10,948 bis 2,608; p = 0,047).

Schlussfolgerung:

Die Teilnahme an INPUT führte zu einer signifikanten Verbesserung der glykämischen Kontrolle, und zu einem höheren Anteil von Probanden mit einer gemäß DDG-Leitlinie für Typ-1-Diabetes zufriedenstellenden glykämischen Glukoseeinstellung. Die Wirksamkeit von INPUT konnte bestätigt werden. Eine Integration von INPUT in die klinische Praxis kann die Effizienz der Insulinpumpentherapie weiter steigern.}
}

@inproceedings{hermanns2018_46257,
  title = {Gibt es einen Unterschied in der glykämischen Kontrolle zwischen erfahrenen und neuen Nutzern von Flash Glukose Monitoring?},
  author = {Hermanns, Norbert and Ehrmann, Dominic and Schipfer, Melanie and Haak, Thomas and Kulzer, Bernhard},
  year = {2018},
  volume = {13},
  number = {Suppl. 1},
  pages = {S73 (P216)},
  publisher = {Thieme},
  address = {Stuttgart [u.a.]},
  issn = {1861-9002},
  doi = {10.1055/s-0038-1641974},
  url = {https://fis.uni-bamberg.de/handle/uniba/46257},
  language = {deu},
  abstract = {Fragestellung:

In einer randomisierten kontrollierten Studie zur Überprüfung eines neu entwickelten Schulungs- und Behandlungsprogramms (FLASH) wurden erfahrene und unerfahrene Nutzer von Flash Glukose Monitoring (FlashGM) eingeschlossen. In dieser deskriptiven Auswertung wurden Baseline-Daten von Teilnehmern, die FlashGM schon vor Beginn der Studie nutzten, verglichen mit Daten von Teilnehmern, die FlashGM erstmalig im Rahmen dieser Studie verwendeten.

Methode:

Von insgesamt 216 Studienteilnehmern, benutzten 133 FlashGM bereits vor der Studie, während 83 Probanden bis dahin keine Erfahrungen mit FlashGM hatten. Vor Beginn der Baseline-Erhebung wurde der HbA1c-Wert bestimmt (Zentrallabor), danach trugen die Teilnehmer für 14 Tage das FlashGM zur Baselineerhebung.

Ergebnisse:

Der HbA1c-Wert war zwischen beiden Gruppen vergleichbar (8,4 ± 1,0\% vs. 8,4 ± 0,9\%; p = 0,89). Nach 2 Wochen wiesen Probanden, die FlashGM neu nutzten einen niedrigeren mittleren Glukosewert auf als erfahrene Nutzer (179,6 ± 25,9 mg/dl vs. 192,3 ± 39,2 mg/dl; p = 0,005). Neue Nutzer des FlashGM wiesen zur Baseline eine signifikant längere Zeit in der Normoglykämie („time in range“ 71 – 180 mg/dl: 716,5 ± 174,1 vs. 660,2 ± 209,2 Min/Tag; p = 0,036) und weniger hyperglykämische Werte (> 180 mg/dl: 656,0 ± 194,0 vs. 715,0 ± 232,8 Min/Tag; p = 0,048) auf als erfahrene Nutzer dieses Systems, während sich die beiden Gruppen hinsichtlich der Dauer hypoglykämischer Phasen (≤70 mg/dl) nicht unterschieden (69,3 ± 52,0 vs. 67,9 ± 52,9 Min/Tag; p = 0,85).

Schlussfolgerung:

Überraschenderweise wiesen Personen die bereits FlashGM benutzten keinen niedrigeren HbA1c-Wert auf als Neunutzer. Ebenso wiesen sie auch keine Vorteile bzgl. der Dauer der normo- und hyperglykämischen Phasen zur Baseline auf. Beide Gruppen könnten demnach von einem strukturierten Schulungs- und Behandlungsprogramm profitieren.}
}

@article{kampling2018_46243,
  title = {Can trajectories of glycemic control be predicted by depression, anxiety, or diabetes-related distress in a prospective cohort of adults with newly diagnosed type 1 diabetes? Results of a five-year follow-up from the German multicenter diabetes cohort study (GMDC-Study)},
  author = {Kampling, Hanna and Mittag, Oskar and Herpertz, Stephan and Baumeister, Harald and Kulzer, Bernd and Petrak, Frank},
  year = {2018},
  journal = {Diabetes research and clinical practice : the official journal of the International Diabetes Federation},
  number = {141},
  pages = {106-117},
  publisher = {Elsevier},
  address = {Amsterdam [u.a.]},
  issn = {0168-8227},
  doi = {10.1016/j.diabres.2018.04.017},
  url = {https://fis.uni-bamberg.de/handle/uniba/46243},
  language = {eng}
}

@article{herder2018_46244,
  title = {Longitudinal associations between biomarkers of inflammation and changes in depressive symptoms in patients with type 1 and type 2 diabetes},
  author = {Herder, Christian and Schmitt, Andreas and Budden, Florian and Reimer, André and Kulzer, Bernhard and Roden, Michael and Haak, Thomas and Hermanns, Norbert},
  year = {2018},
  journal = {Psychoneuroendocrinology : an international journal ; the official journal of the International Society of Psychoneuroendocrinology},
  volume = {91},
  pages = {216-225},
  publisher = {Elsevier},
  address = {Amsterdam [u.a.]},
  issn = {0306-4530},
  doi = {10.1016/j.psyneuen.2018.02.032},
  url = {https://fis.uni-bamberg.de/handle/uniba/46244},
  language = {eng},
  abstract = {Background: Depressive disorders represent a frequent comorbidity of type 1 diabetes (T1D) and type 2 diabetes (T2D). Subclinical inflammation increases the risk of depressive symptoms in the general population, but the relationship appears complex and bidirectional, and longitudinal data from patients with diabetes are lacking. Therefore, this study aimed to analyse associations between changes in depressive symptoms and changes in biomarkers of inflammation in patients with T1D and T2D and to investigate the hypothesis that higher baseline levels of biomarkers of inflammation are related to a less pronounced reduction of depressive symptoms over time.
Methods: Depressive symptoms and systemic levels of six biomarkers of inflammation were assessed in 168 individuals with T1D and 103 individuals with T2D who participated in baseline and 1-year follow-up examinations. Data were obtained from two matching randomised controlled trials addressing diabetes distress and depressive symptoms. Longitudinal associations between biomarkers and depressive symptoms were estimated using linear regression models adjusting for multiple confounders.
Results:In patients with T2D, reductions in depressive symptoms were associated with reductions in high-sensitivity C-reactive protein (hsCRP), interleukin (IL)-18 and IL-1 receptor antagonist (IL-1RA) (P ≤ 0.016), whereas no associations were seen for IL-6, CCL2 and adiponectin. Higher CCL2 levels at baseline were associated with lower subsequent reduction in depressive symptoms (P = 0.018). Neither baseline levels nor changes in biomarkers in subclinical inflammation were associated with changes in depressive symptoms in patients with T1D.
Conclusions: Reductions of depressive symptoms were longitudinally associated with reductions in biomarkers of inflammation in patients with T2D. Higher baseline CCL2 levels were related with lower reduction of depressive symptoms in this group. No such associations were observed in patients with T1D, suggesting that risk factors and pathomechanisms linking inflammation and depression may differ between diabetes types.},
  keywords = {Inflammation, Biomarkers, Type 1 diabetes, Type 2 diabetes, Depression}
}

@article{schipfer2018_46246,
  title = {Makes FLASH the difference between the intervention group and the treatment-as-usual group in an evaluation study of a structured education and treatment programme for flash glucose monitoring devices in people with diabetes on intensive insulin therapy: study protocol for a randomised controlled trial},
  author = {Schipfer, Melanie and Albrecht, Carmen and Ehrmann, Dominic and Haak, Thomas and Kulzer, Bernd and Hermanns, Norbert},
  year = {2018},
  journal = {Trials},
  volume = {19},
  publisher = {BioMed Central},
  address = {London},
  issn = {1745-6215},
  doi = {10.1186/s13063-018-2479-9},
  url = {https://fis.uni-bamberg.de/handle/uniba/46246},
  language = {eng}
}

@article{reitzle2018_46247,
  title = {National public health system responses to diabetes and other important noncommunicable diseases : Background, goals, and results of an international workshop at the Robert Koch Institute},
  author = {Reitzle, Lukas and Hansen, Sylvia and Paprott, Rebecca and Achtermann, Wally and Baumert, Jens and Bogaert, Petronille and Curt, Laure and Diem, Peter and Du, Yong and Eiser, Stefanie and Fitzpatrick, Justine and Heidemann, Christin and Jousilahti, Pekka and Kulzer, Bernhard and Lindström, Jaana and Neuhauser, Hannelore and van Oyen, Herman and Pelletier, Louise and Schmidt, Christian and Valabhji, Jonathan and Weitgasser, Raimund and Ziese, Thomas and Zahn, Daniela and Scheidt-Nave, Christa},
  year = {2018},
  journal = {Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz},
  volume = {61},
  number = {10},
  pages = {1300-1306},
  publisher = {Springer},
  address = {Berlin, Heidelberg},
  issn = {1436-9990},
  doi = {10.1007/s00103-018-2806-z},
  url = {https://fis.uni-bamberg.de/handle/uniba/46247},
  language = {eng},
  abstract = {Diabetes mellitus and other noncommunicable diseases (NCDs) represent an emerging global public health challenge. In Germany, about 6.7 million adults are affected by diabetes according to national health surveys, including 1.3 million with undiagnosed diabetes. Complications of diabetes result in an increasing burden for individuals and society as well as enormous costs for the health care system. In response, the Federal Ministry of Health commissioned the Robert Koch Institute (RKI) to implement a diabetes surveillance system and the Federal Center for Health Education (BZgA) to develop a diabetes prevention strategy. In a two-day workshop jointly organized by the RKI and the BZgA, representatives from public health institutes in seven countries shared their expertise and knowledge on diabetes prevention and surveillance. Day one focused on NCD surveillance systems and emphasized both the strengthening of sustainable data sources and the timely and targeted dissemination of results using innovative formats. The second day focused on diabetes prevention strategies and highlighted the importance of involving all relevant stakeholders in the development process to facilitate its acceptance and implementation. Furthermore, the effective translation of prevention measures into real-world settings requires data from surveillance systems to identify high-risk groups and evaluate the effect of measures at the population level based on analyses of time trends in risk factors and disease outcomes. Overall, the workshop highlighted the close link between diabetes prevention strategies and surveillance systems. It was generally stated that only robust data enables effective prevention measures to encounter the increasing burden from diabetes and other NCDs.},
  keywords = {Diabetes mellitus, Noncommunicable diseases, Public Health, Surveillance, Prevention}
}

@article{ebert2018_46239,
  title = {S2e-Leitlinie Diabetes und Straßenverkehr},
  author = {Ebert, Oliver and Bohn, Barbara and Bertram, Bernd and Buchberger, Barbara and Finck, Hermann and Hoß, Jürgen and Hübner, Peter and Krabbe, Laura and Kulzer, Bernhard and Küstner, Eva and Lachenmayr, Bernhard and Lemmen, Klaus-Dieter and Petry, Friedhelm and Rinnert, Kurt and Salomon, Markus and Schütt, Wolfgang and Holl, Reinhard W},
  year = {2018},
  journal = {Diabetologie und Stoffwechsel : offizielles Organ der Deutschen Diabetes Gesellschaft},
  volume = {13},
  number = {1},
  pages = {54-97},
  publisher = {Thieme},
  address = {Stuttgart [u.a.]},
  issn = {1861-9002},
  doi = {10.1055/s-0043-124953},
  url = {https://fis.uni-bamberg.de/handle/uniba/46239},
  language = {deu}
}

@article{herder2018_46227,
  title = {Association between pro- and anti-inflammatory cytokines and depressive symptoms in patients with diabetes : potential differences by diabetes type and depression scores},
  author = {Herder, Christian and Schmitt, Andreas and Budden, Florian and Reimer, André and Kulzer, Bernhard and Roden, Michael and Haak, Thomas and Hermanns, Norbert},
  year = {2018},
  journal = {Translational Psychiatry},
  volume = {7},
  number = {1},
  publisher = {Nature Publishing Group},
  address = {London},
  issn = {2158-3188},
  doi = {10.1038/s41398-017-0009-2},
  url = {https://fis.uni-bamberg.de/handle/uniba/46227},
  language = {eng},
  abstract = {Subclinical inflammation has been implicated in the development of depression, a common comorbidity of type 1 diabetes (T1D) and type 2 diabetes (T2D). This study aimed to characterise the relationships between biomarkers of inflammation and depressive symptoms in T1D and T2D. Biomarkers of inflammation were measured in serum of participants with elevated depressive symptoms and T1D (n = 389, mean age 38 years, diabetes duration 15 ± 11 years) or T2D (n = 204, mean age 56 years, diabetes duration 13 ± 8 years). Subclinical depression was examined using three questionnaires (Center for Epidemiologic Studies Depression [CES-D], Patient Health Questionnaire-9 [PHQ-9], 5-item World Health Organization Well-Being Index [WHO-5]). In T1D, levels of interleukin-1 receptor antagonist (IL-1RA) were positively associated with two depression scores (CES-D, PHQ-9), and high-sensitivity C-reactive protein (hsCRP) was positively associated with depression for one score (WHO-5) after adjustment for age, sex, body mass index, diabetes duration, metabolic variables, medication and comorbidities (P = 0.008-0.042). In T2D, IL-18 and IL-1RA were positively associated with depression for two scores (IL-18: PHQ-9, WHO-5; IL-1RA: CES-D, WHO-5), hsCRP was associated with one depression score (PHQ-9), and adiponectin showed an inverse association with one depression score (PHQ-9) after adjustment (P = 0.006–0.048). No associations were found for IL-6 and CC-chemokine ligand 2 (CCL2). In conclusion, we observed associations between hsCRP, IL-1RA and depressive symptoms in patients with diabetes. In T2D, there was additional evidence for associations of IL-18 and (inversely) adiponectin with depressive symptoms. The strength of the associations appeared to depend on diabetes type and the method used to asssess depressive symptoms.},
  keywords = {-}
}

@article{ebert2018_46229,
  title = {Diabetes und Straßenverkehr},
  author = {Ebert, Oliver and Bohn, Barbara and Bertram, Bernd and Buchberger, Barbara and Finck, Hermann and Hoß, Jürgen and Hübner, Peter and Krabbe, Laura and Kulzer, Bernhard and Küstner, Eva and Lachenmayr, Bernhard and Lemmen, Klaus-Dieter and Petry, Friedhelm and Rinnert, Kurt and Salomon, Markus and Schütt, Wolfgang and Holl, Reinhard W.},
  year = {2018},
  journal = {Diabetologie und Stoffwechsel : offizielles Organ der Deutschen Diabetes Gesellschaft},
  volume = {13},
  number = {Supplement 2},
  pages = {253-267},
  publisher = {Thieme},
  address = {Stuttgart [u.a.]},
  issn = {1861-9002},
  doi = {10.1055/s-0043-124945},
  url = {https://fis.uni-bamberg.de/handle/uniba/46229},
  language = {deu}
}

@article{loerbroks2018_46231,
  title = {Psychosocial working conditions and diabetes self-management at work: A qualitative study},
  author = {Loerbroks, Adrian and Nguyen, Xuan Quynh and Vu-Eickmann, Patricia and Krichbaum, Michael and Kulzer, Bernhard and Icks, Andrea and Angerer, Peter},
  year = {2018},
  journal = {Diabetes research and clinical practice : the official journal of the International Diabetes Federation},
  number = {140},
  pages = {129-138},
  publisher = {Elsevier},
  address = {Amsterdam [u.a.]},
  issn = {0168-8227},
  doi = {10.1016/j.diabres.2018.03.023},
  url = {https://fis.uni-bamberg.de/handle/uniba/46231},
  language = {eng}
}

@article{ehrmann2018_46214,
  title = {Adherence Over Time : The Course of Adherence to Customized Diabetic Insoles as Objectively Assessed by a Temperature Sensor},
  author = {Ehrmann, Dominic and Spengler, Monika and Jahn, Michael and Niebuhr, Dea and Haak, Thomas and Kulzer, Bernhard and Hermanns, Norbert},
  year = {2018},
  journal = {Journal of diabetes science and technology},
  volume = {12},
  number = {3},
  pages = {695-700},
  publisher = {Sage},
  address = {London},
  issn = {1932-2968},
  doi = {10.1177/1932296817747618},
  url = {https://fis.uni-bamberg.de/handle/uniba/46214},
  language = {eng}
}

@article{kulzer2018_46217,
  title = {Integrated personalized diabetes management improves glycemic control in patients with insulin-treated type 2 diabetes: Results of the PDM-ProValue study program},
  author = {Kulzer, Bernhard and Daenschel, Wilfried and Daenschel, Ingrid and Schramm, Wendelin and Messinger, Diethelm and Weissmann, Joerg and Vesper, Iris and Parkin, Christopher G. and Heinemann, Lutz},
  year = {2018},
  journal = {Diabetes research and clinical practice : the official journal of the International Diabetes Federation},
  number = {144},
  pages = {200-212},
  publisher = {Elsevier},
  address = {Amsterdam [u.a.]},
  issn = {0168-8227},
  doi = {10.1016/j.diabres.2018.09.002},
  url = {https://fis.uni-bamberg.de/handle/uniba/46217},
  language = {eng},
  abstract = {Aims: Globally, many patients with insulin-treated type-2 diabetes are suboptimally controlled. The PDM-ProValue study program evaluated whether integrated personalized diabetes management (iPDM) has the potential to improve clinical outcomes.
Methods: 101 practices with 907 patients participated in the 12-month, prospective, controlled, cluster-randomized study program. HbA1c levels, therapy changes, frequency of hypoglycemic episodes, patient reported outcomes, and physician satisfaction were assessed.
Results: iPDM led to a greater reduction in HbA1c after 12 months vs. usual care (−0.5\%, p < 0.0001 vs. −0.3\%, p < 0.0001), (Diff. 0.2\%, p = 0.0324). Most of the HbA1c reduction occurred after 3 months and remained stable thereafter. The percentage of patients with therapy adjustments was higher in the iPDM group at all visits (p < 0.01 at week 3, month 3, month 6). Patient adherence at month 12 was higher in the iPDM group compared to baseline (Odds ratio = 2.39; p = 0.0003); also, patient treatment satisfaction (DTSQc: 12.2 vs. 10.4, δ = 1.78, p = 0.004; DTSQs: 31.0 vs. 30.0, δ = 0.924, p = 0.02), and physician satisfaction was higher in the intervention group.
Conclusions: iPDM improved the use of diagnostic data leading to better glycemic control, more timely treatment adjustments (indicating reduced clinical inertia), and increased patient adherence and treatment satisfaction among patients and physicians.},
  keywords = {Diabetes management, SMBG, Type 2 diabetes, Personalized diabetes therapy, Digital tools}
}

@article{schmitt2018_46222,
  title = {Measurement of psychological adjustment to diabetes with the diabetes acceptance scale},
  author = {Schmitt, Andreas and Reimer, André and Kulzer, Bernhard and Icks, Andrea and Paust, Rainer and Roelver, Klaus-Martin and Kaltheuner, Matthias and Ehrmann, Dominic and Krichbaum, Michael and Haak, Thomas and Hermanns, Norbert},
  year = {2018},
  journal = {Journal of Diabetes and its Complications},
  volume = {32},
  number = {4},
  pages = {384-392},
  publisher = {Elsevier},
  address = {Amsterdam [u.a.]},
  issn = {1056-8727},
  doi = {10.1016/j.jdiacomp.2018.01.005},
  url = {https://fis.uni-bamberg.de/handle/uniba/46222},
  language = {eng}
}

@article{kulzer2018_45111,
  title = {Efficacy of an Education Program for People With Diabetes and Insulin Pump Treatment (INPUT): Results From a Randomized Controlled Trial},
  author = {Kulzer, Bernhard and Schipfer, Melanie and Lippmann-Grob, Bernhard and Haak, Thomas and Hermanns, Norbert and Ehrmann, Dominic},
  year = {2018},
  journal = {Diabetes Care},
  volume = {41},
  number = {12},
  pages = {2453-2462},
  address = {Alexandria, Va.},
  issn = {0149-5992},
  doi = {10.2337/dc18-0917},
  url = {https://fis.uni-bamberg.de/handle/uniba/45111},
  language = {eng},
  abstract = {OBJECTIVE Continuous subcutaneous insulin infusion (CSII) is the most advanced form of insulin delivery, but it requires structured education to provide users with the necessary knowledge/skills and to support their motivation. Currently, no structured education program designed to provide this training has been evaluated. We developed a CSII-specific, structured education program (Insulin Pump Treatment [INPUT]) and evaluated its impact on glycemic control, behavior, and psychosocial status.

RESEARCH DESIGN AND METHODS This was a multicenter, randomized, parallel trial with a 6-month follow-up. Eligible participants (age 16–75 years) currently were treated with insulin pump therapy. Participants were randomly assigned (1:1) to the INPUT program or to usual care using a computer-generated algorithm, with study center as the stratification factor. The primary outcome was HbA1c change from baseline to 6 months. Secondary outcomes were incidence of severe hypoglycemia and changes in behavioral and psychosocial measures.

RESULTS Between 1 April 2016 and 26 April 2016, 268 people with diabetes and a mean duration of CSII therapy of 9.5 years were randomly assigned to the INPUT group (n = 135) or control group (n = 133). At 6 months, HbA1c improved in the INPUT group (8.33 ± 0.8 vs. 8.04 ± 0.9; P < 0.0001) but not in the control group (8.33 ± 1.0 vs. 8.27 ± 1.0; P = 0.11). The between-group difference in HbA1c reduction was significant, favoring INPUT (−0.28\% vs. −0.06\%, Δ −0.22\%, 95\% CI −0.38 to −0.06; P = 0.0029). The incidence rate ratio of severe hypoglycemia was 3.55 times higher for participants in the control group than for those in the INPUT group (95\% CI 1.50–8.43; P = 0.0041).

CONCLUSIONS The INPUT education program led to a significant improvement in glycemic control and incidence of severe hypoglycemia in insulin pump users.},
  keywords = {Diabetes, Psychoedukation, Education}
}

@inproceedings{hermanns2018_44291,
  title = {Use of technological Features of Insulin Pump as Predictors of Glycaemic Control in Patients with CSII Therapy},
  author = {Hermanns, Norbert and Kulzer, Bernhard and Ehrmann, Dominic and Schipfer, Melanie and Bergis-Jurgan, Nikola and Haak, Thomas},
  year = {2018},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.20378/irbo-52602},
  urn = {urn:nbn:de:bvb:473-opus4-526025},
  url = {https://fis.uni-bamberg.de/handle/uniba/44291},
  language = {eng},
  abstract = {Technological features of CSII therapy comprise temporal basal rates, different basal rate profiles, use of bolus calculators, and bolus variants. In addition, real-time CGM data as well as computerized analysis of glucose data can be used to adjust insulin pump therapy. In this study, the associations between the frequency of use of these technological features and glycaemic control were analysed.}
}

@inproceedings{hermanns2018_44243,
  title = {Wie häufig nutzen Patienten mit einer Insulinpumpentherapie (CSII) die Features Ihrer Insulinpumpe?},
  author = {Hermanns, Norbert and Ehrmann, Dominic and Schipfer, Melanie and Kulzer, Bernhard and Haak, Thomas},
  year = {2018},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.20378/irbo-52601},
  urn = {urn:nbn:de:bvb:473-opus4-526017},
  url = {https://fis.uni-bamberg.de/handle/uniba/44243},
  language = {deu},
  abstract = {Fragestellung: Die Insulinpumpentherapie (CSII) bietet mehrere Zusatzoptionen, um die Blutglukose im Alltag besser steuern zu können. Hierzu zählen eine temporäre Basalrate, unterschiedliche Basalratenprofile und Bolusoptionen sowie die Nutzung von Boluskalkulatoren, Softwareprogrammen zur Analyse von Glukosedaten und eine kontinuierliche Glukosemessung. In dieser Studie wurde untersucht wie häufig langjährige CSII-Träger solche Zusatzoptionen im Alltag nutzen.
Methodik: Die Stichprobe umfasst 278 Typ-1-Diabetiker (Teilnehmer der INPUT-Studie) mit CSII-Therapie (Alter 43,7±14,3 Jahre; 59,9 \% weiblich; DD 23,0 ±12,4 Jahre; HbA1c 8,4±0,9\% bzw. 68±9,8 mmol/mol; Dauer CSII-Therapie 9,6±7,4 Jahre). Die Häufigkeit der Nutzung von Zusatz-Features für die CSII-Therapie wurde mittels Fragebogen erhoben.
Ergebnisse: 67,9\% der INPUT-Studienteilnehmer geben an, regelmäßig (d.h. mehrmals pro Woche oder täglich) einen Boluskalkulator zu benutzen. Verschiedenen Bolusoptionen werden regelmäßig von 38,4\% genutzt, temporäre Basalraten von 31\% der Befragten. Unterschiedliche Basalratenprofile werden dagegen nur von 8,5\% der CSII-Träger regelmäßig eingesetzt. Nur wenige der Befragten nutzen eine kontinuierliche Glukosemessung (6,8\%) oder die technische Möglichkeit Glukosedaten auszulesen und zu analysieren (5,6\%). In einer schrittweisen Regressionsanalyse war jedoch die Häufigkeit der software-gestützten Analyse von Glukosedaten mit einem signifikante niedrigeren HbA1c (ß=-0,15, p=0,012) assoziiert.
Schlussfolgerung: Obwohl die CSII-Therapie die aufwändigste Form der Insulintherapie darstellt, bleibt die glykämische Kontrolle häufig suboptimal. Die technischen Möglichkeiten einer Insulinpumpentherapie - mit Ausnahme der Nutzung von Boluskalkulatoren - werden von der
Mehrzahl der langjährigen CSII-Träger nicht regelmäßig genutzt. Es sollte daher geprüft werden, ob mit Hilfe von speziellen Schulungsmaßnahmen zur Insulinpumpentherapie eine bessere Nutzung der
technischen Möglichkeiten dieser Therapieform und damit einhergehend auch eine bessere Therapieeffizienz erreicht werden kann.},
  keywords = {Insulinpumpentherapie}
}

@inproceedings{schmitt2018_44147,
  title = {Depression and Diabetes Control Trial (DDCT) : Baseline-Ergebnisse einer randomisiert-kontrollierten Studie zur Behandlung von Diabetespatienten mit erhöhten affektiven Symptomen und suboptimaler glykämischer Kontrolle},
  author = {Schmitt, Andreas and Reimer, André and Hermanns, Norbert and Ehrmann, Dominic and Haak, Thomas and Kulzer, Bernhard},
  year = {2018},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.20378/irbo-52424},
  urn = {urn:nbn:de:bvb:473-opus4-524244},
  url = {https://fis.uni-bamberg.de/handle/uniba/44147},
  language = {deu},
  abstract = {Depressivität und diabetesspezifische Belastungen sind häufige Begleiterscheinungen bei Diabetes und assoziiert mit reduzierter Selbstbehandlungsadhärenz sowie geringerer glykämischer Kontrolle. Daher wird angenommen, dass bei Diabetespatienten mit hohen Depressions- und Diabetesbelastungswerten sowie hyperglykämischer Blutzuckereinstellung spezifische Behandlungsmaßnahmen sowohl Stimmung als auch glykämische Kontrolle positiv beeinflussen können. Diese Hypothese wird innerhalb der DDCTStudie untersucht, deren Baseline-Ergebnisse hier dargestellt werden.}
}

@inproceedings{reimer2018_44149,
  title = {Glykämische Kontrolle bei Einnahme von Antidepressiva : Erste Ergebnisse der DDCT-Studie},
  author = {Reimer, André and Schmitt, Andreas and Ehrmann, Dominic and Kulzer, Bernhard and Haak, Thomas and Hermanns, Norbert},
  year = {2018},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.20378/irbo-52422},
  urn = {urn:nbn:de:bvb:473-opus4-524226},
  url = {https://fis.uni-bamberg.de/handle/uniba/44149},
  language = {deu},
  abstract = {Die Komorbidität von Diabetes und Depression ist mit einer schlechteren Prognose des Diabetes Mellitus assoziiert. Antidepressiva sind leitliniengeeignete Mittel zur Behandlung von Depression bei Menschen mit Diabetes, aktuell werden dabei diabetogene Effekte von Antidepressiva diskutiert, da keine eindeutigen Ergebnisse hinsichtlich der Assoziation von Antidepressiva und glykämischer Kontrolle vorliegen. Diese Studie untersucht, ob mit Antidepressiva behandelte Menschen mit Diabetes höhere HbA1c-Werte aufweisen als Menschen ohne Antidepressivatherapie.}
}

@inproceedings{schmitt2018_44145,
  title = {Suboptimale Diabetesakzeptanz ist mit einer schlechteren Diabetes-Selbstbehandlung und darüber mit einer schlechteren glykämischen Kontrolle assoziiert : Eine Mediationsanalyse},
  author = {Schmitt, Andreas and Reimer, André and Kulzer, Bernhard and Icks, A and Paust, R and Rölver, K. M. and Kaltheuner, M and Ehrmann, Dominic and Schipfer, Melanie and Haak, Thomas and Hermanns, Norbert},
  year = {2018},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.20378/irbo-52418},
  urn = {urn:nbn:de:bvb:473-opus4-524183},
  url = {https://fis.uni-bamberg.de/handle/uniba/44145},
  language = {deu},
  abstract = {Die klinische Bedeutung von Diabetesakzeptanz ist bisher nicht eindeutig
geklärt. In dieser Studie wurde untersucht, in welcher Weise
Diabetesakzeptanz mit Selbstbehandlungsverhalten und glykämischer
Kontrolle assoziiert ist - unabhängig von Diabetesbelastung und Depressivität.}
}

@inproceedings{kulzer2018_44144,
  title = {Wie effektiv ist die strukturierte Diabetesschulung bei Menschen mit Typ-1-Diabetes und Insulinpumpentherapie (CSII)?},
  author = {Kulzer, Bernhard and Ehrmann, Dominic and Schipfer, Melanie and Hermanns, Norbert and Haak, Thomas},
  year = {2018},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.20378/irbo-52421},
  urn = {urn:nbn:de:bvb:473-opus4-524218},
  url = {https://fis.uni-bamberg.de/handle/uniba/44144},
  language = {deu},
  abstract = {In dieser Studie wurde untersucht, ob sich Menschen mit Typ-1-Diabetes und Insulinpumpentherapie (CSII), die einen erhöhten HbA1c-Wert, eine Hyperglykämie- oder Hypoglykämie-Problematik im letzten Jahr, oder einen erhöhten Diabetes-Distress aufwiesen, hinsichtlich der Anzahl der bisherigen Schulungen von Personen ohne diese jeweilige Problematik unterscheiden.}
}

@inproceedings{hermanns2018_44142,
  title = {Wie misst man Erfahrungen und Einstellungen zur Insulinpumpentherapie : Eine psychometrische Analyse des Fragebogens zu Erfahrungen und Einstellungen zur CSII-Therapie (CSII-EE)},
  author = {Hermanns, Norbert and Ehrmann, Dominic and Schipfer, Melanie and Kulzer, Bernhard and Haak, Thomas},
  year = {2018},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.20378/irbo-52420},
  urn = {urn:nbn:de:bvb:473-opus4-524206},
  url = {https://fis.uni-bamberg.de/handle/uniba/44142},
  language = {deu},
  abstract = {Die Ergebnisse der Insulinpumpentherapie (CSII) bleiben hinter ihren Möglichkeiten zurück.
Eine potentielle Ursache hierfür können subjektive Erfahrungen und Einstellungen der Anwender sein. In dieser Evaluationsstudie wurden die psychometrischen Eigenschaften eines Fragebogens zur Erfassung von „Erfahrungen und Einstellungen zur Insulinpumpentherapie“ (CSII-EE) untersucht.}
}

@article{ehrmann2018_44137,
  title = {Change in the usage of pump features predicts improvement of glycemic control},
  author = {Ehrmann, Dominic and Hermanns, Norbert and Schipfer, Melanie and Lippmann-Grob, Bernhard and Haak, Thomas and Kulzer, Bernhard},
  year = {2018},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.20378/irbo-52413},
  urn = {urn:nbn:de:bvb:473-opus4-524137},
  url = {https://fis.uni-bamberg.de/handle/uniba/44137},
  language = {eng},
  abstract = {Insulin pumps offer a wide range of technical features designed to help patients with achieving optimal glycemic control. However, many patients do not achieve better glycemic control despite CSII therapy. In this study, we analyzed whether a change in using pump features was associated with an improvement in glycemic control. 197 patients with CSII treatment were analyzed at baseline and 12-weeks later (age 42.2 ± 14.3 yrs.; 59\% female; diabetes duration 22.2 ± 11.9 yrs.; duration of CSII 9.4 ± 7.3 yrs.; baseline A1c 8.3 ± 0.9\%). Change in using pump features (see table) were the independent variables of interest in a linear regression analysis on the difference in HbA1c (follow-up – baseline).<cr><nl>
The analysis was controlled for demographic (age, gender, BMI, education) and medical variables (diabetes duration, duration of CSII, use of CGM/FGM, complications, SMBG).<cr><nl>
Increased use of pump features standardized beta p<cr><nl>
Temporary basal rates -0.16 .027<cr><nl>
Different basal rate profiles -0.09 .219<cr><nl>
Bolus options 0.16 .031<cr><nl>
Bolus calculators 0.02 .790<cr><nl>
Analysis software -0.16 .025<cr><nl>
CGM pairing -0.23 .002<cr><nl>
An increased use of temporary basal rates as well as using analysis software more often predicted an improvement in HbA1c (see table). Linking a CGM system to the insulin pump was the strongest predictor of better glycemic control. In clinical practice, patients with CSII therapy should be educated how to make use of their pump features and should be encouraged to do so.}
}

@inproceedings{kulzer2018_44136,
  title = {How effective is structured diabetes education in people with diabetes and CSII-treatment?},
  author = {Kulzer, Bernhard and Ehrmann, Dominic and Schipfer, Melanie and Lippmann-Grob, Bernhard and Haak, Thomas and Hermanns, Norbert},
  year = {2018},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.20378/irbo-52410},
  urn = {urn:nbn:de:bvb:473-opus4-524106},
  url = {https://fis.uni-bamberg.de/handle/uniba/44136},
  language = {eng},
  abstract = {We analyzed the impact of structured diabetes education on clinical problems in people with diabetes and CSII-therapy. In this analysis, baseline data of 278 people with diabetes and CSII-therapy were included (age 43.7 ± 14.3 yrs., diabetes duration 23.0 ± 12.4 yrs., HbA1c 8.3 ± 0.9\%; duration of CSII-therapy 9.6 yrs. ± 7.3 yrs.; 4.4 ± 3.3 structured diabetes education courses) who participated in the INPUT study. From these 278 participants, 90\% had an A1c higher than 7.5\%, 12.6\% reported the occurrence of ketoacidosis in the last year, 9\% reported severe hypoglycemia during the last year, 50.5\% reported elevated diabetes-related distress (DDS score > 2.0) and 10\% reported low well-being which could be indicative for likely depression (WHO score < 28). The following table shows the number of previous structured diabetes education courses in people with and without clinical problems.
Elevated HbA1c Ketoacidosis Hypoglycemia Diabetes Distress Likely depression
No 3.3 ±2.1 4.4 ±3.3 4.4 ±3.4 3.9 ±2.7 4.3 ±3.2
Yes 4.5 ±3.4 4.4 ±3.8 4.2 ±3.3 4.8 ±3.8 5.2 ±4.2
p 0.016 0.917 0.750 0.024 0.230
People with elevated HbA1c and elevated diabetes distress were previously more likely referred to structured diabetes education. Participation in structured diabetes education was not different in people with acute complications like hypoglycemia or ketoacidosis. Current structured diabetes education programs may not be optimally suited for ameliorating clinical or psychosocial problems in people with diabetes and CSII Treatment. There might be a need for more CSII specific diabetes education programs.}
}

@inproceedings{ehrmann2018_44139,
  title = {Unterschiede zwischen Patienten mit einer Insulinpumpe und Patienten mit intensivierter Insulintherapie},
  author = {Ehrmann, Dominic and Kulzer, Bernhard and Schipfer, Melanie and Lippmann-Grob, Bernhard and Haak, Thomas and Hermanns, Norbert},
  year = {2018},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.20378/irbo-52416},
  urn = {urn:nbn:de:bvb:473-opus4-524164},
  url = {https://fis.uni-bamberg.de/handle/uniba/44139},
  language = {deu},
  abstract = {Die Insulinpumpentherapie (CSII) bietet die besten Chancen auf eine optimale glykämische Kontrolle, doch stellt sie besondere Anforderungen an die Patienten. Patienten benötigen sehr viel Wissen und Fertigkeiten, um die Möglichkeiten der CSII-Therapie vollständig und effektiv zu nutzen. Zudem stellt die CSII-Therapie andere Anforderungen an den Alltag der Patienten und das Leben mit der Pumpe. Die CSII-Therapie hebt sich daher sehr deutlich von der intensivierten Insulintherapie ab. Diese Studie untersuchte inwiefern sich Patienten mit CSII-Therapie und Patienten mit mehrmals täglichen Insulininjektionen (MDI-Therapie) hinsichtlich demographischer, therapierelevanter und psychosozialer Parameter unterscheiden.}
}

@inproceedings{reimer2018_44112,
  title = {Depressivität und diabetesbezogene Belastungen bei Behandlung mit Antidepressiva : Screening-Ergebnisse der DDCT-Studie},
  author = {Reimer, André and Schmitt, Andreas and Ehrmann, Dominic and Kulzer, Bernhard and Haak, Thomas and Hermanns, Norbert},
  year = {2018},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.20378/irbo-52423},
  urn = {urn:nbn:de:bvb:473-opus4-524239},
  url = {https://fis.uni-bamberg.de/handle/uniba/44112},
  language = {deu},
  abstract = {Antidepressiva werden häufig zur Behandlung von Depressionen bei Menschen mit Diabetes eingesetzt. Diese Studie untersucht die Behandlungsprävalenz einer Therapie mit Antidepressiva anhand einer Stichprobe von Menschen mit einer Diabeteserkrankung auf einer tertiären Versorgungsstufe.}
}

@inproceedings{schmitt2018_44107,
  title = {Erfassung von Angst vor diabetischen Folgekrankheiten : Reliabilität und Validität der deutschen Version des Fear of Complications Questionnaire (FCQ)},
  author = {Schmitt, Andreas and Reimer, André and Kulzer, Bernhard and Baumeister, H and Ehrmann, Dominic and Schipfer, Melanie and Haak, Thomas and Hermanns, Norbert},
  year = {2018},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.20378/irbo-52419},
  urn = {urn:nbn:de:bvb:473-opus4-524191},
  url = {https://fis.uni-bamberg.de/handle/uniba/44107},
  language = {deu},
  abstract = {Angst vor diabetischen Folgekrankheiten ist neben Hypoglykämieangst die verbreitetste diabetesspezifische Angstproblematik und assoziiert mit affektiven Belastungen sowie reduzierter Lebensqualität. Zur Erfassung dieser Angst wurde von Taylor et al. (2005)* der „Fear of Complications Questionnaire (FCQ)“ entwickelt. Diese Studie untersuchte die Messeigenschaften der neuentwickelten deutschen Version.}
}

@inproceedings{ehrmann2018_44054,
  title = {Using temperature sensors to assess the course of adherence to customised diabetic insoles},
  author = {Ehrmann, Dominic and Spengler, Monika and Jahn, Michael and Niebuhr, Dea and Haak, Thomas and Kulzer, Bernhard and Hermanns, Norbert},
  year = {2018},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.20378/irbo-52341},
  urn = {urn:nbn:de:bvb:473-opus4-523414},
  url = {https://fis.uni-bamberg.de/handle/uniba/44054},
  language = {eng},
  abstract = {Diabetic foot problems are still a leading cause for major amputation. Effective therapy of diabetic foot problems includes the prevention of foot ulcerations via customised diabetic footwear that reduces the mechanical stress by re-distributing pressure to the plantar tissue. Adherence to the customised diabetic footwear is crucial for a preventive effect regarding serious diabetic foot problems. However,
adherence data often rely on self-report or cover rather short time spans. The aim of this study was to objectively assess the course of patients’ adherence with a temperature sensor. In addition, possible gender effects on adherence were analysed.}
}

@inproceedings{hermanns2017_111300,
  title = {Wie häufig nutzen Patienten mit einer Insulinpumpentherapie (CSII) die Features Ihrer Insulinpumpe?},
  author = {Hermanns, Norbert and Ehrmann, Dominic and Schipfer, Melanie and Kulzer, Bernhard and Haak, Thomas},
  year = {2017},
  volume = {12},
  number = {S 01},
  pages = {S1-S84},
  publisher = {Thieme},
  address = {Stuttgart},
  issn = {1861-9010},
  doi = {10.1055/s-0037-1601607},
  url = {https://fis.uni-bamberg.de/handle/uniba/111300},
  language = {deu},
  abstract = {Fragestellung: Die Insulinpumpentherapie (CSII) bietet mehrere Zusatzoptionen, um die Blutglukose im Alltag besser steuern zu können. Hierzu zählen eine temporäre Basalrate, unterschiedliche Basalratenprofile und Bolusoptionen sowie die Nutzung von Boluskalkulatoren, Softwareprogrammen zur Analyse von Glukosedaten und eine kontinuierliche Glukosemessung. In dieser Studie wurde untersucht wie häufig langjährige CSII-Träger solche Zusatzoptionen im Alltag nutzen.
Methodik: Die Stichprobe umfasst 278 Typ-1-Diabetiker (Teilnehmer der INPUT-Studie) mit CSII-Therapie (Alter 43,7±14,3 Jahre; 59,9 \% weiblich; DD 23,0 ±12,4 Jahre; HbA1c 8,4±0,9\% bzw. 68±9,8 mmol/mol; Dauer CSII-Therapie 9,6±7,4 Jahre). Die Häufigkeit der Nutzung von Zusatz-Features für die CSII-Therapie wurde mittels Fragebogen erhoben.
Ergebnisse: 67,9\% der INPUT-Studienteilnehmer geben an, regelmäßig (d.h. mehrmals pro Woche oder täglich) einen Boluskalkulator zu benutzen. Verschiedenen Bolusoptionen werden regelmäßig von 38,4\% genutzt, temporäre Basalraten von 31\% der Befragten. Unterschiedliche Basalratenprofile werden dagegen nur von 8,5\% der CSII-Träger regelmäßig eingesetzt. Nur wenige der Befragten nutzen eine kontinuierliche Glukosemessung (6,8\%) oder die technische Möglichkeit Glukosedaten auszulesen und zu analysieren (5,6\%). In einer schrittweisen Regressionsanalyse war jedoch die Häufigkeit der software-gestützten Analyse von Glukosedaten mit einem signifikante niedrigeren HbA1c (ß=-0,15, p=0,012) assoziiert.
Schlussfolgerung: Obwohl die CSII-Therapie die aufwändigste Form der Insulintherapie darstellt, bleibt die glykämische Kontrolle häufig suboptimal. Die technischen Möglichkeiten einer Insulinpumpentherapie - mit Ausnahme der Nutzung von Boluskalkulatoren - werden von der
Mehrzahl der langjährigen CSII-Träger nicht regelmäßig genutzt. Es sollte daher geprüft werden, ob mit Hilfe von speziellen Schulungsmaßnahmen zur Insulinpumpentherapie eine bessere Nutzung der
technischen Möglichkeiten dieser Therapieform und damit einhergehend auch eine bessere Therapieeffizienz erreicht werden kann.},
  keywords = {Insulinpumpentherapie}
}

@article{ehrmann2017_44297,
  title = {Change in the usage of pump features predicts improvement of glycemic control},
  author = {Ehrmann, Dominic and Hermanns, Norbert and Schipfer, Melanie and Lippmann-Grob, Bernhard and Haak, Thomas and Kulzer, Bernhard},
  year = {2017},
  journal = {Diabetes : a journal of the American Diabetes Association},
  volume = {66},
  number = {Suppl. 1},
  pages = {A274 (1040-P)},
  issn = {0012-1797},
  url = {https://fis.uni-bamberg.de/handle/uniba/44297},
  language = {eng},
  abstract = {Insulin pumps offer a wide range of technical features designed to help patients with achieving optimal glycemic control. However, many patients do not achieve better glycemic control despite CSII therapy. In this study, we analyzed whether a change in using pump features was associated with an improvement in glycemic control. 197 patients with CSII treatment were analyzed at baseline and 12-weeks later (age 42.2 ± 14.3 yrs.; 59\% female; diabetes duration 22.2 ± 11.9 yrs.; duration of CSII 9.4 ± 7.3 yrs.; baseline A1c 8.3 ± 0.9\%). Change in using pump features (see table) were the independent variables of interest in a linear regression analysis on the difference in HbA1c (follow-up – baseline).<cr><nl>
The analysis was controlled for demographic (age, gender, BMI, education) and medical variables (diabetes duration, duration of CSII, use of CGM/FGM, complications, SMBG).<cr><nl>
Increased use of pump features standardized beta p<cr><nl>
Temporary basal rates -0.16 .027<cr><nl>
Different basal rate profiles -0.09 .219<cr><nl>
Bolus options 0.16 .031<cr><nl>
Bolus calculators 0.02 .790<cr><nl>
Analysis software -0.16 .025<cr><nl>
CGM pairing -0.23 .002<cr><nl>
An increased use of temporary basal rates as well as using analysis software more often predicted an improvement in HbA1c (see table). Linking a CGM system to the insulin pump was the strongest predictor of better glycemic control. In clinical practice, patients with CSII therapy should be educated how to make use of their pump features and should be encouraged to do so.}
}

@article{kulzer2017_44228,
  title = {How effective is structured diabetes education in people with diabetes and CSII-treatment?},
  author = {Kulzer, Bernhard and Ehrmann, Dominic and Schipfer, Melanie and Lippmann-Grob, Bernhard and Haak, Thomas and Hermanns, Norbert},
  year = {2017},
  journal = {Diabetes : a journal of the American Diabetes Association},
  volume = {66},
  number = {Suppl.1},
  pages = {A181 (696-P)},
  publisher = {American Diabetes Association},
  address = {Alexandria, VA},
  issn = {0012-1797},
  url = {https://fis.uni-bamberg.de/handle/uniba/44228},
  language = {eng}
}

@book{gehr2017_44006,
  title = {Spectrum Curriculum : Schulungs- und Behandlungsprogramm zur kontinuierlichen Glukosemessung (CGM) für Menschen mit Typ-1-Diabetes : Erwachsene, Eltern mit Kindern, Jugendliche},
  author = {Gehr, B and Holder, M and Kulzer, Bernhard and Thurm, U and Siegmund, T and Sahm, Claudia and Biermann, E and Carstensen, S and Freckmann, G and Heinemann, L. and Kolossa, R and Kerth, E and Liebl, A and Lohr, R and Maier, Berthold and Remus, K and Schulz-Braun, M and Schlüter, S and Wernsing, M and Deiss, D and Heidtmann, B and Ludwig-Seibold, C and von Sengbusch, S and Wadien, T and Ziegler, R and Lange, K},
  year = {2017},
  publisher = {Verlag Kirchheim},
  address = {Mainz},
  isbn = {978-3-87409-645-4},
  url = {https://fis.uni-bamberg.de/handle/uniba/44006},
  language = {deu},
  abstract = {Mit SPECTRUM lernen Ihre Patienten ein CGM-System sicher und erfolgreich anzuwenden, z. B. die CGM-Informationen auf dem Display zu verstehen, die Alarmfunktionen optimal zu nutzen und aus den CGM-Daten die richtigen therapeutischen Schlüsse zu ziehen.

• SPECTRUM ist bei den Inhalten, der Sprache und der Herangehensweise jeweils auf die unterschiedlichen Zielgruppen abgestimmt: für Erwachsene, für Eltern mit Kleinkindern und für Jugendliche mit Typ-1-Diabetes.

• SPECTRUM kann unabhängig von der Insulin­therapieform (ICT oder CSII) genutzt werden.

• SPECTRUM berücksichtigt die Tatsache, dass im deutschsprachigen Raum die Glukoseeinheiten mg/dl und mmol/l parallel verwendet werden.}
}

@article{kulzer2017_43986,
  title = {Wie belastend erleben Angehörige den Diabetes? Deutsche Stichprobe der internationalen DAWN2™-Studie},
  author = {Kulzer, Bernhard and Lüthgens, B. and Landgraf, R and Krichbaum, Michael and Hermanns, Norbert},
  year = {2017},
  journal = {Der Diabetologe},
  volume = {13},
  number = {8},
  pages = {570-580},
  publisher = {Springer},
  address = {Berlin ; Heidelberg [u.a.]},
  issn = {1860-9716},
  doi = {10.1007/s11428-017-0286-7},
  url = {https://fis.uni-bamberg.de/handle/uniba/43986},
  language = {deu}
}

@article{schmitt2017_43932,
  title = {Reduction of depressive symptoms predicts improved glycaemic control: Secondary results from the DIAMOS study},
  author = {Schmitt, Andreas and Reimer, André and Ehrmann, Dominic and Kulzer, Bernhard and Haak, Thomas and Hermanns, Norbert},
  year = {2017},
  journal = {Journal of Diabetes and its Complications},
  volume = {31},
  number = {11},
  pages = {1608-1613},
  publisher = {Elsevier},
  address = {Amsterdam},
  issn = {1056-8727},
  doi = {10.1016/j.jdiacomp.2017.08.004},
  url = {https://fis.uni-bamberg.de/handle/uniba/43932},
  language = {eng},
  abstract = {Aims: Evidence from randomised trials analysing effects of depression treatment on glycaemic control in group comparisons is inconsistent. The aim of this study was to test if the reduction of depressive symptoms would explain improved glycaemic control irrespective of treatment groups.
Methods: The DIAMOS study tested effects of cognitive-behavioural therapy (CBT) versus usual care on depressive symptoms in a 12-month prospective trial; HbA1c was a secondary outcome. Since the results suggested superiority of CBT for improving depressive symptoms, but not HbA1c, we conducted this secondary analysis to test if reduction of depressive symptoms could explain improved glycaemic control when assessed irrespective of treatment group affiliation. Reduction of depressive symptoms was assessed using baseline-to-follow-up changes in the Center for Epidemiologic Studies Depression Scale (CES-D). We used multiple regression analyses, adjusting for baseline HbA1c and depression, group affiliation and covariates, to assess associations between reduction of depressive symptoms and follow-up HbA1c.
Results: 181 participants provided eligible data. Depressive symptoms decreased between baseline and follow-up by averagely − 5.1 ± 11.8 CES-D points. Greater reduction of depressive symptoms predicted greater improvement of HbA1c at follow-up, while adjusting for baseline HbA1c and covariates (Beta = − 0.24, P = 0.004). Additionally, patients with greater reduction of depressive symptoms were more likely to reach in-target HbA1c (< 7.5\%) at follow-up (adjusted OR = 1.04, 95\% CI 1.01–1.08, P = 0.023).
Conclusions: The findings suggest that reduction of depressive symptoms can explain improved glycaemic control. Behavioural treatments might aim to improve both affective and glycaemic outcomes.},
  keywords = {Depression, Affective disorder, Mood, HbA1c, Metabolic control}
}

@article{kulzer2017_43928,
  title = {Adhärenzprobleme und therapeutische Trägheit: 11 Tipps, um Diabetiker bei der Stange zu halten},
  author = {Kulzer, Bernhard},
  year = {2017},
  journal = {MMW - Fortschritte der Medizin},
  volume = {159},
  number = {4},
  pages = {67-72},
  publisher = {Springer Medizin Verlag GmbH},
  address = {Berlin},
  issn = {1438-3276},
  doi = {10.1007/s15006-017-9343-9},
  url = {https://fis.uni-bamberg.de/handle/uniba/43928},
  language = {deu},
  abstract = {Die beste Therapie hilft nur etwas, wenn sie auch umgesetzt wird. Wie können Sie Ihre Diabetespatienten zur besseren „Mitarbeit“ motivieren? Oder liegt es vielleicht gar nicht nur am Patienten? Eine Spurensuche und wertvolle Strategien für die Praxis.},
  keywords = {Adherence, clinical inertia, diabetes mellitus}
}

@article{thurm2017_43924,
  title = {Continuous glucose monitoring: A training programme for all age groups},
  author = {Thurm, Ulrike and Gehr, Bernhard and Holder, Martin and Kulzer, Bernhard and Lange, Karin and Liebl, Andreas and Sahm, Claudia and von Sengbusch, Simone and Schlüter, Sandra and Siegmund, Thorsten and Ziegler, Ralph and Freckmann, Guido and Heinemann, Lutz},
  year = {2017},
  journal = {International Diabetes Nursing},
  volume = {14},
  number = {1: Special Issue: Current Issues in the Care of the Older Person with Diabetes},
  pages = {26-31},
  publisher = {Taylor \& Francis},
  address = {London [u.a.]},
  issn = {2057-3316},
  doi = {10.1080/20573316.2017.1335970},
  url = {https://fis.uni-bamberg.de/handle/uniba/43924},
  language = {eng},
  abstract = {Optimal usage of continuous glucose monitoring (CGM) requires adequate preparation and training. Patients using a CGM system without special training often do not achieve their intended improvement of metabolic control. Some stop using the system due to disappointing results. For this reason a structured training programme called ‘SPECTRUM’ was developed in Germany to ensure a high-quality standard for the initiation of CGM systems. This programme is suitable for patients of all age groups and is applicable to all CGM systems and all forms of insulin therapy. Structured curricula (adults, parents of young children, adolescents) were developed enabling diabetes centres with less experience to offer comprehensive CGM training. Key requirements of SPECTRUM were (1) independent from manufactures and (2) product-neutrality enabling certification for reimbursement after formal evaluation within the framework of a large clinical trial. SPECTRUM was published in January 2016 in German and translations into other languages are planned.},
  keywords = {Continuous glucose monitoring, CGM, Education programme, Diabetes, Children}
}

@article{gehr2017_43920,
  title = {SPECTRUM: A Training and Treatment Program for Continuous Glucose Monitoring for All Age Groups},
  author = {Gehr, Bernhard and Holder, Martin and Kulzer, Bernhard and Lange, Karin and Liebl, Andreas and Sahm, Claudia and von Sengbusch, Simone and Schlüter, Sandra and Siegmund, Thorsten and Thurm, Ulrike and Ziegler, Ralph and Freckmann, Guido and Heinemann, Lutz},
  year = {2017},
  journal = {Journal of Diabetes Science and Technology},
  volume = {11},
  number = {2},
  pages = {284-289},
  publisher = {Sage Publishing},
  address = {London},
  issn = {1932-2968},
  doi = {10.1177/1932296816661735},
  url = {https://fis.uni-bamberg.de/handle/uniba/43920},
  language = {eng},
  abstract = {Background: Optimal usage of continuous glucose monitoring (CGM) requires adequate training of the users. Providing patients with a CGM system without such a training usually doesn’t lead to the intended improvement in metabolic control.
Methods: In Germany we developed a structured training program (“SPECTRUM”) to ensure a high quality standard for the use of CGM systems.
Results: This program is suitably for patients of all age groups and is applicable to all CGM systems and all forms of insulin therapy. A curriculum was also developed so that training centers with less experience with CGM could become capable of offering comprehensive CGM training.
Conclusions: We believe that usage of such a program can be an important step forward in achieving more widespread acceptance and use of CGM systems. Translations in other languages and evaluation with a controlled clinical trial are planned.},
  keywords = {continuous glucose monitoring, CGM, teaching program, educational program, training program}
}

@article{hermanns2017_43923,
  title = {The effect of an education programme (MEDIAS 2 BSC) of non‐intensive insulin treatment regimens for people with Type 2 diabetes: arandomized, multi‐centre trial},
  author = {Hermanns, Norbert and Ehrmann, Dominic and Schall, S and Maier, Berthold and Haak, Thomas and Kulzer, Bernhard},
  year = {2017},
  journal = {Diabetic Medicine},
  volume = {34},
  number = {8},
  pages = {1084-1091},
  publisher = {Wiley-Blackwell},
  address = {Oxford [u.a.]},
  issn = {1464-5491},
  doi = {10.1111/dme.13346},
  url = {https://fis.uni-bamberg.de/handle/uniba/43923},
  language = {eng},
  abstract = {AIMS: A self-management oriented education programme (MEDIAS 2 BSC) for people with Type 2 diabetes who are on a non-intensive insulin treatment regimen was developed. In a randomized, multi-centre trial, the effect of MEDIAS 2 BSC was compared with an established education programme that acted as a control group.
METHODS: The primary outcome was the impact of MEDIAS 2 BSC on glycaemic control. Secondary outcomes included the incidence of severe hypoglycaemia, hypoglycaemia unawareness, diabetes-related distress, diabetes knowledge, quality of life and self-care behaviour.
RESULTS: In total, 182 participants were randomized to the control group or MEDIAS 2 BSC [median age 64.0 (interquartile range 58.0-68.5) vs. 63.5 (57.0-70.0) years; HbA1c 62.8 ± 12.7 mmol/mol vs. 63.7 ± 14.0 mmol/mol; 7.9\% ± 1.2\% vs. 8.0\% ± 1.3\%]. After a 6-month follow-up, there was a mean decrease in HbA1c of 3.5 mmol/mol (0.32\%) in the control group and 6.7 mmol/mol (0.61\%) in MEDIAS 2 BSC. After adjusting for baseline differences and study centre, the mean difference between the groups was -3.3 mmol/mol [95\% confidence interval (CI) -0.54 to -5.90 mmol/mol] [-0.30\% (95\% CI -0.05 to -0.54)] in favour of MEDIAS 2 BSC (P = 0.018). There were no increases in severe hypoglycaemia or hypoglycaemia unawareness. The education programmes had no significant effects on psychosocial outcome variables.
CONCLUSION: MEDIAS 2 BSC was more effective in lowering HbA1c than the control condition. MEDIAS 2 BSC is a safe educational tool that improves glycaemic control without increasing the risk for hypoglycaemia. (Clinical Trials Registry No; NCT 02748239).}
}

@article{hermanns2017_43905,
  title = {How Much Accuracy of Interstitial Glucose Measurement Is Enough? Is There a Need for New Evidence?},
  author = {Hermanns, Norbert and Ehrmann, Dominic and Kulzer, Bernhard},
  year = {2017},
  journal = {Journal of diabetes science and technology : JDST},
  volume = {11},
  number = {2},
  pages = {296-298},
  publisher = {Sage Publishing},
  address = {London},
  issn = {1932-2968},
  doi = {10.1177/1932296816677578},
  url = {https://fis.uni-bamberg.de/handle/uniba/43905},
  language = {eng},
  abstract = {Abstract

This analytical comment discusses what standards are needed for the evaluation of the accuracy of glucose measurement systems continuously measuring glucose in the interstitial fluid. Since accuracy standards for continuous glucose monitoring (CGM)/flash glucose monitoring (FGM) systems are currently based on modeling studies or consensus of experts, we raised the question whether non-inferiority trials evaluating the safety and efficacy of CGM/FGM measurements compared to capillary blood glucose measurement with point-of-care devices could help to establish clarity about the needed accuracy standards of CGM/FGM. Such trials could also support the replacement of capillary blood glucose measurements by modern CGM/FGM systems.},
  keywords = {accuracy standards of continuous glucose monitoring systems, blood glucose monitoring, continuous glucose monitoring, flash glucose monitoring}
}

@article{reimer2017_43913,
  title = {Reduction of diabetes-related distress predicts improved depressive symptoms: A secondary analysis of the DIAMOS study},
  author = {Reimer, André and Schmitt, Andreas and Ehrmann, Dominic and Kulzer, Bernhard and Hermanns, Norbert},
  year = {2017},
  journal = {PLOS ONE},
  volume = {12},
  number = {7},
  publisher = {PLOS},
  address = {San Francisco, California, US},
  issn = {1932-6203},
  doi = {10.1371/journal.pone.0181218},
  url = {https://fis.uni-bamberg.de/handle/uniba/43913},
  language = {eng},
  abstract = {Objective: Depressive symptoms in people with diabetes are associated with increased risk of adverse outcomes. Although successful psychosocial treatment options are available, little is known about factors that facilitate treatment response for depression in diabetes. This prospective study aims to examine the impact of known risk factors on improvement of depressive symptoms with a special interest in the role of diabetes-related distress.
Methods: 181 people with diabetes participated in a randomized controlled trial. Diabetes-related distress was assessed using the Problem Areas In Diabetes (PAID) scale; depressive symptoms were assessed using the Center for Epidemiologic Studies Depression (CES-D) scale. Multiple logistic and linear regression analyses were used to assess associations between risk factors for depression (independent variables) and improvement of depressive symptoms (dependent variable). Reliable change indices were established as criteria of meaningful reductions in diabetes distress and depressive symptoms.
Results: A reliable reduction of diabetes-related distress (15.43 points in the PAID) was significantly associated with fourfold increased odds for reliable improvement of depressive symptoms (OR = 4.25, 95\% CI: 2.05–8.79; P<0.001). This result was corroborated using continuous measures of diabetes distress and depressive symptoms, showing that greater reduction of diabetes-related distress independently predicted greater improvement in depressive symptoms (ß = -0.40; P<0.001). Higher age had a positive (Odds Ratio = 2.04, 95\% CI: 1.21–3.43; P<0.01) and type 2 diabetes had a negative effect on the meaningful reduction of depressive symptoms (Odds Ratio = 0.12, 95\% CI: 0.04–0.35; P<0.001).
Conclusions: The reduction of diabetes distress is a statistical predictor of improvement of depressive symptoms. Diabetes patients with comorbid depressive symptomatology might benefit from treatments to reduce diabetes-related distress.}
}

@article{kern2017_43908,
  title = {Self-reported Hypoglycaemic Events in 2 430 Patients with Insulin-treated Diabetes in the German Sub-population of the HAT Study},
  author = {Kern, Werner and Holstein, Andreas and Moenninghoff, Christian and Kienhöfer, Joachim and Riedl, Matthias and Kulzer, Bernhard},
  year = {2017},
  journal = {Experimental and Clinical Endocrinology \& Diabetes},
  volume = {125},
  number = {9},
  pages = {592-597},
  publisher = {Georg Thieme Verlag KG},
  address = {Stuttgart; New York},
  issn = {0947-7349},
  doi = {10.1055/s-0043-112350},
  url = {https://fis.uni-bamberg.de/handle/uniba/43908},
  language = {eng},
  abstract = {Abstract

Data concerning true hypoglycaemic incidence in insulin-treated patients with diabetes in real-world clinical practice are lacking in Germany. The aim of this analysis was to determine the incidence of hypoglycaemia experienced by the German cohort of patients enrolled in the global Hypoglycaemia Assessment Tool (HAT) study. This was a non-interventional, 6-month retrospective and 4-week prospective study using self-assessment questionnaires and patient diaries assessing patients aged ≥18 years in Germany, with type 1 diabetes (T1D) (n=811) or type 2 diabetes (T2D) (n=1 619) treated with insulin for >12 months. The primary endpoint was the percentage of patients experiencing ≥1 hypoglycaemic event during the prospective observational period (4 weeks after baseline). Predictive and continuous factors (such as age, gender, duration of insulin use and HbA1c) contributing to hypoglycaemia risk were explored.During the prospective period, at least one hypoglycaemic event was reported by 81.3\% of patients with T1D and 39.7\% of patients with T2D, indicating that hypoglycaemia is a common acute complication among patients with insulin-treated diabetes. Severe hypoglycaemia was reported by 9.1\% of patients with T1D and 5.4\% of patients with T2D. Higher rates of any and severe hypoglycaemia were reported prospectively than retrospectively, regardless of diabetes type, indicating that patients retrospectively under-report hypoglycaemia. Prospective rates (events per patient-year) of any, nocturnal and severe hypoglycaemia were 80.3, 9.9 and 3.0 for T1D and 15.6, 2.4 and 1.1 for T2D, respectively. Given the potential for recall bias in retrospective reporting, this prospective assessment of hypoglycaemia appears more reliable than retrospective assessment.},
  keywords = {hypoglycaemia, real-world, severe, nocturnal, Germany}
}

@article{ehrmann2017_43899,
  title = {The affective and somatic side of depression: subtypes of depressive symptoms show diametrically opposed associations with glycemic control in people with type 1 diabetes},
  author = {Ehrmann, Dominic and Schmitt, Andreas and Reimer, André and Haak, Thomas and Kulzer, Bernhard and Hermanns, Norbert},
  year = {2017},
  journal = {Acta Diabetologica},
  volume = {54},
  number = {8},
  pages = {749-756},
  publisher = {Springer},
  address = {Mailand},
  issn = {0940-5429},
  doi = {10.1007/s00592-017-1006-x},
  url = {https://fis.uni-bamberg.de/handle/uniba/43899},
  language = {eng},
  abstract = {Aims: While depression has been linked to serious adverse outcomes in diabetes, associations with glycemic control are not conclusive. Inconsistencies could be due to the complex symptomatology of depression. Aim of this study was to analyze the associations of depressive subtypes with glycemic control in people with type 1 and type 2 diabetes.
Methods: Patients completed the Center for Epidemiological Studies-Depression scale which comprises affective, somatic, and anhedonic symptoms. These subtypes were analyzed in a joint linear regression analysis with glycemic control as a dependent variable. Subtype scores were calculated as mean item scores. Separate analyses for people with type 1 and type 2 diabetes were conducted. All analyses were controlled for demographic and medical confounders.
Results: The sample comprised 604 patients with type 1 and 382 patients with type 2 diabetes. In people with type 1 diabetes, the somatic and affective subtype showed diametrically opposed associations with glycemic control (somatic: β =+0.23, p < .05; affective: β = −0.23, p < .05). Anhedonia was not significantly associated with glycemic control. In people with type 2 diabetes, none of the depressive subtypes was significantly associated with glycemic control.
Conclusions: For people with type 1 diabetes, the distinction of subtypes offered a detailed picture of the associations of depressive symptoms with glycemic control. However, due to the cross-sectional design, inferences about the direction of these associations cannot be made. In clinical practice, instead of focusing on overall depression, healthcare providers should examine the nature of depressive symptoms and how they might be related to having diabetes.},
  keywords = {Depressive symptoms, Glycemic control, Subtypes, Psychosocial aspects}
}

@article{schmitt2017_43887,
  title = {Depression is linked to hyperglycaemia via suboptimal diabetes self-management: A cross-sectional mediation analysis},
  author = {Schmitt, Andreas and Reimer, André and Hermanns, Norbert and Kulzer, Bernhard and Ehrmann, Dominic and Krichbaum, Michael and Huber, Jorg and Haak, Thomas},
  year = {2017},
  journal = {Journal of Psychosomatic Research},
  volume = {94},
  number = {March},
  pages = {17-23},
  publisher = {Elsevier},
  address = {Amsterdam},
  issn = {0022-3999},
  doi = {10.1016/j.jpsychores.2016.12.015},
  url = {https://fis.uni-bamberg.de/handle/uniba/43887},
  language = {eng}
}

@article{kampling2017_43879,
  title = {Trajectories of depression in adults with newly diagnosed type 1 diabetes: results from the German Multicenter Diabetes Cohort Study.},
  author = {Kampling, Hanna and Petrak, Frank and Farin, Erik and Kulzer, Bernhard and Herpertz, Stephan and Mittag, Oskar},
  year = {2017},
  journal = {Diabetologia},
  volume = {60},
  number = {1},
  pages = {60-68},
  publisher = {Springer},
  address = {Berlin ; Heidelberg},
  issn = {0012-186X},
  doi = {10.1007/s00125-016-4123-0},
  url = {https://fis.uni-bamberg.de/handle/uniba/43879},
  language = {eng},
  abstract = {Abstract
There is a paucity of longitudinal data on type 1 diabetes and depression, especially in adults. The present study prospectively analysed trajectories of depressive symptoms in adults during the first 5 years of living with type 1 diabetes. We aimed to identify distinct trajectories of depressive symptoms and to examine how they affect diabetes outcome.We reanalysed data from a prospective multicentre observational cohort study including 313 adults with newly diagnosed type 1 diabetes. At baseline and in annual postal surveys over 5 consecutive years, we gathered patient characteristics and behavioural and psychosocial data (e.g. Symptom Checklist-90-R [SCL-90-R]). Medical data (e.g. HbA1c levels) was obtained from the treating physicians. We applied growth mixture modelling (GMM) to identify distinct trajectories of depression over time.Five years after diagnosis, 7.8\% (n = 20) of patients were moderately depressed and 10.2\% (n = 26) were severely depressed. GMM statistics identified three possible models of trajectories (class 1, 'no depressive symptoms'; class 2, 'worsening depressive symptoms that improve after 2 years'; class 3, 'worsening depressive symptoms'). Severity of depression symptoms at baseline (subscale of the SCL-90-R questionnaire) significantly predicted membership of classes 2 and 3 vs class 1. After 5 years, higher HbA1c values were detected in class 3 patients (mean = 8.2\%, 66 mmol/mol) compared with class 1 and class 2 (both: mean = 7.2\%, 55 mmol/mol).We identified distinct trajectories of depressive symptoms that are also relevant for diabetes outcome. Patients with worsening depressive symptoms over time exhibited poor glycaemic control after the first 5 years of living with diabetes. They also exhibited a reduced quality of life and increased diabetes-related distress.},
  keywords = {Adults, Depression, Growth mixture modelling, Longitudinal data, Onset cohort}
}

@inproceedings{reimer2017_42301,
  title = {Erhöhte Depressivität bei Menschen mit Diabetes trotz Antidepressivatherapie : Ergebnisse der Ecce Homo-Studie},
  author = {Reimer, André and Schmitt, Andreas and Ehrmann, Dominic and Hermanns, Norbert and Haak, Thomas and Kulzer, Bernhard},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0036-1580844},
  urn = {urn:nbn:de:bvb:473-opus4-497470},
  url = {https://fis.uni-bamberg.de/handle/uniba/42301},
  language = {deu},
  abstract = {Fragestellung: Die häufige Komorbidität von Diabetes und Depression geht erhöhtem Risiko für Folgeerkrankungen und eine schlechtere Diabeteskontrolle einher. Antidepressiva sind eine leitliniengerechte Behandlungsmethode bei klinischer Depression. Diese Studie untersucht, ob die Depression bei Menschen mit Diabetes unter antidepressiver Pharmakotherapie ausreichend remittiert ist.

Methodik: 2370 Menschen mit Diabetes (Alter 47 ± 14 Jahre, 46\% weiblich, Diabetesdauer 16 ± 11 Jahre, BMI 29 ± 7 kg/m2, HbA1c 8,7 ± 1,7\%) wurden im Rahmen der ECCE HOMO-Studie mittels der Allgemeinen Depressionsskala (ADS) auf depressive Symptome gescreent. Ein Cutoff-Wert von ≥22 wurde als Kriterium für eine klinisch ausgeprägte Depressionssymptomatik verwendet.

Ergebnisse: 318 der befragten Patienten (13\%) befanden sich zum Zeitpunkt der Befragung unter laufender Antidepressivatherapie. Lediglich 35\% dieser Personen wiesen ADS-Summenwerte unter dem Cutoff-Wert für klinische Depressivität auf. Die übrigen 65\% berichteten Werte, die auf ausgeprägte Depressivität sowie ein mögliches Vorliegen einer Major Depression hinweisen.

Schlussfolgerungen: Die Studienergebnisse weisen darauf hin, dass die Einnahme von Antidepressiva bei einem hohen Prozentsatz der Diabetespatienten keine ausreichende Verbesserung der Depressionssymptomatik erzielt. Daher sollte jede Antidepressiva-Behandlung regelmäßig monitoriert werden, um Effektivität und Nutzen der Medikation zu bestimmen. Einschränkend ist zu sagen, dass in dieser Untersuchung Art, Dosis und Regelmäßigkeit der Einnahme von Antidepressiva nicht erhoben wurden.}
}

@inproceedings{ehrmann2017_42306,
  title = {Wer profitiert von strukturierten Schulungs- und Behandlungsprogrammen?},
  author = {Ehrmann, Dominic and Hermanns, Norbert and Bergis-Jurgan, Nikola and Haak, Thomas and Kulzer, Bernhard},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0036-1580985},
  urn = {urn:nbn:de:bvb:473-opus4-497510},
  url = {https://fis.uni-bamberg.de/handle/uniba/42306},
  language = {deu},
  abstract = {Fragestellung: Schulung gilt als integraler Bestandteil der Therapie des Typ-1-Diabetes, die allen Patienten angeboten werden soll. Jedoch gibt es wenige Daten darüber, ob alle Patienten gleichermaßen von der Teilnahme an strukturierten Schulungs- und Behandlungsprogrammen profitieren oder Unterschiede in der Wirksamkeit von Schulung bestehen. Diese Analyse untersucht die Effekte der Schulung mit dem PRIMAS-Programm auf wichtige klinische Parameter in Abhängigkeit von verschiedenen demographischen und medizinischen Ausgangsvariablen.

Methodik: 75 Typ-1-Diabetespatienten, die PRIMAS im Rahmen einer randomisierten, kontrollierten Studie erhalten haben, sowie 179 Patienten, die an PRIMAS im klinischen Alltag teilnahmen wurden analysiert. Mittels einer logistischen Regression wurde der Einfluss auf eine klinisch bedeutsame Verbesserung durch die Schulung mit PRIMAS untersucht. Diese wurde definiert als Verbesserung des HbA1c und/oder Verbesserung von Hypoglykämie-Problemen und/oder der Reduktion des Diabetes Distress. Als unabhängige Variablen gingen das Studiensetting (RCT vs. klinischer Alltag), Alter, Diabetesdauer, BMI, Geschlecht, Pumpentherapie, sowie HbA1c, Hypoglykämie-Wahrnehmungsfähigkeit und Diabetes Distress jeweils zu Baseline ein.

Ergebnisse: Patienten mit höherem HbA1c (OR = 1,47; 95\% KI 1,07 – 2,02), mehr Hypoglykämie-Problemen (OR = 2,25; 95\% KI 1,59 – 3,17) und höherem Diabetes Distress (OR = 1,45; 95\% KI 1,07 – 1,97) hatten eine höhere Chance auf klinische Verbesserung durch die PRIMAS Schulung. Weder das Studiensetting noch demographische und medizinische Variablen hatten einen Einfluss auf die klinische Verbesserung.

Schlussfolgerungen: Durch die Schulung mit PRIMAS können relevante klinische Probleme effektiv verbessert werden. Für die Effekte der Schulung war es nicht von Bedeutung, ob diese in einem streng kontrollierten Studiensetting oder im klinischen Alltag stattfand. Die Wirksamkeit von PRIMAS ist unabhängig von Alter, Geschlecht, Diabetesdauer und Therapieform.}
}

@inproceedings{schipfer2017_42270,
  title = {Evaluation des Fragebogens zu Unterzuckerungen bei Erwachsenen mit Typ-1-Diabetes (HFS)},
  author = {Schipfer, M and Ehrmann, Dominic and Hermanns, Norbert and Kulzer, Bernhard and Haak, Thomas and Bergis-Jurgan, Nikola},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0036-1580877},
  urn = {urn:nbn:de:bvb:473-opus4-497484},
  url = {https://fis.uni-bamberg.de/handle/uniba/42270},
  language = {deu},
  abstract = {Fragestellung: Der Hypoglycemia Fear Survey (HFS) erfasst Sorgen und Befürchtungen im Zusammenhang mit Hypoglykämien. Eine psychometrische Validierung der HFS an einer deutschen Stichprobe liegt bisher noch nicht vor. Ziel dieser Studie war die psychometrische Validierung der deutschsprachigen Fassung der HFS an einer Stichprobe von Menschen mit einem Typ-1-Diabetes.

Methodik: Der HFS besteht aus den Subskalen „Besorgnis“ (Worries) und „Vermeidungsverhalten“ (Behavior). Zusätzlich zur HFS wurden der WHO5 zur Erfassung des Wohlbefindens, die Problem Areas in Diabetes Scale (PAID) zur Erfassung der Diabetesbelastungen, ein Fragebogen zur Erfassung der Hypoglykämie-Wahrnehmungsstörung, sowie demographische (Alter, Geschlecht, BMI) und medizinische Variablen (HbA1c, Diabetesdauer) erhoben.

Ergebnisse: Es beteiligten sich 177 Menschen mit Typ-1-Diabetes (65\% weiblich; Alter 32 ± 12 Jahre; BMI 25 ± 5 kg/m2; Diabetesdauer 18 ± 14 Jahre; HbA1c 7,4\%± 1,3\%; 17,5\% Hypoglykämie-Wahrnehmungsstörung). Die HFS zeigt eine gute Reliabilität für die Subskalen „Vermeidungsverhalten“ (Cronbachs α= 0,858) und „Besorgnis“ (Cronbachs α= 0,957). Hohe „Besorgnis“ und „Vermeidungsverhalten“ standen signifikant mit erhöhten diabetesbezogenen Belastungen, („Vermeidungsverhalten“ r = 0,462, p < 0,001; „Besorgnis“ r = 0,586, p < 0,001), niederem Wohlbefinden („Vermeidungsverhalten“ r = 0,320, p < 0,001; „Besorgnis“ r = 0,458, p < 0,001), einer hohen Anzahl aufgetretener Hypoglykämien („Vermeidungsverhalten“ r = 0,335, p < 0,001; „Besorgnis“ r = 0,369, p < 0,001) und einer reduzierten Hypoglykämie-Wahrnehmung („Vermeidungsverhalten“ r =-0,237 p < 0,001; „Besorgnis“ r = 0,282, p < 0,001) im Zusammenhang. Eine erhöhte „Besorgnis“ ging mit einem erhöhten HbA1c-Wert (r = 0,210, p < 0,05) einher.

Schlussfolgerungen: Die Validierungsstudie an einer deutschen Stichprobe zeigt eine gute psychometrische Qualität der deutschen Fassung der HFS. Die signifikante Korrelation zwischen „Besorgnis“ und erhöhtem HbA1c könnte ein Hinweis auf die Vermeidung normoglykämischer Werte aufgrund einer erhöhten Hypoglykämieangst sein.}
}

@inproceedings{schmitt2017_42267,
  title = {Validierung eines Fragebogens zu Problemen der Krankheitsakzeptanz bei Diabetes mellitus : Diabetes Acceptance Scale (DAS)},
  author = {Schmitt, Andreas and Reimer, Andre and Kulzer, Bernhard and Icks, Andrea and Paust, R and Rölver, K-M and Matthaei, S and Kaltheuner, Matthias and Ehrmann, Dominic and Krichbaum, Michael and Haak, Thomas and Hermanns, Norbert},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0036-1580981},
  urn = {urn:nbn:de:bvb:473-opus4-497508},
  url = {https://fis.uni-bamberg.de/handle/uniba/42267},
  language = {deu},
  abstract = {Fragestellung: Probleme der Diabetesakzeptanz sind assoziiert mit non-adhärentem Selbstbehandlungsverhalten und hyperglykämischer Blutzuckereinstellung. Zur Erfassung von Diabetesakzeptanzproblemen existierte bisher allerdings nur ein recht limitiertes Messinstrument, der Acceptance and Action Diabetes Questionnaire (AADQ). Um differenziertere Messungen zu ermöglichen, wurde die Diabetes Acceptance Scale (DAS) entwickelt, deren Validierung hier berichtet wird.

Methodik: Die DAS ist eine 28-Item-Selbstberichtsskala mit Subskalen zur diabetesbezogenen „Akzeptanz/Integration“, „Behandlungsmotivation“, „Abwehr/Vermeidung“ und „emotionalen Belastung“ sowie einer Summenskala zur Gesamt-Diabetesakzeptanz; Entwicklung beschrieben in Diabetologie und Stoffwechsel 2015; 10 – P137. 460 Diabetespatienten (50\% Typ-1, 48\% Typ-2, 2\% Typ-3; 50\% weiblich; Alter 52 ± 15 Jahre; BMI 30 ± 7 kg/m2; Diabetesdauer 15 ± 12 Jahre; HbA1c 7,8 ± 1,4\%) bearbeiteten die DAS sowie Fragebögen zu Diabetesakzeptanzproblemen (AADQ), diabetesbezogener Belastung (PAID-5), depressiver Stimmung (PHQ-9) und Diabetes-Selbstbehandlungsverhalten (DSMQ). Gleichzeitig wurde der HbA1c-Wert bestimmt. Anhand dieser Daten wurden Kennwerte der Reliabilität (Cronbachs α) und Validität (kriterienbezogene Korrelationen) der DAS untersucht.

Ergebnisse: Alle DAS-Skalen zeigten durchweg hohe Reliabilität (Subskalen: α= 0,89 – 0,93; Summenskala: α= 0,96). Höhere DAS-Summenwerte (bessere Diabetesakzeptanz) waren hoch korreliert mit weniger Diabetesakzeptanzproblemen nach AADQ (r=-0,65), geringerer diabetesbezogener Belastung (r=-0,69) und weniger Depressivität (r=-0,56); alle P< 0,001. Weiter korrelierten höhere DAS-Summenwerte mit günstigeren Selbstbehandlungsverhaltensweisen nach DSMQ (diabetesgerechte Ernährung: r= 0,56; Medikamentenadhärenz: r= 0,54; Blutzuckerselbstkontrolle: r= 0,42; körperliche Betätigung: r= 0,26; Arztkontakt: r= 0,51) sowie einer besseren Blutzuckereinstellung (HbA1c-Wert: r=-0,42); alle P< 0,001.

Schlussfolgerungen: Die Ergebnisse sprechen für eine hohe Reliabilität und Validität der Diabetes Acceptance Scale. Die Skala erscheint als sehr gutes Messinstrument zur Erkennung von Problemen der Diabetesakzeptanz sowie zur besseren Erforschung dieser gravierenden psychologischen Problematik.},
  keywords = {Diabetes Acceptance Scale}
}

@inproceedings{schipfer2017_42254,
  title = {Evaluation einer deutschen Fassung der Diabetes Distress Scale für Typ-1-Diabetes (T1-DDS)},
  author = {Schipfer, M and Ehrmann, Dominic and Schmitt, Andreas and Kulzer, Bernhard and Haak, Thomas and Hermanns, Norbert and Bergis-Jurgan, Nikola},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0036-1580842},
  urn = {urn:nbn:de:bvb:473-opus4-496911},
  url = {https://fis.uni-bamberg.de/handle/uniba/42254},
  language = {deu},
  abstract = {Fragestellung: Die Diabetes Distress Scale für Typ-1-Diabetes (T1-DDS) ist ein spezifischer Fragebogen, der diabetesbezogenen Belastungen bei Menschen mit Typ-1-Diabetes (MmT1D) misst. Eine psychometrische Validierung der T1-DDS an einer deutschen Stichprobe liegt bisher noch nicht vor. Ziel dieser Studie war die psychometrische Validierung der deutschsprachigen Fassung der T1-DDS.

Methodik: Die T1-DDS besteht aus einer Gesamtskala der Diabetesbelastungen und sieben Subskalen zu speziellen Problembereichen (hypoglykämie-, therpie-, ernährungsbezogene Probleme, sowie Belastung durch Gefühle der Hilflosigkeit, negative Reaktionen Anderer, mangelnde Unterstützung durch Freunde/Famile und Arzt). Zusätzlich zur T1-DDS wurden der WHO5 zur Erfassung des Wohlbefindens, die Problem Areas in Diabetes Scale (PAID) zur Erfassung der Diabetesbelastungen, ein Fragebogen zur Erfassung der Hypoglykämie-Wahrnehmungsstörung, sowie demographische (Alter, Geschlecht, BMI) und medizinische Variablen (HbA1c, Diabetesdauer, Hypoglykämien) erhoben.

Ergebnisse: Es beteiligten sich 170 MmT1D (65\% weiblich; Alter 32 ± 12 Jahre; BMI 25 ± 5 kg/m2; Diabetesdauer 18 (± 14) Jahre; HbA1c 7,4\%± 1,3\%; 17,5\% Hypoglykämie-Wahrnehmungsstörung). Die T1-DDS zeigt eine sehr gute Reliabilität (Cronbachs α: Gesamtskala: 0,929; Subskalen: 0,783 bis 0,870). MmT1D mit hoher diabetesbezogenen Belastungen hatten einen signifikant erhöhten PAID-Score (r = 0,876, p < 0,001) und ein geringeres Wohlbefinden (r =-0,598, p < 0,001). MmT1D mit schweren Hypoglykämien zeigten eine höhere Gesamtbelastung, als MmT1D ohne schwere Hypoglykämien (M = 3,0 ± 1,0 vs. M = 2,4 ± 0,8, p < 0,01). Eine geringe Hypoglykämiewahrnehmung ist ebenfalls mit einer erhöhten Gesamtbelastung (r = 0,172, p < 0,05) und berichten eine sehr hohe Belastung in der Subskala „Belastung durch Hypoglykämien“ (r = 0,535, p < 00,1) assoziiert.

Schlussfolgerungen: Die Validierungsstudie an einer deutschen Stichprobe zeigt eine gute psychometrische Qualität der deutschen Fassung der T1-DDS.}
}

@inproceedings{hermanns2017_42241,
  title = {Depression in diabetes is associated with subclinical inflammation},
  author = {Hermanns, Norbert and Schmitt, Andreas and Reimer, André and Haak, Thomas and Kulzer, Bernhard},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-opus4-496821},
  url = {https://fis.uni-bamberg.de/handle/uniba/42241},
  language = {eng},
  abstract = {There is evidence that in non-diabetic people depression is associated with an elevation of circulating levels of inflammatory markers. Cross-sectionally, this study examines if high-sensitivity C-reactive protein (hsCRP), interleukin (IL)-6, IL-18, IL-1 receptor antagonis (IL-1RA), monocyte chemotactic protein (MCP)-1 and adiponektin are associated with depression at baseline in people with diabetes. Longitudinally, this study also analyzes if a significantly improved depression score after a 12 month follow-up was associated with a reduction in the systemic inflammatory markers mentioned above. At baseline and at the 12 month follow-up 132 people with diabetes and subthreshold depression completed a depression questionnaire (CES-D). A significant improvement of depression was operationalized as a reduction by 9.1 points of the depression score (reliable change index). At both measurement points blood samples for the determination of the systemic inflammatory markers were drawn and analyzed in a central laboratory using the same assays and plates for baseline as well as for follow-up samples. The multivariate analysis was adjusted for age, sex, BMI, HbA1c, diabetes type, macrovascular disease and medication intake (statins, NSAID, anti-coagulant drugs, thyroid medication). Pre-post data were available for 132 people with diabetes (age 44.5 ± 13.7 yrs., 44.1 \% female, HbA1c 8.8 ± 1.7\%, 64.1\% type 1 diabetes, CES-D score 23.4 ± 8.0). At baseline IL-1RA was significantly correlated with the depression score (ß=0.135, p=0.026). Patients with a significant reduction of their depression score at the 12 month follow-up had significant lower IL-1RA (396 ± 51 vs. 540 ± 32 pg/ml; p=0.034) and IL-18 serum levels (270 ± 29 vs. 337 ± 19 pg/ml; p=0.023). In addition, there was a significant interaction effect between IL-1RA reduction and diabetes type (more pronounced reduction in type-2-diabetes).In the cross-sectional as well as in the longitudinal responder analyses, IL-1RA levels showed a significant association with elevated depression scores as well as with the reduction of depression scores. In addition, people with a significant reduction of their depression score had a significant lower IL-18 level at followup. Besides lifestyle factors, adherence and glycemic control, systemic inflammatory processes involving cytokines of the IL-1 family might present a mediating mechanism between depression and the prognosis of diabetes. Supported by ‘Competence Network for Diabetes mellitus’ funded by the BMBF (FKZ 01GI1107)}
}

@inproceedings{schmitt2017_42248,
  title = {Die Assoziation zwischen Depressivität und schlechter glykämischer Kontrolle wird durch eine reduzierte Diabetes-Selbstbehandlung vermittelt : Eine Strukturgleichungsanalyse},
  author = {Schmitt, Andreas and Reimer, Andre and Hermanns, Norbert and Kulzer, Bernhard and Ehrmann, Dominic and Krichbaum, Michael and Huber, Jörg and Haak, Thomas},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0036-1580835},
  urn = {urn:nbn:de:bvb:473-opus4-496879},
  url = {https://fis.uni-bamberg.de/handle/uniba/42248},
  language = {deu},
  abstract = {Fragestellung: Die behaviorale Hypothese von Depression und Hyperglykämie besagt, Depressivität sei mit einer reduzierten Diabetes-Selbstbehandlung assoziiert und führe daher zu einer schlechteren Blutzuckereinstellung. Für diese Auffassung gibt es jedoch kaum überzeugende Evidenz. Daher untersuchte die vorliegende Studie Assoziationen zwischen depressiver Stimmung, Diabetes-Selbstbehandlung und Blutzuckereinstellung.

Methodik: 248 Typ-1- und 182 Typ-2-Diabetespatienten (54\% weiblich; Alter 47 ± 15 Jahre; BMI 30 ± 10 kg/m2; Diabetesdauer 15 ± 10 Jahre; HbA1c 8,5 ± 1,6\%) wurden mittels Fragebögen bezüglich depressiver Stimmung (Allgemeine Depressionsskala) und Diabetes-Selbstbehandlungsverhalten (Diabetes Self-Management Questionnaire) querschnittlich untersucht. Als Maß der Blutzuckereinstellung wurde der HbA1c-Wert bestimmt. Mittels Strukturgleichungsanalyse wurde getestet, ob die Assoziation zwischen depressiver Stimmung und Blutzuckereinstellung durch eine reduzierte Diabetes-Selbstbehandlung mediiert wird (separate Analysen für Typ-1- und Typ-2-Diabetes).

Ergebnisse: Das hypothetische Modell von depressiver Stimmung, Diabetes-Selbstbehandlung und Blutzuckereinstellung zeigte bei beiden Patientengruppen gute Passung (SRMR≤0,026; CFI≥0,999; TLI≥0,998; RMSEA≤0,012). Sowohl bei Typ-1- als auch Typ-2-Diabetes war depressive Stimmung mit einer geringeren Diabetes-Selbstbehandlung assoziiert (β=-0,25 bzw. -0,42, beide P< 0,001), und geringere Diabetes-Selbstbehandlung mit höheren HbA1c-Werten (β=-0,56 bzw. -0,50, beide P< 0,001). Die Analyse zeigte signifikante indirekte Assoziationen zwischen depressiver Stimmung und HbA1c, vermittelt durch die Diabetes-Selbstbehandlung, von β= 0,14 bei Typ-1- und β= 0,21 bei Typ-2-Diabetes (beide P< 0,001). Signifikante direkte Assoziationen zwischen depressiver Stimmung und Blutzuckereinstellung zeigten sich nicht, was für eine vollständige Mediation durch die Selbstbehandlung spricht.

Schlussfolgerungen: Die Untersuchung zeigte überzeugende querschnittliche Evidenz für die behaviorale Hypothese von Depression und Hyperglykämie. Die Befunde sprechen dafür, dass die Assoziation zwischen Depression und schlechterer Blutzuckereinstellung bei Diabetes durch eine reduzierte Selbstbehandlung vermittelt wird.},
  keywords = {Depression}
}

@inproceedings{hermanns2017_42244,
  title = {Indikation zur Teilnahme an dem MEDIAS2 BOT+SIT+CT Schulungs- und Behandlungsprogramm für Menschen mit einem Typ-2-Diabetes und einer nicht-intensivierten Insulintherapie},
  author = {Hermanns, Norbert and Kulzer, Bernhard and Maier, Berthold and Schall, Sabine and Haak, Thomas},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0036-1580980},
  urn = {urn:nbn:de:bvb:473-opus4-497496},
  url = {https://fis.uni-bamberg.de/handle/uniba/42244},
  language = {deu},
  abstract = {Hintergrund: Eine suboptimale glykämische Kontrolle, ein erhöhtes Hypoglykämierisiko oder eine deutliche Diabetesbelastung sind Indikationen für die Teilnahme an einer Diabetesschulung. Im Rahmen der Evaluationsstudie von MEDIAS2 BOT+SIT+CT wurde untersucht, welche dieser klinischen Probleme bei den Schulungsteilnehmern vorlagen und inwieweit bei einer Follow-up-Untersuchung nach 6 Monaten verbessert werden konnten.

Methodik: Eine suboptimale glykämische Kontrolle wurde operationalisiert über einen HbA1c > 7,5\%, ein erhöhtes Hypoglykämierisiko über einen Score ≥4 im Hypoglykämieunawareness-Fragebogen und das Vorliegen einer erhöhten Diabetesbelastung über eine Score ≥40 im PAID-Fragebogen.

Ergebnisse: Es nahmen 182 MmT2DM aus 13 diabetologischen Schwerpunktpraxen teil (Alter 63,6 ± 7,6 Jahre, Diabetesdauer 11,6 ± 6,4 Jahre, Dauer der Insulinbehandlung 3,6 ± 4,3 Jahre, HbA1c 7,9 ± 1,2\% Hypoglykämiewahrnehmungsscore 2,0 ± 0,9). Zur Baseline wiesen 63,1\% eine suboptimale glykämische Kontrolle auf, 5,1\% hatten ein erhöhtes Hypoglykämierisiko, 22,5\% berichteten erhöhte diabetesbezogene Belastungen und 80,0\% hatten noch nicht an einer Schulung zur Insulintherapie teilgenommen. Beide Interventionsgruppen unterscheiden sich nicht signifikant voneinander. Zum Follow-up Zeitpunkt kam es bei 31\% der MEDIAS2 BOT+SIT+CT Teilnehmer zu einer Verbesserung in mindestens einer der oben genannten Indikationen, während dies nur bei 17\% der Teilnehmer der KG beobachtbar war (p = 0,03). Die Odds Ratio für eine Verbesserung in mindestens einer Schulungsindikation betrug 2,2 (95\% KI 1,1 bis 4,7) zugunsten von MEDIAS2 BOT+SIT+CT.

Diskussion: Eine suboptimale glykämische Kontrolle war das häufigste Problem in dieser Patientengruppe, gefolgt von erhöhten diabetesbezogenen Belastungen. Trotz mehr als 3-jähriger Dauer der Insulintherapie waren 80\% bislang noch nicht geschult. Die Teilnahme an MEDIAS2 BOT+SIT+CT erhöht die Wahrscheinlichkeit einer klinischen Verbesserung bzgl. glykämischer Kontrolle, Hypoglykämierisiko oder Diabetesbelastung signifikant.}
}

@inproceedings{kulzer2017_42227,
  title = {Effekte des MEDIAS2 BOT+SIT+CT Schulungs- und Behandlungsprogrammes für Menschen mit einem Typ-2-Diabetes und einer nicht-intensivierten Insulintherapie auf HbA1c und Hypoglykämierisiko},
  author = {Kulzer, Bernhard and Hermanns, Norbert and Maier, Berthold and Schall, Sabine and Haak, Thomas},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0036-1580834},
  urn = {urn:nbn:de:bvb:473-opus4-496869},
  url = {https://fis.uni-bamberg.de/handle/uniba/42227},
  language = {deu},
  abstract = {Hintergrund: MEDIAS2 BOT+SIT+CT ist ein neues Schulungs-und Behandlungsprogramm für Menschen mit einem Typ-2-Diabetes (MmT2DM) und einer nicht-intensivierten Insulintherapie (BOT, SIT oder CT). Die Effektivität des neuen Schulungsprogramms auf die glykämische Kontrolle wurde in einer multizentrischen, randomisierten, kontrollierten Studie mit einem 6-Monats-follow-up überprüft. Die Kontrollgruppe (KG) wurde mit dem Behandlungs- und Schulungsprogramm für Typ-2-Diabetiker, die Normalinsulin (und Verzögerungsinsulin) spritzen, geschult.

Methodik: Beide Schulungsprogramme umfassen 6 Unterrichtseinheiten. Zur Baseline und zum 6-Monats-follow-up wurden der HbA1c (Zentrallabor) und psychosoziale Outcomes (Diabetes-Distress, Empowerment, Therapiezufriedenheit, Diabeteswissen, Hypoglykämieinzidenz und Hypoglykämiewahrnehmung) erhoben.

Ergebnisse: Es nahmen 182 MmT2DM aus 13 diabetologischen Schwerpunktpraxen teil (MEDIAS2 BOT+SIT+CT vs. KG: Alter 63,0 ± 8,4 vs. 63,2 ± 7,6 Jahre, Diabetesdauer 11,5 ± 5,7 vs. 11,4 ± 7,0 Jahre, Dauer der Insulinbehandlung 3,6 ± 4,0 vs. 3,6 ± 4,5 Jahre, HbA1c 8,0 ± 1,3 vs. 7,9 ± 1,2\% Hypoglykämiewahrnehmungsscore 2,0 ± 1,0 vs. 2,1 ± 0,9). Beide Interventionsgruppen unterscheiden sich zur Baseline nicht signifikant voneinander. In MEDIAS2 BOT+SIT+CT wurde der HbA1c im Vergleich zur KG (-0,7 ± 0,1 vs. -0 – 3 ± 0,1 Prozentpunkte) signifikant reduziert (p = 0,02 adjustiert für Studienzentren). Die Hypoglykämiewahrnehmung verschlechterte sich nicht (1,9 ± 0,1 vs. 2,1 p = 0,276). Psychologische Outcomes verbesserten sich in beiden Gruppen jeweils signifikant.

Diskussion: Das Erlernen zentraler Fertigkeiten zur Durchführung einer Insulintherapie mithilfe des MEDIAS2 BOT+SIT+CT Programmes führte zu einer signifikanten Verbesserung der glykämischen Kontrolle im Vergleich zur Kontrollgruppe, ohne dass es zu einer Zunahme des Hypoglykämierisikos kam. Ausschlaggebend hierfür könnten die im MEDIAS2 BOT+SIT+CT vermittelten Fertigkeiten zur Selbsttitration der fixen Insulindosen gewesen sein. Damit hat sich MEDIAS2 BOT+SIT+CT als effektive Schulungs- und Behandlungsmaßnahme erwiesen.}
}

@inproceedings{schipfer2017_42232,
  title = {Evaluation des Fragebogens zur Erfassung der Zufriedenheit des Glukosemonitorings bei Typ-1-Diabetes (T1-GMSS)},
  author = {Schipfer, M and Ehrmann, Dominic and Haak, Thomas and Hermanns, Norbert and Kulzer, Bernhard and Bergis-Jurgan, Nikola},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0036-1580840},
  urn = {urn:nbn:de:bvb:473-opus4-496909},
  url = {https://fis.uni-bamberg.de/handle/uniba/42232},
  language = {deu},
  abstract = {Fragestellung: Der Fragebogen zur Zufriedenheit des Glukosemonitorings bei Typ-1-Diabetes (T1-GMSS) erfasst die Zufriedenheit mit der Glukosekontrolle bei Menschen mit Typ-1-Diabetes. Eine psychometrische Validierung des T1-GMSS an einer deutschen Stichprobe liegt bisher noch nicht vor. Ziel dieser Studie war die psychometrische Validierung der deutschsprachigen Fassung des T1-GMSS.

Methodik: Der T1-GMSS besteht aus den vier Subskalen „Flexibilität“, „emotionale Hindernisse“, „verhaltensbezogene Hindernisse“ und „Vertrauen in die Genauigkeit“. Zusätzlich zum T1-GMSS wurden die Problem Areas in Diabetes Scale (PAID) zur Erfassung der Diabetesbelastungen, sowie demographische (Alter, Geschlecht, BMI) und medizinische Variablen (HbA1c, Diabetesdauer, Blutzuckermessungen/Tag) beantwortet.

Ergebnisse: Es beteiligten sich 172 Menschen mit Typ-1-Diabetes (65\% weiblich; Alter 32 ± 12 Jahre; BMI 25 ± 5 kg/m2; Diabetesdauer 18 (± 14) Jahre; HbA1c 7,4\%± 1,3\%; 17,5\% Hypoglykämie-Wahrnehmungsstörung). Der T1-GMSS zeigt eine gute Reliabilität für die Subskalen „Flexibilität“ (Cronbachs α= 0,830), „emotionale Hindernisse“ (Cronbachs α= 0,759), „verhaltensbezogene Hindernisse“ (Cronbachs α= 0,659) und „Vertrauen in die Genauigkeit“ (Cronbachs α= 0,794). Die Subskalen „emotionale Hindernisse“ (r = 0,593, p < 0,001) und „verhaltensbezogene Hindernisse“ (r = 0,395, p < 0,001) gingen mit einer erhöhten, die Subskalen „Flexibilität“ (r =-0,523, p < 0,001) und „Vertrauen in die Genauigkeit“(r =-0,313, p < 0,001) mit einer reduzierten diabetesbezogenen Belastung einher. Die „Flexibilität“ gegenüber dem verwendeten Glukosemesssystem war assoziiert mit häufigeren Blutzuckerselbstkontrollen (r = 0,244, p < 0,001) und einem niedrigeren HbA1c (r =-0,220, p < 0,05).

Schlussfolgerungen: Die Validierungsstudie an einer deutschen Stichprobe zeigt eine gute psychometrische Qualität der deutschen Fassung des T1-GMSS.}
}

@inproceedings{reimer2017_42226,
  title = {Hohe Diabetesbelastung bei Menschen mit Typ-1-Diabetes vor allem in den ersten Jahren nach Manifestation},
  author = {Reimer, Andre and Schmitt, Andreas and Ehrmann, Dominic and Hermanns, Norbert and Kulzer, Bernhard and Haak, Thomas},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0036-1580837},
  urn = {urn:nbn:de:bvb:473-opus4-496881},
  url = {https://fis.uni-bamberg.de/handle/uniba/42226},
  language = {deu},
  abstract = {Fragestellung: Die Diagnose eines Typ-1-Diabetes stellt Betroffene vor das Erfordernis umfassender Verhaltensanpassungen zur erfolgreichen Umsetzung ihres Diabetes-Selbstmanagements und geht häufig mit emotionalen Belastungen einher. Obwohl anzunehmen ist, dass die emotionale Bewältigung des Diabetes mit zunehmender Dauer des Diabetes besser gelingt, sind bisherige Untersuchungen zum Zusammenhang von Diabetesdauer und diabetesbezogener emotionaler Belastung bei Typ-1-Diabetes uneindeutig.

Methodik: 1381 Menschen mit Typ-1-Diabetes (Alter 41 ± 13 Jahre, 53\% weiblich, Diabetesdauer 18 ± 12 Jahre, HbA1c 8,5 ± 1,8\%) wurden im Rahmen eines klinikinternen Screenings auf affektive Symptome befragt. Die Diabetesbelastung wurde mit der Problem Areas In Diabetes (PAID) Skala erfasst, depressive Stimmung mit der Allgemeinen Depressionsskala (ADS). Die Assoziation zwischen Diabetesdauer und Diabetesbelastung, adjustiert für Alter, Geschlecht und weitere relevante Kovariaten, wurde mittels multipler Regression untersucht.

Ergebnisse: Das multiple Regressionsmodell zeigte eine signifikant negative Assoziation von Diabetesdauer und -belastung (ß=-0,11; p < 0,001) unter Kontrolle klinisch bedeutsamer Variablen wie des HbA1c-Wertes (ß= 0,06; p < 0,01), depressiver Symptome (ß= 0,65; p < 0,001), Folgeerkrankungen (ß=-0,01; p > 0,05) sowie Insulinpumpentherapie (ß= 0,02; p > 0,05).

Personen mit einer Diabetesdauer bis einschließlich drei Jahre wiesen neben einer höheren Diabetesbelastung (34,1 vs. 29,6; p < 0,01) auch einen höheren HbA1c-Wert (8,9\% vs. 8,4\%, p < 0,01) und stärker ausgeprägte Depressionssymptome auf (17,7 vs. 15,9; p = 0,076).

Schlussfolgerungen: Die Ergebnisse deuten auf eine erhöhte Diabetesbelastung bei Menschen mit Typ-1-Diabetes insbesondere in den ersten Jahren nach der Manifestation hin. Dementsprechend kann besonders bei Menschen mit kurzer Diabetesdauer eine intensivere medizinische und psychosoziale Betreuung sinnvoll sein.}
}

@inproceedings{ehrmann2017_42221,
  title = {Bolus calculation is more important for achieving good glycemic control than carbohydrate estimation},
  author = {Ehrmann, Dominic and Hermanns, Norbert and Reimer, André and Weißmann, Jörg and Haak, Thomas and Kulzer, Bernhard},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-opus4-496811},
  url = {https://fis.uni-bamberg.de/handle/uniba/42221},
  language = {eng},
  abstract = {Intensive insulin therapy requires patients to estimate their carbohydrates and calculate their insulin boluses. Thus, Bolus calculation and carbohydrate estimation are two basic and essential skills that are considered relevant for achieving good glycemic control. However, data is missing as to how the performance in these two skills affects glycemic control. A linear regression analysis was performed with glycemic control as dependent variable. Independent variables of interest were the bolus calculation and carbohydrate estimation skills. We assessed the two skills through the recently evaluated SMART-tool that consists of 10 items for Bolus calculation and 12 items for carbohydrate estimation. Furthermore, demographic (age, gender, years of education) and medical (diabetes type, diabetes duration, body-mass-index, late complications, frequency of SMBG, CSII therapy) variables were controlled for. An additional logistic regression analysis was performed with HbA1c < 7.5\% as categorical dependent variable. 311 patients with type 1 or type 2 diabetes treated with an intensive insulin therapy (MDI, CSII) were analyzed. In the linear regression analysis, better Bolus calculation was associated with better glycemic control (beta= -0.22, p<.001) while carbohydrate estimation was not significant (beta=-0.1, p=.088). In the logistic regression analysis, the chance to achieve optimal glycemic control (HbA1c < 7.5\%) was significantly increased by 17\% (odds ratio=1.17, p=.011) with every correct answer in the Bolus calculation scale. Again, carbohydrate estimation was not significant (OR=0.98, p=.79).
The results demonstrated the importance of good Bolus calculation skills within intensive insulin therapy. Thus, Bolus calculation skills should be regularly assessed in clinical practice. Consequently, patients with deficits in Bolus calculation should receive immediate training or support e.g. via Bolus calculators.}
}

@inproceedings{kulzer2017_42223,
  title = {Comparison of the effects of diabetes education for patients with MDI vs. CSII therapy},
  author = {Kulzer, Bernhard and Ehrmann, Dominic and Bergis-Jurgan, Nikola and Haak, Thomas and Hermanns, Norbert},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-opus4-496847},
  url = {https://fis.uni-bamberg.de/handle/uniba/42223},
  language = {eng},
  abstract = {Structured diabetes education for patients with type 1 diabetes is a cornerstone of the therapy. However, it is unclear whether patients with MDI and CSII equally benefit from diabetes education. In a prospective analysis, we investigated the differential effects of diabetes education on patients with MDI and CSII therapy. A total of 409 patients with type 1 diabetes that participated in a diabetes education course were analyzed. The education course consisted of 12 lessons and was conducted as a group program for 3-8 patients. 19\% of the patients were treated with an insulin pump. Prior to the education course and six months after the end of the education course, HbA1c was measured and patients completed questionnaires assessing diabetes distress and hypoglycemia unawareness. At baseline, patients with CSII therapy did not differ from MDI patients with regard to age (43.8 ± 14.0 vs. 44.1 ± 13.6 years, p=.86), gender (47\% vs. 42\% female, p=.42), glycemic control (8.1 ± 1.3 vs. 8.1 ±1.1 \%, p=.81), hypoglycemia unawareness (1.6 ± 1.5 vs. 1.7 ±1.8, p=.93), and diabetes distress (1.1 ±0.9 vs. 1.1 ± 10.7, p=.93). CSII patients had a significantly longer diabetes duration than MDI patients (22.0 ±10.8 vs. 11.0 ±12.3 years, p<.01). After 6 months, HbA1c reduction was significantly lower in CSII patients than in MDI patients (-0.0 ±0.7 vs. -0.4 ±1.1\%, p=.01). Improvements in hypoglycemia unawareness (0.5 ± 11.4 vs. 0.4 ±1.4, p=.32) and diabetes distress (-0.3 ±0.6 vs.-0.2 ±0.6, p=.13) were comparable. At baseline, glycemic control of CSII patients was not better than that of MDI patients despite the fact that CSII therapy is the best available therapy option for patients with type 1 diabetes. Furthermore, CSII patients did benefit less from diabetes education than MDI patients. Specific interventions are needed to address the special needs of patients performing a CSII therapy. In a group setting, it can be questioned whether CSII and MDI patients should be mixed.}
}

@inproceedings{ehrmann2017_42204,
  title = {Zusammenhang von Depression auf die glykämische Kontrolle in Abhängigkeit des Schweregrades der depressiven Symptomatik},
  author = {Ehrmann, Dominic and Schmitt, Andreas and Reimer, Andre and Haak, Thomas and Kulzer, Bernhard and Hermanns, Norbert},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0036-1580838},
  urn = {urn:nbn:de:bvb:473-opus4-496890},
  url = {https://fis.uni-bamberg.de/handle/uniba/42204},
  language = {deu},
  abstract = {Fragestellung: Studien hinsichtlich des Zusammenhangs von Depressionen und glykämischer Kontrolle sind uneinheitlich. Zudem konnte gezeigt werden, dass die depressive Symptomatik in Subtypen (somatisch vs. affektiv) unterschieden werden kann und diese Subtypen unterschiedliche Korrelationen mit dem HbA1c zeigen. Diese Analyse untersucht den Zusammenhang zwischen depressiven Subtypen und HbA1c in Abhängigkeit der Ausprägung der depressiven Symptomatik.

Methode: 1035 Menschen mit Typ-1- und Typ-2-Diabetes bearbeiteten die Allgemeine Depressionsskala (ADS), welche die Berechnung eines somatischen und affektiven Scores erlaubt. Eine Depression wurde mittels klinischem Interview bei 49 Patienten diagnostiziert (Gruppe 1). Patienten ohne diagnostizierte Depression wurden anhand des ADS Cut-Offs von 16 in Gruppen mit bzw. ohne erhöhte depressive Symptomatik unterteilt (Gruppe 2 = 351 bzw. Gruppe 3 = 635). Für diese drei Gruppen wurden lineare Regressionen mit HbA1c als abhängiger Variable gerechnet. Somatischer und affektiver Score waren die unabhängigen Variablen, kontrolliert für Alter, Geschlecht, BMI, Bildungsjahre, Diabetes-Typ, Diabetesdauer, SMBG/Tag und Folgeerkrankungen.

Ergebnisse: Bei Patienten ohne erhöhte depressive Symptomatik zeigte sich ein positiver Zusammenhang des somatischen Scores mit dem HbA1c (beta = 0,10, p < 0,05). Bei Patienten mit erhöhter depressiver Symptomatik (ohne Diagnose) zeigte sich ein positiver Zusammenhang des somatischen Scores (beta = 0,19, p < 0,05) und ein negativer Zusammenhang des affektiven Scores (beta =-0,17, p < 0,05). Patienten mit diagnostizierter Depression zeigten einen negativen Zusammenhang des somatischen Scores mit HbA1c (beta =-0,37, p < 0,05).

Schlussfolgerungen: Der positive Zusammenhang des somatischen Scores bei Patienten ohne diagnostizierter Depression dreht sich ins negative sobald die Depression diagnostiziert wurde. Diese komplexe Interaktion zeigt deutlich, dass sich Patienten mit Depressionsdiagnose von Patienten mit lediglich erhöhter depressiver Symptomatik unterscheiden.}
}

@inproceedings{hermanns2017_42200,
  title = {Efficacy of an education and treatment programme for people with type 2 diabetes on a non-intensive insulin regimen (MEDIAS2 BOT+SIT+CT): results of a RCT},
  author = {Hermanns, Norbert and Maier, Berthold and Schall, Sabine and Haak, Thomas and Kulzer, Bernd},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-opus4-496851},
  url = {https://fis.uni-bamberg.de/handle/uniba/42200},
  language = {eng},
  abstract = {Background and aims: MEDIAS2 BOT+SIT+CT (More Diabetes Selfmanagement for People with type 2 diabetes on a Basal insulin supported Oral Therapy or on Supplementary Insulin Treatment with prandial insulin or Conventional Insulin Treatment with biphasic insulin) is a newly developed diabetes education and treatment programme for people with type 2 diabetes(PWD-T2) on a non-intensive insulin treatment regimen. The development of MEDIAS2 BOT+SIT+CT was based on self-management and empowerment theory. The efficacy of the newly developed intervention MEDIAS 2 BOT+SIT+CT (IG) was evaluated in a randomized trial with a six month follow-up period. The control group (CG) participated in an established education programme (Treatment- and education programme for type 2 diabetic patients with injection of prandial and/or basal insulin). The primary outcome of this study was the reduction of HbA1c. Materials and methods: Both interventions in IG and CG consisted of 6 lessons. At baseline and follow-up the HbA1c was measured in a central laboratory. Participants also completed questionnaires to measure diabetes distress, empowerment, diabetes knowledge and hypoglycaemia awareness. Results: 186 PWD-T2 participated in the study (IG vs. CG: age 63.0 ±8.4 vs. 63.2 ±7.6 yrs.; diabetes duration 11.5 ±5.7 vs. 11.4 ±7.0 yrs.; duration of insulin treatment 3.6 ±4.0 vs. 3.6 ±4.5 yrs.; HbA1c 8.0 ±1.3 vs. 7.9 ±1.2 \%; respectively 63.9 ± 14.2 mmol/mol vs. 62.8 ± 13.1 mmol/mol; hypoglycaemia-unawareness score 2.0 ±1.0 vs. 2.1 ±0.9). There were no significant differences at baseline between IG and CG. HbA1c was significantly more reduced in IG compared to CG (-0.7 ±0.1 vs. -0.3 ±0.1 percentage Points, respectively -7.7 ±1.1 mmol/mol vs. 4.4 ±1.1 mmol/mol; p=.02). Hypoglycaemia awareness did not deteriorate in both groups (1.9 ±0.1 vs. 2.1 ±0.1 p=.276). Diabetes distress and empowerment improved in both groups, but there were no significant between group differences. Conclusion: Participation in the newly developed MEDIAS2 BOT+SIT+CT treatment and education programme led to a significant improvement of glycaemic control without a measurable increase in risk for hypoglycaemia. An important component of the newly developed MEDIAS2 BOT+SIT+CT was self-titration of insulin doses; this might have contributed to the positive impact of this programme on glycaemic control. In summary, MEDIAS2 BOT+SIT+CT has been proven as an effective treatment and education tool.},
  keywords = {type 2 diabetes}
}

@article{ehrmann2017_41760,
  title = {Comparison of the efficacy of a diabetes education programme for type 1 diabetes (PRIMAS) in a randomised controlled trial setting and the effectiveness in a routine care setting : Results of a comparative effectiveness study},
  author = {Ehrmann, Dominic and Bergis-Jurgan, Nikola and Haak, Thomas and Kulzer, Bernhard and Hermanns, Norbert},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-opus4-489058},
  url = {https://fis.uni-bamberg.de/handle/uniba/41760},
  language = {eng},
  abstract = {Background: The effectiveness of an intervention in clinical practice is often reduced compared to the efficacy demonstrated in a randomised controlled trial (RCT). In this comparative effectiveness study, the RCT-proven efficacy of a diabetes education programme for type 1 diabetic patients (PRIMAS) was compared to the effectiveness observed in an implementation trial (IT) under routine care conditions.

Methods: 75 patients with type 1 diabetes received PRIMAS through an RCT, whereas 179 patients were observed in an implementation trial. Baseline characteristics and treatment outcomes at the 6-month follow-up (improvement of HbA1c, hypoglycaemia problems, and diabetes-related distress) were compared.

Results: At baseline, the type 1 diabetic patients in the RCT had a significant longer diabetes duration (18.7±12.3 vs. 13.8±12.7 yrs., p = .005), lower self-efficacy scores (21.9±4.7 vs. 23.7±6.1, p = .02) and a greater number of diabetes complications (0.8±1.3 vs. 0.4±0.9, p = .02). After 6 months, PRIMAS achieved comparable effects under RCT and implementation trial conditions, as demonstrated by improvement in HbA1c (-0.36\%±1.1 vs. -0.37±1.2; Δ -0.01, 95\% CI -0.33 to 0.31) and hypoglycaemia unawareness (-0.5±1.4 vs. -0.3±1.4; Δ 0.18, 95\% CI -0.21 to 0.57). The likelihood of clinical improvement did not depend on the trial setting (RCT vs. IT: OR 1.18, 95\% CI 0.60 to 2.33). The participants with worse glycaemic control (OR 1.40, 95\% CI 1.02 to 1.92), hypoglycaemia problems (OR 2.13, 95\% CI 1.53 to 2.97) or elevated diabetes distress (OR 1.40, 95\% CI 1.03 to 1.89) had a better chance of clinical improvement.

Conclusions: The effectiveness of PRIMAS under routine care conditions was comparable to the efficacy demonstrated in the RCT. Clinical improvement was independent of the setting in which PRIMAS was evaluated. The PRIMAS education programme for type 1 diabetes can be delivered under conditions of routine care without a loss of effectiveness, compared to its original evaluation in an RCT.},
  keywords = {PRIMAS, Insulin therapy}
}

@inproceedings{hermanns2017_41648,
  title = {Local heating at the insulin injection site by the use of the InsuPad is able to reduce post-prandial glucose excursion in daily life},
  author = {Hermanns, Norbert and Kulzer, Bernhard and Haak, Thomas},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1007/s00125-012-2688-9},
  urn = {urn:nbn:de:bvb:473-opus4-486930},
  url = {https://fis.uni-bamberg.de/handle/uniba/41648},
  language = {deu},
  abstract = {Background and aims: The insulin action profiles of subcutaneously injected short acting insulin analogues are still slow compared to physiologically released human insulin. Thus, postprandial glucose excursions cannot be avoided. InsuPad is a medical device designed to accelerate insulin delivery crate by applying local heat at the insulin injection site. Whenever an insulin injection is given, the skin surface temperature is heated up locally to 38.5 C° for 30 minutes. This pilot-study examines the impact of the InsuPad use on postprandial glucose excursions after breakfast and dinner in daily life conditions.
Materials and methods: Insulin resistant diabetic patients were instructed to use the InsuPad when injecting bolus insulin prior to breakfast and dinner for one month and to measure their blood glucose at least five times per day (pre- and post-breakfast, pre-lunch and pre- and post-dinner). In the other study phase patients were instructed to maintain the same blood glucose measurement schedule for one month, without using the InsuPad. The order of the study phases was randomized. All blood glucose data were transmitted to a central computer using the DIASEND System. A valid pre-post-prandial measurement time difference was 75 - 135 minutes. An ANOVA, controlling for order of study phase, patient and meal (breakfast vs. dinner) was used to analyze the effect of the InsuPad on postprandial glucose excursions. In this study 10 diabetic patients took part (30\% type 1 diabetes, age: 51.5 ±7.7 yrs., diabetes duration: 15.7 ± 7.7 yrs.; HbA1c: 8.2 ± 0.9\%; bolus insulin dose: 51.7 ± 22.2 insulin units per day; total insulin dose 0.92 insulin units per kg).
Results: Preprandial blood glucose levels were similar in the phase with (151.7 ±46.8 mg/dl) and without the InsuPad (148.5 ±38.6 mg/dl, p=.385). Postprandial glucose decreased by 0.05 ± 59.1 mg/dl, if InsuPad was used, whereas the postprandial glucose levels increased by 11.3 ± 56.3 mg/dl if the InsuPad was not used (p=.011). The number (283 vs. 257) and proportion of valid measurements (65.5\% vs. 64.4\%, p=.740) in the phase with and without InsuPad were highly comparable. The time differences between pre- and post-prandial glucose measurements were very similar in both study phases (102.7 ± 19.0 vs. 102.3 ± 15.6 minutes with and without InsuPad, p=.777). The overall glycaemic control (mean total blood glucose values) was significantly lower when using the InsuPad compared to the no-use-phase (149.7 ± 54.5 mg/dl vs. 158.7 ±57.7 mg/dl; p=.016). The percentage of hypoglycaemic (< 60 mg/dl) or hyperglycaemic values (> 300 mg/dl) was slightly decreased when using the InsuPad, but the difference was not statistically significant (\% hypoglycaemic values 1.5\% vs. 1.8\%, p=.496; \% hyperglycaemic values 1.6\% vs. 2.1\%, p=.250).
Conclusion: This pilot-study indicates that local heating of the insulin injection site in insulin resistant diabetic patients by using the InsuPad is able to reduce post-prandial blood glucose excursions as well as mean daily glucose values significantly in daily life conditions. Safety parameters like the prevalence of hypoglycaemic and hyperglycaemic glucose measurements were not affected by the use of InsuPad.}
}

@inproceedings{schmitt2017_41631,
  title = {Einfluss von Depressivität und diabetesbezogener emotionaler Belastung auf die gesundheitsbezogene Lebensqualität},
  author = {Schmitt, Andreas and Gahr, Annika and Hermanns, Norbert and Kulzer, Bernhard and Haak, Thomas},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0032-1314632},
  urn = {urn:nbn:de:bvb:473-opus4-486850},
  url = {https://fis.uni-bamberg.de/handle/uniba/41631},
  language = {deu},
  abstract = {Hintergrund: Viele Studien weisen darauf hin, dass Depression bei Diabetespatienten mit einer eingeschränkten Lebensqualität (LQ) assoziiert ist. In dieser Studie wurde untersucht, welchen zusätzlichen Einfluss die diabetesbezogene emotionale Belastung auf die körperliche und psychische gesundheitsbezogene LQ hat.

Methodik: 309 Diabetespatienten (Alter=44±14J; 53\% weiblich; BMI=29±7kg/m2; 66\% Typ 1 Diabetes; Diabetesdauer=14±10J; 95\% mit Insulintherapie; HbA1c=8,7±1,7\%) wurden mit einem Depressionsfragebogen (Allgemeine Depressionsskala (CES-D)), einem Fragebogen zur diabetesbezogenen Belastung (Problem areas in diabetes scale (PAID)) sowie einem Fragebogen zur psychischen (PSK) und körperlichen (KSK) gesundheitsbezogenen LQ (SF-36) untersucht. Die Faktoren 'Depressivität' und 'diabetesbezogene Belastung' wurden mittels Mediansplit dichotomisiert und ihre Haupt- und Interaktionseffekte auf die LQ in einer zweifaktoriellen ANOVA analysiert.

Ergebnisse: Patienten mit höheren Depressionswerten zeigten eine signifikant geringere psychische LQ (M=31 vs. M=48, p<0,01), allerdings zeigte die Depressivität keinen signifikanten Effekt auf die körperliche LQ (M=45 vs. M=48, p=0,16). Patienten mit diabetesspezifischer Belastung wiesen eine geringere psychische (M=32 vs. M=47, p<0,01) und eine geringere körperliche LQ (M=45 vs. M=49, p<0,05) auf. Es zeigten sich signifikante Interaktionseffekte von Depressivität und diabetesbezogener Belastung sowohl auf die psychische (geringe Depressivität und geringe Belastung: M=51; geringe Depressivität und hohe Belastung: M=39; hohe Depressivität und geringe Belastung: M=34; hohe Depressivität und hohe Belastung: M=30; p<0,01) als auch auf die körperliche LQ (geringe Depressivität und geringe Belastung: M=48; geringe Depressivität und hohe Belastung: M=48; hohe Depressivität und geringe Belastung: M=49; hohe Depressivität und hohe Belastung: M=43; p<0,05), wobei jeweils das Zusammenspiel hoher Depressivität und hoher Diabetesbelastung mit den niedrigsten Lebensqualitätswerten einherging.

Schlussfolgerung: Sowohl die Depressivität als auch die diabetesbezogene Belastung wirken sich unabhängig voneinander beeinträchtigend auf die psychische LQ aus. Zusätzlich wirkt sich die diabetesbezogene Belastung negativ auf die körperliche LQ aus, während die Depressivität hier keinen signifikanten Einfluss hat. Die Interaktionseffekte zeigen, dass insbesondere ein Zusammenwirken hoher Depressivität und hoher diabetesbezogener Belastung starke negative Effekte auf beide Bereiche der LQ hat. Da sowohl Depressivität als auch diabetesbezogene emotionale Belastung negative Auswirkungen haben, kann für die klinische Praxis die Erfassung beider Belastungsfaktoren empfohlen werden.}
}

@inproceedings{gahr2017_41637,
  title = {Erhöhte Thrombozytenkonzentration bei Diabetespatienten mit depressiver Stimmung},
  author = {Gahr, Annika and Schmitt, Andreas and Kulzer, Bernhard and Hermanns, Norbert and Haak, Thomas},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0032-1314631},
  urn = {urn:nbn:de:bvb:473-opus4-486890},
  url = {https://fis.uni-bamberg.de/handle/uniba/41637},
  language = {deu},
  abstract = {Hintergrund: Diabetespatienten mit depressiver Symptomatik weisen ein signifikant höheres Risiko für diabetesbedingte Folgekomplikationen und eine höhere Mortalität auf. Bisher ist jedoch wenig über die vermittelnden Mechanismen zwischen Depressivität und dem ungünstigen Krankheitsverlauf bekannt. In der vorliegenden Studie wurden Zusammenhänge zwischen Depressivität und Parametern des kleinen Blutbildes (Anzahl der Thrombozyten, Erythrozyten, Leukozyten und Hämoglobinwert) untersucht.

Methodik: Mithilfe eines Depressionsfragebogens (dt. Version der Center of Epidemiologic Studies Depression Scale (CES-D)) wurde das Ausmaß der Depressivität erfasst. Die Erythrozyten-, Leukozyten- und Thrombozytenkonzentrationen sowie der Hämoglobinwert wurden bestimmt. Zusätzlich wurden medizinische Variablen (Alter, BMI, Diabetesdauer und Anzahl von Folgekrankheiten) sowie psychosoziale Variablen (diabetesbezogene Belastung, Diabetesakzeptanz und Selbstbehandlungverhalten) als Kontrollfaktoren erhoben.

Ergebnisse: 273 Diabetespatienten (Alter=43±14J; 54\% weiblich; BMI=29±7kg/m2; 66\% Typ-1-Diabetes; Diabetesdauer=14±10J; 96\% mit Insulintherapie; HbA1c=8,8±1,8\%) nahmen an der Untersuchung teil. Der mittlere Depressionswert lag bei 20,4±10,5, dies zeigt eine moderat erhöhte Depressivität an. Die mittlere Thrombozytenkonzentration lag mit 250000±62000 St./µl im Normbereich. Die bivariate Regression zeigte einen signifikanten Zusammenhang zwischen dem Depressionswert und der Thrombozytenzahl (β=0,18, p<0,01). Die Zusammenhänge zwischen Depressionswert und Erythrozytenzahl (β=-0,08, p=0,21), Leukozytenzahl (β=0,11, p=0,06) und Hämoglobinwert (β=-0,11, p=0,07) waren nicht signifikant. In der multivariaten Analyse mit der Thrombozytenzahl als abhängiger Variablen erwiesen sich der Depressivitätswert (β=0,14, p=0,03), der Hämoglobinwert (β=-0,41, p<0,01), die Leukozytenzahl (β=0,20, p<0,01), das Alter (β=-0,26, p<0,01) sowie die Diabetesdauer (β=0,16, p<0,01) als signifikante Prädiktoren. Die übrigen Variablen zeigten keine signifikanten Zusammenhänge mit der Thrombozytenzahl.

Diskussion: In der vorliegenden Untersuchung war eine erhöhte Depressivität mit einer höheren Thrombozytenkonzentration als einzigem der untersuchten Laborparameter signifikant assoziiert. Aufgrund des Querschnittscharakters der Untersuchung kann die beobachtete Assoziation allerdings nicht kausal interpretiert werden. Der auch in der multivariaten Analyse bestätigte Zusammenhang zwischen erhöhter Depressivität und der Thrombozytenkonzentration könnte ein erster Hinweis darauf sein, dass nicht nur bei dem Vorliegen einer klinischen Depression, sondern bereits bei einer leicht bis moderat erhöhten Depressivität ein Einfluss auf die Blutgerinnung bestehen kann.}
}

@inproceedings{schmitt2017_41635,
  title = {Problematisches Bewältigungsverhalten bei Patienten mit hoher emotionaler Diabetesbelastung},
  author = {Schmitt, Andreas and Gahr, Annika and Hermanns, Norbert and Kulzer, Bernhard and Haak, Thomas},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0032-1314630},
  urn = {urn:nbn:de:bvb:473-opus4-486841},
  url = {https://fis.uni-bamberg.de/handle/uniba/41635},
  language = {deu},
  abstract = {Hintergrund: Rund 20\% aller Diabetespatienten erleben eine erhöhte diabetesbezogene emotionale Belastung. Einige Studien weisen darauf hin, dass Patienten mit hoher diabetesbezogener Belastung durchschnittlich schlechtere Therapieergebnisse aufweisen. Die Ursachen dieser Zusammenhänge konnten jedoch bislang nur wenig geklärt werden. In dieser Studie wurde untersucht, inwieweit sich Patienten mit unterschiedlich starker Diabetesbelastung hinsichtlich spezifischer Verhaltensweisen im Rahmen der Krankheitsbewältigung unterscheiden.

Methodik: 305 Diabetespatienten (Alter=44±14J; 52\% weiblich; BMI=29±7kg/m2; 66\% Typ 1; Diabetesdauer=14±10J; 95\% mit Insulin; HbA1c=8,7±1,7\%) wurden mit Fragebögen zur diabetesbezogenen Belastung (Diabetes Distress Scale (DDS)) sowie zur Krankheitsverarbeitung (Freiburger Fragebogen zur Krankheitsverarbeitung (FKV-15)) untersucht. Der FKV-15 misst auf einer Skala von 1 („gar nicht“) bis 5 („sehr stark“) die Tendenz, die eigene Krankheit aktiv und zielorientiert anzugehen (Subskala „Aktives Coping“), mit dem Arzt zusammen zu arbeiten (Subskala „Compliance“), sich von der Krankheit abzulenken (Subskala „Ablenkung“), Krankheitsprobleme zu leugnen (Subskala „Bagatellisierung“) und/oder mit Depression und Rückzug zu reagieren (Subskala „Depressive Verarbeitung“). Mittels Mediansplit wurden die Patientengruppen mit niedriger (n=155) vs. hoher (n=150) Diabetesbelastung unterschieden. Die Gruppenunterschiede bzgl. der Merkmale der Krankheitsverarbeitung wurden mittels t-Test für unabhängige Stichproben überprüft.

Ergebnisse: Der mittlere Belastungswert lag in der Patientengruppe mit niedriger Diabetesbelastung bei 1,8±0,4, was dem Normalbereich entspricht. In der Gruppe mit hoher Diabetesbelastung lag er mit 3,2±0,6 über dem Cut-Off-Wert (≥3) für eine klinisch bedeutsame Diabetesbelastung. Patienten mit hoher Diabetesbelastung zeigten im Vergleich zu Patienten mit niedriger Belastung signifikant weniger aktives Coping (M=3,3 vs. M=3,7, p<0,01), weniger Compliance (M=3,7 vs. M=4,0, p<0,001), mehr Ablenkung (M=2,9 vs. M=2,4, p<0,001), mehr Bagatellisierung (M=2,5 vs. M=1,7, p<0,001) und mehr depressive Verarbeitung (M=2,7 vs. M=1,9, p<0,001).

Diskussion: In der vorliegenden Untersuchung konnten hohe Ausprägungen diabetesbezogener Belastung mit einem reduzierten aktiven Bewältigungsverhalten und einer geringeren Compliance in Verbindung gebracht werden. Außerdem zeigte sich bei Patienten mit hoher Diabetesbelastung eine Reihe von problematischen Verhaltensweisen (Ablenkung von der Krankheit, Bagatellisierung und depressive Reaktion), die vermutlich einer erfolgreichen Krankheitsbewältigung im Wege stehen und möglicherweise die negativen Effekte einer hohen Diabetesbelastung auf den Therapieerfolg erklären können. Die Befunde legen nahe, dass sich emotionale Probleme mit dem Diabetes negativ auf die erfolgreiche Bewältigung der Krankheit auswirken können.}
}

@inproceedings{hermanns2017_41642,
  title = {Welche Inhalte sind für die Schulung von Menschen mit Typ 1 Diabetes relevant?},
  author = {Hermanns, Norbert and Kulzer, Bernhard and Hasche, Sven and Silbermann, Stephan and Thoma, S and Haak, Thomas},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0032-1314618},
  urn = {urn:nbn:de:bvb:473-opus4-486880},
  url = {https://fis.uni-bamberg.de/handle/uniba/41642},
  language = {deu},
  abstract = {Einleitung: Bisher gibt es keine Daten, welche Schulungsinhalte von Ärzten bei Patienten mit Typ 1 Diabetes als wichtig angesehen werden. Im Rahmen der Versorgungsstudie „Primascope“ wurde dieser Frage nachgegangen und Ärzte von diabetologischen Schwerpunktpraxen (DSP) mittels Fragebogen nach Zielen der Schulung, deren Inhalten und Relevanz befragt.

Methodik: Der Fragebogen wurde an insgesamt 1192 DSP in Deutschland ausgeteilt, auswertbar waren die Antworten von 818 Praxen. Die Befragten beurteilten auf einer zehnstufigen Ratingskala (1=gar nicht wichtig; 10=sehr wichtig) die Bedeutung unterschiedlicher Schulungsziele und -inhalte.

Ergebnisse: Als wichtigste Ziele der Typ 1 Diabetesschulung wurde die „Vermittlung von Fertigkeiten zur eigenständigen Therapieanpassung“(9,6), die „Vermittlung von Selbstmanagementfertigkeiten“ (9,4), die „Optimierung der Lebensqualität“ (9,3) und die „Erhöhung der Motivation zur eigenständigen Umsetzung der Diabetestherapie“ (9,3) genannt. Eher medizinische Ziele wie die „Reduktion des HbA1c“ (8,3), eine „Gewichtsreduktion bzw. -stabilisierung“ (7,3), das „Erreichen guter Lipid-„ (7,3) oder „Blutdruckwerte“ (7,9) wurden zwar als auch wichtig, insgesamt jedoch nicht so hoch eingestuft, wie die psychosozialen Ziele (Mittel: psychosoziale Ziele 9,1– medizinische Ziele 8,0). Die zur Beurteilung vorgegebenen 18 Schulungsinhalte wurden insgesamt alle als bedeutsam eingeschätzt (Minimum 6,4). Am wichtigsten wurden der „Umgang mit Hypoglykämien“ (9,6), „Insulinanpassung bei Sport“ (9,4), „Hilfestellungen zur Insulindosisanpassung“ (9,2), „Umgang mit besonderen Ernährungssituationen“ (9,2), „Unterstützung zum positiven Umgang mit Diabetes im Alltag“ (9,1) und „Strategien zur Verbesserung der Behandlungsmotivation“ (8,9) eingeschätzt. Technische Aspekte der Diabetestherapie wie „Insulininjektion“ (8,9) oder „Blutzuckermessung“ (8,7) waren ebenfalls wichtig, wie auch die Themen „soziale Unterstützung“ (8,1), „sozialrechtliche Aspekte“(8,0) oder „Diabetes und Reisen“ (7,9).

Diskussion: Nach Einschätzung der befragten DSP sollte eine Diabetesschulung für Menschen mit Typ 1 Diabetes neben der Optimierung medizinischer Outcomes vor allem die Vermittlung von Selbstmanagementfertigkeiten, eine Steigerung der Behandlungsmotivation und die Optimierung der Lebensqualität zum Ziel haben. Die als wichtig angesehenen Inhalte von Diabetesschulungen bei Typ 1 Diabetikern sind vielfältig. Ein Schulungsprogramm für Menschen mit Typ 1 Diabetes sollte daher ein multimodales Konzept und einen genügenden zeitlichen Umfang haben, um das breite Spektrum an Schulungsinhalten abzudecken.}
}

@inproceedings{kulzer2017_41616,
  title = {Bewertung strukturierter Schulungs- und Behandlungsprogramme},
  author = {Kulzer, Bernhard and Hermanns, Norbert and Hasche, Sven and Silbermann, Stephan and Thoma, S and Haak, Thomas},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0032-1314620},
  urn = {urn:nbn:de:bvb:473-opus4-486863},
  url = {https://fis.uni-bamberg.de/handle/uniba/41616},
  language = {deu},
  abstract = {Einleitung: In Deutschland stehen eine Vielzahl von strukturierten Schulungs- und Behandlungsprogrammen für Typ-1- wie Typ-2-Diabetiker mit ganz unterschiedlichen Schulungsphilosophien, Inhalten, Methodik und Dauer zur Verfügung. Bisher gibt es keine Befragung der Anwender, wie sie die Qualität dieser unterschiedlichen Schulungsprogramme einschätzen. Im Rahmen der Versorgungsstudie „Primascope“ wurden daher Diabetologen von diabetologischen Schwerpunktpraxen (DSP) gebeten, die verschiedenen Programme zu bewerten. Da die die Zertifizierung der Programme durch die DDG und/oder das Bundesversicherungsamt (wichtig für die Zulassung für DMP-Programme) ein wesentliches Qualitätsmerkmal darstellt, erfolgt in dieser Arbeit werden nur die durch DDG oder Bundesversicherungsamt zertifizierten Programme betrachtet.

Methodik: Insgesamt wurden 1192 DSP zu einer Studienteilnahme eingeladen, 818 ausgefüllte Fragebogen konnten ausgewertet werden. In einem ersten Schritt wurde erfragt, ob das Schulungsprogramm bekannt ist, in einem zweiten Schritt eine Bewertung der Zufriedenheit mit dem Programm auf einer Skala von 0 (nicht zufrieden) bis 10 (sehr zufrieden) abgegeben, wenn das Programm bekannt war.

Ergebnisse: In der Praxis wenden 24,8 der DSP=< als 4, 53,6=< als 6 und 75,3=< als 8 unterschiedliche Schulungsprogramme an. Am bekanntesten sind die ZI-Programme, die allerdings von den Anwendern eher kritisch bewertet werden: „Behandlungs- und Schulungsprogramm für Typ-2-Diabetiker, die nicht Insulin spritzen“ (Bekanntheit: 96,7\%; Zufriedenheit: 4,5), „Behandlungs- und Schulungsprogramm für Typ-2-Diabetiker, die Insulin spritzen“ (96,7\% –4,5), „Behandlungs- und Schulungsprogramm für Typ-2-Diabetiker, die Normalinsulin spritzen“ (93,2\% –4,5), „Behandlungs- und Schulungsprogramm für intensivierte Insulintherapie“ (92,9\% –4,4). Am wenigsten bekannt sind die Programme „Diabetes im Gespräch“ (12,5\% –6,6), „Diabetes und Verhalten“ (25,1\% –7,2) und „BGAT“ (28,5\% –6,7). Am besten bewerten die Anwender die Programme „MEDIAS ICT“ (68,5\% –8,1), „MEDIAS Basis“ (81,7\% –8,0), „HYPOS“ (63\% –7,5), „Barfuss“ (42,9\% –7,4), „Diabetes und Verhalten“ (25,1\% –7,2) und „SGS“ (32,6\% –7,0).

Schlussfolgerung: Die Ergebnisse zeigen ein differenziertes Bild der Diabetesschulung in DSP. Trotz der Zertifizierung weisen die verschiedenen Schulungs- und Behandlungsprogramme in der Praxis einen ganz unterschiedlichen Bekanntheitsgrad auf. Hier sind die bereits älteren und etablierten Programme deutlich im Vorteil, die einen sehr hohen Bekanntheits- und Verbreitungsgrad aufweisen. Auf der anderen Seite sind die Anwender gerade mit diesen Programmen eher unzufrieden. Vergleicht man die Programme, die von den Diabetologen deutlich besser eingeschätzt werden, so zeigt sich, dass diese eher modernen Schulungsphilosophien (Selbstmanagement) umsetzen, zielgruppengenauer und teilweise auch zeitlich umfangreicher sind.}
}

@inproceedings{ehrmann2017_41621,
  title = {Einfluss von Folgeerkrankungen und Depressivität auf die qualitätsadjustierten Lebensjahre (QALY) von Menschen mit Typ-1-Diabetes},
  author = {Ehrmann, Dominik and Hermanns, Norbert and Kulzer, Bernhard and Bergis-Jurgan, Nikola and Haak, Thomas},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0033-1341894},
  urn = {urn:nbn:de:bvb:473-opus4-486741},
  url = {https://fis.uni-bamberg.de/handle/uniba/41621},
  language = {deu},
  abstract = {Fragestellung: Der Erhalt einer möglichst optimalen Lebensqualität ist ein wichtiges Therapieziel bei der Behandlung des Diabetes. Folgeerkrankungen und Depressionen stehen diesem Ziel im Wege und stellen für die Patienten eine große Belastung dar. Ziel dieser Studie war es herauszufinden, wie groß der Einfluss einer erhöhten Depressivität und bestehender Folgeerkrankungen auf die Lebensqualität von Patienten mit Typ-1-Diabetes ist.

Methodik: 148 Patienten (45,2 ± 13,3 Jahre; 45\% weiblich; HbA1c 8,0 ± 1,1\%; 26\% CSII) bearbeiteten den EQ-5D. Dieser Fragebogen misst gesundheitsbezogene Lebensqualität und ermittelt einen sog. „Utility Score“. Mithilfe des Utility Scores lassen qualitätsadjustierten Lebensjahre (QALY) bestimmen. Ein Score von „1“ bedeutet ein Jahr bei perfekter Gesundheit. Des Weiteren bearbeiteten die Patienten den CES-D Bogen zur Messung der Depressivität, dabei wurde ein Cut-off Wert von 16 verwendet, um eine erhöhte Depressivität festzustellen. Zusätzlich wurden die Folgeerkrankungen der Patienten erfasst.

Ergebnisse: Patienten, die eine erhöhte Depressivität aufweisen, haben einen signifikant niedrigeren Utility Score als Patienten, die nicht depressiv sind (0,77 ± 0,25 vs. 0,93 ± 0,15; p < 0,001). Patienten mit Folgeerkrankungen haben einen signifikant niedrigeren Utility Score als Patienten ohne Folgeerkrankungen (0,83 ± 0,22 vs. 0,90 ± 0,18; p < 0,05). Da Depressionen und Folgeerkrankungen häufig gleichzeitig auftreten, wurde die Interaktion der beiden mittels ANOVA getestet. Bei gleichzeitiger Betrachtung bleibt der signifikant negative Effekt einer erhöhten Depressivität bestehen (F(1,142)= 11,2; p < 0,01), Folgeerkrankungen alleine haben aber keinen Einfluss mehr auf den Utility Score (F(2,142)= 1,4; p > 0,05). Jedoch wird die Interaktion zwischen Depressivität und Folgeerkrankungen signifikant (F(2,142)= 3,3; p < 0,05). Bestand keine oder nur eine Folgeerkrankung hängt der Utility Score nur von der Depressivität ab. Liegt keine erhöhte Depressivität vor, sind die Utility Scores unabhängig vom Bestehen einer Folgeerkrankung signifikant höher als bei einer gleichzeitig erhöhten Depressivität (keine Folgeerkrankung: 0,96 ± 0,1 vs. 0,75 ± 0,26; eine Folgeerkrankung: 0,95 ± 0,1 vs. 0,79 ± 0,25; beide p < 0,05). Bestehen zwei oder mehr Folgeerkrankungen, ist der Utility Score unabhängig der Depressivität gleich niedrig (depressiv: 0,79 ± 0,23; nicht depressiv: 0,79 ± 0,26; p > 0,05).

Schlussfolgerungen: Die Ergebnisse zeigen, dass sowohl Folgeerkrankungen als auch Depressionen einen substantiellen Einfluss auf die Lebensqualität von Patienten mit Typ-1-Diabetes haben. Zudem konnte gezeigt werden, dass Depressionen die Auswirkungen von Folgeerkrankungen auf die Lebensqualität beeinflussen können. Die Wichtigkeit der Erfassung depressiver Störungen wird durch diese Ergebnisse untermauert.}
}

@inproceedings{ehrmann2017_41620,
  title = {Empowerment und Selbstwirksamkeit sind mit einer positiven Einstellung zur Insulintherapie assoziiert},
  author = {Ehrmann, Dominic and Bergis, Nikola and Kulzer, Bernhard and Hermanns, Norbert and Haak, Thomas},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0032-1314629},
  urn = {urn:nbn:de:bvb:473-opus4-486907},
  url = {https://fis.uni-bamberg.de/handle/uniba/41620},
  language = {eng},
  abstract = {Einleitung: Eine negative Einstellung zur Insulintherapie kann eine bedeutsame Barriere für eine erfolgreiche Diabetestherapie darstellen. Dies kann man sowohl bei Typ-1 als auch Typ-2-Diabetikern beobachten. Die negative Einstellung führt häufig zu mangelnder Adhärenz und hat somit direkte Folgen auf den Blutzuckerverlauf und die Lebensqualität. Diese Studie untersucht die Zusammenhänge zwischen der Einstellung zur Insulintherapie und dem Ausmaß an Empowerment und Selbstwirksamkeit bei insulinbehandelten Diabetespatienten.

Methode: An der Studie nahmen 346 Patienten teil (Alter 52,2±14,4J.; 57\% Typ-1-Diabetes; 58\% männlich; HbA1c 8,2±1,4\%; Diabetesdauer 16,2±11J.). Die Patienten bearbeiteten den „ITEQ-Fragebogen“, der aus 8 Subskalen (Freizeit, Barrieren, Kontrolle, Gewicht, Handhabung, Unabhängigkeit, Schlaf, Zufriedenheit) besteht, für die ein Gesamt-Skalenwert gebildet werden kann. Höhere Werte des ITEQ (Range: 0 bis 100) bedeuten eine positivere Einstellung zur Insulintherapie. Zusätzlich wurde der „Empowerment-Fragebogen“ und ein Fragebogen zu Messung der „Selbstwirksamkeit“ eingesetzt.

Ergebnisse: Typ-1-Diabetiker hatten insgesamt eine signifikant positivere Einstellung zur Insulintherapie als Typ-2-Diabetiker (67,7±10,8 vs. 64,9±11,6, p<0,05). Bei beiden Gruppen ergaben sich signifikante Korrelationen der ITEQ-Subskalen mit „Empowerment“ und „Selbstwirksamkeit“: Eine höhere Ausprägung bei „Empowerment“/“Selbstwirksamkeit“ ging einher mit weniger Barrieren der Insulintherapie (Typ-1: 0,28/0,19; Typ-2: 0,24/0,18), weniger negativer Auswirkungen auf den Alltag und die Freizeitgestaltung (Typ-1: 0,36/0,14; Typ-2: 0,32/0,17), besserer Handhabung der Insulintherapie (Typ-1: 0,36/0,28; Typ-2: 0,25/0,22), besserer Kontrollierbarkeit des Blutzuckers durch die Insulintherapie (Typ-1: 0,39/0,24; Typ-2: -), mehr Unabhängigkeit (Typ-1: 0,16/-; Typ-2: -/0,15), besserer Schlafqualität (Typ-1: 0,27/0,23; Typ-2: 0,24/0,19) und einer größeren Zufriedenheit bei Typ-1-Diabetikern (r=0,37/0,26). Eine erhöhte Selbstwirksamkeit war bei den Typ-2-Diabetikern mit einer höheren Zufriedenheit bezüglich der Gewichtskontrolle korreliert (r=0,15). Der Gesamt-Skalenwert war ebenfalls größer, wenn mehr „Empowerment/Selbstwirksamkeit“ berichtet wurde (Typ-1: 0,45/0,27; Typ-2: 0,3/0,28).

Schlussfolgerung: Es zeigt sich, dass Empowerment und Selbstwirksamkeit bedeutsam mit der Einstellung zur Insulintherapie assoziiert sind. Schulungsmaßnahmen sollten daher darauf abzielen, das Empowerment und die Selbstwirksamkeit von Menschen mit Diabetes zu stärken, um eine negative Einstellung zur Insulintherapie zu verhindern. Die Patienten sollten zum einen lernen, wie sie im Alltag mit ihrem Diabetes und der Insulintherapie möglichst eigenständig zurechtkommen (Empowerment), zum anderen sollte auch das Vertrauen der Patienten in sich selbst gestärkt werden, die dazu notwendigen Maßnahmen korrekt umsetzen zu können (Selbstwirksamkeit).}
}

@inproceedings{ehrmann2017_41622,
  title = {Hoher Schulungsbedarf bei Typ-2-Diabetes : Ergebnisse einer Erhebung zur Schulungssituation in diabetologischen Schwerpunktpraxen},
  author = {Ehrmann, Dominik and Kulzer, Bernhard and Hermanns, Norbert and Hasche, Sven and Silbermann, Stephan and Thoma, S and Haak, Thomas},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0033-1341796},
  urn = {urn:nbn:de:bvb:473-opus4-486737},
  url = {https://fis.uni-bamberg.de/handle/uniba/41622},
  language = {deu},
  abstract = {Fragestellung: Bislang gibt es in Deutschland nur wenige Daten zur Schulungssituation. Im Rahmen einer Fragebogenbefragung wurde die aktuelle Schulungspraxis bei Typ-2-Diabetes in diabetologischen Schwerpunktpraxen (DSP) erhoben. Insbesondere wurden Daten zur Häufigkeit, Art, Inhalten und dem Setting von Schulungen erfragt

Methodik: Insgesamt wurden deutschlandweit 1192 DSP zur Studienteilnahme eingeladen. 818 vollständig ausgefüllte Fragebogen konnten ausgewertet werden. Kategoriale Häufigkeitsangaben wurden ermittelt, indem der jeweilige kategoriale Mittelwert entsprechend der Anzahl der Nennungen gewichtet wurde.

Ergebnisse: Pro Quartal werden in einer DSP im Mittel 627 Menschen mit Typ-2-Diabetes behandelt, ca. 83,5\% der insgesamt behandelten Diabetiker pro Quartal. Von diesen hatten 70\% bislang an einer strukturierten Gruppenschulung teilgenommen. Ca. 25\% der Typ-2-Diabetiker hatten in den letzten 2 Jahren an einer strukturierten Schulung teilgenommen, bei ca. 50\% lag die letzte Schulung mehr als 5 Jahre zurück, bei ca. 20\% mehr als 10 Jahre. Im Durchschnitt werden in einer Praxis 25,5 Gruppenschulungen für Typ-2-Diabetiker pro Jahr durchgeführt. Die mittlere Gruppengröße liegt dabei bei 6 Teilnehmern pro Kurs. Die meisten DSP (65,4\%) bieten die Kursstunden der Schulung ein- bis zweimal pro Woche an. Klassische „Blockschulungen“ werden in 10,6\% der teilnehmenden Schwerpunktpraxen durchgeführt. Als wichtigster Effekt einer Schulung bei Typ-2-Diabetes werden auf einer Skala von 1 bis 10 die „Stärkung der Motivation“ (9,4) angegeben, gefolgt von der „Verbesserung der Lebensqualität“ (9,2), einer „hohen Therapiezufriedenheit“ (9,0) und der „Prävention von Folgeerkrankungen“ (8,9). Zu den wichtigsten Schulungsinhalten bei Menschen mit Typ-2-Diabetes mit Insulin zählen „Ernährungsempfehlungen“ (9,4), „Bedeutung nicht-medikamentöser Therapiemaßnahmen“ (9,2), „Bewegungsempfehlungen“ (9,2), „Motivation“ (9,2), „Stärkung des Selbstmanagements“ (9,0) und „Hypoglykämien“ (9,1).

Schlussfolgerung: Die Ergebnisse geben einen interessanten Einblick in die Schulungssituation von Menschen mit Typ-2-Diabetes in Deutschland, die in einer DSP betreut werden. Immerhin 30\% aller Typ-2-Diabetiker wurden bislang noch nie geschult, bei 20\% lag die letzte Schulung schon mehr als 10 Jahre zurück. Basierend auf diesen Daten ist daher aktuell von einem relativ großen Schulungs- bzw. Nachschulungsbedarf bei Menschen mit Typ-2-Diabetes auszugehen. Die wichtigsten Effekte einer Typ-2-Schulung sehen die DSP eher in psychosozialen Variablen wie der Steigerung der Motivation sowie der Verbesserung der Lebensqualität und Therapiezufriedenheit.}
}

@inproceedings{kulzer2017_41607,
  title = {Ambulante strukturierte Schulung bei Typ-1-Diabetes},
  author = {Kulzer, Bernhard and Hermanns, Norbert and Hasche, Sven and Silbermann, Stephan and Thoma, S and Haak, Thomas},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0032-1314619},
  urn = {urn:nbn:de:bvb:473-opus4-486870},
  url = {https://fis.uni-bamberg.de/handle/uniba/41607},
  language = {deu},
  abstract = {Fragestellung: Im Rahmen der Versorgungsstudie „Primascope“ wurde die aktuelle Schulungspraxis bei Typ-1-Diabetes in diabetologischen Schwerpunktpraxen (DSP) erhoben. Daten zur Häufigkeit, der Art und dem Setting von Schulungen sollen Informationen zur Schulungsrealität für Menschen mit Typ-1-Diabetes in DSP liefern, die bislang für Deutschland weitgehend fehlen.

Methodik: Insgesamt 1192 DSP wurden zu einer Studienteilnahme eingeladen, 818 ausgefüllte Fragebogen konnten ausgewertet werden. Kategoriale Häufigkeitsangaben wurden gemittelt, indem der jeweilige kategoriale Mittelwert entsprechend der Anzahl der Nennungen gewichtet wurde.

Ergebnisse: Pro Quartal wurden in einer DSP im Mittel 124 Menschen mit Typ -1-Diabetes behandelt. Von diesen hatten 80\% (Median) jemals an einer Diabetesschulung teilgenommen, 50\% davon wurden in der eigenen Praxis geschult. 20\% der Typ-1-Diabetiker hatten in den letzten 2 Jahren an einer strukturierten Schulung teilgenommen, bei 50\% lag die letzte Schulung mehr als 5 Jahre zurück, bei 20\% mehr als 10 Jahre. Im Durchschnitt wurden in der DSP 4 Gruppenschulungen für Typ-1-Diabetiker pro Jahr durchgeführt. Die Gruppengröße lag bei durchschnittlich 6 Teilnehmern. In 67,1\% der Praxen werden Gruppen mit ausschließlich Typ-1-Diabetikern geschult. In 19\% der Praxen werden gemischte Gruppen mit Typ-1- und Typ-2-Diabetikern durchgeführt. Die meisten DSP (77\%) bieten die Kursstunden der Schulung ein- bis zweimal pro Woche an. Klassische „Blockschulungen“ werden bei 17\% der DSP durchgeführt. In 80\% der Praxen kam das strukturierte „Behandlungs- und Schulungsprogramm für intensivierte Insulintherapie“ (ZI-Programm ICT) zum Einsatz, in 37\% „LINDA“ und in 7\% „Diamand“. Als spezifische Schulungsprogramme wurden „HyPOS“ (46,9\%), „Subito“ (21,6\%), „BGAT“ 10,1\%, „ConClusio“ (10,0\%) und die „Copingschulung“ (2,6\%) eingesetzt.

Schlussfolgerung: Die Ergebnisse von „Primascope“ erbrachten erstmals Daten zur Schulungssituation von Menschen mit Typ-1-Diabetes in Deutschland. Danach sind rund 20\% aller Typ-1-Diabetiker noch nie geschult worden, bei weiteren 20\% lag die letzte Schulung schon mehr als 10 Jahre zurück. Basierend auf diesen Daten ist daher aktuell von einem relativ großen Schulungs- bzw. Nachschulungsbedarf bei Typ-1-Diabetikern auszugehen. In den DSP findet aktuell das ZI-Programm für ICT die größte Verbreitung.}
}

@inproceedings{bergisjurgan2017_41610,
  title = {Einfluss der Selbstwirksamkeit auf die glykämische Kontrolle bei Typ-1 und Typ-2-Diabetikern mit einer intensivierten Insulintherapie},
  author = {Bergis-Jurgan, Nikola and Hermanns, Norbert and Kulzer, Bernhard and Ehrmann, Dominik and Haak, Thomas},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0033-1341794},
  urn = {urn:nbn:de:bvb:473-opus4-486751},
  url = {https://fis.uni-bamberg.de/handle/uniba/41610},
  language = {deu},
  abstract = {Fragestellung: Die Insulintherapie des Diabetes mellitus erfordert ein hohes Maß an Eigenverantwortlichkeit, da vom Patienten wichtige Therapiemaßnahmen und -entscheidungen im Alltag selbstständig getroffen werden müssen. Das Ausmaß an Selbstmanagement ist somit essentiell für eine erfolgreiche Diabetestherapie. Hierfür ist die Überzeugung, den Blutzuckerverlauf durch eigenes Handeln steuern zu können („Selbstwirksamkeit“) eine wesentliche Voraussetzung. In dieser Studie gingen wir der Frage nach, in wieweit ein etabliertes Messinstrument zur Messung der Selbstwirksamkeit zum Einsatz bei Menschen mit Diabetes geeignet ist und es relevante Zusammenhänge mit der glykämischen Kontrolle gibt.

Methode: 393 Patienten, die sich in Betreuung in diabetologischen Schwerpunktpraxen befanden (Alter 53,4 ± 14,2J.; 55\% Typ-1-Diabetes; 57\% männlich; HbA1c 8,1 ± 1,3\%; Diabetesdauer 16,7 ± 11J.), bearbeiteten den 10-Item umfassenden „Fragebogen zur Erfassung der Allgemeinen Selbstwirksamkeitserwartung (SWE)“. Zusätzlich wurden der HbA1c zu drei Messzeitpunkten (t0, nach 10 Wochen, nach 6 Monaten) erfasst und von den Patienten die Fragebögen WHO-5 (Lebensqualität) und CES-D (Depression) beantwortet.

Ergebnisse: Die Reliabilität des Fragebogens war sehr gut (Cronbach Alpha = 0,92), ebenfalls die „mittlere Trennschärfe“ (r = 0,71). Bei einer Skala von ‚0' bis 3'‚ lag die „mittlere Itemschwierigkeit“ bei 2,24. Es ergaben sich erwartbare Korrelationen mit den Außenkriterien: Je höher die Selbstwirksamkeit, desto höher wurde die Lebensqualität (WH0 – 5) angegeben (r = 0,46), Patienten mit höherer Selbstwirksamkeit wiesen weniger depressive Symptome auf (Korrelation mit CES-D r =-0,43). Bei Typ-1-Diabetikern zeigte sich ein signifikanter Einfluss der Selbstwirksamkeit auf den Therapieerfolg: Je höher die Selbstwirksamkeit ausgeprägt war, desto niedriger war der HbA1c zu t0 (r =-0,2), 10 Wochen später (r =-0,18) und 6 Monate später (r =-0,3). Dieser Effekt bleibt selbst dann signifikant, wenn der HbA1c zum Zeitpunkt t0 als Kontrollvariable mit einbezogen wird. Für Typ-2-Diabetes ergaben sich hingegen keine signifikanten Zusammenhänge zum HbA1c.

Schlussfolgerung: Der SWE-Fragebogen ist ein reliables und valides Instrument zur Erfassung der Selbstwirksamkeit bei Typ-1 und Typ-2-Diabetikern mit einer ICT. Bei Typ-1-Diabetikern konnte gezeigt werden, dass ein hohes Ausmaß an Selbstwirksamkeit mit einer guten glykämischen Kontrolle assoziiert ist. Aufgrund der Kürze und Qualität des Fragebogens eignet sich der SWE für den Einsatz in der klinischen Praxis.}
}

@inproceedings{bergis2017_41611,
  title = {Lässt sich Empowerment bei Menschen mit Diabetes messen?},
  author = {Bergis, Nikola and Ehrmann, Dominik and Hermanns, Norbert and Kulzer, Bernhard and Haak, Thomas},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0032-1314506},
  urn = {urn:nbn:de:bvb:473-opus4-486923},
  url = {https://fis.uni-bamberg.de/handle/uniba/41611},
  language = {deu},
  abstract = {Ziele: In vielen Leitlinien, unter anderem auch denen der DDG, wird das Empowerment der Patienten als ein wichtiges Therapieziel beschrieben. Die vorliegende Studie überprüft deshalb die psychometrischen Eigenschaften eines deutschsprachigen Fragebogens zur Erfassung des Empowerment bei Typ-1- und insulinbehandelten Typ-2-Diabetikern. Dieser Fragebogen wurde auf der Grundlage der englischsprachigen „Diabetes Empowerment Scale“ von Anderson et al (2000) entwickelt.

Methodik: 409 Patienten bearbeiteten den Fragebogen (54,5\% Typ-1-Diabetiker, 56,5\% männlich, Alter 53,7±14,2J., HbA1c 8,1±1,3\%). 70,3\% der Patienten haben bereits an einer strukturierten Schulung teilgenommen. Der Empowerment-Fragebogen besteht aus 11 Items, die mittels 4-stufiger Ratingskala eingestuft werden. Als Indikator der psychometrischen Qualität wurden Itemcharakteristika (Trennschärfen und Schwierigkeitsindizes) und die Reliabilität berechnet. Zur Bestimmung der Validität wurde des Empowerment-Fragebogens wurden Korrelationsanalysen zwischen dem Empowerment-Fragebogen und diabetesbezogener Belastungen (PAID und DDS), der Diabetesdauer sowie dem HbA1c- Wert vorgenommen. Es wurde auch überprüft, ob geschulte Diabetiker ein höheres Empowerment aufweisen als ungeschulte Diabetiker.

Ergebnisse: Der Empowerment- Fragebogen zeigte eine hohe Reliabilität (Cronbach α=0,89). Die mittlere Trennschärfe lag bei rtt=0,61, der mittlere Schwierigkeitsindex betrug 74\%. Im Sinne der Validität sind die Ergebnisse der Korrrelationsanalysen zu werten: Je höher das Empowerment ausgeprägt war, desto niedriger waren diabetesbezogene Belastungen (PAID r=-0,38 und DDS r=-0,31) und der HbA1c (r=-0,13). Mit längerer Diabetesdauer nahm das Empowerment zu (r=0,18). Alle Korrelationen waren statistisch signifikant (p<0,05). Patienten, die zuvor an einer Schulung teilgenommen haben, zeigten im Durchschnitt ein signifikant höheres Maß an Empowerment (25,7±5,9) als Patienten ohne Schulungsteilnahme (23,1±7,5, p<0,001).

Schlussfolgerung: Der Empowerment-Fragebogen zeigt gute psychometrische Eigenschaften im Hinblick auf die Itemcharakteristika und die Reliabilität. Die signifikanten Zusammenhänge zwischen einem hohen Ausmaß an Empowerment und niedrigem HbA1c, niedrigen diabetesbezogenen Belastungen und frühere Teilnahme an einer Diabetikerschulung belegen die Validität dieses Fragebogens. Diese Zusammenhänge belegen auch die Relevanz von Empowerment im Hinblick auf die glykämische Kontrolle und diabetesbezogenen Belastungen. Es kann davon ausgegangen werden, dass Empowerment auf Seiten des Diabetespatienten ein wichtiger Bestandteil einer erfolgreichen Diabetestherapie ist. Mithilfe dieses Empowerment Fragebogens kann dieses zuverlässig und valide bestimmt werden.}
}

@inproceedings{hermanns2017_41604,
  title = {Lokale Erwärmung der Insulinjektionsstelle mithilfe des InsuPad kann postprandiale Blutzuckerspitzen reduzieren},
  author = {Hermanns, Norbert and Kulzer, Bernhard and Krichbaum, Michael and Reimer, Andre and Haak, Thomas},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0033-1341844},
  urn = {urn:nbn:de:bvb:473-opus4-486713},
  url = {https://fis.uni-bamberg.de/handle/uniba/41604},
  language = {deu},
  abstract = {Fragestellung: Die blutzuckersenkende Wirkung von subkutan injiziertem kurzwirksamem Analoginsulin setzt im Vergleich zu physiologisch freigesetztem endogenem Insulin immer noch vergleichsweise spät ein. Daher können auch mit kurzwirksamem Analoginsulin postprandiale Blutzuckeranstiege nicht immer zuverlässig vermieden werden. Das InsuPad ist ein CE-zertifiziertes, nicht-invasives Medizinprodukt, das die Insulinresorption aus dem subkutanen Fettgewebe beschleunigt, indem es die Injektionsstelle lokal erwärmt. Bei jeder Insulininjektion wird die Hautoberfläche für 30 Minuten lokal auf 38,5 °C erwärmt. Diese randomisierte Crossover-Studie untersucht den Einfluss des InsuPad auf die postprandialen Blutzuckererhöhungen nach dem Frühstück und dem Abendessen.

Methode: Insulinresistente Diabetiker mit einer intensivierten Insulintherapie benutzten zum Frühstück und zum Abendessen für 4 Wochen das InsuPad bei der Injektion des Bolusinsulins. Gleichzeitig kontrollierten sie 5-mal täglich den Blutzucker (vor und nach dem Frühstück, vor dem Mittagessen sowie vor und nach dem Abendessen). In der zweiten Studienphase wurde das Schema der Blutzuckerselbsttestung beibehalten, nun jedoch ohne Nutzung des InsuPad. Die Reihenfolge der beiden Studienphasen war randomisiert.

Ergebnisse: An dieser Studie nahmen 16 Diabetespatienten teil (37,5\% Typ 1); Alter: 52,0 ± 7,9J.; Diabetesdauer: 16,1 ± 7,4J.; HbA1c: 8,3 ± 0,9\%; Bolusinsulindosis: 55,7 ± 22,7 IE; Gesamtinsulinbedarf: 0,97 ± 0,35 IE/kg). Die präprandialen Blutzuckerwerte in den beiden Studienphasen mit und ohne InsuPad (163,9 ± 33,8 mg/dl vs. 160,5 ± 28,9 mg/dl; p = 0,56) waren vergleichbar. Bei Benutzung des InsuPad stiegen die postprandialen Blutzuckerwerte um 2,1 ± 27,8 mg/dl an, bei Nichtbenutzung des InsuPad um 20,5 ± 21,6 mg/dl (p = 0,01). Die Anzahl valider prä- und postprandialer Blutzuckervergleiche war in den Phasen mit und ohne InsuPad vergleichbar (\# BZSK pro Patient: 29,2 ± 12,6 vs. 29,1 ± 16,9; p = 0,97). Auch die Zeitdifferenz zwischen den prä- und postprandialen Blutzuckermessungen war in den Phasen mit und ohne InsuPad gut vergleichbar (105,4 ± 11,0 Min. vs. 107,1 ± 6,5 Min.; p = 0,32). Der mittlere Blutzucker in der Phase mit InsuPad war signifikant niedriger im Vergleich zur Phase ohne InsuPad (159,7 ± 62,4 mg/dl vs. 166,5 ± 65,1 mg/dl; p < 0,001). Die Anzahl hypoglykämischer (2,0 ± 1,6 vs. 2,1 ± 2,4 Glukosewerte < 70 mg/dl pro Woche: p = 0,76) oder hyperglykämischer Blutzuckerwerte (6,0 ± 6,2 vs. 6,7 ± 6,5 Glukosewerte > 240 mg/dl pro Woche: p = 0,39) unterschied sich zwischen beiden Phasen ebenfalls nicht bedeutsam.

Schlussfolgerung: Die lokale Erwärmung an der Injektionsstelle konnte postprandiale Blutzuckeranstiege signifikant reduzieren, während der Anteil hypo- oder hyperglykämischer Glukoseexkursionen in beiden Studienphasen vergleichbar war. Für insulinresistente Diabetiker könnte das InsuPad eine interessante zusätzliche Therapieoption darstellen.},
  keywords = {InsuPad}
}

@inproceedings{maier2017_41513,
  title = {Welche Effekte hat eine Verbesserung der Hypoglykämiewahrnehmung bei Teilnehmern des Hypoglykämiewahrnehmungstrainings „HyPOS“ auf das Wohlbefinden sowie auf das Ausmaß von diabetesbezogene Belastungen und Hypoglykämie-Ängsten?},
  author = {Maier, Bernhard and Hermanns, Norbert and Kulzer, Bernhard and Krichbaum, Michael and Haak, Thomas},
  year = {2017},
  booktitle = {Diabetologie und Stoffwechsel},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0033-1341790},
  urn = {urn:nbn:de:bvb:473-opus4-484853},
  url = {https://fis.uni-bamberg.de/handle/uniba/41513},
  language = {deu},
  abstract = {Fragestellung: Die Studie untersucht die mittelfristigen Auswirkungen einer interventionsbedingten Verbesserung der Hypoglykämiewahrnehmung auf das psychosoziale Wohlbefinden bei Typ-1-Diabetikern.

Methodik: Bei 65 Teilnehmern (Alter 46,2 ± 11,8J.; Diabetesdauer 20,7 ± 10,7J.; HbA1c 7,2 ± 0,9\%; 50\% weiblich) des ambulanten Schulungsprogramms „HyPOS“ (6 UE) wurde mithilfe des HAQ-Fragebogens (Clarke et al., 1995) die Hypoglykämiewahrnehmung zu Beginn (t0) und zum 6-Monats Follow-up (t2) erfasst. Teilnehmer mit einem HAQ-Score (0 – 7) > 3 wurden als „unaware“ kategorisiert. Zum 6-Monats Follow-up wurden „Responder“ (t0: „unaware“, t2: „aware“) und „Non-Responder“ (t0: „unaware“, t2: „unaware“) hinsichtlich des Wohlbefindens (WHO-5), des Ausmaßes diabetesbezogener Belastungen (PAID) sowie Hypoglykämie-Ängsten (HFS) verglichen.

Ergebnisse: Zur Baseline zeigte sich eine vergleichbare Qualität der Hypoglykämiewahrnehmung bei Respondern (n = 35) und Non-Respondern (n = 30). Non-Responder wiesen jedoch ein höheres Alter (p < 0,03), eine längere Diabetesdauer (p = 0,003) sowie ein beeinträchtigteres Wohlbefinden (p < 0,02) auf. Zum 6-Monats Follow-up beschrieben Teilnehmer mit einer verbesserten vs. einer weiterhin defizitären Hypoglykämiewahrnehmung ein tendenziell besseres Wohlbefinden (16,9 ± 4,2 vs. 14,6 ± 5,9; p < 0,07). Weiterhin beschrieben Responder ein signifikant geringeres Ausmaß an diabetesbezogenen Belastungen (19,0 ± 13,1 vs. 29,5 ± 14,2; p = 0,003). Die Itemanalyse ergab bei Respondern eine reduzierte Sorge vor Hypoglykämien (PAID Item 9: 1,3 ± 1,2 vs. 2,4 ± 1,1; p < 0,0001), eine geringere Belastung durch unangenehme Situationen (PAID Item 4: 0,6 ± 0,6 vs. 1,3 ± 1,2; p < 0,01) und ein geringer ausgeprägtes Gefühl, mit dem Diabetes alleine zu sein (PAID Item 17: 0,4 ± 0,6 vs. 1,0 ± 1,0; p = 0,005). Im Hinblick auf Hypoglykämie-Ängste beschrieben Responder ein geringeres Ausmaß an Vermeidungs- und Sicherheitsverhalten (HFS-B: 20,1 ± 5,6 vs. 22,8 ± 4,8; p < 0,05) und weniger Sorgen um Unterzuckerungen (HFS-W: 20,1 ± 11,8 vs. 27,8 ± 11,5; p = 0,01). Dabei gaben Responder an, weniger Blutzuckerkontrollen in sozialen Situationen durchzuführen (HFS-B Item 10: 2,4 ± 1,4 vs. 3,2 ± 0,8; p < 0,01). Ebenso beschrieben sie eine geringere Sorge, einen Unfall zu verursachen (HFS-W Item 10: 1,7 ± 1,3 vs. 2,5 ± 1,3; p < 0,03) und hatten weniger Befürchtungen, in verantwortungsvollen Situationen nicht klar denken zu können (HFS-W Item 12: 1,9 ± 1,2 vs. 2,8 ± 1,1; p < 0,003).

Schlussfolgerungen: Typ-1-Diabetiker mit einer verbesserten Hypoglykämiewahrnehmung beschrieben nach 6 Monaten ein geringeres Ausmaß an diabetesbezogenen Belastungen. Die Reduktion dieser Belastungen ist insbesondere mit einer signifikanten Reduktion von hypoglykämiebezogenen Ängsten und Befürchtungen assoziiert. Möglicherweise erschweren ein höheres Lebensalter, eine längere Diabetesdauer sowie ein reduziertes Wohlbefinden den Erfolg eines Hypoglykämiewahrnehmungstrainings.},
  keywords = {Hypoglykämiewahrnehmung}
}

@inproceedings{schmitt2017_41485,
  title = {Depressionsscreening mit der Allgemeinen Depressionsskala (ADS) bei Diabetespatienten im stationären Setting},
  author = {Schmitt, Andreas and Hermanns, Norbert and Kulzer, Bernhard and Gahr, Annika and Haak, Thomas},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0033-1341892},
  urn = {urn:nbn:de:bvb:473-opus4-484835},
  url = {https://fis.uni-bamberg.de/handle/uniba/41485},
  language = {deu},
  abstract = {Fragestellung: 25 – 30\% aller Diabetespatienten haben eine erhöhte Depressivität. Etwa ein Drittel dieser Patienten weist eine klinische Depression entsprechend den ICD-10-Kriterien auf. Klinische Depressionen sind langfristig mit einer erhöhten Morbidität und Mortalität assoziiert. Kurzfristig führen depressive Störungen zu einem reduzierten Selbsthandlungsverhalten und einer schlechteren glykämischen Kontrolle. Allerdings werden Depressionen bei Menschen mit Diabetes häufig nicht erkannt, weshalb in den DDG-Praxisleitlinien ein Depressionsscreening empfohlen wird. Ziel dieser Studie war die Analyse der Screeningeigenschaften der deutschen Version des CES-D-Fragebogens, der Allgemeinen Depressionsskala (ADS).

Methodik: In einer stationären Diabeteseinrichtung wurde über 6 Monate ein Depressionsscreening mit der ADS durchgeführt. Patienten mit erhöhten Depressionswerten (ADS-Score > 16) wurden mittels eines diagnostischen Interviews nachuntersucht, um zu überprüfen, ob eine depressive Störung entsprechend den ICD-10 Kriterien vorlag. Zur Beurteilung der Screeningeigenschaften der ADS wurden die Fläche unter der Receiver Operating Characteristic (ROC) Curve berechnet und Sensitivität, Spezifität sowie positiver und negativer prädiktiver Wert bestimmt.

Ergebnisse: Insgesamt wurden 1167 Patienten (Alter: 50 ± 15J.; 43\% weibl.; BMI: 30 ± 7 kg/m2; 50\% Typ-1 DM; Dauer: 15 ± 11J.; 90\% mit Insulin; 61\% mit Folgekrankheiten; HbA1c: 8,9 ± 1,7\%) gescreent. 10,2\% der Stichprobe litten aktuell unter einer klinischen depressiven Störung. Zusätzlich wiesen 15,6\% eine subklinische Depression (ADS-Wert ≥23, Kriterien einer depressiven Störung jedoch nicht erfüllt) auf. Die ROC-Analyse ergab eine Fläche unter der Kurve von 0,90 (95\% CI: 0,87 – 0,92), welche sehr gute Screeningeigenschaften anzeigt (p < 0,001). Anhand des Youden-Index wurde ein optimaler Cut-Off-Wert von > 23 ermittelt. Bei diesem Wert betrug die Sensitivität 81\%, die Spezifität 83\%. Der positive prädiktive Wert war 40\%, der negative prädiktive Wert betrug 97\%.

Schlussfolgerungen: Innerhalb dieser stationären Stichprobe war jeder zehnte Patient von einer klinischen Depression betroffen. Zusätzlich zeigte sich bei rund 16\% der Patienten eine subklinische Depressionssymptomatik. Die ADS zeigte eine sehr gute Eignung als Depressionsscreeningverfahren: 81\% aller depressiven Diabetiker konnten korrekt identifiziert werden, die Rate der falsch positiven Befunde betrug dagegen nur 17\%. Bei Vorliegen eines positiven Screeningbefundens hatten 40\% der Patienten tatsächlich eine klinische Depression. Angesichts der hohen Prävalenz depressiver Störungen ist es sinnvoll in einem Diabetes-Fachkrankenhaus, ein spezifisches Depressionsscreening durchzuführen. Die ADS ist neben dem WHO-5 ein Instrument, das sich hierfür sehr gut eignet.}
}

@inproceedings{reimer2017_41487,
  title = {Psychometrische Validierung eines Assessmenttools zur Einschätzung von Kohlenhydraten und Boluskalkulation für Diabetespatienten mit einer intensivierten Insulintherapie},
  author = {Reimer, Andre and Ehrmann, Dominic and Kulzer, Bernhard and Hermanns, Norbert and Weißmann, Jörg and Haak, Thomas},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0033-1341805},
  urn = {urn:nbn:de:bvb:473-opus4-484842},
  url = {https://fis.uni-bamberg.de/handle/uniba/41487},
  language = {deu},
  abstract = {Fragestellung: Die erfolgreiche Durchführung einer intensivierten Insulintherapie setzt voraus, dass ein Patient den Kohlenhydratgehalts von Mahlzeiten richtig einschätzt sowie die Menge des kurzwirksamen Insulins richtig berechnet. Bislang gibt es nur wenige Studien, zur Güte dieser Therapieentscheidungen von Patienten und darüber, in welchem Ausmaß Patienten therapierelevante Fehler machen. Ziel dieser Studie ist die Entwicklung eines reliablen und validen Assessmenttools zur Kohlenhydratschätzung und der Erfassung der Boluskalkulation (SAMRT), mit der in der klinischen Praxis überprüft werden kann, in wie weit dies ien Patient adäquat beherrscht.

Methoden: Nach verschiedenen Voruntersuchungen wurden aus einem Itempool mittels einer Itemanalyse 28 Aufgaben extrahiert, welche die Fähigkeit der Kohlenhydratschätzung (12 Items) und zur Boluskalkulation (16 Items) abbilden. Die Aufgaben zur Kohlenhydratschätzung bestanden aus Abbildungen mit einfachen Nahrungsmitteln und komplexen Mahlzeiten. Die Fähigkeit zur Boluskakulation wurde mit Textaufgaben erfragt (Multiple Choice-Verfahren). Zur Erfassung der psychometrischen Qualität von SMART wurden Itemcharakteristika sowie die Reliabilität und Validität bestimmt.

Ergebnisse: An dieser Studie nahmen 300 Diabetespatienten mit einer intensivierten Insulintherapie teil (Alter 43,0 ± 14,2J.; Diabetesdauer 16,7 ± 12,2J.; 51,3 1\% männlich; 92\% Typ 1 Diabetes; 35,1\% mit CSII-Therapie). Die Gesamtskala von SMART wies mit einer mittleren Schwierigkeit von 57,3 ± 43\% und einer mittleren Trennschärfe von rit = 0,37 gute Itemcharakteristika sowie eine hohe Reliabilität (Cronbach's α= 0,84) auf. Für die Validität von SMART spricht, dass Patienten mit einem höheren SMART Score einen signifikant niedrigeren HbA1c-Wert (r =-0,15; p = 0,01) sowie niedrigere prä- (r =-0,21; p < 0,01) und postprandiale (r =-0,17; p < 0,01) Blutzuckerwerte aufwiesen. Außerdem hatten Teilnehmer mit einer geringeren Schulbildung einen signifikant geringeren SMART Score (14,9 ± 5,1 vs. 17,9 ± 5,3; p < 0,01) als Personen mit einem höheren Bildungsstand (Abitur oder Hochschulabschluss). Patienten mit einer CSII-Therapie wiesen zudem einen höheren SMART-Score auf als Patienten mit einer multiplen Insulininjektionstherapie (15,5 ± 5,3 vs. 17,1 ± 4,9 p = 0,018).

Schlussfolgerung: Die Untersuchung der psychometrischen Qualität von SMART zeigte, dass es gelungen ist, ein valides und reliables Assessmenttool zur Erfassung von Fertigkeiten zur praktischen Durchführung einer intensivierten Insulintherapie zu entwickeln. Mithilfe von SMART kann ein potenzieller (Nach-) Schulungsbedarf bei Patienten (z.B. KE/BE-Schätztraining) erhoben werden. Ebenso können mithilfe des SMART aber auch Patienten identifiziert werden, für die der Einsatz eines Boluskalkulators sinnvoll sein könnte.}
}

@inproceedings{kulzer2017_41473,
  title = {Treatment of subclinical depression with a CBT program (DIAMOS) : Results of a prospective randomized, controlled study},
  author = {Kulzer, Bernhard and Schmitt, Andreas and Reimer, Andre and Ehrmann, Dominic and Haak, Thomas and Hermanns, Norbert},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.2337/db14-665-832},
  urn = {urn:nbn:de:bvb:473-opus4-484630},
  url = {https://fis.uni-bamberg.de/handle/uniba/41473},
  language = {eng},
  abstract = {Depression without meeting the criteria of a major depression. However, elevated depressive symptoms are associated with a reduced quality of life, lower self-care activities, and a higher mortality. To target this large group of people, a diabetes-specific treatment program (DIAMOS) was developed and evaluated in a randomized controlled trial with a 12-month follow-up. DIAMOS is a group program based on cognitive-behavioral-therapy (CBT). It consists of 5 group sessions which lasts for 90 minutes each. 214 inpatients with subclinical depression were randomized either to DIAMOS or to a control group receiving diabetes education. Depression, diabetesrelated distress, and quality of life were assessed via questionnaires (CES-D, PAID, WHO-5 respectively). HbA1c was analyzed in a central laboratory.181 patients (age: 45±14 yrs.; 57\% female; 63\% Type 1 DM; diabetes duration 15±11 yrs.; 95\% with insulin; 51\% with late complications; HbA1c 8.8±1.7\%; CES-D 23.3±8.1; PAID 39.5±18.4; WHO-5 8.9±4.5) were available at the 12-month follow-up (drop-out rate: 15\%). Compared to the control group, patients treated with DIAMOS showed a significantly greater reduction of depressive symptoms (- 7.4 ± 11.4 vs. - 2.7 ± 11.7; p < .01), and diabetes-related distress (- 13.0 ± 18.9 vs. - 4.2 ± 16.9; p < .01), as well as a significantly greater improvement of quality of life (+ 4.5 ± 6.1 vs. + 2.5 ± 6.3; p = .03). HbA1c improvement was comparable in both groups. The results demonstrate that DIAMOS is an effective tool for the treatment of subclinical depression in people with diabetes. In addition, DIAMOS positively affects diabetes-related distress and quality of life. Interestingly, the reduction of depressive symptoms and distress was not associated with an improvement of glycemic control. DIAMOS proofs to be an innovative tool for routine care to improve the situation of people with diabetes and subclinical depression.}
}

@inproceedings{ehrmann2017_41456,
  title = {Diabetesadaptierte Schuhversorgung : Erfassung der Patientenzufriedenheit zur Charakterisierung des patientenrelevanten Nutzens},
  author = {Ehrmann, Dominic and Siebert, Hendrik and Spengler, N and Jahn, M and Niehbur, D and Kulzer, Bernhard and Haak, Thomas and Hermanns, Norbert},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0034-1374944},
  urn = {urn:nbn:de:bvb:473-opus4-483924},
  url = {https://fis.uni-bamberg.de/handle/uniba/41456},
  language = {deu},
  abstract = {Fragestellung: Die Adhärenz beim Tragen einer diabetesadaptierten Schuhversorgung, bei Patienten mit bestehendem oder hohem Risiko für ein diabetisches Fußsyndrom, wird als eher gering eingeschätzt. Die Zufriedenheit mit der diabetesadaptierten Schuhversorgung kann diese Adhärenz erheblich beeinflussen. In dieser Studie wurde ein Fragebogen zur Messung der Patientenzufriedenheit mit der diabetesadaptieren Schuhversorgung entwickelt und psychometrisch evaluiert.

Methodik: Der Fragebogen wurde 67 Diabetes-Patienten vorgelegt, die eine diabetesadaptierte Schuhversorgung in Anspruch nehmen (Alter: 67,8 ± 8,7 Jahre, 85\% Typ-2-Diabetes, BMI: 33 ± 6,8 kg/m2, Diabetesdauer: 19,4 ± 12 Jahre, HbA1c: 7,7 ± 1,5\%, Dauer des DFS: 8,4 ± 7,4 Jahre). Der Fragebogen wurde hinsichtlich Trennschärfe, Reliabilität optimiert und faktorenanalytisch überprüft.

Ergebnisse: Der Fragebogen besteht aus 13 Items, die eine Reliabilität von Cronbachs Alpha = 0,83 und eine mittlere Trennschärfe von r = 0,51 erreichten. Die Faktorenanalyse (Hauptkomponentenanalyse, Varimax-Rotation) zeigte eine 4-faktorielle Struktur, die 74\% der Varianz aufklärten. Nach inhaltlicher Analyse konnten diese Faktoren als „Zufriedenheit mit der Schuhversorgung“ (5 Items), „Adhärenz“ (3 Items), „Alltag/Praktikabilität der Schuhversorgung“ (3 Items) und „Verständnis der Notwendigkeit der Schuhversorgung“ (2 Items) identifiziert werden. Reliabilitäten der einzelnen Faktoren waren angesichts der Kürze ausreichend (Verständnis: 0,57; Alltag: 0,67) bis sehr gut (Adhärenz: 0,81; Zufriedenheit: 0,91). Die Gesamt-Skala korrelierte zudem signifikant mit dem WHO-5 Fragebogen, so dass eine höhere Zufriedenheit mit einem höheren Wohlbefinden einherging (r = 0,3, p < 0,05).

Schlussfolgerungen: Der Fragebogen ist ein kurzes und reliables Maß zur Erfassung der Zufriedenheit mit der diabetesadaptierten Schuhversorgung. Die faktorielle Struktur zeigt, dass mehrere Facetten der Zufriedenheit erfasst werden können. Der Fragebogen kann eingesetzt werden, um den patientenrelevanten Nutzen diabetesadaptierter Schuhversorgungen zu profilieren.}
}

@inproceedings{bergisjurgan2017_41457,
  title = {Die Effektivität eines Schulungs-und Behandlungsprogramms für Typ-1-Diabetiker (PRIMAS) unter Versorgungsbedingungen},
  author = {Bergis-Jurgan, Nikola and Ehrmann, Dominic and Kulzer, Bernhard and Hermanns, Norbert and Haak, Thomas},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0034-1375145},
  urn = {urn:nbn:de:bvb:473-opus4-483964},
  url = {https://fis.uni-bamberg.de/handle/uniba/41457},
  language = {deu},
  abstract = {Fragestellung: Vielfach sind Therapiemaßnahmen unter klinischen Versorgungsbedingungen weniger effektiv als in randomisierten-kontrollierten Evaluationsstudien (RCT). Daher wurde in dieser Versorgungsstudie (VS) überprüft, inwieweit das erfolgreich in einer RCT evaluierte Schulungs-und Behandlungsprogramm für Typ-1-Diabetiker (PRIMAS) unter Versorgungsbedingungen eine ähnliche Effektivität aufweist.

Methodik: In der VS wurden 255 Typ-1-Diabetiker aus 42 diabetologischen Schwerpunktpraxen (Alter 43 ± 14 Jahre; 54\% männlich; Diabetesdauer 13 ± 12; HbA1c 8,1 ± 1,4\%) mit PRIMAS geschult und 6 Monate nach Schulungsende evaluiert. Die Effektstärken der RCT wurden als Cohens d (Verbesserung relativiert an der Standardabweichungen) angegeben. Zentrale Outcomevariable war die Differenz der Effekte zwischen der RCT und VS ± 95\%-Konfidenzintervall (95\%-KI).

Ergebnisse: In der RCT wurden Effektstärken in Bezug auf die Verbesserung des HbA1c-Wertes von 0,4, der Hypoglykämiewahrnehmung von 0,35, des Depressions-Scores von 0,15, der Diabetesbelastung von 0,42, des Empowerments von 0,41 und der Selbstwirksamkeit von 0,39 ermittelt. Im Vergleich zur RCT unterschied sich der primäre Endpunkt HbA1c nicht signifikant zwischen RCT vs. VS (D 0,032 95\%-KI -0,26 bis 0,32). Das Konfidenzintervall der HbA1c-Differenz lag unterhalb der von der FDA definierten Non-Inferioritätsschwelle. Auch die Effekte der übrigen Parameter unterschieden sich unter Versorgungsbedingungen nicht signifikant von den Ergebnissen der RCT: Hypoglykämiewahrnehmung -0,14 95\%-KI -0,55 bis 0,39; Depression 0,67 95\%-KI -1,48 bis 2,8; Diabetesbelastung -0,14 95\%-KI -34 bis 0,06; Empowerment 0,27 95\%-KI -1,92 bis 140, Selbstwirksamkeit -0,28 95\%-KI -0,-1,42 bis 0,86. Die Effektstärken in der Versorgungsstudie lagen zwischen 0,18 und 0,33.

Schlussfolgerungen: Das PRIMAS-Schulungsprogramm weist unter Versorgungsbedingungen im Vergleich zur RCT ähnlich gute Effekte auf.}
}

@inproceedings{schmitt2017_41462,
  title = {The Diabetes Self-Management Questionnaire (DSMQ) can detect inadequate self-care behaviour and help identify patients at risk of a negative diabetes prognosis},
  author = {Schmitt, Andreas and Hermanns, Norbert and Kulzer, Bernhard and Reimer, Andre and Schall, Sabine and Haak, Thomas},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1007/s00125-014-3355-0},
  urn = {urn:nbn:de:bvb:473-opus4-483982},
  url = {https://fis.uni-bamberg.de/handle/uniba/41462},
  language = {eng},
  abstract = {Background and aims: Existing psychometric instruments to assess diabetes self-management often reveal weak or inconsistent associations with ‚hard data‘ such as medical outcomes and HbA1c. To fill this gap, the Diabetes SelfManagement Questionnaire (DSMQ) was developed, focussing on self-care activities which directly impact medical diabetes outcomes. This study evaluates the questionnaire’s practical utility in detecting high-risk patients at a tertiary diabetes 
Materials and methods: 226 people with diabetes (age 43 ± 15 y.; 55\% female; BMI 29 ± 7; 70\% type 1 diabetes; illness duration 15 ± 10 y.; 92\% treated with insulin; HbA1c 8.9 ± 1.6\%) were assessed with the DSMQ and further questionnaires regarding diabetes acceptance (AADQ), coping with illness (FQCI), treatment satisfaction (DTSQ), diabetes distress (PAID), and depressive symptoms (CES-D); additional data (demographic variables, self-monitoring of blood glucose, HbA1c, and long-term complications) were gained from electronic patient records. People were then categorized by a median split of the DSMQ total score into groups performing ‘adequate’ (n = 107) versus ‘inadequate’ diabetes self-care (n = 119); the groups were compared regarding relevant outcomes using multivariate ANOVA (subsequently presented data are M ± SD, F statistic, and effect size Cohen’s d).
Results: After adjusting for sex, age, BMI, diabetes type, diabetes duration, and type of treatment, people performing ‘inadequate self-care’ compared to those with ‘adequate self-care’ showed stronger diabetes non-acceptance (31 ± 8 vs. 22 ± 6, F = 90.5, d = 1.24), less active coping with diabetes (2.7 ± 0.9 vs. 3.4 ± 0.8, F = 18.1, d = 0.82), lower diabetes treatment satisfaction (20 ± 7 vs. 24 ± 6, F = 21.3, d = 0.60), higher diabetes distress (43 ± 21 vs. 33 ± 19, F = 17.0, d = 0.85), and more depressive symptoms (24 ± 11 vs. 20 ± 11, F = 4.8, d = 0.36). Moreover, they performed fewer blood glucose self-tests (3.3 ± 3.5 vs. 5.6 ± 2.4 times per day, F = 24.7, d = 0.74), consulted their diabetologist less often (1.9 ± 1.8 vs. 2.6 ± 2.3 times per half-year, F = 6.6, d = 0.34), had a higher HbA1c value (9.5 ± 1.5 vs. 8.2 ± 1.4\%, F = 34.6, d = 0.87), and showed a higher prevalence of retinopathy (28\% vs. 14\%, F = 6.0, d = 0.35).
Conclusion: The DSMQ yields excellent distinction between people with diabetes performing adequate versus insufficient diabetes self-care, thus enabling detection of people at high risk of a negative diabetes prognosis. The 16-item questionnaire is an efficient tool which may be used for screening and diagnostic purposes or clinical diabetes research.}
}

@article{schmitt2017_41438,
  title = {Der Diabetes Self-Management Questionnaire (DSMQ) identifiziert Diabetespatienten mit hohem Risiko einer negativen Prognose},
  author = {Schmitt, Andreas and Reimer, Andre and Hermanns, Norbert and Schall, Sabine and Haak, Thomas and Kulzer, Bernhard},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-opus4-483587},
  url = {https://fis.uni-bamberg.de/handle/uniba/41438},
  language = {deu},
  abstract = {Fragestellung: Bestehende Fragebögen zur Erfassung von Selbstbehandlungsverhaltensweisen zeigen oft nur geringe Assoziationen mit medizinischen Outcomemaßen wie dem HbA1c-Wert. Daher wurde der Diabetes Self-Management Questionnaire (DSMQ) entwickelt, dessen Evaluation eine hohe Validität belegt. Diese Studie bewertet die Qualität des Bogens im praktischen klinischen Gebrauch.

Methodik: 207 Diabetespatienten (Alter 42 ± 15; 57\% weiblich; BMI 29 ± 7; 70\% Typ-1; Diabetesdauer 14 ± 10; 92\% insulinbehandelt; HbA1c 8,9 ± 1,6\%) wurden mit dem DSMQ und weiteren Fragebögen zu Diabetesakzeptanz (AADQ-6), Krankheitsbewältigung (FKV-15), Diabetesbelastung (PAID), Behandlungszufriedenheit (DTSQ), und Depressionssymptomen (ADS) untersucht. Weitere Variablen wurden aus der Patientenakte gewonnen. Anhand eines Mediansplits wurden Patienten mit „gutem“ versus „schlechtem“ Selbstbehandlungsverhalten nach DSMQ-Summenwert unterschieden und hinsichtlich zentraler Outcomemaße verglichen (t-Test).

Ergebnisse: Patienten mit „schlechtem“ Selbstbehandlungsverhalten zeigten eine signifikant stärkere Diabetes-Nonakzeptanz (18 ± 6 vs. 12 ± 3, d= 1,23), weniger aktive Krankheitsbewältigung (2,7 ± 0,9 vs. 3,4 ± 0,8, d= 0,85), geringere Behandlungszufriedenheit (20 ± 7 vs. 24 ± 6, d= 0,58), höhere Diabetesbelastung (43 ± 22 vs. 33 ± 19, d= 0,45) und stärkere Depressivität (25 ± 11 vs. 20 ± 11, d= 0,47) (alle p< 0,01). Darüber hinaus maßen sie seltener ihren Blutzucker (2,4 ± 3,7 vs. 4,0 ± 3,3 Mal/Tag, d= 0,46), besuchten seltener ihren Diabetologen (2,0 ± 1,9 vs. 2,6 ± 2,3 Mal/Halbjahr, d= 0,27) und hatten einen höheren HbA1c-Wert (9,5 ± 1,5 vs. 8,2 ± 1,4\%, d= 1,35) sowie eine höhere Prävalenz retinopathischer Folgekrankheiten (28\% vs. 18\%, d= 0,32) (alle p< 0,05).

Schlussfolgerungen: Der DSMQ zeigt eine ausgezeichnete Differenzierung zwischen Patienten mit gutem versus schlechtem Selbstbehandlungsverhalten und ermöglicht damit die Identifikation von Patienten mit hohem Risiko einer negativen Diabetesprognose. Der Fragebogen ist mit 16 Items sehr ökonomisch und eignet sich als Screeninginstrument, zur Diagnostik oder für den wissenschaftlichen Gebrauch.}
}

@article{schmitt2017_41442,
  title = {Negative Effekte von Depression auf die Diabetes-Selbstbehandlung werden möglicherweise durch eine reduzierte Krankheitsakzeptanz vermittelt},
  author = {Schmitt, Andreas and Reimer, Andre and Hermanns, Norbert and Haak, Thomas and Kulzer, Bernhard},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-opus4-483626},
  url = {https://fis.uni-bamberg.de/handle/uniba/41442},
  language = {deu},
  abstract = {Fragestellung: Eine komorbide Depression ist bei Diabetes mit einer reduzierten Selbstbehandlung assoziiert. Es ist jedoch unklar, in welcher Weise Depression und Diabetesbehandlung interagieren. Diese querschnittliche Studie untersuchte die Rolle von Krankheitsakzeptanz als vermittelndem Faktor.

Methodik: 180 Diabetespatienten (Alter 41 ± 15; 56\% weiblich; BMI 29 ± 7; 72\% Typ-1; Diabetesdauer 14 ± 10; 92\% insulinbehandelt; HbA1c 8,9 ± 1,6\%) wurden hinsichtlich Depressivität (ADS), Selbstbehandlungsverhalten (DSMQ) und Diabetes-Nonakzeptanz (AADQ-6) untersucht. Die Variablenzusammenhänge wurden mittels multipler Regressionsanalyse und Mediationseffekte mittels Sobel-Test untersucht.

Ergebnisse: Unter Adjustierung für Alter, Geschlecht, Bildung, BMI, Diabetestyp, Insulinbehandlung, und Folgeerkrankungsstatus war Depressivität signifikant assoziiert mit einem geringeren Blutzuckermanagementverhalten (BZSK/Medikamente) (β =-0,22, p < 0,01), einer weniger diabetesgerechten Ernährung (β=-0,24, p < 0,01), einer geringeren körperlichen Aktivität (β=-0,36, p < 0,01) und einem reduziertem Arztkontakt bzgl. Diabetes (β=-0,18, p < 0,05). Wurde zusätzlich der Einfluss der Krankheitsakzeptanz kontrolliert, so verloren die Zusammenhänge bei Blutzuckermanagement, Ernährung und Arztkontakt ihre Signifikanz, während Nonakzeptanz signifikante negative Assoziationen aufwies (alle p < 0,01). Da dieses Befundmusters eine vermittelnde Funktion von Krankheitsakzeptanz nahelegt, wurde der Sobel-Test angewandt, welcher tatsächlich signifikante Mediationseffekte anzeigte (alle p < 0,01).

Schlussfolgerungen: Die Befunde bestätigen negative Wechselwirkungen zwischen Depressivität und Diabetes-Selbstbehandlung. Sie sprechen zusätzlich dafür, dass bei diesen Wechselwirkungen eine reduzierte Krankheitsakzeptanz von zentraler Bedeutung ist. Möglicherweise neigen depressive Patienten verstärkt zu Abwehr/Vermeidung des Diabetes, was eine adäquate Selbstbehandlung verhindert. Bei der Therapie komorbider Depressionen sollte daher besonderes Augenmerk auf die emotionale Einstellung zum Diabetes gelegt werden.}
}

@inproceedings{hermanns2017_41451,
  title = {Prävalenz und psychosoziale Konsequenzen von Hypoglykämien in der deutschen Stichprobe der globalen DAWN2™ Studie},
  author = {Hermanns, Norbert and Mattenklodt, Peter and Kröger, Jens and Landgraf, Rüdiger and Lüthgens, Birgit and Kulzer, Bernhard},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0034-1375005},
  urn = {urn:nbn:de:bvb:473-opus4-483916},
  url = {https://fis.uni-bamberg.de/handle/uniba/41451},
  language = {deu},
  abstract = {Hintergrund: Hypoglykämien sind ein limitierender Faktor einer erfolgreichen Diabetestherapie und stellen für Menschen mit Diabetes (MmD) eine Belastung dar. Im Rahmen der DAWN2™ Studie, einer globalen Untersuchung in 17 Ländern (n = 15.438) wurden die Prävalenz schwerer, durch Fremdhilfe behandelter Hypoglykämien sowie deren Zusammenhänge mit anderen psychosozialen Variablen bei MmD untersucht. In dieser Auswertung werden die an der deutschen Stichprobe gewonnen Daten zu Hypoglykämien präsentiert.

Methoden: In Deutschland nahmen an dieser Studie 502 MmD stratifiziert nach Diabetestyp und Behandlung teil: 80 Typ 1 Diabetes [MmT1D], 422 Typ 2 Diabetes [MmT2D]. Die Studienteilnehmer wurden u.a. nach dem Auftreten schwerer Hypoglykämien befragt, und beantworteten validierte Fragebögen zu diabetesbezogenen Belastungen (PAID 5) oder ihrem Wohlbefinden (WHO 5).

Ergebnisse: Die Prävalenz schwerer Hypoglykämien war bei MmT1D signifikant höher als bei MmT2D (2,3 ± 2,98 vs. 0,9 ± 2,5). Sowohl MmT1D als auch MmT2D mit mindestens einer vorausgegangenen schweren Hypoglykämie wiesen ein signifikant geringeres Wohlbefinden auf:T1D: 53,6 ± 18,0 vs. 66,0 ± 22,0; T2D: 51,9 ± 22,3 vs. 58,2 ± 22,5. Es fanden sich auch signifikant höhere diabetesbezogene Belastungen als bei MmD ohne Hypoglykämieprobleme (T1D: 41,6 ± 20,4 vs. 21,0 ± 21,6; T2D: 35,4 ± 23,8 vs. 20,8 ± 20,9). Das Auftreten schwerer Hypoglykämien ging mit signifikant höheren Hypoglykämieängsten einher (T1D: 2,8 ± 0,9 vs. 2,1 ± 0,9; T2D: 2,6 ± 1,0 vs. 2,1 ± 0,9).

Diskussion: Das Auftreten von Hypoglykämien war bei MmT1D und MmT2D mit deutlich negativen Konsequenzen auf das Wohlbefinden, dem Ausmaß diabetesbezogener Belastungen und Hypoglykämieängsten verbunden. Auch psychosozialen Konsequenzen von Hypoglykämien sollten daher thematisiert werden.}
}

@inproceedings{mattenklodt2017_41440,
  title = {Psychosoziale Belastungen der Angehörigen von Menschen mit Diabetes},
  author = {Mattenklodt, Peter and Hermanns, Norbert and Kröger, Jens and Landgraf, Rüdiger and Lüthgens, Birgit and Kulzer, Bernhard},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0034-1375159},
  urn = {urn:nbn:de:bvb:473-opus4-483682},
  url = {https://fis.uni-bamberg.de/handle/uniba/41440},
  language = {deu},
  abstract = {Hintergrund: Angehörige von Menschen mit Diabetes (AMmD) sind auf vielfältige Weise mitbetroffen. In der weltweit größten Studie zu psychosozialen Belastungen im Zusammenhang mit Diabetes (DAWN2™ Studie, n = 15.438 aus 17 Ländern) wurden erstmals auch die Auswirkungen des Diabetes auf das familiäre Umfeld systematisch untersucht. Es werden die Daten der deutschen Stichprobe präsentiert.

Methoden: An der Studie nahmen 120 AMmD stratifiziert nach Insulinbehandlung teil. Die AMmD wurden nach Belastungen im Zusammenhang mit der Diabeteserkankung ihres Angehörigen befragt und beantworteten validierte Fragebögen (PAID 5, WHO 5) zu ihrem Wohlbefinden und diabetesbezogenen Belastungen.

Ergebnisse: 37\% der Angehörigen von insulinbehandelten Menschen mit Diabetes (MmD) sowie 33\% der Angehörigen von nicht-insulinbehandelten MmD fühlten sich durch den Diabetes stark belastet (PAID), vor allem bezüglich des psychischen Wohlbefindens (38\% vs. 38\%), der Freizeitaktivitäten (34\% vs. 17\%) und der finanziellen Situation (22\% vs. 23\%). Ein deutlich reduziertes Wohlbefinden (WHO-5), welches das Vorliegen einer Depression wahrscheinlich macht, fand sich bei 13\% bzw. 12\% der AMmD. Der Anteil der AMmD mit reduziertem Wohlbefinden war ähnlich hoch wie bei MmD und damit signifikant höher als bei Menschen ohne Diabetes. Die Sorge vor Unterzuckerungen (65\% vs. 60\%) und Gewichtszunahme (56\% vs. 58\%) stellten die größte Belastung dar. 40\% der Angehörigen insulinbehandelter MmD und 33\% der Angehörigen nicht-insulinbehandelter MmD möchten ihre Unterstützung bei der Diabetesversorgung verstärken. AMmD werden von MmD als die wichtigste Quelle sozialer Unterstützung bei Diabetes angesehen.

Diskussion: AMmD sind für die soziale Unterstützung von MmD sehr wichtig. Sie sind fast in einem ähnlichen Ausmaß wie MmD durch den Diabetes belastet.}
}

@inproceedings{kulzer2017_41441,
  title = {The effect of a diabetes-specific cognitive behavioural treatment programme (DIAMOS) for people with diabetes and subthreshold depression},
  author = {Kulzer, Bernhard and Schmitt, Andreas and Gahr, Annika and Haak, Thomas and Hermanns, Norbert},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1007/s00125-014-3355-0},
  urn = {urn:nbn:de:bvb:473-opus4-484007},
  url = {https://fis.uni-bamberg.de/handle/uniba/41441},
  language = {eng},
  abstract = {Background and aims: Subthreshold depression is one of the most frequent mental comorbidities in people with diabetes and is associated with a poorer long-term prognosis. Since specific intervention concepts are missing a new self-management oriented group programme (DIAMOS) was developed for this patient group and evaluated in a randomised trial.
Materials and methods: The active control group (CG) received diabetes education. DIAMOS consisted of cognitive behavioural interventions aiming at the reduction of diabetes distress. Patients completed several questionnaires at baseline and follow-up: The Center of Epidemiological Studies-Depression Scale (CES-D), the Patient Health Questionnaire (PHQ 9), the Problem Areas in Diabetes Questionnaire (PAID) and the Diabetes Distress Scale (DDS). Primary outcome was the reduction of depressive symptoms. Secondary outcomes were diabetes distress, well-being, self-care behaviour, diabetes acceptance, diabetes treatment satisfaction, HbA1c and inflammatory markers. 214 participants were randomised.
 Results: Baseline characteristics (age 43.3 ±13.3 yrs., female gender 56.5\%, diabetes duration 14.2 ±10.5 yrs., type 2 diabetes 34.1\%, BMI 28.7 ±71 kg/m²) were comparable between both interventions groups except BMI and diabetes type. At 12-month follow-up there was a significant greater reduction of the CESD- and PHQ 9-scores in DIAMOS compared to the CG (Δ -3.7, 95\%-CI 0.57 to 6.85 p=.021 respectively Δ -1.49, 95\%-CI 0.08 to 2.90; p=.039). The risk of incident major depression was reduced (OR 0.63, 95\%-CI 0.42 to 0.96, p=.028) Also PAID-scores (Δ -8.3 95\%-CI 3.33 to 12.72, p=.001) and DDS-scores (Δ -0.22 95\%-CI 0.02 to 0.42, p=.042) were significantly reduced. C-reactive protein was significantly more lowered (Δ -0.25 95\%-CI 0.02 to0.48 p=.035). No effect of the intervention was observed in other inflammatory markers (IL1RA, IL6 and adiponectin).
 Conclusion: DIAMOS is more effective in lowering depressive symptomsand diabetes related distress in diabetic patients with subthreshold depression. DIAMOS also has a preventive effect regarding the incidence of major depression.}
}

@inproceedings{kulzer2017_41435,
  title = {Diabetesbezogene emotionale und psychische Belastungen bei Menschen mit Diabetes : Deutsche Ergebnisse der globalen DAWN2™ Studie},
  author = {Kulzer, Bernhard and Mattenklodt, Peter and Kröger, Jörg and Landgraf, Reiner and Lüthgens, Birgit and Hermanns, Norbert},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0034-1375111},
  urn = {urn:nbn:de:bvb:473-opus4-483862},
  url = {https://fis.uni-bamberg.de/handle/uniba/41435},
  language = {deu},
  abstract = {Hintergrund: Die DAWN2™ Studie ist eine globale Untersuchung in 17 Ländern (n = 15.438), bei der psychosoziale Aspekte des Diabetes von Menschen mit Diabetes (MmD), sowie deren Familienangehörigen (FM) und Behandlern (HCP) erfasst werden. In dieser Auswertung werden die deutschen Daten von MmD präsentiert.

Methoden: An dieser Studie nahmen 502 MmD stratifiziert nach Diabetestyp und Behandlung teil: 80 Typ 1 Diabetes (MmT1D), 422 Typ 2 Diabetes (MmT2D). Als Erhebungsinstrumente dienten u.a. validierte Fragebogen zu diabetesbezogenen Belastungen (PAID 5), zum Wohlbefinden (WHO 5) und der Lebensqualität (EQ-5-VAS, Health Utility Index).

Ergebnisse: Ein hoher Anteil von MmT1D (48\%) im Vergleich zu MmT2D (23,5\%) berichteten über erhöhte diabetesbezogene Belastungen. Ein deutlich reduziertes Wohlbefinden, welches das Vorliegen einer Depression wahrscheinlich macht, lag bei 13\% der MmT2D und bei 9\% der MmT1D vor. Im Vergleich zu Menschen ohne Diabetes berichten ca. doppelt so viele MmD über ein deutlich reduziertes Wohlbefinden. MmD, die über eine eingeschränkte Lebensqualität (LQ) berichteten, hatten signifikant mehr körperliche und psychische Begleiterkrankungen, welche bei MmD wesentliche Prädiktor-Variablen für eine schlechte LQ sind. Deutlich mehr MmT1D als MmT2D fühlten sich durch den Diabetes in ihren Freizeitaktivität (46\% vs. 38\%), bei der Arbeit oder dem Studium (34\% vs. 22\%) beeinträchtigt. Aufgrund der Diabeteserkrankung fanden sich 23\% aller MmT1D und 9\% aller MmT2D diskriminiert.

Diskussion: Die Ergebnisse der DAWN2™Studie zeigen, dass diabetesbezogene Belastungen bei MmD in Deutschland relativ häufig sind. Eine reduzierte LQ und ein deutlich erhöhtes Risiko für Depressionen sind mit Diabetes assoziiert. Überraschend viele MmD fühlen sich aufgrund ihrer Erkrankung diskriminiert.}
}

@article{reimer2017_41425,
  title = {Effektivität eines systematischen Depressions-Screenings bei Diabetespatienten},
  author = {Reimer, Andre and Schmitt, Andreas and Hermanns, Norbert and Kulzer, Bernhard and Haak, Thomas},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-opus4-483667},
  url = {https://fis.uni-bamberg.de/handle/uniba/41425},
  language = {deu},
  abstract = {Fragestellung: Die Komorbidität von Diabetes und Depression ist mit einer negativen Prognose assoziiert. Um die Erkennungsrate depressiver Diabetespatienten zu ermitteln, wurde in dieser Studie die Effektivität eines Depressionsscreenings auf der tertiären Versorgungsebene. (Krankenhaus) untersucht.

Methodik: Das Depressionsscreening wurde mit der „Allgemeinen Depressionsskala (ADS)“ und der „Problem Areas in Diabetes Scale (PAID)“ durchgeführt. Patienten mit positivem Screeningbefund (ADS-Wert ≥16 und/oder PAID-Wert ≥40) wurden mittels eines diagnostischen Interviews nachuntersucht.

Ergebnisse: 806 Patienten (Alter 49 ± 15, 55\% männlich, 57\% Typ-1-Diabetes, HbA1c 8,7 ± 1,6\%) nahmen an der Untersuchung teil. 325 Patienten (40\%) zeigten einen positiven Screeningbefund. Die Sensitivität des Depressionscreenings betrug 100\%, die Spezifität 79\%., der positive prädiktive Wert (ppW) 61,5\%, der negative prädiktive Wert (npW) 100\%. Von den identifizierten depressiven Patienten waren 120 bereits diagnostiziert, 80 wurden neu entdeckt. Die Sensitivität des Screenings für die Entdeckung bisher nicht erkannter Personen mit Depression ergab ebenfalls eine Sensitivität von 100\%, eine Spezifität von 79,4\% bei einem ppW von 39\% und einem npW von 100\%. Neuidentifizierte depressive Diabetiker wiesen eine annähernd ähnliche schlechte glykämische Kontrolle auf, wie bereits bekannte depressive Diabetiker 8,9 ± 1,4 vs. 8,9 ± 1,6 (p = 0,807).

Schlussfolgerungen: Es zeigte sich eine hohe Depressionsprävalenz (24,8\%). Das Depressionsscreenings wies sehr gute Screeningeigenschaften auf. Aufgrund des Depressionsscreenings konnten auch bisher unentdeckte depressive Patienten mit ausreichender Sensitivität und Spezifität identifiziert werden, welche eine unzureichende glykämische Kontrolle aufwiesen. Die große Zahl entdeckter wie unterentdeckter Menschen mit Diabetes und einer komorbiden Depression sprechen für ein routinemäßiges Depressionsscreening im Krankenhaus.}
}

@inproceedings{ehrmann2017_41437,
  title = {Fragebogen zur Zufriedenheit von Ärzten mit der Diabetestherapie},
  author = {Ehrmann, Dominic and Hermanns, Norbert and Müller, A and Weissmann, J and Haak, T. and Kulzer, Bernhard},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0034-1375144},
  urn = {urn:nbn:de:bvb:473-opus4-483943},
  url = {https://fis.uni-bamberg.de/handle/uniba/41437},
  language = {deu},
  abstract = {Fragestellung: Bisher existieren zwar Erhebungsinstrumente zur Patientenzufriedenheit, jedoch bislang noch kein Fragebogen zur Erfassung der Zufriedenheit von Ärzten mit der Diabetestherapie. In dieser Studie wurde daher ein Fragebogen entwickelt und psychometrisch evaluiert, der die Zufriedenheit des Arztes mit der Diabetestherapie (Zufr-DT) und der Analyse und Besprechung der Blutzuckerwerte (Zufr-BZ) erfasst.

Methodik: Ein Itempool (Zufr-DT, Zufr-BZ) wurde generiert und von 188 Diabetologen und Ärzten aus Deutschland beantwortet.

Ergebnisse: Die Zufr-DT-Skala enthält 13 Items und erreicht ein Cronbachs Alpha von α= 0,93 mit einer mittleren Trennschärfe von r = 0,71. Die Zufr-BZ-Skala enthält 10 Items mit einem Cronbachs Alpha von α= 0,92 und einer mittleren Trennschärfe von r = 0,73. Die Korrelation der beiden Skalen beträgt r = 0,63 (p < 0,05). Faktorenanalytisch kann die Zufr-DT-Skala in zwei Unterfaktoren „Effekte der Diabetestherapie“ und „Aufwand und Nutzen“ unterteilt werden (65\% Varianzaufklärung). Die Zufr-BZ-Skala konnte faktorenanalytisch in „Nutzung der Blutzuckerwerte“ und „Effektivität der Besprechung“ unterteilt werden (75,5\% Varianzaufklärung). Eine höhere Zufriedenheit in beiden Skalen geht einher mit einer größeren Zufriedenheit mit der Tätigkeit als Arzt (Zufr-DT: r = 0,2, p < 0,05; Zufr-BZ: r = 0,32, p < 0,05), mit einer größeren Zufriedenheit mit dem Therapieergebnis (Zufr-DT: r = 0,34, p < 0,05; Zufr-BZ: r = 0,3, p < 0,05) und einer größeren Zufriedenheit mit dem Ergebnis der ärztlichen Tätigkeit (Zufr-DT: r = 0,27, p < 0,05; Zufr-BZ: r = 0,25, p < 0,05)

Schlussfolgerungen: Mit den beiden Skalen stehen reliable und valide Instrumente zur Verfügung, um die Zufriedenheit der behandelten Ärzte zu erfassen. Mithilfe dieses Fragebogens kann zukünftig evaluiert werden, welchen Einfluss die Zufriedenheit des Arztes auf die weitere Therapie hat bzw. wodurch die Zufriedenheit des Arztes beeinflusst wird.}
}

@inproceedings{ehrmann2017_41433,
  title = {Kohlenhydratschätzung und Boluskalkulation zeigen differenzierte Assoziationen mit verschiedenen Indikatoren der glykämischen Kontrolle},
  author = {Ehrmann, Dominic and Hermanns, Norbert and Reimer, Andre and Weissmann, J and Haak, Thomas and Kulzer, Bernhard},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0034-1375025},
  urn = {urn:nbn:de:bvb:473-opus4-483934},
  url = {https://fis.uni-bamberg.de/handle/uniba/41433},
  language = {deu},
  abstract = {Fragestellung: Für die Insulindosierung müssen Diabetespatienten mit einer intensivierten Insulintherapie auf der Basis des Kohlenhydratgehalts der Nahrungsmittel und den aktuellen Blutzuckerwerten den individuellen Bolus errechnen.Die vorliegende Studie untersucht den Einfluss der Fähigkeit zur Kohlenhydratschätzung und Boluskalkulation auf den HbA1c sowie der Blutzuckerkontrolle im Alltag.

Methodik: Der SMART-Fragebogen zur Erfassung der Boluskalkulations- und Kohlenhydratschätzfähigkeiten wurde 114 Typ-1 und Typ-2-Patienten mit intensivierter Insulintherapie vorgelegt. Der HbA1c wurde im Zentrallabor gemessen. Zur Bestimmung der Blutzuckerkontrolle im Alltag wurden gespeicherten Blutzuckerwerte ausgelesen (> 56.000 Blutzuckermessungen wurden analysiert).

Ergebnisse: Eine bessere Fähigkeit zur Boluskalkulation war signifikant mit einem niedrigeren HbA1c (r =-0,39, p < 0,05), einem niedrigeren mittleren Blutzucker (r =-0,29, p < 0,05) und einer geringeren Streuung der Blutzuckerwerte (r =-0,43, p < 0,05) assoziiert. Eine bessere Fähigkeit zur Boluskalkulation ging zudem mit weniger Hyperglykämien (r =-0,32, p < 0,05) und einem niedrigeren Nüchternblutzuckerwert einher (r =-0,25, p < 0,05). Die Fähigkeit zur Kohlenhydratschätzung zeigte eine niedrige Korrelation mit dem HbA1c (r =-0,14, p > 0,05), jedoch eine signifikante Assoziation mit einem niedrigeren mittleren Blutzucker (r =-0,3, p < 0,05) und einer niedrigeren Anzahl an Hyperglykämien (r =-0,27, p < 0,05). Ein höherer Anteil an euglykämischen Blutzuckerwerten (r = 0,26, p < 0,05) und ein niedrigerer Nüchternblutzuckerwert waren ebenfalls mit einer besseren Kohlenhydratschätzung assoziiert (r =-0,25, p < 0,05).

Schlussfolgerungen: Eine bessere Fähigkeit zur Boluskalkulation geht mit einem besseren HbA1c, einem stabileren Blutzuckerverlauf und weniger Hyperglykämien im Alltag, eine gute Fähigkeit zur Kohlenhydratschätzung mit einem niedrigeren mittleren Blutzucker, weniger Hyperglykämien und einem höheren Anteil euglykämischer Blutzuckerwerte einher. Eine standardisierte Erfassung beider Fähigkeiten erscheint sinnvoll, um Patienten mit Defiziten zu identifizieren und diese bei einer Verbesserung zu unterstützen.}
}

@inproceedings{landgraf2017_41428,
  title = {Zukunftsaufgaben der Diabetologie},
  author = {Landgraf, Reiner and Kröger, Jens and Hermanns, Norbert and Mattenklodt, Peter and Lüthgens, Birgit and Kulzer, Bernhard},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0034-1375143},
  urn = {urn:nbn:de:bvb:473-opus4-483842},
  url = {https://fis.uni-bamberg.de/handle/uniba/41428},
  language = {deu},
  abstract = {Hintergrund: In der bislang weltweit größten Studie zu psychosozialen Belastungen bei Diabetes (DAWN2™, n = 15.438 aus 17 Ländern) wurden Patienten (MmD) wie Behandler nach notwendigen Weiterentwicklungen der momentanen Versorgungspraxis befragt.

Methoden: An dieser Studie nahmen in Deutschland 502 MmD stratifiziert nach Diabetestyp und Behandlung teil: 80 Typ 1 Diabetes (MmT1D), 422 Typ 2 Diabetes (MmT2D). Zusätzlich wurden 280 Behandler (Hausärzte n = 120, Fachärzte = n = 80, Diabetesberaterinnen/Diätassistenten n = 80) befragt.

Ergebnisse: Für 90\% der Diabetesberater/Innen, 84\% der Fachärzte und 82\% der Hausärzte stellt die Prävention des Diabetes die wichtigste Aufgabe und Herausforderung für die Zukunft dar. Auch bessere Strategien für den Umgang mit psychologischen Problemen der MmD (68\% vs. 55\% vs. 35\%), zur Motivation und Unterstützung langfristiger Änderungen des Lebensstils (54\% vs. 55\% vs. 45\%), der Verbesserung des Selbstmanagements (53\% vs. 42\% vs. 46\%), einem besseren Zugang zu Psychologen/Psychiatern (68\% vs. 48\% vs. 41\%), besseren Vergütungsformen (k.A. vs. 68\% vs. 56\%), einer besseren Wahrnehmung des Diabetes in der Öffentlichkeit (64\% vs. 60\% vs. 58\%), sowie der Verfügbarkeit von mehr qualifizierten Diabetesberatern (55. vs. 58\% vs. 43\%) werden von den Behandlern als bedeutsame Felder für eine Verbesserung der Diabetesversorgung erachtet. Zukünftige Antidiabetika sollen vor allem ein geringes Risiko zur Gewichtszunahme (H: 93\%, F: 89\%) und zu Hypoglykämien (H: 79\%, F: 84\%) aufweisen.

Diskussion: Die Verbesserung der Prävention stellt die wichtigste Zukunftsaufgabe der Diabetologie dar. Auch eine bessere Berücksichtigung und Behandlung psychosozialer Probleme im Zusammenhang mit Diabetes wird von der Mehrzahl der Behandler als bedeutsam eingeschätzt. Moderne Antidiabetika sollen möglichst nebenwirkungsfrei sein.}
}

@article{schall2017_41418,
  title = {Übereinstimmung von selbstberichtetem Behandlungsverhalten und klinisch-medizinischen Außenkriterien},
  author = {Schall, Sabine and Schmitt, Andreas and Hermanns, Norbert and Query, S and Kulzer, Bernhard and Haak, Thomas},
  year = {2017},
  publisher = {opus},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-opus4-483642},
  url = {https://fis.uni-bamberg.de/handle/uniba/41418},
  language = {deu},
  abstract = {Fragestellung: In der klinischen Praxis beruht die Erfassung des Selbstbehandlungsverhaltens meist auf dem Selbstbericht von Patienten. In dieser Studie wurde geprüft, inwieweit selbstberichtetes Behandlungsverhalten durch klinisch-medizinische Außenkriterien validiert werden kann. Der Diabetes Self-Management Questionnaire (DSMQ) erfasst verschiedene Aspekte des Selbstbehandlungsverhaltens: Blutzucker-Management (Skala BZ), Ernährungsverhalten (Skala DE), Arztkontakte (Skala AK) und körperliche Aktivität (Skala KA). Als klinisch-medizinische Außenkriterien dienten: Gespeicherte Werte der Blutzuckerselbstkontrolle, HbA1c-Wert, Blutfette, Gewicht, Resultate eines Fitnesstests, Fähigkeit zur Boluskalkulation, Anzahl der Folgeerkrankungen und der Arztkontakte.

Methodik: 70 Diabetespatienten (Alter 37 ± 16 Jahre; 61\% weiblich; BMI 28 ± 7 kg/m2; 79\% Typ-1; Diabetesdauer 13 ± 10J.; 96\% insulinbehandelt; HbA1c 8,9 ± 1,9\%) bearbeiteten den DSMQ.

Ergebnisse: Ein höherer Wert in der Gesamtskala des DSMQ geht mit einem niedrigeren HbA1c-Wert (r=-0,60; p < 0,001); ein besseres Blutzucker-Management (Skala BZ) mit einem geringeren HbA1c-Wert (r=-0,58, p < 0,001), einer höheren Anzahl an Blutzuckerselbstkontrollen (r= 0,49, p < 0,001) sowie einer besseren Bolusanpassung (r= 0,36, p = 0,003) einher. Ein höherer Wert in der Skala DE ist mit einem niedrigeren BMI (r=-0,27, p = 0,028) und Triglyceridwerten (r=-0,32, p = 0,009) assoziiert. Eine höherer Wert in der Skala AK korrelierte mit häufigeren Diabetologenbesuchen (r= 0,45, p < 0,001), einer geringeren Anzahl von Folgeerkrankungen (r=-0,32, p = 0,009) sowie einem geringeren HbA1c-Wert (r=-0,38, p = 0,002). Interessanterweise korrelierte die Skala KA nur mäßig mit dem erhobenen Fitnessmaß (r = 0,17 p > 0,05).

Schlussfolgerungen: Das selbstberichte Behandlungsverhalten wies besonders in den Bereichen Blutzuckermanagement, Ernährungsverhalten und Arztkontakte eine relevante Übereinstimmung mit klinisch-medizinischen Outcomes auf. Der DSMQ ist ein Selbstberichtsverfahren, welches therapeutisch relevantes Selbstbehandlungsverhalten valide und objektiv erfasst.}
}

@article{ehrmann2016_41831,
  title = {Comparison of the efficacy of a diabetes education programme for type 1 diabetes (PRIMAS) in a randomised controlled trial setting and the effectiveness in a routine care setting : Results of a comparative effectiveness study},
  author = {Ehrmann, Dominic and Bergis-Jurgan, Nikola and Haak, Thomas and Kulzer, Bernhard and Hermanns, Norbert},
  year = {2016},
  journal = {PLoS ONE / Public Library of Science},
  volume = {11},
  number = {1},
  publisher = {PLoS},
  address = {Lawrence, Kan.},
  issn = {1932-6203},
  doi = {10.1371/journal.pone.0147581},
  url = {https://fis.uni-bamberg.de/handle/uniba/41831},
  language = {eng},
  abstract = {Background: The effectiveness of an intervention in clinical practice is often reduced compared to the efficacy demonstrated in a randomised controlled trial (RCT). In this comparative effectiveness study, the RCT-proven efficacy of a diabetes education programme for type 1 diabetic patients (PRIMAS) was compared to the effectiveness observed in an implementation trial (IT) under routine care conditions.

Methods: 75 patients with type 1 diabetes received PRIMAS through an RCT, whereas 179 patients were observed in an implementation trial. Baseline characteristics and treatment outcomes at the 6-month follow-up (improvement of HbA1c, hypoglycaemia problems, and diabetes-related distress) were compared.

Results: At baseline, the type 1 diabetic patients in the RCT had a significant longer diabetes duration (18.7±12.3 vs. 13.8±12.7 yrs., p = .005), lower self-efficacy scores (21.9±4.7 vs. 23.7±6.1, p = .02) and a greater number of diabetes complications (0.8±1.3 vs. 0.4±0.9, p = .02). After 6 months, PRIMAS achieved comparable effects under RCT and implementation trial conditions, as demonstrated by improvement in HbA1c (-0.36\%±1.1 vs. -0.37±1.2; Δ -0.01, 95\% CI -0.33 to 0.31) and hypoglycaemia unawareness (-0.5±1.4 vs. -0.3±1.4; Δ 0.18, 95\% CI -0.21 to 0.57). The likelihood of clinical improvement did not depend on the trial setting (RCT vs. IT: OR 1.18, 95\% CI 0.60 to 2.33). The participants with worse glycaemic control (OR 1.40, 95\% CI 1.02 to 1.92), hypoglycaemia problems (OR 2.13, 95\% CI 1.53 to 2.97) or elevated diabetes distress (OR 1.40, 95\% CI 1.03 to 1.89) had a better chance of clinical improvement.

Conclusions: The effectiveness of PRIMAS under routine care conditions was comparable to the efficacy demonstrated in the RCT. Clinical improvement was independent of the setting in which PRIMAS was evaluated. The PRIMAS education programme for type 1 diabetes can be delivered under conditions of routine care without a loss of effectiveness, compared to its original evaluation in an RCT.},
  keywords = {PRIMAS, Insulin therapy}
}

@book{gehr2016_41820,
  title = {Spectrum Curriculum : Schulungs- und Behandlungsprogramm zur kontinuierlichen Glukosemessung (CGM) für Menschen mit Typ-1-Diabetes : Erwachsene, Eltern mit Kindern, Jugendliche},
  author = {Gehr, Bernhard and Holder, Martin and Kulzer, Bernhard and Thurm, U and Siegmund, T and Sahm, Claudia and Biermann, E and Carstensen, S and Freckmann, G and Heinemann, L and Kolossa, R and Kerth, E and Liebl, A and Lohr, R and Maier, Berthold and Remus, K and Schulz-Braun, M and Schlüter, S and Wernsing, M and Deiss, D and Heidtmann, B and Ludwig-Seibold, C and von Sengbusch, S and Wadien, T and Ziegler, R and Lange, K},
  year = {2016},
  publisher = {Verlag Kirchheim + Co. GmbH},
  address = {Mainz},
  edition = {1},
  isbn = {978-3-87409-596-9},
  url = {https://fis.uni-bamberg.de/handle/uniba/41820},
  language = {deu}
}

@article{schmitt2016_41776,
  title = {Assessing diabetes self-management with the Diabetes Self-Management Questionnaire (DSMQ) can help analyse behavioural problems related to reduced glycaemic control},
  author = {Schmitt, Andreas and Reimer, André and Hermanns, Norbert and Huber, Jörg and Ehrmann, Dominic and Schall, Sabine and Kulzer, Bernhard},
  year = {2016},
  journal = {PLoS one / Public Library of Science},
  volume = {11},
  number = {3},
  pages = {1-12},
  publisher = {PLoS},
  address = {Lawrence, Kan.},
  issn = {1932-6203},
  doi = {10.1371/journal.pone.0150774},
  url = {https://fis.uni-bamberg.de/handle/uniba/41776},
  language = {eng},
  abstract = {Aim: To appraise the Diabetes Self-Management Questionnaire (DSMQ)’s measurement of diabetes self-management as a statistical predictor of glycaemic control relative to the widely used SDSCA.

Methods: 248 patients with type 1 diabetes and 182 patients with type 2 diabetes were cross-sectionally assessed using the two self-report measures of diabetes self-management DSMQ and SDSCA; the scales were used as competing predictors of HbA1c. We developed a structural equation model of self-management as measured by the DSMQ and analysed the amount of variation explained in HbA1c; an analogue model was developed for the SDSCA.

Results: The structural equation models of self-management and glycaemic control showed very good fit to the data. The DSMQ’s measurement of self-management showed associations with HbA1c of –0.53 for type 1 and –0.46 for type 2 diabetes (both P < 0.001), explaining 21\% and 28\% of variation in glycaemic control, respectively. The SDSCA’s measurement showed associations with HbA1c of –0.14 (P = 0.030) for type 1 and –0.31 (P = 0.003) for type 2 diabetes, explaining 2\% and 10\% of glycaemic variation. Predictive power for glycaemic control was significantly higher for the DSMQ (P < 0.001).

Conclusions: This study supports the DSMQ as the preferred tool when analysing self-reported behavioural problems related to reduced glycaemic control. The scale may be useful for clinical assessments of patients with suboptimal diabetes outcomes or research on factors affecting associations between self-management behaviours and glycaemic control.},
  keywords = {Diabetes melitus, HbA1c, Type 2 diabetes, Blood sugar, Behavior, Patients, Diet, Pychometrics}
}

@article{kulzer2016_41789,
  title = {Diabetes Typ 2 : Die Umsetzung von Diabetesprävention in der Praxis},
  author = {Kulzer, Bernhard},
  year = {2016},
  journal = {Info Diabetologie : interdisziplinäre Fortbildung in der Diabetologie},
  volume = {10},
  number = {5},
  pages = {30-35},
  publisher = {Springer Medizin},
  address = {Berlin},
  issn = {1865-5459},
  doi = {10.1007/s15034-016-0950-9},
  url = {https://fis.uni-bamberg.de/handle/uniba/41789},
  language = {deu}
}

@article{schmitt2016_41790,
  title = {How to assess diabetes distress : comparison of the Problem Areas in Diabetes Scale (PAID) and the Diabetes Distress Scale (DDS)},
  author = {Schmitt, Andreas and Reimer, André and Kulzer, Bernhard and Haak, Thomas and Ehrmann, Dominic and Hermanns, Norbert},
  year = {2016},
  journal = {Diabetic Medicine},
  volume = {33},
  number = {6},
  pages = {835-843},
  publisher = {Wiley},
  address = {Chichester [u.a.]},
  issn = {1464-5491},
  doi = {10.1111/dme.12887},
  url = {https://fis.uni-bamberg.de/handle/uniba/41790},
  language = {eng}
}

@article{zahn2016_41792,
  title = {hs-CRP predicts improvement in depression in patients with type 1 diabetes and major depression undergoing depression treatment: Results from the Diabetes and Depression (DAD) study},
  author = {Zahn, Daniela and Herpertz, Stephan and Albus, Christian and Hermanns, Norbert and Hiemke, Christoph and Hiller, Wolfgang and Kronfeld, Kai and Kruse, Johannes and Kulzer, Bernd and Müller, Matthias J. and Ruckes, Christian and Petrak, Frank},
  year = {2016},
  journal = {Diabetes Care},
  volume = {39},
  number = {10},
  pages = {e171-e173},
  address = {Alexandria, Va.},
  issn = {1935-5548},
  doi = {10.2337/dc16-0710},
  url = {https://fis.uni-bamberg.de/handle/uniba/41792},
  language = {eng}
}

@article{kulzer2016_41791,
  title = {Integrated Personalized Diabetes Management (PDM): Design of the ProValue Studies: Prospective, Cluster-Randomized, Controlled, Intervention Trials for Evaluation of the Effectiveness and Benefit of PDM in Patients with Insulin-Treated Type 2 Diabetes},
  author = {Kulzer, Bernhard and Daenschel, Wilfried and Daenschel, Ingrid and Siegel, Erhard G. and Schramm, Wendelin and Parkin, Christopher G. and Messinger, Diethelm and Djuric, Zdenka and Weißmann, Jörg and Mueller, Angelika and Vesper, Iris and Heinemann, Lutz},
  year = {2016},
  journal = {Journal of Diabetes Science and Technology},
  volume = {10},
  number = {3},
  pages = {772-781},
  publisher = {Sage Publishing},
  address = {London},
  issn = {1932-2968},
  doi = {10.1177/1932296815617487},
  url = {https://fis.uni-bamberg.de/handle/uniba/41791},
  language = {eng}
}

@article{erbach2016_41779,
  title = {Interferences and Limitations in Blood Glucose Self-Testing : An Overview of the Current Knowledge},
  author = {Erbach, Michael and Freckmann, Guido and Hinzmann, Rolf and Kulzer, Bernhard and Ziegler, Ralph and Heinemann, Lutz and Schnell, Oliver},
  year = {2016},
  volume = {10},
  number = {5},
  pages = {1161-1168},
  publisher = {Sage Publishing},
  address = {London},
  issn = {1932-2968},
  doi = {10.1177/1932296816641433},
  url = {https://fis.uni-bamberg.de/handle/uniba/41779},
  language = {eng}
}

@article{hummel2016_41786,
  title = {Online-Studie : Zusammenarbeit bei der Versorgung von Patienten mit Typ-2-Diabetes},
  author = {Hummel, Michael and Simon, J and Jacob, S. and Braun, P and Haller, N and Vogel, C and Koch, K and Kulzer, Bernhard and Schnell, O and Heinemann, L},
  year = {2016},
  journal = {Diabetes, Stoffwechsel und Herz = Diabetes, metabolism, and the heart},
  volume = {25},
  number = {3},
  pages = {151-158},
  publisher = {Kirchheim-Verlag},
  address = {Mainz},
  issn = {1861-7603},
  url = {https://fis.uni-bamberg.de/handle/uniba/41786},
  language = {deu}
}

@article{hermanns2016_41784,
  title = {Response to Comment on Hermanns et al. The Effect of a Diabetes-Specific Cognitive Behavioral Treatment Program (DIAMOS) for Patients With Diabetes and Subclinical Depression: Results of a Randomized Controlled Trial},
  author = {Hermanns, Norbert and Schmitt, Andreas and Reimer, André and Ehrmann, Dominic and Haak, Thomas and Kulzer, Bernhard},
  year = {2016},
  journal = {Diabetes Care},
  volume = {39},
  number = {1},
  pages = {e13-e14},
  address = {Alexandria, Va.},
  issn = {1935-5548},
  doi = {10.2337/dci15-0017},
  url = {https://fis.uni-bamberg.de/handle/uniba/41784},
  language = {eng}
}

@article{heinemann2016_41782,
  title = {Usability of medical devices for patients with diabetes who are visually impaired or blind},
  author = {Heinemann, Lutz and Droßel, Diana and Freckmann, Guido and Kulzer, Bernhard},
  year = {2016},
  journal = {Journal of diabetes science and technology : JDST},
  volume = {10},
  number = {6},
  pages = {1382-1387},
  publisher = {Sage Publishing},
  address = {London},
  issn = {1932-2968},
  doi = {10.1177/1932296816666536},
  url = {https://fis.uni-bamberg.de/handle/uniba/41782},
  language = {eng}
}

@article{ehrmann2016_41766,
  title = {Development of a new tool to assess bolus calculation and carbohydrate estimation},
  author = {Ehrmann, Dominic and Hermanns, Norbert and Reimer, André and Weißmann, Jörg and Haak, Thomas and Kulzer, Bernd},
  year = {2016},
  volume = {18},
  number = {3},
  pages = {194-199},
  publisher = {Liebert},
  address = {Larchmont, NY},
  issn = {1557-8593},
  doi = {10.1089/dia.2015.0292},
  url = {https://fis.uni-bamberg.de/handle/uniba/41766},
  language = {eng}
}

@article{hermanns2016_41769,
  title = {How should we treat people with diabetes and comorbid depression?},
  author = {Hermanns, Norbert and Ehrmann, Dominic and Kulzer, Bernhard},
  year = {2016},
  journal = {Journal of Diabetes and its Complications},
  volume = {30},
  number = {2},
  pages = {187-188},
  publisher = {Elsevier},
  address = {Amsterdam [u.a.]},
  issn = {0891-6632},
  doi = {10.1016/j.jdiacomp.2015.11.023},
  url = {https://fis.uni-bamberg.de/handle/uniba/41769},
  language = {eng}
}

@inproceedings{ehrmann2016_41417,
  title = {The Influence of Diabetes-related Distress on Depression},
  author = {Ehrmann, Dominic and Hermanns, Norbert and Haak, Thomas and Kulzer, Bernhard},
  year = {2016},
  publisher = {opus},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-opus4-483042},
  url = {https://fis.uni-bamberg.de/handle/uniba/41417},
  language = {eng},
  abstract = {Depressive disorders in diabetic patients are nearly twice as likely compared to the non-diabetic population. There is evidence that patients’ perception of diabetes is a decisive aspect of this association. Therefore this study prospectively investigates the role of patients’ perceived diabetesrelated distress on incidence depression and recovery. 343 patients with type 1 diabetes completed the CES-D and the Problems Areas in Diabetes Scale (PAID) at baseline and at the 6-month follow-up. A CES-D score of ≥16 indicated elevated depressive symptoms. A PAID score of ≥30 indicated elevated diabetes-related distress. Logistic regression analyses were performed with recovery from and incidence of depressive symptoms as dependent variables. Independent variable was diabetesrelated distress adjusted for possible demographic (age, gender, BMI) and medical confounders (diabetes duration, HbA1c, insulin pump therapy, and late complications). At baseline 130 patients (37.9\%) reported elevated depressive symptoms and 40 of these patients (30.8\%) recovered 6 months later. Of the 213 patients without elevated depressive symptoms, 27 (12.7\%) had elevated depressive symptoms 6 months later. Diabetes-related distress at baseline diminished the chance to recover from elevated depressive symptoms by 64\% (OR = 0.36, p<.05). In addition, the chance for incident depressive symptoms if diabetes-related distress was present at baseline is 2.5 times more likely in contrast to no diabetes-related distress at baseline (OR=2.5; p<.05). In both analyses, no other variables reached a signifi cant influence. It could be demonstrated that preventing diabetes-related distress is a protective factor regarding the incidence of elevated depressive symptoms. Furthermore, preventing diabetes-related distress supports the recovery from already elevated depressive symptoms. This supports the notion that diabetes per se is not a risk factor for depressive disorders but the perceived emotional distress is.}
}

@inproceedings{ehrmann2016_41401,
  title = {A new assessment tool to measure the ability of Bolus Calculation and Carbohydrate Estimation (SMART)  in people with diabetes performing an intensive insulin therapy},
  author = {Ehrmann, Dominic and Hermanns, Norbert and Reimer, Andre and Weißmann, Jörg and Haak, Thomas and Kulzer, Bernhard},
  year = {2016},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1007/s00125-014-3355-0},
  urn = {urn:nbn:de:bvb:473-opus4-483058},
  url = {https://fis.uni-bamberg.de/handle/uniba/41401},
  language = {eng},
  abstract = {Background and aims: Intensive insulin therapy relies on correct prandial insulin dose adaptation dependent from current glucose level, amount of planned carbohydrate intake and the consideration of other situational factors like physical activity or circadian fluctuation of insulin sensitivity. People with diabetes and intensive insulin therapy should be able to estimate carbohydrates and calculate insulin bolus correctly, while regarding the factors mentioned above. An assessment tool for the measurement of the ability of carbohydrate estimation and bolus calculation is missing. The objective of this study was the development and psychometric evaluation of an assessment tool for carbohydrate estimation and bolus calculation (“aSsessMent of the Ability of Bolus Calculation and CaRbohydrate esTimation” SMART). Of special interest were the associations of both abilities with glycaemic control.
Materials and methods: The SMART consisted of one scale for the assessment of bolus calculation (BOLUS) with 10 items and a scale for carbohydrate estimation (CARB) with 12 items. People with type 1 or type 2 diabetes on an intensive insulin regimen were invited to participate. HbA1c and stored data of blood glucose meters were used to determine glycaemic control.
Results: 411 patients participated (age 42.9 ±15.7, 58\% female, HbA1c 8.6 ±1.8\%, 28\% with CSII-treatment) and approx. 56,000 blood glucose meter readings could be obtained. The reliability of both scales was sufficient (Cron-bachs alpha for BOLUS r= 0.78 and the CARB r = 0.67). Better bolus calculation was associated with a higher level of education (r = 0.24, p<.05), lower HbA1c (r = -0.27, p<.05), lower mean blood glucose (r = -0.29, p<.05), and a lower standard deviation of blood glucose values (r = -0.43, p<.05). Better carbohydrate estimation was associated with a lower body mass index (r =-0.2, p<.05), lower mean blood glucose (r = -0.3, p<.05), a lower frequency of hyperglycaemia (r = -0.27, p<.05), and a higher frequency of euglycaemia (r = 0.26, p<.05). Patients with an insulin pump were better on both scales than patients with multiple daily insulin injections (BOLUS: 7.2 ± 2.4 vs. 6.4 ± 2.7, p<.01; CARB: 7.8 ± 2.1 vs. 7.1 ± 2.6, p<.01). Patients with previous diabetes education performed significantly better on both scales (BOLUS: 6.8 ± 2.5 vs. 5.7 ± 2.8, p<.01; CARB: 7.4 ± 2.4 vs. 6.5 ± 2.6, p<.01).
Conclusion: SMART provides a reliable and valid assessment of the ability to estimate the correct amount of carbohydrates and to calculate the appropriate prandial insulin dose. SMART is also sensitive to depict effects of diabetes education and of CSII treatment in comparison to multiple daily insulin injections. In summary SMART can assist the identification of people with diabetes on an intensive insulin regimen, who are in need for improvements in carbohydrate estimation and/or calculation of prandial insulin dose}
}

@article{gerlach2016_41318,
  title = {Soziale Ungleichheit und Diabetes},
  author = {Gerlach, Stefanie and Kulzer, Bernhard},
  year = {2016},
  journal = {Deutscher Gesundheitsbericht Diabetes : die Bestandsaufnahme},
  pages = {207-216},
  publisher = {Kirchheim},
  address = {Mainz},
  issn = {1614-824X},
  url = {https://fis.uni-bamberg.de/handle/uniba/41318},
  language = {deu},
  abstract = {Soziale Faktoren spielen bei der Entstehung, Behandlung und Prognose des Diabetes eine bedeutsame Rolle. Auch wenn von unterschiedlicher genetischer Vorprägung abgesehen wird, haben nicht alle Menschen dieselbe Chance, gesund zu bleiben und die Erkrankung Typ-2-Diabetes zu vermeiden. Ebenso sind das Erreichen der Therapieziele, die Entwicklung von Folgekomplikationen des Diabetes und die Lebenserwartung auch von sozialen Faktoren abhängig.}
}

@article{hermanns2016_40898,
  title = {The impact of continuous glucose monitoring (CGM) on low interstitial glucose values and low blood glucose values assessed by Point-of-Care glucose meters (POC-GM).},
  author = {Hermanns, Norbert and Schumann, Beatrix and Kulzer, Bernhard and Haak, Thomas},
  year = {2016},
  publisher = {opus},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-opus4-474953},
  url = {https://fis.uni-bamberg.de/handle/uniba/40898},
  language = {eng},
  abstract = {The impact of CGM on the duration of periods with low glucose measured in interstitial fluid is well known. But studies showing an impact of CGM on low blood glucose values, measured by POC-GM are rare. This crossover study examines the impact of CGM on duration of periods spent in low interstitial glucose range (70 mg/dl) as well as on the proportion of low blood glucose (BG) values measured by POC-GM (Glukometer 3000, Bio Sensor Technology, Germany)and time until detection of low BG by use of POC-GM. 41 type 1 diabetic patients (age 42.0 ±11.3 yrs, diabetes duration 15.3 ±10.1; A1c 8.2 ±1.4\%) used the DEXCOM 7 Plus CGM system twice; once participants were blinded against the results and in the other study phase (Open GCM) patients received real-time glucose values and current glucose trends, used the CGM data to determine their insulin dose, and were alerted if hypoglycaemic or hyperglycaemic glucose ranges were approached. In addition, BG was routinely measured 6 times a day by POC-GM. The order of study phases was randomized. The time spent in a hypoglycaemic glucose range (< 70 mg/dl) was reduced by open CGM from 180.6 ±125 to 125 ± 89.2 minutes per day (p=.005). Also time spent in the euglycemic glucose range was increased from 946 ±176 to 1023 ±168 minutes per day (p=.003). Open CGM reduced the proportion of low BG measurements by POC-GM from 10.3 ±7.6\% to 7.4 ±5.8\% (p=.039), whereas the euglycemic POC readings was increased from 68.3 ±12.1\% to 73.7 ±12.1\% (p=.007). The time until a hypoglycaemic BG value was detected by POC-GM was signifi cantly (p.028) shortened by 33.1 (95\% CI 3.8 -62.3) minutes.
These results demonstrate that CGM used for insulin dosing and hypoglycaemia alerts not only diminishes low interstitial glucose values but also reduces the proportion of low BG measured by POC-GM. In addition the time for the detection of a hypoglycaemic episode by POC-GM was significantly shortened}
}

@inproceedings{schmitt2016_40731,
  title = {Diabetesspezifische Risikofaktoren depressiver Stimmung in querschnittlichen und prospektiven Analysen},
  author = {Schmitt, Andreas and Reimer, Andre and Kulzer, Bernhard and Haak, Thomas and Ehrmann, Dominic and Hermanns, Norbert},
  year = {2016},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0035-1549729},
  urn = {urn:nbn:de:bvb:473-opus4-471188},
  url = {https://fis.uni-bamberg.de/handle/uniba/40731},
  language = {deu},
  abstract = {Fragestellung: Depression ist eine häufige Komorbidität des Diabetes. Allerdings ist weitgehend unklar, welche spezifischen Diabetesmerkmale das gesteigerte Depressionsrisiko hervorrufen. Diese Studie untersucht diabetesspezifische Merkmale als Risikofaktoren depressiver Stimmung.

Methodik: 325 Diabetespatienten (Alter: 44 ± 15; 52\% weiblich; BMI: 29 ± 7 kg/m2; 66\% Typ-1-Diabetes; 94\% mit Insulin; HbA1c: 8,7 ± 1,7\%) wurden untersucht, 215 im 12-Monats-Follow-Up (FU) nachuntersucht. Als Risikofaktoren depressiver Stimmung (ADS) wurden Folgekrankheiten (Retinopathie, Neuropathie, Nephropathie, Fußsyndrom, KHK, AVK), Stoffwechselentgleisungen (Hypoglykämie mit Bewusstlosigkeit, Ketoazidose mit Arztbehandlung [6-Monats-Anamnese]) und psychologische Merkmale (Diabetes-Nonakzeptanz [AADQ], Angst vor Folgekrankheiten [Skala aus PAID/DDS-Items; α= 0,77], Diabetesbelastung [DDS]) erfasst. Adjustierte (für Geschlecht, Alter, BMI, Bildung, Diabetestyp, Diabetesdauer, Insulinbehandlung) querschnittliche und prospektive Assoziationen wurden mittels multipler Regression analysiert.

Ergebnisse: Als querschnittliche Prädiktoren depressiver Stimmung erwiesen sich eine Nephropathie (r= 0,14, p< 0,05), höhere Diabetes-Nonakzeptanz (r= 0,13, p< 0,05), höhere Diabetesbelastung (r= 0,25, p< 0,001) und höhere Angst vor Folgekrankheiten (r= 0,23, p< 0,001); andere Folgekrankheiten (alle p≥0,46) und Stoffwechselentgleisungen (alle p≥0,12) zeigten keinen signifikanten Prädiktionswert. Als prospektive Prädiktoren depressiver Stimmung im 12-Monats-FU erwiesen sich eine Nephropathie (r= 0,17, p< 0,05), höhere Diabetes-Nonakzeptanz (r= 0,16, p< 0,05) und höhere Angst vor Folgekrankheiten (r= 0,23, p< 0,01) bei Baseline; andere Folgekrankheiten (alle p≥0,60), Stoffwechselentgleisungen (alle p≥0,54) und Diabetesbelastung (p= 0,26) (Baseline) zeigten keinen signifikanten Prädiktionswert.

Schlussfolgerungen: Die Befunde legen nahe, dass weder Stoffwechselentgleisungen noch die untersuchten Folgekrankheiten (außer der Nephropathie) das Depressionsrisiko bedeutend steigern. Als Risikofaktoren aktueller Depressivität kommen Nephropathie, Diabetes-Nonakzeptanz, Diabetesbelastung und Angst vor Folgekrankheiten, als Risikofaktoren zukünftiger Depressivität Nephropathie, Diabetes-Nonakzeptanz und Angst vor Folgekrankheiten in Frage.

Unterstützt vom „Kompetenznetz Diabetes mellitus“ (FKZ01GI1107).}
}

@inproceedings{kulzer2016_40728,
  title = {Differentielle Effekte der strukturierten Gruppenschulung bei Patienten mit einer ICT und CSII},
  author = {Kulzer, Bernhard and Ehrmann, Dominic and Bergis, Nikola and Haak, Thomas and Hermanns, Norbert},
  year = {2016},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0035-1549607},
  urn = {urn:nbn:de:bvb:473-opus4-471102},
  url = {https://fis.uni-bamberg.de/handle/uniba/40728},
  language = {deu},
  abstract = {Einleitung: Typ -1-Diabetiker wurden in einer randomisierten Studie mit PRIMAS oder dem ZI-Programm für Typ-1-Diabetes (n = 160) bzw. in einer Umsetzungsstudie (PRIMUM n = 249) mit PRIMAS geschult. Von 409 Studienteilnehmern wurden 19\% mit einer Insulinpumpe (CSII) behandelt. Untersucht wurde, inwieweit sich Typ-1-Diabetiker mit CSII initial und nach der Schulung von Patienten mit einer intensivierten Insulintherapie (ICT) unterscheiden.

Methodik: Zur Baseline und nach 6 Monaten wurden HbA1c-Werte bestimmt und Fragebögen zur Diabetesbelastung (DDS) und zur Hypoglykämiewahrnehmungsfähigkeit (HAQ) bearbeitet.

Ergebnisse: Patienten mit CSII Therapie unterschieden sich zur Baseline nur hinsichtlich ihrer Diabetesdauer (22,0 ± 10,8 vs. 11,0 ± 12,3 Jahre, p < 0,01) von Patienten mit ICT. Alter (43,8 ± 14,0 vs. 44,1 ± 13,6 Jahre, p = 0,86), Geschlecht (47\% vs. 42\% weiblich, p = 0,42), glykämische Kontrolle (8,1 ± 1,3 vs. 8,1 ± 1,1, p = 0,81), Hypoglykämiewahrnehmung (1,6 ± 1,5 vs. 1,7 ± 1,8, p = 0,93), Diabetesbelastung (1,1 ± 0,9 vs. 1,1 ± 10,7, p = 0,93) unterschieden sich zur Baseline nicht zwischen beiden Gruppen. Patienten mit CSII profitierten in Hinblick auf den HbA1c signifikant geringer als ICT-Patienten (HbA1c -0,0 ± 0,7 vs. -0,4 ± 1,1\%, p = 0,01) von der Schulung. Bezüglich einer Verbesserung der Hypoglykämiewahrnehmungsfähigkeit (0,5 ± 11,4 vs. 0,4 ± 1,4, p = 0,32) und des Diabetesbelastung (-0,3 ± 0,6 vs.-0,2 ± 0,6, p = 0,13) unterschieden sich beide Patientengruppen ebenfalls nicht.

Schlussfolgerung: Obwohl eine CSII-Therapie potenziell die beste Blutzuckersteuerung erlaubt, hatten Patienten mit einer CSII-Therapie initial keine besseren HbA1c-Werte als die ICT-Patienten. CSII-Patienten profitierten auch im Hinblick auf die glykämische Kontrolle weniger von der Schulung. Es erscheint daher sinnvoll, für Patienten mit einer CSII-Therapie spezielle Schulungsinterventionen zu entwickeln.}
}

@inproceedings{schall2016_40727,
  title = {Einflussfaktoren auf die gesundheitsbezogene Lebensqualität bei Menschen mit Typ-2-Diabetes},
  author = {Schall, Sabine and Hermanns, Norbert and Kulzer, Bernhard and Haak, Thomas},
  year = {2016},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0035-1549641},
  urn = {urn:nbn:de:bvb:473-opus4-471124},
  url = {https://fis.uni-bamberg.de/handle/uniba/40727},
  language = {deu},
  abstract = {Fragestellung: In dieser Studie wurde untersucht, inwieweit sich Typ-2-Diabetespatienten mit intensivierter (ICT) und nicht-intensivierter Insulintherapie (NIT) hinsichtlich ihrer gesundheitsbezogenen Lebensqualität unterscheiden und welche Faktoren diese beeinflussen.

Methodik: Lebensqualität wurde mittels EQ-5D erfasst. Neben univariaten Analysen wurde eine multivariate Regressionsanalyse durchgeführt. Abhängige Variable war die Lebensqualität, unabhängige Variablen waren demographische und diabetesspezifische Parameter.

Ergebnisse: Beide Gruppen (N = 356; 52\% NIT vs. 48\% ICT) wiesen die gleiche Alters- und Geschlechterverteilung (62,8 ± 8,2 Jahre; 45\% weiblich) auf. ICT-Patienten zeigten eine signifikant längere Diabetesdauer 11,6 ± 6,9 vs. 13,7 ± 7,6 Jahre (p = 0,005) und Dauer der Insulintherapie 2,7 ± 4,1 vs. 5,4 ± 5,0 Jahre (p = 0,001), höheren BMI 31,5 ± 5,2 vs. 33,3 ± 5,9 kg/m2 (p = 0,003), häufigere BZSK/Tag 2,25 ± 1,49 vs. 3,33 ± 1,37 (p = 0,001) und Insulininjektionen/Tag 2,33 ± 4,15 vs. 3,93 ± 2,44 (p = 0,001) sowie einen höheren HbA1c 7,9 ± 1,2 vs. 8,3 ± 1,4\% (p = 0,004) und geringere diabetesbezogene Belastungen 26,77 ± 19,39 vs. 23,61 ± 16,21 (p = 0,097). Gleichzeitig zeigte die ICT-Stichprobe eine signifikant geringere Lebensqualität als die NIT-Stichprobe (0,86 ± 0,16 vs. 0,81 ± 0,21; p = 0,019).

In einer multivariaten Analyse hatten diabetesbezogene Belastungen den größten Einfluss auf die Lebensqualität (β=-0,24; p = 0,001), gefolgt von der Anzahl der Folgekomplikationen (β=-0,14; p = 0,005), weiblichem Geschlecht (β=-0,13; p = 0,013), erhöhtem BMI (β=-0,12; p = 0,018). Die Therapieform blieb ein signifikanter Prädiktor (β=-0,12; p = 0,028). Alter, Diabetesdauer, HbA1c und Blutzuckerselbstkontrollen/Tag hatten multivariat keinen signifikanten Einfluss auf die Lebensqualität.

Schlussfolgerungen: Patienten mit einer ICT berichten eine signifikant geringere Lebensqualität als Patienten mit einer NIT. Dieser Unterschied bleibt auch multivariat nach Kontrolle demographischer und diabetesspezifischer Variablen bestehen. Aufgrund ihres großen Einflusses sollten diabetesbezogene Belastungen in der Behandlung von Typ-2-Diabetikern größere Beachtung finden. Übergewichtige Patienten mit Folgeerkrankungen scheinen eine Risikogruppe für eine reduzierte Lebensqualität zu bilden.}
}

@inproceedings{schmitt2016_40733,
  title = {Entwicklung und erste Evaluation eines Fragebogens zur Erfassung von Abwehr/Vermeidung versus Akzeptanz/Integration des Diabetes : „Denial versus Integration of Diabetes Scale (DIDS)“},
  author = {Schmitt, Andreas and Reimer, Andre and Ehrmann, Dominic and Kulzer, Bernhard and Haak, Thomas and Hermanns, Norbert},
  year = {2016},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0035-1549643},
  urn = {urn:nbn:de:bvb:473-opus4-471161},
  url = {https://fis.uni-bamberg.de/handle/uniba/40733},
  language = {deu},
  abstract = {Fragestellung: Ungenügende Diabetes-Akzeptanz ist assoziiert mit nonadhärenter Selbstbehandlung und Hyperglykämie. Allerdings existierte bislang nur ein Messinstrument, welches zudem das Konstrukt unvollständig erfasst. Für differenziertere Messungen wurde die DIDS entwickelt, deren Entwicklung und erste Evaluation hier beschrieben wird.

Methodik: 56 Items bezüglich Abwehr/Vermeidung („Ich schiebe den Diabetes oft beiseite“; 29 Items) versus Akzeptanz/Integration („Der Diabetes gehört zu mir“; 27 Items) und eine vierstufige Likert-Antwortskala (0-„trifft nicht zu“ bis 3-„trifft voll zu“) wurden entwickelt. In einer Pilotstudie mit 222 Diabetespatienten (49 ± 16 Jahre; 49\% weiblich; 64\% Typ-1-Diabetes; HbA1c: 8,5 ± 1,7\%) wurden suboptimale Items ausgeschlossen und die Skala finalisiert.

Ergebnisse: 28 Items wurden ausgeschlossen. Eine Faktorenanalyse ergab vier Faktoren („Akzeptanz/Integration“ (7 Items/α= 0,93), „Behandlungsmotivation“ (7 Items/α= 0,93), „Abwehr/Vermeidung“ (7 Items/α= 0,91), „Emotionales Leiden“ (7 Items/α= 0,92)) mit 71\% Varianzaufklärung. Die Summenskala zeigte hohe Reliabilität (α= 0,97). Höhere DIDS-Summenwerte (bessere Akzeptanz/Integration) korrelierten mit männlichem Geschlecht (r= 0,13, p< 0,05), Lebensalter (r= 0,29, p< 0,001), Diabetesdauer (r= 0,15, p< 0,05) und HbA1c-Wert (r=-0,20, p< 0,01), jedoch nicht Diabetestyp (p= 0,74) oder Folgekrankheiten (alle p≥0,11). Patienten mit unterdurchschnittlichen DIDS-Werten (T-Standardwerte< 40; mehr Abwehr/Vermeidung) zeigten häufiger die ICD-F54-Diagnose „Diabetes-Akzeptanzprobleme“ (29\% vs. 9\%, p< 0,01), mehr Depressionsdiagnosen (38\% vs. 14\%, p< 0,001) und schlechtere HbA1c-Werte (9,0 ± 1,9 vs. 8,3 ± 1,6\%, p< 0,05).

Schlussfolgerungen: Die Studie zeigt erste Evidenz für Reliabilität und Validität der Erfassung von Abwehr/Vermeidung versus Akzeptanz/Integration des Diabetes mit der DIDS. Daten zur Erweiterung dieser Evidenz werden gesammelt.

Unterstützt vom „Kompetenznetz Diabetes mellitus“ (FKZ01GI1107).}
}

@inproceedings{reimer2016_40725,
  title = {Geringere Lebensqualität und höhere gesundheitsökonomische Kosten bei Menschen mit Diabetes und erhöhter Depressivität},
  author = {Reimer, Andre and Schmitt, Andreas and Ehrmann, Dominic and Hermanns, Norbert and Kulzer, Bernhard and Haak, Thomas},
  year = {2016},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0035-1549638},
  urn = {urn:nbn:de:bvb:473-opus4-471116},
  url = {https://fis.uni-bamberg.de/handle/uniba/40725},
  language = {deu},
  abstract = {Fragestellung: Depressive Symptome kommen bei Menschen mit Diabetes häufiger vor als in der Normalbevölkerung und werden mit geringerer gesundheitsbezogener Lebensqualität, höheren Gesundheitskosten sowie Produktivitätseinbußen am Arbeitsplatz assoziiert. Diese Studie untersuchte, inwiefern Depressivität auch bei Diabetespatienten mit gesundheitsökonomischen Belastungen einhergeht.

Methodik: Erhöhte Depressivität wurde mit der Allgemeinen Depressionsskala (ADS≥16), gesundheitsbezogene Lebensqualität mit dem Shortform-36-Health-Survey (SF-36) sowie dem EuroQol-Five-Dimensions-Questionnaire (EQ-5D) erhoben. Teilnehmende Patienten wurden zu ihrem Gesundheitsverhalten befragt.

Ergebnisse: 324 Diabetespatienten (Alter 43 ± 15 Jahre, 52\% weiblich, 66\% Typ-1-Diabetes, Diabetesdauer 14 ± 10 Jahre, HbA1c 8,7 ± 1,7\%) nahmen an der Untersuchung teil.

Unter Adjustierung für Geschlecht, Alter und Diabetestyp zeigten Patienten mit depressiver Stimmung eine geringere Lebensqualität nach EQ-5D (0,86 ± 0,22 vs. 0,92 ± 0,15; p= 0,03) sowie stärkere Beeinträchtigungen nach SF-36 hinsichtlich körperlicher (45,3 ± 11,7 vs. 48,8 ± 9,4; p< 0,01) und insbesondere psychischer (32,9 ± 10,3 vs. 50,5 ± 9,7; p< 0,001) Gesundheit.

Erhöhte Depressivität war außerdem mit signifikant mehr Hausarztbesuchen (5,1 ± 7,0 vs. 3,3 ± 4,3; p= 0,02), psychologischen Terminen (0,3 ± 1,4 vs. 0,1 ± 0,5; p= 0,04) und Krankschreibungstagen (10,6 ± 21,2 vs. 5,5 ± 18,3; p< 0,05) pro Halbjahr, sowie Medikamenteneinnahmen (2,8 ± 3,0 vs. 2,2 ± 2,4; p= 0,05) verbunden, nicht jedoch mit mehr Diabetologenbesuchen (2,5 ± 3,3 vs. 2,1 ± 2,1; p= 0,32) und Krankenhaustagen (2,6 ± 6,5 vs. 1,5 ± 4,0; p= 0,12).

Schlussfolgerungen: Die Ergebnisse zeigen, dass Depressivität bei Diabetespatienten mit einer erheblich geringeren subjektiven Lebensqualität und einer negativeren Gesundheitswahrnehmung vor allem im psychischen Bereich assoziiert ist, während Unterschiede hinsichtlich körperlicher Gesundheit zwar signifikant, aber weniger ausgeprägt waren. Zugleich berichteten Patienten mit depressiver Stimmung eine signifikant höhere Inanspruchnahme von Gesundheitsleistungen. Die höhere Anzahl von Krankschreibungstagen suggeriert dabei zusätzlich Produktivitätseinbußen durch unbehandelte depressive Symptome bei Menschen mit Diabetes.

Unterstützt vom „Kompetenznetz Diabetes mellitus“ (FKZ01GI1107).}
}

@inproceedings{hermanns2016_40722,
  title = {Entwicklung und Evaluation eines Assessment-Tools zur Erfassung von Barrieren der Blutzuckerselbstkontrolle.},
  author = {Hermanns, Norbert and Ehrmann, Dominic and Schall, Sabine and Kulzer, Bernhard and Haak, Thomas},
  year = {2016},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0035-1549821},
  urn = {urn:nbn:de:bvb:473-opus4-471083},
  url = {https://fis.uni-bamberg.de/handle/uniba/40722},
  language = {deu},
  abstract = {Einleitung: Eine regelmäßige Blutzuckerselbstkontrolle ist ein wesentlicher Bestandteil für eine erfolgreiche Anpassung oder Überprüfung der Diabetestherapie. Viele Patienten berichten Barrieren, die einer regelmäßigen Blutzuckerselbstkontrolle im Alltag entgegenstehen. In dieser Studie wurde ein Assessment-Tool für die Erfassung solcher Barrieren entwickelt und evaluiert.

Methodik: Patienteninterviews zu Erfahrungen mit der Blutzuckerselbstkontrolle wurden durchgeführt und ausgewertet. Folgende Aspekte erwiesen sich in Bezug auf die Blutzuckerselbstkontrolle als relevant: Handling im Alltag („Zu viele Utensilien sind notwendig“), psychologische Barrieren der Glukosekontrolle („Blutzuckerselbstkontrolle in der Öffentlichkeit ist peinlich“), Zuverlässigkeit der Blutzuckerselbstkontrolle („Vertrauen in die gemessenen Blutzuckerwerte“), aber auch Vorteile der Blutzuckerselbstkontrolle („Blutzuckermessungen vermitteln ein Sicherheitsgefühl“). Zur Evaluation wurden Faktoren- und Itemanalysen vorgenommen.

Ergebnisse: 60 Fragebogenitems wurden einer diabetischen Stichprobe (n = 140) mit intensivierter Insulintherapie (Alter 43,6 ± 15,3J., 70\% Typ-1-Diabetes, HbA1c 8,8 ± 2,1\%; 53\% weiblich) vorgegeben. Die Faktorenanalyse ergab 4 Skalen mit insgesamt 18 Items, die alle zufriedenstellende Reliabilitätskennwerte erreichten („Handling“ Cronbachs a = 0,84; „psychologische Barrieren“ a = 0,74, „Zuverlässigkeit“ a = 0,82 und „Vorteile der Blutzuckerselbstkontrolle“ a = 0,72). Ein hoher HbA1c Wert war signifikant mit höheren psychologischen Barrieren (r = 0,20) und geringerem Vertrauen in die Zuverlässigkeit (r = 0,32) sowie geringeren Vorteilen der Blutzuckerselbstkontrolle (r = 0,32) assoziiert. Höheres Lebensalter (r = 0,32) und längere Diabetesdauer (r = 0,19) waren mit weniger psychologischen Barrieren der Blutzuckerselbstkontrolle korreliert. Patienten, welche mehr psychologische Barrieren berichteten, testeten seltener ihren Blutzucker (r =-0,26).

Schlussfolgerung: Das neue entwickelte Assessment-Tool zur Erfassung von Barrieren der Blutzuckerselbstkontrolle hat eine gute Reliabilität sowie Validität. Zudem ist es in der Lage, praktische Barrieren einer Blutzuckerselbstkontrolle bei Diabetespatienten zu identifizieren.

Unterstützt durch Abbott Diabetes Care, Germany}
}

@inproceedings{hermanns2016_40720,
  title = {Erhöhte Depressivität ist mit systemischen Inflammationsmarkern bei Diabetes mellitus assoziiert.},
  author = {Hermanns, Norbert and Schmitt, Andreas and Reimer, A. and Herder, C. and Haak, Thomas and Kulzer, Bernhard},
  year = {2016},
  publisher = {opus},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-opus4-471073},
  url = {https://fis.uni-bamberg.de/handle/uniba/40720},
  language = {deu},
  abstract = {Einleitung: Bei Nichtdiabetikern ist eine erhöhte Depressivität mit erhöhten systemischen Inflammationsmarkern assoziiert. In dieser Studie wurde untersucht, inwieweit hsCRP, IL-6, IL-18, IL-1RA, MCP-1 und Adiponektin bei Diabetikern mit einer erhöhten Depressivität assoziiert sind. Zusätzlich wurde geprüft, ob eine signifikante Verbesserung der Depressivität auch mit einer Reduktion der oben genannten Inflammationsparameter nach einem Jahr einhergeht.

Methodik: Die Depressivität wurde mittels des CES-D gemessen. Eine signifikante Verbesserung der Depressivität lag vor, wenn sich der Depressionsscore im 1-Jahres-Follow-up um mehr als 9,1 Punkte (reliabler Veränderungsindex) reduzierte. Zur Baseline und nach einem Jahr wurden die oben genannten Inflammationsparameter bestimmt. Die multivariate Analyse wurde für Alter, Geschlecht, BMI, HbA1c, Diabetestyp und Medikamenteneinnahme (Statine, NSAID, Antikoagulanzien und Thyroide) adjustiert.

Ergebnisse: Die Stichprobe umfasste 125 Diabetespatienten (Alter 44,5 ± 13,7 Jahre, 44,1\% weiblich, HbA1c 8,8 ± 1,7\%, 64,1\% Typ-1-Diabetes, CES-D 23,4 ± 8,0). Zur Baseline korrelierte IL-1RA signifikant mit dem Depressionsscore (ß= 0,135, p = 0,026). Diabetespatienten mit einer deutlichen Reduktion ihrer Depressionssymptomatik wiesen im 1-Jahres-Follow-Up signifikant niedrige IL-1RA- (381 ± 51 vs. 534 ± 32 pg/ml; p = 0,041) und IL-18-Spiegel (269 ± 29 vs. 336 ± 19 pg/ml; p = 0,028) auf. Bei IL-1RA gab es einen signifikanten Interaktionseffekt mit dem Diabetestyp (stärkere Reduktion bei Typ-2-Diabetes).

Diskussion: IL-1RA-Spiegel weisen sowohl in der Querschnitts- als auch Längsschnittanalyse einen signifikanten Zusammenhang zu einer erhöhten Depressivität auf. Systemische Inflammationsprozesse könnten neben der glykämischen Kontrolle und Lebensstilfaktoren einen pathophysiologischen Mechanismus darstellen, wie sich eine erhöhte Depressivität negativ auf die langfristige Diabetesprognose auswirkt.

Unterstützt vom Kompetenznetz Diabetes mellitus (FKZ01GI0809).}
}

@inproceedings{schmitt2016_40718,
  title = {Hohe Prävalenz depressiver Störungen bei Diabetespatienten im tertiären Versorgungssektor},
  author = {Schmitt, Andreas and Reimer, Andre and Kulzer, Bernhard and Ehrmann, Dominic and Haak, Thomas and Hermanns, Norbert},
  year = {2016},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0035-1549637},
  urn = {urn:nbn:de:bvb:473-opus4-471152},
  url = {https://fis.uni-bamberg.de/handle/uniba/40718},
  language = {deu},
  abstract = {Fragestellung: Internationale Metaanalysen weisen auf erhöhte Prävalenzen depressiver Störungen bei Diabetes hin. Die Evidenz für den deutschen Sprachraum ist jedoch begrenzt und auch widersprüchlich. Diese Studie untersuchte Prävalenzen depressiver Störungen bei Patienten im tertiären Versorgungssektor.

Methodik: 1172 zufällig ausgewählte Patienten im Diabetes Zentrum Mergentheim (Alter: 50 ± 15; 43\% weiblich; BMI: 30 ± 7 kg/m2; 50,5\% T1DM, 46,7\% T2DM, 2,8\% T3DM; 91\% mit Insulin; HbA1c: 8,9 ± 1,7\%) nahmen an einem Depressionsscreening mittels Allgemeiner Depressionsskala (ADS) und bei auffälligen ADS-Werten (≥16) einem klinisch-diagnostischem Interview teil. Es wurden Punktprävalenzen von Major Depression (MD) und subklinischer Depression (SKD; definiert als ADS-Wert ≥22 ohne Major Depression) bestimmt, hinsichtlich Geschlecht und Alter auf die Normalbevölkerung standardisiert und mit aktuellen Bevölkerungsprävalenzen verglichen (Binomialtest).

Ergebnisse: Die MD-Prävalenz (bevölkerungsstandardisierte Werte in Klammern) betrug 10,0\% (8,7) bei T1DM, 14,1\% (15,8) bei T2DM und 18,2\% (n/a) bei T3DM. Gegenüber 6,0\% in der Normalbevölkerung (DEGS1-MH) waren alle Prävalenzwerte signifikant erhöht (alle p < 0,01). Die SKD-Prävalenz betrug 20,4\% (19,1) bei T1DM, 19,0\% (22,2) bei T2DM und 15,2\% (n/a) bei T3DM. Gegenüber maximal 6,8\% in der Normalbevölkerung (BGS98) waren auch diese Prävalenzen signifikant erhöht (alle p < 0,01). Ferner zeigten sich signifikante Geschlechtsunterschiede mit 1,6- bis 2,0-mal höheren MD-Prävalenzen und 1,3- bis 1,6-mal höheren SKD-Prävalenzen beim weiblichen Geschlecht.

Schlussfolgerungen: Die Befunde sprechen dafür, dass die Prävalenzen depressiver Störungen bei Diabetespatienten im tertiären Sektor erhöht sind. Zusammen mit der internationalen Evidenz weisen sie darauf hin, dass depressive Störungen bei Diabetes auch in Deutschland häufiger vorkommen als in der Normalbevölkerung.

Unterstützt vom „Kompetenznetz Diabetes mellitus“ (FKZ01GI1107).}
}

@inproceedings{kern2016_40714,
  title = {Self-reported hypoglycaemia : a global study of 24 countries with 27,585 insulin-treated patients with diabetes: the HAT study.},
  author = {Kern, Werner and Kienhöfer, J and Kulzer, Bernhard and Mönninghoff, C},
  year = {2016},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0035-1549767},
  urn = {urn:nbn:de:bvb:473-opus4-471097},
  url = {https://fis.uni-bamberg.de/handle/uniba/40714},
  language = {eng},
  abstract = {Background and aims: Hypoglycaemia is an important concern for patients with diabetes and physicians when setting glycaemic targets. The Hypoglycaemia Assessment Tool (HAT) study, the largest and most comprehensive of its kind, assessed self-reported hypoglycaemia and associated predictive factors in a global population of patients with insulin-treated diabetes.

Materials and methods: HAT was a non-interventional, multicentre, 6-month retrospective and 1-month prospective study of hypoglycaemic events in 24 countries using self-assessment questionnaires and patient diaries (for 28 days) in people aged ≥18 years with type 1 (T1D) or type 2 (T2D) diabetes using insulin for ≥12 months attending routine clinics. Associations between predictive factors and hypoglycaemia were examined using negative binomial regression models adjusted for period and country.

Results: 27,585 patients completed the study (Table 1). 83.4\% of patients with T1D and 50.8\% of patients with T2D experienced ≥1 hypoglycaemic event in the 4 weeks before baseline (51.5 and 16.5 events per patient year). Higher (p < 0.001) incidence rates were reported in the 4 weeks after baseline (73.3 [T1D] and 19.3 [T2D] events per patient year). A greater percentage of patients with T1D vs. T2D reported any (83.0 vs. 46.5\%), nocturnal (40.6 vs. 15.9\%) or severe (14.4 vs. 8.9) hypoglycaemia in the prospective period.

Conclusion: In this large, multinational population of patients (insulin-treated) with T1D or T2D, rates of overall, nocturnal and severe hypoglycaemia were higher than previously published. An increased incidence of overall hypoglycaemia in the prospective study indicated significant under-reporting of hypoglycaemia.}
}

@book{kulzer2016_40682,
  title = {Typ-2-Diabetes : Insulin nach Maß : Ein Leitfaden für den Alltag : Für Menschen mit Typ-2-Diabetes und einer nicht-intensivierten Insulintherapie (BOT+SIT+CT)},
  author = {Kulzer, Bernhard and Hermanns, Norbert and Schall, Sabine and Maier, Bernhard and Haak, Thomas},
  year = {2016},
  publisher = {Kirchheim + Co GmbH},
  address = {Mainz},
  isbn = {978-3-87409-594-5},
  url = {https://fis.uni-bamberg.de/handle/uniba/40682},
  language = {deu},
  abstract = {Das Patientenbuch „Typ-2-Diabetes: Insulin nach Maß“ 

Im Patientenbuch „Typ-2-Diabetes Insulin nach Maß“ sind alle Inhalte des Kurses übersichtlich zusammengefasst. Komplexe Inhalte werden in einfachen Worten dargestellt und anschaulich illustriert. Das Buch enthält neben einem Selbstkontrollheft für die Insulintherapie Typ-2-Diabetes selbst kontrollieren - Nicht intensivierte Insulintherapie auch eine Bausteintabelle Essen nach Maß sowie ein BE/KE-Poster Das ist eine BE/KE und Arbeitsblätter. Mit deren Hilfe können die Teilnehmer Fertigkeiten für die Durchführung der nicht intensievierten Insulintherapie im Alltag üben und ihre bisherigen Erfahrungen und Einstellungen im Umgang mit der Diabetesbehandlung strukturiert erfassen.}
}

@book{kulzer2016_40661,
  title = {MEDIAS 2 BOT+SIT+CT Schulungskoffer : Ein Schulungs- und und Behandlungsprogramm für Menschen mit Typ-2-Diabetes und einer nicht-intensivierten Insulintherapie (BOT + SIT + CT)},
  author = {Kulzer, Bernhard and Hermanns, Norbert and Schall, Sabine and Maier, Bernhard and Haak, Thomas},
  year = {2016},
  publisher = {Kirchheim + Co GmbH},
  address = {Mainz},
  isbn = {978-3-87409-594-5},
  url = {https://fis.uni-bamberg.de/handle/uniba/40661},
  language = {deu}
}

@inproceedings{ehrmann2016_40395,
  title = {Wie häufig tragen Risikopatienten Schuhe mit diabetesadaptierter Fußbettung?},
  author = {Ehrmann, Dominic and Spengler, M and Jahn, M and Siebert, Hendrik and Haak, Thomas and Kulzer, Bernhard and Hermanns, Norbert and Niebuhr, Dea},
  year = {2016},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0035-1549649},
  urn = {urn:nbn:de:bvb:473-opus4-465520},
  url = {https://fis.uni-bamberg.de/handle/uniba/40395},
  language = {deu},
  abstract = {Fragestellung: Die diabetesadaptierte Fußbettung (DAF) ist Mittel der Wahl, um bei Patienten mit diabetesbedingten Fußproblemen der Risikogruppe III durch eine Druckumverteilung Rezidive/Ulzerationen zu verhindern. Personen mit Diabetischem Fußsyndrom (DFS) der Risikogruppe III sollten nur Diabetesschutzschuhe mit DAF tragen. Bisher gibt es keine objektivierbaren Daten zum Trageverhalten von diesen Schuhen mit DAF. Ziel dieser Studie war es, die Tragedauer von Schuhen mit DAF bei Risikopatienten für ein DFS über eine Temperaturmessung objektiv zu quantifizieren.

Methodik: Die Schuhe von 26 Patienten mit Typ-2-Diabetes und DFS (67,5 ± 10,8 Jahre; 35\% weiblich; BMI: 30,3 ± 4,7 kg/m2; Diabetesdauer: 10,4 ± 6,8 Jahre; HbA1c: 7,7 ± 0,6\%) wurden mit einer DAF und einem Temperatur-Sensor ausgestattet. Ab einer Schuhinnentemperatur von 25 °C wurde davon ausgegangen, dass der Schuh mit DAF getragen wurde.

Ergebnisse: Im Mittel konnte das Trageverhalten von Diabetsschutzschuhen mit DAF an durchschnittlich 133,5 Tagen ausgewertet werden. Die Tragedauer pro Tag betrug im Median 3,4 Stunden (25 – 75\% Quartil: 0,5 – 6,9 Stunden). Im Median wurde der Schuh mit DAF an 51\% der Tage nicht getragen (25 – 75\% Quartil: 16,9 – 81,8\%).

Schlussfolgerungen: Die Studie liefert erstmals objektive Daten zum Trageverhalten von Schuhen mit DAF. Bei einer mittleren täglichen Tragedauer von nur 3,4 Stunden, ist die Tragezeit der Schuhe mit DAF eindeutig zu kurz, um einen ausreichenden Präventionseffekt für das Auftreten/Verschlimmerung eines DFS erreichen zu können. Besonders problematisch war, dass an der Hälfte der beobachteten Tage, die Schuhe mit DAF nicht getragen wurden. Es bedarf daher edukativer und technologischer Anstrengungen, um DFS-Patienten zu unterstützen, Diabetsschutzschuhe mit DAF regelmäßig zu tragen.},
  keywords = {-}
}

@inproceedings{kovacsburns2016_40377,
  title = {Comparing national policy and programme strategies for managing the psychosocial aspects of diabetes},
  author = {Kovacs Burns, Katharina and Skovlund, Soren and Comaschi, Marco and Hermanns, Norbert and Kulzer, Bernhard and Oortwijn, Wija and Peyrot, Mark},
  year = {2016},
  publisher = {opus},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-opus4-465300},
  url = {https://fis.uni-bamberg.de/handle/uniba/40377},
  language = {eng},
  abstract = {The DAWN2 findings emphasise the importance of having national person-centred diabetes care policies supporting clinical guidelines or standards of care that include regular psychosocial assessments, and reimbursement of psychological care as part of routine diabetes care.
● The responses of HCPs and PWD across the 17 countries confirm the need for policies, diabetes care standards and reimbursement for psychological aspects of diabetes.}
}

@inproceedings{ehrmann2016_40383,
  title = {Erfassung des Umgangs mit den Auswirkungen der Diabeteserkrankung in wichtigen Lebensbereichen.},
  author = {Ehrmann, Dominic and Bergis-Jurgan, N and Haak, Thomas and Kulzer, Bernhard and Hermanns, Norbert},
  year = {2016},
  publisher = {opus},
  address = {Bamberg},
  doi = {10.1055/s-0035-1549730},
  urn = {urn:nbn:de:bvb:473-opus4-465535},
  url = {https://fis.uni-bamberg.de/handle/uniba/40383},
  language = {deu},
  abstract = {Fragestellung: Diabetes beeinflusst wichtige Freizeitbereiche wie Sport oder Reisen aber auch die Partnerschaft. Oftmals hat der Diabetes auch sozialrechtliche Konsequenzen. Ziel der Untersuchung war die Evaluation von Fragebögen zur Erfassung des Umgangs mit diesen Auswirkungen des Diabetes auf den Alltag.

Methodik: Vier Fragebögen wurden entwickelt, um den Umgang in den Bereichen Partnerschaft, Sport, Reisen und Soziales zu erfassen. Die Fragebögen wurden 195 Patienten mit Typ-1- und Typ-2-Diabetes vorgegeben (43,3 ± 14,6 Jahre; 46\% weiblich; BMI: 27,2 ± 6,3 kg/m2; 10\% Typ-2-Diabetes; Diabetesdauer: 17,9 ± 13,1 Jahre; HbA1c: 8,4 ± 1,8\%). Zur Validierung füllten Patienten die Empowerment-Skala und einen Fragebogen zur Diabetesbelastung (PAID) aus.

Ergebnisse: Alle Fragebögen waren hoch reliabel (Partnerschaft: α= 0,92; Sport: α= 0,91; Reisen: α= 0,85; Soziales: α= 0,92). Höheres Empowerment ging mit einem besseren Umgang bezüglich Partnerschaft (r = 0,55), Sport (r = 0,58), Reisen (r = 0,69) und Soziales (r = 0,59) (alle p < 0,001) einher. Umgekehrt waren erhöhte diabetesbezogene Belastungen mit einem ungünstigeren Umgang bezüglich Partnerschaft (r =-0,31), Sport (r =-0,30), Reisen (r =-0,41) und Soziales (r =-0,38) assoziiert (alle p < 0,001). Häufigere und länger-andauernde sportliche Aktivitäten korrelierten mit einem höheren Score im Sport-Fragebogen (r = 0,19 bzw. r = 0,23; p < 0,05). Patienten mit Führerschein erreichten einen höheren Score im Umgang mit sozialrechtlichen Angelegenheiten (Effektstärke d = 0,96). Patienten mit Partnerschaft hatten einen besseren Umgang bezüglich Partnerschaft (d = 0,44).

Schlussfolgerungen: Es ist gelungen, reliable und valide Fragebögen zur Erfassung des Umgangs mit den Auswirkungen des Diabetes in den Bereichen Partnerschaft, Sport, Reisen und Soziales zu erstellen und damit das Empowerment in diesen Bereichen zu erfassen. Diese Fragebögen können eingesetzt werden, um den Schulungsbedarf abzuklären bzw. um problemspezifische Schulungsmodule zu evaluieren.}
}

@inproceedings{kovacsburns2016_40369,
  title = {Comparing national policies and programmes for education and training in diabetes management},
  author = {Kovacs Burns, Katharina and Skovlund, Soren and Comaschi, Marco and Hermanns, Norbert and Kulzer, Bernd and Oortwijn, Wija and Peyrot, Mark},
  year = {2016},
  publisher = {opus},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-opus4-465327},
  url = {https://fis.uni-bamberg.de/handle/uniba/40369},
  language = {eng},
  abstract = {The 2012 situational policy desk research proved useful for identifying national public policies responsive to diabetes education and training, but these did not align with survey participation rates for diabetes education and training as reported by PWD, FMs and HCPs.
● In the 2012 situational analysis of national policies, it was found that making education accessible, reimbursed and part of mandatory treatment or care did not result in higher diabetes education participation rates for PWD, FMs and HCPs. Further research on policies and diabetes education programmes is needed to understand why participation rates are low.
● Policies are needed to support education for PWD as it has been shown in other studies that PWD who participated in diabetes education reported fewer psychological problems and enhanced self-management compared with those who had not participated in any educational programme.5
● As part of a global call to action, each country has a responsibility to make improvements in diabetes education and training access, standards or certification, and reimbursement, all of which promote active stakeholder participation and improved diabetes care and outcomes.},
  keywords = {diabetes management}
}

@inproceedings{schmitt2016_40363,
  title = {Recovery from depressive symptoms is associated with improvements in diabetes self-care, glycaemic control, diabetes distress, and quality of life : a prospective study},
  author = {Schmitt, Andreas and Reimer, André and Kulzer, Bernhard and Ehrmann, Dominic and Haak, Thomas and Hermanns, Norbert},
  year = {2016},
  publisher = {opus},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-opus4-465135},
  url = {https://fis.uni-bamberg.de/handle/uniba/40363},
  language = {eng},
  abstract = {Depressive symptoms in diabetes are associated with reduced self-care, glycaemic control and health-related quality of life (hrQOL) and increased diabetes-specifi c distress. We analysed if the recovery from depressive symptoms would be associated with improvements in these aspects. 182 diabetes patients (age 46 ± 13 y.; 56\% female; BMI 30 ± 7; 62\% type 1 diabetes; illness duration 15 ± 10 y.; 95\% with insulin; HbA1c 8.7 ± 1.7\%) with subclinical depressive symptoms (CES-D score ≥ 16 without meeting criteria for clinical depression; mean CES-D score: 23 ± 8) participated in a prospective study. Recovery was defi ned as CES-D score < 16 at 12-month follow up. Dependent variables were diabetes self-care (SDSCA), glycaemic control (HbA1c), diabetes distress (PAID) and hrQOL (SF-36). We compared baseline-to-follow up changes between recovered versus nonrecovered patients using ANCOVA (adjusted for baseline values). At follow up, 85 patients (47\%) showed recovery. The mean reduction of depressive symptoms in this group was -13 ± 9 CES-D scale points; the mean change in the 97 patients remaining depressed (53\%) was +2 ± 9 CES-D scale points. Recovered patients compared to unrecovered ones showed signifi cantly greater improvement (baseline-to-follow up change) regarding self-care (+0.14 ± 1.11 vs. -0.19 ± 1.05 SDSCA scale points, Δ = 0.31, P = 0.014), glycaemic control (-0.78 ± 2.19 vs. -0.56 ± 1.53 HbA1c \%-points, Δ = 0.12, P = 0.042), diabetes distress (-13.6 ± 18.8 vs. -4.4 ± 17.1 PAID scale points, Δ = 0.51, P < 0.01) and hrQOL (physical hrQOL: +2.0 ± 8.7 vs. -1.1 ± 9.6 T scores, Δ = 0.341, P = 0.005; mental hrQOL: +14.5 ± 11.9 vs. +0.1 ± 12.2 T scores, Δ = 1.19, P < 0.01). This study provides evidence that recovery from depressive symptoms may have positive impact on diabetes control, diabetes-specifi distress and quality of life.}
}

@article{ehrmann2016_40349,
  title = {Subtypen der Depression und deren Assoziation mit glykämischer Kontrolle},
  author = {Ehrmann, Dominic and Hermanns, Norbert and Schmitt, Andreas and Haak, Thomas and Kulzer, Bernhard},
  year = {2016},
  publisher = {opus},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-opus4-465510},
  url = {https://fis.uni-bamberg.de/handle/uniba/40349},
  language = {deu},
  abstract = {Fragestellung: Es gibt widersprüchliche Befunde zur Assoziation von Depressionen mit einer schlechteren glykämischen Kontrolle. Ein Grund dafür könnte in der Vielgestalt der depressiven Symptomatik liegen. Häufig findet eine Differenzierung in somatische (z.B. Appetit- und Schlafstörungen) und affektive Symptome (z.B. Niedergeschlagenheit, Traurigkeit) statt. Diese Studie untersuchte die Assoziationen dieser depressiven Subtypen mit der glykämischen Kontrolle.

Methodik: 986 Menschen mit Typ-1 bzw. Typ-2-Diabetes bearbeiteten die Allgemeine Depressionsskala (ADS) sowie den Problem Areas in Diabetes (PAID) Fragebogen zur Erfassung diabetesbezogener Belastungen. Der ADS ermöglicht die Berechnung eines somatischen und eines affektiven Scores. Prädiktoren der linearen Regression auf den HbA1c waren der somatische und affektive Score, adjustiert für demographische (Alter, Geschlecht, BMI, Bildungsjahre) und medizinische Variablen (Diabetestyp, Diabetesdauer, Folgeerkrankungen, Blutzuckermessungen/Tag) sowie diabetesbezogene Belastungen.

Ergebnisse: Eine erhöhte somatische Symptomatik war signifikant mit einem höheren HbA1c (β= 0,15; p = 0,001) assoziiert. Eine erhöhte affektive Symptomatik war signifikant mit einem niedrigeren HbA1c (β=-0,15; p = 0,001) assoziiert. Diabetesbezogene Belastungen waren ebenfalls assoziiert mit einem höheren HbA1c (β= 0,13; p = 0,001). Wurde die depressive Symptomatik insgesamt (ADS-Summenwert) als unabhängige Variable in die Analyse aufgenommen, zeigte sich keine signifikante Assoziation mit dem HbA1c (β=-0,01; p = 0,86).

Schlussfolgerungen: Die Studie zeigte, dass die depressiven Subtypen entgegengesetzte Assoziationen mit der glykämische Kontrolle aufwiesen. Die Tatsache, dass kein Effekt des Gesamtscores der Depressivität vorlag, könnte dafür sprechen, dass sich die gegensätzlichen Effekte der depressiven Subtypen auf die glykämische Kontrolle gegenseitig aufheben. Eine differenzierte Betrachtung depressiver Subtypen kann möglicherweise dazu beitragen die Heterogenität der Assoziationen von Depressivität und glykämischer Kontrolle besser zu verstehen.}
}

@article{schmitt2016_40333,
  title = {Development and evaluation of a psychometric instrument to assess problems related to illness acceptance in diabetes : the Denial versus Integration of Diabetes Scale (DIDS).},
  author = {Schmitt, Andreas and Reimer, André and Ehrmann, Dominic and Kulzer, Bernhard and Haak, Thomas and Hermanns, Norbert},
  year = {2016},
  publisher = {opus},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-opus4-465215},
  url = {https://fis.uni-bamberg.de/handle/uniba/40333},
  language = {eng},
  abstract = {Background and aims:
 Insufficient diabetes acceptance has been associated with reduced self-care and glycaemic control. However, satisfactory tools to measure diabetes acceptance are lacking. Therefore, the Denial versus Integration of Diabetes Scale (DIDS) was developed. This report presents its development and preliminary evaluation.

Materials and methods:
 56 items were generated and revised based on patient feedback and expert reviews (27 directed towards acceptance/ integration, e. g. ‘I accept diabetes as a part of my life’, 29 towards denial/non-acceptance/avoidance, e. g. ‘I often push diabetes to the back of my mind’). A four-point Likert scale (3 - ‘applies to me very much’ to 0 - ‘does not apply to me’) was used for responses. Negatively keyed items were reverse-scored; hence, higher scores indicate higher acceptance. The items were tested in a pilot study with 222 patients (age 49±16 y.; 49\% female; BMI 30±7; 64\% type 1 DM; duration 17±11 y.; HbA1c 8.5± 1.7\%) to exclude unsatisfactory items and define the scale. A subsequent validation study is recruiting; at the time of this report, 66 patients (age 48 ±13 y.; 46\% female; BMI 28±5; 62\% type 1 DM; duration 14±10 y.; HbA1c 8.0±1.0\%) had been included, providing data on diabetes nonacceptance (AADQ), self-care (DSMQ), treatment satisfaction (DTSQ), diabetes distress (PAID), depression (PHQ-9) and HbA1c (central lab). Analyses comprised item and scale properties, exploratory factor analyses (EFA), correlations and t-Test.

Results:
 Item selection: Initially, 5 items were excluded for psychometric problems. Through EFA, 8 items were excluded for loadings on noninterpretable factors, finally yielding an interpretable four-factor structure. Based on this, 11 items were excluded for poor statistical or semantic fit and 4 for redundancy, leading to the final 28-item scale. Scales/reliability: EFA of the selected items yielded four factors (71\% explained variance), interpreted as ‘acceptance/integration’ (7 items, Cronbach’s α=0.93), ‘treatment motivation’ (7 items, α=0.93), ‘denial/defence’ (7 items, α= 0.91) and ‘emotional suffering’ (7 items, α=0.92). The derived subscales were highly correlated, providing summing to a reliable total score (α= 0.97). Reliability was again tested on the validation sample, yielding the following α coefficients (scales in above order): 0.91, 0.91, 0.90, 0.87 and 0.96. Validity: A correlation of -0.76 (P<0.01) was found with the AADQ, a measure of diabetes non-acceptance. The correlation with HbA1c was -0.45 (P<0.01). Patients with higher DIDS scores (suggesting higher acceptance; n=34) compared to those with lower ones (n=32; median split) reported better self-care, particularly regarding diet (6.4± 1.9 vs. 4.0±2.0, P<0.01), glycaemic self-management (8.7±1.9 vs. 7.1± 2.3, P<0.01) and physician visiting (9.2±1.3 vs. 7.9±3.3, P<0.01), and showed better glycaemic control (HbA1c: 7.6±1.1 vs. 8.3±1.1\%, P<0.05). They also reported higher treatment satisfaction (30±4 vs. 24 ±6), less diabetes distress (21±15 vs. 37±16) and less depressive symptoms (6±4 vs. 9±6); all P<0.01.

Conclusion: The DIDS appears reliable and valid in assessing problems related to illness acceptance in both major types of diabetes. It may help explain inadequate self-care and suboptimal glycaemic control. Further data to expand these initial findings are being collected.}
}

@article{ehrmann2016_40329,
  title = {Patients' adherence to customised diabetic insoles as objectively assessed by a temperature sensor},
  author = {Ehrmann, Dominic and Spengler, Monika and Jahn, Michael and Siebert, Hendrik and Niebuhr, Dea and Haak, Thomas and Kulzer, Bernhard and Hermanns, Norbert},
  year = {2016},
  publisher = {opus},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-opus4-465157},
  url = {https://fis.uni-bamberg.de/handle/uniba/40329},
  language = {eng},
  abstract = {Background and aims: Customized diabetic insoles reduce the mechanical stress by re-distributing pressure to the plantar tissue. Thus, customized diabetic insoles are an effective means to prevent the reoccurrence of neuropathic diabetic foot ulcerations. However, the efficacy of these insoles is highly dependent on patients’ adherence. By recommendation, patients should wear their customized diabetic insoles as much as possible for the prevention of diabetic foot problems. However, adherence data often rely on self-report since objective parameters are not available. The aim of this study was to objectively assess patients’ adherence with a temperature sensor directly incorporated into their insoles. Materials and methods: In a pilot study, the cut-off value for optimal temperature was determined that differentiates between wearing and not wearing footwear. For this purpose, a ROC analysis was conducted that yielded an area under the curve of .996 (p<.0001). A cut-off value of 25°Celsius was determined that achieved a sensitivity of 95.3\%, a specificity of 99.8\%, a positive predictive value of 98.7\%, and a negative predictive value of 99.2\%. In the main study, temperature sensors were incorporated into the specialized diabetic insoles of 26 patients with type-2-diabetes and diabetic foot syndrome (age: 67.5±10.8 yrs.; 35\% female; BMI: 30.3± 4.7 kg/m2; diabetes duration: 10.4±6.8 yrs.; HbA1c: 7.7±0.6\%).
Results: On average, data from 133.5 days per patient could be analysed. Patients wore their diabetic footwear (temperature>25°C) on an average (median) of 3.4 hours per day (inter-quartile-range (IQR): 0.5 - 6.9 hours/per day). On an average (median) of 51\% of days, patients did not wear their diabetic footwear (IQR: 16.9 - 81.8\%).
Conclusion: Wearing time of diabetic insoles and other specialized diabetic footwear can be objectively and validly assessed by temperature sensors. This study offers objective data regarding patients’ adherence to their customized diabetic insoles. Nearly every second day, patients did not wear their insoles at all. Results of this study indicate that the utilization of specialized diabetic footwear is suboptimal in order to prevent re-ulcerations and other diabetes foot problems. Future studies should examine how the adherence of patients with a high risk for foot ulcerations can be enhanced, e.g. by patient education or technological assistance or reminders.}
}

@inproceedings{kulzer2016_40312,
  title = {Assessing physicians’ satisfaction with diabetes therapy : development and evaluation of a new questionnaire.},
  author = {Kulzer, Bernhard and Ehrmann, Dominic and Hermanns, Norbert and Weißmann, J. and Müller, A. and Haak, Thomas},
  year = {2016},
  publisher = {opus},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-opus4-464374},
  url = {https://fis.uni-bamberg.de/handle/uniba/40312},
  language = {eng},
  abstract = {Questionnaires assessing the satisfaction of patients already exist, but no questionnaire assesses the satisfaction of physicians. However, physicians’ satisfaction with patient-communication and with diabetes therapy is a crucial factor for the efficacy of diabetes therapy. A relevant part of patientcommunication is the discussion of blood glucose values with the patient. In order to systematically assess the perspective of physicians, we developed
WITHDRAWN
A232
For author disclosure information, see page A810.
CATEGORY
 \& Guided Audio Tour poster ADA-Funded Research
Behavioral Medicine, Clinical
Nutrition, Education, and Exercise
POSTERS
PSYCHOSOCIAL, BEHAVIORAL MEDICINE
a questionnaire that assesses satisfaction of physicians with diabetes therapy in general (Sat-DT) and with the discussion of blood glucose values (SatBG) in particular. Data from 188 physicians who completed the questionnaire was analyzed. The final Sat-DT scale comprised 13 items and achieved a Cronbach’s Alpha of 0.93 wit a mean item-total correlation of r=0.71. The final Sat-BG scale comprised 10 items and achieved a Cronbach’s Alpha of 0.92 with a mean item-total correlation of r=0.73. Factor analysis (Varimax rotation) revealed two factors within the Sat-DT scale (65\% explained variance): “Effects of diabetes therapy” and “costs and benefits.” The Sat-BG scale could be divided into “Usage of blood glucose data” and “efficacy of the discussion” by factor analysis (76\% explained variance). A greater satisfaction in both scales was associated with a greater satisfaction with the work as a physician (Sat-DT: r=0.2, p<.05; Sat-BG: r=0.32, p<.05), a greater satisfaction with therapy outcomes (Sat-DT: r=0.34, p<.05; Sat-BG: r=0.3, p<.05), and with a greater satisfaction with the results of working as a physician (Sat-DT: r=0.27, p<.05; Sat-BG: r=0.25, p<.05). This new questionnaire with its two scales is a reliable and valid assessment tool to measure the satisfaction of physicians. In future studies, this questionnaire can be used to investigate the influence of physicians’ satisfaction on diabetes therapy as well as how physicians’ satisfaction can be altered.}
}

@article{ehrmann2016_40286,
  title = {Different associations of depressive subtypes with glycemic control},
  author = {Ehrmann, Dominic and Hermanns, Norbert and Schmitt, Andreas and Haak, Thomas and Kulzer, Bernhard},
  year = {2016},
  publisher = {opus},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-opus4-464165},
  url = {https://fis.uni-bamberg.de/handle/uniba/40286},
  language = {eng},
  abstract = {Association of depression with glycemic control are not conclusive. While some studies found a positive association, others found none or found that diabetes distress is a mediating factor. These inconsistencies might be due to the complex symptomatology of depression. Depressive symptoms can range from sleep or appetite disorders to depressed mood and having crying spells. Thus, depressive symptoms can be divided into somatic and affective symptoms. This study investigated the associations of the different depressive subtypes with glycemic control. 923 patients completed the Center for Epidemiological Studies - Depression scale (CES-D) which offers subscales for somatic and affective symptoms. Linear regression analysis with HbA1c as dependent variable was conducted. Independent variables of interest were the somatic and affective scores of the CES-D controlled for demographic (age, gender, body mass index, education) and medical (diabetes type, diabetes duration, number of SMBG, late-complications) variables as well as diabetes distress. Both depressive subtypes were signifi cantly associated with HbA1c. A greater somatic symptomatology was associated with a higher HbA1c (β = .15; p = .001) whereas a greater affective symp A219.
For author disclosure information, see page A810.<cr><nl>
CATEGORY<cr><nl>
ADA-Funded Research \& Guided Audio Tour poster Behavioral Medicine, Clinical Nutrition, Education, and Exercise<cr><nl>
POSTERS<cr><nl>
PSYCHOSOCIAL, BEHAVIORAL MEDICINE<cr><nl>
tomatology was associated with a lower HbA1c (β = -.15; p = .001). Greater diabetes distress was associated with higher HbA1c (β = .13; p = .001). Linear regression with depressive symptoms in general (CES-D total score) as independent variable revealed no signifi cant association (β = -.01; p = .86). This study demonstrated that depression is a complex condition and offers an explanation for the inconsistencies in current literature regarding associations with glycemic control. Only the differentiation of subtypes offered a more complete picture of the associations of depression with glycemic control. In clinical practice and further research, a closer look which symptoms of depression are present may be helpful to better understand depression as a vulnerability factor.}
}

@inproceedings{hermanns2016_40298,
  title = {The use of CGM to identify type 1 diabetic patients with hypoglycemia problems and its impact for avoidance of biochemical hypoglycemia.},
  author = {Hermanns, Norbert and Kulzer, Bernhard and Ehrmann, Dominic and Haak, Thomas},
  year = {2016},
  publisher = {opus},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-opus4-464356},
  url = {https://fis.uni-bamberg.de/handle/uniba/40298},
  language = {eng},
  abstract = {This cross-over study used a CGM system (DexCom SEVEN PLUS CGM). In a randomized order, participants had either no access (CGM blind) or real time access to current glucose data (CGM open). One objective was to analyze if type 1 diabetic patients with hypoglycemia problems (at least one episode requiring third party assistance) could be identifi ed by the use of the blinded CGM data. We also analyzed the impact of CGM use on biochemical hypoglycemia. Type 1 diabetic patients with hypoglycemia problems had significant longer diabetes duration (17.0 vs. 11.0 yrs.), a higher unawareness score (4.0 vs. 2.0) and lower thresholds for detecting hypoglycemia (50.0 vs. 65.0 mg/dl) than patients without hypoglycemia problems. During the blinded CGM phase patients with hypoglycemic problems had a significant longer duration of low glucose phases 248 vs. 153 minutes per day (p=.037; <70 mg/dl) respectively 173 vs. 96 minutes per day (p=.041; <60 mg/dl). Area under the receiver operating curve (ROC 0.72 p=.03) indicated a sufficient screening performance of the duration of low glucose periods (< 70 mg/dl) for the identification of patients with hypoglycemia problems. A cut-off of 170 minutes per day of time spend in the low glucose range had a sensitivity of 75\% and a specificity of 70.3\%; the positive predictive value was 52.9\%, the negative predictive value was 86.4\%. A comparison of blind vs. open CGM showed that time spend in a low glucose range could be significantly more reduced in patients with hypoglycemia problems than in patients without hypoglycemia problems during CGM open (< 60 mg/dl; - 67.8 min per day p=.040; < 50 mg/dl; -50.6 min per day, p=.038; < 40 mg/dl; -41.4 min. per day, p=.03). This study shows that CGM has an unused potential for identifying type 1 diabetic patients at risk for hypoglycemia problems in clinical practice as well as for avoidance of biochemical hypoglycemia, which plays a pivotal role for the development of hypoglycemia associated autonomic failure.}
}

@article{ehrmann2016_40272,
  title = {Education in daily routine vs. RCT : health care research on the efficacy of an education and treatment program (Primas) for people with type 1 diabetes.},
  author = {Ehrmann, Dominic and Hermanns, Norbert and Bergis-Jurgan, Nikola and Haak, Thomas and Kulzer, Bernhard},
  year = {2016},
  publisher = {opus},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-opus4-464159},
  url = {https://fis.uni-bamberg.de/handle/uniba/40272},
  language = {eng},
  abstract = {A new treatment program has to prove its effectiveness in a randomized controlled trial (RCT). However, health care research trials (HCRT) show that the efficacy of education programs is far less convincing in daily routine. We evaluated whether a new education and treatment program for type 1 diabetic patients (PRIMAS) had similar effects in daily routine as in the RCT 255 people with type 1 diabetes from 42 practices took part in the PRIMAS course and were observed in this HCRT. As in the RCT, PRIMAS consisted of 12 lessons and the outcomes were assessed 6 months after the education course. Primary outcome in both studies was HbA1c assessed in the same central laboratory. Improvement in hypoglycemia Awareness, depressive symptoms, diabetes-related distress, self-efficacy, and diabetes empowerment were secondary outcomes. In order to compare the effects of PRIMAS in the RCT with the effects in the HCRT, effect sizes of differences for each study were contrasted. The difference of the two respective effect sizes (RCT - HCRT) along with the 95\% confidence interval was analyzed. HbA1c reduction in the RCT was -0.36\% (-3.9 mmol/mol) as compared to -0.39\% (-4.3 mmol/mol) in the HCRT. The difference of the effect sizes didn’t exceed the non-inferiority margin of 0.4 (difference of effect size: α -0.03, 95\% CI -0.29 to 0.22). Effect sizes in all secondary outcomes were also highly comparable: Improvement of hypoglycemia awareness α 0.11, 95\% CI -0.15 to 0.38; reduction of depressive symptoms α -0.08, 95\% CI -0.34 to 0.18; reduction of diabetes distress α 0.23, 95\% CI -0.04 to 0.49; improvement of self-efficacy α 0.05, 95\% CI -0.21 to 0.32; improvement of empowerment α 0.04, 95\% CI -0.23 to 0.36. PRIMAS proofed its effi cacy in daily routine and showed similar effect sizes as in the RCT. PRIMAS can contribute to an improvement of routine health care in people with type 1 diabetes.}
}

@inproceedings{kulzer2016_40253,
  title = {The Effect of a Self-Management Oriented Education and Treatment Programme (PRIMAS) for Type 1 Diabetic Patients},
  author = {Kulzer, Bernhard and Hermanns, Norbert and Ehrmann, Dominic and Bergis, Nikola and Haak, Thomas},
  year = {2016},
  publisher = {opus},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-opus4-463511},
  url = {https://fis.uni-bamberg.de/handle/uniba/40253},
  language = {eng},
  abstract = {Background and aims: In a randomised, multi-centre trial, the effect of a structured education and treatment programme to promote self-management and empowerment for type 1 diabetic patients (PRIMAS) was compared to an established education programme (Structured education and treatment programme for type 1 diabetic patients) as an active comparator condition (ACC). Besides optimizing insulin treatment by testing basal insulin doses and carbohydrate factors as well as avoiding acute and late complications the PRIMAS programme also aims at motivational factors and the daily routine of living with diabetes.
Materials and methods: A total of 160 patients with type 1 diabetes recruited in diabetologist practices (PRIMAS: age 45.9 ±13.8 yrs, diabetes duration 19.6 ±12.8 yrs., 38.3\% female, HbA1c 8.3 ±1.1\%, 23.5\% with CSII vs. ACC: age 45.2 ±13.4 yrs, diabetes duration 19.4 ±13.2 yrs., 49.4\% female, HbA1c 8.1 ±0.9\%, 27.8\% with CSII) were randomised to either PRIMAS or the ACC. Main outcome was the HbA1c 6 months after participation in the respective programme. Secondary outcomes were diabetes related distress (Diabetes Distress Scale 17 items), extent of self-perceived empowerment (Empowerment scale 11 items), self-efficacy for diabetes management (Self-efficacy scale 10 items), diabetes knowledge (Knowledge test 11 items), and self-care behaviour (Summary of Diabetes Self Care Activity Scale). Baseline adjusted results are reported as mean ± SEM.
Results: Baseline adjusted HbA1c was significantly more improved in PRIMAS than in the ACC (-0.33 ± 0.1\% vs. -0.03 ± 0.1\%, p=.028) at 6 month follow-up. Also patients treated with PRIMAS reported lower baseline adjusted diabetes related distress levels (mean item score 0.9 ± 0.1 vs. 1.1 ± 0.1, p=.049), higher empowerment (27.4 ± 0.5 vs. 26.0 ± 0.5 p=.027) and self-efficacy levels (mean score: 23.3 ± 0.4 vs. 21.9 ± 0.4 p=.044) than patients in the ACC. Satisfaction with insulin treatment was also higher after 6 month in PRIMAS than in the ACC (mean score: 27.1 ± 0.6 vs. 25.3 ± 0.6; p=.028). Effects on knowledge (mean score 7.7 ± 0.2 vs. 7.9 ± 0.2 p=.555) and self-care behaviours (mean score: 3.7 ± 0.1 vs. 3.8 ± 0.1; p=.846) did not differ significantly between the education programmes nor did insulin dose (0.66 ± 0.02 vs. 0.63 ± 0.02 IU/kg; p=.284).
Conclusion: PRIMAS is more effective in lowering HbA1c than the established education programme in type 1 diabetic patients. In addition, PRIMAS has proven its efficacy regarding the improvement of empowerment, self-efficacy and satisfaction with insulin treatment as well as regarding the reduction of diabetes related distress. The effects on knowledge and self-care behaviour are similar to those of the established education programme. Thus, PRIMAS provides a good alternative for treatment and education of type 1 diabetic patients.},
  keywords = {Education}
}

@inproceedings{hermanns2016_40088,
  title = {Is Diabetes Related Distress a Risk Factor for Depression in Diabetes?},
  author = {Hermanns, Norbert and Kulzer, Bernhard and Haak, Thomas},
  year = {2016},
  publisher = {opus},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-opus4-461022},
  url = {https://fis.uni-bamberg.de/handle/uniba/40088},
  language = {eng},
  abstract = {Introduction: Recent meta-analysis showed that diabetes seems to be a risk factor for incident depression. This prospective study examines the role of elevated diabetes distress on the persistence or the recovery from elevated depressive symptoms at a 6-month follow-up.Methods: Participants completed the CES-D. A score of >=16 indicate elevated depressive symptoms. The Problem Areas in Diabetes Scale (PAID) assessed diabetes related distress; a PAID score of >=30 indicate moderate diabetes related distress. Logistic regression models were performed. Persistence and recovery from elevated depressive symptoms were the dependent variables. The independent variable was diabetes related distress. The models were adjusted for potential demographic (age, gender) or medial confounders (BMI, diabetes duration, A1C, diabetes type and late complications).Results: 351 diabetic patients were included (age 50,8 ±11.4 yrs, 52\% female, 58\% type 2 diabetic patients, diabetes duration 12.9 ±11.1 yrs, BMI 29,9 ±6,9 kg/m², A1c 7.9 ±1.5\%). At baseline 125 patients (35.6\%) reported elevated depressive symptoms. At follow up 96 patients (27.3\%) still had an elevated depression score. If diabetes related distress was present at baseline the hazard ratio of having persistent elevated depressive symptoms at follow up was 6.67 (95\% CI 3.79 - 11.72). Adjusting for confounding variables did not change the hazard ratio substantially (HR 6.02 95\% CI 3.32 - 10.89). In addition the chance for recovery from elevated depressive symptoms was significantly reduced if diabetes related distress was present (Odds ratio 0.37 95\% CI 0.17 - 0.77). Controlling for possible confounders did not change the odds ratio (0.36 95\% CI 0.16 - 0.82).Conclusion: Diabetes related distress seems to play a decisive role for an unfavorable course of depressive symptoms. Diabetes related distress may be a mediating factor between diabetes and depression. Addressing diabetes related distress may be able to ameliorate depression in people with diabetes.},
  keywords = {-}
}

@inproceedings{kern2015_104245,
  title = {Self-reported hypoglycaemia : a global study of 24 countries with 27,585 insulin-treated patients with diabetes: the HAT study},
  author = {Kern, Werner and Kienhöfer, J and Kulzer, Bernhard and Mönninghoff, C},
  year = {2015},
  volume = {10},
  number = {Supplement 1},
  pages = {P261},
  publisher = {Thieme},
  address = {Stuttgart [u.a.]},
  issn = {1861-9010},
  url = {https://fis.uni-bamberg.de/handle/uniba/104245},
  language = {eng}
}

@inproceedings{ehrmann2015_104232,
  title = {Wie häufig tragen Risikopatienten Schuhe mit diabetesadaptierter Fußbettung?},
  author = {Ehrmann, Dominic and Spengler, M and Siebert, Hendrik and Haak, Thomas and Kulzer, Bernhard and Hermanns, Norbert and Jahn, Michael and Niebuhr, Dea},
  year = {2015},
  volume = {10},
  number = {Supplement 1},
  pages = {P-143},
  publisher = {Thieme},
  address = {Stuttgart [u.a.]},
  issn = {1861-9002},
  url = {https://fis.uni-bamberg.de/handle/uniba/104232},
  language = {deu}
}

@inproceedings{ehrmann2015_104231,
  title = {Erfassung des Umgangs mit den Auswirkungen der Diabeteserkrankung in wichtigen Lebensbereichen},
  author = {Ehrmann, Dominic and Bergis-Jurgan, N and Haak, Thomas and Kulzer, Bernhard and Hermanns, Norbert},
  year = {2015},
  volume = {10},
  number = {Supplement 1},
  pages = {P-224},
  publisher = {Thieme},
  address = {Stuttgart [u.a.]},
  issn = {1861-9010},
  url = {https://fis.uni-bamberg.de/handle/uniba/104231},
  language = {deu}
}

@inproceedings{schmitt2015_104230,
  title = {Recovery from depressive symptoms is associated with improvements in diabetes self-care, glycaemic control, diabetes distress, and quality of life : a prospective study},
  author = {Schmitt, Andreas and Reimer, Andre and Kulzer, Bernhard and Ehrmann, Dominic and Haak, Thomas Jürgen and Hermanns, Norbert},
  year = {2015},
  volume = {64},
  number = {Supplement 1,},
  pages = {A221 (876-P)},
  address = {Alexandria, Va},
  issn = {0012-1797},
  url = {https://fis.uni-bamberg.de/handle/uniba/104230},
  language = {eng}
}

@inproceedings{kulzer2015_104229,
  title = {Assessing physicians’ satisfaction with diabetes therapy : development and evaluation of a new questionnaire},
  author = {Kulzer, Bernhard and Ehrmann, Dominic and Hermanns, Norbert and Weißmann, J. and Müller, A and Haak, Thomas},
  year = {2015},
  volume = {64},
  number = {Supplement 1},
  pages = {A231-A232},
  address = {Alexandria, Va},
  issn = {0012-1797},
  url = {https://fis.uni-bamberg.de/handle/uniba/104229},
  language = {eng}
}

@inproceedings{hermanns2015_104228,
  title = {The use of CGM to identify type 1 diabetic patients with hypoglycemia problems and its impact for avoidance of biochemical hypoglycemia},
  author = {Hermanns, Norbert and Kulzer, Bernhard and Ehrmann, Dominic and Haak, Thomas},
  year = {2015},
  volume = {64},
  number = {Supplement 1},
  pages = {A244},
  address = {Alexandria, Va},
  issn = {0012-1797},
  url = {https://fis.uni-bamberg.de/handle/uniba/104228},
  language = {eng}
}

@article{ehrmann2015_55634,
  title = {Subtypen der Depression und deren Assoziation mit glykämischer Kontrolle},
  author = {Ehrmann, Dominic and Hermanns, Norbert and Schmitt, Andreas and Haak, Thomas and Kulzer, Bernhard},
  year = {2015},
  journal = {Diabetologie und Stoffwechsel},
  volume = {10},
  number = {Supplement 1},
  pages = {P-134},
  publisher = {Thieme},
  address = {Stuttgart [u.a.]},
  issn = {1861-9010},
  doi = {10.1055/s-0035-1549640},
  url = {https://fis.uni-bamberg.de/handle/uniba/55634},
  language = {deu},
  abstract = {Fragestellung: Es gibt widersprüchliche Befunde zur Assoziation von Depressionen mit einer schlechteren glykämischen Kontrolle. Ein Grund dafür könnte in der Vielgestalt der depressiven Symptomatik liegen. Häufig findet eine Differenzierung in somatische (z.B. Appetit- und Schlafstörungen) und affektive Symptome (z.B. Niedergeschlagenheit, Traurigkeit) statt. Diese Studie untersuchte die Assoziationen dieser depressiven Subtypen mit der glykämischen Kontrolle.

Methodik: 986 Menschen mit Typ-1 bzw. Typ-2-Diabetes bearbeiteten die Allgemeine Depressionsskala (ADS) sowie den Problem Areas in Diabetes (PAID) Fragebogen zur Erfassung diabetesbezogener Belastungen. Der ADS ermöglicht die Berechnung eines somatischen und eines affektiven Scores. Prädiktoren der linearen Regression auf den HbA1c waren der somatische und affektive Score, adjustiert für demographische (Alter, Geschlecht, BMI, Bildungsjahre) und medizinische Variablen (Diabetestyp, Diabetesdauer, Folgeerkrankungen, Blutzuckermessungen/Tag) sowie diabetesbezogene Belastungen.

Ergebnisse: Eine erhöhte somatische Symptomatik war signifikant mit einem höheren HbA1c (β= 0,15; p = 0,001) assoziiert. Eine erhöhte affektive Symptomatik war signifikant mit einem niedrigeren HbA1c (β=-0,15; p = 0,001) assoziiert. Diabetesbezogene Belastungen waren ebenfalls assoziiert mit einem höheren HbA1c (β= 0,13; p = 0,001). Wurde die depressive Symptomatik insgesamt (ADS-Summenwert) als unabhängige Variable in die Analyse aufgenommen, zeigte sich keine signifikante Assoziation mit dem HbA1c (β=-0,01; p = 0,86).

Schlussfolgerungen: Die Studie zeigte, dass die depressiven Subtypen entgegengesetzte Assoziationen mit der glykämische Kontrolle aufwiesen. Die Tatsache, dass kein Effekt des Gesamtscores der Depressivität vorlag, könnte dafür sprechen, dass sich die gegensätzlichen Effekte der depressiven Subtypen auf die glykämische Kontrolle gegenseitig aufheben. Eine differenzierte Betrachtung depressiver Subtypen kann möglicherweise dazu beitragen die Heterogenität der Assoziationen von Depressivität und glykämischer Kontrolle besser zu verstehen.}
}

@article{schmitt2015_55632,
  title = {Development and evaluation of a psychometric instrument to assess problems related to illness acceptance in diabetes : the Denial versus Integration of Diabetes Scale (DIDS).},
  author = {Schmitt, Andreas and Reimer, André and Ehrmann, Dominic and Kulzer, Bernhard and Haak, Thomas and Hermanns, Norbert},
  year = {2015},
  volume = {58},
  number = {Supplement 1},
  pages = {S456 (946-P)},
  publisher = {Springer},
  address = {Berlin ; Heidelberg},
  doi = {10.1007/s00125-015-3687-4},
  url = {https://fis.uni-bamberg.de/handle/uniba/55632},
  language = {eng},
  abstract = {Background and aims:
 Insufficient diabetes acceptance has been associated with reduced self-care and glycaemic control. However, satisfactory tools to measure diabetes acceptance are lacking. Therefore, the Denial versus Integration of Diabetes Scale (DIDS) was developed. This report presents its development and preliminary evaluation.

Materials and methods:
 56 items were generated and revised based on patient feedback and expert reviews (27 directed towards acceptance/ integration, e. g. ‘I accept diabetes as a part of my life’, 29 towards denial/non-acceptance/avoidance, e. g. ‘I often push diabetes to the back of my mind’). A four-point Likert scale (3 - ‘applies to me very much’ to 0 - ‘does not apply to me’) was used for responses. Negatively keyed items were reverse-scored; hence, higher scores indicate higher acceptance. The items were tested in a pilot study with 222 patients (age 49±16 y.; 49\% female; BMI 30±7; 64\% type 1 DM; duration 17±11 y.; HbA1c 8.5± 1.7\%) to exclude unsatisfactory items and define the scale. A subsequent validation study is recruiting; at the time of this report, 66 patients (age 48 ±13 y.; 46\% female; BMI 28±5; 62\% type 1 DM; duration 14±10 y.; HbA1c 8.0±1.0\%) had been included, providing data on diabetes nonacceptance (AADQ), self-care (DSMQ), treatment satisfaction (DTSQ), diabetes distress (PAID), depression (PHQ-9) and HbA1c (central lab). Analyses comprised item and scale properties, exploratory factor analyses (EFA), correlations and t-Test.

Results:
 Item selection: Initially, 5 items were excluded for psychometric problems. Through EFA, 8 items were excluded for loadings on noninterpretable factors, finally yielding an interpretable four-factor structure. Based on this, 11 items were excluded for poor statistical or semantic fit and 4 for redundancy, leading to the final 28-item scale. Scales/reliability: EFA of the selected items yielded four factors (71\% explained variance), interpreted as ‘acceptance/integration’ (7 items, Cronbach’s α=0.93), ‘treatment motivation’ (7 items, α=0.93), ‘denial/defence’ (7 items, α= 0.91) and ‘emotional suffering’ (7 items, α=0.92). The derived subscales were highly correlated, providing summing to a reliable total score (α= 0.97). Reliability was again tested on the validation sample, yielding the following α coefficients (scales in above order): 0.91, 0.91, 0.90, 0.87 and 0.96. Validity: A correlation of -0.76 (P<0.01) was found with the AADQ, a measure of diabetes non-acceptance. The correlation with HbA1c was -0.45 (P<0.01). Patients with higher DIDS scores (suggesting higher acceptance; n=34) compared to those with lower ones (n=32; median split) reported better self-care, particularly regarding diet (6.4± 1.9 vs. 4.0±2.0, P<0.01), glycaemic self-management (8.7±1.9 vs. 7.1± 2.3, P<0.01) and physician visiting (9.2±1.3 vs. 7.9±3.3, P<0.01), and showed better glycaemic control (HbA1c: 7.6±1.1 vs. 8.3±1.1\%, P<0.05). They also reported higher treatment satisfaction (30±4 vs. 24 ±6), less diabetes distress (21±15 vs. 37±16) and less depressive symptoms (6±4 vs. 9±6); all P<0.01.

Conclusion: The DIDS appears reliable and valid in assessing problems related to illness acceptance in both major types of diabetes. It may help explain inadequate self-care and suboptimal glycaemic control. Further data to expand these initial findings are being collected.}
}

@article{ehrmann2015_55631,
  title = {Patients' adherence to customised diabetic insoles as objectively assessed by a temperature sensor},
  author = {Ehrmann, Dominic and Spengler, Monika and Jahn, Michael and Siebert, Hendrik and Niebuhr, Dea and Haak, Thomas and Kulzer, Bernhard and Hermanns, Norbert},
  year = {2015},
  volume = {58},
  number = {Supplement 1},
  pages = {S509 (1056-P)},
  publisher = {Springer},
  address = {Berlin ; Heidelberg},
  issn = {1432-0428},
  doi = {10.1007/s00125-015-3687-4},
  url = {https://fis.uni-bamberg.de/handle/uniba/55631},
  language = {eng},
  abstract = {Background and aims: Customized diabetic insoles reduce the mechanical stress by re-distributing pressure to the plantar tissue. Thus, customized diabetic insoles are an effective means to prevent the reoccurrence of neuropathic diabetic foot ulcerations. However, the efficacy of these insoles is highly dependent on patients’ adherence. By recommendation, patients should wear their customized diabetic insoles as much as possible for the prevention of diabetic foot problems. However, adherence data often rely on self-report since objective parameters are not available. The aim of this study was to objectively assess patients’ adherence with a temperature sensor directly incorporated into their insoles. Materials and methods: In a pilot study, the cut-off value for optimal temperature was determined that differentiates between wearing and not wearing footwear. For this purpose, a ROC analysis was conducted that yielded an area under the curve of .996 (p<.0001). A cut-off value of 25°Celsius was determined that achieved a sensitivity of 95.3\%, a specificity of 99.8\%, a positive predictive value of 98.7\%, and a negative predictive value of 99.2\%. In the main study, temperature sensors were incorporated into the specialized diabetic insoles of 26 patients with type-2-diabetes and diabetic foot syndrome (age: 67.5±10.8 yrs.; 35\% female; BMI: 30.3± 4.7 kg/m2; diabetes duration: 10.4±6.8 yrs.; HbA1c: 7.7±0.6\%).
Results: On average, data from 133.5 days per patient could be analysed. Patients wore their diabetic footwear (temperature>25°C) on an average (median) of 3.4 hours per day (inter-quartile-range (IQR): 0.5 - 6.9 hours/per day). On an average (median) of 51\% of days, patients did not wear their diabetic footwear (IQR: 16.9 - 81.8\%).
Conclusion: Wearing time of diabetic insoles and other specialized diabetic footwear can be objectively and validly assessed by temperature sensors. This study offers objective data regarding patients’ adherence to their customized diabetic insoles. Nearly every second day, patients did not wear their insoles at all. Results of this study indicate that the utilization of specialized diabetic footwear is suboptimal in order to prevent re-ulcerations and other diabetes foot problems. Future studies should examine how the adherence of patients with a high risk for foot ulcerations can be enhanced, e.g. by patient education or technological assistance or reminders.}
}

@article{ehrmann2015_55628,
  title = {Different associations of depressive subtypes with glycemic control},
  author = {Ehrmann, Dominic and Hermanns, Norbert and Schmitt, Andreas and Haak, Thomas and Kulzer, Bernhard},
  year = {2015},
  journal = {Diabetes},
  volume = {64},
  number = {Supplement 1},
  pages = {A218-A219},
  address = {Alexandria, VA, USA},
  issn = {0012-1797},
  url = {https://fis.uni-bamberg.de/handle/uniba/55628},
  language = {eng},
  abstract = {Association of depression with glycemic control are not conclusive. While some studies found a positive association, others found none or found that diabetes distress is a mediating factor. These inconsistencies might be due to the complex symptomatology of depression. Depressive symptoms can range from sleep or appetite disorders to depressed mood and having crying spells. Thus, depressive symptoms can be divided into somatic and affective symptoms. This study investigated the associations of the different depressive subtypes with glycemic control. 923 patients completed the Center for Epidemiological Studies - Depression scale (CES-D) which offers subscales for somatic and affective symptoms. Linear regression analysis with HbA1c as dependent variable was conducted. Independent variables of interest were the somatic and affective scores of the CES-D controlled for demographic (age, gender, body mass index, education) and medical (diabetes type, diabetes duration, number of SMBG, late-complications) variables as well as diabetes distress. Both depressive subtypes were signifi cantly associated with HbA1c. A greater somatic symptomatology was associated with a higher HbA1c (β = .15; p = .001) whereas a greater affective symp A219.
For author disclosure information, see page A810.<cr><nl>
CATEGORY<cr><nl>
ADA-Funded Research \& Guided Audio Tour poster Behavioral Medicine, Clinical Nutrition, Education, and Exercise<cr><nl>
POSTERS<cr><nl>
PSYCHOSOCIAL, BEHAVIORAL MEDICINE<cr><nl>
tomatology was associated with a lower HbA1c (β = -.15; p = .001). Greater diabetes distress was associated with higher HbA1c (β = .13; p = .001). Linear regression with depressive symptoms in general (CES-D total score) as independent variable revealed no signifi cant association (β = -.01; p = .86). This study demonstrated that depression is a complex condition and offers an explanation for the inconsistencies in current literature regarding associations with glycemic control. Only the differentiation of subtypes offered a more complete picture of the associations of depression with glycemic control. In clinical practice and further research, a closer look which symptoms of depression are present may be helpful to better understand depression as a vulnerability factor.}
}

@article{ehrmann2015_55593,
  title = {Education in daily routine vs. RCT : health care research on the efficacy of an education and treatment program (Primas) for people with type 1 diabetes.},
  author = {Ehrmann, Dominic and Hermanns, Norbert and Bergis-Jurgan, Nikola and Haak, Thomas and Kulzer, Bernhard},
  year = {2015},
  journal = {Diabetes},
  volume = {64},
  number = {Supplement 1},
  pages = {A189-A189},
  address = {Alexandria, VA, USA},
  issn = {1939-327X},
  doi = {10.2337/db15-742-931},
  url = {https://fis.uni-bamberg.de/handle/uniba/55593},
  language = {eng},
  abstract = {A new treatment program has to prove its effectiveness in a randomized controlled trial (RCT). However, health care research trials (HCRT) show that the efficacy of education programs is far less convincing in daily routine. We evaluated whether a new education and treatment program for type 1 diabetic patients (PRIMAS) had similar effects in daily routine as in the RCT 255 people with type 1 diabetes from 42 practices took part in the PRIMAS course and were observed in this HCRT. As in the RCT, PRIMAS consisted of 12 lessons and the outcomes were assessed 6 months after the education course. Primary outcome in both studies was HbA1c assessed in the same central laboratory. Improvement in hypoglycemia Awareness, depressive symptoms, diabetes-related distress, self-efficacy, and diabetes empowerment were secondary outcomes. In order to compare the effects of PRIMAS in the RCT with the effects in the HCRT, effect sizes of differences for each study were contrasted. The difference of the two respective effect sizes (RCT - HCRT) along with the 95\% confidence interval was analyzed. HbA1c reduction in the RCT was -0.36\% (-3.9 mmol/mol) as compared to -0.39\% (-4.3 mmol/mol) in the HCRT. The difference of the effect sizes didn’t exceed the non-inferiority margin of 0.4 (difference of effect size: α -0.03, 95\% CI -0.29 to 0.22). Effect sizes in all secondary outcomes were also highly comparable: Improvement of hypoglycemia awareness α 0.11, 95\% CI -0.15 to 0.38; reduction of depressive symptoms α -0.08, 95\% CI -0.34 to 0.18; reduction of diabetes distress α 0.23, 95\% CI -0.04 to 0.49; improvement of self-efficacy α 0.05, 95\% CI -0.21 to 0.32; improvement of empowerment α 0.04, 95\% CI -0.23 to 0.36. PRIMAS proofed its effi cacy in daily routine and showed similar effect sizes as in the RCT. PRIMAS can contribute to an improvement of routine health care in people with type 1 diabetes.}
}

@incollection{kulzer2015_40651,
  title = {Behandlung der Adipositas bei Diabetes mellitus},
  author = {Kulzer, Bernhard},
  year = {2015},
  booktitle = {Handbuch Essstörungen und Adipositas},
  pages = {567-579},
  publisher = {Springer Verlag},
  address = {Berlin Heidelberg},
  isbn = {978-3-642-54573-3},
  doi = {10.1007/978-3-642-54573-3\_72},
  url = {https://fis.uni-bamberg.de/handle/uniba/40651},
  language = {deu},
  abstract = {Für alle Zielgruppen, die mit Patienten mit Essstörungen oder Adipositas zu tun haben, bietet das Handbuch aktuellen und umfassenden Einblick in die verschiedenen Arten der Essstörungen, deren Diagnostik und Behandlung.
Die Autoren legen hohen Wert auf Vollständigkeit und schulenübergreifende Interventionsverfahren. Es ist ihnen zudem ein Anliegen, die wichtigen und aktuellen wissenschaftlichen Aspekte der Störungen komprimiert und doch praxisnah darzustellen.
Hervorzuheben ist die Verknüpfung von pharmakologischen und psychotherapeutischen Behandlungsmethoden.}
}

@article{kulzer2015_40442,
  title = {Insulin degludec : Auswirkungen auf die Lebensqualität bei Typ-2-Diabetes},
  author = {Kulzer, Bernhard and Wilhelm, B and Hermanns, Norbert},
  year = {2015},
  journal = {Diabetes, Stoffwechsel und Herz},
  volume = {24},
  number = {4},
  pages = {241-249},
  publisher = {Kirchheim},
  address = {Mainz},
  issn = {1861-7603},
  url = {https://fis.uni-bamberg.de/handle/uniba/40442},
  language = {deu},
  abstract = {Die Diabetestherapie soll dazu beitragen, dass Menschen mit Diabetes mellitus trotz dieser chronischen Erkrankung ein möglichst normales und erfülltes Leben führen können. Dementsprechend sind für die Bewertung von Antidiabetika nicht nur Studienendpunkte zur Morbidität, Mortalität und zu Nebenwirkungen, sondern auch "Patient reported outcomes" (PROs), zu denen insbesondere Therapiezufriedenheit und Lebensqualität gehören, relevant. Die Beurteilung der Lebensqualität wird auch vom Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) zur Kosten-Nutzen-Bewertung empfohlen (1) und wird in der Verordnung über die Nutzenbewertung von Arzneimitteln (AM-NutzenV) bei der genaueren Beschreibung des patientenrelevanten therapeutischen Effekts mit aufgeführt (2).}
}

@article{lange2015_40433,
  title = {Optimizing insulin pump therapy : the potential advantages of using a structured diabetes management program},
  author = {Lange, Karin and Ziegler, Ralph and Neu, Andreas and Reinehr, Thomas and Daab, Iris and Walz, Marion and Maraun, Michael and Schnell, Oliver and Kulzer, Bernhard and Reichel, Andreas and Heinemann, Lutz and Parkin, Christopher G. and Haak, Thomas},
  year = {2015},
  journal = {Current Medical Research and Opinion},
  volume = {31},
  number = {3},
  pages = {477-485},
  publisher = {Taylor \& Francis Group},
  address = {Abingdon},
  issn = {1473-4877},
  doi = {10.1185/03007995.2015.1006355},
  url = {https://fis.uni-bamberg.de/handle/uniba/40433},
  language = {deu},
  abstract = {Use of continuous subcutaneous insulin infusion (CSII) therapy improves glycemic control, reduces hypoglycemia and increases treatment satisfaction in individuals with diabetes. As a number of patient- and clinician-related factors can hinder the effectiveness and optimal usage of CSII therapy, new approaches are needed to address these obstacles.
Ceriello and colleagues recently proposed a model of care that incorporates the collaborative use of structured SMBG into a formal approach to personalized diabetes management within all diabetes populations. We adapted this model for use in CSII-treated patients in order to enable the implementation of a workflow structure that enhances patient–physician communication and supports patients’ diabetes self-management skills.
We recognize that time constraints and current reimbursement policies pose significant challenges to healthcare providers integrating the Personalised Diabetes Management (PDM) process into clinical practice. We believe, however, that the time invested in modifying practice workflow and learning to apply the various steps of the PDM process will be offset by improved workflow and more effective patient consultations. This article describes how to implement PDM into clinical practice as a systematic, standardized process that can optimize CSII therapy.},
  keywords = {Adherence, CSII, Data management, Patient satisfaction, SMBG}
}

@article{kulzer2015_40425,
  title = {Psychosoziales und Diabetes : DDG Praxisempfehlung},
  author = {Kulzer, Bernhard and Albus, C and Herpertz, Stephan and Kruse, J and Lange, K and Lederbogen, F and Petrak, F},
  year = {2015},
  journal = {Diabetologie und Stoffwechsel: offizielles Organ der Deutschen Diabetes Gesellschaft},
  volume = {10},
  number = {Supplement 2},
  pages = {158-171},
  publisher = {Thieme},
  address = {Stuttgart [u.a.]},
  issn = {1861-9002},
  doi = {10.1055/s-0035-1553881},
  url = {https://fis.uni-bamberg.de/handle/uniba/40425},
  language = {deu}
}

@article{kulzer2015_40410,
  title = {Diabetesbezogene Belastungen, Wohlbefinden und Einstellung von Menschen mit Diabetes : Deutsche Ergebnisse der internationalen DAWN2™ Studie},
  author = {Kulzer, Bernhard and Lüthgens, B and Landgraf, R and Hermanns, Norbert},
  year = {2015},
  journal = {Der Diabetologe},
  volume = {11},
  number = {3},
  pages = {211-218},
  publisher = {Springer},
  address = {Berlin ; Heidelberg [u.a.]},
  issn = {1860-9724},
  doi = {10.1007/s11428-015-1335-8},
  url = {https://fis.uni-bamberg.de/handle/uniba/40410},
  language = {deu},
  abstract = {Hintergrund

Ziel der DAWN2™-Studie ist ein besseres Verständnis von Bedürfnissen und Problemen von Menschen mit Diabetes, deren Angehörigen, Behandlern und Patientenorganisationen bzw. Entscheidungsträgern. Es werden die Ergebnisse der deutschen Stichprobe berichtet und mit den internationalen Ergebnissen verglichen.

Methodik

An der DAWN2TM-Studie nahmen 8596 Menschen mit Diabetes aus 17 Ländern in 4 Kontinenten teil. In jedem Land wurden ca. 500 Menschen mit Diabetes befragt. Die deutsche Teilstichprobe umfasst 502 Personen (80 Menschen mit Typ-1-Diabetes und 422 Menschen mit Typ-2-Diabetes). Es wurden standardisierte Fragebögen zur Erfassung der Lebensqualität, der diabetesbezogenen Belastungen, des Selbstbehandlungsverhaltens, dem Diabetes-Empowerment und der Behandlungszufriedenheit eingesetzt und nach sozialer Diskriminierung gefragt.

Ergebnisse

Diabetespatienten in Deutschland haben im Vergleich zur Allgemeinbevölkerung eine reduzierte Lebensqualität und ein geringeres Wohlbefinden. Trotz dieses negativen Einflusses der Erkrankung auf die Lebensqualität werden psychosoziale Aspekte in der Diabetesversorgung relativ selten thematisiert. Im globalen Vergleich zeigen sich eine hohe Behandlungszufriedenheit und eine hohe Schulungsrate. Das Ausmaß an sozialer Diskriminierung ist bemerkenswert hoch, jedoch niedriger als im internationalen Vergleich.

Schlussfolgerung

Die DAWN2™-Studie zeigt, dass Diabetes mit einer Reihe psychosozialer Belastungen verbunden ist. Es gibt erhebliche Defizite in der psychosozialen Versorgung von Menschen mit Diabetes, die es im Interesse der Betroffenen zu verbessern gilt.},
  keywords = {Lebensqualität, Depression, Psychosoziale Belastungen, Diabetesschulung, Diskriminierung}
}

@article{petrak2015_40398,
  title = {Cognitive Behavioral Therapy Versus Sertraline in Patients With Depression and Poorly Controlled Diabetes. The Diabetes and Depression (DAD) Study: A Randomized Controlled Multicenter Trial},
  author = {Petrak, Frank and Herpertz, Stephan and Albus, Christian and Hermanns, Norbert and Hiemke, Christoph and Hiller, Wolfgang and Kronfeld, Kai and Kruse, Johannes and Kulzer, Bernhard and Ruckes, Christian and Zahn, Daniela and Müller, Matthias J.},
  year = {2015},
  journal = {Diabetes care},
  volume = {38},
  number = {5},
  pages = {767-775},
  address = {Alexandria, Va.},
  issn = {1935-5548},
  doi = {10.2337/dc14-1599},
  url = {https://fis.uni-bamberg.de/handle/uniba/40398},
  language = {eng},
  abstract = {OBJECTIVE
This study compared the long-term efficacy of a diabetes-specific cognitive behavioral
group therapy (CBT) with sertraline in patients with diabetes and depression
who initially responded to short-term depression treatment.
RESEARCH DESIGN AND METHODS
A randomized controlled single-blind trial was conducted in 70 secondary care
centers across Germany comparing 12 weeks of CBT with sertraline in 251 patients
with type 1 or 2 diabetes (mean HbA1c 9.3\%, 78 mmol/mol) and major depression
(Structured Clinical Interview for DSM-IV [SCID]). After 12 weeks, treatment responders
(‡50\% reduction Hamilton Depression Rating Scale [HAMD-17]) were
included in the 1-year study phase where CBT patients were encouraged to use
bibliotherapy and sertraline patients received continuous treatment. We analyzed
differences for HbA1c (primary outcome) and reduction (HAMD-17) or remission
(SCID) of depression from baseline to the 1-year follow-up using ANCOVA
or logistic regression analysis.
RESULTS
After 12 weeks, 45.8\% of patients responded to antidepressant treatment and
were included in the 1-year study phase. Adjusted HbA1c mean score changes from
baseline to the end of the long-term phase (20.27, 95\% CI 20.62 to 0.08) revealed
no significant difference between interventions. Depression improved in both
groups, with a significant advantage for sertraline (HAMD-17 change: 22.59,
95\% CI 1.15–4.04, P < 0.05).
CONCLUSIONS
Depression improved under CBT and sertraline in patients with diabetes and depression,
with a significant advantage for sertraline, but glycemic control
remained unchanged. CBT and sertraline as single treatment are insufficient to treat secondary care diabetes patients with depression and poor glycemic control.}
}

@article{petrak2015_40396,
  title = {Psychologie bei Diabetes : Erkennen Sie Angststörungen und diabetesbezogene Ängste?},
  author = {Petrak, Frank and Albus, Christian and Herpertz, Stephan and Kruse, Johannes and Lange, Karin and Lederbogen, Florian and Kulzer, Bernhard},
  year = {2015},
  journal = {Info Diabetologie},
  volume = {9},
  number = {4},
  pages = {35-44},
  publisher = {Springer Medizin Urban \& Vogel},
  address = {München},
  issn = {1865-5459},
  doi = {10.1007/s15034-015-0497-1},
  url = {https://fis.uni-bamberg.de/handle/uniba/40396},
  language = {deu},
  abstract = {Lernziele: Durch die Lektüre dieser Lerneinheit erfahren Sie, welche Formen pathologischer Ängste der neuen S2-Leitlinie „Psychologie und Diabetes“ der Deutschen Diabetes Gesellschaft zufolge unterschieden werden, wissen Sie, woran man sie erkennen kann und was bei Verdacht darauf getan werden kann, um den betroffenen Patienten zu helfen. Eine gewisse Furcht vor der chronischen Erkrankung Diabetes und ihren Folgen ist angemessen und hilft mitunter, sich konsequent um die eigene Therapie zu bemühen. Völlige Sorglosigkeit kann ebenso zum Problem werden wie übertriebene Angst, die die Lebensqualität vermeidbar einschränkt. Hier gilt es gegenzusteuern. Die S2-Leitlinie „Psychosoziales und Diabetes“ der Deutschen Diabetes-Gesellschaft bietet Entscheidungshilfen für Diagnostik und Therapie.}
}

@article{kulzer2015_40376,
  title = {Die Angst vor der Spritze},
  author = {Kulzer, Bernhard},
  year = {2015},
  journal = {Diabetes-Forum : Forum für integriertes Diabetesmanagement ; offizielles Organ: VDBD, BDD, BVKD, DDU, DDB, VDO E Diabetes Forum},
  volume = {27},
  number = {9},
  pages = {28-32},
  publisher = {Kirchheim},
  address = {Mainz},
  url = {https://fis.uni-bamberg.de/handle/uniba/40376},
  language = {deu},
  abstract = {Befürchtungen bezüglich einer Insulintherapie können bei Typ-2-Diabetikern eine entscheidende Barriere für die rechtzeitige Initialisierung einer Insulinbehandlung sein. Man nennt dies auch "psychologische Insulinresistenz".}
}

@article{ehrmann2015_40261,
  title = {Longitudinal relationship of diabetes-related distress and depressive symptoms: Analysing incidence and persistence.},
  author = {Ehrmann, Dominic and Kulzer, Bernhard and Haak, Thomas and Hermanns, Norbert},
  year = {2015},
  journal = {Diabetic Medicine},
  volume = {32},
  number = {10},
  pages = {1264-1271},
  publisher = {Wiley-Blackwell},
  address = {Oxford [u.a.]},
  doi = {10.1111/dme.12861},
  url = {https://fis.uni-bamberg.de/handle/uniba/40261},
  language = {eng},
  abstract = {Aim
To investigate the longitudinal bi-directionality of diabetes-related distress and depressive symptoms.

Methods
A total of 509 patients receiving intensified insulin therapy completed the Centre for Epidemiological Studies Depression scale questionnaire for the assessment of depressive symptoms as well as the Problem Areas in Diabetes questionnaire for the assessment of diabetes-related distress at baseline and at 6-month follow-up. Separate logistic and linear regression analyses for incidence and persistence were performed with demographic (age, gender, BMI) and medical (diabetes type, HbA1c, diabetes duration, late complications) control variables.

Results
Diabetes-related distress at baseline increased the risk of the incidence of elevated depressive symptoms by 2.56-fold (odds ratio 2.56; 95\% CI 1.15–5.72; P = 0.02) when controlling for demographic and medical variables. In addition, diabetes-related distress at baseline doubled the chance of the persistence of elevated depressive symptoms (odds ratio 2.04, 95\% CI 1.04–3.99; P = 0.04) when controlling for demographic and medical variables. The chance of having persistent elevated diabetes-related distress was increased 5.94-fold (odds ratio 5.94, 95\% CI 2.60–13.59; P < 0.0001) when elevated depressive symptoms were present at baseline. None of the medical variables had an influence on incidence or persistence.

Conclusions
Diabetes-related distress was identified as a risk factor for the incidence and persistence of depressive symptoms. Reducing diabetes-related distress could help to prevent the development of elevated depressive symptoms. Furthermore, depressive symptoms were identified as an amplifier for diabetes-related distress. Diabetes-related distress and depressive symptoms were independent risk factors for each other and should be monitored in routine care to disentangle their influence.}
}

@article{kulzer2015_40254,
  title = {Arzt-Patienten-Beziehung : Im digitalen Zeitalter grundlegend verändert},
  author = {Kulzer, Bernhard},
  year = {2015},
  journal = {Deutsches Ärzteblatt : ärztliche Mitteilungen},
  volume = {112},
  number = {43},
  pages = {20-23},
  publisher = {Dt. Ärzte-Verl.},
  address = {Köln},
  doi = {10.3238/PersDia.2015.10.23.06},
  url = {https://fis.uni-bamberg.de/handle/uniba/40254},
  language = {deu},
  abstract = {Neue Technologien wie Software zur Auswertung des Blutzuckerverlaufs, kontinuierliches Glukose-Monitoring oder Flash-Glukose-Monitoring setzen die Patienten in die Lage, ihre Erkrankung selbstständig zu „managen“.}
}

@article{drossel2015_40249,
  title = {Diabetestechnologie für Patienten mit einer Sehbehinderung und für blinde Patienten},
  author = {Drossel, D and Kulzer, Bernhard and Freckmann, G and Heinemann, L},
  year = {2015},
  journal = {Diabetes, Stoffwechsel und Herz},
  volume = {24},
  number = {5},
  pages = {321-330},
  publisher = {Kirchheim},
  address = {Mainz},
  issn = {1861-7603},
  url = {https://fis.uni-bamberg.de/handle/uniba/40249},
  language = {deu},
  abstract = {Es sollte möglich sein, mit einem vertretbaren Aufwand eine Barrierefreiheit bei Medizinprodukten zu erreichen.}
}

@article{hermanns2015_40244,
  title = {Treatment satisfaction and quality-of-life between type 2 diabetes patients initiating long- vs. intermediate-acting basal insulin therapy in combination with oral hypoglycemic agents – a randomized, prospective, crossover, open clinical trial},
  author = {Hermanns, Norbert and Kulzer, Bernhard and Kohlmann, Thomas and Jacob, Stephan and Landgraf, Wolfgang and Theobald, Karlheinz and Haak, Thomas},
  year = {2015},
  journal = {Health and Quality of Life Outcomes},
  volume = {13},
  number = {1},
  pages = {77},
  publisher = {BioMed Central},
  address = {London},
  doi = {10.1186/s12955-015-0279-4},
  url = {https://fis.uni-bamberg.de/handle/uniba/40244},
  language = {eng},
  abstract = {Background: Pharmacological and clinical differences between insulin glargine and NPH insulin may translate into differences in patient reported outcomes, but existing data are equivocal.
Methods: In this 48-week, open-label, randomized, multi center, crossover phase IV trial, insulin naïve type 2 diabetes patients with blood glucose not at target on oral hypoglycemic agents had basal insulin added to their treatment regimen. A total of 343 patients were randomized to either receive insulin glargine (n = 176; sequence A) or neutral protamine Hagedorn (NPH) insulin (n = 167; sequence B) in period 1 (weeks 1–24) and vice versa in period 2 (weeks 25–48). The primary objective was to assess patient reported outcomes using a composite Diabetes Related Quality of Life (DRQoL) score based on an unweighted Insulin Treatment Experience Questionnaire (ITEQ) score, a Problem Areas in Diabetes (PAID) questionnaire score, and the mental health score in the Short Form (SF)-12® Health Survey, analyzed by analysis of covariance (ANCOVA).
Results: Patients (mean age 62.3 ± 9.0; 39.5 \% female) had a mean diabetes duration of 9.6 ± 5.9 years, a mean baseline HbA1c of 8.15 ± 0.72 \%, and a mean fasting blood glucose (FBG) level of 9.37 ± 2.19 mmol/L. A total of 229 patients were available for primary endpoint evaluation (modified intention to treat population). Combining all data from both periods for each insulin treatment, on a 0–100 scale, the mean DRQoL score was 69.6 (±9.04) with insulin glargine and 70.0 (±9.40) with NPH insulin. Neither an effect of treatment with insulin glargine vs NPH insulin (p = 0.31) nor a period effect (p = 0.96), nor a sequence effect (p = 0.76) was observed using ANCOVA.
Conclusions: The results show that in a patient population with sub-optimal glycemic control at baseline, and a low target achievement rate together with a low rate of hypoglycemia, differences in the patient reported outcomes evaluated in this study were negligible between insulin glargine and NPH insulin.
Trial registration: Clinicaltrials.gov identifier: NCT00941369},
  keywords = {Diabetes, Insulin glargine, NPH insulin, Health assessment, Treatment satisfaction}
}

@article{hermanns2015_40234,
  title = {The Effect of a Diabetes-Specific Cognitive Behavioral Treatment Program (DIAMOS) for Patients With Diabetes and Subclinical Depression: Results of a Randomized Controlled Trial},
  author = {Hermanns, Norbert and Schmitt, Andreas and Gahr, Annika and Herder, Christian and Nowotny, Bettina and Roden, Michael and Ohmann, Christian and Kruse, Johannes and Haak, Thomas and Kulzer, Bernhard},
  year = {2015},
  journal = {Diabetes Care},
  volume = {38},
  number = {4},
  pages = {551-560},
  publisher = {Assoc.},
  address = {Alexandria, Va.},
  doi = {10.2337/dc14-1416},
  url = {https://fis.uni-bamberg.de/handle/uniba/40234},
  language = {eng},
  abstract = {OBJECTIVE
Subclinical depression is one of the most frequent mental comorbidities in patients with diabetes and is associated with a poorer long-term prognosis. Since there is a lack of specific intervention concepts for this patient group, a selfmanagement–oriented group program (DIAMOS [Diabetes Motivation Strengthening]) was newly developed and evaluated in a randomized trial.
RESEARCH DESIGN AND METHODS
DIAMOS is composed of cognitive behavioral interventions aiming at the reduction of diabetes distress. The active control group (CG) received diabetes education. The primary outcome was depressive symptoms. Secondary outcomes were diabetes distress, well-being, self-care behavior, diabetes acceptance, diabetes treatment satisfaction, HbA1c, and subclinical inflammation.
RESULTS
Two hundred fourteen participants (mean age 43.3 6 13.3 years, female sex 56.5\%, type 2 diabetes 34.1\%, mean diabetes duration 14.2 6 10.5 years, HbA1c 8.9 6 1.8\%, BMI 28.7 6 71 kg/m2) were randomized. The 12-month follow-up revealed a significantly stronger reduction of depressive symptoms (Center for Epidemiologic Studies Depression Scale score) in the DIAMOS group compared with the CG (D3.9 [95\% CI 0.6–7.3], P = 0.021). Of the secondary variables, the Patient Health Questionnaire-9 (D1.7 [95\% CI 0.2–3.2], P = 0.023), Problem Areas in Diabetes scale (D8.2 [95\% CI 3.1–13.3], P = 0.002), and Diabetes Distress Scale scores (D0.3 [95\% CI 0.1–0.5], P = 0.012) displayed significant treatment effects. Moreover, the risk of incident major depression in the DIAMOS group was significantly reduced (odds ratio 0.63 [95\% CI 0.42–0.96], P = 0.028). Inflammatory variables were not substantially affected.
CONCLUSIONS
DIAMOS is more effective in lowering depressive symptoms and diabetes-related distress in diabetic patients with subclinical depression. DIAMOS also has a preventive effect with respect to the incidence of major depression.}
}

@article{schmitt2015_39430,
  title = {Negative association between depression and diabetes control only when accompanied by diabetes-specific distress},
  author = {Schmitt, Andreas and Reimer, André and Kulzer, Bernhard and Haak, Thomas and Gahr, Annika and Hermanns, Norbert},
  year = {2015},
  journal = {Journal of Behavioral Medicine},
  volume = {38},
  number = {3},
  pages = {556-564},
  publisher = {Springer Science + Business Media B.V.},
  address = {Dordrecht [u.a.]},
  issn = {1573-3521},
  doi = {10.1007/s10865-014-9604-3},
  url = {https://fis.uni-bamberg.de/handle/uniba/39430},
  language = {eng},
  abstract = {Evidence of the negative impact of depression on glycaemic control is equivocal, and diabetes-related distress has been proposed as potential mediator. 466 diabetes patients were cross-sectionally assessed for depression (Center for Epidemiologic Studies Depression Scale), diabetes-related distress (Diabetes Distress Scale), and glycaemic control (HbA1c). We distinguished the associations of depression and diabetes distress with glycaemic control using analysis of variance and multiple regression. Neither patients with depression only nor diabetes distress only differed significantly from controls regarding HbA1c. However, HbA1c was substantially increased when both conditions were present (9.2 vs. 8.6 \%, P = 0.01). As in previous studies, we observed a significant association between depression and hyperglycaemia (P < 0.01). However, a mediation analysis revealed that this association in fact depended on the presence of diabetes distress (P < 0.01). Depression seems to be associated with hyperglycaemia particularly when accompanied by diabetes distress, suggesting that adjusting clinical procedures regarding diabetes distress may facilitate the identification and care of high-risk patients.},
  keywords = {Mood disorder, Depression, Hyperglycaemia, HbA1c, Mediation}
}

@article{schmitt2014_55865,
  title = {Negative Effekte von Depression auf die Diabetes-Selbstbehandlung werden möglicherweise durch eine reduzierte Krankheitsakzeptanz vermittelt},
  author = {Schmitt, Andreas and Reimer, Andre and Hermanns, Norbert and Haak, Thomas and Kulzer, Bernhard},
  year = {2014},
  journal = {Diabetologie und Stoffwechsel},
  number = {Supplement 1},
  pages = {P253},
  publisher = {Thieme},
  address = {Stuttgart},
  issn = {1861-9010},
  doi = {10.1055/s-0034-1375110},
  url = {https://fis.uni-bamberg.de/handle/uniba/55865},
  language = {deu},
  abstract = {Fragestellung: Eine komorbide Depression ist bei Diabetes mit einer reduzierten Selbstbehandlung assoziiert. Es ist jedoch unklar, in welcher Weise Depression und Diabetesbehandlung interagieren. Diese querschnittliche Studie untersuchte die Rolle von Krankheitsakzeptanz als vermittelndem Faktor.

Methodik: 180 Diabetespatienten (Alter 41 ± 15; 56\% weiblich; BMI 29 ± 7; 72\% Typ-1; Diabetesdauer 14 ± 10; 92\% insulinbehandelt; HbA1c 8,9 ± 1,6\%) wurden hinsichtlich Depressivität (ADS), Selbstbehandlungsverhalten (DSMQ) und Diabetes-Nonakzeptanz (AADQ-6) untersucht. Die Variablenzusammenhänge wurden mittels multipler Regressionsanalyse und Mediationseffekte mittels Sobel-Test untersucht.

Ergebnisse: Unter Adjustierung für Alter, Geschlecht, Bildung, BMI, Diabetestyp, Insulinbehandlung, und Folgeerkrankungsstatus war Depressivität signifikant assoziiert mit einem geringeren Blutzuckermanagementverhalten (BZSK/Medikamente) (β =-0,22, p < 0,01), einer weniger diabetesgerechten Ernährung (β=-0,24, p < 0,01), einer geringeren körperlichen Aktivität (β=-0,36, p < 0,01) und einem reduziertem Arztkontakt bzgl. Diabetes (β=-0,18, p < 0,05). Wurde zusätzlich der Einfluss der Krankheitsakzeptanz kontrolliert, so verloren die Zusammenhänge bei Blutzuckermanagement, Ernährung und Arztkontakt ihre Signifikanz, während Nonakzeptanz signifikante negative Assoziationen aufwies (alle p < 0,01). Da dieses Befundmusters eine vermittelnde Funktion von Krankheitsakzeptanz nahelegt, wurde der Sobel-Test angewandt, welcher tatsächlich signifikante Mediationseffekte anzeigte (alle p < 0,01).

Schlussfolgerungen: Die Befunde bestätigen negative Wechselwirkungen zwischen Depressivität und Diabetes-Selbstbehandlung. Sie sprechen zusätzlich dafür, dass bei diesen Wechselwirkungen eine reduzierte Krankheitsakzeptanz von zentraler Bedeutung ist. Möglicherweise neigen depressive Patienten verstärkt zu Abwehr/Vermeidung des Diabetes, was eine adäquate Selbstbehandlung verhindert. Bei der Therapie komorbider Depressionen sollte daher besonderes Augenmerk auf die emotionale Einstellung zum Diabetes gelegt werden.}
}

@article{schmitt2014_55863,
  title = {Der Diabetes Self-Management Questionnaire (DSMQ) identifiziert Diabetespatienten mit hohem Risiko einer negativen Prognose},
  author = {Schmitt, Andreas and Reimer, Andre and Hermanns, Norbert and Schall, Sabine and Haak, Thomas and Kulzer, Bernhard},
  year = {2014},
  journal = {Diabetologie und Stoffwechsel},
  volume = {9},
  number = {Supplement 1},
  pages = {P301},
  publisher = {Thieme},
  address = {Stuttgart},
  issn = {1861-9010},
  doi = {10.1055/s-0034-1375158},
  url = {https://fis.uni-bamberg.de/handle/uniba/55863},
  language = {deu},
  abstract = {Fragestellung: Bestehende Fragebögen zur Erfassung von Selbstbehandlungsverhaltensweisen zeigen oft nur geringe Assoziationen mit medizinischen Outcomemaßen wie dem HbA1c-Wert. Daher wurde der Diabetes Self-Management Questionnaire (DSMQ) entwickelt, dessen Evaluation eine hohe Validität belegt. Diese Studie bewertet die Qualität des Bogens im praktischen klinischen Gebrauch.

Methodik: 207 Diabetespatienten (Alter 42 ± 15; 57\% weiblich; BMI 29 ± 7; 70\% Typ-1; Diabetesdauer 14 ± 10; 92\% insulinbehandelt; HbA1c 8,9 ± 1,6\%) wurden mit dem DSMQ und weiteren Fragebögen zu Diabetesakzeptanz (AADQ-6), Krankheitsbewältigung (FKV-15), Diabetesbelastung (PAID), Behandlungszufriedenheit (DTSQ), und Depressionssymptomen (ADS) untersucht. Weitere Variablen wurden aus der Patientenakte gewonnen. Anhand eines Mediansplits wurden Patienten mit „gutem“ versus „schlechtem“ Selbstbehandlungsverhalten nach DSMQ-Summenwert unterschieden und hinsichtlich zentraler Outcomemaße verglichen (t-Test).

Ergebnisse: Patienten mit „schlechtem“ Selbstbehandlungsverhalten zeigten eine signifikant stärkere Diabetes-Nonakzeptanz (18 ± 6 vs. 12 ± 3, d= 1,23), weniger aktive Krankheitsbewältigung (2,7 ± 0,9 vs. 3,4 ± 0,8, d= 0,85), geringere Behandlungszufriedenheit (20 ± 7 vs. 24 ± 6, d= 0,58), höhere Diabetesbelastung (43 ± 22 vs. 33 ± 19, d= 0,45) und stärkere Depressivität (25 ± 11 vs. 20 ± 11, d= 0,47) (alle p< 0,01). Darüber hinaus maßen sie seltener ihren Blutzucker (2,4 ± 3,7 vs. 4,0 ± 3,3 Mal/Tag, d= 0,46), besuchten seltener ihren Diabetologen (2,0 ± 1,9 vs. 2,6 ± 2,3 Mal/Halbjahr, d= 0,27) und hatten einen höheren HbA1c-Wert (9,5 ± 1,5 vs. 8,2 ± 1,4\%, d= 1,35) sowie eine höhere Prävalenz retinopathischer Folgekrankheiten (28\% vs. 18\%, d= 0,32) (alle p< 0,05).

Schlussfolgerungen: Der DSMQ zeigt eine ausgezeichnete Differenzierung zwischen Patienten mit gutem versus schlechtem Selbstbehandlungsverhalten und ermöglicht damit die Identifikation von Patienten mit hohem Risiko einer negativen Diabetesprognose. Der Fragebogen ist mit 16 Items sehr ökonomisch und eignet sich als Screeninginstrument, zur Diagnostik oder für den wissenschaftlichen Gebrauch.}
}

@article{reimer2014_55862,
  title = {Effektivität eines systematischen Depressions-Screenings bei Diabetespatienten},
  author = {Reimer, Andre and Schmitt, Andreas and Hermanns, Norbert and Kulzer, Bernhard and Haak, Thomas},
  year = {2014},
  volume = {9},
  number = {Supplement 1},
  pages = {P88},
  publisher = {Thieme},
  address = {Stuttgart},
  issn = {1861-9010},
  doi = {10.1055/s-0034-1374945},
  url = {https://fis.uni-bamberg.de/handle/uniba/55862},
  language = {deu},
  abstract = {Fragestellung: Die Komorbidität von Diabetes und Depression ist mit einer negativen Prognose assoziiert. Um die Erkennungsrate depressiver Diabetespatienten zu ermitteln, wurde in dieser Studie die Effektivität eines Depressionsscreenings auf der tertiären Versorgungsebene. (Krankenhaus) untersucht.

Methodik: Das Depressionsscreening wurde mit der „Allgemeinen Depressionsskala (ADS)“ und der „Problem Areas in Diabetes Scale (PAID)“ durchgeführt. Patienten mit positivem Screeningbefund (ADS-Wert ≥16 und/oder PAID-Wert ≥40) wurden mittels eines diagnostischen Interviews nachuntersucht.

Ergebnisse: 806 Patienten (Alter 49 ± 15, 55\% männlich, 57\% Typ-1-Diabetes, HbA1c 8,7 ± 1,6\%) nahmen an der Untersuchung teil. 325 Patienten (40\%) zeigten einen positiven Screeningbefund. Die Sensitivität des Depressionscreenings betrug 100\%, die Spezifität 79\%., der positive prädiktive Wert (ppW) 61,5\%, der negative prädiktive Wert (npW) 100\%. Von den identifizierten depressiven Patienten waren 120 bereits diagnostiziert, 80 wurden neu entdeckt. Die Sensitivität des Screenings für die Entdeckung bisher nicht erkannter Personen mit Depression ergab ebenfalls eine Sensitivität von 100\%, eine Spezifität von 79,4\% bei einem ppW von 39\% und einem npW von 100\%. Neuidentifizierte depressive Diabetiker wiesen eine annähernd ähnliche schlechte glykämische Kontrolle auf, wie bereits bekannte depressive Diabetiker 8,9 ± 1,4 vs. 8,9 ± 1,6 (p = 0,807).

Schlussfolgerungen: Es zeigte sich eine hohe Depressionsprävalenz (24,8\%). Das Depressionsscreenings wies sehr gute Screeningeigenschaften auf. Aufgrund des Depressionsscreenings konnten auch bisher unentdeckte depressive Patienten mit ausreichender Sensitivität und Spezifität identifiziert werden, welche eine unzureichende glykämische Kontrolle aufwiesen. Die große Zahl entdeckter wie unterentdeckter Menschen mit Diabetes und einer komorbiden Depression sprechen für ein routinemäßiges Depressionsscreening im Krankenhaus.}
}

@article{hermanns2014_55861,
  title = {Übereinstimmung von selbstberichtetem Behandlungsverhalten und klinisch-medizinischen Außenkriterien},
  author = {Hermanns, Norbert and Kulzer, Bernhard and Haak, Thomas and Query, S and Schall, Sabine and Schmitt, Andreas},
  year = {2014},
  journal = {Diabetologie und Stoffwechsel},
  volume = {9},
  number = {Supplement 1},
  pages = {P169},
  publisher = {Thieme},
  address = {Stuttgart},
  issn = {1861-9010},
  doi = {10.1055/s-0034-1375026},
  url = {https://fis.uni-bamberg.de/handle/uniba/55861},
  language = {deu},
  abstract = {Fragestellung: In der klinischen Praxis beruht die Erfassung des Selbstbehandlungsverhaltens meist auf dem Selbstbericht von Patienten. In dieser Studie wurde geprüft, inwieweit selbstberichtetes Behandlungsverhalten durch klinisch-medizinische Außenkriterien validiert werden kann. Der Diabetes Self-Management Questionnaire (DSMQ) erfasst verschiedene Aspekte des Selbstbehandlungsverhaltens: Blutzucker-Management (Skala BZ), Ernährungsverhalten (Skala DE), Arztkontakte (Skala AK) und körperliche Aktivität (Skala KA). Als klinisch-medizinische Außenkriterien dienten: Gespeicherte Werte der Blutzuckerselbstkontrolle, HbA1c-Wert, Blutfette, Gewicht, Resultate eines Fitnesstests, Fähigkeit zur Boluskalkulation, Anzahl der Folgeerkrankungen und der Arztkontakte.

Methodik: 70 Diabetespatienten (Alter 37 ± 16 Jahre; 61\% weiblich; BMI 28 ± 7 kg/m2; 79\% Typ-1; Diabetesdauer 13 ± 10J.; 96\% insulinbehandelt; HbA1c 8,9 ± 1,9\%) bearbeiteten den DSMQ.

Ergebnisse: Ein höherer Wert in der Gesamtskala des DSMQ geht mit einem niedrigeren HbA1c-Wert (r=-0,60; p < 0,001); ein besseres Blutzucker-Management (Skala BZ) mit einem geringeren HbA1c-Wert (r=-0,58, p < 0,001), einer höheren Anzahl an Blutzuckerselbstkontrollen (r= 0,49, p < 0,001) sowie einer besseren Bolusanpassung (r= 0,36, p = 0,003) einher. Ein höherer Wert in der Skala DE ist mit einem niedrigeren BMI (r=-0,27, p = 0,028) und Triglyceridwerten (r=-0,32, p = 0,009) assoziiert. Eine höherer Wert in der Skala AK korrelierte mit häufigeren Diabetologenbesuchen (r= 0,45, p < 0,001), einer geringeren Anzahl von Folgeerkrankungen (r=-0,32, p = 0,009) sowie einem geringeren HbA1c-Wert (r=-0,38, p = 0,002). Interessanterweise korrelierte die Skala KA nur mäßig mit dem erhobenen Fitnessmaß (r = 0,17 p > 0,05).

Schlussfolgerungen: Das selbstberichte Behandlungsverhalten wies besonders in den Bereichen Blutzuckermanagement, Ernährungsverhalten und Arztkontakte eine relevante Übereinstimmung mit klinisch-medizinischen Outcomes auf. Der DSMQ ist ein Selbstberichtsverfahren, welches therapeutisch relevantes Selbstbehandlungsverhalten valide und objektiv erfasst.}
}

@article{schmitt2014_41640,
  title = {Assessment of diabetes acceptance can help identify patients with ineffective diabetes self-care and poor diabetes control},
  author = {Schmitt, Andreas and Reimer, Andre and Kulzer, Bernhard and Haak, Thomas and Gahr, Annika and Hermanns, Norbert},
  year = {2014},
  journal = {Diabetic Medicine},
  volume = {31},
  number = {11},
  pages = {1446-1451},
  publisher = {Wiley-Blackwell},
  address = {Oxford [u.a.]},
  issn = {1464-5491},
  doi = {10.1111/dme.12553},
  url = {https://fis.uni-bamberg.de/handle/uniba/41640},
  language = {eng},
  abstract = {AIMS:
To estimate the associations between insufficient diabetes acceptance and relevant diabetes outcomes.
METHODS:
A total of 320 patients completed questionnaires on diabetes non-acceptance (the Acceptance and Action Diabetes Questionnaire), diabetes distress (the Problem Areas in Diabetes Scale), depressive mood (the Center for Epidemiologic Studies Depression Scale), coping with illness (the Freiburg Questionnaire of Coping with Illness), self-care activities (the Summary of Diabetes Self-Care Activities Measure) and quality of life (the Short Form-36 Health Questionnaire). A six-item version of the Acceptance and Action Diabetes Questionnaire showing good reliability and validity was established, and the associations between insufficient acceptance and clinical outcomes were estimated.
RESULTS:
Higher diabetes non-acceptance correlated significantly with less active coping (-0.37), reduced self-care (-0.43) and higher HbA1c levels (0.31), higher diabetes distress (0.53) and more depressive symptoms (0.36). Correlations of diabetes non-acceptance with diabetes self-care/glycaemic control were significantly higher than were those of depressive mood or diabetes distress with these criteria.
CONCLUSIONS:
Low diabetes acceptance is associated with impaired self-care and glycaemic control. Assessment of diabetes acceptance may facilitate the detection of patients at high risk and may present an essential target for treatments to improve diabetes control that is more relevant than elevated depressive mood or diabetes distress.}
}

@incollection{kulzer2014_39602,
  title = {Psychologische Aspekte des Diabetes mellitus},
  author = {Kulzer, Bernhard},
  year = {2014},
  booktitle = {Diabetologie kompakt},
  pages = {24-29},
  publisher = {Springer Medizin},
  address = {Berlin ; Heidelberg},
  edition = {5., vollst. überarb. u. aktualisierte Aufl.},
  isbn = {978-3-642-41357-5},
  url = {https://fis.uni-bamberg.de/handle/uniba/39602},
  language = {deu}
}

@article{ziegler2014_39480,
  title = {Freedom of Science : Can Industry Influence What Scientists Publish?},
  author = {Ziegler, Ralph and Schnell, Oliver and Kulzer, Bernd and Gilbart, James and Heinemann, Lutz},
  year = {2014},
  journal = {European Endocrinology},
  volume = {10},
  number = {1},
  pages = {10-13},
  publisher = {Touch Medical Media},
  address = {Goring-on-Thames},
  issn = {1758-3780},
  doi = {10.17925/EE.2014.10.01.i},
  url = {https://fis.uni-bamberg.de/handle/uniba/39480},
  language = {eng}
}

@article{lodwig2014_39474,
  title = {What Are the Next Steps in Continuous Glucose Monitoring?},
  author = {Lodwig, Volker and Kulzer, Bernhard and Schnell, Oliver and Heinemann, Lutz},
  year = {2014},
  journal = {Journal of diabetes science and technology : from basic science to clinical practice ; DST},
  volume = {8},
  number = {2},
  pages = {397-402},
  publisher = {Sage},
  address = {Thousand Oaks, Calif.,},
  issn = {1932-2968},
  doi = {10.1177/1932296814525825},
  url = {https://fis.uni-bamberg.de/handle/uniba/39474},
  language = {eng},
  abstract = {The development of glucose sensors for continuous glucose monitoring (CGM) is likely still in its early days. A number of novel approaches—along with many attempts to improve current CGM systems—are in development. The next generation of glucose sensors (NGGS) will also enable, for example, reliable glucose measurement in the low glycemic range. NGGS systems represent an important step forward for closed-loop systems. This commentary discusses a number of aspects that are relevant in this context.},
  keywords = {Glucose sensors, continuous glucose monitoring, diabetes therapy, artificial pancreas, quality of life}
}

@article{bergis2014_39463,
  title = {Ambulante Schulung bei Typ-2-Diabetes},
  author = {Bergis, N. and Ehrmann, Dominic and Haak, Thomas and Kulzer, Bernhard and Hermanns, Norbert},
  year = {2014},
  journal = {Der Diabetologe},
  volume = {10},
  number = {4},
  pages = {293-299},
  publisher = {Springer},
  address = {Berlin ; Heidelberg},
  issn = {1860-9724},
  doi = {10.1007/s11428-013-1185-1},
  url = {https://fis.uni-bamberg.de/handle/uniba/39463},
  language = {deu},
  abstract = {Fragestellung

Die Schulung von Menschen mit Typ-2-Diabetes wird in den Leitlinien als ein unverzichtbarer Bestandteil der Therapie bezeichnet. Zahlreiche Studien und Metaanalysen belegen die Effektivität von Schulungen. Allerdings stehen kaum Informationen zur derzeitigen Schulungssituation in Deutschland zur Verfügung.
Ziel der Arbeit

Mit der aktuellen Versorgungsstudie „PRIMASCOPE“ wurden erstmals Daten zu dieser Thematik erhoben. Im vorliegenden Beitrag werden die Ergebnisse zur Typ-2-Diabetes-Schulung berichtet.
Material und Methoden

Diabetologische Schwerpunktpraxen (DSP) in ganz Deutschland wurden mithilfe eines Fragebogens zu relevanten Aspekten der Schulung wie z. B. Schulungsfrequenz, Zielen der Schulung, Bekanntheit, Anwendung und Beurteilung von Schulungsprogrammen befragt. Insgesamt konnten die Daten von 818 DSP ausgewertet werden.
Ergebnisse

Fast jeder 3. Patient mit Typ-2-Diabetes wurde bislang noch nicht geschult; bei etwa 20 \% der Patienten liegt die letzte Schulung schon mehr als 10 Jahre zurück. Im Schnitt werden in einer DSP jährlich etwa 25 Gruppenschulungen für Menschen mit Typ-2-Diabetes in einer durchschnittlichen Gruppengröße von etwa 7 Teilnehmern (6,8 ± 3,5) durchgeführt. Der größte Teil der Typ-2-Diabetes-Patienten (91,4 \%) wird in einer Gruppe geschult, wobei 47,3 \% eine Einzelberatung erhalten. Psychosoziale Ziele und Schulungsinhalte werden von den DSP als mindestens genauso wichtig eingeschätzt wie eher medizinische Themen. Die ZI-Programme sind in den DSP am bekanntesten und werden aktuell noch immer am häufigsten eingesetzt. Gleichzeitig bewerten die DSP die Qualität dieser Programme am schlechtesten. Die Schulungsprogramme MEDIAS ICT, MEDIAS BASIS und HyPOS werden von den DSP hinsichtlich der Qualität am besten beurteilt.
Diskussion

Die Ergebnisse von PRIMASCOPE zeigen erstmals Daten zu der Schulungsrealität auf der Ebene 2 (DSP) in Deutschland. Bezüglich der Schulungsfrequenz können in der Praxis die Empfehlungen der Leitlinien noch nicht erfüllt werden; hinsichtlich der Schulungsziele und -inhalte besteht gute Übereinstimmung.},
  keywords = {Selbstmanagement, Patientenzufriedenheit, Qualität der Gesundheitsversorgung, Evidenzbasierte Leitlinien, Fragebogen}
}

@article{kulzer2014_39472,
  title = {Patientenschulung bei Diabetes mellitus},
  author = {Kulzer, Bernhard and Hermanns, Norbert},
  year = {2014},
  journal = {Der Diabetologe},
  volume = {10},
  number = {4},
  pages = {274-275},
  publisher = {Springer},
  address = {Berlin ; Heidelberg},
  issn = {1860-9724},
  doi = {10.1007/s11428-013-1115-2},
  url = {https://fis.uni-bamberg.de/handle/uniba/39472},
  language = {deu}
}

@article{hermanns2014_39466,
  title = {The Impact of Continuous Glucose Monitoring on Low Interstitial Glucose Values and Low Blood Glucose Values Assessed by Point-of-care Blood Glucose Meters : Results of a Crossover Trial},
  author = {Hermanns, Norbert and Schumann, Beatrix and Kulzer, Bernhard and Haak, Thomas},
  year = {2014},
  journal = {Journal of diabetes science and technology : from basic science to clinical practice ; DST},
  volume = {8},
  number = {3},
  pages = {516-522},
  publisher = {Sage},
  address = {Thousand Oaks, Calif.},
  issn = {1932-2968},
  doi = {10.1177/1932296814524105},
  url = {https://fis.uni-bamberg.de/handle/uniba/39466},
  language = {eng},
  abstract = {Objective: In a randomized crossover trial the impact of continuous glucose monitoring (CGM) was tested on the occurrence of low blood glucose values measured by point of care (POC) measurement and on low glucose values measured by CGM in the interstitial fluid.

Methods: A total of 41 type 1 diabetic patients (age 42.0 ± 11.4 years, diabetes duration 15.3 ± 10.1 years, A1c 8.2 ± 1.4\%) used a CGM system (Dexcom SEVEN PLUS system) twice. In first study phase (CGM blind), patients were blind regarding the CGM current glucose levels and were not alerted when critical glucose values were reached. In the second phase (CGM real time), patients had access to current glucose levels and were alerted if critical glucose values were reached.

Results: During CGM real time the proportion of hypoglycemic POC blood glucose values were significantly reduced (7.5 ± 5.6\% vs 10.1 ± 7.5\%; P = .04), whereas the proportion of euglycemic blood glucose values were significantly enhanced (73.7 ± 18.3\% vs 68.3 ± 12.1\%; P = .01). The duration of low glucose periods in the interstitial fluid was significantly lower in the CGM real time phase (125 ± 89 vs 181 ± 125 minutes per day; P = .005). The time until a low blood glucose was detected by POC measurement was shortened by 33.2 ± 76.1 minutes (P = .03).

Conclusion: The study demonstrated that CGM is able to not only reduce duration of hypoglycemia measured by CGM in interstitial fluid, but also reduce the proportion of low POC blood glucose measurements. In addition, hypoglycemia can be detected earlier.},
  keywords = {continuous glucose monitoring, hypoglycemia, type 1 diabetes}
}

@article{maier2014_39428,
  title = {Abrechnungsmodalitäten von zertifizierten Schulungs- und Behandlungsprogrammen},
  author = {Maier, Berthold and Kulzer, Bernhard and Hermanns, Norbert},
  year = {2014},
  journal = {Der Diabetologe},
  volume = {10},
  number = {4},
  pages = {300-306},
  publisher = {Springer},
  address = {Berlin ; Heidelberg},
  issn = {1860-9724},
  doi = {10.1007/s11428-013-1186-0},
  url = {https://fis.uni-bamberg.de/handle/uniba/39428},
  language = {deu},
  abstract = {Hintergrund: Die Diabetesschulung ist ein integraler und effektiver Bestandteil der Diabetestherapie. Im Rahmen der Disease-Management-Programme (DMP) für Typ-1- und Typ-2-Diabetes haben eingeschriebene Patienten das Recht auf die Teilnahme an einem evaluierten sowie strukturierten Schulungs- und Behandlungsprogramm.
Ziel der Arbeit: In der vorliegenden Übersicht werden die vertraglich definierten Voraussetzungen für die Diabetesschulung und ihre Abrechnungsmodalitäten innerhalb der DMP-Verträge in Deutschland dargestellt.
Material und Methoden: Die vom Bundesversicherungsamt (BVA) für DMP zugelassenen Schulungsprogramme wurden auf der Grundlage verfügbarer DMP-Verträge bezüglich der Abrechnungsfähigkeit, Vergütung und Umsetzung verglichen. Dabei werden auch die Unterschiede in der Umsetzung und Vergütung von Schulungsprogrammen innerhalb der DMP der 17 regionalen kassenärztlichen Vereinigungen (KVen) beleuchtet.
Ergebnisse: Die DMP unterscheiden sich in der Zahl abrechnungsfähiger Schulungsprogramme, der notwendigen Qualifikation von Schulungskräften sowie der Dauer und Vergütung von Schulungskursen und Patientenmaterialien.
Schlussfolgerung: Vor dem Hintergrund der hohen Zahl qualifizierter Schulungskräfte und der breiten Palette zugelassener Schulungsprogramme sollten Bemühungen intensiviert werden, die Qualität in der Durchführung abgerechneter Schulungsprogramme sicherzustellen.},
  keywords = {Patientenschulung als Thema, Typ-1-Diabetes, Typ-2-Diabetes, Vergütung, Qualität}
}

@article{lodwig2014_39427,
  title = {Current Trends in Continuous Glucose Monitoring},
  author = {Lodwig, Volker and Kulzer, Bernhard and Schnell, Oliver and Heinemann, Lutz},
  year = {2014},
  journal = {Journal of Diabetes Science and Technology},
  volume = {8},
  number = {2},
  pages = {390-396},
  publisher = {Sage},
  address = {Thousand Oaks, Calif.,},
  issn = {1932-2968},
  doi = {10.1177/1932296814525826},
  url = {https://fis.uni-bamberg.de/handle/uniba/39427},
  language = {eng},
  abstract = {The market introduction of systems for continuous glucose monitoring (CGM) some 15 years ago did not immediately revolutionize the treatment of diabetes; however, for a given group of patients, it would almost be inconceivable nowadays to imagine life without CGM. One day the development of insulin pumps together with CGM could culminate in an artificial pancreas system. The performance of the glucose sensors used for glucose measurement in the interstitial fluid in the subcutaneous tissue and the algorithms employed to analyze these data have improved so much over the past decade that current CGM systems by far outperform those of the first generations. This commentary discusses a number of aspects about what we have learned since CGM systems entered the market and what current trends exist in their usage. Some of these are major hurdles facing a more widespread usage of CGM.},
  keywords = {glucose sensors, continuous glucose monitoring, diabetes therapy, artificial pancreas, quality of life}
}

@article{kulzer2014_39424,
  title = {Depression bei Diabetes},
  author = {Kulzer, Bernhard and Krichbaum, Michael and Hermanns, Norbert},
  year = {2014},
  journal = {Der Diabetologe},
  volume = {10},
  number = {6},
  pages = {497-510},
  publisher = {Springer},
  address = {Berlin ; Heidelberg},
  issn = {1860-9724},
  doi = {10.1007/s11428-014-1263-z},
  url = {https://fis.uni-bamberg.de/handle/uniba/39424},
  language = {deu}
}

@article{kulzer2014_39423,
  title = {Primäre Prävention des Typ-2-Diabetes durch Lebensstilmodifikation},
  author = {Kulzer, Bernhard and Hermanns, Norbert and Krichbaum, Michael and Gorges, D. and Haak, Thomas},
  year = {2014},
  journal = {Der Diabetologe},
  volume = {10},
  number = {4},
  pages = {276-285},
  publisher = {Springer},
  address = {Berlin ; Heidelberg},
  issn = {1860-9724},
  doi = {10.1007/s11428-013-1182-4},
  url = {https://fis.uni-bamberg.de/handle/uniba/39423},
  language = {deu}
}

@article{kulzer2014_39426,
  title = {Real-world Patient-reported Rates of Non-severe Hypoglycaemic Events in Germany},
  author = {Kulzer, Bernhard and Seitz, L. and Kern, W.},
  year = {2014},
  journal = {Experimental and clinical endocrinology \& diabetes : official journal},
  volume = {122},
  number = {03, 57th Symposium of the German Society of Endocrinology (DGE)},
  pages = {167-172},
  publisher = {Thieme},
  address = {Stuttgart},
  issn = {0947-7349},
  doi = {10.1055/s-0033-1363688},
  url = {https://fis.uni-bamberg.de/handle/uniba/39426},
  language = {eng},
  abstract = {Aims: Hypoglycaemia is a common side effect of insulin therapy in diabetes patients, with negative physical and emotional impacts. Despite this, there are few studies investigating the frequency of non-severe hypoglycaemic events from the perspective of patients in the real-world setting. We investigated self-reported NSHE frequency and levels of hypoglycaemia awareness in Germany.
Methods: Respondents>15 years with Type 1 or insulin-treated Type 2 diabetes (receiving basal only, basal-bolus or other insulin regimens) were recruited using online panels to complete≤4 questionnaires. Questionnaires collected demographics, non-severe hypoglycaemic event rates and patient-reported level of hypoglycaemia awareness. Non-severe hypoglycaemic event rates are reported as respondent-week records and calculated using data from all respondents completing at least one questionnaire.
Results: A total of 1 771 respondent-week records were obtained from 614 participants. Mean non-severe hypoglycaemic event rates per respondent-week were 1.6 for Type 1 and 0.6–0.8 for Type 2, with estimated annual rates of 83 and 31–42 respectively. Two-thirds of Type 1 (65\%) and Type 2 (61–72\%) respondents reported impaired levels of awareness or unawareness of hypoglycaemic events (inability or impaired ability to recognise the symptoms of hypoglycaemia). Respon­dents’ self-reported hypoglycaemia-awareness was significantly associated with the proportion of asymptomatic non-severe hypoglycaemic events; respondents classified as being unaware of hypoglycaemia had a higher proportion of asymptomatic non-severe hypoglycaemic events than aware respondents.
Conclusion: Non-severe hypoglycaemic events are common in people with Type 1 or insulin-treated Type 2 diabetes in the real-world setting in Germany but may still be underestimated due to an inability to recognise the symptoms of hypoglycaemia.},
  keywords = {hypoglycaemia, insulin therapy, diabetes-related distress, hypoglycaemia awareness}
}

@article{ehrmann2014_39414,
  title = {Ambulante Schulung bei Typ-1-Diabetes},
  author = {Ehrmann, Dominic and Bergis-Jurgan, N. and Haak, Thomas and Kulzer, Bernhard and Hermanns, Norbert},
  year = {2014},
  journal = {Der Diabetologe},
  volume = {10},
  number = {4},
  pages = {286-292},
  publisher = {Springer},
  address = {Berlin ; Heidelberg},
  issn = {1860-9724},
  doi = {10.1007/s11428-013-1184-2},
  url = {https://fis.uni-bamberg.de/handle/uniba/39414},
  language = {deu},
  abstract = {Ziel der Arbeit: Mit der PRIMASCOPE-Versorgungsstudie konnten dazu erstmals repräsentative Daten gewonnen werden.
Material und Methoden: Fragen zu Art und Häufigkeit der Schulung, zu Bekanntheit und Zufriedenheit mit verfügbaren Schulungsprogrammen sowie zur Einschätzung von Schulungszielen und -inhalten bei Typ-1-Diabetes wurden an diabetologische Schwerpunktpraxen (DSP) in ganz Deutschland versendet. Insgesamt konnten Fragebogen von 818 DSP ausgewertet werden.
Ergebnisse: Laut Angaben der DSP wurden ca. 25 \% der Patienten mit Typ-1-Diabetes noch nie geschult. Als wichtigste Ziele einer Typ-1-Diabetes-Schulung werden „Vermittlung von Selbstmanagementfähigkeiten“, „Optimierung der Lebensqualität“ und „Stärkung der Motivation“ angegeben. Psychosoziale Inhalte und Ziele werden als ähnlich wichtig eingeschätzt wie medizinische Inhalte und Ziele. Des Weiteren zeigt sich ein großer Nachschulungsbedarf nach 2 Jahren für die Themen „Motivation“, „körperliche Bewegung“, „Ernährung“ und „Hypoglykämien“. Mit dem bekanntesten Basisprogramm „Behandlungs- und Schulungsprogramm für intensivierte Insulintherapie“ sind die Anwender eher unzufrieden. Das bekannteste problemspezifische Schulungsprogramm „HyPOS“ erreicht die höchste Zufriedenheit.
Schlussfolgerung: Die Ergebnisse belegen, dass viele Typ-1-Diabetes-Patienten einen erhöhten Schulungsbedarf aufweisen. Zudem ist zu erkennen, dass die Typ-1-Diabetes-Schulung eine komplexe Maßnahme darstellt, die sowohl medizinische als auch psychosoziale Themen abdecken muss. Die Unzufriedenheit mit vorhandenen Basisschulungsprogrammen legt nahe, dass ein umfangreiches Konzept fehlt, das sowohl medizinische als auch psychosoziale Themen ausreichend vermittelt.},
  keywords = {Selbstmanagement, Patientenzufriedenheit, Lebensqualität, Motivation, Fragebogen}
}

@article{hermanns2014_39413,
  title = {Effect of Local Heating on Postprandial Blood Glucose Excursions Using the InsuPad Device - Results of an Outpatient Crossover Study},
  author = {Hermanns, Norbert and Bitton, Gabriel and Reimer, André and Krichbaum, Michael and Kulzer, Bernhard and Haak, Thomas},
  year = {2014},
  journal = {Journal of diabetes science and technology : from basic science to clinical practice ; DST},
  volume = {8},
  number = {6},
  pages = {1126-1132},
  publisher = {Sage},
  address = {Thousand Oaks, Calif.,},
  issn = {1932-2968},
  doi = {10.1177/1932296814546162},
  url = {https://fis.uni-bamberg.de/handle/uniba/39413},
  language = {eng}
}

@article{hermanns2013_55801,
  title = {The impact of continuous glucose monitoring (CGM) on low interstitial glucose values and low blood glucose values assessed by Point-of-Care glucose meters (POC-GM).},
  author = {Hermanns, Norbert and Schumann, Beatrix and Kulzer, Bernhard and Haak, Thomas},
  year = {2013},
  journal = {Diabetes},
  volume = {62},
  number = {Supplement 1},
  pages = {864-P},
  address = {Alexandria, Virginia, USA},
  issn = {1939-327X},
  doi = {10.2337/db13-859-1394},
  url = {https://fis.uni-bamberg.de/handle/uniba/55801},
  language = {eng},
  abstract = {The impact of CGM on the duration of periods with low glucose measured in interstitial fluid is well known. But studies showing an impact of CGM on low blood glucose values, measured by POC-GM are rare. This crossover study examines the impact of CGM on duration of periods spent in low interstitial glucose range (70 mg/dl) as well as on the proportion of low blood glucose (BG) values measured by POC-GM (Glukometer 3000, Bio Sensor Technology, Germany)and time until detection of low BG by use of POC-GM. 41 type 1 diabetic patients (age 42.0 ±11.3 yrs, diabetes duration 15.3 ±10.1; A1c 8.2 ±1.4\%) used the DEXCOM 7 Plus CGM system twice; once participants were blinded against the results and in the other study phase (Open GCM) patients received real-time glucose values and current glucose trends, used the CGM data to determine their insulin dose, and were alerted if hypoglycaemic or hyperglycaemic glucose ranges were approached. In addition, BG was routinely measured 6 times a day by POC-GM. The order of study phases was randomized. The time spent in a hypoglycaemic glucose range (< 70 mg/dl) was reduced by open CGM from 180.6 ±125 to 125 ± 89.2 minutes per day (p=.005). Also time spent in the euglycemic glucose range was increased from 946 ±176 to 1023 ±168 minutes per day (p=.003). Open CGM reduced the proportion of low BG measurements by POC-GM from 10.3 ±7.6\% to 7.4 ±5.8\% (p=.039), whereas the euglycemic POC readings was increased from 68.3 ±12.1\% to 73.7 ±12.1\% (p=.007). The time until a hypoglycaemic BG value was detected by POC-GM was signifi cantly (p.028) shortened by 33.1 (95\% CI 3.8 -62.3) minutes.
These results demonstrate that CGM used for insulin dosing and hypoglycaemia alerts not only diminishes low interstitial glucose values but also reduces the proportion of low BG measured by POC-GM. In addition the time for the detection of a hypoglycaemic episode by POC-GM was significantly shortened}
}

@book{kulzer2013_39556,
  title = {PRIMAS - Leben mit Typ-1-Diabetes : Schulungs- und Behandlungsprogramm für ein selbstbestimmtes Leben mit Typ-1-Diabetes},
  author = {Kulzer, Bernhard and Hermanns, Norbert and Ehrmann, Dominic and Bergis-Jurgan, N and Haak, Thomas},
  year = {2013},
  publisher = {Kirchheim Verlag},
  address = {Mainz},
  url = {https://fis.uni-bamberg.de/handle/uniba/39556},
  language = {deu}
}

@article{schmitt2013_39457,
  title = {AADQ : Evaluation der deutschen Fassung des Fragebogens},
  author = {Schmitt, Andreas and Gahr, A. and Hermanns, Norbert and Kulzer, Bernhard and Haak, Thomas},
  year = {2013},
  journal = {Diabetes, Stoffwechsel und Herz},
  volume = {22},
  number = {(2014), 1},
  pages = {9-15},
  publisher = {Kirchheim},
  address = {Mainz},
  issn = {1861-7603},
  url = {https://fis.uni-bamberg.de/handle/uniba/39457},
  language = {deu},
  abstract = {Einleitung: Eine angemessene Diabetesakzeptanz ist Voraussetzung für eine effektive Diabetesbehandlung. Zur Erfassung der Akzeptanz wurde der Acceptance and Action Diabetes Questionnaire (AADQ) entwickelt. Die vorliegende Studie evaluiert die Testgüte seiner deutschen Fassung.

Methodik: Die Messeigenschaften des AADQ wurden an 310 Diabetespatienten untersucht. Die Validität wurde anhand von Korrelationen mit Krankheitsverarbeitung (FKV-15), Diabetesbelastung (PAID), Behandlungszufriedenheit (DTSQ), Selbstbehandlung (SDSCA), gesundheitsbezogener Lebensqualität (SF-36), depressiven Symptomen (ADS) und dem HbA1c-Wert beurteilt.

Ergebnisse: Die mittlere Itemtrennschärfe lag bei 0,53 und die mittlere Interitemkorrelation bei 0,34. Es wurde ein α von 0,85 und eine Split-half-Korrelation von 0,81 ermittelt. Der AADQ-Summenwert korrelierte signifikant mit aktiver Krankheitsverarbeitung (r = 0,35), Diabetesbelastung (r = -0,65), Behandlungszufriedenheit (r = 0,34), Selbstbehandlungsverhalten (Ernährung: r = 0,20; Blutzuckerselbstkontrolle: r = 0,26), HbA1c-Wert (r = -0,21), Lebensqualität (mittleres r = 0,29) und Depressivität (r = -0,40).

Schlussfolgerung: Mit dem AADQ liegt nun ein reliables, valides und ökonomisches Messinstrument zur Diabetesakzeptanz in deutscher Sprache vor. Dieses kann für wissenschaftliche Analysen von Aspekten der Krankheitsverarbeitung wie auch zur Identifikation von Patienten mit Akzeptanzproblemen in der klinischen Praxis von Nutzen sein.},
  keywords = {Diabetesakzeptanz, Selbstbehandlungsverhalten, Adhärenz, Vermeidung, Fragebogeninventar}
}

@article{schnell2013_39410,
  title = {Assessing the Analytical Performance of Systems for Self-Monitoring of Blood Glucose: Concepts of Performance Evaluation and Definition of Metrological Key Terms},
  author = {Schnell, Oliver and Hinzmann, Rolf and Kulzer, Bernhard and Freckmann, Guido and Erbach, Michael and Lodwig, Volker and Heinemann, Lutz},
  year = {2013},
  journal = {Journal of diabetes science and technology : from basic science to clinical practice ; DST},
  volume = {7},
  number = {6},
  pages = {1585-1594},
  publisher = {Sage},
  address = {Thousand Oaks, Calif..},
  issn = {1932-2968},
  url = {https://fis.uni-bamberg.de/handle/uniba/39410},
  language = {eng},
  abstract = {Reliability of blood glucose (BG) measurements is a prerequisite for successful diabetes management. Publications on the evaluation of self-monitored glucose values, however, are frequently characterized by a confusion in terminology. We provide an inventory of key terms such as accuracy, trueness, precision, traceability, calibration, and matrix effect to avoid future misunderstanding. Definitions are taken from the metrological literature and international norms and explained in a language intended for nonspecialists in metrology. The terms are presented in light of the need to apply generally accepted definitions. In addition, a description of requirements and components for a sound evaluation of BG measurement systems is presented. These factors will also enable improvement in future comparisons of study results.},
  keywords = {accuracy, blood glucose meter evaluation, diabetes, self-monitoring of blood glucose, trueness}
}

@article{schmitt2013_39411,
  title = {The Diabetes Self-Management Questionnaire (DSMQ) : development and evaluation of an instrument to assess diabetes self-care activities associated with glycaemic control},
  author = {Schmitt, Andreas and Gahr, Annika and Hermanns, Norbert and Kulzer, Bernhard and Huber, Jörg and Haak, Thomas},
  year = {2013},
  journal = {Health and Quality of Life Outcomes},
  volume = {11},
  pages = {138},
  publisher = {BioMed Central},
  address = {London},
  issn = {1477-7525},
  doi = {10.1186/1477-7525-11-138},
  url = {https://fis.uni-bamberg.de/handle/uniba/39411},
  language = {eng},
  abstract = {Background: Though several questionnaires on self-care and regimen adherence have been introduced, the evaluations do not always report consistent and substantial correlations with measures of glycaemic control. Small ability to explain variance in HbA1c constitutes a significant limitation of an instrument’s use for scientific purposes as well as clinical practice. In order to assess self-care activities which can predict glycaemic control, the Diabetes Self-Management Questionnaire (DSMQ) was designed.
Methods: A 16 item questionnaire to assess self-care activities associated with glycaemic control was developed, based on theoretical considerations and a process of empirical improvements. Four subscales, ‘Glucose Management’ (GM), ‘Dietary Control’ (DC), ‘Physical Activity’ (PA), and ‘Health-Care Use’ (HU), as well as a ‘Sum Scale’ (SS) as a global measure of self care were derived. To evaluate its psychometric quality, 261 patients with type 1 or 2 diabetes were assessed with the DSMQ and an established analogous scale, the Summary of Diabetes Self-Care Activities Measure (SDSCA). The DSMQ’s item and scale characteristics as well as factorial and convergent validity were analysed, and its convergence with HbA1c was compared to the SDSCA.
Results: The items showed appropriate characteristics (mean item-total-correlation: 0.46 ± 0.12; mean correlation with HbA1c: -0.23 ± 0.09). Overall internal consistency (Cronbach’s alpha) was good (0.84), consistencies of the subscales were acceptable (GM: 0.77; DC: 0.77; PA: 0.76; HU: 0.60). Principal component analysis indicated a four factor structure and confirmed the designed scale structure. Confirmatory factor analysis indicated appropriate fit of the four factor model. The DSMQ scales showed significant convergent correlations with their parallel SDSCA scales (GM: 0.57; DC: 0.52; PA: 0.58; HU: n/a; SS: 0.57) and HbA1c (GM: -0.39; DC: -0.30; PA: -0.15; HU: -0.22; SS: -0.40). All correlations with HbA1c were significantly stronger than those obtained with the SDSCA.
Conclusions: This study provides preliminary evidence that the DSMQ is a reliable and valid instrument and enables an efficient assessment of self-care behaviours associated with glycaemic control. The questionnaire should be valuable for scientific analyses as well as clinical use in both type 1 and type 2 diabetes patients.},
  keywords = {Diabetes care, Self-management, Self-care behaviour, Metabolic control, Psychometric instrument}
}

@article{kulzer2013_39404,
  title = {Psychosoziales und Diabetes (Teil 2) : S2-Leitlinie Psychosoziales und Diabetes ; Langfassung},
  author = {Kulzer, Bernhard and Albus, Christian and Herpertz, Stephan and Kruse, Johannes and Lange, Karin and Lederbogen, Florian and Petrak, Frank},
  year = {2013},
  journal = {Diabetologie und Stoffwechsel : offizielles Organ der Deutschen Diabetes-Gesellschaft},
  volume = {8},
  number = {4},
  pages = {292-324},
  publisher = {Thieme},
  address = {Stuttgart},
  issn = {1861-9002},
  doi = {10.1055/s-0033-1335889},
  url = {https://fis.uni-bamberg.de/handle/uniba/39404},
  language = {deu}
}

@article{icks2013_39394,
  title = {Risk for High Depressive Symptoms in Diagnosed and Previously Undetected Diabetes: 5-Year Follow-Up Results of the Heinz Nixdorf Recall Study},
  author = {Icks, Andrea and Albers, Bernd and Haastert, Burkhard and Pechlivanis, Sonali and Pundt, Noreen and Slomiany, Uta and Erbel, Raimund and Jöckel, Karl-Heinz and Kruse, Johannes and Kulzer, Bernd and Nowotny, Bettina and Herder, Christian and Giani, Guido and Moebus, Susanne},
  year = {2013},
  journal = {PLoS ONE},
  volume = {6},
  number = {2},
  publisher = {PLoS},
  address = {Lawrence, Kan.},
  issn = {1932-6203},
  doi = {10.1371/journal.pone.0056300},
  url = {https://fis.uni-bamberg.de/handle/uniba/39394},
  language = {eng}
}

@article{kulzer2013_39363,
  title = {Behandlung von subklinischer Depression bei Menschen mit Diabetes},
  author = {Kulzer, Bernhard and Schmitt, Andreas and Haak, Thomas and Kruse, Johannes and Hermanns, Norbert},
  year = {2013},
  journal = {Diabetes, Stoffwechsel und Herz},
  volume = {22},
  number = {3},
  pages = {169-174},
  publisher = {Kirchheim},
  address = {Mainz},
  issn = {1861-7603},
  url = {https://fis.uni-bamberg.de/handle/uniba/39363},
  language = {deu}
}

@article{kulzer2013_39361,
  title = {Hypoglykämien und Psyche},
  author = {Kulzer, Bernhard and Krichbaum, Michael and Hermanns, Norbert},
  year = {2013},
  journal = {Der Diabetologe},
  volume = {9},
  number = {1},
  pages = {33-40},
  publisher = {Springer},
  address = {Berlin ; Heidelberg},
  issn = {1860-9724},
  doi = {10.1007/s11428-012-0912-3},
  url = {https://fis.uni-bamberg.de/handle/uniba/39361},
  language = {deu}
}

@article{kulzer2013_39365,
  title = {Patientenschulung bei Diabetes mellitus},
  author = {Kulzer, Bernhard and Krichbaum, Michael},
  year = {2013},
  journal = {Diabetologie und Stoffwechsel : offizielles Organ der Deutschen Diabetes-Gesellschaft},
  volume = {8},
  number = {1},
  pages = {R1-R13},
  publisher = {Thieme},
  address = {Stuttgart},
  issn = {1860-9724},
  doi = {10.1055/s-0032-1330707},
  url = {https://fis.uni-bamberg.de/handle/uniba/39365},
  language = {deu}
}

@article{kulzer2013_39360,
  title = {Psychosoziales und Diabetes (Teil 1): S2-Leitlinie Psychosoziales und Diabetes ; Langfassung},
  author = {Kulzer, Bernhard and Albus, Christian and Herpertz, Stephan and Kruse, Johannes and Lange, Karin and Lederbogen, Florian and Petrak, Frank},
  year = {2013},
  journal = {Diabetologie und Stoffwechsel : offizielles Organ der Deutschen Diabetes-Gesellschaft},
  volume = {8},
  number = {3},
  pages = {198-242},
  publisher = {Thieme},
  address = {Stuttgart},
  issn = {1861-9002},
  doi = {10.1055/s-0033-1335785},
  url = {https://fis.uni-bamberg.de/handle/uniba/39360},
  language = {deu}
}

@article{petrak2013_39366,
  title = {Study protocol of the Diabetes and Depression Study (DAD): a multi-center randomized controlled trial to compare the efficacy of a diabetes-specific cognitive behavioral group therapy versus sertraline in patients with major depression and poorly controlled diabetes mellitus},
  author = {Petrak, Frank and Herpertz, Stephan and Albus, Christian and Hermanns, Norbert and Hiemke, Christoph and Hiller, Wolfgang and Kronfeld, Kai and Kruse, Johannes and Kulzer, Bernhard and Ruckes, Christian and Müller, Matthias J},
  year = {2013},
  journal = {BMC Psychiatry},
  volume = {13},
  number = {206},
  publisher = {BioMed Central},
  address = {London},
  issn = {1471-244X},
  doi = {10.1186/1471-244X-13-206},
  url = {https://fis.uni-bamberg.de/handle/uniba/39366},
  language = {eng},
  abstract = {Background: Depression is common in diabetes and associated with hyperglycemia, diabetes related complications and mortality. No single intervention has been identified that consistently leads to simultaneous improvement of depression and glycemic control. Our aim is to analyze the efficacy of a diabetes-specific cognitive behavioral group therapy (CBT) compared to sertraline (SER) in adults with depression and poorly controlled diabetes.
Methods/Design: This study is a multi-center parallel arm randomized controlled trial currently in its data analysis phase. We included 251 patients in 70 secondary care centers across Germany. Key inclusion criteria were: type 1 or 2 diabetes, major depression (diagnosed with the Structured Clinical Interview for DSM-IV, SCID) and hemoglobin A1C >7.5\% despite current insulin therapy. During the initial phase, patients received either 50–200 mg/d sertraline or 10 CBT sessions aiming at the remission of depression and enhanced adherence to diabetes treatment and coping with diabetes. Both groups received diabetes treatment as usual. After 12 weeks of this initial open-label therapy, only the treatment-responders (50\% depression symptoms reduction, Hamilton Depression Rating Scale, 17-item version [HAMD]) were included in the subsequent one year study phase and represented the primary analysis population. CBT-responders received no further treatment, while SER-responders obtained a continuous, flexible-dose SER regimen as relapse prevention. Adherence to treatment was analyzed using therapeutic drug monitoring (measurement of sertraline and N-desmethylsertraline concentrations in blood serum) and by counting the numbers of CBT sessions received. Outcome assessments were conducted by trained psychologists blinded to group assignment. Group differences in HbA1c (primary outcome) and depression (HAMD, secondary outcome) between 1-year follow-up and baseline will be analyzed by ANCOVA controlling for baseline values. As primary hypothesis we expect that CBT leads to significantly greater improvement of glycemic control in the one year follow-up in treatment responders of the short term phase.
Discussion: The DAD study is the first randomized controlled trial comparing antidepressants to a psychological treatment in diabetes patients with depression.}
}

@article{hermanns2013_39344,
  title = {The effect of a diabetes education programme (PRIMAS) for people with type 1 diabetes : Results of a randomized trial},
  author = {Hermanns, Norbert and Kulzer, Bernhard and Ehrmann, Dominic and Bergis-Jurgan, Nikola and Haak, Thomas},
  year = {2013},
  journal = {Diabetes research and clinical practice : the official journal of the International Diabetes Federation, West Pacific Region},
  volume = {102},
  number = {3},
  pages = {149-157},
  publisher = {Elsevier Science},
  address = {Amsterdam [u.a.]},
  issn = {1872-8227},
  doi = {10.1016/j.diabres.2013.10.009},
  url = {https://fis.uni-bamberg.de/handle/uniba/39344},
  language = {eng},
  abstract = {Objective
In a randomized, multi-centre trial, the efficacy of a self-management-oriented education programme (PRIMAS) for people with type 1 diabetes was compared with an established education programme as control group (CG). Primary outcome was the effect on glycaemic control in a 6-month follow-up. Secondary outcomes were the impact on emotional aspects, self-management related aspects and hypoglycaemia problems.

Methods
The study was conducted in an outpatient setting. 160 participants were randomized. Baseline characteristics in PRIMAS and CG were similar (age 45.1 ± 13.5 vs. 45.9 ± 13.1 years, p = .716; diabetes duration 18.8 ± 12.3 vs. 19.8 ± 13.4 years, p = .615; BMI 26.5 ± 4.6 vs. 27.5 ± 5.0 kg/m2, p = .236; HbA1c 8.3 ± 1.1 vs. 8.1 ± 1.0\%, p = .236).

Results
At follow-up there was a significant 0.4 percentage points greater reduction of HbA1c in PRIMAS compared to CG (Δ −0.4 ± 1.0\% vs. Δ 0.0 ± 0.6\%; p = .012). Also, diabetes-related distress (Δ −0.3 ± 0.7 vs. −0.1 ± 0.4, p = .032) and dissatisfaction with diabetes treatment (Δ −3.3 ± 6.9 vs. −1.9 ± 5.6, p = .024) decreased more in PRIMAS. Diabetes empowerment (Δ 2.6 ± 5.9 vs. 0.8 ± 5.1, p = .037) and diabetes self-efficacy (Δ 1.4 ± 3.6 vs. 0.2 ± 4.0, p = .013) increased in PRIMAS. Incidence of severe hypoglycemia, hypoglycemia awareness, diabetes knowledge, and self-care behaviour improved in both groups with no significant differences between groups.

Conclusion
PRIMAS is more effective in lowering HbA1c than a previously established education programmes and also showed superiority in reducing diabetes-related distress and increasing diabetes empowerment, diabetes self-efficacy and satisfaction with insulin therapy.},
  keywords = {Type 1 diabetes, Diabetes self-management education, Diabetes education programme, Intensive insulin treatment}
}

@incollection{kulzer2013_39203,
  title = {Alkohol- und Tabakmissbrauch bei Diabetes},
  author = {Kulzer, Bernhard},
  year = {2013},
  booktitle = {Psychodiabetologie},
  pages = {207-223},
  publisher = {Springer},
  address = {Berlin Heidelberg},
  edition = {1},
  isbn = {978-3-642-29907-0},
  doi = {10.1007/978-3-642-29908-7},
  url = {https://fis.uni-bamberg.de/handle/uniba/39203},
  language = {deu},
  keywords = {Psychodiabetologie}
}

@incollection{kulzer2013_39219,
  title = {Patientenschulung bei Diabetes mellitus},
  author = {Kulzer, Bernhard},
  year = {2013},
  booktitle = {Psychodiabetologie},
  pages = {251-267},
  publisher = {Springer},
  address = {Berlin Heidelberg},
  edition = {1},
  isbn = {978-3-642-29907-0},
  doi = {10.1007/978-3-642-29908-7},
  url = {https://fis.uni-bamberg.de/handle/uniba/39219},
  language = {deu},
  keywords = {Psychodiabetologie}
}

@inproceedings{kulzer2012_104227,
  title = {The Effect of a Self-Management Oriented Education and Treatment Programme (PRIMAS) for Type 1 Diabetic Patients},
  author = {Kulzer, Bernhard and Hermanns, Norbert and Ehrmann, Dominic and Bergis, Nikola and Haak, Thomas},
  year = {2012},
  volume = {55},
  number = {Supplement 1},
  pages = {408},
  publisher = {Springer},
  address = {Berlin ; Heidelberg},
  url = {https://fis.uni-bamberg.de/handle/uniba/104227},
  language = {eng}
}

@article{krichbaum2012_41615,
  title = {Compliance, Adherence, Empowerment : Durch bessere Kooperation mehr Erfolg in der Diabetestherapie},
  author = {Krichbaum, Michael and Kulzer, Bernhard},
  year = {2012},
  journal = {MMW - Fortschritte der Medizin},
  volume = {154},
  number = {1},
  pages = {72-75},
  publisher = {Urban \& Vogel},
  address = {München},
  issn = {1613-3560},
  doi = {10.1007/s15006-012-0042-2},
  url = {https://fis.uni-bamberg.de/handle/uniba/41615},
  language = {deu}
}

@article{kruse2012_41626,
  title = {Individuelle Therapieziele bei Patienten mit Diabetes und Depression},
  author = {Kruse, Johannes and Kulzer, Bernhard},
  year = {2012},
  journal = {Der Diabetologe},
  volume = {8},
  number = {2},
  pages = {139-142},
  publisher = {Springer},
  address = {Berlin ; Heidelberg [u.a.]},
  issn = {1860-9724},
  doi = {10.1007/s11428-011-0817-6},
  url = {https://fis.uni-bamberg.de/handle/uniba/41626},
  language = {deu},
  abstract = {Nahezu 25\% der an Diabetes Erkrankten haben zumindest eine beeinträchtigende subklinische Depression, 10\% leiden an einer depressiven Störung. Diese beeinflusst die Lebensqualität, das Krankheitsverhalten und den Verlauf der Diabeteserkrankung. Die diabetesbezogenen Therapieziele sind bei depressiven Patienten anzupassen, da diese infolge der depressiven Symptomatik in der Alltagsbewältigung eingeschränkt sind. Überforderungssituationen können die depressive Symptomatik aufrechterhalten. Ein Depressionsscreening ist in die Therapie zu integrieren. Der Behandlung der Depression kommt bei Patienten mit Diabetes wegen der multiplen Interaktionen zwischen der Diabeteserkrankung und der Depression eine besondere Bedeutung zu.},
  keywords = {Depression, Diabetes, Therapieziele, Screening, Therapie}
}

@article{hermanns2012_40190,
  title = {Is Diabetes Related Distress a Risk Factor for Depression in Diabetes?},
  author = {Hermanns, Norbert and Kulzer, Bernhard and Haak, Thomas},
  year = {2012},
  journal = {Diabetes : the journal of the American Diabetes Association},
  volume = {61},
  number = {Suppl. 1},
  pages = {A197},
  issn = {1939-327X},
  url = {https://fis.uni-bamberg.de/handle/uniba/40190},
  language = {eng},
  abstract = {Introduction: Recent meta-analysis showed that diabetes seems to be a risk factor for incident depression. This prospective study examines the role of elevated diabetes distress on the persistence or the recovery from elevated depressive symptoms at a 6-month follow-up.Methods: Participants completed the CES-D. A score of >=16 indicate elevated depressive symptoms. The Problem Areas in Diabetes Scale (PAID) assessed diabetes related distress; a PAID score of >=30 indicate moderate diabetes related distress. Logistic regression models were performed. Persistence and recovery from elevated depressive symptoms were the dependent variables. The independent variable was diabetes related distress. The models were adjusted for potential demographic (age, gender) or medial confounders (BMI, diabetes duration, A1C, diabetes type and late complications).Results: 351 diabetic patients were included (age 50,8 ±11.4 yrs, 52\% female, 58\% type 2 diabetic patients, diabetes duration 12.9 ±11.1 yrs, BMI 29,9 ±6,9 kg/m², A1c 7.9 ±1.5\%). At baseline 125 patients (35.6\%) reported elevated depressive symptoms. At follow up 96 patients (27.3\%) still had an elevated depression score. If diabetes related distress was present at baseline the hazard ratio of having persistent elevated depressive symptoms at follow up was 6.67 (95\% CI 3.79 - 11.72). Adjusting for confounding variables did not change the hazard ratio substantially (HR 6.02 95\% CI 3.32 - 10.89). In addition the chance for recovery from elevated depressive symptoms was significantly reduced if diabetes related distress was present (Odds ratio 0.37 95\% CI 0.17 - 0.77). Controlling for possible confounders did not change the odds ratio (0.36 95\% CI 0.16 - 0.82).Conclusion: Diabetes related distress seems to play a decisive role for an unfavorable course of depressive symptoms. Diabetes related distress may be a mediating factor between diabetes and depression. Addressing diabetes related distress may be able to ameliorate depression in people with diabetes.},
  keywords = {-}
}

@incollection{kulzer2012_39573,
  title = {Psychologisches Assessment},
  author = {Kulzer, Bernhard},
  year = {2012},
  booktitle = {Diabetologie für die Praxis : fallorientierte Darstellung - Diagnostik und Therapie},
  pages = {291-294},
  publisher = {Thieme Verlag},
  address = {Stuttgart},
  isbn = {978-3-13-162141-2},
  url = {https://fis.uni-bamberg.de/handle/uniba/39573},
  language = {deu}
}

@book{kulzer2012_39568,
  title = {Typ-2-Diabetes selbst behandeln : Ein Leitfaden für den Alltag.},
  author = {Kulzer, Bernhard and Hermanns, Norbert and Maier, Berthold and Haak, Thomas and Reinecker, Hans},
  year = {2012},
  publisher = {Kirchheim},
  address = {Mainz},
  isbn = {978-3-87409-512-9},
  url = {https://fis.uni-bamberg.de/handle/uniba/39568},
  language = {deu}
}

@incollection{kulzer2012_39559,
  title = {Psychosoziale Erschwernisse bei Diabetes mellitus},
  author = {Kulzer, Bernhard},
  year = {2012},
  booktitle = {Diabetologie für die Praxis : fallorientierte Darstellung - Diagnostik und Therapie},
  pages = {233-245},
  publisher = {Thieme},
  address = {Stuttgart},
  isbn = {978-3-13-162141-2},
  url = {https://fis.uni-bamberg.de/handle/uniba/39559},
  language = {deu}
}

@article{kulzer2012_39384,
  title = {“Stepped-Care-Ansatz” zur Behandlung von Depressionen},
  author = {Kulzer, Bernhard and Schmitt, Andreas and Gahr, Annika and Haak, Thomas and Kruse, Johannes and Hermanns, Norbert},
  year = {2012},
  journal = {Diabetes, Stoffwechsel und Herz},
  volume = {21},
  number = {4},
  pages = {241-244},
  publisher = {Kirchheim},
  address = {Mainz},
  issn = {1861-7603},
  url = {https://fis.uni-bamberg.de/handle/uniba/39384},
  language = {deu},
  abstract = {Die gestuften Versorgungskonzepte nach Wayne J. Katon können bei depressiven Diabetikern eine effektive Behandlungsmethode darstellen. Um dies zu überprüfen, führt das Forschungsinstitut der Diabetes-Akademie Bad Mergentheim (FIDAM) eine klinische Interventionsstudie bei Menschen mit Diabetes und einer erhöhten Depressivität/Depression durch.}
}

@article{schmitt2012_39336,
  title = {Behandlung von Depressivität bei Diabetes},
  author = {Schmitt, Andreas and Gahr, Annika and Hermanns, Norbert and Haak, Thomas and Kruse, Johannes and Kulzer, Bernhard},
  year = {2012},
  journal = {Die Medizinische Welt : aus der Wissenschaft in die Praxis},
  volume = {63},
  number = {5},
  pages = {271-274},
  publisher = {Schattauer},
  address = {Stuttgart},
  issn = {0025-8512},
  url = {https://fis.uni-bamberg.de/handle/uniba/39336},
  language = {deu},
  abstract = {Depressivität ist ein häufiger Begleiter des Diabetes. Bereits subklinische depressive Zustände wirken sich sehr negativ auf die Diabetestherapie und Prognose der Betroffenen aus. Mit dem Ziel der effektiven und effizienten Versorgung subklinisch depressiver Diabetespatienten wurde das kognitiv-behaviourale Gruppentherapieprogramm „DIAMOS – Diabetesmotivation stärken“ entwickelt. Das Programm ist für Patienten mit Typ-1- wie auch Typ-2-Diabetes geeignet und für vier bis sechs Teilnehmer vorgesehen. Es zielt in erster Linie auf die Reduktion diabetesbezogener Belastungen und Probleme. Innerhalb von zehn Kursstunden werden Strategien zur Bewältigung der Belastungen erarbeitet und motivierende Ziele entwickelt. Der Artikel stellt Konzept, Struktur und Inhalte des Therapieprogramms vor.},
  keywords = {Therapie, Depression, Motivation, Diabetes}
}

@article{ceriello2012_39335,
  title = {Diabetes as a case study of chronic disease management with a personalized approach : The role of a structured feedback loop},
  author = {Ceriello, Antonio and Barkai, László and Christiansen, Jens Sandahl and Czupryniak, Leszek and Gomis, Ramon and Harno, Kari and Kulzer, Bernhard and Ludvigsson, Johnny and Némethyová, Zuzana and Owens, David and Schnell, Oliver and Tankova, Tsvetalina and Taskinen, Marja-Riitta and Vergès, Bruno and Weitgasser, Raimund and Wens, Johan},
  year = {2012},
  journal = {Diabetes Research and Clinical Practice},
  volume = {98},
  number = {1},
  pages = {5-10},
  publisher = {Elsevier},
  address = {Amsterdam},
  issn = {0168-8227},
  doi = {10.1016/j.diabres.2012.07.005},
  url = {https://fis.uni-bamberg.de/handle/uniba/39335},
  language = {eng},
  abstract = {As non-communicable or chronic diseases are a growing threat to human health and economic growth, political stakeholders are aiming to identify options for improved response to the challenges of prevention and management of non-communicable diseases. This paper is intended to contribute ideas on personalized chronic disease management which are based on experience with one major chronic disease, namely diabetes mellitus. Diabetes provides a pertinent case of chronic disease management with a particular focus on patient self-management. Despite advances in diabetes therapy, many people with diabetes still fail to achieve treatment targets thus remaining at risk of complications. Personalizing the management of diabetes according to the patient's individual profile can help in improving therapy adherence and treatment outcomes. This paper suggests using a six-step cycle for personalized diabetes (self-)management and collaborative use of structured blood glucose data. E-health solutions can be used to improve process efficiencies and allow remote access. Decision support tools and algorithms can help doctors in making therapeutic decisions based on individual patient profiles. Available evidence about the effectiveness of the cycle's constituting elements justifies expectations that the diabetes management cycle as a whole can generate medical and economic benefit.},
  keywords = {Diabetes, Chronic disease, Management, SMBG, Personalized}
}

@article{kulzer2012_39340,
  title = {Nationaler Diabetesplan},
  author = {Kulzer, Bernhard and Reuter, Hans-Martin},
  year = {2012},
  journal = {DMW : Deutsche Medizinische Wochenschfrift},
  volume = {137},
  number = {19},
  pages = {1009-1012},
  publisher = {Thieme},
  address = {Stuttgart},
  issn = {0012-0472},
  doi = {10.1055/s-0032-1304929},
  url = {https://fis.uni-bamberg.de/handle/uniba/39340},
  language = {deu},
  abstract = {In Deutschland gibt es, wie auch in vielen anderen Ländern, eine kontinuierliche Zunahme von Menschen mit Diabetes. Bereits heute beläuft sich die Zahl der Menschen mit Diabetes auf über 7 Millionen Menschen. Jährlich erkranken ca. 270000 Menschen neu. Die Zahl der Personen mit einem undiagnostizierten Diabetes wird auf 2 bis 3 Millionen geschätzt. Angesichts dieser großen Zahl von Menschen, die bereits an Diabetes erkrankt sind oder künftig daran erkranken werden, sowie der bisher fehlenden Möglichkeit, den Diabetes zu heilen, werden von der UNO, der EU und maßgeblichen diabetologischen Verbände und Patientenorganisationen aus Deutschland die Entwicklung eines „Nationalen Diabetesplans“ gefordert. Damit sollen strukturierte Vorschläge erarbeitet werden, wie die Prävention, Therapie, Versorgung und Forschung des Diabetes verbessert werden kann. Wichtige Handlungsfelder eines Nationalen Diabetesplans sind die Themen „Primäre Prävention“, „Früherkennung des Typ 2 Diabetes“, “Epidemiologie, Diabetesregister“, „Versorgungsforschung, Versorgungsstrukturen, Qualitätssicherung“ sowie „Patienteninformation, Patientenschulung und Empowerment“.},
  keywords = {Nationaler Diabetesplan - Diabetesprävention - Diabetesregister - Versorgungsforschung - Empowerment, national diabetes plan - diabetes prevention - diabetes register - health services research - empowerment}
}

@article{hermanns2012_39197,
  title = {The effect of an education programme (MEDIAS 2 ICT) involving intensive insulin treatment for people with type 2 diabetes},
  author = {Hermanns, Norbert and Kulzer, Bernhard and Maier, Berthold and Mahr, Marina and Haak, Thomas},
  year = {2012},
  journal = {Patient Education and Counseling},
  volume = {86},
  number = {2},
  pages = {226-232},
  publisher = {Elsevier Science},
  address = {Amsterdam [u.a.]},
  issn = {1873-5134},
  doi = {10.1016/j.pec.2011.05.017},
  url = {https://fis.uni-bamberg.de/handle/uniba/39197},
  language = {eng},
  keywords = {Diabetes mellitus, Patientenschulung, MEDIAS 2 ICT, Insulinbehandlung}
}

@book{siegl2012_570,
  title = {Horizonte der Klinischen Psychologie und Psychotherapie. Festschrift für Hans Reinecker},
  author = {Siegl, Judith and Schmelzer, Dieter and Mackinger, Herbert and Pabst, Wolfgang and Reinecker, Christa and Reinecker, Eva and Reinecker, Agnes and Bastine, Rainer and Broda, Michael and Butollo, Willi and Caspar, Franz and Crombach, Gerhard and Dörner, Dietrich and Dumbs, Franz and Ehlert, Ulrike and Fiedler, Peter and Fliegel, Steffen and Gmelch, Markus and Press, Hans and Härtl, Kristin and Hartung, Doreen and Hahlweg, Kurt and Hellhammer, Dirk and Hellhammer, Juliane and Huber, Oswald and Kaimer, Peter and Köhler, Thomas and Kostal, Mario Alexander and Kreuzpointner, Ludwig and Stiller, Klaus D. and Lukesch, Helmut and Kryspin-Exner, Ilse and Kulzer, Bernhard and Hermanns, Norbert and Lakatos-Witt, Angelika and Lautenbacher, Stefan and Kunz, Miriam and Laux, Lothar and Lieb, Hans and Linden, Michael and Perrez, Meinrad and Hänggi, Yves and Petermann, Franz and Pietrowsky, Reinhard and Revenstorf, Dirk and Ulrike, S. and Schaub, Annette and Möller, Hans-Jürgen and Schiepek, Günter and Traue, Harald C. and Tunner, Wolfgang and Vogel, Heiner and Wolf, Sebastian and Hautzinger, Martin and Wolstein, Jörg and Wünsche, Manfred and Zimmer, Dirk},
  editor = {Siegl, Judith and Schmelzer, Dieter and Mackinger, Herbert},
  year = {2012},
  publisher = {Pabst Science Publ.},
  address = {Lengerich},
  isbn = {978-3-89967-799-7},
  url = {https://fis.uni-bamberg.de/handle/uniba/570},
  language = {deu}
}

@incollection{kruse2011_5801,
  title = {Diabetes mellitus},
  author = {Kruse, J. and Kulzer, Bernhard and Lange, K.},
  year = {2011},
  booktitle = {Psychosomatische Medizin : theoretische Modelle und klinische Praxis},
  pages = {851 - 863},
  address = {München},
  edition = {7., komplett überarb. Aufl.},
  isbn = {978-3-437-21831-6},
  url = {https://fis.uni-bamberg.de/handle/uniba/5801},
  language = {deu}
}

@article{kulzer2011_5793,
  title = {Ganz in Grün: Gesundheits-Pass Diabetes auf Türkisch},
  author = {Kulzer, Bernhard},
  year = {2011},
  journal = {Diabetes-Forum : Forum für integriertes Diabetesmanagement ; offizielles Organ: VDBD, BDD, BVKD, DDU, DDB, VDO E},
  volume = {23},
  number = {9},
  pages = {42 - 43},
  issn = {1614-6476},
  url = {https://fis.uni-bamberg.de/handle/uniba/5793},
  language = {deu}
}

@article{krichbaumm2011_5791,
  title = {Hypoglykämien: Ein ernstzunehmendes Problem in der Diabetesbehandlung},
  author = {Krichbaum M, and Kulzer, Bernhard},
  year = {2011},
  journal = {Journal für klinische Endokrinologie und Stoffwechsel  = Austrian journal of clinical endocrinology and metabolism},
  volume = {4},
  number = {3},
  pages = {18-24},
  issn = {1998-7773},
  url = {https://fis.uni-bamberg.de/handle/uniba/5791},
  language = {deu}
}

@article{kulzer2011_5814,
  title = {Neuauflage der verschiedenen "Gesundheitspässe Diabetes": Blau-rot- grüne Koalition},
  author = {Kulzer, Bernhard},
  year = {2011},
  journal = {Diabetes-Journal : aktiv gesund leben ; offizielles Organ des Deutschen Diabetiker-Bundes},
  volume = {60},
  number = {8},
  pages = {36-38},
  issn = {0341-8812},
  url = {https://fis.uni-bamberg.de/handle/uniba/5814},
  language = {deu}
}

@article{kulzer2011_5810,
  title = {Was ist dran an der Adipositas-Chirurgie?},
  author = {Kulzer, Bernhard},
  year = {2011},
  journal = {Diabetes-Journal : aktiv gesund leben ; offizielles Organ des Deutschen Diabetiker-Bundes. - 60 (2011), 1, S. 26 - 31},
  volume = {60},
  number = {1},
  pages = {26-31},
  issn = {0341-8812},
  url = {https://fis.uni-bamberg.de/handle/uniba/5810},
  language = {deu}
}

@article{kulzer2011_5764,
  title = {Die "lieben" Pfunde Übergewicht und Abnehmen - neue Trends der Therapie: Jo-Jo-Effekt nach dem Abnehmen verhindern},
  author = {Kulzer, Bernhard},
  year = {2011},
  journal = {Diabetes-Journal : aktiv gesund leben ; offizielles Organ des Deutschen Diabetiker-Bundes. - 60 (2011), 1, S. 20 - 25},
  volume = {60},
  number = {1},
  pages = {20-25},
  issn = {0341-8812},
  url = {https://fis.uni-bamberg.de/handle/uniba/5764},
  language = {deu}
}

@article{schnell2011_5762,
  title = {Die "Silent Diabetes" Studie: Oraler Glukosetoleranztest vs. HbA1c zur Neudiagnose des Diabetes bei Patienten mit KHK- Verdacht},
  author = {Schnell, O. and Hoffmann, U. and Otter, W. and Heinemann, L. and Hunger-Battefeld, W. and Kulzer, Bernhard and Klinge, A. and Lodwig, V. and Amann-Zalán, I. and Sturm, D. and Tschöpe, D. and Spitzer, SG. and Stumpf, J. and Lohmann, T. and Dörr, R.},
  year = {2011},
  journal = {Diabetologie und Stoffwechsel : offizielles Organ der Deutschen Diabetes Gesellschaft},
  volume = {6},
  number = {Suppl.1=46. Jahrestagung der Deutschen Diabetes-Gesellschaft ; Tagungsmotto - Perspektiven Leipzig 2011 - Dialog - Erfahrung - Gewinn - www. ddg2011.de, Leipzig, 1.-4. Juni 2011 / Tagungspräsidentin: Olga Kordonouri},
  pages = {P132},
  issn = {1861-9002},
  url = {https://fis.uni-bamberg.de/handle/uniba/5762},
  language = {deu}
}

@article{kulzer2011_5765,
  title = {Interview-Tipp: "Zunächst notieren, was man isst und trinkt!"},
  author = {Kulzer, Bernhard},
  year = {2011},
  journal = {Diabetes-Journal : aktiv gesund leben ; offizielles Organ des Deutschen Diabetiker-Bundes},
  volume = {60},
  number = {1},
  pages = {34-37},
  issn = {0341-8812},
  url = {https://fis.uni-bamberg.de/handle/uniba/5765},
  language = {deu}
}

@article{kulzer2011_5768,
  title = {"Nationaler Diabetesplan": Profitieren Diabetiker davon?},
  author = {Kulzer, Bernhard},
  year = {2011},
  journal = {Diabetes-Journal : aktiv gesund leben ; offizielles Organ des Deutschen Diabetiker-Bundes},
  volume = {60},
  number = {8},
  pages = {12},
  issn = {0341-8812},
  url = {https://fis.uni-bamberg.de/handle/uniba/5768},
  language = {other}
}

@article{kulzer2011_5758,
  title = {Blutzuckerselbstkontrolle bei nicht mit Insulin behandelten Typ 2 Diabetikern verbessert das Wohlbefinden, vermindert die Depressivität und reduziert das Ausmaß diabetesspezifischer Belastungen:  Ergebnisse der STeP Studie},
  author = {Kulzer, Bernhard and Fisher, L. and Polonsky, W. and Moritz, A. and Jelsovsky, Z. and Petersen, B. and Wagner, R.},
  year = {2011},
  journal = {Diabetologie und Stoffwechsel : offizielles Organ der Deutschen Diabetes Gesellschaft},
  volume = {6},
  number = {Suppl.1=46. Jahrestagung der Deutschen Diabetes-Gesellschaft ; Tagungsmotto - Perspektiven Leipzig 2011 - Dialog - Erfahrung - Gewinn - www. ddg2011.de, Leipzig, 1.-4. Juni 2011 / Tagungspräsidentin: Olga Kordonouri},
  pages = {P268},
  issn = {1861-9002},
  url = {https://fis.uni-bamberg.de/handle/uniba/5758},
  language = {deu}
}

@article{krichbaum2011_5743,
  title = {Compliance, Adherence, Empowerment - Wege zu mehr Kooperation und Erfolg in der Diabetestherapie},
  author = {Krichbaum, Michael and Kulzer, Bernhard},
  year = {2011},
  journal = {Info Diabetologie : interdisziplinäre Fortbildung in der Diabetologie},
  volume = {5},
  number = {2},
  pages = {42 - 44},
  issn = {1865-5459},
  url = {https://fis.uni-bamberg.de/handle/uniba/5743},
  language = {deu}
}

@article{kulzer2011_5744,
  title = {Empfehlungen der WHO: Nationaler Diabetesplan},
  author = {Kulzer, Bernhard},
  year = {2011},
  journal = {Diabetes-Forum : Forum für integriertes Diabetesmanagement ; offizielles Organ: VDBD, BDD, BVKD, DDU, DDB, VDO E.},
  volume = {23},
  number = {9},
  pages = {46 - 48},
  issn = {1614-6476},
  url = {https://fis.uni-bamberg.de/handle/uniba/5744},
  language = {deu}
}

@article{kulzer2011_5746,
  title = {Ganz in Rot: Neuauflage "Kinder- und Jugendpass Diabetes"},
  author = {Kulzer, Bernhard},
  year = {2011},
  journal = {Diabetes-Forum : Forum für integriertes Diabetesmanagement ; offizielles Organ: VDBD, BDD, BVKD, DDU, DDB, VDO E},
  volume = {23},
  number = {10},
  pages = {44 - 45},
  issn = {1614-6476},
  url = {https://fis.uni-bamberg.de/handle/uniba/5746},
  language = {deu}
}

@article{kulzer2011_5754,
  title = {Gesundheits-Pass Diabetes},
  author = {Kulzer, Bernhard},
  year = {2011},
  journal = {Deutscher Gesundheitsbericht : Diabetes 2012},
  pages = {204 - 208},
  issn = {1614-824X},
  url = {https://fis.uni-bamberg.de/handle/uniba/5754},
  language = {deu}
}

@article{hermanns2011_5757,
  title = {Inwieweit eignet sich der CES-D zum Depressionsscreening bei Diabetikern?},
  author = {Hermanns, Norbert and Kulzer, Bernhard and Kruse H.},
  year = {2011},
  journal = {PPmP - Psychotherapie, Psychosomatik, Medizinische Psychologie},
  volume = {51},
  number = {2= 62. Jahrestagung des Deutschen Kollegiums für Psychosomatische Medizin (DKPM) und - 19. Jahrestagung der Deutschen Gesellschaft für Psychosomatische Medizin und Ärztliche Psychotherapie (DGPM) ; Deutscher Kongress für Psychosomatische Medizin und Psychotherapie, Essen, 23.-26. 03. 2011 ; Kongresspräsidenten: Wolfgang Senf ; Hans Georg Nehen},
  pages = {A030},
  issn = {0937-2032},
  url = {https://fis.uni-bamberg.de/handle/uniba/5757},
  language = {deu}
}

@article{kulzer2011_5760,
  title = {Kosten der Adipositas-Chirurgie: Nicht immer zahlt die Kasse},
  author = {Kulzer, Bernhard},
  year = {2011},
  journal = {Diabetes-Journal : aktiv gesund leben ; offizielles Organ des Deutschen Diabetiker-Bundes},
  volume = {60},
  number = {1},
  pages = {32-33},
  issn = {0341-8812},
  url = {https://fis.uni-bamberg.de/handle/uniba/5760},
  language = {deu}
}

@article{kulzer2011_5750,
  title = {Nationaler Diabetesplan},
  author = {Kulzer, Bernhard},
  year = {2011},
  journal = {Deutscher Gesundheitsbericht : Diabetes 2012},
  pages = {194 - 203},
  issn = {1614-824X},
  url = {https://fis.uni-bamberg.de/handle/uniba/5750},
  language = {deu}
}

@article{kulzer2011_5748,
  title = {Neuauflage: "Gesundheits-Pass Diabetes"},
  author = {Kulzer, Bernhard},
  year = {2011},
  journal = {Diabetes-Forum : Forum für integriertes Diabetesmanagement ; offizielles Organ: VDBD, BDD, BVKD, DDU, DDB, VDO E},
  volume = {23},
  number = {7/8},
  pages = {44 - 45},
  issn = {1614-6476},
  url = {https://fis.uni-bamberg.de/handle/uniba/5748},
  language = {other}
}

@article{dorr2011_5742,
  title = {Oral glucose tolerance test and HbA1c for diagnosis of diabetes in patients undergoing coronary angiography the Silent Diabetes Study},
  author = {Dörr, R. and Hoffmann, U. and Otter, W, and Heinemann, L. and Hunger-Battefeld, W. and Kulzer, Bernhard},
  year = {2011},
  journal = {Diabetologia : journal of the European Association for the Study of Diabetes (EASD)},
  volume = {54},
  number = {11},
  pages = {2923-2930},
  issn = {0012-186X},
  url = {https://fis.uni-bamberg.de/handle/uniba/5742},
  language = {eng}
}

@article{petrak2011_5715,
  title = {Cognitive Behavioral Therapy vs. Sertraline in Patients with Depression and Poorly Controlled Diabetes: A Multicenter Randomized Controlled Trial},
  author = {Petrak, F. and Herpertz, Sabine C. and Albus, C. and Hermanns, Norbert and Kronfeld, K. and Kruse, J. and Kulzer, Bernhard and Ruckes, C. and Zahn, D. and Müller, MJ.},
  year = {2011},
  journal = {Diabetes : a journal of the American Diabetes Association},
  volume = {60},
  number = {Suppl. 1},
  pages = {0302-OR},
  issn = {0012-1797},
  url = {https://fis.uni-bamberg.de/handle/uniba/5715},
  language = {deu}
}

@article{kruse2011_5728,
  title = {DIAMANT: Interaktion zwischen Diabetes und Depression},
  author = {Kruse, J. and Herder, C. and Hermanns, Norbert and Icks, A. and Kulzer, Bernhard and Moebus, S. and Nowotny, B.},
  year = {2011},
  journal = {Diabetes, metabolism, and the heart : Journal for diabetes and cardiovascular diseases = Diabetes, Stoffwechsel und Herz},
  volume = {20},
  number = {2},
  pages = {88 - 90},
  issn = {1861-7603},
  url = {https://fis.uni-bamberg.de/handle/uniba/5728},
  language = {deu}
}

@article{hermanns2011_5710,
  title = {The Effect of an Education Programm (MEDIAS ICT) for Type 2 Diabetic Patients with Intensive Insulin Therapy},
  author = {Hermanns, Norbert and Kulzer, Bernhard and Maier, Berthold and Mahr, Marina and Haak, Thomas},
  year = {2011},
  journal = {Diabetes : a journal of the American Diabetes Association},
  volume = {60},
  number = {Suppl.1},
  pages = {0862-P},
  issn = {0012-1797},
  url = {https://fis.uni-bamberg.de/handle/uniba/5710},
  language = {eng}
}

@article{hermanns2011_5683,
  title = {Depressionen bei Diabetes mellitus - Ein Update},
  author = {Hermanns, Norbert and Kulzer, Bernhard and Krichbaum, Michael},
  year = {2011},
  journal = {Diabetes aktuell},
  volume = {9},
  number = {4},
  pages = {163-169},
  issn = {0176-2559},
  url = {https://fis.uni-bamberg.de/handle/uniba/5683},
  language = {deu}
}

@article{bergis2011_5697,
  title = {Die Entwicklung der Kurzfassung eines Fragebogens zur Diagnostik und Erfassung neuropathiespezifischer Symptome und neuropathiebedingter Alltagseinschränkungen},
  author = {Bergis, N. and Hermanns, Norbert and Kulzer, Bernhard and Haak, T.},
  year = {2011},
  journal = {Diabetologie und Stoffwechsel : offizielles Organ der Deutschen Diabetes Gesellschaft},
  number = {Suppl.1=46. Jahrestagung der Deutschen Diabetes-Gesellschaft ; Tagungsmotto - Perspektiven Leipzig 2011 - Dialog - Erfahrung - Gewinn - www. ddg2011.de, Leipzig, 1.-4. Juni 2011 / Tagungspräsidentin: Olga Kordonouri},
  pages = {32},
  issn = {1861-9002},
  url = {https://fis.uni-bamberg.de/handle/uniba/5697},
  language = {deu}
}

@article{hermanns2011_5701,
  title = {Effektivität eines neu entwickelten Schulungsprogramms (MEDIAS 2 ICT) für Typ 2 Diabetes Patienten mit einer intensivierten Insulintherapie},
  author = {Hermanns, Norbert and Kulzer, Bernhard and Maier, Berthold and Mahr, Marina and Haak, T.},
  year = {2011},
  journal = {Diabetologie und Stoffwechsel : offizielles Organ der Deutschen Diabetes Gesellschaft},
  volume = {6},
  number = {Suppl.1=46. Jahrestagung der Deutschen Diabetes-Gesellschaft ; Tagungsmotto - Perspektiven Leipzig 2011 - Dialog - Erfahrung - Gewinn - www. ddg2011.de, Leipzig, 1.-4. Juni 2011 / Tagungspräsidentin: Olga Kordonouri},
  issn = {1861-9002},
  url = {https://fis.uni-bamberg.de/handle/uniba/5701},
  language = {deu}
}

@article{petrak2011_5705,
  title = {Kognitive Verhaltenstherapie vs. Sertralin bei depressiven Patienten mit Diabetes mellitus: Ergebnisse der Diabetes- Depressions-Studie (DAD- Studie)},
  author = {Petrak, F and Herpertz, S. and Albus, C. and Hermanns, Norbert and Kronfeld, K. and Kruse, J. and Kulzer, Bernhard},
  year = {2011},
  journal = {Diabetologie und Stoffwechsel : offizielles Organ der Deutschen Diabetes Gesellschaft.},
  volume = {6},
  number = {Suppl.1=46. Jahrestagung der Deutschen Diabetes-Gesellschaft ; Tagungsmotto - Perspektiven Leipzig 2011 - Dialog - Erfahrung - Gewinn - www. ddg2011.de, Leipzig, 1.-4. Juni 2011 / Tagungspräsidentin: Olga Kordonouri},
  pages = {25},
  issn = {1861-9002},
  url = {https://fis.uni-bamberg.de/handle/uniba/5705},
  language = {deu}
}

@incollection{kulzer2011_5703,
  title = {Psychologische Aspekte des Diabetes Mellitus},
  author = {Kulzer, Bernhard and Hermanns, Norbert},
  year = {2011},
  booktitle = {Diabetologie in Klinik und Praxis : 195 Tabellen},
  pages = {268-282},
  address = {Stuttgart u.a.},
  edition = {6., vollst. überarb. und erw. Aufl.},
  isbn = {978-3-13-512806-1},
  url = {https://fis.uni-bamberg.de/handle/uniba/5703},
  language = {deu}
}

@article{gahr2011_5656,
  title = {Psychometrische Eigenschaften der deutschen Fassung eines Fragebogens zur Diabetesakzeptanz},
  author = {Gahr, A. and Schmitt, Andreas and Hermanns, Norbert and Haak, T. and Kulzer, Bernhard},
  year = {2011},
  journal = {Diabetologie und Stoffwechsel : offizielles Organ der Deutschen Diabetes Gesellschaft.},
  volume = {6},
  number = {Suppl.1=46. Jahrestagung der Deutschen Diabetes-Gesellschaft ; Tagungsmotto - Perspektiven Leipzig 2011 - Dialog - Erfahrung - Gewinn - www. ddg2011.de, Leipzig, 1.-4. Juni 2011 / Tagungspräsidentin: Olga Kordonouri},
  pages = {26},
  issn = {1861-9002},
  url = {https://fis.uni-bamberg.de/handle/uniba/5656},
  language = {deu}
}

@article{maier2011_5658,
  title = {Welchen Einfluss hat das Auftreten schwerer Hypoglykämien bei Typ 1 Diabetikern auf das Wohlbefinden?},
  author = {Maier, Berthold and Hermanns, Norbert and Kulzer, Bernhard and Ehrmann, Dominic and Bergis, N. and Haak, T.},
  year = {2011},
  journal = {Diabetologie und Stoffwechsel : offizielles Organ der Deutschen Diabetes Gesellschaft.},
  volume = {6},
  number = {Suppl.1=46. Jahrestagung der Deutschen Diabetes-Gesellschaft ; Tagungsmotto - Perspektiven Leipzig 2011 - Dialog - Erfahrung - Gewinn - www. ddg2011.de, Leipzig, 1.-4. Juni 2011 / Tagungspräsidentin: Olga Kordonouri},
  pages = {24},
  issn = {1861-9002},
  url = {https://fis.uni-bamberg.de/handle/uniba/5658},
  language = {deu}
}

@article{mahr2011_5660,
  title = {Wie unterscheiden sich die Einstellungen bezüglich der Insulintherapie zwischen Menschen mit Typ 1 und Typ 2 Diabetes und intensivierter Insulintherapie?},
  author = {Mahr, Marina and Hermanns, Norbert and Maier, Berthold and Kulzer, Bernhard and Haak, T.},
  year = {2011},
  journal = {Diabetologie und Stoffwechsel : offizielles Organ der Deutschen Diabetes Gesellschaft},
  volume = {6},
  number = {Suppl.1=46. Jahrestagung der Deutschen Diabetes-Gesellschaft ; Tagungsmotto - Perspektiven Leipzig 2011 - Dialog - Erfahrung - Gewinn - www.ddg2011.de, Leipzig,  1.-4. Juni 2011 / Tagungspräsidentin: Olga Kordonouri},
  pages = {89},
  issn = {1861-9002},
  url = {https://fis.uni-bamberg.de/handle/uniba/5660},
  language = {deu}
}

@article{schmitt2011_5659,
  title = {Zusammenhang von glykämischer Kontrolle und Depressivität},
  author = {Schmitt, Andreas and Gahr, A. and Kulzer, Bernhard and Haak, T. and Hermanns, Norbert},
  year = {2011},
  journal = {Diabetologie und Stoffwechsel : offizielles Organ der Deutschen Diabetes Gesellschaft},
  volume = {6},
  number = {Suppl.1=46. Jahrestagung der Deutschen Diabetes-Gesellschaft ; Tagungsmotto - Perspektiven Leipzig 2011 - Dialog - Erfahrung - Gewinn - www. ddg2011.de, Leipzig, 1.-4. Juni 2011 / Tagungspräsidentin: Olga Kordonouri,},
  pages = {24},
  issn = {1861-9002},
  url = {https://fis.uni-bamberg.de/handle/uniba/5659},
  language = {deu}
}

@article{kulzer2011_5655,
  title = {Einfluss der Blutzuckerselbstkontrolle auf die glykämische Kontrolle bei Typ 1 Diabetes},
  author = {Kulzer, Bernhard and Krichbaum, Michael and Hermanns, Norbert and Haak, T.},
  year = {2011},
  journal = {Diabetologie und Stoffwechsel : offizielles Organ der Deutschen Diabetes Gesellschaft},
  volume = {6},
  number = {Suppl.1=46. Jahrestagung der Deutschen Diabetes-Gesellschaft ; Tagungsmotto - Perspektiven Leipzig 2011 - Dialog - Erfahrung - Gewinn - www. ddg2011.de, Leipzig, 1.-4. Juni 2011 / Tagungspräsidentin: Olga Kordonouri},
  pages = {23},
  issn = {1861-9002},
  url = {https://fis.uni-bamberg.de/handle/uniba/5655},
  language = {deu}
}

@article{ehrmann2011_5651,
  title = {Psychometrische Analyse eines Wissenstest zur Messung therapierelevanten Wissens und Fertigkeiten bei Typ 1 und Typ 2 Diabetikern mit einer intensivierten Insulinbehandlung},
  author = {Ehrmann, Dominic and Hermanns, Norbert and Kulzer, Bernhard and Bergis, N. and Haak, Thomas},
  year = {2011},
  journal = {Diabetologie und Stoffwechsel : offizielles Organ der Deutschen Diabetes Gesellschaft},
  volume = {6},
  number = {Suppl.1=46. Jahrestagung der Deutschen Diabetes-Gesellschaft ; Tagungsmotto - Perspektiven Leipzig 2011 - Dialog - Erfahrung - Gewinn - www. ddg2011.de, Leipzig, 1.-4. Juni 2011 / Tagungspräsidentin: Olga Kordonouri},
  pages = {62},
  issn = {1861-9002},
  url = {https://fis.uni-bamberg.de/handle/uniba/5651},
  language = {deu}
}

@article{kulzer2010_5797,
  title = {Problembereiche der Patienten erfassen},
  author = {Kulzer, Bernhard},
  year = {2010},
  journal = {Diabetes-Forum : Forum für integriertes Diabetesmanagement ; offizielles Organ: VDBD, BDD, BVKD, DDU, DDB, VDO E.},
  volume = {22},
  number = {7-8},
  pages = {26 - 28},
  issn = {1614-6476},
  url = {https://fis.uni-bamberg.de/handle/uniba/5797},
  language = {deu}
}

@inproceedings{kulzer2010_5806,
  title = {Psyche},
  author = {Kulzer, Bernhard},
  year = {2010},
  booktitle = {Handbuch Diabetologie 2010 : 5. Diabetes-Update 2010},
  pages = {Kapitel 11},
  publisher = {Springer},
  address = {Heidelberg},
  isbn = {978-3-642-11974-3},
  url = {https://fis.uni-bamberg.de/handle/uniba/5806},
  language = {deu}
}

@article{kulzer2010_5766,
  title = {Abschlussbericht Urin- und Blutzuckerselbstkontrolle. IQWiG-Methode: diskussionswürdig},
  author = {Kulzer, Bernhard},
  year = {2010},
  journal = {Diabetes-Journal : aktiv gesund leben ; offizielles Organ des Deutschen Diabetiker-Bundes},
  volume = {59},
  number = {1},
  pages = {10-13},
  issn = {0341-8812},
  url = {https://fis.uni-bamberg.de/handle/uniba/5766},
  language = {deu}
}

@article{kulzer2010_5769,
  title = {Aktuelles Umfrageergebnis: Blutzucker-Selbstkontrolle auch ohne Insulin? Leser sagen ja!},
  author = {Kulzer, Bernhard},
  year = {2010},
  journal = {Diabetes-Journal : aktiv gesund leben ; offizielles Organ des Deutschen Diabetiker-Bundes},
  volume = {59},
  number = {4},
  pages = {10 - 17},
  issn = {0341-8812},
  url = {https://fis.uni-bamberg.de/handle/uniba/5769},
  language = {deu}
}

@article{paulweber2010_5745,
  title = {A European evidence-based guideline for the prevention of type 2 diabetes},
  author = {Paulweber, B and Valensi, P and Lindstrom, J and Lalic, NM and Greaves, CJ and McKee, M and Kulzer, Bernhard and Hermanns, Norbert},
  year = {2010},
  journal = {Hormone and Metabolic Research : Horm Metab Res},
  volume = {42},
  number = {Suppl. 1},
  pages = {33-36},
  issn = {0018-5043},
  url = {https://fis.uni-bamberg.de/handle/uniba/5745},
  language = {eng}
}

@article{kulzer2010_5751,
  title = {Depression: Screening und Diagnostik},
  author = {Kulzer, Bernhard},
  year = {2010},
  journal = {Diabetes-Forum : Forum für integriertes Diabetesmanagement ; offizielles Organ: VDBD, BDD, BVKD, DDU, DDB, VDO E},
  volume = {22},
  number = {7-8},
  pages = {11 - 15},
  issn = {1614-6476},
  url = {https://fis.uni-bamberg.de/handle/uniba/5751},
  language = {deu}
}

@article{kulzer2010_5747,
  title = {Der IQWIG-Bericht zum Nutzen der Blutzuckerselbstkontrolle und seine mögliche Folgen: "Trendwende in der Diabetesversorgung?"},
  author = {Kulzer, Bernhard},
  year = {2010},
  journal = {Monitor Versorgungsforschung : Fachzeitschrift zu Realität, Qualität und Innovation der Gesundheitsversorgung},
  volume = {3},
  number = {4},
  pages = {21 - 23},
  issn = {1866-0533},
  url = {https://fis.uni-bamberg.de/handle/uniba/5747},
  language = {deu}
}

@article{icks2010_5759,
  title = {Diabetes bei Migranten},
  author = {Icks, Andrea and Kulzer, Bernhard and Razum, Oliver},
  year = {2010},
  journal = {Deutscher Gesundheitsbericht : Diabetes 2011},
  pages = {148 - 154},
  issn = {1614-824X},
  url = {https://fis.uni-bamberg.de/handle/uniba/5759},
  language = {deu}
}

@article{kulzer2010_5761,
  title = {Die Psychologische Dimension des Diabetes mellitus},
  author = {Kulzer, Bernhard},
  year = {2010},
  journal = {Deutscher Gesundheitsbericht : Diabetes 2011},
  pages = {40 - 47},
  issn = {1614-824X},
  url = {https://fis.uni-bamberg.de/handle/uniba/5761},
  language = {deu}
}

@article{kruse2010_5755,
  title = {Einführung zum Thema - Diabetes und Depression},
  author = {Kruse, J. and Kulzer, Bernhard},
  year = {2010},
  journal = {Der Diabetologe},
  volume = {6},
  number = {4},
  pages = {253-254},
  issn = {1860-9716},
  url = {https://fis.uni-bamberg.de/handle/uniba/5755},
  language = {deu}
}

@article{kulzer2010_5736,
  title = {Lebensqualität bei Diabetes mellitus (1) - Wichtig für Therapie und Prognose},
  author = {Kulzer, Bernhard and Krichbaum, Michael and Hermanns, Norbert},
  year = {2010},
  journal = {Info Diabetologie : interdisziplinäre Fortbildung in der Diabetologie},
  volume = {4},
  number = {4},
  pages = {32 - 35},
  issn = {1865-5459},
  url = {https://fis.uni-bamberg.de/handle/uniba/5736},
  language = {deu}
}

@article{kulzer2010_5753,
  title = {Screenen mit dem WHO-5-fragebogen},
  author = {Kulzer, Bernhard},
  year = {2010},
  journal = {Diabetes-Forum : Forum für integriertes Diabetesmanagement ; offizielles Organ: VDBD, BDD, BVKD, DDU, DDB, VDO E},
  volume = {22},
  number = {7-8},
  pages = {16 - 21},
  issn = {1614-6476},
  url = {https://fis.uni-bamberg.de/handle/uniba/5753},
  language = {other}
}

@incollection{hermanns2010_5749,
  title = {Screening in Diabetes Care: Detecting and Managing Depression in Diabetes},
  author = {Hermanns, Norbert and Kulzer, Bernhard},
  year = {2010},
  booktitle = {Screening for depression in clinical practice : an evidence-based},
  pages = {335 - 348},
  address = {Oxford u.a.},
  isbn = {9780199701650},
  url = {https://fis.uni-bamberg.de/handle/uniba/5749},
  language = {eng}
}

@article{kruse2010_5756,
  title = {Screening, Diagnostik und psychosomatische Therapieansätze bei Patienten mit Diabetes und Depression},
  author = {Kruse, J. and Kulzer, Bernhard},
  year = {2010},
  journal = {Der Diabetologe},
  volume = {6},
  number = {4},
  pages = {272-279},
  issn = {1860-9716},
  url = {https://fis.uni-bamberg.de/handle/uniba/5756},
  language = {deu}
}

@article{lindstrom2010_5740,
  title = {Take action to prevent diabetes - the IMAGE toolkit for the prevention of type 2 diabetes in Europe},
  author = {Lindstrom, J and Neumann, A. and Sheppard, KE.Gilis and Januszewska, A, and Greaves, CJ and Handke, U, and Kulzer, Bernhard and Hermanns, Norbert},
  year = {2010},
  journal = {Hormone and Metabolic Research : Horm Metab Res},
  volume = {42},
  number = {Suppl 1},
  pages = {37-55},
  issn = {0018-5043},
  url = {https://fis.uni-bamberg.de/handle/uniba/5740},
  language = {eng}
}

@book{kulzer2010_5752,
  title = {Typ-2-Diabetes selbst behandeln : ein Leitfaden für den Alltag ; für Menschen mit Typ-2-Diabetes, die nicht Insulin spritzen ; Medias 2 Basis ;  für DMPs zugelassen},
  author = {Kulzer, Bernhard and Hermanns, Norbert and Maier, B. and Mahr, M. and Haak, T. and Reinecker, Hans},
  year = {2010},
  publisher = {Kirchheim},
  address = {Mainz},
  series = {Fit und gesund bleiben},
  edition = {8},
  url = {https://fis.uni-bamberg.de/handle/uniba/5752},
  language = {deu}
}

@book{kulzer2010_5711,
  title = {Das ist eine BE/KE : Lebensmittelposter zum Aufklappen, Tabelle zum Nachschlagen ; Medias 2 ICT},
  author = {Kulzer, Bernhard and Hermanns, Norbert and Maier, B. and Mahr, M. and Haak, T. and Reinecker, Hans},
  year = {2010},
  publisher = {Kirchheim},
  address = {Mainz},
  series = {Medias 2 ICT Schulungskoffer},
  edition = {1},
  url = {https://fis.uni-bamberg.de/handle/uniba/5711},
  language = {deu}
}

@article{schmitt2010_5712,
  title = {Gesundheitsbezogene Lebensqualität bei insulinbehandelten Typ 2- Diabetikern},
  author = {Schmitt, Andreas and Maier, Berthold and Mahr, Marina and Hermanns, Norbert and Kulzer, Bernhard and Haak, Thomas},
  year = {2010},
  journal = {Diabetologie und Stoffwechsel : offizielles Organ der Deutschen Diabetes Gesellschaft},
  volume = {5},
  number = {Suppl. 1=45. Jahrestagung der Deutschen Diabetes-Gesellschaft ; Tagungsmotto "Diabetestherapie in Bewegung" - www.ddg2010.de, Stuttgart, 12.-15. Mai 2010 / Tagungspräsident: Michael Nauck},
  pages = {38},
  issn = {1861-9002},
  url = {https://fis.uni-bamberg.de/handle/uniba/5712},
  language = {deu}
}

@article{gorges2010_5709,
  title = {Gesundheitsbezogene Lebensqualität bei Personen mit einem erhöhten Typ 2-Diabetesrisiko},
  author = {Gorges, D. and Kulzer, Bernhard and Hermanns, Norbert and Haak, Thomas},
  year = {2010},
  journal = {Diabetologie und Stoffwechsel : offizielles Organ der Deutschen Diabetes Gesellschaft},
  volume = {5},
  number = {Suppl. 1=45. Jahrestagung der Deutschen Diabetes-Gesellschaft ; Tagungsmotto "Diabetestherapie in Bewegung" - www.ddg2010.de, Stuttgart, 12.-15. Mai 2010 / Tagungspräsident: Michael Nauck},
  pages = {38},
  issn = {1861-9002},
  url = {https://fis.uni-bamberg.de/handle/uniba/5709},
  language = {deu}
}

@book{kulzer2010_5708,
  title = {MEDIAS 2 - Mehr Diabetesselbstmanagement für Typ-2. Schulungs- und Behandlungsprogramm für Menschen mit Typ-2-Diabetes und einer intensivierten Insulintherapie (MEDIAS 2 ICT)},
  author = {Kulzer, Bernhard and Hermanns, Norbert and Maier, B. and Mahr, M. and Haak, T. and Reinecker, Hans},
  year = {2010},
  publisher = {Kirchheim},
  address = {Mainz},
  edition = {1},
  url = {https://fis.uni-bamberg.de/handle/uniba/5708},
  language = {deu}
}

@book{kulzer2010_5713,
  title = {Meine Insulintherapie : Insulinbehandlung verstehen ; Medias 2 CT, ICT ; Hinweise zur Anwendung der Insulinschablonen: Wirkdauer verschiedener Insuline, Schablonen für kurz- und langwirksame Insuline sowie Mischinsuline, Insulinwirkkurven},
  author = {Kulzer, Bernhard and Hermanns, Norbert and Maier, B. and Mahr, M. and Haak, T. and Reinecker, Hans},
  year = {2010},
  publisher = {Kirchheim},
  address = {Mainz},
  series = {Medias 2 ICT Schulungskoffer},
  edition = {1},
  url = {https://fis.uni-bamberg.de/handle/uniba/5713},
  language = {deu}
}

@book{kulzer2010_5707,
  title = {Schulungsmanual mit Curriculum : MEDIAS 2 - Mehr Diabetesselbstmanagement für Typ-2. Schulungs- und Behandlungsprogramm für Menschen mit Typ-2-Diabetes, die nicht Insulin spritzen (MEDIAS 2 Basis)},
  author = {Kulzer, Bernhard and Hermanns, Norbert and Maier, B. and Haak, T. and Reinecker, Hans},
  year = {2010},
  publisher = {Kirchheim},
  address = {Mainz},
  series = {MEDIAS 2 Basis Schulungskoffer},
  edition = {8},
  url = {https://fis.uni-bamberg.de/handle/uniba/5707},
  language = {deu}
}

@article{chernyak2010_5732,
  title = {Within-trial economic evaluation of diabetes-specific cognitive behaviour therapy in patients with type 2 diabetes and subthreshold depression},
  author = {Chernyak, Nadja and Kulzer, Bernd and Hermanns, Norbert and Schmitt, Andreas and Gahr, Annika and Haak, Thomas and Kruse, Johannes and Ohmann, Christian and Scheer, Marsel and Giani, Guido and Icks, Andrea},
  year = {2010},
  journal = {BMC public health},
  volume = {10},
  number = {625},
  issn = {1471-2458},
  url = {https://fis.uni-bamberg.de/handle/uniba/5732},
  language = {deu}
}

@article{hermanns2010_5691,
  title = {Barriers towards insulin therapy in type 2 diabetic patients: results of an observational longitudinal study},
  author = {Hermanns, Norbert and Mahr, Marina and Kulzer, Bernhard and Skovlund, Sören  E and Haak, Thomas},
  year = {2010},
  journal = {Health and quality of life outcomes},
  volume = {8},
  number = {113},
  issn = {1477-7525},
  url = {https://fis.uni-bamberg.de/handle/uniba/5691},
  language = {eng}
}

@article{kulzer2010_5684,
  title = {Diabetes und Depression - Risiken und Zusammenhänge},
  author = {Kulzer, Bernhard and Hermanns, Norbert and Kruse, J.},
  year = {2010},
  journal = {Der Diabetologe},
  volume = {6},
  number = {4},
  pages = {255-265},
  issn = {1860-9716},
  url = {https://fis.uni-bamberg.de/handle/uniba/5684},
  language = {deu}
}

@article{kruse2010_5692,
  title = {Diabetes und Depression. Der DIAMANT-Verbund untersucht eine Interaktion mit bedeutsamen Folgen},
  author = {Kruse, J. and Icks, A. and Moebus, S. and Rose, B. and Kulzer, Bernhard and Hermanns, Norbert},
  year = {2010},
  journal = {Die medizinische Welt : aus der Wissenschaft in die Praxis},
  volume = {61},
  number = {2},
  pages = {97-99},
  issn = {0025-8512},
  url = {https://fis.uni-bamberg.de/handle/uniba/5692},
  language = {deu}
}

@article{kulzer2010_5700,
  title = {Effect of a diabetes prevention programme (PREDIAS) on metabolic risk factors and quality of life: results of a randomised controlled trail},
  author = {Kulzer, Bernhard and Hermanns, Norbert and Gorges, D. and Schwarz, P and Haak, T.},
  year = {2010},
  journal = {Diabetologia : journal of the European Association for the Study of Diabetes (EASD)},
  volume = {53},
  number = {Suppl. 1=Abstracts of the EASD, Stockholm 2010, held in Messe Wien, Vienna, Austria on 1 October 2009},
  pages = {S83},
  issn = {0012-186X},
  url = {https://fis.uni-bamberg.de/handle/uniba/5700},
  language = {eng}
}

@article{hermanns2010_5686,
  title = {Insulin glargine and incidence of cancer - an ongoing debate},
  author = {Hermanns, Norbert and Kulzer, Bernhard},
  year = {2010},
  journal = {Journal of diabetes science and technology : from basic science to clinical practice ; DST},
  volume = {4},
  number = {2},
  pages = {497-499},
  issn = {1932-2968},
  url = {https://fis.uni-bamberg.de/handle/uniba/5686},
  language = {eng}
}

@article{kulzer2010_5690,
  title = {Lebensqualität bei Diabetes mellitus (2) - Wie wird sie in der Praxis gemessen?},
  author = {Kulzer, Bernhard and Krichbaum, Michael and Hermanns, Norbert},
  year = {2010},
  journal = {Info Diabetologie : interdisziplinäre Fortbildung in der Diabetologie},
  volume = {4},
  number = {4},
  pages = {36 - 39},
  issn = {1865-5459},
  url = {https://fis.uni-bamberg.de/handle/uniba/5690},
  language = {deu}
}

@article{hermanns2010_5688,
  title = {Long-term effect of an education programme (HyPOS) on the incidence of severe hypoglycaemia in patients with type 1 diabetes},
  author = {Hermanns, Norbert and Kulzer, Bernhard and Krichbaum, Michael and Kubiak, Thomas and Haak, Thomas},
  year = {2010},
  journal = {Diabetes Care},
  volume = {33},
  number = {3},
  pages = {e36},
  issn = {0149-5992},
  doi = {10.2337/dc09-1656},
  url = {https://fis.uni-bamberg.de/handle/uniba/5688},
  language = {eng}
}

@book{kulzer2010_5702,
  title = {MEDIAS 2 - Mehr Diabetesselbstmanagement für Typ-2. Schulungs- und Behandlungsprogramm für Menschen mit Typ-2- Diabetes, die nicht Insulin spritzen (MEDIAS 2 Basis)},
  author = {Kulzer, Bernhard and Hermanns, Norbert and Maier, B. and Haak, T. and Reinecker, Hans},
  year = {2010},
  publisher = {Kirchheim},
  address = {Mainz},
  edition = {5},
  url = {https://fis.uni-bamberg.de/handle/uniba/5702},
  language = {deu}
}

@article{hermanns2010_5694,
  title = {Negative attitudes towards insulin treatment in type 2 diabetes seems to be a rather temporal and benign phenomenon: Results of an observational longitudinal study},
  author = {Hermanns, Norbert and Kulzer, Bernhard and Mahr, Marina and Skovlund, S, and Haak, Thomas},
  year = {2010},
  journal = {Diabetologia : journal of the European Association for the Study of Diabetes (EASD)},
  volume = {53},
  number = {Suppl. 1=Abstracts of the EASD, Stockholm 2010, held in Messe Wien, Vienna, Austria on 1 October 2009},
  pages = {S380},
  issn = {0012-186X},
  url = {https://fis.uni-bamberg.de/handle/uniba/5694},
  language = {eng}
}

@article{kulzer2010_5696,
  title = {Patientenschulung bei Diabetes - Von der Complianceförderung zum Selbstmanagement},
  author = {Kulzer, Bernhard and Krichbaum, Michael and Kruse, J. and Haak, Thomas and Hermanns, Norbert},
  year = {2010},
  journal = {Ärztliche Psychotherapie und Psychosomatische Medizin},
  volume = {5},
  number = {2},
  pages = {89-94},
  issn = {1862-4715},
  url = {https://fis.uni-bamberg.de/handle/uniba/5696},
  language = {deu}
}

@article{pajunen2010_5699,
  title = {Quality indicators for the prevention of type 2 diabetes in Europe},
  author = {Pajunen, P. and Landgraf, R. and Muylle, F, and Neumann, A. and Lindstrom, J, and Schwarz, PE, and Kulzer, Bernhard and Hermanns, Norbert},
  year = {2010},
  journal = {Hormone and Metabolic Research : Horm Metab Res.},
  volume = {42},
  number = {Suppl. 1},
  pages = {56-63},
  issn = {0018-5043},
  url = {https://fis.uni-bamberg.de/handle/uniba/5699},
  language = {eng}
}

@book{kulzer2010_5706,
  title = {Schulungsmanual mit Curriculum : MEDIAS 2 - Mehr Diabetesselbstmanagement für Typ-2. Schulungs- und Behandlungsprogramm für Menschen mit Typ-2-Diabetes und einer intensivierten Insulintherapie (MEDIAS 2 ICT)},
  author = {Kulzer, Bernhard and Hermanns, Norbert and Maier, B. and Mahr, M. and Haak, T. and Reinecker, Hans},
  year = {2010},
  publisher = {Kirchheim},
  address = {Mainz},
  series = {Medias 2 ICT Schulungskoffer},
  edition = {1},
  url = {https://fis.uni-bamberg.de/handle/uniba/5706},
  language = {deu}
}

@incollection{hermanns2010_5698,
  title = {Verhaltensmodifikation zur Umstellung der Ernährung und Steigerung der körperlichen Aktivität},
  author = {Hermanns, Norbert and Kulzer, Bernhard},
  year = {2010},
  booktitle = {Das Metabolische Syndrom},
  pages = {233-249},
  address = {München},
  edition = {2. aktulaisierte Auflage},
  isbn = {978-3-89935-257-3},
  url = {https://fis.uni-bamberg.de/handle/uniba/5698},
  language = {deu}
}

@article{gahr2010_5662,
  title = {Inwieweit eignet sich die "Center for Epidemiologic Studies Depression Scale" (CES-D) zum Depressionsscreening bei Diabetikern?},
  author = {Gahr, A. and Schmitt, Andreas and Kulzer, Bernhard and Hermanns, Norbert and Haak, Thomas},
  year = {2010},
  journal = {Diabetologie und Stoffwechsel : offizielles Organ der Deutschen Diabetes Gesellschaft},
  volume = {5},
  number = {Suppl. 1=45. Jahrestagung der Deutschen Diabetes-Gesellschaft ; Tagungsmotto "Diabetestherapie in Bewegung" - www.ddg2010.de, Stuttgart, 12.-15. Mai 2010 / Tagungspräsident: Michael Nauck},
  pages = {6},
  issn = {1861-9002},
  url = {https://fis.uni-bamberg.de/handle/uniba/5662},
  language = {deu}
}

@article{ehrmann2010_5664,
  title = {Kurzform des PAID-Fragebogens zur Erfassung diabetesbezogener Belastungen},
  author = {Ehrmann, Dominic and Hermanns, Norbert and Kulzer, Bernhard and Krichbaum, Michael and Mahr, Marina and Haak, T.},
  year = {2010},
  journal = {Diabetologie und Stoffwechsel : offizielles Organ der Deutschen Diabetes Gesellschaft.},
  volume = {5},
  number = {Suppl. 1=45. Jahrestagung der Deutschen Diabetes-Gesellschaft ; Tagungsmotto "Diabetestherapie in Bewegung" - www.ddg2010.de, Stuttgart, 12.-15. Mai 2010 / Tagungspräsident: Michael Nauck},
  pages = {5},
  issn = {1861-9002},
  url = {https://fis.uni-bamberg.de/handle/uniba/5664},
  language = {deu}
}

@article{maier2010_5666,
  title = {Lohnt sich die Erfassung des Wohlbefindens und diabetesbezogener Belastungen bei insulinbehandelten Typ 2-Diabetikern in der diabetologischen Schwerpunktpraxis?},
  author = {Maier, B. and Kulzer, Bernhard and Hermanns, Norbert and Mahr, Marina and Haak, Thomas},
  year = {2010},
  journal = {Diabetologie und Stoffwechsel : offizielles Organ der Deutschen Diabetes Gesellschaft},
  volume = {5},
  number = {Suppl. 1=45. Jahrestagung der Deutschen Diabetes-Gesellschaft ; Tagungsmotto "Diabetestherapie in Bewegung" - www.ddg2010.de, Stuttgart, 12.-15. Mai 2010 / Tagungspräsident: Michael Nauck},
  pages = {38-39},
  issn = {1861-9002},
  url = {https://fis.uni-bamberg.de/handle/uniba/5666},
  language = {deu}
}

@article{hermanns2010_5663,
  title = {Prävalenz von Hypoglykämieproblemen bei insulinbehandelten Typ 2- Diabetikern},
  author = {Hermanns, Norbert and Kulzer, Bernhard and Mahr, Marina and Maier, Berthold and Haak, Thomas},
  year = {2010},
  journal = {Diabetologie und Stoffwechsel : offizielles Organ der Deutschen Diabetes Gesellschaft},
  volume = {5},
  number = {Suppl. 1=45. Jahrestagung der Deutschen Diabetes-Gesellschaft ; Tagungsmotto "Diabetestherapie in Bewegung" - www.ddg2010.de, Stuttgart, 12.-15. Mai 2010 / Tagungspräsident: Michael Nauck},
  pages = {66},
  issn = {1861-9002},
  url = {https://fis.uni-bamberg.de/handle/uniba/5663},
  language = {deu}
}

@article{mahr2010_5668,
  title = {Welche Faktoren beeinflussen die Zufriedenheit mit der Insulintherapie bei Typ 2-Diabetikern?},
  author = {Mahr, Marina and Maier, Berthold and Hermanns, Norbert and Kulzer, Bernhard and Haak, Thomas},
  year = {2010},
  journal = {Diabetologie und Stoffwechsel : offizielles Organ der Deutschen Diabetes Gesellschaft},
  volume = {5},
  number = {Suppl. 1=45. Jahrestagung der Deutschen Diabetes-Gesellschaft ; Tagungsmotto "Diabetestherapie in Bewegung" - www.ddg2010.de, Stuttgart, 12.-15. Mai 2010 / Tagungspräsident: Michael Nauck},
  pages = {39},
  issn = {1861-9002},
  url = {https://fis.uni-bamberg.de/handle/uniba/5668},
  language = {deu}
}

@article{mahr2010_4025,
  title = {Befürchtungen von Typ-2-Diabetikern bezüglich einer Insulintherapie - eine prospektive Studie},
  author = {Mahr, Marina and Hermanns, Norbert and Kulzer, Bernhard and Haak, Thomas and Reinecker, Hans},
  year = {2010},
  journal = {Verhaltenstherapie \& Verhaltensmedizin},
  volume = {31},
  pages = {50 - 63},
  issn = {1865-9985},
  url = {https://fis.uni-bamberg.de/handle/uniba/4025},
  language = {deu}
}

@article{kulzer2009_20708,
  title = {Sex: Diabetes beeinträchtigt auch Frauen},
  author = {Kulzer, Bernhard},
  year = {2009},
  journal = {Diabetes-Journal : aktiv gesund leben ; offizielles Organ des Deutschen Diabetiker-Bundes},
  volume = {58},
  number = {6},
  pages = {36-37},
  issn = {0341-8812},
  url = {https://fis.uni-bamberg.de/handle/uniba/20708},
  language = {deu}
}

@article{kulzer2009_20700,
  title = {Für Sie und Ihre Angehörigen: Nützliche Tipps zum Umgang mit Depressionen},
  author = {Kulzer, Bernhard},
  year = {2009},
  journal = {Diabetes-Journal : aktiv gesund leben ; offizielles Organ des Deutschen Diabetiker-Bundes},
  volume = {58},
  number = {1},
  pages = {32-34},
  issn = {0341-8812},
  url = {https://fis.uni-bamberg.de/handle/uniba/20700},
  language = {deu}
}

@article{kulzer2009_20704,
  title = {Niere: 200 Gramm reinigen den Körper. Serie "Gesundheits-Pass Diabetes" Teil 6},
  author = {Kulzer, Bernhard},
  year = {2009},
  journal = {Diabetes-Journal : aktiv gesund leben ; offizielles Organ des Deutschen Diabetiker-Bundes},
  volume = {58},
  number = {4},
  pages = {50-51},
  issn = {0341-8812},
  url = {https://fis.uni-bamberg.de/handle/uniba/20704},
  language = {deu}
}

@incollection{kulzer2009_20662,
  title = {Das Arzt-Patient-Gespräch in der Inneren Medizin. Beratung und Begleitung bei lebensstilinduzierten Erkrankungen},
  author = {Kulzer, Bernhard},
  year = {2009},
  booktitle = {Das Arzt-Patient Patient-Arzt Gespräch : ein Leitfaden für Klinik und Praxis},
  pages = {29 - 42},
  address = {München},
  isbn = {978-3-88616-131-7},
  url = {https://fis.uni-bamberg.de/handle/uniba/20662},
  language = {deu}
}

@article{kulzer2009_20660,
  title = {Der Blutzuckerlangzeitwert. Serie "Gesundheits-Pass Diabetes" Teil 3},
  author = {Kulzer, Bernhard},
  year = {2009},
  journal = {Diabetes-Journal : aktiv gesund leben ; offizielles Organ des Deutschen Diabetiker-Bundes},
  volume = {58},
  number = {1},
  pages = {40-41},
  issn = {0341-8812},
  url = {https://fis.uni-bamberg.de/handle/uniba/20660},
  language = {deu}
}

@article{kulzer2009_20678,
  title = {Diabetes gemeinsam meistern},
  author = {Kulzer, Bernhard},
  year = {2009},
  journal = {Accu-Chek / Diabetes live : das Forum für die Insulinpumpen-Therapie},
  volume = {1},
  pages = {16-17},
  issn = {1611-4655},
  url = {https://fis.uni-bamberg.de/handle/uniba/20678},
  language = {deu}
}

@inproceedings{hermanns2009_20659,
  title = {Effekte der kontinuierlichen Glukosemessung mit einer retrospektiven Analyse vs. einer Echtzeitanzeige der Glukosewerte bei Typ 1 Diabetikern mit und ohne Hypoglykämieproblemen},
  author = {Hermanns, Norbert and Eberle, H. and Kulzer, Bernhard and Haak, T.},
  year = {2009},
  volume = {4},
  number = {Suppl. 1=44. Jahrestagung der Deutschen Diabetes-Gesellschaft ; Tagungsmotto "Einheit und Zuversicht", Leipzig, 20.-23. Mai 2009},
  pages = {75 - 76},
  issn = {1861-9002},
  url = {https://fis.uni-bamberg.de/handle/uniba/20659},
  language = {deu}
}

@article{kulzer2009_20674,
  title = {Erektionsstörungen, kein Verlangen: Sexualität ; Beziehungen: Lebenswichtig und gesund ; Sexualität und Partnerschaft},
  author = {Kulzer, Bernhard},
  year = {2009},
  journal = {Diabetes-Journal : aktiv gesund leben ; offizielles Organ des Deutschen Diabetiker-Bundes},
  volume = {58},
  number = {6},
  pages = {24-29},
  issn = {0341-8812},
  url = {https://fis.uni-bamberg.de/handle/uniba/20674},
  language = {deu}
}

@article{kulzer2009_20670,
  title = {Es geht um Ihre Augen! Serie "Gesundheits-Pass Diabetes" Teil 5},
  author = {Kulzer, Bernhard},
  year = {2009},
  journal = {Diabetes-Journal : aktiv gesund leben ; offizielles Organ des Deutschen Diabetiker-Bundes},
  volume = {58},
  number = {3},
  pages = {52-53},
  issn = {0341-8812},
  url = {https://fis.uni-bamberg.de/handle/uniba/20670},
  language = {deu}
}

@article{kulzer2009_20663,
  title = {Fußuntersuchung - bei Durchblutungsstörungen und/oder Nervenschäden: Selbst regelmäßig kontrollieren. Serie "Gesundheits- Pass Diabetes" Teil 7},
  author = {Kulzer, Bernhard},
  year = {2009},
  journal = {Diabetes-Journal : aktiv gesund leben ; offizielles Organ des Deutschen Diabetiker-Bundes},
  volume = {58},
  number = {5},
  pages = {60-61},
  issn = {0341-8812},
  url = {https://fis.uni-bamberg.de/handle/uniba/20663},
  language = {deu}
}

@article{kulzer2009_20681,
  title = {Prevention of Diabetes Self-Management Program (PREDIAS) : Efects on Weight, Metabolic Risk Factors, and Behavioral Outcomes},
  author = {Kulzer, Bernhard and Hermanns, Norbert and Gorges, Daniela and Schwarz, P. and Haak, T.},
  year = {2009},
  journal = {Diabetes Care.},
  volume = {32},
  number = {7},
  pages = {1143 - 1146},
  issn = {0149-5992},
  url = {https://fis.uni-bamberg.de/handle/uniba/20681},
  language = {eng}
}

@article{kulzer2009_20661,
  title = {Selbsttest der WHO: Punkten fürs Wohlbefinden. Serie "Gesundheits- Pass Diabetes" Teil 8},
  author = {Kulzer, Bernhard},
  year = {2009},
  journal = {Diabetes-Journal : aktiv gesund leben ; offizielles Organ des Deutschen Diabetiker-Bundes},
  volume = {58},
  number = {6},
  pages = {56-57},
  issn = {0341-8812},
  url = {https://fis.uni-bamberg.de/handle/uniba/20661},
  language = {deu}
}

@article{kulzer2009_20666,
  title = {Was Diabetiker beachten sollten: Medikamente und Psychotherapie gegen Depressionen},
  author = {Kulzer, Bernhard},
  year = {2009},
  journal = {Diabetes-Journal : aktiv gesund leben ; offizielles Organ des Deutschen Diabetiker-Bundes},
  volume = {58},
  number = {1},
  pages = {26-31},
  issn = {0341-8812},
  url = {https://fis.uni-bamberg.de/handle/uniba/20666},
  language = {deu}
}

@inproceedings{hermanns2009_20664,
  title = {Wie viel Gewichtsabnahme ist für die Erzielung eines positiven Effekts in Hinblick auf die Prävention des Typ 2 Diabetes notwendig?},
  author = {Hermanns, Norbert and Kulzer, Bernhard and Gorges, D. and Schwarz, P. and Haak, T.},
  year = {2009},
  volume = {4},
  number = {Suppl. 1=44. Jahrestagung der Deutschen Diabetes-Gesellschaft ; Tagungsmotto "Einheit und Zuversicht", Leipzig, 20.-23. Mai 2009},
  pages = {88},
  issn = {1861-9002},
  url = {https://fis.uni-bamberg.de/handle/uniba/20664},
  language = {deu}
}

@inproceedings{kulzer2009_20669,
  title = {Zusammenhang zwischen neuropathisch bedingten Defiziten, Schmerz-/ Missempfindungssymptomatik und diabetesbezogenen Belastungen},
  author = {Kulzer, Bernhard and Stark, S. and Hermanns, Norbert and Haak, T.},
  year = {2009},
  volume = {4},
  number = {Suppl. 1=44. Jahrestagung der Deutschen Diabetes-Gesellschaft ; Tagungsmotto "Einheit und Zuversicht", Leipzig, 20.-23. Mai 2009},
  pages = {56},
  issn = {1861-9002},
  url = {https://fis.uni-bamberg.de/handle/uniba/20669},
  language = {deu}
}

@article{kulzer2009_20637,
  title = {Depression, Angst und Schlafstörungen - wichtige Komorbiditäten der Neuropathie},
  author = {Kulzer, Bernhard and Hermanns, Norbert},
  year = {2009},
  journal = {Der Diabetologe},
  volume = {5},
  number = {5},
  pages = {350-359},
  issn = {1860-9716},
  url = {https://fis.uni-bamberg.de/handle/uniba/20637},
  language = {deu}
}

@article{hermanns2009_20638,
  title = {Diabetes and Depression - A burdensome Co-morbidity},
  author = {Hermanns, Norbert and Kulzer, Bernhard},
  year = {2009},
  journal = {European Endocrinology},
  volume = {4},
  number = {2},
  pages = {19 - 22},
  issn = {1758-3780},
  url = {https://fis.uni-bamberg.de/handle/uniba/20638},
  language = {eng}
}

@incollection{kulzer2009_20658,
  title = {Diabetes bei Migranten},
  author = {Kulzer, Bernhard and Icks, Andrea and Razum, Oliver},
  year = {2009},
  booktitle = {Deutscher Gesundheitsbericht : Diabetes 2010},
  pages = {134-140},
  url = {https://fis.uni-bamberg.de/handle/uniba/20658},
  language = {deu}
}

@article{hermanns2009_20641,
  title = {Diabetes und Depression - Ein Update},
  author = {Hermanns, Norbert and Krichbaum, Michael and Kulzer, Bernhard},
  year = {2009},
  journal = {Kompendium Diabetes},
  volume = {4},
  pages = {77-82},
  issn = {1861-8413},
  url = {https://fis.uni-bamberg.de/handle/uniba/20641},
  language = {deu}
}

@article{kulzer2009_20657,
  title = {Diabetes und Depression ; Sich die Erkrankung eingestehen},
  author = {Kulzer, Bernhard},
  year = {2009},
  journal = {Diabetes-Journal : aktiv gesund leben ; offizielles Organ des Deutschen Diabetiker-Bundes},
  volume = {58},
  number = {1},
  pages = {20-23},
  issn = {0341-8812},
  url = {https://fis.uni-bamberg.de/handle/uniba/20657},
  language = {deu}
}

@incollection{kulzer2009_20652,
  title = {Die Psychologische Dimension des Diabetes mellitus},
  author = {Kulzer, Bernhard},
  year = {2009},
  booktitle = {Deutscher Gesundheitsbericht : Diabetes 2010},
  pages = {37-44},
  url = {https://fis.uni-bamberg.de/handle/uniba/20652},
  language = {deu}
}

@article{kulzer2009_20654,
  title = {Efficacy of a Behavioral Lifestyle Intervention Group Program (PREDIAS) for the Prevention of Type 2 Diabetes},
  author = {Kulzer, Bernhard and Hermanns, Norbert and Gorges, D. and Schwarz, P. and Haak, Thomas},
  year = {2009},
  journal = {Diabetes : a journal of the American Diabetes Association},
  volume = {58},
  number = {Suppl. 1},
  pages = {1856-P.},
  issn = {0012-1797},
  url = {https://fis.uni-bamberg.de/handle/uniba/20654},
  language = {eng}
}

@article{kulzer2009_20656,
  title = {Gewicht. Serie "Gesundheits-Pass Diabetes" Teil 4},
  author = {Kulzer, Bernhard},
  year = {2009},
  journal = {Diabetes-Journal : aktiv gesund leben ; offizielles Organ des Deutschen Diabetiker-Bundes},
  volume = {58},
  number = {2},
  pages = {62-63},
  issn = {0341-8812},
  url = {https://fis.uni-bamberg.de/handle/uniba/20656},
  language = {deu}
}

@article{hermanns2009_20642,
  title = {Long Term Effect of an Education Programme (HyPOS) on the Incidence of Severe Hypoglycaemia in Patients with Type 1 Diabetes},
  author = {Hermanns, Norbert and Kulzer, Bernhard and Krichbaum, Michael and Haak, Thomas},
  year = {2009},
  journal = {Diabetes : a journal of the American Diabetes Association},
  volume = {58},
  number = {Suppl. 1},
  pages = {1874-P.},
  issn = {0012-1797},
  url = {https://fis.uni-bamberg.de/handle/uniba/20642},
  language = {eng}
}

@article{kulzer2009_20645,
  title = {Motivation - Was ist entscheidend? - Lebensstilintervention bei Risikopersonen für Typ-2-Diabetes},
  author = {Kulzer, Bernhard and Gorges, Daniela and Hermanns, Norbert},
  year = {2009},
  journal = {Diabetes aktuell für die Hausarztpraxis},
  volume = {7},
  number = {2},
  pages = {74 - 81},
  issn = {1861-6089},
  doi = {10.1055/s-0029-1222480},
  url = {https://fis.uni-bamberg.de/handle/uniba/20645},
  language = {deu}
}

@inproceedings{kulzer2009_20650,
  title = {Psyche},
  author = {Kulzer, Bernhard},
  year = {2009},
  booktitle = {Handbuch Diabetologie 2009 : Diabetes-Update 2009},
  address = {Heidelberg},
  url = {https://fis.uni-bamberg.de/handle/uniba/20650},
  language = {deu}
}

@article{hermanns2009_20649,
  title = {Short-term effects on patient satisfaction of continuous glucose monitoring with the GlucoDay with real-time and retrospective access to glucose values: a crossover study},
  author = {Hermanns, Norbert and Kulzer, Bernhard and Gulde, C. and Eberle, H. and Pradler, E, and Patzelt-Bath,  A. and Haak, T.},
  year = {2009},
  journal = {Diabetes Technology \& Therapeutics},
  volume = {11},
  number = {5},
  pages = {275 - 281},
  issn = {1520-9156},
  doi = {10.1089/dia.2008.0078},
  url = {https://fis.uni-bamberg.de/handle/uniba/20649},
  language = {eng}
}

@article{gorges2009_20634,
  title = {Therapiemotivation - Psychologische Aspekte - Empathie, Empowerment und Compliance},
  author = {Gorges, Daniela and Hermanns, Norbert and Kulzer, Bernhard},
  year = {2009},
  journal = {Diabetes aktuell für die Hausarztpraxis},
  number = {4},
  pages = {170 - 174},
  issn = {1861-6089},
  doi = {10.1055/s-0029-1233442},
  url = {https://fis.uni-bamberg.de/handle/uniba/20634},
  language = {deu}
}

@article{kulzer2009_20653,
  title = {Wie wohl fühlen Sie sich?},
  author = {Kulzer, Bernhard},
  year = {2009},
  journal = {Diabetes-Journal : aktiv gesund leben ; offizielles Organ des Deutschen Diabetiker-Bundes},
  volume = {58},
  number = {1},
  pages = {24-25},
  issn = {0341-8812},
  url = {https://fis.uni-bamberg.de/handle/uniba/20653},
  language = {deu}
}

@inproceedings{kulzer2009_20632,
  title = {Effektivität von PRAEDIAS, einem verhaltens- orientierten Gruppenprogramm zur primären Typ 2 Diabetesprävention:  1 Jahres- Follow-up},
  author = {Kulzer, Bernhard and Hermanns, Norbert and Gorges, D. and Haak, T.},
  year = {2009},
  volume = {4},
  number = {Suppl. 1=44. Jahrestagung der Deutschen Diabetes-Gesellschaft ; Tagungsmotto "Einheit und Zuversicht", Leipzig, 20.-23. Mai 2009},
  pages = {12},
  issn = {1861-9010},
  url = {https://fis.uni-bamberg.de/handle/uniba/20632},
  language = {deu}
}

@article{hermanns2009_20618,
  title = {Hypoglykämiewahrnehmungsstörungen},
  author = {Hermanns, Norbert and Krichbaum, Michael and Kulzer, Bernhard},
  year = {2009},
  journal = {Diabetologie und Stoffwechsel : offizielles Organ der Deutschen Diabetes Gesellschaft},
  volume = {4},
  number = {6},
  pages = {R93 - R112},
  issn = {1861-9010},
  doi = {10.1055/s-0029-1224693},
  url = {https://fis.uni-bamberg.de/handle/uniba/20618},
  language = {deu}
}

@inproceedings{hermanns2009_20627,
  title = {Metabolische Effekte einer erfolgreichen Lebensstiländerung mit Gewichtsabnahme bei Personen mit einem erhöhten Diabetesrisko},
  author = {Hermanns, Norbert and Kulzer, Bernhard and Gorges, D. and Schwarz, P. and Haak, T.},
  year = {2009},
  volume = {4},
  number = {Suppl. 1=44. Jahrestagung der Deutschen Diabetes-Gesellschaft ; Tagungsmotto "Einheit und Zuversicht", Leipzig, 20.-23. Mai 2009},
  pages = {89},
  issn = {1861-9010},
  url = {https://fis.uni-bamberg.de/handle/uniba/20627},
  language = {deu}
}

@inproceedings{gorges2009_20616,
  title = {Prädiktoren des Übergewichts bei Hochrisikopersonen für die Entstehung eines Typ 2 Diabetes},
  author = {Gorges, D. and Kulzer, Bernhard and Hermanns, Norbert and Schwarz, P. and Haak, T.},
  year = {2009},
  volume = {4},
  number = {Suppl. 1=44. Jahrestagung der Deutschen Diabetes-Gesellschaft ; Tagungsmotto "Einheit und Zuversicht", Leipzig, 20.-23. Mai 2009},
  pages = {35 - 36},
  issn = {1861-9010},
  url = {https://fis.uni-bamberg.de/handle/uniba/20616},
  language = {deu}
}

@inproceedings{gorges2009_20622,
  title = {Psychologische und verhaltensbezogene Prädiktoren einer erfolgreichen Gewichtsreduktion in der Prävention des Typ 2 Diabetes},
  author = {Gorges, D. and Kulzer, Bernhard and Hermanns, Norbert and Schwarz, P. and Haak, T.},
  year = {2009},
  volume = {4},
  number = {Suppl. 1=44. Jahrestagung der Deutschen Diabetes-Gesellschaft ; Tagungsmotto "Einheit und Zuversicht", Leipzig, 20.-23. Mai 2009},
  pages = {88},
  issn = {1861-9010},
  url = {https://fis.uni-bamberg.de/handle/uniba/20622},
  language = {deu}
}

@inproceedings{hermanns2009_20619,
  title = {Überprüfung der Messgenauigkeit des "Point of Care" Blutzuckermesssystems smart LAB®},
  author = {Hermanns, Norbert and Khoury, M. and Krichbaum, Michael and Kulzer, Bernhard and Haak, T.},
  year = {2009},
  volume = {4},
  number = {Suppl. 1=44. Jahrestagung der Deutschen Diabetes-Gesellschaft ; Tagungsmotto "Einheit und Zuversicht", Leipzig, 20.-23. Mai 2009},
  pages = {100},
  issn = {1861-9010},
  url = {https://fis.uni-bamberg.de/handle/uniba/20619},
  language = {deu}
}

@inproceedings{hermanns2009_20625,
  title = {Validierung eines Fragebogens zur Erfassung von diabetesbezogenen Belastungen (Diabetes Distress Skala - DDS)},
  author = {Hermanns, Norbert and Scheff, C. and Kulzer, Bernhard and Haak, T.},
  year = {2009},
  volume = {4},
  number = {Suppl. 1=44. Jahrestagung der Deutschen Diabetes-Gesellschaft ; Tagungsmotto "Einheit und Zuversicht", Leipzig, 20.-23. Mai 2009},
  pages = {37},
  issn = {1861-9010},
  url = {https://fis.uni-bamberg.de/handle/uniba/20625},
  language = {deu}
}

@article{gulde2009_20223,
  title = {Psychologische Effekte der kontinuierlichen Glukosemessung bei Typ-1-Diabetikern},
  author = {Gulde, Ch. and Hermanns, Norbert and Eberle, H. and Kulzer, Bernhard and Reinecker, Hans and Haak, Thomas},
  year = {2009},
  journal = {Verhaltenstherapie \& Verhaltensmedizin},
  volume = {30},
  pages = {458-469},
  issn = {1865-9985},
  url = {https://fis.uni-bamberg.de/handle/uniba/20223},
  language = {deu}
}

@article{stark2009_20192,
  title = {Psychosoziale Aspekte der diabetischen Polyneuropathie},
  author = {Stark, S. and Hermanns, Norbert and Kulzer, Bernhard and Reinecker, Hans and Haak, Thomas},
  year = {2009},
  journal = {Verhaltenstherapie \& Verhaltensmedizin},
  volume = {30},
  number = {2},
  pages = {155-168},
  issn = {1865-9985},
  url = {https://fis.uni-bamberg.de/handle/uniba/20192},
  language = {deu}
}

@article{krille2008_40095,
  title = {Einflüsse von Psyche und Verhalten auf den Krankheitsverlauf (F54) bei Diabetes mellitus: Prävalenz und Screeningmethoden},
  author = {Krille, Stefanie and Kulzer, Bernhard and Reinecker, Hans and Haak, Thomas and Hermanns, Norbert},
  year = {2008},
  journal = {Verhaltenstherapie \& Verhaltensmedizin},
  volume = {29},
  number = {4},
  pages = {323-335},
  publisher = {Pabst Science Publ.},
  address = {Lengerich ; Berlin ; Düsseldorf ; Leipzig [u.a.]},
  issn = {1013-1973},
  url = {https://fis.uni-bamberg.de/handle/uniba/40095},
  language = {deu},
  abstract = {Fragestellung: Depressionen kommen bei Diabetikern häufig vor und beeinflussen den Verlauf des Diabetes negativ. Hinzu kommen subklinische psychische und Verhaltenseinflüsse, die sich ebenfalls nachteilig auswirken. Untersucht wurden Prävalenzen von Depressionen und psychischen und Verhaltenseinflüssen (ICD-10: F54) bei Diabetes mellitus sowie die Fähigkeit zweier Screeninginstrumente, diese zu identifizieren. Methodik: Die Screening-Performance des WHO-5 und PAID wurde an 253 Diabetikern mittels ROC-Analysen erhoben. Verum zur Prüfung der Screeningeigenschaften beider Fragebögen war die Einschätzung des psychischen Zustandes nach ICD-10. Ergebnisse: Bei 9.1 \% wurde eine depressive Erkrankung, bei 21.3 \% wurde eine F54 diagnostiziert. Der WHO-5 erreichte bezüglich der Identifikation depressiver Erkrankungen einen AUC-Wert von .807 sowie eine hohe Sensitivität. Der PAID erzielte bezüglich der Identifikation von F54 einen AUC-Wert von .703 und eine hohe Spezifität. Schlussfolgerungen: Die Prävalenz depressiver Erkrankungen und von F54 war hoch. Beide Instrumente können zur Identifikation dieser psychischen Faktoren bei Diabetes mellitus als Screeninginstrumente empfohlen werden.},
  keywords = {Diabetes, Depression, psychische Einflüsse (F54), Screening, ROC-Kurve}
}

@incollection{kubiak2008_20712,
  title = {PAID - Problem Areas in Diabetes},
  author = {Kubiak, T. and Hermanns, Norbert and Kulzer, Bernhard},
  year = {2008},
  booktitle = {Diagnostische Verfahren in der Rehabilitation},
  pages = {276-279},
  address = {Göttingen u. a.},
  url = {https://fis.uni-bamberg.de/handle/uniba/20712},
  language = {deu}
}

@incollection{kulzer2008_20693,
  title = {Diabetes bei Migranten},
  author = {Kulzer, Bernhard and Icks, Andrea and Razum, Oliver},
  year = {2008},
  booktitle = {Deutscher Gesundheitsbericht : Diabetes 2009},
  pages = {130-136},
  url = {https://fis.uni-bamberg.de/handle/uniba/20693},
  language = {deu}
}

@incollection{kulzer2008_20697,
  title = {Die Psychologische Dimension des Diabetes mellitus},
  author = {Kulzer, Bernhard},
  year = {2008},
  booktitle = {Deutscher Gesundheitsbericht : Diabetes 2009},
  pages = {35-42},
  url = {https://fis.uni-bamberg.de/handle/uniba/20697},
  language = {deu}
}

@article{kulzer2008_20665,
  title = {Blutdruck selbst messen. Serie "Gesundheits-Pass Diabetes" Teil 2},
  author = {Kulzer, Bernhard},
  year = {2008},
  journal = {Diabetes-Journal : aktiv gesund leben ; offizielles Organ des Deutschen Diabetiker-Bundes},
  volume = {57},
  number = {12},
  pages = {50-51},
  issn = {0341-8812},
  url = {https://fis.uni-bamberg.de/handle/uniba/20665},
  language = {deu}
}

@article{kulzer2008_20667,
  title = {Im neuen Look: der Gesundheits-Pass Diabetes. Serie "Gesundheits- Pass Diabetes" Teil 1},
  author = {Kulzer, Bernhard},
  year = {2008},
  journal = {Diabetes-Journal : aktiv gesund leben ; offizielles Organ des Deutschen Diabetiker-Bundes},
  volume = {57},
  number = {11},
  pages = {48-50},
  issn = {0341-8812},
  url = {https://fis.uni-bamberg.de/handle/uniba/20667},
  language = {deu}
}

@article{krille2008_20180,
  title = {Depression sowie psychische und Verhaltenseinflüsse auf den Krankheitsverlauf (F54) bei Diabetes Mellitus : Prävalenz und Screeningmethoden},
  author = {Krille, S. and Kulzer, Bernhard and Reinecker, Hans and Haak, Thomas and Hermanns, Norbert},
  year = {2008},
  journal = {Verhaltenstherapie \& Verhaltensmedizin},
  volume = {29},
  number = {4},
  pages = {323-335},
  issn = {1865-9985},
  url = {https://fis.uni-bamberg.de/handle/uniba/20180},
  language = {deu}
}

@article{kulzer2007_16395,
  title = {Effects of self-management training in Type 2 diabetes: a randomized, prospective trial},
  author = {Kulzer, Bernhard and Hermanns, Norbert and Reinecker, Hans and Haak, T.},
  year = {2007},
  journal = {Diabetic medicine},
  volume = {24},
  number = {4 April},
  pages = {415 - 423},
  issn = {0742-3071},
  url = {https://fis.uni-bamberg.de/handle/uniba/16395},
  language = {eng}
}

@article{maier2006_16352,
  title = {Prädiktoren einer erfolgreichen Gewichtsabnahme bei Typ 2 Diabetikern},
  author = {Maier, B. and Kulzer, Bernhard and Hermanns, Norbert and Reinecker, Hans and Haak, T.},
  year = {2006},
  journal = {Diabetologie und Stoffwechsel : offizielles Organ der Deutschen Diabetes Gesellschaft},
  volume = {1},
  number = {Suppl. 1},
  pages = {52},
  issn = {1861-9010},
  doi = {10.1055/s-2006-943819},
  url = {https://fis.uni-bamberg.de/handle/uniba/16352},
  language = {deu}
}

@article{kulzer2005_16389,
  title = {Welche Gründe geben Typ-2-Diabetiker für die Ablehnung einer Insulintherapie an?},
  author = {Kulzer, Bernhard and Scholze, Andrea and Hermanns, Norbert and Reinecker, Hans and Haak, T.},
  year = {2005},
  journal = {Diabetes und Stoffwechsel : Zeitschrift für angewandte Diabetologie},
  volume = {14},
  number = {Suppl. 1},
  pages = {180},
  issn = {0942-0037},
  url = {https://fis.uni-bamberg.de/handle/uniba/16389},
  language = {deu}
}

@article{reinecker2005_16349,
  title = {Effektivität von MEDIAS 2 (8-Stunden-Version)},
  author = {Reinecker, Hans and Maier, B. and Glückler, Ch. and Kulzer, Bernhard and Hermanns, Norbert and Reinecker, H. and Haak, T.},
  year = {2005},
  journal = {Diabetes und Stoffwechsel : Zeitschrift für angewandte Diabetologie},
  volume = {14},
  number = {Suppl. 1},
  pages = {170 - 171},
  issn = {0942-0037},
  url = {https://fis.uni-bamberg.de/handle/uniba/16349},
  language = {deu}
}

@article{kubiak2005_16347,
  title = {Erwartungen an die Insulinpumpentherapie: Entwicklung und erste empirische Überprüfung eines Fragebogeninstruments},
  author = {Kubiak, T. and Scholze, Andrea and Kulzer, Bernhard and Hermanns, Norbert and Reinecker, Hans and Haak, T.},
  year = {2005},
  journal = {Verhaltenstherapie : Praxis, Forschung, Perspektiven},
  volume = {15},
  number = {Suppl. 1, March, (IV, DGVM-Kongress)},
  pages = {23},
  issn = {1016-6262},
  url = {https://fis.uni-bamberg.de/handle/uniba/16347},
  language = {deu}
}

@article{kulzer2005_16351,
  title = {Wie ausgeprägt sind die Befürchtungen vor einer Insulintherapie?},
  author = {Kulzer, Bernhard and Hermanns, Norbert and Scholze, Andrea and Reinecker, Hans and Kubiak, T. and Haak, T.},
  year = {2005},
  journal = {Diabetes und Stoffwechsel : Zeitschrift für angewandte Diabetologie},
  volume = {14},
  number = {Suppl. 1},
  pages = {178},
  issn = {0942-0037},
  url = {https://fis.uni-bamberg.de/handle/uniba/16351},
  language = {deu}
}

@article{kulzer2005_16345,
  title = {Verlauf depressiver Symptome bei Typ II Diabetes mellitus},
  author = {Kulzer, Bernhard and Hermanns, Norbert and Reinecker, Hans and Kubiak, T. and Haak, T.},
  year = {2005},
  journal = {Verhaltenstherapie : Praxis, Forschung, Perspektiven},
  volume = {15},
  number = {Suppl. 1, March (IV, DGVM-Kongress)},
  pages = {24},
  issn = {1016-6262},
  url = {https://fis.uni-bamberg.de/handle/uniba/16345},
  language = {deu}
}

@article{hermanns2004_16348,
  title = {Verlauf depressiver Symptome bei Typ-2-Diabetes mellitus},
  author = {Hermanns, Norbert and Kulzer, Bernhard and Reinecker, Hans and Kubiak, Thomas and Haak, T.},
  year = {2004},
  journal = {Diabetes und Stoffwechsel : Zeitschrift für angewandte Diabetologie},
  volume = {13},
  number = {Suppl. 1},
  pages = {5},
  issn = {0942-0037},
  url = {https://fis.uni-bamberg.de/handle/uniba/16348},
  language = {deu}
}

@phdthesis{kulzer2004_46,
  title = {Verhaltensmedizin des Typ-2-Diabetes},
  author = {Kulzer, Bernhard},
  year = {2004},
  publisher = {opus},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-opus-430},
  url = {https://fis.uni-bamberg.de/handle/uniba/46},
  language = {deu},
  abstract = {In einer randomisierten, prospektiven Studie wurde untersucht, welche Form der Diabetesschulung für nicht insulinpflichtige Typ-2-Diabetiker im mittleren Lebensalter am effektivsten ist: (1) ein 12 stündiges Schulungsprogramm, das sich an den Prinzipien des Selbstmanagements orientiert (MEDIAS 2), (2) ein ebenfalls 12 stündiges Schulungsprogramm, das aus einer Kombination aus Gruppen- (6) und Einzelterminen (6) besteht (Kombination) und einem 4-stündigen, konventionellen Schulungsprogramm, das vor allem auf die Vermittlung von Wissen über die Erkrankung und die Therapiemaßnahmen abzielt (Standard). Die Hauptfragestellung bezog sich auf die Wirksamkeit der drei Schulungsprogramme auf die metabolischen Faktoren glykämische Kontrolle und Körpergewicht 1 Jahr nach Abschluss der Interventionen. Die weiteren abhängigen Variablen waren: physiologische Messparameter (z.B. Triglyceride), Verhaltensfaktoren (z.B. körperliche Aktivität), Prozessvariablen (z.B.Wissenstest), psychologisches Faktoren (z.B. Depression) und gesundheitsökonomische Variablen (z.B. Medikamentenkosten). 193 Typ-2-Diabetiker wurden randomsiert. Zu t1 gab es zwischen den drei Gruppen keine signifikanten Unterschiede in den Hauptvariablen. Entsprechend der intention to treat Auswertung konnten zum entscheidenden Katamnesezeitpunkt (1 Jahr nach Beendigung der Behandlungsgruppen) 176 Personen (Alter 55.8 ±6.2 Jahre; HbA1c 7.8 ± 1.6\%, BMI 32.2 ± 3.7 kg/m²) untersucht werden (dropout-rate 8,8\%). Die medikamentöse Diabetestherapie wurde in allen drei Gruppen nicht systematisch verändert und war vergleichbar. In Bezug auf die glykämische Kontrolle war MEDIAS 2 (ΔHbA1c -0.7 ±1.4\%) sowohl der Kombinationsgruppe (ΔHbA1c -0,2 ±1,6\%), als auch der Standardgruppe (ΔHbA1c 0.1 ±1.5\%) signifikant (p=.005) überlegen. Das Körpergewicht (ΔBMI -0.9 ±1.5 kg/m²) wurde ebenfalls im Vergleich zu der Standardgruppe (ΔBMI -0.4 ±1.6 kg/m²) und der Kombinationsgruppe (ΔBMI -0.9 ±1.5 kg/m²) signifikant (p=.025) reduziert. Die Verbesserungen waren nicht auf den Einfluss der medikamentösen Behandlung zurückzuführen. Insgesamt erreichte das an den Prinzipien des Selbstmanagement orientierte Gruppenprogramm die besten Effekte in Bezug auf die für nichtinsulinpflichtige Typ-2-Diabetiker im mittleren Lebensalter wichtigen metabolischen Faktoren glykämische Kontrolle und Übergewicht. Darüber hinaus zeigte MEDIAS 2 auch eine Reihe von positiven Effekten bezüglich der anderen physiologischen, psychologischen, behavioralen, prozessualen und sozioökonomischen Variablen. Der mehr individualisierte Ansatz (Kombination) erbrachte im Vergleich zu MEDIAS 2 keinen zusätzlichen Vorteil.},
  keywords = {Diabetes, Typ-2-Diabetes, Verhaltensmedizin, Diabetesschulung, Selbstmanagement, randomisierte Studie, type-2-diabetes, behavioral medicine, diabetes education, self-management, randomized study, Diabetes, Typ-2-Diabetes, Verhaltensmedizin, Diabetesschulung, Selbstmanagement, randomisierte Studie, type-2-diabetes, behavioral medicine, diabetes education, self-management, randomized study},
  school = {Otto-Friedrich-Universität Bamberg}
}

@phdthesis{kulzer2003_12028,
  title = {Verhaltensmedizin des Typ-2-Diabetes},
  author = {Kulzer, Bernhard},
  year = {2003},
  address = {Bamberg},
  url = {https://fis.uni-bamberg.de/handle/uniba/12028},
  language = {deu},
  school = {Otto-Friedrich-Universität Bamberg}
}

